data_2ofn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ofn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.212 0.53 . . . . 4.54 111.328 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.06 150.84 21.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.393 -0.821 . . . . 2.71 109.156 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -98.9 151.58 20.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.898 -0.408 . . . . 2.4399999999999999 109.898 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -101.42 104.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.545 -0.909 . . . . 1.3100000000000001 108.545 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.54 108.49 20.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.222 -0.899 . . . . 2.1600000000000001 110.825 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 84.1 mt 65.01 69.5 0.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 2.04 110.406 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -65.21 163.7 14.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.838 -0.619 . . . . 1.26 110.571 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.37 -3.74 29.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.672 0.619 . . . . 1.3700000000000001 112.672 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.524 ' HB3' HG13 ' A' ' 80' ' ' ILE . 29.1 t70 -90.55 14.76 12.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.361 0.601 . . . . 2.3999999999999999 110.946 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.03 19.46 2.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.323 -0.942 . . . . 0.83999999999999997 114.241 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 69.03 76.64 0.45 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.639 0.615 . . . . 0.62 114.639 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.519 ' HB ' HG22 ' A' ' 80' ' ' ILE . 96.9 t -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.85 -0.426 . . . . 1.1799999999999999 109.85 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 13.7 mm -91.86 116.02 32.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 O-C-N 123.385 0.428 . . . . 1.1799999999999999 110.594 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -135.12 146.46 48.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 1.96 111.263 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 m -108.56 131.91 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.691 . . . . 1.21 110.356 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -80.44 120.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.109 0.48 . . . . 1.3 111.188 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.38 -52.57 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 1.3999999999999999 110.632 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 39.5 ttmt -127.44 149.19 50.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.351 -0.611 . . . . 2.0600000000000001 109.351 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -115.15 140.83 48.75 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.134 0.271 . . . . 3.25 110.325 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.03 121.7 25.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.956 -0.64 . . . . 1.3200000000000001 112.009 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.05 -60.29 4.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.342 . . . . 2.77 111.511 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -160.96 141.01 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 2.6400000000000001 110.407 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.622 ' HA3' ' HB2' ' A' ' 32' ' ' ASN . . . 167.86 103.31 0.17 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.551 -0.833 . . . . 1.3 112.026 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.65 -41.62 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.598 0.714 . . . . 2.29 109.246 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -88.48 -10.4 49.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.521 -1.218 . . . . 2.6400000000000001 110.607 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.622 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.5 m-80 -84.86 75.52 10.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.989 -0.551 . . . . 1.49 111.036 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 31.8 mm -144.58 102.22 4.63 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.757 -0.656 . . . . 1.3700000000000001 110.262 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HG3' HD21 ' A' ' 122' ' ' LEU . 65.2 Cg_endo -71.81 111.33 3.12 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 123.329 2.686 . . . . 0.84999999999999998 112.181 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -116.87 166.47 12.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.624 0.726 . . . . 3.1400000000000001 112.189 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 1.011 ' HE3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -70.11 153.88 42.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.891 -1.05 . . . . 2.9100000000000001 111.736 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' H ' ' HB2' ' A' ' 70' ' ' GLU . . . 86.68 -5.11 85.53 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.365 -0.834 . . . . 1.1899999999999999 111.49 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -119.85 163.8 16.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.163 0.506 . . . . 1.3799999999999999 111.119 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -87.54 121.79 30.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 2.2000000000000002 110.769 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 17.8 m -132.73 156.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.217 -0.447 . . . . 1.3300000000000001 109.974 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 124' ' ' SER . 39.0 m -127.75 116.58 20.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.229 -0.442 . . . . 1.23 109.916 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.848 HG11 ' HA ' ' A' ' 122' ' ' LEU . 33.7 m -137.46 156.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.614 -0.266 . . . . 1.6200000000000001 111.088 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.73 142.71 45.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.956 -0.757 . . . . 3.5600000000000001 108.956 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -124.16 141.23 52.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.88 110.71 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -168.77 161.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 109.251 -0.648 . . . . 1.1899999999999999 109.251 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.22 -128.61 1.79 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.312 -0.947 . . . . 0.37 112.341 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 117' ' ' LEU . 18.6 pttm -156.69 173.16 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.929 0.395 . . . . 1.96 110.805 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.602 HD23 HG13 ' A' ' 110' ' ' ILE . 65.9 tp -91.15 98.29 11.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 1.1200000000000001 110.184 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HB2' HD11 ' A' ' 117' ' ' LEU . 35.7 tt0 -66.58 -21.15 66.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.846 0.355 . . . . 1.96 110.704 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.508 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 23.2 t -55.89 -29.97 60.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 1.1100000000000001 111.48 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 53' ' ' LYS . 9.6 t -138.04 1.31 2.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.868 0.366 . . . . 1.24 111.406 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.91 20.42 73.41 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.215 -0.517 . . . . 0.78000000000000003 112.869 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HB2' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -84.19 116.42 22.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.629 0.252 . . . . 3.2999999999999998 110.784 -178.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.566 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.2 p -70.57 150.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 1.3400000000000001 110.054 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 8.4 m-30 -74.92 124.52 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.971 0.415 . . . . 0.96999999999999997 111.425 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.63 85.25 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.504 0.669 . . . . 2.1800000000000002 110.674 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.401 ' HB3' ' OD1' ' A' ' 60' ' ' ASP . 46.8 t -126.53 166.59 17.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.656 -0.702 . . . . 1.6799999999999999 109.227 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -71.18 -22.05 62.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.897 0.38 . . . . 1.8600000000000001 111.082 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.565 ' O ' HG11 ' A' ' 63' ' ' VAL . 43.3 m-85 -95.02 -55.65 3.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.793 0.664 . . . . 2.1200000000000001 112.793 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 5.5 p-10 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.548 0.573 . . . . 2.1899999999999999 112.548 -167.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -1.94 55.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.842 0.353 . . . . 3.1899999999999999 111.278 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -116.29 -53.99 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 1.27 111.765 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 59' ' ' PHE . 13.0 p -87.09 127.27 59.99 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.441 0.638 . . . . 2.6099999999999999 111.858 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.18 90.48 1.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.586 2.191 . . . . 2.1299999999999999 111.027 173.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -94.39 132.61 38.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.148 -0.686 . . . . 1.6299999999999999 109.148 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -138.55 147.31 42.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.106 -0.497 . . . . 2.0099999999999998 110.206 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -115.47 178.35 4.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.68999999999999995 109.722 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -115.72 148.9 39.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.237 -1.023 . . . . 2.6600000000000001 108.237 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.614 ' HG ' ' HA ' ' A' ' 36' ' ' LYS . 18.3 tp -74.36 128.91 36.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.995 0.426 . . . . 1.5600000000000001 111.226 -175.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 1.011 ' HG3' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 58.93 64.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.879 -1.055 . . . . 2.0800000000000001 112.229 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 73' ' ' GLU . 10.0 pt20 -115.84 10.13 15.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.3 -1.318 . . . . 1.98 108.967 172.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.8 -18.7 41.89 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.78000000000000003 112.772 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' HE21 ' A' ' 71' ' ' GLN . 19.9 mm-40 -76.63 -32.92 58.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.178 0.513 . . . . 0.96999999999999997 110.791 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.78 129.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.813 -0.631 . . . . 1.25 109.725 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.656 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.93 -73.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.261 -0.427 . . . . 1.3500000000000001 111.592 -175.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.656 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -138.16 -44.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.022 -0.424 . . . . 2.5600000000000001 112.018 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 93' ' ' VAL . . . -54.5 -53.87 35.93 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.792 -0.718 . . . . 0.34000000000000002 113.101 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.596 ' O ' HG21 ' A' ' 82' ' ' VAL . 11.4 m-90 -75.78 -36.59 59.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.439 -0.448 . . . . 0.56000000000000005 110.266 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -51.41 -53.79 33.2 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.063 0.852 . . . . 1.1399999999999999 111.951 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 15' ' ' ASP . 1.6 mp -65.23 -38.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.829 0.347 . . . . 1.3999999999999999 111.164 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 85' ' ' MET . 23.6 t -66.86 -55.85 12.94 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.888 -0.325 . . . . 0.98999999999999999 110.616 -176.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 78' ' ' TRP . 29.9 m -71.76 -33.23 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.038 0.385 . . . . 1.49 112.038 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 t -78.05 0.83 23.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.264 0.555 . . . . 1.9399999999999999 110.734 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 t -131.69 20.48 4.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.687 . . . . 1.8700000000000001 109.843 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.801 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 2.1 mmt -90.81 -174.66 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 2.79 110.699 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 50.8 mtt85 -149.42 154.97 39.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.03 -1.1 . . . . 4.9199999999999999 108.03 172.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 62.2 tttm -65.27 -14.33 60.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.128 0.489 . . . . 2.4300000000000002 111.911 -173.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -124.06 25.08 8.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.96 0.41 . . . . 1.4199999999999999 110.185 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 32.3 tt0 -123.61 166.66 15.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.862 -0.608 . . . . 1.6000000000000001 110.363 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -158.8 133.72 8.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.715 0.293 . . . . 1.74 111.301 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.3 m -136.79 153.94 50.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.342 -0.39 . . . . 1.3600000000000001 110.738 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.463 ' HG ' ' HG2' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -101.21 121.46 41.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.35 -0.611 . . . . 2.2999999999999998 109.35 175.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 77' ' ' GLY . 12.6 p -106.44 145.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.453 -0.34 . . . . 1.46 110.896 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.521 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 41.5 mmt-85 -96.5 118.14 32.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.976 -0.557 . . . . 2.29 110.497 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.2 mp -96.43 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.227 -0.657 . . . . 1.2 109.227 175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.468 ' H ' ' HB2' ' A' ' 99' ' ' TYR . 42.1 tt0 -92.63 173.29 7.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.975 -1.012 . . . . 1.3700000000000001 108.898 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 17.1 p -51.42 -50.05 60.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.765 0.283 . . . . 1.22 111.765 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.6 ptm -77.55 -16.82 58.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.074 0.398 . . . . 2.3199999999999998 112.074 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.468 ' HB2' ' H ' ' A' ' 96' ' ' GLU . 21.7 m-30 -85.59 -17.17 37.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.177 -0.305 . . . . 0.92000000000000004 110.177 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.85 -154.22 9.25 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.488 -0.778 . . . . 0.85999999999999999 111.463 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 1.52 111.847 -178.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.509 ' HB2' HD11 ' A' ' 110' ' ' ILE . 11.4 p . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 111.753 0.279 . . . . 1.71 111.753 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.602 HG13 HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -144.43 84.27 9.36 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.617 0.722 . . . . 1.3700000000000001 110.861 177.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -95.15 90.9 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.029 2.486 . . . . 1.5800000000000001 112.272 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.95 47.66 1.0 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.079 -1.058 . . . . 2.0499999999999998 112.302 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 3.6 m-20 60.34 21.68 11.2 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.534 0.683 . . . . 2.2999999999999998 110.76 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.508 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 7.4 m -96.46 156.55 16.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 1.5700000000000001 109.852 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -87.03 121.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.404 0.621 . . . . 1.1799999999999999 110.766 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -114.57 157.27 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.601 -0.727 . . . . 1.25 110.159 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.589 HD13 ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -116.77 129.19 55.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 110.0 -0.37 . . . . 1.3500000000000001 110.0 175.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.46 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 21.1 m-85 -122.33 122.0 38.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.598 -0.274 . . . . 0.56000000000000005 110.351 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.463 ' HG2' ' HG ' ' A' ' 92' ' ' LEU . 42.7 mt-10 -75.25 114.52 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.191 -0.67 . . . . 1.46 109.191 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.498 HD12 ' HG ' ' A' ' 81' ' ' CYS . 65.4 mt -106.76 122.29 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.913 0.387 . . . . 1.1599999999999999 110.005 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.29 115.66 22.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 109.5 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.848 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -86.0 94.43 9.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 1.75 110.362 -176.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.608 ' H ' HD21 ' A' ' 123' ' ' LEU . 1.2 pt? -86.08 -28.65 23.94 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.018 -0.273 . . . . 1.78 111.16 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 t -141.05 144.82 35.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.044 0.45 . . . . 1.53 110.555 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 87' ' ' LYS . 6.1 p90 -164.47 168.16 18.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.931 -0.766 . . . . 0.90000000000000002 108.931 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -161.97 109.16 1.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 3.4700000000000002 111.339 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.541 -0.754 . . . . 3.3799999999999999 110.365 176.658 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.822 0.344 . . . . 4.54 110.466 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.28 150.07 49.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.038 0.447 . . . . 2.71 110.826 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HG3' HG23 ' A' ' 21' ' ' THR . 3.6 mppt? -91.6 144.4 25.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 2.4399999999999999 109.605 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 41.4 t -101.34 103.85 15.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 1.3100000000000001 108.427 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -103.45 113.75 27.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.129 -0.941 . . . . 2.1600000000000001 110.66 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.2 mt 60.67 54.65 3.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.962 0.789 . . . . 2.04 111.206 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -57.29 148.63 22.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.92 . . . . 1.26 110.607 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.43 1.3 4.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 1.3700000000000001 110.502 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 13' ' ' THR . 31.7 t70 -87.1 16.64 4.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 2.3999999999999999 110.908 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.18 5.04 8.98 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.396 -0.907 . . . . 0.83999999999999997 114.114 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.34 72.26 0.9 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.226 -0.512 . . . . 0.62 113.652 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.494 HG21 ' HB ' ' A' ' 80' ' ' ILE . 62.4 t -135.68 142.72 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.782 -0.451 . . . . 1.1799999999999999 109.782 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.5 mm -88.11 114.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.721 -0.474 . . . . 1.1799999999999999 109.721 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HE2' ' OG ' ' A' ' 84' ' ' SER . 12.1 pttp -142.4 138.51 31.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.314 0.578 . . . . 1.96 111.418 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 24.6 m -100.02 123.81 44.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 1.21 110.126 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.553 HG12 ' HE2' ' A' ' 25' ' ' LYS . 8.9 tp -80.42 132.76 31.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.997 0.427 . . . . 1.3 110.1 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.68 -51.06 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.049 -0.523 . . . . 1.3999999999999999 110.983 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 117.19 19.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.454 -0.339 . . . . 2.0600000000000001 110.392 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.556 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 58.0 mttm -101.91 160.63 14.32 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.148 -0.478 . . . . 3.25 110.312 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.42 -142.23 12.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.789 -0.719 . . . . 1.3200000000000001 111.919 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -76.0 0.56 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.961 0.41 . . . . 2.77 110.293 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.79 -178.58 3.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.136 -0.483 . . . . 2.6400000000000001 110.116 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 52.31 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.081 -0.807 . . . . 1.3 111.081 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.78 -40.64 93.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.983 0.42 . . . . 2.29 110.948 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.79 9.28 26.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.536 . . . . 2.6400000000000001 110.474 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -111.79 77.37 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 1.49 110.296 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 36.4 mm -132.87 120.69 16.57 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.398 -0.819 . . . . 1.3700000000000001 110.101 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HG3' HD23 ' A' ' 122' ' ' LEU . 85.7 Cg_endo -87.04 115.9 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.815 2.343 . . . . 0.84999999999999998 112.576 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HE2' ' CG2' ' A' ' 33' ' ' ILE . 71.3 mmtt -129.9 158.29 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 3.1400000000000001 111.444 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 12.1 ttmm -65.43 150.27 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.158 -0.928 . . . . 2.9100000000000001 111.365 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.2 -11.66 68.92 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.934 -0.867 . . . . 1.1899999999999999 110.934 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -105.05 155.71 18.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.517 . . . . 1.3799999999999999 110.878 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.25 104.25 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 2.2000000000000002 110.682 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 m -118.08 162.12 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 1.3300000000000001 110.655 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 31.5 m -133.45 120.91 21.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.797 -0.638 . . . . 1.23 109.611 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.68 148.79 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 1.6200000000000001 111.577 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.22 143.84 30.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.297 -0.631 . . . . 3.5600000000000001 109.297 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 30.6 p90 -141.97 137.02 30.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.88 110.505 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.55 160.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.125 -0.694 . . . . 1.1899999999999999 109.125 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.11 -118.88 0.68 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.539 -0.839 . . . . 0.37 112.597 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -149.94 171.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 1.96 110.111 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.473 HD11 ' HG ' ' A' ' 116' ' ' LEU . 57.0 tp -87.23 98.01 11.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.879 -0.6 . . . . 1.1200000000000001 109.533 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 4.9 tp10 -57.59 -35.09 69.94 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.46 0.541 . . . . 1.96 112.46 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -58.26 -20.06 39.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.372 0.508 . . . . 1.1100000000000001 112.372 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.4 t -134.05 -30.81 1.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.971 0.415 . . . . 1.24 110.773 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.26 15.84 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.254 -0.498 . . . . 0.78000000000000003 113.151 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -81.49 125.33 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.932 0.366 . . . . 3.2999999999999998 110.67 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.24 154.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 1.3400000000000001 110.03 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.483 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 22.0 m-30 -75.2 99.96 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.167 0.508 . . . . 0.96999999999999997 111.918 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -116.87 85.89 2.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.371 -0.974 . . . . 2.1800000000000002 108.371 168.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -135.33 158.06 45.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.62 -0.718 . . . . 1.6799999999999999 110.248 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -48.67 -42.08 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.769 0.668 . . . . 1.8600000000000001 112.496 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -93.88 -50.64 5.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.771 0.32 . . . . 2.1200000000000001 110.609 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.66 -37.87 59.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 2.1899999999999999 112.626 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -84.53 -4.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 3.1899999999999999 111.267 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.425 ' C ' HD21 ' A' ' 62' ' ' ASN . 0.2 OUTLIER -115.49 -61.44 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.939 -0.305 . . . . 1.27 110.569 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.19 109.61 6.96 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.32 -0.4 . . . . 2.6099999999999999 110.225 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.49 161.17 42.32 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.709 2.273 . . . . 2.1299999999999999 112.137 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -94.03 154.12 17.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.079 -0.509 . . . . 1.6299999999999999 110.279 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.8 pptp? -134.47 151.1 50.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 2.0099999999999998 110.263 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.68 -171.85 2.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.37 -0.377 . . . . 0.68999999999999995 110.989 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -116.72 149.2 40.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.289 -0.634 . . . . 2.6600000000000001 109.289 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 82' ' ' VAL . 9.8 tp -67.81 112.86 5.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 1.5600000000000001 111.89 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.97 73.11 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.334 -1.303 . . . . 2.0800000000000001 111.63 176.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -113.44 17.43 18.43 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.187 -1.042 . . . . 1.98 108.187 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.99 -18.28 55.99 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.585 -1.189 . . . . 0.78000000000000003 113.062 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.25 -14.54 28.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.956 0.378 . . . . 0.96999999999999997 111.446 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.15 121.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.643 0.735 . . . . 1.25 109.751 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.37 -62.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.08 -0.964 . . . . 1.3500000000000001 112.774 -172.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -125.92 -66.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.278 0.473 . . . . 2.5600000000000001 112.278 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.33 -52.6 35.82 Favored Glycine 0 C--N 1.333 0.384 0 O-C-N 123.56 0.538 . . . . 0.34000000000000002 113.59 -169.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.409 ' O ' HG21 ' A' ' 82' ' ' VAL . 5.9 m-90 -75.39 -46.44 32.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.769 0.318 . . . . 0.56000000000000005 110.393 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.36 -48.26 65.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.026 -0.988 . . . . 1.1399999999999999 112.251 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.494 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -73.89 -45.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.488 -0.324 . . . . 1.3999999999999999 110.894 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.484 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 53.1 t -63.56 -41.8 98.4 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.591 0.219 . . . . 0.98999999999999999 111.591 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 69' ' ' LEU . 34.4 m -67.66 -32.34 56.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.768 -0.373 . . . . 1.49 110.805 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.1 m -79.48 -4.0 49.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.946 0.403 . . . . 1.9399999999999999 111.169 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.418 ' OG ' ' HE2' ' A' ' 20' ' ' LYS . 9.7 p -124.01 39.32 3.99 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.227 0.537 . . . . 1.8700000000000001 111.096 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.568 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -116.13 174.57 5.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 2.79 110.488 176.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -127.51 163.36 24.31 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.36 -1.348 . . . . 4.9199999999999999 107.36 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -64.42 -17.55 63.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.238 0.542 . . . . 2.4300000000000002 110.846 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -122.81 16.73 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.069 -0.514 . . . . 1.4199999999999999 110.703 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HG3' ' HA ' ' A' ' 25' ' ' LYS . 33.6 tt0 -123.7 129.38 51.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 1.6000000000000001 110.642 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.465 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 85.4 tttt -136.58 143.75 43.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 1.74 109.894 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 21' ' ' THR . 28.8 p -149.79 165.26 33.0 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.001 0.429 . . . . 1.3600000000000001 111.733 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.97 120.65 32.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.291 -0.868 . . . . 2.2999999999999998 110.007 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.484 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.5 p -99.89 134.59 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.286 -0.415 . . . . 1.46 110.096 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.611 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 26.2 mmm-85 -96.1 111.38 23.43 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.463 -0.569 . . . . 2.29 109.463 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 118' ' ' PHE . 2.1 mp -91.44 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.019 -0.734 . . . . 1.2 109.019 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 97' ' ' SER . 43.7 tt0 -79.7 168.52 19.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.313 -0.858 . . . . 1.3700000000000001 109.449 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.413 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -48.16 -48.48 34.32 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.323 0.649 . . . . 1.22 111.463 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -78.56 -8.07 58.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.362 0.504 . . . . 2.3199999999999998 112.362 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -96.25 -12.86 23.95 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.237 -0.289 . . . . 0.92000000000000004 110.848 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 176.06 19.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.847 -0.692 . . . . 0.85999999999999999 112.36 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.916 0.388 . . . . 1.52 110.996 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.147 -0.686 . . . . 1.71 109.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -143.62 112.38 5.43 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.35 -0.387 . . . . 1.3700000000000001 110.095 175.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -83.06 -83.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.516 2.144 . . . . 1.5800000000000001 112.831 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.89 18.16 59.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.952 -0.36 . . . . 2.0499999999999998 113.694 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 52.65 35.39 18.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.006 0.431 . . . . 2.2999999999999998 111.181 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.3 m -107.77 179.49 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 1.5700000000000001 110.67 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.33 129.57 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.174 0.512 . . . . 1.1799999999999999 111.008 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.473 ' HG ' HD11 ' A' ' 48' ' ' LEU . 6.3 mp -127.21 174.82 8.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.297 -0.631 . . . . 1.25 109.297 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.611 ' HB3' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -147.01 133.04 19.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.29 0.567 . . . . 1.3500000000000001 110.578 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.483 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 43.6 m-85 -127.98 141.76 51.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.56000000000000005 110.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.3 mt-10 -76.26 127.15 32.32 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.062 -0.718 . . . . 1.46 109.062 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.7 mt -105.89 118.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.601 0.715 . . . . 1.1599999999999999 110.216 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -110.68 116.0 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.687 -1.142 . . . . 1.8799999999999999 110.458 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.447 HD23 ' HG3' ' A' ' 34' ' ' PRO . 30.3 tp -91.89 89.6 7.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 1.75 109.977 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.7 pt? -95.17 -33.32 12.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 1.78 111.042 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 13.8 m -135.12 128.18 31.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.024 -0.362 . . . . 1.53 110.024 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.25 171.16 11.01 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.559 -0.534 . . . . 0.90000000000000002 109.559 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -162.11 168.49 22.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.007 -0.368 . . . . 3.4700000000000002 110.007 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 108.139 -1.06 . . . . 3.3799999999999999 108.139 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.236 0.368 0 CA-C-O 121.271 0.558 . . . . 4.54 111.57 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -94.14 153.99 17.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.013 -0.994 . . . . 2.71 110.053 -175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 11.5 mptt -114.73 147.51 39.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.765 0.317 . . . . 2.4399999999999999 110.697 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.98 108.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.536 -0.542 . . . . 1.3100000000000001 109.536 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -89.45 125.06 35.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.237 0.542 . . . . 2.1600000000000001 111.421 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.432 ' H ' HD13 ' A' ' 19' ' ' ILE . 11.1 tp 54.76 64.38 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.953 -1.021 . . . . 2.04 111.027 174.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.549 HG21 HG23 ' A' ' 80' ' ' ILE . 9.0 t -59.16 156.03 12.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.636 -0.711 . . . . 1.26 111.61 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -19.86 64.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.743 -0.662 . . . . 1.3700000000000001 112.588 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.62 19.93 1.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.324 0.49 . . . . 2.3999999999999999 112.324 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.64 30.64 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.83999999999999997 114.429 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.85 83.6 0.06 OUTLIER Glycine 0 C--O 1.227 -0.334 0 N-CA-C 114.648 0.619 . . . . 0.62 114.648 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.0 t -141.21 140.1 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.38 -0.6 . . . . 1.1799999999999999 109.38 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 12' ' ' LEU . 10.0 mm -93.07 113.58 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.228 0.33 . . . . 1.1799999999999999 110.113 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -141.27 146.9 37.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.338 0.59 . . . . 1.96 111.616 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -109.68 138.65 45.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.106 -0.952 . . . . 1.21 110.113 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.84 132.3 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.234 -0.284 . . . . 1.3 110.234 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 92' ' ' LEU . 3.5 mm? -115.57 -51.58 2.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.456 -0.338 . . . . 1.3999999999999999 110.64 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 29.1 ttmt -122.9 135.07 54.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.726 -0.472 . . . . 2.0600000000000001 109.726 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -99.63 147.12 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 123.46 0.475 . . . . 3.25 110.785 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 171.4 52.15 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 116.028 -0.533 . . . . 1.3200000000000001 111.939 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.55 -65.92 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 2.77 110.768 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -151.7 153.05 33.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 2.6400000000000001 110.074 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.43 100.8 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.181 -1.009 . . . . 1.3 112.98 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -74.63 -42.33 58.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.574 . . . . 2.29 109.793 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -81.4 -23.31 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.377 -0.829 . . . . 2.6400000000000001 110.663 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.69 75.78 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.421 0.629 . . . . 1.49 109.611 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mm -146.4 118.78 4.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.735 -1.12 . . . . 1.3700000000000001 109.209 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.477 ' HG3' HD21 ' A' ' 122' ' ' LEU . 20.3 Cg_endo -60.78 124.73 15.57 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.799 2.333 . . . . 0.84999999999999998 111.716 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -116.37 149.54 39.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.601 -0.518 . . . . 3.1400000000000001 109.601 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.565 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -77.19 144.54 38.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.416 -0.514 . . . . 2.9100000000000001 110.633 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.34 -22.31 41.32 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.162 -0.775 . . . . 1.1899999999999999 111.162 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -99.33 169.96 8.98 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.079 -0.341 . . . . 1.3799999999999999 110.079 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.05 125.63 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.286 0.565 . . . . 2.2000000000000002 111.324 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 125' ' ' PHE . 19.0 m -135.12 160.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.598 -0.728 . . . . 1.3300000000000001 109.235 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 28.6 m -130.51 111.85 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.407 -0.59 . . . . 1.23 109.407 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.26 153.34 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 1.6200000000000001 111.751 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -116.18 130.25 56.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 3.5600000000000001 109.022 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 21.8 p90 -127.23 144.3 51.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.788 0.327 . . . . 0.88 110.143 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -167.82 158.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.892 -0.781 . . . . 1.1899999999999999 108.892 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.67 -130.35 1.98 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.841 -1.171 . . . . 0.37 113.05 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HG3' HD13 ' A' ' 117' ' ' LEU . 57.2 pttt -157.38 173.07 17.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.377 . . . . 1.96 110.682 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 66.7 tp -94.53 109.34 21.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 1.1200000000000001 110.28 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.517 ' HB2' HD12 ' A' ' 117' ' ' LEU . 24.2 tt0 -68.43 -20.69 64.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.204 0.526 . . . . 1.96 110.091 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.442 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 39.7 t -55.1 -43.27 73.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.154 -0.93 . . . . 1.1100000000000001 111.328 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.429 HG22 HD23 ' A' ' 48' ' ' LEU . 8.8 t -124.38 3.31 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 1.24 111.41 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.35 78.51 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 120.902 -0.666 . . . . 0.78000000000000003 113.039 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 67.0 mmtt -91.82 132.92 36.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 3.2999999999999998 110.917 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.649 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.8 p -75.84 166.84 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 1.3400000000000001 109.95 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.96 117.99 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.431 0.634 . . . . 0.96999999999999997 110.582 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.72 95.01 2.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.113 -0.949 . . . . 2.1800000000000002 109.42 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 m -137.4 171.2 14.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.933 0.397 . . . . 1.6799999999999999 110.337 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -70.41 -33.7 71.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.15 -0.477 . . . . 1.8600000000000001 110.9 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -92.33 -35.93 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.541 0.571 . . . . 2.1200000000000001 112.541 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -33.77 74.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.819 0.342 . . . . 2.1899999999999999 111.544 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.71 -12.15 51.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.051 0.453 . . . . 3.1899999999999999 110.941 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.81 HD21 HG21 ' A' ' 63' ' ' VAL . 6.9 t30 -112.24 -61.04 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.129 -0.487 . . . . 1.27 111.815 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.81 HG21 HD21 ' A' ' 62' ' ' ASN . 96.9 t -119.25 104.09 46.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.598 -0.274 . . . . 2.6099999999999999 110.289 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.42 147.83 47.44 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.086 2.524 . . . . 2.1299999999999999 112.035 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -101.99 150.39 23.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.295 -0.411 . . . . 1.6299999999999999 109.929 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.09 146.35 31.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 2.0099999999999998 109.792 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -127.59 -177.32 4.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.895 0.379 . . . . 0.68999999999999995 111.278 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -118.51 149.81 40.67 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.363 -0.606 . . . . 2.6600000000000001 109.363 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.625 HD12 HG21 ' A' ' 82' ' ' VAL . 15.9 tp -75.87 117.08 17.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.026 0.38 . . . . 1.5600000000000001 112.026 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 68.26 48.79 0.87 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.187 -0.915 . . . . 2.0800000000000001 112.395 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 1.3 pm0 -92.33 0.67 57.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.096 -0.705 . . . . 1.98 109.096 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.37 1.38 44.09 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.78000000000000003 113.091 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 7.9 mm-40 -99.04 -24.27 14.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.412 0.606 . . . . 0.96999999999999997 111.255 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.8 123.64 57.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 1.25 110.923 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.531 HD12 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -97.17 -62.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 1.3500000000000001 112.293 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.611 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 8.7 mmpt? -129.2 -61.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 2.5600000000000001 112.494 -172.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 -53.21 34.38 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.065 -0.588 . . . . 0.34000000000000002 113.459 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.563 ' O ' HG23 ' A' ' 82' ' ' VAL . 10.0 m-90 -75.24 -37.12 61.17 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.841 -0.211 . . . . 0.56000000000000005 110.644 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.75 -52.09 57.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.826 0.703 . . . . 1.1399999999999999 111.685 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.549 HG23 HG21 ' A' ' 13' ' ' THR . 2.4 mp -74.26 -41.89 50.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 1.3999999999999999 110.995 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.501 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 44.6 t -60.33 -51.03 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.98999999999999999 111.589 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.759 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 28.6 m -67.69 -43.1 86.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 111.975 0.361 . . . . 1.49 111.975 -174.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.418 ' OG ' HD22 ' A' ' 69' ' ' LEU . 21.6 m -70.16 -14.92 62.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.028 0.442 . . . . 1.9399999999999999 111.463 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -99.46 24.95 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.367 -0.379 . . . . 1.8700000000000001 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.759 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 37.2 mtm -118.83 -173.58 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.215 0.531 . . . . 2.79 111.214 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 53.5 mtm180 -142.2 175.46 9.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.155 -0.93 . . . . 4.9199999999999999 109.271 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -62.31 -16.88 56.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.563 0.579 . . . . 2.4300000000000002 112.563 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -135.32 29.4 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 1.4199999999999999 110.747 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 4.5 tt0 -113.91 153.95 28.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.527 -0.546 . . . . 1.6000000000000001 109.527 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 1.5 tmtp? -143.58 127.49 17.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.972 -0.291 . . . . 1.74 110.955 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 71.2 m -127.61 151.45 48.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.222 -0.445 . . . . 1.3600000000000001 111.425 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -107.29 118.96 38.1 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.151 -0.685 . . . . 2.2999999999999998 109.151 173.01 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.501 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.2 p -109.7 141.89 23.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.243 0.544 . . . . 1.46 111.43 -173.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -99.29 117.44 33.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 2.29 109.88 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.9 mp -96.92 104.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.462 . . . . 1.2 109.751 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 97' ' ' SER . 28.9 tt0 -83.76 170.87 13.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.787 -0.82 . . . . 1.3700000000000001 108.787 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.402 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 9.5 p -49.6 -49.9 44.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.526 0.33 . . . . 1.22 111.85 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.9 ptp -76.61 -13.5 60.06 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.236 -0.438 . . . . 2.3199999999999998 111.635 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 16.1 m-30 -84.54 -5.84 59.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.871 0.367 . . . . 0.92000000000000004 110.149 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.531 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -138.39 -161.2 8.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.55 -0.75 . . . . 0.85999999999999999 111.52 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 1.52 110.975 179.615 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.673 -0.491 . . . . 1.71 109.673 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.467 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -143.21 117.0 6.13 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 1.3700000000000001 110.452 176.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -80.56 -68.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.015 1.81 . . . . 1.5800000000000001 111.717 170.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.87 1.25 17.2 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.176 -0.466 . . . . 2.0499999999999998 113.409 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 m120 60.88 27.71 17.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.192 0.52 . . . . 2.2999999999999998 110.917 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -119.7 -163.69 1.01 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.896 -0.593 . . . . 1.5700000000000001 110.307 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 7.6 p -108.17 130.05 61.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.309 0.576 . . . . 1.1799999999999999 111.775 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -112.94 161.89 16.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 1.25 109.79 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.715 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.28 116.82 28.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.494 -0.558 . . . . 1.3500000000000001 109.494 175.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.418 ' HD2' HD12 ' A' ' 95' ' ' ILE . 29.4 m-85 -113.87 125.0 53.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 0.56000000000000005 111.045 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 47.9 mt-10 -80.13 113.96 18.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.463 -0.789 . . . . 1.46 109.081 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.605 HG23 HG13 ' A' ' 82' ' ' VAL . 40.0 mt -107.93 123.94 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.028 0.442 . . . . 1.1599999999999999 110.352 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.515 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 18.3 mt-10 -127.87 130.33 48.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.646 -0.706 . . . . 1.8799999999999999 109.875 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.664 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 25.6 tp -91.82 100.4 13.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 1.75 110.341 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.74 -30.2 18.19 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.824 -0.351 . . . . 1.78 111.082 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 58.0 m -150.41 147.76 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 1.53 111.436 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.523 ' HB2' HG13 ' A' ' 40' ' ' VAL . 2.0 p90 -165.05 159.62 18.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.90000000000000002 109.352 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -158.63 113.72 2.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.95 0.405 . . . . 3.4700000000000002 111.352 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.363 -0.38 . . . . 3.3799999999999999 110.758 175.818 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.267 0.556 . . . . 4.54 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.85 143.07 42.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 2.71 110.447 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.18 136.27 47.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 2.4399999999999999 109.84 -174.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.6 107.65 23.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.601 -0.518 . . . . 1.3100000000000001 109.601 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.417 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -102.58 134.95 45.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.138 -0.483 . . . . 2.1600000000000001 111.462 -176.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt 56.64 51.74 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.248 -0.887 . . . . 2.04 112.493 171.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -61.29 153.65 25.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.275 -0.42 . . . . 1.26 110.117 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.9 1.07 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.688 0.625 . . . . 1.3700000000000001 112.688 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.64 24.81 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 2.3999999999999999 111.264 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.47 10.42 5.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.378 -0.915 . . . . 0.83999999999999997 114.011 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 57.75 67.14 2.36 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.892 0.717 . . . . 0.62 114.892 170.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' HB ' ' A' ' 80' ' ' ILE . 25.6 t -116.83 139.21 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 122.285 -0.538 . . . . 1.1799999999999999 110.58 173.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 94' ' ' ARG . 5.6 mm -88.18 109.34 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.214 -0.661 . . . . 1.1799999999999999 109.214 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -125.66 146.23 49.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.393 0.616 . . . . 1.96 111.222 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 m -114.07 121.43 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.419 -0.81 . . . . 1.21 109.603 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 tp -72.43 125.96 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.883 0.373 . . . . 1.3 111.565 -174.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.03 -63.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.17 0.509 . . . . 1.3999999999999999 109.954 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 50.7 mtmt -117.6 134.9 54.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 2.0600000000000001 108.981 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -102.99 139.46 38.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.754 0.311 . . . . 3.25 110.985 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 134.26 12.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.77 -0.729 . . . . 1.3200000000000001 111.718 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.9 -65.32 1.02 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.827 -0.435 . . . . 2.77 109.827 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -96.0 144.17 26.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.0 -0.545 . . . . 2.6400000000000001 109.548 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -154.34 14.54 0.55 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.547 -0.835 . . . . 1.3 111.852 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.21 -21.05 62.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 2.29 110.406 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.486 ' C ' HD21 ' A' ' 32' ' ' ASN . 47.4 mt-10 -115.18 14.49 16.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.773 -0.649 . . . . 2.6400000000000001 109.927 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.533 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -138.78 80.86 1.81 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.083 -0.508 . . . . 1.49 111.4 -172.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.82 113.03 27.0 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.223 0.535 . . . . 1.3700000000000001 111.923 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.2 Cg_endo -91.04 111.08 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.963 2.442 . . . . 0.84999999999999998 112.384 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' C ' HD23 ' A' ' 69' ' ' LEU . 27.9 mmtp -136.64 -173.68 3.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 3.1400000000000001 110.951 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.36 152.94 20.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 2.9100000000000001 110.726 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.27 -5.19 38.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.744 . . . . 1.1899999999999999 111.904 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' OD1' HG12 ' A' ' 40' ' ' VAL . 31.4 p30 -135.24 -175.77 4.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.74 0.305 . . . . 1.3799999999999999 110.513 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -96.99 94.21 7.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 2.2000000000000002 110.743 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG12 ' OD1' ' A' ' 38' ' ' ASN . 9.6 m -97.85 122.22 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.903 -0.777 . . . . 1.3300000000000001 108.903 168.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.516 HG21 ' HD3' ' A' ' 66' ' ' LYS . 27.0 m -96.72 111.42 23.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.198 0.523 . . . . 1.23 109.96 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.456 ' CG1' HG21 ' A' ' 120' ' ' ILE . 54.1 t -117.24 130.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.499 -0.773 . . . . 1.6200000000000001 110.329 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -101.79 127.96 48.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.204 -0.665 . . . . 3.5600000000000001 109.204 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 6.6 p90 -128.23 144.5 51.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 0.88 111.105 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -166.38 144.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.557 -0.747 . . . . 1.1899999999999999 109.841 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 118' ' ' PHE . . . -171.02 -139.91 2.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.613 -0.803 . . . . 0.37 112.135 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 64.7 pttt -157.69 172.3 18.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 1.96 110.886 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 114' ' ' SER . 60.7 tp -85.55 101.15 12.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.046 -0.525 . . . . 1.1200000000000001 110.539 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 40.8 tt0 -68.42 -25.87 65.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.771 0.319 . . . . 1.96 110.935 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -54.38 -27.1 34.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 1.1100000000000001 111.543 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 53' ' ' LYS . 14.8 t -139.18 9.05 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.051 0.453 . . . . 1.24 110.482 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.13 41.59 98.18 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.635 -0.711 . . . . 0.78000000000000003 112.755 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.557 ' HB2' HG22 ' A' ' 51' ' ' THR . 4.3 tmtt? -102.83 118.34 36.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 3.2999999999999998 110.29 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.7 p -74.1 160.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 1.3400000000000001 109.856 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 13.0 m-30 -78.0 124.58 28.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.129 0.49 . . . . 0.96999999999999997 111.083 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.95 88.27 2.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.854 0.835 . . . . 2.1800000000000002 109.306 171.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.8 m -136.48 172.97 12.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.596 -0.729 . . . . 1.6799999999999999 111.19 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -71.6 -23.83 61.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.79 -0.641 . . . . 1.8600000000000001 110.865 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -93.83 -51.1 5.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.147 0.795 . . . . 2.1200000000000001 113.147 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.8 -43.23 85.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.335 0.397 . . . . 2.1899999999999999 111.996 -168.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -92.22 9.34 34.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.928 0.394 . . . . 3.1899999999999999 111.602 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -115.7 -64.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.283 -0.417 . . . . 1.27 111.597 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.8 m -105.01 127.56 28.48 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.384 0.611 . . . . 2.6099999999999999 111.997 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.5 Cg_endo -83.44 111.29 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.956 2.437 . . . . 2.1299999999999999 111.511 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -94.72 154.57 17.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 1.6299999999999999 110.888 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HD3' HG21 ' A' ' 41' ' ' THR . 1.7 pptp? -142.44 157.48 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.942 -0.572 . . . . 2.0099999999999998 110.01 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.09 172.65 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.68999999999999995 110.912 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -122.47 150.3 42.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.813 -0.63 . . . . 2.6600000000000001 109.641 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.492 HD21 HG23 ' A' ' 82' ' ' VAL . 35.2 tp -71.38 136.29 47.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.792 0.33 . . . . 1.5600000000000001 111.528 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 51.69 37.72 20.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.57 -0.741 . . . . 2.0800000000000001 112.205 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 73' ' ' GLU . 13.8 pt20 -77.49 -8.28 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.359 0.599 . . . . 1.98 109.597 169.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.21 46.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.78000000000000003 112.845 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB2' HE21 ' A' ' 71' ' ' GLN . 10.1 mm-40 -84.0 -21.92 31.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.883 0.342 . . . . 0.96999999999999997 110.754 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 m -113.61 135.11 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 1.25 110.379 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.465 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -96.02 -61.29 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.083 0.772 . . . . 1.3500000000000001 113.083 -172.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.721 ' HZ2' HD13 ' A' ' 80' ' ' ILE . 5.3 mmpt? -143.18 -44.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.957 0.725 . . . . 2.5600000000000001 112.957 -171.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.03 -53.0 36.14 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.651 -0.785 . . . . 0.34000000000000002 112.684 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.435 ' O ' HG21 ' A' ' 82' ' ' VAL . 4.2 m-90 -75.94 -30.94 58.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.853 0.359 . . . . 0.56000000000000005 110.501 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.24 -54.3 32.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.169 -0.923 . . . . 1.1399999999999999 112.148 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.721 HD13 ' HZ2' ' A' ' 76' ' ' LYS . 2.8 mp -75.38 -42.31 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 1.3999999999999999 110.985 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 85' ' ' MET . 20.7 t -56.99 -47.34 81.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.98999999999999999 111.182 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.492 HG23 HD21 ' A' ' 69' ' ' LEU . 27.1 m -72.91 -32.21 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 123.0 0.188 . . . . 1.49 110.979 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 66.2 m -65.79 -23.3 66.68 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.436 0.636 . . . . 1.9399999999999999 110.869 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -112.25 46.4 1.17 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 1.8700000000000001 110.455 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.765 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.6 mmt -125.41 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.281 0.562 . . . . 2.79 111.226 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.98 ' HD3' ' H ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -155.25 160.69 41.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.056 -1.09 . . . . 4.9199999999999999 108.056 174.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -46.97 -38.27 10.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.461 0.541 . . . . 2.4300000000000002 112.461 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.98 ' H ' ' HD3' ' A' ' 86' ' ' ARG . 16.5 m120 -109.54 6.24 23.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 1.4199999999999999 111.122 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 30.6 tt0 -105.38 140.85 37.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.161 -0.681 . . . . 1.6000000000000001 109.161 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.5 tttt -146.93 135.92 22.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.266 -0.424 . . . . 1.74 110.728 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 22' ' ' ILE . 83.9 m -136.06 159.19 42.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.234 0.54 . . . . 1.3600000000000001 110.825 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 117' ' ' LEU . 1.8 tp -91.34 142.18 27.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.25 -1.018 . . . . 2.2999999999999998 108.25 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.97 135.48 52.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 O-C-N 123.366 0.416 . . . . 1.46 110.36 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.433 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -107.28 111.86 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.638 -0.505 . . . . 2.29 109.638 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -96.4 107.1 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.898 -0.408 . . . . 1.2 109.898 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.612 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 9.7 tt0 -85.43 177.41 7.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.107 -0.701 . . . . 1.3700000000000001 109.107 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -57.32 -37.29 72.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.893 0.331 . . . . 1.22 111.893 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.4 ptp -77.62 -9.73 59.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.182 0.438 . . . . 2.3199999999999998 112.182 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.612 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.7 m-85 -103.62 6.33 37.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.017 -0.273 . . . . 0.92000000000000004 111.037 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.71 174.92 16.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.952 -0.642 . . . . 0.85999999999999999 112.468 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.941 0.401 . . . . 1.52 111.183 177.4 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 111.33 0.122 . . . . 1.71 111.33 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -148.23 104.16 3.56 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 1.3700000000000001 111.225 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -97.42 179.89 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.076 2.517 . . . . 1.5800000000000001 112.274 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.61 66.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.267 -0.968 . . . . 2.0499999999999998 113.187 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 m120 55.48 23.84 6.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.954 0.406 . . . . 2.2999999999999998 111.835 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.547 ' HB3' HD12 ' A' ' 48' ' ' LEU . 30.1 m -110.03 150.71 28.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.942 -0.572 . . . . 1.5700000000000001 110.003 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.17 130.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 1.1799999999999999 110.206 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.6 mp -123.34 151.45 42.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.063 -0.517 . . . . 1.25 110.411 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.51 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -128.22 125.54 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.497 . . . . 1.3500000000000001 110.926 177.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.414 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 46.1 m-85 -126.14 153.22 44.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.745 -0.661 . . . . 0.56000000000000005 110.221 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.539 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 42.7 mt-10 -85.46 126.88 34.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.279 -0.638 . . . . 1.46 109.279 170.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.456 HG21 ' CG1' ' A' ' 42' ' ' VAL . 10.6 mt -108.58 118.18 55.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 1.1599999999999999 109.865 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.472 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 45.2 tt0 -132.96 132.29 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 1.8799999999999999 110.24 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.21 115.7 28.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 1.75 110.678 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.31 -21.4 13.84 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.757 -0.377 . . . . 1.78 112.016 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.51 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 29.3 t -155.63 149.61 25.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.003 -0.279 . . . . 1.53 110.393 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -168.19 172.66 8.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 0.90000000000000002 110.036 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -161.04 126.38 3.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 3.4700000000000002 110.177 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 3.3799999999999999 111.536 -173.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.39 . . . . 4.54 110.887 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.39 157.07 17.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.51 0.672 . . . . 2.71 110.609 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -103.0 148.26 25.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.789 -1.096 . . . . 2.4399999999999999 111.052 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.41 106.92 20.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 1.3100000000000001 109.495 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 7.4 pt-20 -78.85 113.35 16.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.803 -0.635 . . . . 2.1600000000000001 111.542 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 19' ' ' ILE . 17.2 tp 58.25 65.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 2.04 111.215 169.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 t -61.73 144.9 53.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 1.26 110.076 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 0.72 7.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.95 0.352 . . . . 1.3700000000000001 111.95 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.48 25.73 1.01 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.532 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.09 2.64 9.16 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.83999999999999997 113.92 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.47 78.28 0.61 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.072 -0.585 . . . . 0.62 114.169 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 80' ' ' ILE . 53.7 t -140.78 143.82 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.935 -0.394 . . . . 1.1799999999999999 109.935 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 17.9 mm -86.27 116.31 28.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.595 -0.52 . . . . 1.1799999999999999 109.595 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -138.19 144.34 40.64 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.507 -0.477 . . . . 1.96 111.464 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 6.8 m -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.916 -0.583 . . . . 1.21 109.864 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.5 tp -84.82 118.91 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 1.3 110.585 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.18 -70.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 1.3999999999999999 110.605 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 36.9 ttpt -109.7 116.33 31.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.519 -0.31 . . . . 2.0600000000000001 110.531 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.55 137.62 42.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.033 -0.531 . . . . 3.25 110.171 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.44 162.35 54.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.735 -0.745 . . . . 1.3200000000000001 112.309 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.76 -68.26 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 2.77 110.74 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.37 132.61 15.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.095 0.474 . . . . 2.6400000000000001 109.781 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.08 33.33 0.94 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.498 -0.858 . . . . 1.3 111.492 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.26 -28.93 70.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.24 0.543 . . . . 2.29 110.402 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -94.88 -4.75 46.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.332 -0.849 . . . . 2.6400000000000001 110.381 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -138.81 91.46 2.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.051 0.453 . . . . 1.49 111.259 -173.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.09 123.98 28.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 1.3700000000000001 110.776 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 43.0 Cg_endo -69.96 92.54 0.53 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.644 2.229 . . . . 0.84999999999999998 111.807 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 53.5 mmtt -94.7 146.53 24.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.365 0.602 . . . . 3.1400000000000001 112.261 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.526 ' HZ2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -71.99 124.54 25.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.933 -1.031 . . . . 2.9100000000000001 110.0 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.89 -9.24 43.49 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.422 -0.671 . . . . 1.1899999999999999 111.422 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -101.09 154.65 18.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.343 . . . . 1.3799999999999999 110.219 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -79.3 106.21 11.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.329 0.585 . . . . 2.2000000000000002 111.123 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 68' ' ' HIS . 3.1 m -121.68 152.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.843 -0.799 . . . . 1.3300000000000001 108.843 174.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.2 m -117.75 119.42 34.86 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.651 -0.5 . . . . 1.23 109.651 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 120' ' ' ILE . 90.3 t -131.82 144.06 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.999 -0.546 . . . . 1.6200000000000001 110.764 -174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.457 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 24.5 m80 -99.96 145.29 28.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.044 -0.354 . . . . 3.5600000000000001 110.044 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 29.2 p90 -143.06 130.63 21.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.055 0.455 . . . . 0.88 110.934 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.57 159.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.224 -0.658 . . . . 1.1899999999999999 109.224 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.41 -121.0 0.7 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.041 -1.076 . . . . 0.37 112.751 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 50.1 pttt -150.9 168.06 25.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.666 0.27 . . . . 1.96 110.505 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 HD11 ' HG ' ' A' ' 116' ' ' LEU . 57.3 tp -85.02 98.37 10.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.031 -0.729 . . . . 1.1200000000000001 109.031 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 50.0 tp10 -62.55 -26.94 68.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 1.96 112.381 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 t -63.17 -18.56 63.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 1.1100000000000001 111.279 -177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -129.63 -26.12 2.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.034 0.445 . . . . 1.24 110.767 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.44 35.64 10.4 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.369 -0.443 . . . . 0.78000000000000003 112.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.38 128.86 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.715 0.293 . . . . 3.2999999999999998 110.362 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.446 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.8 p -71.77 158.35 6.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 1.3400000000000001 109.78 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.412 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 21.7 m-85 -73.93 98.49 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.315 0.579 . . . . 0.96999999999999997 111.784 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.72 86.15 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.13 -1.063 . . . . 2.1800000000000002 108.13 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -136.54 164.47 28.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.811 -0.631 . . . . 1.6799999999999999 110.571 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -57.97 -45.76 86.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 1.8600000000000001 112.046 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -93.32 -45.45 7.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.012 0.434 . . . . 2.1200000000000001 110.943 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -34.49 58.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.122 -0.944 . . . . 2.1899999999999999 111.655 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -77.52 -22.88 50.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 3.1899999999999999 111.801 -174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -100.66 -52.79 3.24 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.818 -0.353 . . . . 1.27 110.942 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.26 108.77 6.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.996 0.427 . . . . 2.6099999999999999 111.698 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.7 153.34 56.61 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.553 2.169 . . . . 2.1299999999999999 110.547 173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -93.47 149.14 21.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.007 0.432 . . . . 1.6299999999999999 110.515 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 3.0 pptp? -123.12 142.67 50.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.794 -0.639 . . . . 2.0099999999999998 109.587 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CZ ' HG12 ' A' ' 82' ' ' VAL . 42.5 p90 -128.86 171.42 12.3 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.985 0.421 . . . . 0.68999999999999995 110.999 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 98.0 m-70 -112.22 145.94 39.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.464 -0.789 . . . . 2.6600000000000001 109.113 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 36' ' ' LYS . 16.6 tp -72.62 120.42 18.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.315 0.579 . . . . 1.5600000000000001 110.371 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.526 ' HG2' ' HZ2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 66.56 54.59 0.86 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.447 -1.251 . . . . 2.0800000000000001 111.077 -176.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 73' ' ' GLU . 12.2 pt20 -96.07 10.01 38.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 1.98 109.414 169.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.07 -12.18 62.93 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.422 -0.808 . . . . 0.78000000000000003 112.801 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.402 ' HB2' HE21 ' A' ' 71' ' ' GLN . 13.3 mm-40 -96.18 -10.16 28.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.712 0.291 . . . . 0.96999999999999997 111.279 -174.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.07 125.11 67.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.006 0.431 . . . . 1.25 110.713 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.541 HG12 ' N ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -95.78 -59.13 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.921 0.711 . . . . 1.3500000000000001 112.921 -173.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 75' ' ' ILE . 6.6 mmpt? -140.0 -61.06 0.53 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.094 -0.378 . . . . 2.5600000000000001 111.401 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.42 -52.79 35.12 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.953 -0.567 . . . . 0.34000000000000002 113.656 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.541 ' O ' HG21 ' A' ' 82' ' ' VAL . 10.6 m-90 -74.98 -44.78 46.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.975 0.387 . . . . 0.56000000000000005 110.738 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -51.61 -51.83 52.48 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.039 0.837 . . . . 1.1399999999999999 111.933 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.479 ' HB ' HG22 ' A' ' 18' ' ' VAL . 2.1 mp -75.05 -38.64 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 1.3999999999999999 110.972 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.693 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 34.3 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.98999999999999999 110.68 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 78' ' ' TRP . 34.7 m -67.74 -32.64 57.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 1.49 110.738 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.0 t -62.38 -32.73 73.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.9399999999999999 110.886 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.7 t -96.09 31.18 2.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.141 -0.481 . . . . 1.8700000000000001 110.627 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.795 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 2.0 mmt -110.42 -173.33 2.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.386 0.613 . . . . 2.79 111.609 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 6.4 ttm180 -139.76 168.46 19.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.878 -1.156 . . . . 4.9199999999999999 107.878 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.0 -35.18 70.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.338 . . . . 2.4300000000000002 111.392 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -122.2 31.98 5.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 1.4199999999999999 110.862 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 23.6 tt0 -122.36 143.98 49.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.308 -0.405 . . . . 1.6000000000000001 110.452 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.87 137.9 35.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.716 0.293 . . . . 1.74 110.529 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 21' ' ' THR . 27.5 p -141.22 171.37 14.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 1.3600000000000001 111.194 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.09 123.05 49.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.68 . . . . 2.2999999999999998 109.533 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.693 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.0 p -99.92 137.48 27.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.255 0.55 . . . . 1.46 110.8 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.518 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 55.2 mmt-85 -91.11 112.38 24.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.633 -0.712 . . . . 2.29 110.086 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.458 HD12 HG12 ' A' ' 93' ' ' VAL . 2.9 mp -93.7 100.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.368 -0.604 . . . . 1.2 109.368 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 97' ' ' SER . 29.6 tt0 -81.05 170.25 16.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.484 -0.932 . . . . 1.3700000000000001 108.484 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.404 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 8.7 p -51.4 -44.13 62.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.767 0.284 . . . . 1.22 111.767 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.6 ptp -77.56 -8.43 57.81 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.128 0.418 . . . . 2.3199999999999998 112.128 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -103.88 -11.86 17.24 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 122.267 -0.271 . . . . 0.92000000000000004 110.941 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.06 164.61 17.12 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.734 -0.746 . . . . 0.85999999999999999 113.24 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.528 0 N-CA-C 109.995 -0.372 . . . . 1.52 109.995 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.429 0.157 . . . . 1.71 110.666 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.03 83.66 4.22 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-O 120.814 0.34 . . . . 1.3700000000000001 111.844 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -98.54 -160.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.228 2.618 . . . . 1.5800000000000001 111.457 171.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.38 91.48 2.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 2.0499999999999998 113.189 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.4 m120 56.66 27.13 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 2.2999999999999998 111.738 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.7 p -133.93 171.04 14.72 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.633 -0.258 . . . . 1.5700000000000001 110.875 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.24 133.43 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.198 0.523 . . . . 1.1799999999999999 110.348 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.6 mp -122.38 169.6 10.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 1.25 109.699 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.587 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -147.42 133.8 19.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.061 0.457 . . . . 1.3500000000000001 110.596 172.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.412 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 39.9 m-85 -122.41 142.29 50.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.89 -0.595 . . . . 0.56000000000000005 109.616 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 32.5 mt-10 -74.18 122.97 23.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.724 -0.843 . . . . 1.46 108.724 171.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.486 HG22 HG11 ' A' ' 42' ' ' VAL . 8.1 mt -105.95 115.42 47.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.422 0.63 . . . . 1.1599999999999999 109.739 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.08 116.59 17.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.098 -0.955 . . . . 1.8799999999999999 110.284 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 123' ' ' LEU . 6.8 tt -87.12 133.71 33.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 1.75 109.219 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 122' ' ' LEU . 1.1 pt? -117.1 -43.96 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.78 111.786 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.9 t -140.78 140.87 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.783 -0.451 . . . . 1.53 109.783 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.564 ' HB2' HG13 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -167.04 177.57 6.21 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.174 0.297 . . . . 0.90000000000000002 110.6 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -157.49 150.72 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 3.4700000000000002 111.051 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 C--N 1.329 -0.32 0 N-CA-C 109.582 -0.525 . . . . 3.3799999999999999 109.582 174.332 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 109.607 -0.516 . . . . 4.54 109.607 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.34 148.83 29.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.11 0.481 . . . . 2.71 110.878 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.7 mppt? -91.96 143.17 26.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 2.4399999999999999 110.283 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG11 ' HB ' ' A' ' 13' ' ' THR . 5.1 t -108.94 108.55 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 110.054 -0.35 . . . . 1.3100000000000001 110.054 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.81 128.92 43.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.1600000000000001 110.974 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' H ' HD11 ' A' ' 19' ' ' ILE . 13.5 tp 55.76 46.26 22.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.689 0.757 . . . . 2.04 110.113 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.572 ' HB ' HG11 ' A' ' 10' ' ' VAL . 8.5 t -63.84 164.04 10.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.868 -1.06 . . . . 1.26 111.532 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.66 1.37 8.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 1.3700000000000001 111.253 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 80' ' ' ILE . 25.9 m-20 -80.65 14.19 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 2.3999999999999999 111.054 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.27 9.39 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.52 -0.847 . . . . 0.83999999999999997 113.598 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.25 64.07 1.81 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.803 -0.713 . . . . 0.62 114.045 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.529 ' HB ' HG21 ' A' ' 80' ' ' ILE . 3.3 t -145.35 154.23 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.894 -0.41 . . . . 1.1799999999999999 109.894 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.411 HD11 ' H ' ' A' ' 12' ' ' LEU . 4.7 mm -85.24 109.65 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.243 -0.28 . . . . 1.1799999999999999 110.243 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.532 ' HE3' HG22 ' A' ' 13' ' ' THR . 21.6 pttp -132.61 142.65 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.96 111.181 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -110.8 140.87 44.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.476 -0.784 . . . . 1.21 110.246 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.512 ' C ' HD22 ' A' ' 23' ' ' LEU . 7.6 tp -86.44 130.3 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.422 -0.354 . . . . 1.3 110.369 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.512 HD22 ' C ' ' A' ' 22' ' ' ILE . 3.5 mm? -132.72 -69.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.455 0.645 . . . . 1.3999999999999999 110.515 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 80.7 tttt -91.5 97.66 11.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.41 -0.814 . . . . 2.0600000000000001 109.53 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -73.74 127.29 32.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.068 -0.969 . . . . 3.25 110.21 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.7 -148.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.09 -0.505 . . . . 1.3200000000000001 113.33 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.5 -167.84 2.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.463 -0.94 . . . . 2.77 108.463 -172.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -85.46 127.3 34.35 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.739 -0.467 . . . . 2.6400000000000001 109.739 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -168.39 75.37 0.12 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.108 -0.797 . . . . 1.3 111.108 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.44 -32.99 69.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.749 0.278 . . . . 2.29 111.749 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.72 0.38 56.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.272 0.558 . . . . 2.6400000000000001 110.579 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.5 79.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 1.49 110.877 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.8 mm -131.37 122.04 18.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 1.3700000000000001 110.909 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.55 126.56 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.689 2.259 . . . . 0.84999999999999998 112.023 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 27.1 mmtp -132.92 161.92 32.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.905 0.383 . . . . 3.1400000000000001 110.77 177.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -71.77 150.21 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.969 -0.559 . . . . 2.9100000000000001 111.882 -172.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.43 -23.03 29.69 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.722 -0.672 . . . . 1.1899999999999999 111.799 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.66 153.41 21.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.003 0.43 . . . . 1.3799999999999999 110.968 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.649 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 51.0 mt-10 -79.0 95.39 5.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.016 -0.538 . . . . 2.2000000000000002 110.481 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 125' ' ' PHE . 19.9 m -102.87 151.08 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.6 -0.519 . . . . 1.3300000000000001 109.6 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -111.95 106.51 15.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.167 -0.679 . . . . 1.23 109.167 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -126.33 138.99 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 1.6200000000000001 110.863 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 22.3 m-70 -104.16 142.91 33.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.521 -0.548 . . . . 3.5600000000000001 109.521 172.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.5 p90 -137.15 139.52 41.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 0.88 110.021 175.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.11 154.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 1.1899999999999999 109.146 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 179.77 -134.6 2.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.878 -1.153 . . . . 0.37 112.98 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -151.68 171.33 17.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.032 0.444 . . . . 1.96 110.671 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.62 HD12 ' HB3' ' A' ' 114' ' ' SER . 61.3 tp -85.58 107.38 17.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.621 . . . . 1.1200000000000001 109.758 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' HD12 ' A' ' 117' ' ' LEU . 3.6 tp10 -68.05 -31.19 70.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.031 0.443 . . . . 1.96 110.81 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 t -54.3 -43.04 70.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.342 -0.844 . . . . 1.1100000000000001 112.05 -173.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.472 HG23 HD23 ' A' ' 48' ' ' LEU . 15.4 t -119.96 -10.97 9.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 1.24 110.604 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 56.12 3.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.892 -0.671 . . . . 0.78000000000000003 111.648 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -125.03 130.02 51.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.175 -0.305 . . . . 3.2999999999999998 110.175 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.2 156.87 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.114 -0.328 . . . . 1.3400000000000001 110.114 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -74.6 99.33 3.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.386 . . . . 0.96999999999999997 111.763 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.83 91.84 3.82 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.485 -0.932 . . . . 2.1800000000000002 108.485 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 28.7 t -137.59 148.3 45.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.46 -0.791 . . . . 1.6799999999999999 109.985 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -53.8 -42.49 68.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.312 0.486 . . . . 1.8600000000000001 112.312 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -84.84 -46.15 11.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 2.1200000000000001 110.692 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -36.82 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 2.1899999999999999 111.629 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 57' ' ' SER . 14.8 ptm180 -81.56 4.11 22.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.697 0.284 . . . . 3.1899999999999999 111.542 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' ND2' HG13 ' A' ' 63' ' ' VAL . 14.3 t30 -121.29 -60.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.645 -0.252 . . . . 1.27 110.702 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG13 ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -133.32 133.7 23.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.692 0.282 . . . . 2.6099999999999999 111.598 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.0 Cg_exo -77.3 163.35 30.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.838 2.359 . . . . 2.1299999999999999 111.869 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -103.87 154.74 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.427 -0.351 . . . . 1.6299999999999999 110.302 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -137.49 151.36 48.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 2.0099999999999998 109.649 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -136.42 -175.55 4.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.756 0.313 . . . . 0.68999999999999995 110.819 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -121.03 150.05 41.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 2.6600000000000001 109.991 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -58.14 121.67 11.25 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.752 0.657 . . . . 1.5600000000000001 111.348 -174.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER 55.29 45.95 24.58 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.589 0.556 . . . . 2.0800000000000001 111.806 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.538 ' NE2' ' HB2' ' A' ' 73' ' ' GLU . 6.7 pm0 -78.96 -4.3 49.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.094 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.15 -9.13 50.02 Favored Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.78000000000000003 113.161 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 15.9 mm-40 -95.57 -17.08 21.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.96999999999999997 110.724 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.14 132.74 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.74 0.305 . . . . 1.25 110.695 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.476 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.5 -68.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.373 0.508 . . . . 1.3500000000000001 112.373 -178.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 5.6 mtpp -140.94 -41.26 0.4 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.449 0.537 . . . . 2.5600000000000001 112.449 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 93' ' ' VAL . . . -53.02 -46.73 61.08 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.34000000000000002 112.56 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.493 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.9 m-90 -76.13 -36.89 58.61 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.922 -0.163 . . . . 0.56000000000000005 111.127 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.62 ' OD2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -63.42 -40.43 97.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.033 0.383 . . . . 1.1399999999999999 112.033 -169.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.529 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -64.35 -39.45 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.013 0.435 . . . . 1.3999999999999999 110.631 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -72.3 -51.28 21.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.406 -0.361 . . . . 0.98999999999999999 110.891 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.0 m -64.63 -33.89 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.254 0.465 . . . . 1.49 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 t -80.19 -0.84 37.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.018 0.437 . . . . 1.9399999999999999 110.769 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 t -119.88 14.41 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.18 -0.464 . . . . 1.8700000000000001 110.387 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.868 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 4.0 mmt -98.95 179.18 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 2.79 110.809 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' NH1' ' HA3' ' A' ' 29' ' ' GLY . 22.3 ttp85 -143.6 174.05 11.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.133 -1.062 . . . . 4.9199999999999999 108.133 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 60.3 tttm -67.7 -6.09 19.1 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.8 0.334 . . . . 2.4300000000000002 111.832 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -141.56 21.2 2.19 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.581 0.229 . . . . 1.4199999999999999 110.594 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.5 tt0 -118.76 148.64 42.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.512 -0.313 . . . . 1.6000000000000001 110.66 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 24' ' ' LYS . 75.2 tttt -149.06 138.66 21.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 1.74 110.794 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.412 ' SG ' ' HE2' ' A' ' 85' ' ' MET . 87.5 m -134.02 164.33 27.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.44 -0.345 . . . . 1.3600000000000001 111.142 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.493 ' CD2' ' HG2' ' A' ' 119' ' ' GLU . 63.6 mt -100.53 111.62 23.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.037 -0.529 . . . . 2.2999999999999998 109.605 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 77' ' ' GLY . 7.1 p -100.98 135.95 34.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 1.46 109.994 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mmm-85 -100.45 111.43 23.69 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.115 -0.698 . . . . 2.29 109.115 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.425 HD11 HG12 ' A' ' 93' ' ' VAL . 3.2 mp -92.21 103.62 14.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.127 0.489 . . . . 1.2 109.833 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.537 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 32.5 tt0 -82.41 173.44 12.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.321 -0.854 . . . . 1.3700000000000001 109.02 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.535 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.6 p -51.54 -41.31 60.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.631 0.372 . . . . 1.22 111.898 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.0 ptm -77.21 -15.7 59.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 2.3199999999999998 111.771 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.7 m-30 -91.2 -13.96 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.92000000000000004 110.885 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.55 -172.54 15.54 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.348 -0.701 . . . . 0.85999999999999999 111.348 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 1.52 111.209 178.395 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.226 0.06 . . . . 1.71 111.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.43 HG12 HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -146.13 100.2 4.22 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 121.143 0.496 . . . . 1.3700000000000001 111.285 177.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -90.29 -166.33 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.874 2.383 . . . . 1.5800000000000001 111.856 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.82 -139.5 13.49 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.553 -0.832 . . . . 2.0499999999999998 112.748 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.4 m120 -93.42 6.11 49.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.124 0.488 . . . . 2.2999999999999998 110.349 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.62 ' HB3' HD12 ' A' ' 48' ' ' LEU . 47.1 m -94.44 146.95 23.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.74 -0.664 . . . . 1.5700000000000001 111.349 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 49' ' ' GLU . 7.2 p -95.02 138.82 19.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.2 -0.455 . . . . 1.1799999999999999 110.286 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.499 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.4 mp -126.36 174.27 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 1.25 110.622 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -132.78 124.4 28.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.157 -0.683 . . . . 1.3500000000000001 109.157 176.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -116.13 126.6 53.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.56000000000000005 110.546 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.588 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 37.8 mt-10 -81.18 107.66 14.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 1.46 109.504 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' HIS . 58.4 mt -107.85 124.46 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.061 -0.256 . . . . 1.1599999999999999 110.9 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 90' ' ' LYS . 34.3 mt-10 -121.5 131.02 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 1.8799999999999999 110.308 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 42' ' ' VAL . 6.9 tt -100.26 101.85 12.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 1.75 109.576 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -96.69 -16.23 21.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.904 0.335 . . . . 1.78 111.904 -175.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.5 m -153.19 150.76 29.37 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.454 -0.202 . . . . 1.53 110.454 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.496 ' HB3' HD21 ' A' ' 122' ' ' LEU . 1.5 p90 -164.85 178.74 6.96 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.963 -0.384 . . . . 0.90000000000000002 109.963 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.649 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.9 ptp180 -162.17 167.84 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.617 0.573 . . . . 3.4700000000000002 109.547 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.318 0 O-C-N 123.201 0.313 . . . . 3.3799999999999999 110.265 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 110.224 -0.287 . . . . 4.54 110.224 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -89.44 156.08 18.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.444 -0.576 . . . . 2.71 109.444 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.28 153.85 24.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.405 -0.361 . . . . 2.4399999999999999 110.8 -171.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.38 104.83 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 1.3100000000000001 109.029 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.87 120.29 30.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 2.1600000000000001 110.612 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt 58.67 64.72 1.38 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.569 0.7 . . . . 2.04 110.727 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.505 HG22 ' HE2' ' A' ' 20' ' ' LYS . 9.2 t -65.79 160.84 22.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.936 -1.029 . . . . 1.26 111.115 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.33 -5.22 21.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.093 0.405 . . . . 1.3700000000000001 112.093 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -71.05 -0.36 9.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.407 -0.36 . . . . 2.3999999999999999 111.268 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.98 24.79 2.2 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.79 -0.719 . . . . 0.83999999999999997 113.321 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.14 72.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.011 -0.614 . . . . 0.62 113.576 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 80' ' ' ILE . 12.2 t -138.84 146.11 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.856 -0.424 . . . . 1.1799999999999999 109.856 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.0 mm -87.08 110.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.013 -0.365 . . . . 1.1799999999999999 110.013 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HE2' HG22 ' A' ' 13' ' ' THR . 58.3 pttt -125.27 145.53 49.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 1.96 111.096 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -126.01 120.49 30.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 1.21 109.8 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 25' ' ' LYS . 10.0 tp -76.01 145.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.386 . . . . 1.3 110.734 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.39 -34.85 2.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.431 -0.35 . . . . 1.3999999999999999 111.173 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 38.8 ttpt -150.78 118.32 6.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.637 -0.505 . . . . 2.0600000000000001 109.637 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HG3' HG12 ' A' ' 22' ' ' ILE . 88.8 mttt -101.0 154.28 18.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.188 0.518 . . . . 3.25 112.021 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.89 164.75 16.07 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 111.683 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.65 -95.12 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.045 0.422 . . . . 2.77 111.133 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -91.48 145.38 24.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.944 0.402 . . . . 2.6400000000000001 110.845 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 162.51 64.57 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.787 -0.642 . . . . 1.3 111.615 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.23 -35.0 72.86 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.072 0.463 . . . . 2.29 111.011 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -104.25 26.34 8.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 2.6400000000000001 111.539 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.48 74.9 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.753 -0.462 . . . . 1.49 109.753 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' HG2' ' A' ' 35' ' ' LYS . 27.6 mm -136.68 108.92 9.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 1.3700000000000001 110.829 -177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.6 Cg_endo -71.46 88.24 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.643 2.229 . . . . 0.84999999999999998 112.067 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HG2' HG23 ' A' ' 33' ' ' ILE . 29.7 mmtp -97.7 159.41 14.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.533 0.682 . . . . 3.1400000000000001 111.876 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HA ' HD22 ' A' ' 69' ' ' LEU . 8.8 ttmm -67.88 150.29 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.683 -1.144 . . . . 2.9100000000000001 111.531 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.68 -26.13 22.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.192 -0.528 . . . . 1.1899999999999999 112.119 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.13 158.45 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.698 0.285 . . . . 1.3799999999999999 110.726 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.76 97.75 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.19 0.519 . . . . 2.2000000000000002 111.721 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 125' ' ' PHE . 29.9 m -96.86 143.81 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.065 -0.717 . . . . 1.3300000000000001 109.065 170.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 20.1 m -111.62 113.63 26.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.877 0.37 . . . . 1.23 110.755 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -131.6 160.8 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.073 -0.512 . . . . 1.6200000000000001 111.599 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -117.18 153.99 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 3.5600000000000001 109.254 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -137.69 143.56 41.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.44 -0.345 . . . . 0.88 110.233 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.89 160.79 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.878 -0.786 . . . . 1.1899999999999999 108.878 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 167.08 -136.55 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.351 -0.928 . . . . 0.37 112.38 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.62 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 60.6 pttt -158.45 171.97 19.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.653 0.263 . . . . 1.96 110.995 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -88.86 105.25 17.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 1.1200000000000001 110.403 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.61 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 32.7 tt0 -64.04 -27.39 69.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.36 -0.382 . . . . 1.96 111.249 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.458 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.7 t -54.76 -40.59 69.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.894 -0.594 . . . . 1.1100000000000001 111.545 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.422 HG22 HD21 ' A' ' 48' ' ' LEU . 10.1 t -120.01 -12.47 9.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.583 0.23 . . . . 1.24 111.597 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.42 10.75 73.26 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.75 -0.738 . . . . 0.78000000000000003 112.896 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 33.7 mmtp -88.39 132.03 34.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.871 0.367 . . . . 3.2999999999999998 111.163 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.62 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.3 p -81.65 160.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.472 -0.786 . . . . 1.3400000000000001 109.963 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -74.53 114.56 13.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.021 0.439 . . . . 0.96999999999999997 111.249 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -129.03 91.23 3.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.145 -0.687 . . . . 2.1800000000000002 109.145 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -123.95 -173.55 2.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 1.6799999999999999 109.87 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.1 m -72.9 -47.3 47.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.772 0.32 . . . . 1.8600000000000001 111.49 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -95.15 -39.11 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.739 1.015 . . . . 2.1200000000000001 113.739 -171.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.28 -42.84 87.41 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.977 0.362 . . . . 2.1899999999999999 111.977 -168.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.75 11.28 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.39 0.614 . . . . 3.1899999999999999 111.277 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -106.08 -50.15 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 1.27 109.047 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.4 p -149.4 121.82 4.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 2.6099999999999999 110.223 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 10.5 Cg_exo -70.82 154.65 63.42 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.819 2.346 . . . . 2.1299999999999999 112.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -93.94 153.88 17.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.998 -0.546 . . . . 1.6299999999999999 109.717 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -125.99 161.39 27.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.352 -0.61 . . . . 2.0099999999999998 109.352 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.65 175.35 13.35 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.518 -0.473 . . . . 0.68999999999999995 111.489 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 75.1 m-70 -118.37 150.55 39.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.836 . . . . 2.6600000000000001 109.769 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.572 HD12 ' CG2' ' A' ' 82' ' ' VAL . 14.5 tp -66.13 127.43 32.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.366 -0.379 . . . . 1.5600000000000001 111.871 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 50.56 37.58 16.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.193 0.997 . . . . 2.0800000000000001 111.467 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 13.9 tt0 -72.11 -6.07 39.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.865 -1.516 . . . . 1.98 111.192 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.98 56.19 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 111.661 -0.576 . . . . 0.78000000000000003 111.661 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.19 -18.35 25.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.449 0.642 . . . . 0.96999999999999997 109.759 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.6 125.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.372 -0.831 . . . . 1.25 109.578 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.513 HG12 ' N ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -95.94 -58.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.7 1.0 . . . . 1.3500000000000001 113.7 -172.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.513 ' N ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.95 -50.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.79 -0.568 . . . . 2.5600000000000001 112.295 -169.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.13 -52.43 40.17 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.791 -0.719 . . . . 0.34000000000000002 112.707 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.451 ' O ' HG21 ' A' ' 82' ' ' VAL . 12.0 m-90 -75.94 -33.94 59.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.618 0.247 . . . . 0.56000000000000005 110.698 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' A' ' 69' ' ' LEU . 10.4 t70 -53.04 -51.69 60.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.703 -0.681 . . . . 1.1399999999999999 111.428 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.8 mp -65.83 -48.37 82.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.09 -0.505 . . . . 1.3999999999999999 110.75 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 120' ' ' ILE . 28.7 t -60.55 -48.24 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.98999999999999999 111.625 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.832 HG11 HG22 ' A' ' 120' ' ' ILE . 32.0 m -70.12 -33.23 54.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.962 -0.295 . . . . 1.49 111.295 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 32.6 t -79.17 0.25 29.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 1.9399999999999999 110.882 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -110.38 10.6 23.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.285 -0.416 . . . . 1.8700000000000001 111.19 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.655 ' HE1' ' HA ' ' A' ' 82' ' ' VAL . 47.9 mtm -102.3 -173.42 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.797 0.808 . . . . 2.79 112.054 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -140.9 -177.44 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.439 -1.255 . . . . 4.9199999999999999 108.5 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -67.06 -23.44 65.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 2.4300000000000002 111.273 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -126.68 17.93 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 1.4199999999999999 111.219 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 25.8 tt0 -112.2 131.85 55.24 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.695 -0.483 . . . . 1.6000000000000001 109.695 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 12.8 tmtt? -134.93 134.97 41.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.518 -0.765 . . . . 1.74 109.868 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.413 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.7 p -137.57 172.82 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.258 -0.428 . . . . 1.3600000000000001 110.683 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 93' ' ' VAL . 3.2 tt -119.43 140.27 50.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.281 -1.007 . . . . 2.2999999999999998 108.281 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 95' ' ' ILE . 6.1 p -121.39 141.57 41.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 120.958 0.409 . . . . 1.46 110.903 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -98.89 111.65 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.156 -0.683 . . . . 2.29 109.156 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 93' ' ' VAL . 3.2 mp -93.4 109.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.378 . . . . 1.2 110.187 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -84.81 166.04 17.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.579 -0.897 . . . . 1.3700000000000001 108.579 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.4 p -51.01 -40.68 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.29 0.369 . . . . 1.22 111.956 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.5 ptp -77.19 -16.27 59.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.33 -0.395 . . . . 2.3199999999999998 111.993 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -92.67 -16.27 25.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.945 0.402 . . . . 0.92000000000000004 110.432 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -115.24 -160.15 12.56 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.103 -0.799 . . . . 0.85999999999999999 111.103 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 120.722 0.296 . . . . 1.52 111.012 178.43 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.511 0.196 . . . . 1.71 110.581 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.444 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.02 103.45 4.43 Favored Pre-proline 0 N--CA 1.465 0.277 0 N-CA-C 109.879 -0.415 . . . . 1.3700000000000001 109.879 176.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.21 -74.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.346 2.031 . . . . 1.5800000000000001 112.846 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.78 -134.78 44.0 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.805 -0.712 . . . . 2.0499999999999998 112.224 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -133.67 21.39 3.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.466 -0.568 . . . . 2.2999999999999998 109.466 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 22.4 m -105.77 179.19 4.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.76 -0.655 . . . . 1.5700000000000001 111.196 -173.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -97.53 138.57 22.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.128 0.489 . . . . 1.1799999999999999 111.006 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.4 mp -120.41 166.78 13.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.371 -0.377 . . . . 1.25 110.907 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 5.4 mt -116.14 110.21 18.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 1.3500000000000001 109.662 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.64 124.51 48.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.793 0.33 . . . . 0.56000000000000005 110.625 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -92.1 126.25 37.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.304 -0.628 . . . . 1.46 109.304 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.832 HG22 HG11 ' A' ' 82' ' ' VAL . 76.0 mt -120.06 131.62 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.471 -0.331 . . . . 1.1599999999999999 110.979 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -136.25 143.66 44.4 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.103 -0.499 . . . . 1.8799999999999999 110.447 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.53 ' HA ' HG13 ' A' ' 42' ' ' VAL . 24.7 tp -90.94 118.77 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 1.75 110.72 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.36 -27.89 10.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 1.78 111.239 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 39.9 m -151.69 149.8 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.374 . . . . 1.53 109.989 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' A' ' 40' ' ' VAL . 4.0 p90 -165.5 158.5 15.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.808 0.337 . . . . 0.90000000000000002 111.123 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -125.39 123.44 39.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.103 -0.498 . . . . 3.4700000000000002 110.052 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 3.3799999999999999 109.927 171.668 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.989 0.423 . . . . 4.54 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.1 137.77 45.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.529 -0.759 . . . . 2.71 111.262 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -100.39 128.78 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.307 -0.627 . . . . 2.4399999999999999 109.307 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 23.2 t -102.29 105.1 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.11 0.481 . . . . 1.3100000000000001 110.372 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.1 103.9 16.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.607 -0.724 . . . . 2.1600000000000001 110.663 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.6 tp 62.24 76.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.255 -0.884 . . . . 2.04 110.863 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.459 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -80.92 159.82 24.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.731 -0.668 . . . . 1.26 110.928 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.87 -5.09 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.29 0.567 . . . . 1.3700000000000001 111.023 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.523 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.9 t70 -78.17 30.3 0.18 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 2.3999999999999999 111.645 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' HA3' HG13 ' A' ' 80' ' ' ILE . . . 121.91 -26.17 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.754 -0.736 . . . . 0.83999999999999997 112.735 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.05 60.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.394 -0.908 . . . . 0.62 113.372 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 12.2 t -140.09 152.17 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.965 -0.383 . . . . 1.1799999999999999 109.965 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.4 mm -85.75 120.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.505 0.322 . . . . 1.1799999999999999 110.257 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 84' ' ' SER . 51.7 pttt -142.73 147.09 35.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.177 0.513 . . . . 1.96 111.461 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.38 135.29 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.509 -0.769 . . . . 1.21 109.891 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.4 112.97 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.102 0.477 . . . . 1.3 110.624 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 -52.83 3.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 1.3999999999999999 110.813 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -115.93 151.97 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.331 -0.618 . . . . 2.0600000000000001 109.331 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.89 110.97 19.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.823 -0.436 . . . . 3.25 109.823 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.87 163.18 10.46 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.535 -0.757 . . . . 1.3200000000000001 112.821 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 28' ' ' GLU . 12.5 t70 -104.96 -149.22 0.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.554 -0.536 . . . . 2.77 109.554 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 42.4 tt0 -59.27 125.1 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.15 0.5 . . . . 2.6400000000000001 110.793 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.85 52.37 0.24 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 111.215 -0.754 . . . . 1.3 111.215 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.91 -33.87 73.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.5 . . . . 2.29 110.619 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -98.46 18.3 16.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.583 -0.735 . . . . 2.6400000000000001 110.091 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -126.41 76.74 1.64 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.911 -0.586 . . . . 1.49 109.94 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 38.4 mm -129.14 119.98 19.95 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.398 0.618 . . . . 1.3700000000000001 111.886 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -87.05 100.75 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.148 3.232 . . . . 0.84999999999999998 112.186 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.569 ' HE2' ' HB3' ' A' ' 83' ' ' SER . 28.1 mmtp -135.95 178.44 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.15 0.5 . . . . 3.1400000000000001 112.264 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.53 139.51 57.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.145 -0.934 . . . . 2.9100000000000001 111.511 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.51 56.42 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.265 -0.734 . . . . 1.1899999999999999 111.265 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 45.6 m-20 -113.87 161.92 17.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.388 . . . . 1.3799999999999999 110.154 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.562 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 25.7 mt-10 -94.57 103.92 15.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.176 -0.465 . . . . 2.2000000000000002 110.613 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.86 132.2 49.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.63 -0.507 . . . . 1.3300000000000001 109.63 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -108.39 109.83 21.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.581 -0.526 . . . . 1.23 109.581 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.498 ' CG1' HD11 ' A' ' 122' ' ' LEU . 15.8 m -124.04 140.49 47.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.692 -0.685 . . . . 1.6200000000000001 111.009 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -105.6 140.7 38.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.676 -0.693 . . . . 3.5600000000000001 109.482 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -123.73 142.67 50.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.107 -0.331 . . . . 0.88 110.107 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 p -167.08 148.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.237 -0.653 . . . . 1.1899999999999999 109.237 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.6 1.77 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.127 -0.789 . . . . 0.37 111.127 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 63.7 pttt -157.8 171.39 20.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 1.96 111.499 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.853 ' HA ' HD22 ' A' ' 116' ' ' LEU . 63.8 tp -81.75 98.17 8.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.814 -0.63 . . . . 1.1200000000000001 110.253 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.608 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 33.6 tt0 -60.17 -27.75 67.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.756 0.312 . . . . 1.96 111.142 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 t -55.36 -27.2 45.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.955 -0.566 . . . . 1.1100000000000001 111.783 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 53' ' ' LYS . 11.8 t -139.96 4.61 2.09 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.286 0.565 . . . . 1.24 110.926 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.89 13.48 75.57 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.94 -0.573 . . . . 0.78000000000000003 113.077 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -77.8 118.34 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.606 0.241 . . . . 3.2999999999999998 111.141 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.9 p -76.84 159.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 1.3400000000000001 110.039 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 110' ' ' ILE . 18.3 m-30 -80.26 99.44 7.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.518 -0.31 . . . . 0.96999999999999997 110.675 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -124.51 84.72 2.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.889 0.852 . . . . 2.1800000000000002 111.28 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.519 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.9 m -136.92 -178.16 5.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.133 -0.94 . . . . 1.6799999999999999 108.81 175.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.9 p -67.36 -44.15 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 1.8600000000000001 111.104 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.35 -51.59 23.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.039 -0.528 . . . . 2.1200000000000001 110.141 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.7 OUTLIER -45.89 -43.81 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.745 -1.116 . . . . 2.1899999999999999 112.191 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.39 -11.9 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.501 . . . . 3.1899999999999999 112.351 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -103.9 -61.91 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.699 -0.401 . . . . 1.27 111.588 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 29.0 m -86.0 124.11 71.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.488 . . . . 2.6099999999999999 112.03 -169.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.7 Cg_endo -87.22 103.98 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.147 2.565 . . . . 2.1299999999999999 111.21 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -94.8 149.16 21.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.454 -0.339 . . . . 1.6299999999999999 110.519 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -141.41 165.88 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 2.0099999999999998 109.939 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CE2' HG11 ' A' ' 74' ' ' VAL . 54.4 p90 -149.86 -176.88 5.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.088 0.47 . . . . 0.68999999999999995 111.516 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 3.9 m-70 -120.03 150.93 39.77 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.477 -0.783 . . . . 2.6600000000000001 110.075 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.498 HD13 ' CG2' ' A' ' 82' ' ' VAL . 45.6 tp -68.76 134.98 50.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.552 0.215 . . . . 1.5600000000000001 110.46 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 53.21 31.22 11.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.504 0.669 . . . . 2.0800000000000001 111.518 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 16.5 tt0 -69.62 -12.04 61.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.076 -0.965 . . . . 1.98 111.033 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.52 -14.31 54.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.741 -0.743 . . . . 0.78000000000000003 111.744 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -104.07 0.02 29.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.96999999999999997 110.737 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.9 m -132.3 124.65 52.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 1.25 110.266 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.502 HG12 ' N ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -96.36 -60.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.03 0.752 . . . . 1.3500000000000001 113.03 -176.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 75' ' ' ILE . 35.6 mmtt -145.03 -41.49 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.285 0.846 . . . . 2.5600000000000001 113.285 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.36 -52.33 37.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.307 -0.949 . . . . 0.34000000000000002 112.212 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -76.48 -33.13 58.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.543 0.211 . . . . 0.56000000000000005 110.992 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 10.4 t70 -52.33 -53.33 45.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.77 -0.65 . . . . 1.1399999999999999 112.102 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.11 -33.13 59.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.441 0.638 . . . . 1.3999999999999999 111.22 -176.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.68 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 49.8 t -76.19 -39.52 54.56 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.896 -0.502 . . . . 0.98999999999999999 111.661 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.498 ' CG2' HD13 ' A' ' 69' ' ' LEU . 33.8 m -81.02 -32.82 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.452 0.167 . . . . 1.49 111.131 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.569 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 62.6 m -61.27 -40.71 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 1.9399999999999999 110.7 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.481 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 21.4 m -101.42 64.38 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 1.8700000000000001 111.038 174.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.68 ' HE1' ' HG ' ' A' ' 81' ' ' CYS . 11.4 mmt -120.9 172.47 7.89 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.149 -0.932 . . . . 2.79 110.074 171.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -142.96 162.83 34.41 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.69 -0.856 . . . . 4.9199999999999999 108.69 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HA ' HD23 ' A' ' 122' ' ' LEU . 3.4 tmtm? -56.11 -29.56 60.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.981 0.363 . . . . 2.4300000000000002 111.981 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -118.96 18.12 13.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.68 0.276 . . . . 1.4199999999999999 111.13 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.37 158.03 16.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.395 -0.366 . . . . 1.6000000000000001 110.578 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -152.29 124.06 7.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.283 -0.636 . . . . 1.74 109.283 -175.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.603 ' H ' ' HE2' ' A' ' 85' ' ' MET . 63.8 m -129.63 160.7 32.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.324 -0.398 . . . . 1.3600000000000001 110.9 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.17 118.21 36.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.058 -0.519 . . . . 2.2999999999999998 109.655 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 95' ' ' ILE . 7.5 p -100.63 138.17 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.822 0.344 . . . . 1.46 110.224 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 mmm-85 -107.42 111.44 23.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.571 -0.899 . . . . 2.29 108.571 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 93' ' ' VAL . 5.1 mp -104.28 107.17 21.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.181 -173.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.579 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 2.2 tt0 -83.46 176.01 9.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.153 -0.684 . . . . 1.3700000000000001 109.153 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.423 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -58.68 -30.99 67.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.253 -0.431 . . . . 1.22 110.783 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.14 -9.29 59.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.294 -0.412 . . . . 2.3199999999999998 111.983 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.579 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 17.7 m-85 -109.42 -0.69 18.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 0.92000000000000004 110.29 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.58 176.09 22.95 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.85999999999999999 112.134 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 111.704 0.261 . . . . 1.52 111.704 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.473 0.177 . . . . 1.71 111.09 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.542 HD13 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -156.15 72.83 5.1 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 1.3700000000000001 110.95 175.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -94.82 102.81 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.161 2.574 . . . . 1.5800000000000001 112.342 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.3 73.3 0.46 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.969 -0.853 . . . . 2.0499999999999998 110.969 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.02 31.33 0.33 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.92 0.888 . . . . 2.2999999999999998 111.26 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.434 ' HB2' HD12 ' A' ' 48' ' ' LEU . 6.8 p -104.27 -177.33 3.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.5700000000000001 111.018 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.82 137.64 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.07 -0.514 . . . . 1.1799999999999999 110.035 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.853 HD22 ' HA ' ' A' ' 48' ' ' LEU . 10.1 mt -124.55 156.4 37.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 1.25 110.72 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.608 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -125.56 119.67 28.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.829 -0.434 . . . . 1.3500000000000001 109.829 171.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.437 ' CD2' HD13 ' A' ' 95' ' ' ILE . 21.2 m-85 -114.52 137.93 51.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.962 -0.563 . . . . 0.56000000000000005 111.006 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 36.2 mt-10 -89.12 116.09 27.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.295 -0.866 . . . . 1.46 108.869 172.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.457 HG21 HG11 ' A' ' 82' ' ' VAL . 44.6 mt -106.78 127.82 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.705 0.288 . . . . 1.1599999999999999 110.258 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.26 125.82 50.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.806 -0.634 . . . . 1.8799999999999999 110.601 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 87' ' ' LYS . 4.4 tp -91.88 89.86 7.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.518 -0.549 . . . . 1.75 109.518 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -78.78 -37.07 41.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.895 -0.322 . . . . 1.78 111.43 -176.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.3 m -146.77 151.36 37.03 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.128 -0.229 . . . . 1.53 110.794 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -165.86 -177.71 4.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.507 -0.553 . . . . 0.90000000000000002 109.507 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.562 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -162.33 172.38 15.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 3.4700000000000002 109.786 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 26.8 mt-10 . . . . . 0 C--N 1.327 -0.409 0 O-C-N 123.366 0.416 . . . . 3.3799999999999999 110.94 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 C--O 1.233 0.237 0 CA-C-O 120.848 0.356 . . . . 4.54 110.354 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -112.35 136.53 51.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.018 -0.537 . . . . 2.71 110.178 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HG3' HG23 ' A' ' 21' ' ' THR . 7.1 mptt -111.34 125.82 54.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.722 -0.474 . . . . 2.4399999999999999 109.722 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.42 115.54 45.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.537 -0.301 . . . . 1.3100000000000001 110.349 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.04 126.67 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.095 -0.502 . . . . 2.1600000000000001 111.09 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.3 mt 57.26 53.31 7.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 2.04 110.04 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.524 HG23 ' HE2' ' A' ' 20' ' ' LYS . 11.7 t -59.23 157.72 10.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.948 -1.024 . . . . 1.26 111.169 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -2.76 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 1.3700000000000001 112.115 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.53 -4.41 36.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 2.3999999999999999 110.658 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.27 37.41 0.69 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.574 -0.822 . . . . 0.83999999999999997 113.107 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.29 0.85 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.906 -0.664 . . . . 0.62 113.489 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.455 HG22 ' HB ' ' A' ' 80' ' ' ILE . 38.6 t -141.13 141.36 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.272 -0.27 . . . . 1.1799999999999999 110.272 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 12' ' ' LEU . 14.3 mm -90.83 110.82 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 1.1799999999999999 109.753 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' HE2' HG23 ' A' ' 13' ' ' THR . 61.3 pttt -137.09 144.83 43.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.192 0.52 . . . . 1.96 111.076 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.427 HG23 ' HG3' ' A' ' 9' ' ' LYS . 25.2 m -116.77 131.37 56.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.811 . . . . 1.21 110.239 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 25' ' ' LYS . 4.9 tp -91.17 126.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.244 -0.435 . . . . 1.3 110.267 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.568 ' CD2' ' HG ' ' A' ' 92' ' ' LEU . 3.3 mm? -108.04 -72.85 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.38 0.609 . . . . 1.3999999999999999 110.135 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -108.07 103.28 12.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.146 -0.687 . . . . 2.0600000000000001 109.146 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.466 ' HA ' HD11 ' A' ' 22' ' ' ILE . 73.4 tttt -72.26 157.38 37.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.851 -0.425 . . . . 3.25 109.851 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.27 -136.83 0.12 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 114.559 0.583 . . . . 1.3200000000000001 114.559 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 28' ' ' GLU . 14.0 t70 -167.3 -162.98 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.556 -1.275 . . . . 2.77 107.556 -170.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.48 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 39.2 tt0 -77.81 125.38 29.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 2.6400000000000001 110.716 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.93 70.0 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.559 -1.016 . . . . 1.3 110.559 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.46 -22.43 59.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.043 0.449 . . . . 2.29 111.03 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.47 1.1 55.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.645 0.736 . . . . 2.6400000000000001 109.328 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -105.71 76.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.647 -0.706 . . . . 1.49 109.243 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.1 mm -137.07 130.42 17.44 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 1.3700000000000001 111.138 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.503 ' HG3' ' O ' ' A' ' 85' ' ' MET . 74.0 Cg_endo -74.74 133.86 17.55 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.031 2.488 . . . . 0.84999999999999998 111.424 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 29.9 mmmt -134.12 142.06 47.36 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.283 -0.261 . . . . 3.1400000000000001 110.539 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' HE3' ' HB3' ' A' ' 70' ' ' GLU . 17.3 tptm -56.14 127.51 31.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 2.9100000000000001 110.47 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.53 -25.25 23.61 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.474 -0.785 . . . . 1.1899999999999999 111.825 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 78.9 m-20 -94.28 165.73 12.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 1.3799999999999999 110.305 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.27 132.26 34.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.142 0.496 . . . . 2.2000000000000002 111.857 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.8 150.8 35.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.496 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 25.6 m -125.55 106.41 9.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.861 -0.422 . . . . 1.23 109.861 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 122' ' ' LEU . 34.0 m -131.22 160.48 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.573 . . . . 1.6200000000000001 111.385 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -113.92 152.73 30.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.647 -0.872 . . . . 3.5600000000000001 108.647 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -128.06 132.64 49.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.88 110.253 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -165.14 158.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.807 -0.812 . . . . 1.1899999999999999 108.807 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.84 -127.35 1.51 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.038 -1.077 . . . . 0.37 112.372 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -150.42 166.63 29.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 1.96 110.471 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.569 HD23 HG13 ' A' ' 110' ' ' ILE . 66.3 tp -86.23 101.97 13.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 1.1200000000000001 109.694 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 18.9 tt0 -59.78 -24.54 64.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.807 0.337 . . . . 1.96 111.817 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 t -55.86 -25.35 41.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.188 -0.46 . . . . 1.1100000000000001 111.468 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.412 HG21 ' HG2' ' A' ' 53' ' ' LYS . 3.0 t -137.84 -31.62 0.77 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.933 0.396 . . . . 1.24 111.567 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.72 14.75 26.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.84 -0.695 . . . . 0.78000000000000003 112.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HG2' HG21 ' A' ' 51' ' ' THR . 70.2 mmtt -86.59 133.7 33.69 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.652 -0.499 . . . . 3.2999999999999998 109.652 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 p -83.06 155.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.211 -0.45 . . . . 1.3400000000000001 111.46 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 3.2 m-85 -74.33 102.11 4.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.96999999999999997 110.77 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.52 85.3 2.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.375 0.607 . . . . 2.1800000000000002 110.004 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.519 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 67.3 m -138.58 -177.61 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 1.6799999999999999 110.323 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -48.47 -47.0 38.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.887 0.699 . . . . 1.8600000000000001 112.887 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.89 -43.29 8.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 2.1200000000000001 110.339 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.8 OUTLIER -57.29 -30.5 64.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 2.1899999999999999 112.185 -174.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -19.91 21.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 3.1899999999999999 110.973 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.641 HD21 HG11 ' A' ' 63' ' ' VAL . 8.5 t30 -86.81 -61.02 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 1.27 110.94 -171.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.641 HG11 HD21 ' A' ' 62' ' ' ASN . 7.1 p -156.13 126.36 3.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 2.6099999999999999 111.121 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.02 152.74 57.44 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.694 2.262 . . . . 2.1299999999999999 111.326 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.71 146.41 23.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.676 0.274 . . . . 1.6299999999999999 110.328 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 2.7 pptp? -105.89 143.35 34.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.979 -0.378 . . . . 2.0099999999999998 109.979 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.31 170.44 15.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.01 0.433 . . . . 0.68999999999999995 111.131 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -103.96 149.58 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 2.6600000000000001 109.966 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD13 ' CG2' ' A' ' 82' ' ' VAL . 16.5 tp -64.19 119.46 10.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.94 0.4 . . . . 1.5600000000000001 110.928 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.636 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER 42.31 74.94 0.1 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 114.405 -1.271 . . . . 2.0800000000000001 111.767 -174.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -100.85 17.39 22.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.548 -1.206 . . . . 1.98 109.536 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.5 -16.6 59.62 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.604 -0.726 . . . . 0.78000000000000003 111.787 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.53 -41.56 11.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.466 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.87 135.36 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.651 0.262 . . . . 1.25 110.301 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.53 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.61 -68.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.455 0.539 . . . . 1.3500000000000001 112.455 -175.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' H ' HG12 ' A' ' 75' ' ' ILE . 41.7 mtpt -133.52 -51.09 0.86 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 122.026 -0.421 . . . . 2.5600000000000001 111.892 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.07 -53.41 34.22 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.049 -0.596 . . . . 0.34000000000000002 113.513 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.416 ' O ' HG21 ' A' ' 82' ' ' VAL . 17.7 m-90 -75.86 -37.72 58.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.652 0.263 . . . . 0.56000000000000005 110.632 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.01 -54.06 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 1.1399999999999999 111.791 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' HG22 ' A' ' 18' ' ' VAL . 1.9 mp -68.59 -35.31 69.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.129 0.49 . . . . 1.3999999999999999 110.559 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.58 ' SG ' HD13 ' A' ' 120' ' ' ILE . 44.2 t -69.43 -48.19 61.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.096 -0.502 . . . . 0.98999999999999999 111.083 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.596 ' CG2' HD13 ' A' ' 69' ' ' LEU . 34.0 m -66.7 -32.37 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 121.169 -0.212 . . . . 1.49 111.125 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -80.92 3.38 22.99 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.275 0.56 . . . . 1.9399999999999999 110.237 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 t -123.93 27.48 7.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.558 -0.746 . . . . 1.8700000000000001 109.001 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.746 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 40.7 mmm -123.79 116.45 23.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 2.79 111.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.502 HH21 ' HB2' ' A' ' 88' ' ' ASN . 18.0 ttp85 -82.41 162.06 22.27 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 4.9199999999999999 109.753 175.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -66.12 -13.68 60.53 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.108 0.41 . . . . 2.4300000000000002 112.108 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.502 ' HB2' HH21 ' A' ' 86' ' ' ARG . 37.0 m-80 -121.42 25.51 9.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.004 0.43 . . . . 1.4199999999999999 109.976 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -123.16 166.4 15.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.634 -0.712 . . . . 1.6000000000000001 109.737 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.746 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 79.2 tttt -157.28 121.03 4.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 1.74 111.405 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.27 160.96 25.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.522 -0.763 . . . . 1.3600000000000001 110.646 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.568 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 75.2 mt -115.13 126.22 54.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.544 -0.539 . . . . 2.2999999999999998 109.544 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.505 ' HB ' ' HG ' ' A' ' 81' ' ' CYS . 10.0 p -101.22 142.45 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 110.024 -0.362 . . . . 1.46 110.024 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -100.98 112.84 25.38 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.84 -0.8 . . . . 2.29 108.84 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 95' ' ' ILE . 3.3 mp -87.23 101.18 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 1.2 110.928 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.75 159.22 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.433 -0.951 . . . . 1.3700000000000001 108.433 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 p -55.37 -36.1 65.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.889 0.376 . . . . 1.22 111.499 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 22.2 ptp -76.95 -8.27 57.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.166 -0.47 . . . . 2.3199999999999998 111.021 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -96.08 -2.4 46.72 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.154 -0.313 . . . . 0.92000000000000004 110.154 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.53 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -133.72 -152.45 6.78 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.684 -0.689 . . . . 0.85999999999999999 112.335 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.926 0.343 . . . . 1.52 111.926 -177.845 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 110' ' ' ILE . 3.0 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.751 -0.092 . . . . 1.71 110.751 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.569 HG13 HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.59 71.36 17.49 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.922 0.392 . . . . 1.3700000000000001 111.77 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -92.23 -158.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.766 2.311 . . . . 1.5800000000000001 112.558 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.14 -133.0 9.65 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.336 -0.706 . . . . 2.0499999999999998 111.336 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -96.64 24.07 6.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.753 0.787 . . . . 2.2999999999999998 109.732 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -104.93 146.5 28.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.397 -0.82 . . . . 1.5700000000000001 109.737 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.19 132.06 34.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.158 0.504 . . . . 1.1799999999999999 110.66 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.428 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.7 mp -121.07 168.95 10.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.545 . . . . 1.25 109.624 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -138.97 122.83 17.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 1.3500000000000001 110.333 172.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -110.94 140.6 45.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.56000000000000005 111.453 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.42 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 34.3 mt-10 -80.45 119.58 23.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.274 -0.875 . . . . 1.46 108.903 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.582 HG22 HG12 ' A' ' 82' ' ' VAL . 47.8 mt -108.12 134.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.248 -0.649 . . . . 1.1599999999999999 109.248 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -134.93 114.38 12.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.529 . . . . 1.8799999999999999 110.7 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HA ' HG13 ' A' ' 42' ' ' VAL . 4.9 tp -84.0 91.72 7.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.852 -0.425 . . . . 1.75 109.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 41' ' ' THR . 2.8 pp -84.27 -36.81 22.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.1 -0.24 . . . . 1.78 111.279 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.4 m -143.14 150.66 39.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.047 -0.353 . . . . 1.53 110.047 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -165.91 -178.89 4.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.494 -0.558 . . . . 0.90000000000000002 109.494 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.86 138.92 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 3.4700000000000002 110.554 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.318 -0.623 . . . . 3.3799999999999999 109.318 177.726 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.754 -0.462 . . . . 4.54 109.754 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.35 154.13 39.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.263 0.554 . . . . 2.71 110.77 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.4 mppt? -94.42 152.04 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.039 -0.726 . . . . 2.4399999999999999 109.039 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.31 105.19 17.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.562 -0.533 . . . . 1.3100000000000001 109.562 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.8 99.75 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 2.1600000000000001 110.247 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt 66.75 78.63 0.25 Allowed 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.027 0.829 . . . . 2.04 110.858 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -68.3 156.07 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 1.26 110.366 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.27 -20.27 65.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.247 -0.433 . . . . 1.3700000000000001 111.902 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.51 30.69 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.87 0.367 . . . . 2.3999999999999999 111.83 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 11.38 5.32 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.043 -1.075 . . . . 0.83999999999999997 114.548 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.92 64.33 4.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.545 0.578 . . . . 0.62 114.545 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.411 HG21 ' HB ' ' A' ' 80' ' ' ILE . 69.0 t -127.14 147.55 32.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 1.1799999999999999 109.984 173.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.616 HG12 ' HH ' ' A' ' 99' ' ' TYR . 25.9 mm -85.5 111.17 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.789 -0.449 . . . . 1.1799999999999999 109.789 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 18.5 pttp -141.68 146.92 36.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.945 0.402 . . . . 1.96 110.769 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -102.79 132.02 49.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 1.21 110.034 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 tp -93.63 121.93 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.878 0.371 . . . . 1.3 110.194 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.88 -78.83 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 1.3999999999999999 110.419 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 108.69 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.579 -0.737 . . . . 2.0600000000000001 109.675 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HZ3' ' HB2' ' A' ' 25' ' ' LYS . 9.2 mtmp? -72.88 147.39 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.885 -0.598 . . . . 3.25 111.901 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.73 88.75 1.38 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.072 -1.211 . . . . 1.3200000000000001 110.072 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.33 -43.21 43.5 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.767 0.654 . . . . 2.77 112.767 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.32 144.38 34.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.924 0.392 . . . . 2.6400000000000001 110.709 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.81 51.8 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.977 -0.63 . . . . 1.3 111.643 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.95 -45.98 64.58 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.583 0.586 . . . . 2.29 112.583 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.47 27.65 8.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.962 0.411 . . . . 2.6400000000000001 111.035 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.435 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 30.9 m-80 -129.26 78.62 1.86 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 1.49 110.609 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.25 124.31 21.18 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.134 -0.485 . . . . 1.3700000000000001 111.066 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.517 ' HG3' HD23 ' A' ' 122' ' ' LEU . 42.8 Cg_endo -67.65 112.83 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.713 2.275 . . . . 0.84999999999999998 111.504 176.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.7 mmtp -133.39 172.78 12.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.364 0.875 . . . . 3.1400000000000001 113.364 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -43.42 126.48 4.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.02 -1.445 . . . . 2.9100000000000001 113.211 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 -16.01 45.1 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.935 -0.575 . . . . 1.1899999999999999 113.301 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 92.7 m-20 -83.58 146.99 28.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.057 0.456 . . . . 1.3799999999999999 110.913 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -78.5 110.23 13.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.292 0.568 . . . . 2.2000000000000002 110.252 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 125' ' ' PHE . 11.1 m -117.88 159.29 18.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.587 -0.733 . . . . 1.3300000000000001 109.819 175.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.49 HG21 ' HD3' ' A' ' 66' ' ' LYS . 23.7 m -125.55 105.61 9.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.383 -0.599 . . . . 1.23 109.383 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 122' ' ' LEU . 12.7 m -128.01 140.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.864 -0.607 . . . . 1.6200000000000001 110.185 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -100.43 147.64 25.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.06 -0.718 . . . . 3.5600000000000001 109.06 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -126.39 127.84 46.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.371 0.605 . . . . 0.88 110.326 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.22 157.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.355 -0.98 . . . . 1.1899999999999999 108.355 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.61 -128.49 1.71 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.258 -0.972 . . . . 0.37 111.454 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.67 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 59.2 pttt -157.81 170.92 21.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.993 0.425 . . . . 1.96 111.058 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD13 ' HG ' ' A' ' 116' ' ' LEU . 46.2 tp -89.52 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 1.1200000000000001 109.627 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 78.2 tt0 -64.36 -28.55 69.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 1.96 111.233 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 8.7 t -54.84 -29.78 55.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.532 . . . . 1.1100000000000001 111.543 -175.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -130.46 -2.45 4.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.656 0.265 . . . . 1.24 111.086 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 45.34 50.31 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.347 -0.454 . . . . 0.78000000000000003 113.032 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 68.8 mmtt -113.51 127.1 55.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 3.2999999999999998 110.584 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.67 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 14.4 p -72.76 152.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.622 -0.717 . . . . 1.3400000000000001 111.168 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 3.5 m-30 -74.48 115.45 14.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.998 0.428 . . . . 0.96999999999999997 110.749 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -146.21 85.7 1.67 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.655 -0.702 . . . . 2.1800000000000002 109.425 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 15.0 m -116.13 -177.5 3.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.544 -0.753 . . . . 1.6799999999999999 109.734 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -71.17 -37.98 72.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.947 0.404 . . . . 1.8600000000000001 111.212 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.42 -48.09 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.382 0.512 . . . . 2.1200000000000001 112.382 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -62.34 -45.57 92.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.926 0.713 . . . . 2.1899999999999999 112.926 -167.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 57' ' ' SER . 3.4 ptm180 -67.35 -23.25 65.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.776 0.322 . . . . 3.1899999999999999 111.326 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -87.71 -62.32 1.52 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 1.27 110.565 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.3 107.09 30.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.631 0.729 . . . . 2.6099999999999999 110.787 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.14 138.74 37.3 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.114 2.542 . . . . 2.1299999999999999 111.795 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.25 153.85 18.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.902 -0.407 . . . . 1.6299999999999999 109.902 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD3' HG21 ' A' ' 41' ' ' THR . 3.7 pptp? -130.02 146.76 51.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.303 -0.408 . . . . 2.0099999999999998 110.506 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 48.7 p90 -127.86 174.43 9.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.82 0.343 . . . . 0.68999999999999995 111.447 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -110.69 151.36 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 2.6600000000000001 110.664 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -65.18 117.67 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 1.5600000000000001 110.535 -176.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.76 90.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.203 1.001 . . . . 2.0800000000000001 110.228 -171.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.419 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 8.2 tt0 -127.73 8.24 6.32 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.399 -1.273 . . . . 1.98 109.585 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.1 -17.67 31.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.78000000000000003 112.472 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.412 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 9.0 mm-40 -90.4 -15.53 30.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.374 0.606 . . . . 0.96999999999999997 110.329 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.56 124.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.952 -0.567 . . . . 1.25 110.747 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -99.43 -57.07 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.74 0.644 . . . . 1.3500000000000001 112.74 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.499 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.0 mtpt -137.41 -61.18 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 2.5600000000000001 111.665 -171.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.452 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -52.99 -52.74 37.66 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.05 -0.595 . . . . 0.34000000000000002 112.78 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.574 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -74.87 -51.53 13.67 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.74 -0.384 . . . . 0.56000000000000005 110.431 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.41 -51.98 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.545 0.528 . . . . 1.1399999999999999 112.123 -171.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 76' ' ' LYS . 1.8 mp -65.42 -38.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.809 0.338 . . . . 1.3999999999999999 110.453 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.628 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.0 t -68.6 -46.1 70.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.284 . . . . 0.98999999999999999 110.765 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.6 m -67.98 -33.06 59.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 O-C-N 123.153 0.283 . . . . 1.49 110.856 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -61.1 -39.24 89.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 1.9399999999999999 110.58 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.505 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 22.4 m -92.67 31.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.474 . . . . 1.8700000000000001 111.15 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 85.6 mmm -104.52 175.13 5.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.615 -0.266 . . . . 2.79 110.385 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 70.4 mtt85 -144.89 165.71 27.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.465 -0.334 . . . . 4.9199999999999999 110.359 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -53.73 -35.14 60.87 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.618 0.573 . . . . 2.4300000000000002 112.316 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -125.19 41.4 3.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 1.4199999999999999 110.561 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 20.2 tt0 -117.34 154.25 31.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.392 -0.367 . . . . 1.6000000000000001 110.193 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.94 117.49 7.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.376 . . . . 1.74 109.986 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 74.5 m -124.52 162.21 24.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.092 0.472 . . . . 1.3600000000000001 112.018 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.44 114.67 27.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.369 -0.832 . . . . 2.2999999999999998 109.646 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.6 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.1 p -103.77 147.57 9.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.409 -0.359 . . . . 1.46 110.983 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 94' ' ' ARG . 9.5 mmt85 -105.51 112.38 25.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.587 -0.523 . . . . 2.29 109.587 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.519 HD12 ' HD2' ' A' ' 118' ' ' PHE . 2.1 mp -94.1 105.58 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.149 0.499 . . . . 1.2 109.67 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 97' ' ' SER . 23.0 tt0 -93.78 174.85 6.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.424 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -49.0 -45.87 43.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.76 0.424 . . . . 1.22 111.516 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.08 -8.29 58.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.948 -0.569 . . . . 2.3199999999999998 112.027 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.616 ' HH ' HG12 ' A' ' 19' ' ' ILE . 21.6 m-85 -102.28 -18.58 15.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.92000000000000004 110.578 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.487 ' C ' HD13 ' A' ' 75' ' ' ILE . . . -112.99 -174.41 19.13 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.304 -0.718 . . . . 0.85999999999999999 111.304 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 1.52 110.889 179.282 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB2' HD12 ' A' ' 110' ' ' ILE . 4.7 p . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 111.961 0.356 . . . . 1.71 111.961 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.504 HD12 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -160.25 87.67 1.87 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 122.892 0.477 . . . . 1.3700000000000001 110.848 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.83 170.35 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.345 2.03 . . . . 1.5800000000000001 111.597 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.06 36.54 0.02 OUTLIER Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.39 -0.91 . . . . 2.0499999999999998 112.473 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.53 19.01 11.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.274 0.559 . . . . 2.2999999999999998 110.402 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.427 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 2.0 m -95.8 160.93 14.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.493 -0.776 . . . . 1.5700000000000001 110.33 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.22 122.21 45.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.375 0.607 . . . . 1.1799999999999999 110.452 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.0 mp -116.29 142.7 46.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.837 -0.62 . . . . 1.25 109.615 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.44 121.59 45.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.142 0.496 . . . . 1.3500000000000001 110.539 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.519 ' HD2' HD12 ' A' ' 95' ' ' ILE . 44.4 m-85 -112.88 137.95 50.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.747 . . . . 0.56000000000000005 111.219 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 38.7 mt-10 -78.2 122.37 25.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.81 -0.811 . . . . 1.46 108.81 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.484 HG21 HG12 ' A' ' 82' ' ' VAL . 49.9 mt -107.16 121.16 59.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.512 -0.551 . . . . 1.1599999999999999 109.512 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -127.68 112.88 15.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.514 -0.766 . . . . 1.8799999999999999 110.639 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HA ' HG13 ' A' ' 42' ' ' VAL . 24.6 tp -88.93 99.59 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 1.75 109.9 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.8 -31.42 16.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.872 -0.331 . . . . 1.78 111.308 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.3 m -151.21 146.21 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.713 -0.221 . . . . 1.53 110.571 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.555 ' HB2' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -168.39 -179.21 3.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.523 -0.308 . . . . 0.90000000000000002 110.294 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 6.0 ptp180 -155.74 142.22 18.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.055 -0.521 . . . . 3.4700000000000002 109.948 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.756 0.312 . . . . 3.3799999999999999 110.482 174.689 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 112.834 0.679 . . . . 4.54 112.834 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.72 154.26 19.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.9 -1.046 . . . . 2.71 110.025 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 3.2 mppt? -99.41 127.83 45.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.337 -0.616 . . . . 2.4399999999999999 109.337 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -102.53 105.42 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.421 -0.585 . . . . 1.3100000000000001 109.421 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.16 140.98 29.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.253 -0.43 . . . . 2.1600000000000001 110.993 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.511 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.2 mt 54.04 44.0 29.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 2.04 111.677 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 20' ' ' LYS . 9.1 t -55.92 157.3 4.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 1.26 110.817 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 1.16 5.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 1.3700000000000001 111.19 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -80.11 3.51 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 2.3999999999999999 110.592 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.86 25.41 1.9 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.839 -0.696 . . . . 0.83999999999999997 113.539 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 66.02 68.75 1.55 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.231 -0.509 . . . . 0.62 113.941 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' HB ' ' A' ' 80' ' ' ILE . 12.8 t -135.87 145.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.898 -0.408 . . . . 1.1799999999999999 109.898 176.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.769 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 8.8 mm -85.49 109.67 18.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.453 -0.573 . . . . 1.1799999999999999 109.453 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HD3' HG22 ' A' ' 13' ' ' THR . 4.1 ptmt -125.0 129.13 49.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.232 0.539 . . . . 1.96 111.158 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -101.07 114.62 28.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.644 -0.707 . . . . 1.21 109.801 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.497 HD11 ' CG ' ' A' ' 25' ' ' LYS . 10.5 tp -66.16 128.74 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.992 -0.549 . . . . 1.3 109.792 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 0.5 OUTLIER -122.57 -78.3 0.6 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.993 0.425 . . . . 1.3999999999999999 110.776 -177.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -124.55 119.03 27.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.753 -0.658 . . . . 2.0600000000000001 109.983 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 43.7 mtpt -107.09 163.73 12.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.024 0.44 . . . . 3.25 110.692 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.3 -124.67 5.24 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.428 -0.806 . . . . 1.3200000000000001 111.3 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -150.99 -86.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.129 0.49 . . . . 2.77 110.439 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -95.65 158.74 15.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.978 -0.556 . . . . 2.6400000000000001 110.526 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.37 53.79 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 111.218 -0.753 . . . . 1.3 111.218 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.43 -40.19 89.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.109 0.48 . . . . 2.29 110.2 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -106.51 27.18 9.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.493 0.663 . . . . 2.6400000000000001 109.802 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.5 ' OD1' ' HE3' ' A' ' 87' ' ' LYS . 36.1 m-80 -130.51 76.47 1.72 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.521 -0.763 . . . . 1.49 109.857 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.6 mm -130.48 120.53 18.89 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.066 -0.516 . . . . 1.3700000000000001 111.131 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.16 131.74 15.73 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.571 2.181 . . . . 0.84999999999999998 111.52 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -126.05 142.22 51.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.623 -0.262 . . . . 3.1400000000000001 110.5 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -71.22 138.64 49.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 2.9100000000000001 109.471 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.7 -27.15 13.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.809 -0.71 . . . . 1.1899999999999999 111.408 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -88.88 145.37 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.82 -0.437 . . . . 1.3799999999999999 109.82 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 42.8 mt-10 -69.53 98.75 1.17 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.846 -0.615 . . . . 2.2000000000000002 112.126 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 125' ' ' PHE . 22.6 m -116.13 152.23 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 1.3300000000000001 109.828 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.4 m -127.36 131.05 50.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.683 -0.488 . . . . 1.23 109.683 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 122' ' ' LEU . 10.7 m -137.12 152.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.276 0.56 . . . . 1.6200000000000001 112.436 -173.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -105.38 129.44 53.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 3.5600000000000001 109.58 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.694 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 8.7 p90 -134.27 140.13 46.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.854 0.359 . . . . 0.88 111.474 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.14 158.6 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.54 -0.911 . . . . 1.1899999999999999 108.54 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -177.39 -126.63 0.99 Allowed Glycine 0 C--O 1.228 -0.227 0 C-N-CA 119.847 -1.168 . . . . 0.37 113.019 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.559 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 20.6 pttp -155.45 170.68 21.38 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.575 -0.367 . . . . 1.96 111.478 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.448 HD11 ' HG ' ' A' ' 116' ' ' LEU . 66.0 tp -94.1 98.32 10.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 1.1200000000000001 109.683 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' HB2' HD13 ' A' ' 117' ' ' LEU . 2.4 tp10 -69.19 -20.65 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.309 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 5.5 t -55.31 -27.37 46.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 1.1100000000000001 111.504 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 t -138.18 9.22 2.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 1.24 110.452 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.73 55.61 27.6 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.847 -0.615 . . . . 0.78000000000000003 112.636 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -121.14 118.55 29.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.529 -0.175 . . . . 3.2999999999999998 110.529 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.5 p -69.6 153.99 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.864 0.364 . . . . 1.3400000000000001 110.973 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 7.7 m-30 -76.73 105.53 7.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.96999999999999997 110.624 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -130.82 85.58 2.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.549 0.69 . . . . 2.1800000000000002 109.81 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.32 156.17 28.29 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.587 -0.894 . . . . 1.6799999999999999 108.587 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -68.33 -21.32 64.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.177 0.513 . . . . 1.8600000000000001 110.77 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -94.62 -48.8 5.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 2.1200000000000001 112.21 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -42.92 82.75 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.984 0.364 . . . . 2.1899999999999999 111.984 -169.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -77.49 -3.52 40.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.016 0.436 . . . . 3.1899999999999999 111.063 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -90.7 -45.73 8.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 1.27 109.989 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.87 113.51 2.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 2.6099999999999999 110.52 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.22 171.4 17.85 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.798 2.332 . . . . 2.1299999999999999 112.197 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -102.4 142.44 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.176 -0.466 . . . . 1.6299999999999999 110.175 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HD3' ' CG2' ' A' ' 41' ' ' THR . 0.0 OUTLIER -119.14 143.65 47.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 2.0099999999999998 108.996 175.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CE2' HG12 ' A' ' 74' ' ' VAL . 55.8 p90 -133.44 169.89 16.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.68999999999999995 112.054 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' HE1' ' HB3' ' A' ' 39' ' ' GLU . 1.5 m-70 -104.96 148.97 26.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.676 -1.147 . . . . 2.6600000000000001 109.768 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 79' ' ' ASP . 25.3 tp -73.15 129.99 39.28 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.747 -0.381 . . . . 1.5600000000000001 110.144 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 65.72 31.77 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.929 0.768 . . . . 2.0800000000000001 111.165 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.442 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 12.2 pt20 -80.9 12.57 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 1.98 111.114 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.57 48.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.035 -0.602 . . . . 0.78000000000000003 112.828 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' HE21 ' A' ' 71' ' ' GLN . 17.1 mm-40 -87.5 -32.32 19.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.449 . . . . 0.96999999999999997 110.818 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.443 HG12 ' CE2' ' A' ' 67' ' ' PHE . 28.0 m -98.52 127.05 51.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.376 0.607 . . . . 1.25 110.62 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.652 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.65 -76.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 1.3500000000000001 112.27 -175.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.652 ' H ' HG12 ' A' ' 75' ' ' ILE . 4.2 mmpt? -121.15 -57.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.455 . . . . 2.5600000000000001 112.23 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.16 -52.31 36.66 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.292 0.37 . . . . 0.34000000000000002 113.693 -171.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.423 ' O ' HG23 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.63 -43.13 49.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.94 -0.153 . . . . 0.56000000000000005 111.373 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.478 ' HA ' ' CD1' ' A' ' 69' ' ' LEU . 23.2 t70 -51.87 -52.32 50.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.526 0.565 . . . . 1.1399999999999999 112.526 -171.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.472 ' HB ' HG23 ' A' ' 18' ' ' VAL . 1.7 mp -61.62 -50.97 78.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.451 . . . . 1.3999999999999999 111.296 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.501 ' HB3' HD13 ' A' ' 120' ' ' ILE . 47.6 t -71.21 -27.41 63.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.98999999999999999 111.734 -171.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.478 ' HB ' HD13 ' A' ' 69' ' ' LEU . 53.7 t -66.24 -40.12 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.281 . . . . 1.49 110.873 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 t -78.39 -7.84 57.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 1.9399999999999999 110.05 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.5 m -98.09 19.0 14.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 1.8700000000000001 110.76 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.841 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 6.0 mmt -98.26 -173.53 2.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 2.79 111.726 -176.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 38.1 ttm180 -157.43 163.49 38.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.957 -1.127 . . . . 4.9199999999999999 107.957 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HE3' ' OD1' ' A' ' 32' ' ' ASN . 5.3 tppp? -50.85 -40.51 56.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.032 0.382 . . . . 2.4300000000000002 112.032 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -118.96 34.17 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.237 . . . . 1.4199999999999999 110.563 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 4.3 tt0 -122.7 140.09 53.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.722 -0.391 . . . . 1.6000000000000001 110.781 -175.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.9 tmtp? -145.57 129.18 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 1.74 109.977 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 74.4 m -137.58 171.09 14.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.074 0.464 . . . . 1.3600000000000001 111.687 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 119' ' ' GLU . 58.0 mt -105.83 131.68 52.87 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.502 -0.772 . . . . 2.2999999999999998 109.983 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 95' ' ' ILE . 7.3 p -112.45 140.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.044 0.449 . . . . 1.46 110.994 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 8.3 mmm180 -99.13 112.81 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.577 . . . . 2.29 110.028 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 93' ' ' VAL . 3.2 mp -101.45 107.51 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 1.2 110.137 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 31.4 tt0 -84.51 171.81 12.21 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.856 -0.794 . . . . 1.3700000000000001 108.856 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.6 p -56.4 -38.21 71.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.645 0.259 . . . . 1.22 111.612 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -77.21 -7.85 56.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 2.3199999999999998 111.434 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.8 m-30 -97.29 1.96 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.34 -0.225 . . . . 0.92000000000000004 110.508 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.525 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -134.35 -152.59 6.69 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.94 -0.573 . . . . 0.85999999999999999 111.729 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 1.52 110.746 179.451 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 110.277 -0.268 . . . . 1.71 110.277 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -154.59 66.13 5.06 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 121.025 0.441 . . . . 1.3700000000000001 110.594 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.71 53.79 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.203 2.602 . . . . 1.5800000000000001 112.972 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.33 63.8 4.09 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.732 -0.746 . . . . 2.0499999999999998 112.045 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 51.73 66.25 1.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.602 0.715 . . . . 2.2999999999999998 110.407 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 49.6 m -144.93 168.45 20.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.328 -0.851 . . . . 1.5700000000000001 110.097 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.86 128.42 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.182 -0.463 . . . . 1.1799999999999999 110.415 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.448 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.1 mp -123.07 169.18 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 1.25 110.293 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.16 131.64 37.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.448 -0.575 . . . . 1.3500000000000001 109.448 175.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 95' ' ' ILE . 37.9 m-85 -128.96 144.04 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.381 . . . . 0.56000000000000005 110.95 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.694 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 26.9 mt-10 -74.81 128.03 34.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.727 -0.842 . . . . 1.46 108.727 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' A' ' 81' ' ' CYS . 25.8 mt -107.17 120.32 58.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.178 -0.675 . . . . 1.1599999999999999 109.178 172.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -127.07 118.07 23.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.482 -0.781 . . . . 1.8799999999999999 110.51 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.61 ' HA ' HG13 ' A' ' 42' ' ' VAL . 35.8 tp -80.69 113.89 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 1.75 109.902 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.94 -13.41 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.967 -0.293 . . . . 1.78 111.716 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.4 m -155.63 137.84 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.985 -0.376 . . . . 1.53 109.985 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' HB2' HG13 ' A' ' 40' ' ' VAL . 9.0 p90 -160.81 175.0 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.90000000000000002 110.368 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.552 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.6 ptp180 -162.26 147.27 12.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 3.4700000000000002 110.38 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 120.779 0.323 . . . . 3.3799999999999999 110.279 176.828 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.759 0.314 . . . . 4.54 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -121.16 170.81 9.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.013 -0.54 . . . . 2.71 109.897 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 0.0 OUTLIER -90.86 157.24 17.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 2.4399999999999999 110.814 -175.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.93 115.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.328 -0.619 . . . . 1.3100000000000001 109.328 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -87.92 99.82 12.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.474 -0.33 . . . . 2.1600000000000001 111.259 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 66.1 mt 52.88 75.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 2.04 111.19 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -59.29 147.2 36.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 1.26 110.32 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.38 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 1.3700000000000001 111.084 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.15 29.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 2.3999999999999999 111.084 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.35 -5.39 10.15 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.631 -0.795 . . . . 0.83999999999999997 113.933 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.19 71.02 1.09 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.94 -0.648 . . . . 0.62 114.043 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.2 t -138.11 145.64 28.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.693 -0.484 . . . . 1.1799999999999999 109.693 173.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mm -85.61 110.72 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.294 -0.412 . . . . 1.1799999999999999 110.802 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.51 147.24 40.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.286 -0.415 . . . . 1.96 110.697 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 9' ' ' LYS . 26.4 m -112.98 139.46 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 1.21 110.392 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.403 HD12 ' SG ' ' A' ' 91' ' ' CYS . 7.9 tp -80.03 134.97 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.147 -0.479 . . . . 1.3 110.355 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.43 -71.16 0.72 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.086 0.47 . . . . 1.3999999999999999 110.503 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -105.47 97.54 7.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.291 -0.633 . . . . 2.0600000000000001 109.291 -177.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -75.21 138.82 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.884 0.373 . . . . 3.25 110.855 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.69 135.59 14.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.97 -0.633 . . . . 1.3200000000000001 111.681 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.71 -55.21 37.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 2.77 110.174 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.59 170.27 19.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.39 -0.823 . . . . 2.6400000000000001 109.579 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.83 43.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 1.3 111.369 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.52 -38.0 85.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.949 0.404 . . . . 2.29 111.143 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -94.57 -20.55 19.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.809 -0.632 . . . . 2.6400000000000001 110.509 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 38.8 m-80 -95.3 81.81 3.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.129 -0.487 . . . . 1.49 110.927 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.36 120.56 26.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 1.3700000000000001 111.377 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.4 Cg_endo -76.49 132.75 13.76 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.204 2.603 . . . . 0.84999999999999998 111.4 174.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' OG ' ' A' ' 83' ' ' SER . 34.3 mmtm -148.78 158.94 44.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.667 0.27 . . . . 3.1400000000000001 111.109 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.576 ' HZ2' ' CD ' ' A' ' 70' ' ' GLU . 19.1 tptm -55.75 128.47 35.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.961 -0.563 . . . . 2.9100000000000001 110.465 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.75 -26.59 20.65 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.9 -0.591 . . . . 1.1899999999999999 111.793 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -83.63 140.22 32.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.652 -0.499 . . . . 1.3799999999999999 109.652 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -76.91 101.59 6.01 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.325 -0.62 . . . . 2.2000000000000002 109.325 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.586 HG11 ' HB2' ' A' ' 125' ' ' PHE . 26.3 m -115.49 133.83 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.781 -0.645 . . . . 1.3300000000000001 111.309 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.48 HG23 ' HD3' ' A' ' 66' ' ' LYS . 17.4 m -103.26 106.93 17.57 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.5 -0.555 . . . . 1.23 109.5 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 m -119.34 141.66 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.551 0.691 . . . . 1.6200000000000001 112.582 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.42 148.67 25.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.944 -1.025 . . . . 3.5600000000000001 109.601 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.688 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 2.5 p90 -144.24 140.88 29.51 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.226 0.329 . . . . 0.88 110.596 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -168.04 160.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.377 -0.601 . . . . 1.1899999999999999 109.377 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 171.32 -137.87 4.6 Favored Glycine 0 C--N 1.329 0.15 0 C-N-CA 119.59 -1.29 . . . . 0.37 113.249 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.9 pttp -143.49 171.71 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 1.96 110.497 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.744 HD22 HG13 ' A' ' 110' ' ' ILE . 42.7 tp -95.0 101.93 13.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.155 -0.475 . . . . 1.1200000000000001 110.131 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.1 tp10 -61.68 -35.28 77.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 1.96 110.575 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 t -55.21 -32.08 61.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 1.1100000000000001 112.55 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -123.35 -4.05 8.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.885 0.374 . . . . 1.24 110.96 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.03 26.06 74.59 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.183 -0.532 . . . . 0.78000000000000003 113.189 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.18 140.01 43.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.168 0.509 . . . . 3.2999999999999998 110.616 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.549 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 p -84.59 159.99 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.883 -0.599 . . . . 1.3400000000000001 110.035 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -74.35 131.5 41.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.116 -0.327 . . . . 0.96999999999999997 110.116 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.57 89.9 1.6 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.313 0.577 . . . . 2.1800000000000002 109.535 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -136.95 168.08 20.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.879 -0.6 . . . . 1.6799999999999999 111.099 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -62.58 -29.14 70.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.8600000000000001 111.403 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -92.65 -44.54 8.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.147 0.425 . . . . 2.1200000000000001 112.147 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -32.45 72.79 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 2.1899999999999999 111.978 -169.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -94.2 -14.07 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.838 -0.345 . . . . 3.1899999999999999 111.21 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.452 HD21 HG13 ' A' ' 63' ' ' VAL . 11.3 t30 -100.32 -44.82 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.358 . . . . 1.27 111.467 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.452 HG13 HD21 ' A' ' 62' ' ' ASN . 3.5 m -129.31 98.82 22.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.669 0.747 . . . . 2.6099999999999999 111.794 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.98 128.48 14.96 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.206 1.938 . . . . 2.1299999999999999 111.52 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -95.86 148.29 22.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 1.6299999999999999 110.521 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HD3' HG23 ' A' ' 41' ' ' THR . 2.4 pptp? -133.07 143.66 49.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 2.0099999999999998 109.658 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -128.87 -178.72 4.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.68999999999999995 111.548 -173.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.537 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 18.5 m170 -114.04 149.68 35.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.659 . . . . 2.6600000000000001 110.437 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.697 HD13 ' HA ' ' A' ' 79' ' ' ASP . 22.9 tp -67.37 122.81 18.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 1.5600000000000001 111.787 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.576 ' CD ' ' HZ2' ' A' ' 36' ' ' LYS . 1.7 tt0 42.39 72.5 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.222 1.009 . . . . 2.0800000000000001 112.259 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -119.71 19.09 12.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.709 0.766 . . . . 1.98 110.587 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.5 -18.85 46.87 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.276 -0.874 . . . . 0.78000000000000003 112.835 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.83 -50.96 6.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.407 0.622 . . . . 0.96999999999999997 109.617 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -100.16 132.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.604 -0.726 . . . . 1.25 110.381 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.495 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.04 -74.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.799 0.666 . . . . 1.3500000000000001 112.799 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 75' ' ' ILE . 19.8 mtpp -128.82 -40.81 1.51 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.876 -0.515 . . . . 2.5600000000000001 112.174 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -49.51 52.58 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.824 -0.703 . . . . 0.34000000000000002 112.462 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.406 ' O ' HG21 ' A' ' 82' ' ' VAL . 14.7 m-90 -76.02 -41.09 52.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.626 0.25 . . . . 0.56000000000000005 110.858 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.697 ' HA ' HD13 ' A' ' 69' ' ' LEU . 35.0 t70 -56.02 -53.41 57.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.964 -0.562 . . . . 1.1399999999999999 112.329 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.75 -33.35 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 1.3999999999999999 110.873 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.548 ' HG ' HD11 ' A' ' 120' ' ' ILE . 48.7 t -69.25 -50.0 51.08 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.805 -0.358 . . . . 0.98999999999999999 110.243 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' A' ' 69' ' ' LEU . 89.4 t -63.29 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.496 -0.32 . . . . 1.49 111.338 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.431 ' OG ' ' HD3' ' A' ' 35' ' ' LYS . 23.3 t -71.69 -8.47 54.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.813 0.34 . . . . 1.9399999999999999 111.456 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 t -114.0 23.05 13.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.112 0.482 . . . . 1.8700000000000001 110.389 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.933 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 82.8 mmm -99.45 177.33 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 2.79 111.332 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HB2' ' CB ' ' A' ' 89' ' ' GLU . 97.1 mtt180 -141.08 159.4 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 4.9199999999999999 108.417 173.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 63.9 tttm -66.45 -21.68 66.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.093 0.473 . . . . 2.4300000000000002 111.087 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.77 12.13 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 1.4199999999999999 110.703 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.574 ' CB ' ' HB2' ' A' ' 86' ' ' ARG . 18.2 tt0 -122.64 156.26 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.443 -0.344 . . . . 1.6000000000000001 110.444 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.933 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 75.3 tttt -156.51 134.93 11.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.367 -0.379 . . . . 1.74 110.704 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.403 ' SG ' HD12 ' A' ' 22' ' ' ILE . 64.3 m -139.07 171.66 13.99 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.89 0.7 . . . . 1.3600000000000001 112.89 -173.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.33 125.75 53.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.23 -0.895 . . . . 2.2999999999999998 110.062 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.489 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 13.9 p -117.73 150.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.896 0.379 . . . . 1.46 111.101 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -108.27 115.54 30.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 2.29 110.226 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.86 103.8 13.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.163 -0.681 . . . . 1.2 109.163 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.62 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 22.1 tt0 -86.58 176.12 7.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.047 -0.979 . . . . 1.3700000000000001 109.293 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.406 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 20.6 p -49.93 -48.94 51.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.268 0.47 . . . . 1.22 112.268 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.04 -7.83 56.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.307 . . . . 2.3199999999999998 111.72 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.62 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.4 m-30 -94.68 -9.52 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.57 0.224 . . . . 0.92000000000000004 110.724 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 -171.74 14.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.044 -0.598 . . . . 0.85999999999999999 111.797 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 1.52 110.835 176.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.401 ' CB ' HD11 ' A' ' 110' ' ' ILE . 14.4 m . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.371 0.129 . . . . 1.71 111.013 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.744 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.0 57.07 3.28 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-O 120.646 0.26 . . . . 1.3700000000000001 111.537 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 55.5 Cg_endo -97.7 59.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.115 2.543 . . . . 1.5800000000000001 112.538 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.6 56.14 4.16 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.729 -0.748 . . . . 2.0499999999999998 112.043 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 67.01 14.14 9.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.322 0.649 . . . . 2.2999999999999998 109.82 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -86.55 159.56 19.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.343 -0.844 . . . . 1.5700000000000001 110.406 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.87 128.07 43.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.017 0.437 . . . . 1.1799999999999999 110.694 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.6 mp -122.36 165.86 15.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.456 . . . . 1.25 110.544 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -116.56 113.1 22.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.409 -0.589 . . . . 1.3500000000000001 109.409 176.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -111.86 124.69 52.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.374 0.607 . . . . 0.56000000000000005 110.89 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.0 tm-20 -83.0 120.54 25.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.886 -1.052 . . . . 1.46 109.172 174.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.548 HD11 ' HG ' ' A' ' 81' ' ' CYS . 48.4 mt -109.34 130.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.223 0.535 . . . . 1.1599999999999999 111.098 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -126.01 121.66 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.347 -0.842 . . . . 1.8799999999999999 110.329 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.474 HD22 ' HG3' ' A' ' 34' ' ' PRO . 27.7 tp -87.03 89.7 8.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.948 -0.76 . . . . 1.75 108.948 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.71 -25.77 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.082 -0.508 . . . . 1.78 111.762 -172.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 m -154.13 142.26 20.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.758 0.313 . . . . 1.53 110.546 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.586 ' HB2' HG11 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -167.43 179.6 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.245 -0.65 . . . . 0.90000000000000002 109.245 175.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -159.64 158.99 32.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.983 0.421 . . . . 3.4700000000000002 110.682 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 3.3799999999999999 110.492 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.037 0.446 . . . . 4.54 110.807 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.91 142.51 33.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.549 -0.751 . . . . 2.71 109.417 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -82.88 148.63 27.59 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 2.4399999999999999 109.475 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.2 t -101.87 104.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.759 . . . . 1.3100000000000001 108.952 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -91.25 110.37 21.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 2.1600000000000001 110.957 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 87.0 mt 64.38 67.63 0.57 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.082 -0.963 . . . . 2.04 110.574 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -74.45 167.66 21.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.03 -0.532 . . . . 1.26 110.696 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -0.82 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 1.3700000000000001 112.004 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.699 ' OD2' ' HA ' ' A' ' 80' ' ' ILE . 8.4 t70 -79.09 -0.61 32.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.248 0.546 . . . . 2.3999999999999999 110.423 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.16 22.94 2.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.598 -0.811 . . . . 0.83999999999999997 113.69 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 75.68 72.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.091 -0.576 . . . . 0.62 114.524 171.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 80' ' ' ILE . 38.8 t -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.937 -0.394 . . . . 1.1799999999999999 109.937 172.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.7 mm -89.75 112.64 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 1.1799999999999999 110.845 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -136.96 145.97 44.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 1.96 111.382 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -107.95 123.62 48.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 1.21 110.232 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 91' ' ' CYS . 8.2 tp -83.98 130.95 35.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 1.3 110.997 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.578 HD22 ' HG ' ' A' ' 92' ' ' LEU . 2.5 mm? -100.14 -60.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.339 0.59 . . . . 1.3999999999999999 109.733 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 24' ' ' LYS . 32.8 ttpt -122.26 122.71 39.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 2.0600000000000001 109.659 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -82.28 147.48 28.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.295 -0.412 . . . . 3.25 111.38 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.94 144.12 33.19 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.509 -1.036 . . . . 1.3200000000000001 110.509 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.13 -78.14 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.275 0.538 . . . . 2.77 109.62 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.58 164.83 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.218 -0.66 . . . . 2.6400000000000001 109.218 171.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.523 ' HA3' ' CZ ' ' A' ' 86' ' ' ARG . . . 157.24 70.35 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.957 -1.115 . . . . 1.3 113.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -75.36 -30.89 60.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.42 0.629 . . . . 2.29 110.14 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -86.39 -39.0 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.389 -0.823 . . . . 2.6400000000000001 111.419 -174.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.752 ' HB2' HH21 ' A' ' 86' ' ' ARG . 10.6 m120 -93.66 79.54 4.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.186 0.517 . . . . 1.49 111.096 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.09 125.63 21.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.073 -0.967 . . . . 1.3700000000000001 110.338 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HG3' HD22 ' A' ' 122' ' ' LEU . 67.5 Cg_endo -73.57 140.39 29.7 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.908 2.405 . . . . 0.84999999999999998 111.542 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 14.2 mmmm -127.41 147.68 50.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.426 -0.583 . . . . 3.1400000000000001 109.426 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.528 ' HA ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.31 149.14 48.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.774 -0.371 . . . . 2.9100000000000001 111.242 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.89 -17.29 53.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.836 -0.697 . . . . 1.1899999999999999 111.966 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 81.5 m-20 -85.68 175.89 8.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 1.3799999999999999 111.083 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.468 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -97.48 121.57 39.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.534 -0.757 . . . . 2.2000000000000002 109.747 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 HG11 HD23 ' A' ' 69' ' ' LEU . 6.9 m -140.99 166.64 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.767 0.318 . . . . 1.3300000000000001 110.446 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.531 HG21 ' HD3' ' A' ' 66' ' ' LYS . 21.0 m -133.97 116.94 16.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 1.23 110.408 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.681 HG11 ' HA ' ' A' ' 122' ' ' LEU . 34.9 m -134.87 145.25 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.437 -0.347 . . . . 1.6200000000000001 110.687 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -100.84 140.52 35.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.415 -0.587 . . . . 3.5600000000000001 109.415 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 42.6 p90 -125.75 135.47 52.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.88 111.397 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.87 155.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.391 -0.966 . . . . 1.1899999999999999 108.391 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 178.61 -130.03 1.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.744 -1.217 . . . . 0.37 113.27 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.557 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 57.2 pttt -147.06 171.32 15.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 1.96 110.313 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.541 HD21 HG13 ' A' ' 110' ' ' ILE . 61.7 tp -96.73 98.39 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 1.1200000000000001 109.914 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.569 ' HB2' HD13 ' A' ' 117' ' ' LEU . 3.3 tp10 -68.65 -22.41 64.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.248 0.546 . . . . 1.96 110.547 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -25.43 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.389 -0.823 . . . . 1.1100000000000001 111.407 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.599 HG21 ' HD3' ' A' ' 53' ' ' LYS . 7.9 t -132.97 -19.31 2.27 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.986 0.422 . . . . 1.24 111.072 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' C ' ' HD2' ' A' ' 53' ' ' LYS . . . 91.6 34.82 7.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.28 -0.486 . . . . 0.78000000000000003 112.853 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.599 ' HD3' HG21 ' A' ' 51' ' ' THR . 13.7 mptt -116.97 134.93 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.75 0.309 . . . . 3.2999999999999998 110.989 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.557 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.1 p -79.31 156.39 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.935 -0.575 . . . . 1.3400000000000001 110.838 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -74.25 131.15 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.96999999999999997 111.04 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.01 89.13 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.833 -0.621 . . . . 2.1800000000000002 109.882 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.2 m -124.99 147.03 49.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.533 -0.758 . . . . 1.6799999999999999 110.094 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 m -59.24 -20.4 53.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.987 -0.551 . . . . 1.8600000000000001 111.127 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -92.3 -50.85 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.171 -0.468 . . . . 2.1200000000000001 111.901 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -32.4 72.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.936 0.347 . . . . 2.1899999999999999 111.936 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -83.4 1.83 39.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.346 0.593 . . . . 3.1899999999999999 110.26 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.448 HD21 HG11 ' A' ' 63' ' ' VAL . 10.3 t30 -109.23 -48.64 3.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.37 -0.832 . . . . 1.27 110.448 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.448 HG11 HD21 ' A' ' 62' ' ' ASN . 7.6 p -152.13 126.15 4.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.036 0.446 . . . . 2.6099999999999999 111.085 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.53 162.06 19.4 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.78 2.32 . . . . 2.1299999999999999 112.327 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -104.09 154.83 19.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.752 -0.462 . . . . 1.6299999999999999 109.752 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HD3' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.15 136.12 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 2.0099999999999998 110.692 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -114.44 -174.23 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.553 -0.294 . . . . 0.68999999999999995 110.518 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.446 ' HB2' HE21 ' A' ' 71' ' ' GLN . 80.4 m-70 -126.45 153.05 45.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.269 -0.271 . . . . 2.6600000000000001 110.269 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -51.34 151.93 2.74 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.457 0.473 . . . . 1.5600000000000001 111.659 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -22.2 98.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 113.318 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -129.8 8.07 5.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.508 -1.224 . . . . 1.98 108.98 176.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.13 -10.45 43.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.78000000000000003 113.409 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -85.23 -46.56 10.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.804 0.802 . . . . 0.96999999999999997 109.248 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.55 134.06 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.031 -0.531 . . . . 1.25 110.575 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.588 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.6 -69.83 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.461 0.541 . . . . 1.3500000000000001 112.461 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.588 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -140.96 -45.66 0.39 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.563 0.579 . . . . 2.5600000000000001 112.563 -173.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 -53.12 34.79 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.944 -0.646 . . . . 0.34000000000000002 113.005 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 82' ' ' VAL . 18.3 m-90 -76.69 -31.01 56.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 0.56000000000000005 110.75 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -57.92 -49.14 77.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.46 -0.791 . . . . 1.1399999999999999 111.759 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.699 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . 1.6 mp -59.69 -31.32 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.124 0.487 . . . . 1.3999999999999999 111.051 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.777 ' HB2' HG21 ' A' ' 93' ' ' VAL . 14.9 t -77.05 -58.05 3.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.334 -0.546 . . . . 0.98999999999999999 110.713 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.976 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 15.5 m -62.13 -33.54 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.791 0.664 . . . . 1.49 112.791 -170.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t -92.12 5.66 49.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.079 0.466 . . . . 1.9399999999999999 110.974 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 32.0 t -137.73 30.09 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.228 0.537 . . . . 1.8700000000000001 110.083 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.976 ' HE3' ' HA ' ' A' ' 82' ' ' VAL . 45.3 mtm -106.59 -172.12 2.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 2.79 110.373 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.752 HH21 ' HB2' ' A' ' 32' ' ' ASN . 14.5 mtp-105 -138.73 170.74 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.515 . . . . 4.9199999999999999 110.212 171.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -64.12 -20.57 66.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.282 -0.417 . . . . 2.4300000000000002 111.621 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -127.05 16.57 7.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.36 -0.382 . . . . 1.4199999999999999 111.106 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 2.1 tm-20 -110.38 153.72 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -158.86 123.33 4.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.691 -0.231 . . . . 1.74 110.551 -173.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 1.6 p -136.53 159.05 42.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.437 -0.347 . . . . 1.3600000000000001 111.421 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.578 ' HG ' HD22 ' A' ' 23' ' ' LEU . 97.9 mt -105.2 127.17 52.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.12 -0.491 . . . . 2.2999999999999998 110.852 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.777 HG21 ' HB2' ' A' ' 81' ' ' CYS . 39.1 t -105.74 151.08 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.968 -0.56 . . . . 1.46 111.015 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.36 112.17 25.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.445 -0.576 . . . . 2.29 109.445 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.448 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.4 mp -90.3 105.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 1.2 110.43 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 97' ' ' SER . 34.0 tt0 -82.29 166.09 19.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 1.3700000000000001 109.12 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 3.6 p -52.99 -42.94 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.565 0.58 . . . . 1.22 112.565 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -76.99 -7.91 56.46 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.882 -0.327 . . . . 2.3199999999999998 111.5 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -89.03 -1.48 58.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.017 0.437 . . . . 0.92000000000000004 110.196 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.54 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -146.3 -165.42 11.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.681 -0.69 . . . . 0.85999999999999999 111.411 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 117.304 0.552 . . . . 1.52 110.336 179.009 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.405 0.145 . . . . 1.71 111.241 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.541 HG13 HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.04 81.82 10.33 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 121.15 0.5 . . . . 1.3700000000000001 111.432 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -102.7 -149.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.303 3.335 . . . . 1.5800000000000001 111.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.31 73.31 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.838 -0.696 . . . . 2.0499999999999998 112.288 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.534 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 15.6 m120 56.73 23.61 8.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.118 0.485 . . . . 2.2999999999999998 111.188 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 m -114.0 151.59 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.96 -0.564 . . . . 1.5700000000000001 109.594 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.13 132.63 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.599 . . . . 1.1799999999999999 111.295 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -125.02 165.29 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 1.25 109.999 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -124.83 124.74 42.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.178 -0.675 . . . . 1.3500000000000001 109.178 173.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.67 143.24 47.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.74 -0.209 . . . . 0.56000000000000005 110.553 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 38.5 mt-10 -62.63 136.49 57.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.738 -0.467 . . . . 1.46 109.738 168.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.541 ' HB ' ' HG ' ' A' ' 81' ' ' CYS . 22.3 mt -128.09 116.85 44.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.229 -1.026 . . . . 1.1599999999999999 108.229 169.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -135.17 111.47 9.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.692 -0.685 . . . . 1.8799999999999999 110.535 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.681 ' HA ' HG11 ' A' ' 42' ' ' VAL . 23.0 tp -81.47 100.09 9.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.361 -0.381 . . . . 1.75 110.788 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -104.81 -9.45 18.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.868 0.366 . . . . 1.78 111.167 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.506 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 67.5 m -155.28 139.52 16.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 1.53 110.524 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.495 ' HB3' HD13 ' A' ' 122' ' ' LEU . 7.8 p90 -165.74 150.29 8.44 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.29 0.369 . . . . 0.90000000000000002 110.222 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HE ' ' HB3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -146.24 127.33 14.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.943 0.401 . . . . 3.4700000000000002 110.922 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.511 -0.768 . . . . 3.3799999999999999 111.178 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.03 0.443 . . . . 4.54 111.158 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -81.63 151.61 27.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.675 -0.693 . . . . 2.71 109.145 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.58 145.84 25.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.79 0.329 . . . . 2.4399999999999999 110.274 -177.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.504 HG12 ' HB ' ' A' ' 13' ' ' THR . 21.8 t -101.97 103.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.965 -1.124 . . . . 1.3100000000000001 107.965 170.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HG2' HG21 ' A' ' 19' ' ' ILE . 45.9 mt-10 -102.47 120.84 41.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.714 . . . . 2.1600000000000001 110.622 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.9 tp 65.54 50.93 1.58 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.241 -0.89 . . . . 2.04 109.436 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.504 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.9 t -62.97 159.46 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 1.26 111.617 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 2.11 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 1.3700000000000001 111.436 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.595 ' O ' HG13 ' A' ' 80' ' ' ILE . 40.3 m-20 -83.61 7.79 16.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.172 -0.467 . . . . 2.3999999999999999 111.367 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.36 22.6 2.29 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.394 -0.908 . . . . 0.83999999999999997 113.555 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.89 62.7 4.32 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.293 -0.48 . . . . 0.62 114.083 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 80' ' ' ILE . 39.4 t -137.62 152.77 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.081 0.44 . . . . 1.1799999999999999 110.224 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 11' ' ' GLU . 18.1 mm -85.36 109.7 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.474 -0.565 . . . . 1.1799999999999999 109.474 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -118.99 130.45 55.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 1.96 110.65 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 m -109.94 117.69 34.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.097 -0.502 . . . . 1.21 110.703 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.492 HD11 ' SG ' ' A' ' 91' ' ' CYS . 6.2 tp -74.77 131.71 34.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 1.3 111.356 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 2.6 mm? -120.76 -81.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 1.3999999999999999 111.362 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -89.44 134.3 34.15 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.928 0.394 . . . . 2.0600000000000001 110.309 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 41.3 mtmt -111.34 113.18 25.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.779 -0.646 . . . . 3.25 110.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.509 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -73.71 -151.74 2.08 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.219 -0.515 . . . . 1.3200000000000001 111.89 174.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.47 -97.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.104 -0.645 . . . . 2.77 111.725 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.72 126.45 36.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.46 0.647 . . . . 2.6400000000000001 110.934 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.51 47.79 0.86 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.582 -0.818 . . . . 1.3 112.611 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.15 -42.11 99.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 2.29 109.945 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.25 28.2 8.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.977 -1.01 . . . . 2.6400000000000001 109.4 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.79 76.87 1.63 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.49 110.89 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.485 HG21 ' HD3' ' A' ' 35' ' ' LYS . 30.8 mm -141.94 116.28 6.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 123.265 0.353 . . . . 1.3700000000000001 111.274 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 28.1 Cg_endo -63.41 138.69 67.03 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.058 2.505 . . . . 0.84999999999999998 111.065 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HD3' HG21 ' A' ' 33' ' ' ILE . 6.0 mmmm -126.54 155.07 42.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.106 0.479 . . . . 3.1400000000000001 111.713 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -70.38 117.54 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.17 -0.923 . . . . 2.9100000000000001 110.291 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.81 -26.88 22.82 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.99 -0.624 . . . . 1.1899999999999999 111.923 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.69 154.19 42.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 1.3799999999999999 110.179 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 40.8 mt-10 -76.99 99.9 5.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.113 0.482 . . . . 2.2000000000000002 110.822 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.3 m -118.64 143.61 29.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.335 -0.617 . . . . 1.3300000000000001 109.335 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.7 m -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.267 -0.642 . . . . 1.23 109.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.38 139.35 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.334 0.587 . . . . 1.6200000000000001 111.839 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -104.39 134.88 46.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 3.5600000000000001 110.39 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -123.87 136.82 54.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.88 110.464 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.45 153.23 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.488 -0.93 . . . . 1.1899999999999999 108.488 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.93 -124.44 0.91 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.775 -1.202 . . . . 0.37 113.231 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.7 pttp -157.61 170.12 23.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 1.96 111.0 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 69.8 tp -97.26 103.18 15.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.506 -0.77 . . . . 1.1200000000000001 110.145 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 117' ' ' LEU . 6.5 tp10 -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.873 0.368 . . . . 1.96 110.151 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' A' ' 115' ' ' VAL . 8.3 t -55.4 -28.92 57.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 1.1100000000000001 112.089 -174.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 t -140.26 14.55 2.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.285 0.564 . . . . 1.24 110.486 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.9 44.33 96.13 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.336 -0.847 . . . . 0.78000000000000003 113.065 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 12.2 mmmt -105.98 126.03 51.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.278 -0.267 . . . . 3.2999999999999998 110.278 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.1 p -83.99 159.48 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.509 -0.552 . . . . 1.3400000000000001 109.509 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -75.04 102.94 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 0.96999999999999997 110.984 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -125.58 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.604 0.716 . . . . 2.1800000000000002 109.835 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.8 m -126.11 169.22 13.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.959 -0.564 . . . . 1.6799999999999999 110.536 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -71.44 -26.31 62.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.088 0.47 . . . . 1.8600000000000001 110.818 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.2 -44.77 7.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.923 -0.58 . . . . 2.1200000000000001 112.371 -170.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -44.82 80.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.989 0.366 . . . . 2.1899999999999999 111.989 -169.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -77.1 -9.17 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.423 . . . . 3.1899999999999999 110.938 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -96.13 -61.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.018 -0.537 . . . . 1.27 109.978 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.23 109.77 7.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.446 0.641 . . . . 2.6099999999999999 110.474 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.07 158.18 38.08 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.58 2.187 . . . . 2.1299999999999999 112.543 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.56 154.07 19.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 1.6299999999999999 109.775 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -129.91 159.54 36.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 2.0099999999999998 109.999 178.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.69 173.35 11.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.68999999999999995 111.066 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -116.01 140.17 49.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.408 -0.815 . . . . 2.6600000000000001 109.609 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD22 HG21 ' A' ' 82' ' ' VAL . 26.4 tp -69.1 131.91 45.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.232 -0.284 . . . . 1.5600000000000001 110.232 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.56 79.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.92 0.867 . . . . 2.0800000000000001 109.232 -169.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.508 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 28.4 tt0 -131.64 -3.6 3.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.341 -1.3 . . . . 1.98 110.211 -174.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.6 -18.53 24.48 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.998 -0.62 . . . . 0.78000000000000003 112.353 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 2.1 mm-40 -93.64 -11.39 31.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.96999999999999997 109.954 -177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.17 124.48 64.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 1.25 109.702 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.458 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -97.1 -61.45 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 1.3500000000000001 112.925 -176.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 mmpt? -138.11 -48.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 2.5600000000000001 111.881 -173.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.08 -50.72 44.29 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.037 -0.601 . . . . 0.34000000000000002 113.12 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.471 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.12 -41.16 59.06 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.807 -0.231 . . . . 0.56000000000000005 110.433 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.63 -51.57 54.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.607 -0.724 . . . . 1.1399999999999999 112.041 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.7 mp -63.04 -42.97 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 1.3999999999999999 111.52 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.534 ' HB3' HD11 ' A' ' 120' ' ' ILE . 49.3 t -75.32 -42.34 54.75 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.848 0.314 . . . . 0.98999999999999999 111.848 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 69' ' ' LEU . 35.4 m -69.15 -34.41 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.779 0.288 . . . . 1.49 111.779 -175.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 p -72.03 -16.44 62.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.099 0.476 . . . . 1.9399999999999999 110.814 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.7 m -97.57 8.26 44.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.981 -0.554 . . . . 1.8700000000000001 110.928 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.715 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 20.1 mmt -93.94 -173.65 3.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 2.79 111.495 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 33.6 mtp-105 -143.2 -171.27 3.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.349 -0.841 . . . . 4.9199999999999999 109.002 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.42 -24.63 67.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.299 0.374 . . . . 2.4300000000000002 111.992 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -135.39 15.28 3.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 1.4199999999999999 111.309 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -79.87 159.94 26.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.889 0.376 . . . . 1.6000000000000001 110.683 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -158.36 132.45 7.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.089 -0.505 . . . . 1.74 110.354 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 99.9 m -150.7 170.93 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 1.3600000000000001 110.816 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.34 124.95 52.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.54 . . . . 2.2999999999999998 110.237 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 95' ' ' ILE . 6.3 p -100.76 146.22 9.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.15 -0.477 . . . . 1.46 110.264 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 12.3 mmt180 -98.63 112.06 24.23 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.177 -0.675 . . . . 2.29 109.177 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 93' ' ' VAL . 4.1 mp -98.04 103.87 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.131 0.491 . . . . 1.2 110.447 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.56 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 27.6 tt0 -86.49 170.73 11.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.336 -0.987 . . . . 1.3700000000000001 108.336 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.472 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.9 p -51.69 -38.32 54.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.826 0.306 . . . . 1.22 111.826 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -77.71 -8.72 58.35 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.042 0.386 . . . . 2.3199999999999998 112.042 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.56 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 20.6 m-85 -102.62 -16.36 16.09 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.752 0.31 . . . . 0.92000000000000004 110.607 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.36 -163.01 12.45 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.252 -0.739 . . . . 0.85999999999999999 111.252 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.52 110.992 177.285 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 111.426 0.158 . . . . 1.71 111.426 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.45 96.75 4.13 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.059 0.457 . . . . 1.3700000000000001 111.45 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -91.5 -164.1 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.833 2.355 . . . . 1.5800000000000001 111.888 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 121.7 50.26 0.25 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.382 -0.913 . . . . 2.0499999999999998 113.285 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.7 m120 62.8 17.21 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.068 0.461 . . . . 2.2999999999999998 111.336 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.3 p -94.83 175.68 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.833 -0.621 . . . . 1.5700000000000001 111.339 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.447 ' H ' ' HB2' ' A' ' 50' ' ' SER . 6.3 p -114.7 127.49 72.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 116.136 -0.483 . . . . 1.1799999999999999 110.203 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.9 mp -120.97 169.7 10.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.007 -0.542 . . . . 1.25 111.054 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -128.95 126.28 39.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.084 -0.71 . . . . 1.3500000000000001 109.084 175.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -118.8 123.96 46.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.075 0.464 . . . . 0.56000000000000005 111.151 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.86 119.44 16.04 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.186 -1.042 . . . . 1.46 108.186 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 81' ' ' CYS . 42.2 mt -106.41 116.14 49.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 1.1599999999999999 109.5 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -126.94 119.3 26.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.779 -1.1 . . . . 1.8799999999999999 109.466 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 tt -90.88 117.14 29.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.804 -0.635 . . . . 1.75 109.731 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.39 -23.81 15.02 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.019 -0.272 . . . . 1.78 111.668 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -164.05 153.45 14.11 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.004 0.431 . . . . 1.53 110.564 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.573 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -161.83 178.72 8.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.652 -0.704 . . . . 0.90000000000000002 109.618 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HD3' ' HB2' ' A' ' 39' ' ' GLU . 14.0 ptm180 -150.93 137.9 19.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 3.4700000000000002 110.053 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 3.3799999999999999 110.556 179.189 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.056 0.455 . . . . 4.54 111.3 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.86 144.12 32.23 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.876 -0.787 . . . . 2.71 108.876 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.15 139.07 35.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.219 -0.66 . . . . 2.4399999999999999 109.219 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.624 HG13 ' HB ' ' A' ' 13' ' ' THR . 32.9 t -100.99 104.43 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.528 -0.545 . . . . 1.3100000000000001 109.528 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -102.64 134.91 45.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.939 -0.573 . . . . 2.1600000000000001 111.566 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.83 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 81.8 mt 52.25 51.89 15.38 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.511 -0.768 . . . . 2.04 111.332 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.624 ' HB ' HG13 ' A' ' 10' ' ' VAL . 15.4 t -70.68 168.36 16.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.682 -0.69 . . . . 1.26 110.521 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.35 -12.56 61.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.837 0.68 . . . . 1.3700000000000001 112.837 -170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' ILE . 3.3 t70 -89.57 14.02 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.717 -0.393 . . . . 2.3999999999999999 111.638 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.44 29.93 1.04 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.589 -0.815 . . . . 0.83999999999999997 114.119 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.83 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 60.01 33.29 78.46 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.881 1.112 . . . . 0.62 115.881 166.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.529 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 30.6 t -104.06 142.48 17.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 117.886 0.843 . . . . 1.1799999999999999 110.727 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 2.3 mm -88.57 116.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.86 -0.609 . . . . 1.1799999999999999 110.013 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HE2' ' HB3' ' A' ' 84' ' ' SER . 21.4 pttp -138.75 136.02 35.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 1.96 111.021 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 m -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.163 -0.926 . . . . 1.21 109.923 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tp -88.7 127.62 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.087 0.47 . . . . 1.3 110.811 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -116.26 -52.13 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.427 0.632 . . . . 1.3999999999999999 110.499 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.5 ' HE2' ' CB ' ' A' ' 90' ' ' LYS . 29.6 ttpt -119.07 121.91 40.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.63 -0.714 . . . . 2.0600000000000001 110.047 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -99.98 126.19 46.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.392 -0.367 . . . . 3.25 111.14 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 155.64 32.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.972 -0.633 . . . . 1.3200000000000001 111.743 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.4 -81.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.646 0.26 . . . . 2.77 111.171 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.11 150.08 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 2.6400000000000001 110.426 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -156.68 51.05 0.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.308 -0.948 . . . . 1.3 112.854 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.3 -42.23 55.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.584 0.707 . . . . 2.29 109.299 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 -16.59 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 2.6400000000000001 110.562 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.464 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 19.3 m-80 -85.48 76.04 10.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.232 -0.44 . . . . 1.49 110.537 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 33.3 mm -140.87 119.7 8.27 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.857 -0.61 . . . . 1.3700000000000001 109.863 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 1.5 Cg_endo -82.15 111.05 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.84999999999999998 111.638 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -118.06 152.24 35.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.472 -0.566 . . . . 3.1400000000000001 109.472 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 148.97 46.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.977 0.418 . . . . 2.9100000000000001 110.278 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.91 -9.78 65.94 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.887 -0.885 . . . . 1.1899999999999999 110.887 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 95.5 m-20 -107.49 159.42 16.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.856 -0.672 . . . . 1.3799999999999999 109.511 174.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 102.32 14.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.497 -0.557 . . . . 2.2000000000000002 109.497 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -116.19 145.03 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.693 -0.685 . . . . 1.3300000000000001 109.579 175.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 108.63 13.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.047 -0.524 . . . . 1.23 110.263 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 122' ' ' LEU . 18.5 m -131.36 153.3 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.527 -0.306 . . . . 1.6200000000000001 111.544 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.516 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 36.7 m170 -105.24 162.51 13.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 3.5600000000000001 110.337 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 12.7 p90 -145.58 129.44 17.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.88 110.028 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -167.02 153.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.85 -0.426 . . . . 1.1899999999999999 109.85 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 55' ' ' PHE . . . 176.3 -111.57 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.717 -1.23 . . . . 0.37 112.968 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' HG3' HD11 ' A' ' 117' ' ' LEU . 51.7 pttt -157.23 166.95 31.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.987 0.423 . . . . 1.96 110.882 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.2 tp -92.56 102.07 14.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.963 -0.562 . . . . 1.1200000000000001 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 3.6 tp10 -58.71 -30.47 67.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.616 -0.72 . . . . 1.96 111.039 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -55.88 -32.43 63.69 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.563 -0.744 . . . . 1.1100000000000001 112.264 -173.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 53' ' ' LYS . 13.6 t -140.21 5.52 2.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.445 -0.502 . . . . 1.24 111.983 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.83 46.63 59.62 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 121.098 -0.572 . . . . 0.78000000000000003 112.394 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.45 ' HB2' HG23 ' A' ' 51' ' ' THR . 2.0 tmtp? -115.14 126.36 54.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.652 -0.499 . . . . 3.2999999999999998 109.652 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.07 153.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.454 -0.339 . . . . 1.3400000000000001 110.196 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 0.8 OUTLIER -74.45 106.4 6.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.403 . . . . 0.96999999999999997 110.722 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -121.7 103.57 8.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.87 0.843 . . . . 2.1800000000000002 110.324 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 34.8 m -136.81 150.53 48.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.119 -0.491 . . . . 1.6799999999999999 110.004 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.4 m -62.6 -36.09 81.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 1.8600000000000001 111.174 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.21 -33.9 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.348 -0.387 . . . . 2.1200000000000001 110.887 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 6.9 t70 -56.99 -52.48 65.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.934 0.397 . . . . 2.1899999999999999 111.993 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -77.25 2.6 15.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.368 -0.378 . . . . 3.1899999999999999 111.44 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -111.5 -52.85 2.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.42 -0.355 . . . . 1.27 110.845 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.7 p -133.04 117.18 14.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.197 0.522 . . . . 2.6099999999999999 111.167 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.4 Cg_exo -77.03 146.08 25.37 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.041 2.494 . . . . 2.1299999999999999 111.459 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -103.82 151.09 23.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.464 -0.335 . . . . 1.6299999999999999 110.251 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 1.7 pptp? -128.93 154.19 46.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.529 -0.305 . . . . 2.0099999999999998 110.911 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -137.21 174.49 10.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.524 -0.307 . . . . 0.68999999999999995 111.156 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.84 150.21 33.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.076 -0.712 . . . . 2.6600000000000001 109.076 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.749 HD12 HG22 ' A' ' 82' ' ' VAL . 16.8 tp -70.6 124.66 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.475 0.546 . . . . 1.5600000000000001 112.475 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' N ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER 42.4 63.29 1.44 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.388 -1.278 . . . . 2.0800000000000001 112.335 173.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -108.55 9.28 27.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.71 -1.132 . . . . 1.98 108.751 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.6 -16.38 48.06 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.971 -1.013 . . . . 0.78000000000000003 113.084 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -85.48 -39.43 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.457 0.629 . . . . 0.96999999999999997 110.501 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 m -97.9 135.41 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.389 -0.597 . . . . 1.25 109.389 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.762 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -94.55 -76.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.382 0.512 . . . . 1.3500000000000001 112.382 -172.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.762 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.25 -37.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.873 -0.517 . . . . 2.5600000000000001 112.315 -175.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.61 -54.29 31.17 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.449 -0.881 . . . . 0.34000000000000002 113.153 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.618 ' O ' HG23 ' A' ' 82' ' ' VAL . 23.3 m-90 -76.67 -31.52 57.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.736 -0.273 . . . . 0.56000000000000005 110.708 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -51.49 -53.35 38.32 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.019 0.824 . . . . 1.1399999999999999 111.843 -170.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.529 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 2.0 mp -68.77 -29.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.096 0.474 . . . . 1.3999999999999999 111.275 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.617 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 19.9 t -72.55 -38.23 68.05 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.603 -0.439 . . . . 0.98999999999999999 110.514 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG22 HD12 ' A' ' 69' ' ' LEU . 2.1 m -83.86 -33.95 9.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.791 -0.364 . . . . 1.49 111.498 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -65.66 -25.57 67.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.157 0.503 . . . . 1.9399999999999999 110.63 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.539 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 22.0 t -121.92 44.97 2.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.777 -0.647 . . . . 1.8700000000000001 110.489 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 82' ' ' VAL . 19.8 ptm -124.68 -175.89 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.989 -0.551 . . . . 2.79 109.688 173.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 64.3 mtt85 -142.95 162.86 34.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.123 -0.695 . . . . 4.9199999999999999 109.123 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.423 ' HG3' HD23 ' A' ' 122' ' ' LEU . 85.6 tttt -61.31 -43.06 99.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 2.4300000000000002 111.364 -175.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -97.29 24.7 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 1.4199999999999999 110.709 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 37.5 tt0 -114.87 163.68 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.037 -0.727 . . . . 1.6000000000000001 109.037 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.5 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 76.1 tttt -157.54 127.56 6.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.926 0.393 . . . . 1.74 110.439 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.1 p -134.7 148.11 50.24 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.785 -0.643 . . . . 1.3600000000000001 111.01 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.73 122.02 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 2.2999999999999998 109.357 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.617 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.4 p -100.65 143.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.159 0.504 . . . . 1.46 111.427 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.517 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 18.3 mmt180 -106.2 112.15 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.438 -0.801 . . . . 2.29 109.441 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 3.9 mp -93.96 100.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.828 -0.349 . . . . 1.2 110.111 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 9.6 tp10 -70.07 156.72 38.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 1.3700000000000001 109.183 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 p -50.12 -44.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.06 0.544 . . . . 1.22 111.761 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.1 ptp -74.76 -8.09 55.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 2.3199999999999998 111.721 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.476 ' CD2' ' HB3' ' A' ' 96' ' ' GLU . 21.8 m-30 -100.05 8.62 43.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.626 0.25 . . . . 0.92000000000000004 110.426 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -139.09 -176.28 14.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.21 -0.519 . . . . 0.85999999999999999 112.201 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 121.14 0.495 . . . . 1.52 111.077 179.02 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.76 0.281 . . . . 1.71 111.76 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 89.99 3.36 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-O 121.146 0.498 . . . . 1.3700000000000001 110.296 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -96.84 -155.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.488 2.792 . . . . 1.5800000000000001 111.663 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.83 31.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.461 -0.876 . . . . 2.0499999999999998 112.85 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.01 41.81 27.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.314 0.578 . . . . 2.2999999999999998 110.553 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 p -122.13 177.05 5.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.5 -0.773 . . . . 1.5700000000000001 110.38 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 5.3 p -93.94 125.47 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.256 0.55 . . . . 1.1799999999999999 110.889 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.83 162.1 15.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 1.25 110.103 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.582 HD11 ' HG3' ' A' ' 47' ' ' LYS . 36.8 mt -119.04 117.47 28.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 1.3500000000000001 110.228 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -125.81 138.0 53.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.259 0.552 . . . . 0.56000000000000005 112.321 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 50.5 mt-10 -79.16 132.77 36.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.226 -0.897 . . . . 1.46 108.981 167.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.523 HD11 HG11 ' A' ' 82' ' ' VAL . 19.5 mt -113.17 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.516 0.674 . . . . 1.1599999999999999 110.252 171.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 90' ' ' LYS . 5.1 tp10 -118.75 120.1 36.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 1.8799999999999999 109.597 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.749 ' HA ' HG13 ' A' ' 42' ' ' VAL . 4.9 tt -89.87 102.4 15.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.526 -0.546 . . . . 1.75 109.526 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.562 HD22 ' H ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -88.89 -35.63 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.577 -0.283 . . . . 1.78 111.486 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 t -152.26 144.79 24.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.598 -0.274 . . . . 1.53 110.755 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.568 ' HB2' HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -164.97 171.75 13.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.90000000000000002 109.799 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 14.0 ptp180 -150.07 124.6 9.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.579 -0.282 . . . . 3.4700000000000002 110.325 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--N 1.326 -0.451 0 N-CA-C 109.871 -0.418 . . . . 3.3799999999999999 109.871 176.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.457 0.646 . . . . 4.54 112.504 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.95 153.28 21.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.445 -0.798 . . . . 2.71 109.057 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 6.2 mptt -98.79 144.3 28.17 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.208 -0.664 . . . . 2.4399999999999999 109.208 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.11 112.83 38.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.886 -0.326 . . . . 1.3100000000000001 110.704 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 4.2 pt-20 -86.59 131.05 34.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.224 -0.287 . . . . 2.1600000000000001 110.224 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.543 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.9 mt 45.58 59.84 3.41 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.897 0.748 . . . . 2.04 111.869 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 t -59.01 153.75 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 1.26 110.757 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.82 43.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.48 0.548 . . . . 1.3700000000000001 112.48 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.6 t0 -85.39 18.27 2.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.706 0.289 . . . . 2.3999999999999999 111.406 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 2.7 9.22 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.422 -0.894 . . . . 0.83999999999999997 114.41 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 77.59 80.31 0.68 Allowed Glycine 0 C--O 1.224 -0.485 0 C-N-CA 121.021 -0.609 . . . . 0.62 114.172 170.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 t -142.7 145.04 23.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.696 -0.483 . . . . 1.1799999999999999 109.696 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.68 110.99 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 1.1799999999999999 110.244 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -136.09 147.12 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 1.96 111.281 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.6 m -117.95 144.25 45.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 1.21 110.469 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 25' ' ' LYS . 9.7 tp -93.39 135.3 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.9 0.381 . . . . 1.3 111.931 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.482 HD21 ' HG ' ' A' ' 92' ' ' LEU . 3.0 mm? -123.34 -71.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.383 0.611 . . . . 1.3999999999999999 109.369 174.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 2.2 mmmt -104.86 116.19 31.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.331 -0.85 . . . . 2.0600000000000001 109.378 176.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -112.9 150.86 31.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.844 -0.342 . . . . 3.25 110.294 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.85 163.25 47.55 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.923 -0.656 . . . . 1.3200000000000001 111.991 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.38 -57.59 2.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.252 0.548 . . . . 2.77 109.752 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -121.12 174.12 6.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.815 . . . . 2.6400000000000001 108.817 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.554 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 126.55 51.88 0.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.546 -0.835 . . . . 1.3 112.296 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.63 -41.29 98.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.809 0.358 . . . . 2.29 111.408 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -89.07 4.27 48.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.427 0.632 . . . . 2.6400000000000001 110.398 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.596 ' HB2' HH21 ' A' ' 86' ' ' ARG . 0.9 OUTLIER -116.59 78.64 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 1.49 109.617 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.6 mm -134.41 123.85 16.76 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.637 . . . . 1.3700000000000001 110.775 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' HG3' HD21 ' A' ' 122' ' ' LEU . 57.2 Cg_endo -70.18 138.45 36.51 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.876 2.384 . . . . 0.84999999999999998 111.457 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -145.66 156.71 43.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.007 0.432 . . . . 3.1400000000000001 111.871 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HG3' ' HB2' ' A' ' 70' ' ' GLU . 1.9 ttmp? -68.56 147.59 51.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.127 -0.942 . . . . 2.9100000000000001 111.111 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' N ' ' HG2' ' A' ' 36' ' ' LYS . . . 93.23 -18.48 56.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.56 -1.016 . . . . 1.1899999999999999 110.56 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 3.6 m-20 -99.18 163.38 12.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.778 -0.711 . . . . 1.3799999999999999 109.834 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.58 126.16 35.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 2.2000000000000002 110.529 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 125' ' ' PHE . 21.1 m -131.05 153.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 1.3300000000000001 109.691 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 29.7 m -113.61 106.07 14.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.374 -0.602 . . . . 1.23 109.374 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.48 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.195 0.522 . . . . 1.6200000000000001 111.341 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -100.34 136.03 40.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.622 -0.717 . . . . 3.5600000000000001 109.079 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.681 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 47.6 p90 -122.87 144.35 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.88 110.364 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -169.08 157.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.416 -0.957 . . . . 1.1899999999999999 108.416 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.91 -126.66 1.13 Allowed Glycine 0 CA--C 1.51 -0.244 0 C-N-CA 119.739 -1.22 . . . . 0.37 113.262 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 64.7 pttt -150.98 165.76 32.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.218 0.532 . . . . 1.96 111.033 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD11 ' HG ' ' A' ' 116' ' ' LEU . 63.5 tp -83.64 97.42 9.08 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.06 -0.719 . . . . 1.1200000000000001 109.06 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 48.4 tp10 -60.93 -25.76 67.0 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.017 -0.538 . . . . 1.96 111.856 -174.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 t -56.19 -27.17 53.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.426 -0.352 . . . . 1.1100000000000001 111.38 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.617 HG21 ' HD3' ' A' ' 53' ' ' LYS . 10.1 t -134.9 -13.93 2.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.835 0.35 . . . . 1.24 111.571 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.54 28.7 34.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.159 -0.543 . . . . 0.78000000000000003 112.957 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HD3' HG21 ' A' ' 51' ' ' THR . 13.9 mptt -100.42 122.57 43.37 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.604 -0.351 . . . . 3.2999999999999998 110.577 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.469 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 8.6 p -73.98 160.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 1.3400000000000001 110.407 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -74.77 147.86 40.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 0.96999999999999997 111.392 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -159.1 89.91 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.254 -0.885 . . . . 2.1800000000000002 108.939 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -136.72 -177.14 4.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 1.6799999999999999 110.815 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -71.56 -38.63 70.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.973 -0.558 . . . . 1.8600000000000001 111.425 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.86 -36.96 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.211 0.819 . . . . 2.1200000000000001 113.211 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -59.97 -33.01 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.878 0.325 . . . . 2.1899999999999999 111.878 -169.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -104.4 -0.94 27.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.282 0.475 . . . . 3.1899999999999999 112.282 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.489 HD21 HG21 ' A' ' 63' ' ' VAL . 20.4 t30 -114.19 -45.79 3.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.302 -0.559 . . . . 1.27 111.576 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 62' ' ' ASN . 95.2 t -132.08 97.81 17.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.918 0.39 . . . . 2.6099999999999999 110.05 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.29 141.73 43.81 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.988 2.459 . . . . 2.1299999999999999 112.599 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.58 146.55 25.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 1.6299999999999999 110.008 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -144.21 153.71 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.981 -0.377 . . . . 2.0099999999999998 109.981 177.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -133.99 175.07 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.68999999999999995 111.152 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -104.58 148.28 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.942 -0.762 . . . . 2.6600000000000001 108.942 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 82' ' ' VAL . 11.3 tp -69.4 119.47 13.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.034 0.445 . . . . 1.5600000000000001 110.584 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 57.55 66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.654 -1.157 . . . . 2.0800000000000001 110.646 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.01 17.78 23.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.947 -1.024 . . . . 1.98 109.063 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.04 -18.03 38.37 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.78000000000000003 112.479 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.86 -23.31 22.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.96999999999999997 110.984 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.8 126.24 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 1.25 110.353 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.526 HD12 ' HA2' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -95.75 -58.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 1.3500000000000001 113.437 -172.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.66 -48.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 2.5600000000000001 112.644 -170.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -52.4 38.13 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.917 -0.659 . . . . 0.34000000000000002 113.131 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.509 ' O ' HG21 ' A' ' 82' ' ' VAL . 9.0 m-90 -76.01 -32.22 59.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.672 0.273 . . . . 0.56000000000000005 110.702 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -53.86 -51.93 62.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.45 -0.795 . . . . 1.1399999999999999 112.179 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -69.29 -43.84 80.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 1.3999999999999999 110.82 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.652 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.8 t -62.21 -50.06 73.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.53 -0.304 . . . . 0.98999999999999999 111.009 -175.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 HD23 ' A' ' 69' ' ' LEU . 33.9 m -66.09 -32.81 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.652 0.263 . . . . 1.49 110.911 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 t -66.05 -40.12 90.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.931 0.396 . . . . 1.9399999999999999 110.131 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 m -89.69 36.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.579 . . . . 1.8700000000000001 111.08 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.856 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 4.4 mmt -112.81 -175.25 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 2.79 110.468 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.596 HH21 ' HB2' ' A' ' 32' ' ' ASN . 8.3 mtp-105 -149.87 175.4 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 4.9199999999999999 110.116 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.63 -22.24 66.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.654 -0.703 . . . . 2.4300000000000002 112.436 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -136.32 34.88 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 1.4199999999999999 110.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 25' ' ' LYS . 30.8 tt0 -120.51 154.06 35.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 1.6000000000000001 109.787 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.6 tttt -156.94 132.22 9.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.663 0.268 . . . . 1.74 111.359 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 93.8 m -135.2 165.35 25.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.111 0.481 . . . . 1.3600000000000001 111.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HG ' HD21 ' A' ' 23' ' ' LEU . 78.5 mt -106.34 114.95 29.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.461 -0.79 . . . . 2.2999999999999998 109.676 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.4 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.3 p -108.3 141.93 22.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.297 -0.41 . . . . 1.46 111.232 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.47 ' NE ' HD22 ' A' ' 117' ' ' LEU . 7.2 mpt_? -90.91 117.13 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 2.29 110.414 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.618 HD12 ' HD2' ' A' ' 118' ' ' PHE . 2.7 mp -96.64 101.08 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.28 -1.007 . . . . 1.2 108.28 172.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.565 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 8.1 tt0 -98.41 177.04 5.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.268 -0.878 . . . . 1.3700000000000001 109.434 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -55.36 -36.37 66.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 1.22 110.962 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 24.2 ptp -76.86 -7.64 55.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.036 -0.529 . . . . 2.3199999999999998 111.296 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.565 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.0 m-85 -112.65 4.85 17.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.606 0.241 . . . . 0.92000000000000004 110.952 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.526 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -138.7 -173.1 12.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.929 -0.653 . . . . 0.85999999999999999 112.285 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 1.52 111.356 179.635 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 110.085 -0.339 . . . . 1.71 110.085 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.443 HG12 HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -158.47 97.62 1.78 Allowed Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.124 -0.489 . . . . 1.3700000000000001 110.553 176.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.16 177.95 4.94 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.509 2.139 . . . . 1.5800000000000001 111.384 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.67 -162.73 27.35 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.11 -1.043 . . . . 2.0499999999999998 113.038 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -98.08 39.88 1.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 2.2999999999999998 109.086 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.9 m -125.2 158.31 34.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.797 -0.638 . . . . 1.5700000000000001 110.37 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.37 127.42 42.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.51 0.671 . . . . 1.1799999999999999 111.653 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' HG ' HD11 ' A' ' 48' ' ' LEU . 6.7 mp -123.55 167.63 13.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.681 -0.691 . . . . 1.25 109.873 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -138.3 131.89 30.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.006 0.431 . . . . 1.3500000000000001 110.518 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 95' ' ' ILE . 59.3 m-85 -121.6 145.76 47.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.961 -0.563 . . . . 0.56000000000000005 110.669 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.5 mt-10 -68.65 123.62 21.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.816 -0.809 . . . . 1.46 108.816 170.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 81' ' ' CYS . 10.2 mt -107.74 115.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.298 0.57 . . . . 1.1599999999999999 109.622 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -125.62 114.07 18.22 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.002 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 34' ' ' PRO . 14.9 tp -86.84 99.92 12.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 1.75 109.896 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 123' ' ' LEU . 1.1 pt? -98.63 -19.96 17.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.655 -0.418 . . . . 1.78 111.305 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 20.5 m -151.7 145.66 25.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.46 0.171 . . . . 1.53 110.802 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.412 ' HB2' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -166.92 156.98 11.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.448 -0.342 . . . . 0.90000000000000002 110.255 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.81 49.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.202 -0.454 . . . . 3.4700000000000002 110.704 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.433 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mp0 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.137 -0.483 . . . . 3.3799999999999999 110.591 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.075 0.464 . . . . 4.54 110.852 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -116.14 158.42 23.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.783 -0.644 . . . . 2.71 110.013 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 6.4 mptt -102.37 148.16 25.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.048 -0.723 . . . . 2.4399999999999999 109.048 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 15.6 t -101.03 109.24 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.383 0.611 . . . . 1.3100000000000001 110.168 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -79.82 99.74 7.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.031 -0.986 . . . . 2.1600000000000001 111.475 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt 51.32 79.17 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.691 0.619 . . . . 2.04 111.328 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.642 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 11.6 t -89.93 177.17 6.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 1.26 110.903 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.93 -3.63 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.3700000000000001 111.828 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HB2' HG21 ' A' ' 80' ' ' ILE . 27.0 m-20 -75.93 2.33 12.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.533 0.206 . . . . 2.3999999999999999 110.652 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.3 8.92 6.86 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.612 -0.804 . . . . 0.83999999999999997 113.326 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.22 63.48 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.019 -0.61 . . . . 0.62 114.42 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HB ' ' CB ' ' A' ' 80' ' ' ILE . 23.5 t -134.42 148.39 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.929 -0.397 . . . . 1.1799999999999999 109.929 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.92 109.73 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.18 0.514 . . . . 1.1799999999999999 110.44 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.498 ' HE2' HG23 ' A' ' 13' ' ' THR . 47.7 pttt -123.32 148.28 46.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.99 -0.55 . . . . 1.96 110.368 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -109.43 124.33 50.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.828 -0.624 . . . . 1.21 110.332 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.484 HD11 ' SG ' ' A' ' 91' ' ' CYS . 5.1 tp -75.65 113.9 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 1.3 110.924 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 3.5 mm? -99.24 -60.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 1.3999999999999999 110.481 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -120.33 133.96 55.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 2.0600000000000001 110.076 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -106.46 124.17 49.18 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.491 . . . . 3.25 110.212 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 161.85 37.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.66 -0.781 . . . . 1.3200000000000001 111.788 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -68.07 -67.1 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 2.77 110.692 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.17 -177.81 4.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 2.6400000000000001 110.806 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.96 45.85 0.17 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.49 -0.777 . . . . 1.3 111.27 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.32 -41.5 89.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 2.29 110.552 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -113.83 26.03 10.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.309 0.576 . . . . 2.6400000000000001 109.817 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 79.81 1.79 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 1.49 110.07 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 HG23 ' HE3' ' A' ' 35' ' ' LYS . 36.1 mm -129.48 128.46 23.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 1.3700000000000001 111.084 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 1.1 Cg_endo -81.55 114.65 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.896 2.397 . . . . 0.84999999999999998 111.256 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 28.3 mmtp -120.46 146.45 46.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.21 -0.45 . . . . 3.1400000000000001 111.065 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 5.3 tmmm? -57.02 124.58 19.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.701 -0.681 . . . . 2.9100000000000001 109.783 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.58 37.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.752 -0.737 . . . . 1.1899999999999999 112.277 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 82.3 m-20 -79.39 142.57 35.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.964 0.412 . . . . 1.3799999999999999 110.122 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.513 ' HB3' ' CG ' ' A' ' 126' ' ' ARG . 37.6 tp10 -76.46 102.32 5.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.797 -0.638 . . . . 2.2000000000000002 109.797 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 125' ' ' PHE . 28.0 m -112.94 156.02 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.088 -0.505 . . . . 1.3300000000000001 110.868 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.8 m -132.6 110.87 10.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 1.23 109.709 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 122' ' ' LEU . 27.4 m -125.15 151.03 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 1.6200000000000001 111.405 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -101.17 149.28 24.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 3.5600000000000001 109.709 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 39.9 p90 -133.32 136.92 45.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.708 0.29 . . . . 0.88 110.233 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -164.89 146.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.58 -0.526 . . . . 1.1899999999999999 109.58 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -176.18 -127.86 1.07 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.325 -0.94 . . . . 0.37 112.513 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 63.6 pttt -157.77 171.94 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 1.96 110.831 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.738 HD22 HG13 ' A' ' 110' ' ' ILE . 58.2 tp -87.04 108.89 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 1.1200000000000001 110.794 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HB3' HG11 ' A' ' 115' ' ' VAL . 2.1 tp10 -61.46 -35.33 77.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.51 0.672 . . . . 1.96 110.615 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -55.71 -27.82 52.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 1.1100000000000001 112.792 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 53' ' ' LYS . 15.2 t -140.55 -23.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.178 -0.609 . . . . 1.24 112.35 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.69 34.65 4.89 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.502 -0.856 . . . . 0.78000000000000003 113.014 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 51' ' ' THR . 73.8 mmtt -102.84 125.51 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.132 -0.321 . . . . 3.2999999999999998 110.132 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.533 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.7 p -82.44 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.108 -0.33 . . . . 1.3400000000000001 110.108 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -78.69 127.23 31.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.387 0.514 . . . . 0.96999999999999997 112.387 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -161.24 85.74 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.025 -0.989 . . . . 2.1800000000000002 108.549 167.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.557 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 23.5 t -122.54 158.11 30.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.747 -0.66 . . . . 1.6799999999999999 109.986 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -50.0 -44.0 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.245 0.618 . . . . 1.8600000000000001 112.437 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -87.76 -33.67 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 2.1200000000000001 110.532 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -64.71 -52.0 59.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 2.1899999999999999 111.738 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.1 ptp180 -67.49 -20.49 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.352 . . . . 3.1899999999999999 111.309 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.516 ' ND2' HG22 ' A' ' 63' ' ' VAL . 8.3 t30 -75.58 -64.12 1.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.297 -0.411 . . . . 1.27 110.108 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG22 ' ND2' ' A' ' 62' ' ' ASN . 73.1 t -142.55 106.43 5.49 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.382 -0.372 . . . . 2.6099999999999999 111.007 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.37 140.16 92.24 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.287 1.991 . . . . 2.1299999999999999 110.818 171.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -93.3 151.0 20.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.917 0.389 . . . . 1.6299999999999999 110.582 -171.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 143.14 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.117 -0.697 . . . . 2.0099999999999998 109.117 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.408 ' CE1' HG13 ' A' ' 82' ' ' VAL . 30.0 p90 -124.39 153.85 41.27 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.968 -0.693 . . . . 0.68999999999999995 111.212 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . 41.7 t-80 -94.5 145.02 25.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.149 -0.932 . . . . 2.6600000000000001 109.788 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 ' CG2' ' A' ' 82' ' ' VAL . 38.3 tp -69.13 128.84 38.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.991 -0.744 . . . . 1.5600000000000001 108.991 173.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HG2' ' CG ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.49 78.75 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.146 0.974 . . . . 2.0800000000000001 110.403 -168.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 68' ' ' HIS . 26.2 tt0 -126.42 -5.66 6.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.13 -1.395 . . . . 1.98 109.994 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 -19.24 33.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.701 -0.681 . . . . 0.78000000000000003 112.681 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 42.3 mm-40 -87.73 -21.76 25.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.531 0.682 . . . . 0.96999999999999997 109.504 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.9 m -108.87 124.18 65.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.65 -0.705 . . . . 1.25 109.979 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.73 -59.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.179 0.437 . . . . 1.3500000000000001 112.179 -178.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -149.19 -38.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.307 -0.246 . . . . 2.5600000000000001 111.468 -174.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.7 -52.62 44.45 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.561 -0.828 . . . . 0.34000000000000002 112.857 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 82' ' ' VAL . 15.2 m-90 -76.18 -27.72 57.03 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.8 -0.235 . . . . 0.56000000000000005 110.895 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.12 -54.02 35.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.603 -0.726 . . . . 1.1399999999999999 111.37 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -68.16 -30.99 49.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.636 -0.711 . . . . 1.3999999999999999 111.586 -173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 85' ' ' MET . 34.8 t -76.08 -55.92 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.748 0.309 . . . . 0.98999999999999999 111.038 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.842 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 32.0 m -67.34 -33.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.324 0.861 . . . . 1.49 113.324 -169.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 62.2 p -79.64 -0.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.987 0.422 . . . . 1.9399999999999999 111.167 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -125.77 25.5 6.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 1.8700000000000001 110.384 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 31.4 mtm -114.78 142.37 46.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.95 0.405 . . . . 2.79 111.664 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 86' ' ' ARG . 51.2 mtt180 -90.88 164.62 13.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.538 -0.542 . . . . 4.9199999999999999 109.538 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.406 ' HA ' HD22 ' A' ' 122' ' ' LEU . 61.3 tttm -65.16 -21.66 66.81 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.641 0.608 . . . . 2.4300000000000002 112.641 -171.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -117.54 24.65 10.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.537 0.684 . . . . 1.4199999999999999 109.805 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 35.8 tt0 -117.85 132.71 56.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.995 -1.002 . . . . 1.6000000000000001 109.898 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 11.9 tmtt? -137.44 129.68 29.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.94 -0.573 . . . . 1.74 110.226 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 78.9 m -138.51 171.74 13.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.372 -0.377 . . . . 1.3600000000000001 111.269 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.931 HD22 ' HB3' ' A' ' 117' ' ' LEU . 6.1 tt -112.54 145.63 39.96 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.608 -0.886 . . . . 2.2999999999999998 108.608 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 92' ' ' LEU . 13.9 p -121.07 146.34 26.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 116.443 -0.344 . . . . 1.46 110.303 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -107.07 111.13 23.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.643 -1.243 . . . . 2.29 107.643 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.556 HD12 HG13 ' A' ' 93' ' ' VAL . 4.9 mp -93.36 99.8 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.08 -0.648 . . . . 1.2 110.459 -172.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.55 155.55 29.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.926 -1.033 . . . . 1.3700000000000001 109.82 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 6.4 p -53.34 -38.59 63.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.052 -0.522 . . . . 1.22 111.495 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.1 ptp -78.08 -11.18 59.89 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.562 -0.29 . . . . 2.3199999999999998 111.428 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -101.7 -2.66 29.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.877 0.37 . . . . 0.92000000000000004 110.145 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 -178.01 44.91 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.85999999999999999 111.795 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.886 0.374 . . . . 1.52 110.733 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.453 ' CB ' HD13 ' A' ' 110' ' ' ILE . 16.6 m . . . . . 0 C--O 1.235 0.324 0 CA-C-O 120.42 0.152 . . . . 1.71 111.368 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.738 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -141.48 77.68 19.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.211 0.529 . . . . 1.3700000000000001 111.421 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -93.74 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.25 2.633 . . . . 1.5800000000000001 111.649 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.37 -125.32 7.25 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.517 -0.849 . . . . 2.0499999999999998 111.958 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 97' ' ' SER . 3.3 t-20 -105.41 1.16 27.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.61 0.719 . . . . 2.2999999999999998 109.352 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.9 m -79.56 152.15 30.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.323 -0.853 . . . . 1.5700000000000001 110.632 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 49' ' ' GLU . 6.5 p -90.14 135.03 27.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.197 -0.456 . . . . 1.1799999999999999 110.686 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HA ' ' H ' ' A' ' 49' ' ' GLU . 6.2 mp -126.67 167.01 16.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.75 0.31 . . . . 1.25 110.991 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.931 ' HB3' HD22 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -117.26 114.53 23.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.184 -0.673 . . . . 1.3500000000000001 109.184 174.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -113.13 122.04 46.33 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.944 -0.303 . . . . 0.56000000000000005 110.721 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.537 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 33.6 mt-10 -86.12 130.05 34.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.003 -0.74 . . . . 1.46 109.003 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.656 HG21 HG12 ' A' ' 82' ' ' VAL . 70.7 mt -113.5 127.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.997 -0.547 . . . . 1.1599999999999999 111.504 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -115.91 115.34 26.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.462 -0.79 . . . . 1.8799999999999999 110.815 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.691 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 6.0 tt -91.35 102.24 14.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.871 -0.789 . . . . 1.75 108.871 173.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -97.85 -34.43 10.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.556 -0.293 . . . . 1.78 111.184 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.0 t -146.57 144.01 29.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.72 0.295 . . . . 1.53 110.759 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.536 ' HB2' HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -165.39 148.41 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.90000000000000002 109.873 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.513 ' CG ' ' HB3' ' A' ' 39' ' ' GLU . 7.8 ptp85 -127.49 129.48 47.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 3.4700000000000002 109.988 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 110.951 -174.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 121.145 0.498 . . . . 4.54 110.497 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.93 150.26 21.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 2.71 110.63 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -101.67 141.72 34.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 2.4399999999999999 109.129 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.661 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 16.9 t -102.47 109.57 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.092 0.472 . . . . 1.3100000000000001 111.217 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.13 108.79 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.73 -0.668 . . . . 2.1600000000000001 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.0 tp 53.05 72.54 0.42 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.638 0.586 . . . . 2.04 111.201 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.661 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 6.8 t -80.43 156.6 26.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.983 -0.553 . . . . 1.26 111.349 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 1.67 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 1.3700000000000001 111.972 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.6 3.38 3.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.577 0.227 . . . . 2.3999999999999999 110.835 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.26 6.82 8.02 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.091 -0.576 . . . . 0.83999999999999997 112.974 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.01 70.32 1.33 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.708 -0.758 . . . . 0.62 113.928 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' HB ' ' A' ' 80' ' ' ILE . 35.8 t -142.89 145.17 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.786 -0.45 . . . . 1.1799999999999999 109.786 174.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.1 mm -85.53 109.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 1.1799999999999999 110.323 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.52 ' HE3' HG23 ' A' ' 13' ' ' THR . 18.2 pttp -131.05 143.67 50.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.13 0.491 . . . . 1.96 111.011 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -110.73 121.73 46.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.609 -0.723 . . . . 1.21 110.237 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.83 134.87 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 1.3 110.15 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.4 -74.02 0.62 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.019 -0.363 . . . . 1.3999999999999999 110.019 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -88.26 153.17 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.833 -0.803 . . . . 2.0600000000000001 108.833 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -126.28 120.08 29.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.212 0.53 . . . . 3.25 111.001 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.45 27.31 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.124 -0.944 . . . . 1.3200000000000001 112.13 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.92 -65.81 0.97 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.766 0.317 . . . . 2.77 110.877 -176.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -99.69 139.07 35.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.848 0.356 . . . . 2.6400000000000001 110.493 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.669 ' HA3' ' HD3' ' A' ' 86' ' ' ARG . . . -157.17 36.77 0.56 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.567 -0.613 . . . . 1.3 111.567 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.519 0.676 . . . . 2.29 109.188 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -112.09 4.33 17.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.215 -0.902 . . . . 2.6400000000000001 110.353 176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.513 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 11.7 m120 -114.55 78.82 1.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.608 -0.437 . . . . 1.49 111.254 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.1 mm -128.33 114.99 19.89 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.61 -0.723 . . . . 1.3700000000000001 109.559 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.08 106.21 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.132 2.555 . . . . 0.84999999999999998 111.84 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 31.5 mmtp -118.7 158.21 25.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.749 0.309 . . . . 3.1400000000000001 110.671 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 1.043 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -80.56 150.65 29.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 2.9100000000000001 111.384 -175.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.64 -26.06 25.41 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.808 -0.633 . . . . 1.1899999999999999 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -93.46 157.7 16.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 1.3799999999999999 110.186 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -71.67 95.71 1.49 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 2.2000000000000002 110.805 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 125' ' ' PHE . 10.4 m -114.49 153.03 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.459 -0.337 . . . . 1.3300000000000001 110.351 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -128.27 107.09 9.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.447 -0.342 . . . . 1.23 110.406 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -123.75 143.37 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 1.6200000000000001 111.534 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -112.99 145.44 40.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.561 -0.745 . . . . 3.5600000000000001 110.236 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.678 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.2 p90 -132.94 141.42 48.34 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.18 0.3 . . . . 0.88 110.831 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p -168.24 154.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.271 -0.641 . . . . 1.1899999999999999 109.271 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 177.92 -120.31 0.71 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.83 -1.176 . . . . 0.37 113.225 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.754 ' HG3' HD13 ' A' ' 117' ' ' LEU . 21.0 pttp -157.53 173.28 17.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.545 0.212 . . . . 1.96 111.06 -178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.809 HD23 HG13 ' A' ' 110' ' ' ILE . 59.3 tp -90.9 106.66 18.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.688 -0.486 . . . . 1.1200000000000001 109.688 176.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.515 ' HB2' HD12 ' A' ' 117' ' ' LEU . 3.0 tp10 -68.73 -25.61 64.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 1.96 110.793 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 17.1 t -55.0 -35.1 64.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.118 -0.946 . . . . 1.1100000000000001 111.461 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.501 HG21 ' HG2' ' A' ' 53' ' ' LYS . 2.8 t -125.21 -20.64 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.346 -0.388 . . . . 1.24 111.083 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.25 11.58 51.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.78000000000000003 112.771 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.501 ' HG2' HG21 ' A' ' 51' ' ' THR . 29.0 mmmt -85.02 131.03 34.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.955 -0.387 . . . . 3.2999999999999998 109.955 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.662 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.5 p -79.1 164.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.315 -0.402 . . . . 1.3400000000000001 110.097 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 7.3 m-30 -73.61 98.47 2.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.367 0.603 . . . . 0.96999999999999997 110.791 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.32 85.7 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.454 -0.793 . . . . 2.1800000000000002 109.706 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.678 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 19.0 m -135.89 169.24 17.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.376 -0.829 . . . . 1.6799999999999999 109.54 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 m -57.91 -44.57 86.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.818 0.673 . . . . 1.8600000000000001 112.818 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -91.01 -48.26 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 2.1200000000000001 111.456 -171.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.678 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 1.6 m-20 -54.4 -44.74 72.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.985 -1.007 . . . . 2.1899999999999999 112.73 -169.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -83.83 0.7 46.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.851 -0.34 . . . . 3.1899999999999999 111.657 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.536 HD21 HG11 ' A' ' 63' ' ' VAL . 10.7 t30 -104.09 -42.25 5.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.447 -0.342 . . . . 1.27 110.807 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 62' ' ' ASN . 8.4 m -124.24 125.82 25.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.843 0.354 . . . . 2.6099999999999999 111.521 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 1.7 Cg_endo -85.57 139.57 6.81 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.256 2.637 . . . . 2.1299999999999999 112.451 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.79 148.95 32.44 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.891 0.377 . . . . 1.6299999999999999 111.179 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 157.62 46.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.998 -0.546 . . . . 2.0099999999999998 110.198 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -140.34 176.95 8.35 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.034 0.445 . . . . 0.68999999999999995 111.982 -175.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -107.75 148.46 29.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 2.6600000000000001 110.659 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 36' ' ' LYS . 24.0 tp -78.72 124.45 28.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.103 -0.703 . . . . 1.5600000000000001 109.103 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 1.043 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 1.4 mm-40 63.51 79.57 0.25 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.457 1.122 . . . . 2.0800000000000001 110.255 -168.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -130.61 -3.73 4.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.653 -1.612 . . . . 1.98 109.836 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.22 -11.06 61.64 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.557 -0.747 . . . . 0.78000000000000003 111.847 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.02 -18.77 16.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.96999999999999997 110.836 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -111.74 127.95 68.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 1.25 110.282 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.68 -76.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.299 0.481 . . . . 1.3500000000000001 112.299 -176.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' H ' HG12 ' A' ' 75' ' ' ILE . 37.2 mtpt -127.59 -49.87 1.38 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.472 0.545 . . . . 2.5600000000000001 112.472 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.4 -53.06 33.53 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.955 -0.64 . . . . 0.34000000000000002 113.342 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.414 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.6 m-90 -76.03 -44.27 40.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.639 0.257 . . . . 0.56000000000000005 110.571 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.14 -49.32 69.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.587 -0.733 . . . . 1.1399999999999999 112.026 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -73.37 -36.42 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.165 -0.47 . . . . 1.3999999999999999 111.413 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 46.3 t -72.46 -42.84 64.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.687 -0.233 . . . . 0.98999999999999999 111.426 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.874 HG13 HG21 ' A' ' 120' ' ' ILE . 27.4 m -64.06 -32.53 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.895 0.379 . . . . 1.49 111.121 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -79.11 5.1 12.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.062 0.458 . . . . 1.9399999999999999 110.863 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -113.38 5.73 16.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 1.8700000000000001 110.824 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.613 ' HA ' ' OE1' ' A' ' 89' ' ' GLU . 55.9 mtm -93.75 -172.73 2.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.519 0.676 . . . . 2.79 112.288 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.669 ' HD3' ' HA3' ' A' ' 29' ' ' GLY . 1.6 ttm180 -145.55 165.51 28.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.153 -1.054 . . . . 4.9199999999999999 108.153 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -63.2 -23.81 67.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.924 0.392 . . . . 2.4300000000000002 111.715 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -117.49 24.91 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.072 0.463 . . . . 1.4199999999999999 110.065 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 5.3 tm-20 -123.07 152.85 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 1.6000000000000001 109.629 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -155.23 124.67 6.37 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.146 -0.316 . . . . 1.74 110.146 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.69 171.17 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 1.3600000000000001 111.383 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.85 137.41 52.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 2.2999999999999998 110.32 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.696 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 6.2 p -111.73 149.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.89 -0.595 . . . . 1.46 111.075 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -104.14 112.56 25.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.566 -0.531 . . . . 2.29 109.566 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.487 HD11 HG13 ' A' ' 93' ' ' VAL . 2.6 mp -92.2 106.57 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 1.2 110.504 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 28.5 tt0 -90.48 168.29 11.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.393 -0.822 . . . . 1.3700000000000001 108.932 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.8 m -51.03 -39.32 55.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.312 0.486 . . . . 1.22 112.312 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.5 ptp -77.39 -7.91 56.85 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.61 0.243 . . . . 2.3199999999999998 111.487 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.508 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -99.05 -3.35 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.549 0.214 . . . . 0.92000000000000004 110.772 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HD13 ' A' ' 75' ' ' ILE . . . -135.01 -177.51 15.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.253 -0.499 . . . . 0.85999999999999999 112.015 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.697 0.248 . . . . 1.52 111.175 -179.225 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.511 ' HB2' HD13 ' A' ' 110' ' ' ILE . 3.4 m . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.17 0.51 . . . . 1.71 110.803 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.809 HG13 HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.63 85.95 50.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 1.3700000000000001 110.818 178.502 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.55 -175.59 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.292 1.995 . . . . 1.5800000000000001 111.905 175.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.53 -132.44 5.12 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.456 -0.878 . . . . 2.0499999999999998 112.117 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -122.77 36.53 4.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 2.2999999999999998 109.965 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 21.3 p -114.84 179.31 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.5700000000000001 110.819 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 49' ' ' GLU . 7.1 p -104.98 129.17 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.146 0.498 . . . . 1.1799999999999999 111.016 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -119.94 172.73 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 1.25 110.382 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.754 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -128.08 130.83 48.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.695 -0.483 . . . . 1.3500000000000001 109.695 177.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.658 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 34.7 m-85 -130.4 128.34 41.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.672 0.272 . . . . 0.56000000000000005 110.672 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.678 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 62.5 mt-10 -71.28 126.44 29.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.265 -1.013 . . . . 1.46 108.265 169.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.874 HG21 HG13 ' A' ' 82' ' ' VAL . 34.8 mt -107.67 123.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.212 -0.595 . . . . 1.1599999999999999 109.677 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.96 114.7 20.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.682 -0.69 . . . . 1.8799999999999999 110.678 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 35.9 tp -87.29 90.62 8.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.51 . . . . 1.75 109.753 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 124' ' ' SER . 3.5 pp -86.48 -25.26 25.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 1.78 111.741 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.416 ' N ' HD12 ' A' ' 123' ' ' LEU . 75.7 m -159.46 148.23 17.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.361 -0.381 . . . . 1.53 110.292 177.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.53 ' HB3' HD12 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -167.02 -176.22 3.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.90000000000000002 109.877 -178.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.88 170.54 22.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.524 -0.307 . . . . 3.4700000000000002 110.178 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 107.908 -1.145 . . . . 3.3799999999999999 107.908 171.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 121.04 0.448 . . . . 4.54 110.896 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.42 139.01 36.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 2.71 109.899 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -113.51 151.4 31.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 2.4399999999999999 110.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 21.6 t -114.0 120.55 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 1.3100000000000001 111.352 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.93 112.56 25.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 2.1600000000000001 111.138 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.2 mt 49.74 74.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.752 0.657 . . . . 2.04 112.022 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.515 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 3.5 t -86.34 163.01 17.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 1.26 110.739 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.03 -5.45 13.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.363 0.601 . . . . 1.3700000000000001 110.685 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HB3' HG22 ' A' ' 13' ' ' THR . 38.4 t70 -74.52 6.87 3.36 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.629 -0.714 . . . . 2.3999999999999999 111.084 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.28 16.52 3.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.67 -0.776 . . . . 0.83999999999999997 113.851 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.41 62.38 6.07 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.293 -0.479 . . . . 0.62 113.82 173.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.492 HG21 ' HB ' ' A' ' 80' ' ' ILE . 47.3 t -136.57 145.47 30.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.04 -0.356 . . . . 1.1799999999999999 110.04 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.6 mm -85.78 109.95 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 1.1799999999999999 110.372 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -138.38 146.78 42.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.206 -0.452 . . . . 1.96 110.835 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -119.63 137.56 53.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 1.21 110.524 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -80.27 126.9 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.051 0.453 . . . . 1.3 110.844 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 92' ' ' LEU . 4.5 mm? -118.03 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 1.3999999999999999 110.423 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 39.5 ttpt -116.63 106.44 13.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.56 -0.533 . . . . 2.0600000000000001 109.56 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -88.02 148.94 24.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.245 -0.434 . . . . 3.25 110.944 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.93 124.37 8.1 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.635 -0.986 . . . . 1.3200000000000001 110.635 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -61.99 -54.81 36.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.642 0.221 . . . . 2.77 111.493 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.9 151.71 40.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.107 0.48 . . . . 2.6400000000000001 110.719 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.3 34.12 0.11 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.274 -0.875 . . . . 1.3 110.937 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.11 -41.33 78.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 2.29 111.541 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -110.62 26.55 10.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.761 0.791 . . . . 2.6400000000000001 109.274 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.38 77.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.446 -0.797 . . . . 1.49 110.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -123.95 119.48 26.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.956 0.407 . . . . 1.3700000000000001 111.155 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.93 128.68 20.26 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.74 2.293 . . . . 0.84999999999999998 111.525 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mmmm -121.24 147.74 45.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.172 -0.467 . . . . 3.1400000000000001 111.442 -174.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.559 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 7.5 ttmm -76.61 129.72 36.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.617 -0.72 . . . . 2.9100000000000001 109.111 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.9 -21.67 44.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.784 -0.722 . . . . 1.1899999999999999 111.904 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -83.0 156.61 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.65 95.49 3.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.559 -0.534 . . . . 2.2000000000000002 109.559 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -125.06 147.69 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 1.3300000000000001 110.615 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.482 HG22 ' HD3' ' A' ' 66' ' ' LYS . 82.3 m -124.66 119.69 29.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.182 -0.463 . . . . 1.23 109.998 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.95 157.62 38.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 1.6200000000000001 111.576 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 9.8 t60 -110.17 131.04 55.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.347 -0.842 . . . . 3.5600000000000001 109.898 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 14.4 p90 -133.7 135.75 44.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.076 0.465 . . . . 0.88 111.221 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -168.32 151.73 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.295 -1.002 . . . . 1.1899999999999999 108.295 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.78 -126.83 0.98 Allowed Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.504 -1.331 . . . . 0.37 112.714 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.659 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 65.8 pttt -155.87 170.5 21.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.099 0.476 . . . . 1.96 111.441 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 114' ' ' SER . 54.4 tp -92.52 109.71 21.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.774 -0.648 . . . . 1.1200000000000001 110.392 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' HB3' HG13 ' A' ' 115' ' ' VAL . 7.8 tm-20 -66.44 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 1.96 109.942 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -55.29 -20.11 10.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.51 -0.768 . . . . 1.1100000000000001 112.444 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -136.52 -26.57 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.274 -0.266 . . . . 1.24 111.584 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.73 20.03 18.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 0.78000000000000003 112.004 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.9 mmtt -91.99 126.37 37.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.625 0.25 . . . . 3.2999999999999998 111.441 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.659 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.4 p -76.0 159.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 1.3400000000000001 109.956 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.545 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 4.8 m-30 -73.97 110.69 8.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.454 0.645 . . . . 0.96999999999999997 111.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -139.34 89.08 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.09 . . . . 2.1800000000000002 109.02 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.558 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 47.5 m -126.99 -171.01 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.801 -0.636 . . . . 1.6799999999999999 109.947 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -72.84 -48.0 41.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.478 0.547 . . . . 1.8600000000000001 112.478 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -95.64 -47.52 6.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.283 0.475 . . . . 2.1200000000000001 112.283 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.558 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 6.3 p-10 -57.51 -29.86 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.859 -0.61 . . . . 2.1899999999999999 111.878 -172.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -70.83 -14.35 62.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 3.1899999999999999 111.329 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -125.51 -56.4 1.5 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.788 0.328 . . . . 1.27 111.656 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -99.01 113.37 64.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 2.6099999999999999 110.538 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.439 ' HB3' ' CE1' ' A' ' 43' ' ' HIS . 22.4 Cg_exo -65.29 137.66 52.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.966 2.444 . . . . 2.1299999999999999 112.515 -177.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.99 127.28 39.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 1.6299999999999999 109.836 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HD3' HG22 ' A' ' 41' ' ' THR . 3.0 pptp? -125.22 158.2 34.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.947 -0.57 . . . . 2.0099999999999998 109.922 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -148.14 171.75 15.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.652 0.263 . . . . 0.68999999999999995 110.357 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.456 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 12.0 m170 -112.82 148.47 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 2.6600000000000001 108.888 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.623 HD13 ' CG2' ' A' ' 82' ' ' VAL . 10.5 tp -66.63 114.25 5.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.546 0.689 . . . . 1.5600000000000001 111.834 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.22 75.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 113.986 -1.461 . . . . 2.0800000000000001 111.081 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 68' ' ' HIS . 6.3 pt20 -113.16 20.98 15.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 1.98 109.748 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 -10.02 64.8 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.841 -0.618 . . . . 0.78000000000000003 111.908 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.41 -24.91 17.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.998 0.428 . . . . 0.96999999999999997 110.921 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.23 128.14 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.682 -0.488 . . . . 1.25 109.682 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.549 HD12 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -95.75 -64.49 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.536 0.939 . . . . 1.3500000000000001 113.536 -174.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.455 ' H ' HG12 ' A' ' 75' ' ' ILE . 27.5 mtpt -133.07 -48.58 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.214 0.82 . . . . 2.5600000000000001 113.214 -172.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' HA3' HG13 ' A' ' 95' ' ' ILE . . . -52.41 -53.03 33.73 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.815 -0.707 . . . . 0.34000000000000002 113.225 -171.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.494 ' O ' HG22 ' A' ' 82' ' ' VAL . 6.3 m-90 -76.76 -38.29 54.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.888 0.375 . . . . 0.56000000000000005 110.285 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.459 ' OD1' HD12 ' A' ' 69' ' ' LEU . 11.6 t70 -54.28 -53.59 51.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.103 -0.953 . . . . 1.1399999999999999 112.74 -172.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.492 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -66.34 -40.22 86.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 1.3999999999999999 110.629 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.9 t -62.66 -50.02 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.98999999999999999 111.117 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.623 ' CG2' HD13 ' A' ' 69' ' ' LEU . 30.6 m -71.59 -32.84 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.338 0.496 . . . . 1.49 112.338 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.485 ' HB3' HD21 ' A' ' 69' ' ' LEU . 32.8 p -74.61 -9.61 58.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.837 0.31 . . . . 1.9399999999999999 111.837 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 t -118.67 38.87 3.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.404 0.621 . . . . 1.8700000000000001 109.39 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.865 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 5.7 mmt -111.9 -173.93 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.83 . . . . 2.79 111.083 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -134.63 171.0 14.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.148 -1.056 . . . . 4.9199999999999999 108.148 171.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.482 ' HA ' HD22 ' A' ' 122' ' ' LEU . 58.8 tttm -62.7 -31.54 72.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.204 0.446 . . . . 2.4300000000000002 112.204 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.42 25.63 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 1.4199999999999999 110.741 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 26.4 tt0 -104.23 148.58 26.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 1.6000000000000001 110.525 -176.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 79.9 tttt -145.49 129.93 17.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.946 -0.57 . . . . 1.74 110.711 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.571 ' SG ' ' HE2' ' A' ' 85' ' ' MET . 98.1 m -136.23 162.87 31.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.053 0.454 . . . . 1.3600000000000001 111.267 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' A' ' 23' ' ' LEU . 3.8 mm? -102.22 119.79 39.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 2.2999999999999998 109.791 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.0 140.53 28.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.966 -0.561 . . . . 1.46 110.927 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.799 ' HE ' HD21 ' A' ' 117' ' ' LEU . 1.3 mpt_? -99.43 112.4 24.59 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.756 -0.461 . . . . 2.29 109.756 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.581 HD12 ' HD2' ' A' ' 118' ' ' PHE . 1.8 mp -88.38 105.66 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.237 0.541 . . . . 1.2 110.145 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 1.1 tm-20 -79.37 163.79 24.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.645 -1.162 . . . . 1.3700000000000001 107.933 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.9 p -58.74 -29.81 67.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.504 0.192 . . . . 1.22 110.778 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.404 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 17.4 ptm -75.93 -9.67 58.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.883 0.373 . . . . 2.3199999999999998 111.249 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.52 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.3 m-30 -100.93 -4.48 27.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.676 -0.238 . . . . 0.92000000000000004 111.422 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.549 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -141.55 171.36 24.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.638 . . . . 0.85999999999999999 112.371 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.735 0.303 . . . . 1.52 110.614 179.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.419 ' CB ' HD13 ' A' ' 110' ' ' ILE . 37.4 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 111.788 0.292 . . . . 1.71 111.788 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.602 HG13 HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.21 60.64 9.21 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.137 0.421 . . . . 1.3700000000000001 112.137 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 31.7 Cg_endo -96.04 93.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.963 2.442 . . . . 1.5800000000000001 111.992 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.36 82.47 0.19 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.273 -0.731 . . . . 2.0499999999999998 111.273 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.1 m120 63.11 21.84 13.09 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.919 0.866 . . . . 2.2999999999999998 109.468 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.8 ' HB2' HD13 ' A' ' 48' ' ' LEU . 8.0 p -118.7 131.75 56.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.726 -1.125 . . . . 1.5700000000000001 110.389 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.4 p -86.89 135.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 1.1799999999999999 110.419 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -123.03 168.3 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 1.25 110.763 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.799 HD21 ' HE ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -122.33 112.01 17.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.052 -0.722 . . . . 1.3500000000000001 109.052 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.581 ' HD2' HD12 ' A' ' 95' ' ' ILE . 45.3 m-85 -104.07 128.29 51.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.964 0.411 . . . . 0.56000000000000005 111.076 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.64 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 44.2 mt-10 -75.65 112.14 11.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 171.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.606 HG22 HG12 ' A' ' 82' ' ' VAL . 25.4 mt -105.88 120.85 57.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.062 0.458 . . . . 1.1599999999999999 110.254 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.33 -0.85 . . . . 1.8799999999999999 109.287 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 87' ' ' LYS . 7.9 tt -91.9 135.52 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.439 . . . . 1.75 109.813 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.97 -31.27 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.663 -0.415 . . . . 1.78 112.025 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m -149.99 139.38 21.42 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.124 -0.36 . . . . 1.53 111.399 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG12 ' A' ' 40' ' ' VAL . 3.4 p90 -167.62 171.34 10.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.905 -0.776 . . . . 0.90000000000000002 108.905 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.1 153.47 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.697 0.284 . . . . 3.4700000000000002 110.99 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 3.3799999999999999 110.36 176.563 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.105 0.479 . . . . 4.54 110.959 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -96.62 156.98 16.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.888 -0.596 . . . . 2.71 109.605 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 7.0 mptt -101.64 142.63 32.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.344 -0.243 . . . . 2.4399999999999999 110.344 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.7 t -103.89 118.73 51.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.73 -0.47 . . . . 1.3100000000000001 109.73 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.88 126.99 46.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.419 -0.355 . . . . 2.1600000000000001 110.842 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt 50.1 51.15 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.589 -0.732 . . . . 2.04 112.12 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -55.51 151.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 1.26 110.967 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -8.54 13.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.363 0.505 . . . . 1.3700000000000001 112.363 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 80' ' ' ILE . 7.1 t70 -82.31 24.33 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.022 0.439 . . . . 2.3999999999999999 111.066 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.07 -7.42 9.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.026 -0.607 . . . . 0.83999999999999997 114.163 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.43 76.07 1.08 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.415 -0.898 . . . . 0.62 113.942 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 9.4 t -143.76 150.21 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.611 -0.514 . . . . 1.1799999999999999 109.611 175.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mm -85.27 109.89 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 123.237 0.335 . . . . 1.1799999999999999 110.162 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -123.64 147.08 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.272 0.558 . . . . 1.96 111.349 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.1 m -119.08 122.26 41.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.502 -0.772 . . . . 1.21 110.365 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.589 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.7 tp -71.7 131.95 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 1.3 111.315 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 1.6 mm? -121.94 -59.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 1.3999999999999999 110.916 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 88' ' ' ASN . 37.1 ttpt -128.65 154.82 45.88 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.217 -0.66 . . . . 2.0600000000000001 109.217 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -125.23 156.39 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.894 0.378 . . . . 3.25 111.106 -173.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.39 163.2 14.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.815 -0.914 . . . . 1.3200000000000001 110.815 170.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -87.51 -97.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.336 0.568 . . . . 2.77 110.648 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.94 155.99 18.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.515 -0.55 . . . . 2.6400000000000001 109.515 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.504 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 171.68 62.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.092 -1.051 . . . . 1.3 112.299 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.83 -41.65 99.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.009 0.433 . . . . 2.29 110.318 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.79 20.81 13.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.728 0.775 . . . . 2.6400000000000001 110.466 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HB3' HH21 ' A' ' 86' ' ' ARG . 0.2 OUTLIER -135.9 78.3 1.71 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 1.49 109.929 175.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG22 ' HG2' ' A' ' 35' ' ' LYS . 36.0 mm -136.58 123.87 14.34 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 1.3700000000000001 110.811 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 121.49 7.86 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.69 2.26 . . . . 0.84999999999999998 110.911 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -135.73 150.47 49.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.013 -0.429 . . . . 3.1400000000000001 111.263 -178.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -60.4 132.03 52.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.774 -0.648 . . . . 2.9100000000000001 109.857 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -22.36 31.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.475 -0.65 . . . . 1.1899999999999999 111.475 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -104.05 130.97 51.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.851 -0.425 . . . . 1.3799999999999999 109.851 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -69.07 109.21 3.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.051 -0.522 . . . . 2.2000000000000002 111.765 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 69' ' ' LEU . 22.3 m -99.56 154.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.886 -0.597 . . . . 1.3300000000000001 109.693 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -122.43 113.01 18.76 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.407 -0.59 . . . . 1.23 109.407 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.84 159.85 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.019 0.748 . . . . 1.6200000000000001 113.019 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -111.85 128.21 56.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 3.5600000000000001 108.901 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.691 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 55.0 p90 -131.25 139.34 49.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.205 0.526 . . . . 0.88 111.54 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -168.63 158.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.401 -0.962 . . . . 1.1899999999999999 108.401 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.53 -130.87 1.74 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.926 -1.13 . . . . 0.37 112.434 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.71 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 62.4 pttt -156.19 170.05 23.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.13 0.49 . . . . 1.96 111.028 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 tp -82.76 101.64 11.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.811 -0.632 . . . . 1.1200000000000001 110.079 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 44.5 tt0 -57.54 -33.1 67.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.88 0.371 . . . . 1.96 110.942 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -57.27 -19.62 22.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 1.1100000000000001 112.106 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 t -138.22 -8.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.792 -0.363 . . . . 1.24 111.709 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.07 83.14 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.217 -0.516 . . . . 0.78000000000000003 112.981 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 12.8 mmmm -87.99 120.96 29.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.707 0.289 . . . . 3.2999999999999998 110.99 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.71 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 13.6 p -75.56 151.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.591 . . . . 1.3400000000000001 110.195 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.469 ' CE1' HD13 ' A' ' 110' ' ' ILE . 17.7 m-30 -73.85 127.39 32.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.96999999999999997 111.015 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -141.39 85.76 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.868 0.842 . . . . 2.1800000000000002 110.2 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 m -122.57 -175.93 3.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.234 -0.654 . . . . 1.6799999999999999 109.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.4 m -72.31 -47.03 53.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.752 0.31 . . . . 1.8600000000000001 111.604 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -96.42 -36.76 10.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.964 0.727 . . . . 2.1200000000000001 112.964 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 47.7 p-10 -60.62 -45.38 94.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.586 0.587 . . . . 2.1899999999999999 112.586 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.89 15.38 5.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.214 0.531 . . . . 3.1899999999999999 110.775 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.05 -47.09 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 1.27 111.793 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 7.1 p -114.38 124.89 29.96 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 2.6099999999999999 110.947 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 2.8 Cg_exo -75.83 120.67 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.046 2.497 . . . . 2.1299999999999999 111.788 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.44 146.72 23.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.436 -0.579 . . . . 1.6299999999999999 109.436 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 162.08 37.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.331 -0.395 . . . . 2.0099999999999998 110.755 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CE1' HG13 ' A' ' 74' ' ' VAL . 41.0 p90 -144.74 175.63 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.68999999999999995 110.302 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.456 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.8 m-70 -111.4 147.79 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.296 -0.631 . . . . 2.6600000000000001 109.296 173.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.508 ' HB2' HG22 ' A' ' 40' ' ' VAL . 16.9 tp -72.02 127.02 31.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.403 . . . . 1.5600000000000001 109.911 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 64.44 72.78 0.44 Allowed 'General case' 0 C--N 1.331 -0.206 0 O-C-N 124.15 0.906 . . . . 2.0800000000000001 111.453 -175.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -130.35 14.71 5.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.326 -0.852 . . . . 1.98 109.597 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.92 -17.44 31.73 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.78000000000000003 113.11 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.36 -39.41 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.058 0.456 . . . . 0.96999999999999997 111.465 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 67' ' ' PHE . 18.1 m -97.97 127.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.108 -0.496 . . . . 1.25 110.456 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.698 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.61 -68.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.537 0.569 . . . . 1.3500000000000001 112.537 -175.049 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.698 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -139.95 -45.97 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.231 0.456 . . . . 2.5600000000000001 112.231 -175.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.75 -53.16 34.31 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.12 -0.562 . . . . 0.34000000000000002 113.275 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.443 ' O ' HG21 ' A' ' 82' ' ' VAL . 20.2 m-90 -75.8 -31.87 59.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.9 0.381 . . . . 0.56000000000000005 110.628 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' HD11 ' A' ' 69' ' ' LEU . 22.1 t0 -53.98 -52.88 59.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.201 -0.909 . . . . 1.1399999999999999 112.068 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.87 -41.07 81.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.903 0.383 . . . . 1.3999999999999999 111.191 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.655 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 25.4 t -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.712 -0.395 . . . . 0.98999999999999999 111.385 -176.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 HD12 ' A' ' 69' ' ' LEU . 34.9 m -67.96 -32.03 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.97 0.414 . . . . 1.49 110.173 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -64.76 -27.17 68.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 1.9399999999999999 110.802 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 t -101.43 24.66 9.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.815 -0.629 . . . . 1.8700000000000001 110.812 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.895 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 5.1 mmt -104.98 -173.32 2.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.561 -0.29 . . . . 2.79 110.921 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 24.1 mtp-105 -151.99 175.01 12.95 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.937 -0.764 . . . . 4.9199999999999999 108.937 170.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -61.27 -24.32 66.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.061 0.458 . . . . 2.4300000000000002 111.254 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.45 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 35.3 m-80 -130.37 28.62 4.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.444 -0.344 . . . . 1.4199999999999999 110.966 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 28.4 tt0 -121.19 142.85 49.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.58 -0.526 . . . . 1.6000000000000001 109.58 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.551 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.32 130.24 16.23 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.713 -0.477 . . . . 1.74 109.713 -171.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.589 ' SG ' HD12 ' A' ' 22' ' ' ILE . 96.9 m -141.96 171.68 13.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 1.3600000000000001 111.996 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.7 134.76 46.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.36 -0.836 . . . . 2.2999999999999998 110.015 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.655 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.1 p -112.93 140.96 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.901 0.382 . . . . 1.46 111.165 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.594 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.09 112.48 25.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.919 -0.582 . . . . 2.29 110.263 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.459 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.8 mp -95.84 102.1 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 1.2 110.03 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.432 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 24.7 tt0 -83.89 168.74 15.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.43 -0.952 . . . . 1.3700000000000001 108.43 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.4 p -53.22 -36.05 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.0 0.37 . . . . 1.22 112.0 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.52 -7.47 54.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.366 -0.379 . . . . 2.3199999999999998 111.801 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -100.44 0.03 38.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.576 0.227 . . . . 0.92000000000000004 111.265 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.07 -165.15 11.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.891 -0.671 . . . . 0.85999999999999999 111.928 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.876 0.338 . . . . 1.52 111.102 179.144 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.474 ' HB2' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 N-CA-C 111.985 0.365 . . . . 1.71 111.985 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -152.69 87.34 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.139 -0.689 . . . . 1.3700000000000001 109.139 175.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.73 -171.7 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.489 2.793 . . . . 1.5800000000000001 113.196 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.87 -143.51 13.85 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.61 -0.596 . . . . 2.0499999999999998 111.61 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -101.14 1.52 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.907 0.384 . . . . 2.2999999999999998 110.599 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 p -82.43 158.27 23.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.928 -0.578 . . . . 1.5700000000000001 110.939 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.83 132.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 1.1799999999999999 111.095 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.18 155.13 32.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 1.25 109.695 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.644 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -124.67 127.64 47.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 1.3500000000000001 110.48 172.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -122.74 141.31 51.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.814 -0.63 . . . . 0.56000000000000005 110.589 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.691 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 40.3 mt-10 -76.54 121.5 23.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.846 -0.798 . . . . 1.46 108.846 169.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.542 ' HB ' ' HG ' ' A' ' 81' ' ' CYS . 13.1 mt -106.8 127.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.524 -0.547 . . . . 1.1599999999999999 109.524 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -134.16 111.02 9.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.051 -0.977 . . . . 1.8799999999999999 110.354 -169.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 24.9 tp -84.8 96.92 9.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 1.75 109.991 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.14 -21.9 24.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 1.78 111.349 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -173.17 163.54 4.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.503 -0.317 . . . . 1.53 110.203 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.24 174.12 8.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.90000000000000002 110.201 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -137.21 138.79 40.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.431 . . . . 3.4700000000000002 110.904 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.555 -0.748 . . . . 3.3799999999999999 110.207 -177.636 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.831 0.348 . . . . 7.8200000000000003 110.52 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.34 122.74 24.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.322 -0.399 . . . . 6.2699999999999996 110.767 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.548 HG23 ' HG2' ' A' ' 4' ' ' GLU . 13.0 t -91.93 -33.79 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.27 -0.641 . . . . 4.75 109.27 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.548 ' HG2' HG23 ' A' ' 3' ' ' THR . 23.4 mm-40 -109.13 95.94 5.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.509 -0.769 . . . . 4.4400000000000004 108.94 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -67.41 131.65 46.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 4.9000000000000004 111.249 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.78 79.16 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.816 -0.629 . . . . 3.6099999999999999 109.77 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.34 150.47 21.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.212 0.53 . . . . 4.54 111.328 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.06 150.84 21.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.393 -0.821 . . . . 2.71 109.156 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -98.9 151.58 20.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.898 -0.408 . . . . 2.4399999999999999 109.898 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -101.42 104.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.545 -0.909 . . . . 1.3100000000000001 108.545 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.54 108.49 20.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.222 -0.899 . . . . 2.1600000000000001 110.825 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 84.1 mt 65.01 69.5 0.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 2.04 110.406 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -65.21 163.7 14.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.838 -0.619 . . . . 1.26 110.571 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.37 -3.74 29.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.672 0.619 . . . . 1.3700000000000001 112.672 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.524 ' HB3' HG13 ' A' ' 80' ' ' ILE . 29.1 t70 -90.55 14.76 12.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.361 0.601 . . . . 2.3999999999999999 110.946 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.03 19.46 2.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.323 -0.942 . . . . 0.83999999999999997 114.241 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 69.03 76.64 0.45 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.639 0.615 . . . . 0.62 114.639 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.519 ' HB ' HG22 ' A' ' 80' ' ' ILE . 96.9 t -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.85 -0.426 . . . . 1.1799999999999999 109.85 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 13.7 mm -91.86 116.02 32.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 O-C-N 123.385 0.428 . . . . 1.1799999999999999 110.594 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -135.12 146.46 48.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 1.96 111.263 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 m -108.56 131.91 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.691 . . . . 1.21 110.356 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -80.44 120.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.109 0.48 . . . . 1.3 111.188 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.38 -52.57 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 1.3999999999999999 110.632 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 39.5 ttmt -127.44 149.19 50.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.351 -0.611 . . . . 2.0600000000000001 109.351 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -115.15 140.83 48.75 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.134 0.271 . . . . 3.25 110.325 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.03 121.7 25.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.956 -0.64 . . . . 1.3200000000000001 112.009 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.05 -60.29 4.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.342 . . . . 2.77 111.511 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -160.96 141.01 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 2.6400000000000001 110.407 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.622 ' HA3' ' HB2' ' A' ' 32' ' ' ASN . . . 167.86 103.31 0.17 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.551 -0.833 . . . . 1.3 112.026 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.65 -41.62 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.598 0.714 . . . . 2.29 109.246 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -88.48 -10.4 49.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.521 -1.218 . . . . 2.6400000000000001 110.607 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.622 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.5 m-80 -84.86 75.52 10.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.989 -0.551 . . . . 1.49 111.036 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 31.8 mm -144.58 102.22 4.63 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.757 -0.656 . . . . 1.3700000000000001 110.262 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HG3' HD21 ' A' ' 122' ' ' LEU . 65.2 Cg_endo -71.81 111.33 3.12 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 123.329 2.686 . . . . 0.84999999999999998 112.181 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -116.87 166.47 12.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.624 0.726 . . . . 3.1400000000000001 112.189 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 1.011 ' HE3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -70.11 153.88 42.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.891 -1.05 . . . . 2.9100000000000001 111.736 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' H ' ' HB2' ' A' ' 70' ' ' GLU . . . 86.68 -5.11 85.53 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.365 -0.834 . . . . 1.1899999999999999 111.49 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -119.85 163.8 16.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.163 0.506 . . . . 1.3799999999999999 111.119 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -87.54 121.79 30.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 2.2000000000000002 110.769 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 17.8 m -132.73 156.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.217 -0.447 . . . . 1.3300000000000001 109.974 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 124' ' ' SER . 39.0 m -127.75 116.58 20.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.229 -0.442 . . . . 1.23 109.916 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.848 HG11 ' HA ' ' A' ' 122' ' ' LEU . 33.7 m -137.46 156.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.614 -0.266 . . . . 1.6200000000000001 111.088 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.73 142.71 45.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.956 -0.757 . . . . 3.5600000000000001 108.956 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -124.16 141.23 52.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.88 110.71 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -168.77 161.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 109.251 -0.648 . . . . 1.1899999999999999 109.251 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.22 -128.61 1.79 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.312 -0.947 . . . . 0.37 112.341 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 117' ' ' LEU . 18.6 pttm -156.69 173.16 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.929 0.395 . . . . 1.96 110.805 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.602 HD23 HG13 ' A' ' 110' ' ' ILE . 65.9 tp -91.15 98.29 11.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 1.1200000000000001 110.184 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HB2' HD11 ' A' ' 117' ' ' LEU . 35.7 tt0 -66.58 -21.15 66.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.846 0.355 . . . . 1.96 110.704 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.508 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 23.2 t -55.89 -29.97 60.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 1.1100000000000001 111.48 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 53' ' ' LYS . 9.6 t -138.04 1.31 2.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.868 0.366 . . . . 1.24 111.406 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.91 20.42 73.41 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.215 -0.517 . . . . 0.78000000000000003 112.869 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HB2' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -84.19 116.42 22.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.629 0.252 . . . . 3.2999999999999998 110.784 -178.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.566 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.2 p -70.57 150.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 1.3400000000000001 110.054 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 8.4 m-30 -74.92 124.52 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.971 0.415 . . . . 0.96999999999999997 111.425 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.63 85.25 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.504 0.669 . . . . 2.1800000000000002 110.674 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.401 ' HB3' ' OD1' ' A' ' 60' ' ' ASP . 46.8 t -126.53 166.59 17.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.656 -0.702 . . . . 1.6799999999999999 109.227 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -71.18 -22.05 62.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.897 0.38 . . . . 1.8600000000000001 111.082 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.565 ' O ' HG11 ' A' ' 63' ' ' VAL . 43.3 m-85 -95.02 -55.65 3.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.793 0.664 . . . . 2.1200000000000001 112.793 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 5.5 p-10 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.548 0.573 . . . . 2.1899999999999999 112.548 -167.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -1.94 55.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.842 0.353 . . . . 3.1899999999999999 111.278 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -116.29 -53.99 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 1.27 111.765 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 59' ' ' PHE . 13.0 p -87.09 127.27 59.99 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.441 0.638 . . . . 2.6099999999999999 111.858 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.18 90.48 1.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.586 2.191 . . . . 2.1299999999999999 111.027 173.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -94.39 132.61 38.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.148 -0.686 . . . . 1.6299999999999999 109.148 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -138.55 147.31 42.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.106 -0.497 . . . . 2.0099999999999998 110.206 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -115.47 178.35 4.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.68999999999999995 109.722 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -115.72 148.9 39.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.237 -1.023 . . . . 2.6600000000000001 108.237 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' HG ' ' HA ' ' A' ' 36' ' ' LYS . 18.3 tp -74.36 128.91 36.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.995 0.426 . . . . 1.5600000000000001 111.226 -175.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 1.011 ' HG3' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 58.93 64.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.879 -1.055 . . . . 2.0800000000000001 112.229 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 73' ' ' GLU . 10.0 pt20 -115.84 10.13 15.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.3 -1.318 . . . . 1.98 108.967 172.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.8 -18.7 41.89 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.78000000000000003 112.772 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' HE21 ' A' ' 71' ' ' GLN . 19.9 mm-40 -76.63 -32.92 58.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.178 0.513 . . . . 0.96999999999999997 110.791 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.78 129.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.813 -0.631 . . . . 1.25 109.725 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.656 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.93 -73.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.261 -0.427 . . . . 1.3500000000000001 111.592 -175.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.656 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -138.16 -44.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.022 -0.424 . . . . 2.5600000000000001 112.018 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 93' ' ' VAL . . . -54.5 -53.87 35.93 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.792 -0.718 . . . . 0.34000000000000002 113.101 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.596 ' O ' HG21 ' A' ' 82' ' ' VAL . 11.4 m-90 -75.78 -36.59 59.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.439 -0.448 . . . . 0.56000000000000005 110.266 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -51.41 -53.79 33.2 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.063 0.852 . . . . 1.1399999999999999 111.951 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 15' ' ' ASP . 1.6 mp -65.23 -38.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.829 0.347 . . . . 1.3999999999999999 111.164 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 85' ' ' MET . 23.6 t -66.86 -55.85 12.94 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.888 -0.325 . . . . 0.98999999999999999 110.616 -176.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 78' ' ' TRP . 29.9 m -71.76 -33.23 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.038 0.385 . . . . 1.49 112.038 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 t -78.05 0.83 23.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.264 0.555 . . . . 1.9399999999999999 110.734 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 t -131.69 20.48 4.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.687 . . . . 1.8700000000000001 109.843 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.801 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 2.1 mmt -90.81 -174.66 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 2.79 110.699 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 50.8 mtt85 -149.42 154.97 39.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.03 -1.1 . . . . 4.9199999999999999 108.03 172.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 62.2 tttm -65.27 -14.33 60.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.128 0.489 . . . . 2.4300000000000002 111.911 -173.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -124.06 25.08 8.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.96 0.41 . . . . 1.4199999999999999 110.185 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 32.3 tt0 -123.61 166.66 15.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.862 -0.608 . . . . 1.6000000000000001 110.363 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -158.8 133.72 8.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.715 0.293 . . . . 1.74 111.301 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.3 m -136.79 153.94 50.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.342 -0.39 . . . . 1.3600000000000001 110.738 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.463 ' HG ' ' HG2' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -101.21 121.46 41.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.35 -0.611 . . . . 2.2999999999999998 109.35 175.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 77' ' ' GLY . 12.6 p -106.44 145.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.453 -0.34 . . . . 1.46 110.896 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.521 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 41.5 mmt-85 -96.5 118.14 32.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.976 -0.557 . . . . 2.29 110.497 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.2 mp -96.43 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.227 -0.657 . . . . 1.2 109.227 175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.468 ' H ' ' HB2' ' A' ' 99' ' ' TYR . 42.1 tt0 -92.63 173.29 7.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.975 -1.012 . . . . 1.3700000000000001 108.898 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 17.1 p -51.42 -50.05 60.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.765 0.283 . . . . 1.22 111.765 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.6 ptm -77.55 -16.82 58.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.074 0.398 . . . . 2.3199999999999998 112.074 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.468 ' HB2' ' H ' ' A' ' 96' ' ' GLU . 21.7 m-30 -85.59 -17.17 37.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.177 -0.305 . . . . 0.92000000000000004 110.177 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.85 -154.22 9.25 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.488 -0.778 . . . . 0.85999999999999999 111.463 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -93.36 47.31 1.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 1.52 111.847 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.53 -10.39 79.34 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.821 . . . . 2.2999999999999998 111.344 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.34 -59.15 2.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.91 0.386 . . . . 5.8600000000000003 110.837 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.29 -33.5 43.29 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.877 -0.601 . . . . 4.2699999999999996 110.878 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 99.62 -5.21 58.37 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.617 -0.801 . . . . 2.8999999999999999 113.169 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.0 t -82.64 97.45 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.178 0.513 . . . . 3.7799999999999998 110.846 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -122.89 -168.14 13.06 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.857 -0.687 . . . . 1.47 111.594 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.47 -68.82 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.248 0.524 . . . . 3.0800000000000001 111.837 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.509 ' HB2' HD11 ' A' ' 110' ' ' ILE . 11.4 p -79.65 -74.99 0.27 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.959 -0.296 . . . . 1.71 111.753 -174.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.602 HG13 HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -144.43 84.27 9.36 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.617 0.722 . . . . 1.3700000000000001 110.861 177.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.567 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 68.5 Cg_endo -95.15 90.9 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.029 2.486 . . . . 1.5800000000000001 112.272 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.95 47.66 1.0 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.079 -1.058 . . . . 2.0499999999999998 112.302 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 3.6 m-20 60.34 21.68 11.2 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.534 0.683 . . . . 2.2999999999999998 110.76 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.508 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 7.4 m -96.46 156.55 16.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 1.5700000000000001 109.852 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -87.03 121.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.404 0.621 . . . . 1.1799999999999999 110.766 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -114.57 157.27 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.601 -0.727 . . . . 1.25 110.159 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.589 HD13 ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -116.77 129.19 55.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 110.0 -0.37 . . . . 1.3500000000000001 110.0 175.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.46 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 21.1 m-85 -122.33 122.0 38.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.598 -0.274 . . . . 0.56000000000000005 110.351 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.463 ' HG2' ' HG ' ' A' ' 92' ' ' LEU . 42.7 mt-10 -75.25 114.52 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.191 -0.67 . . . . 1.46 109.191 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.498 HD12 ' HG ' ' A' ' 81' ' ' CYS . 65.4 mt -106.76 122.29 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.913 0.387 . . . . 1.1599999999999999 110.005 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.29 115.66 22.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 109.5 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.848 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -86.0 94.43 9.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 1.75 110.362 -176.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.608 ' H ' HD21 ' A' ' 123' ' ' LEU . 1.2 pt? -86.08 -28.65 23.94 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.018 -0.273 . . . . 1.78 111.16 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 t -141.05 144.82 35.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.044 0.45 . . . . 1.53 110.555 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 87' ' ' LYS . 6.1 p90 -164.47 168.16 18.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.931 -0.766 . . . . 0.90000000000000002 108.931 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -161.97 109.16 1.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 3.4700000000000002 111.339 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -71.33 115.44 10.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.541 -0.754 . . . . 3.3799999999999999 110.365 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.7 tp -108.87 122.55 47.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.278 -0.638 . . . . 3.8199999999999998 109.278 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -80.62 91.33 5.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.252 0.548 . . . . 5.3899999999999997 110.874 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -108.78 73.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.862 0.839 . . . . 7.75 110.628 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -156.9 155.69 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.446 -1.252 . . . . 7.8499999999999996 108.0 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -67.77 139.7 56.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.59 -0.444 . . . . 9.5500000000000007 110.842 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.18 110.71 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 10.23 110.398 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -61.37 -39.76 91.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.136 0.493 . . . . 12.85 110.291 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.915 -0.772 . . . . 13.970000000000001 108.915 170.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.652 0.263 . . . . 7.8200000000000003 110.809 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -70.9 159.69 34.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.139 -0.319 . . . . 6.2699999999999996 110.139 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.0 m -150.68 -66.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 4.75 110.836 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -117.19 176.55 5.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.893 0.378 . . . . 4.4400000000000004 110.377 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -76.14 101.28 5.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 4.9000000000000004 110.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.88 34.8 0.98 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.698 0.761 . . . . 3.6099999999999999 109.355 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.13 -170.86 1.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.303 -0.862 . . . . 4.54 110.466 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.28 150.07 49.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.038 0.447 . . . . 2.71 110.826 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HG3' HG23 ' A' ' 21' ' ' THR . 3.6 mppt? -91.6 144.4 25.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 2.4399999999999999 109.605 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 41.4 t -101.34 103.85 15.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 1.3100000000000001 108.427 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -103.45 113.75 27.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.129 -0.941 . . . . 2.1600000000000001 110.66 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.2 mt 60.67 54.65 3.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.962 0.789 . . . . 2.04 111.206 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -57.29 148.63 22.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.92 . . . . 1.26 110.607 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.43 1.3 4.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 1.3700000000000001 110.502 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 13' ' ' THR . 31.7 t70 -87.1 16.64 4.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 2.3999999999999999 110.908 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.18 5.04 8.98 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.396 -0.907 . . . . 0.83999999999999997 114.114 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.34 72.26 0.9 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.226 -0.512 . . . . 0.62 113.652 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.494 HG21 ' HB ' ' A' ' 80' ' ' ILE . 62.4 t -135.68 142.72 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.782 -0.451 . . . . 1.1799999999999999 109.782 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.5 mm -88.11 114.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.721 -0.474 . . . . 1.1799999999999999 109.721 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HE2' ' OG ' ' A' ' 84' ' ' SER . 12.1 pttp -142.4 138.51 31.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.314 0.578 . . . . 1.96 111.418 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 24.6 m -100.02 123.81 44.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 1.21 110.126 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.553 HG12 ' HE2' ' A' ' 25' ' ' LYS . 8.9 tp -80.42 132.76 31.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.997 0.427 . . . . 1.3 110.1 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.68 -51.06 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.049 -0.523 . . . . 1.3999999999999999 110.983 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 117.19 19.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.454 -0.339 . . . . 2.0600000000000001 110.392 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.556 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 58.0 mttm -101.91 160.63 14.32 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.148 -0.478 . . . . 3.25 110.312 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.42 -142.23 12.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.789 -0.719 . . . . 1.3200000000000001 111.919 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -76.0 0.56 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.961 0.41 . . . . 2.77 110.293 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.79 -178.58 3.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.136 -0.483 . . . . 2.6400000000000001 110.116 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 52.31 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.081 -0.807 . . . . 1.3 111.081 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.78 -40.64 93.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.983 0.42 . . . . 2.29 110.948 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.79 9.28 26.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.536 . . . . 2.6400000000000001 110.474 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -111.79 77.37 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 1.49 110.296 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 36.4 mm -132.87 120.69 16.57 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.398 -0.819 . . . . 1.3700000000000001 110.101 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HG3' HD23 ' A' ' 122' ' ' LEU . 85.7 Cg_endo -87.04 115.9 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.815 2.343 . . . . 0.84999999999999998 112.576 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HE2' ' CG2' ' A' ' 33' ' ' ILE . 71.3 mmtt -129.9 158.29 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 3.1400000000000001 111.444 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 12.1 ttmm -65.43 150.27 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.158 -0.928 . . . . 2.9100000000000001 111.365 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.2 -11.66 68.92 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.934 -0.867 . . . . 1.1899999999999999 110.934 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -105.05 155.71 18.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.517 . . . . 1.3799999999999999 110.878 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.25 104.25 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 2.2000000000000002 110.682 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 m -118.08 162.12 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 1.3300000000000001 110.655 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 31.5 m -133.45 120.91 21.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.797 -0.638 . . . . 1.23 109.611 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.68 148.79 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 1.6200000000000001 111.577 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.22 143.84 30.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.297 -0.631 . . . . 3.5600000000000001 109.297 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 30.6 p90 -141.97 137.02 30.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.88 110.505 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.55 160.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.125 -0.694 . . . . 1.1899999999999999 109.125 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.11 -118.88 0.68 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.539 -0.839 . . . . 0.37 112.597 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -149.94 171.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 1.96 110.111 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.473 HD11 ' HG ' ' A' ' 116' ' ' LEU . 57.0 tp -87.23 98.01 11.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.879 -0.6 . . . . 1.1200000000000001 109.533 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 4.9 tp10 -57.59 -35.09 69.94 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.46 0.541 . . . . 1.96 112.46 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -58.26 -20.06 39.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.372 0.508 . . . . 1.1100000000000001 112.372 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.4 t -134.05 -30.81 1.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.971 0.415 . . . . 1.24 110.773 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.26 15.84 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.254 -0.498 . . . . 0.78000000000000003 113.151 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -81.49 125.33 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.932 0.366 . . . . 3.2999999999999998 110.67 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.24 154.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 1.3400000000000001 110.03 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.483 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 22.0 m-30 -75.2 99.96 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.167 0.508 . . . . 0.96999999999999997 111.918 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -116.87 85.89 2.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.371 -0.974 . . . . 2.1800000000000002 108.371 168.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -135.33 158.06 45.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.62 -0.718 . . . . 1.6799999999999999 110.248 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -48.67 -42.08 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.769 0.668 . . . . 1.8600000000000001 112.496 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -93.88 -50.64 5.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.771 0.32 . . . . 2.1200000000000001 110.609 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.66 -37.87 59.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 2.1899999999999999 112.626 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -84.53 -4.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 3.1899999999999999 111.267 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.425 ' C ' HD21 ' A' ' 62' ' ' ASN . 0.2 OUTLIER -115.49 -61.44 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.939 -0.305 . . . . 1.27 110.569 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.19 109.61 6.96 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.32 -0.4 . . . . 2.6099999999999999 110.225 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.49 161.17 42.32 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.709 2.273 . . . . 2.1299999999999999 112.137 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -94.03 154.12 17.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.079 -0.509 . . . . 1.6299999999999999 110.279 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.8 pptp? -134.47 151.1 50.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 2.0099999999999998 110.263 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.68 -171.85 2.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.37 -0.377 . . . . 0.68999999999999995 110.989 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -116.72 149.2 40.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.289 -0.634 . . . . 2.6600000000000001 109.289 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 82' ' ' VAL . 9.8 tp -67.81 112.86 5.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 1.5600000000000001 111.89 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.97 73.11 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.334 -1.303 . . . . 2.0800000000000001 111.63 176.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -113.44 17.43 18.43 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.187 -1.042 . . . . 1.98 108.187 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.99 -18.28 55.99 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.585 -1.189 . . . . 0.78000000000000003 113.062 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.25 -14.54 28.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.956 0.378 . . . . 0.96999999999999997 111.446 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.15 121.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.643 0.735 . . . . 1.25 109.751 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.37 -62.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.08 -0.964 . . . . 1.3500000000000001 112.774 -172.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -125.92 -66.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.278 0.473 . . . . 2.5600000000000001 112.278 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.33 -52.6 35.82 Favored Glycine 0 C--N 1.333 0.384 0 O-C-N 123.56 0.538 . . . . 0.34000000000000002 113.59 -169.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.409 ' O ' HG21 ' A' ' 82' ' ' VAL . 5.9 m-90 -75.39 -46.44 32.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.769 0.318 . . . . 0.56000000000000005 110.393 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.36 -48.26 65.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.026 -0.988 . . . . 1.1399999999999999 112.251 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.494 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -73.89 -45.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.488 -0.324 . . . . 1.3999999999999999 110.894 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.484 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 53.1 t -63.56 -41.8 98.4 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.591 0.219 . . . . 0.98999999999999999 111.591 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 69' ' ' LEU . 34.4 m -67.66 -32.34 56.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.768 -0.373 . . . . 1.49 110.805 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.1 m -79.48 -4.0 49.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.946 0.403 . . . . 1.9399999999999999 111.169 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.418 ' OG ' ' HE2' ' A' ' 20' ' ' LYS . 9.7 p -124.01 39.32 3.99 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.227 0.537 . . . . 1.8700000000000001 111.096 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.568 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -116.13 174.57 5.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 2.79 110.488 176.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -127.51 163.36 24.31 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.36 -1.348 . . . . 4.9199999999999999 107.36 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -64.42 -17.55 63.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.238 0.542 . . . . 2.4300000000000002 110.846 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -122.81 16.73 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.069 -0.514 . . . . 1.4199999999999999 110.703 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HG3' ' HA ' ' A' ' 25' ' ' LYS . 33.6 tt0 -123.7 129.38 51.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 1.6000000000000001 110.642 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.465 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 85.4 tttt -136.58 143.75 43.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 1.74 109.894 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 21' ' ' THR . 28.8 p -149.79 165.26 33.0 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.001 0.429 . . . . 1.3600000000000001 111.733 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.97 120.65 32.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.291 -0.868 . . . . 2.2999999999999998 110.007 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.484 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.5 p -99.89 134.59 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.286 -0.415 . . . . 1.46 110.096 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.611 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 26.2 mmm-85 -96.1 111.38 23.43 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.463 -0.569 . . . . 2.29 109.463 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 118' ' ' PHE . 2.1 mp -91.44 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.019 -0.734 . . . . 1.2 109.019 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 97' ' ' SER . 43.7 tt0 -79.7 168.52 19.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.313 -0.858 . . . . 1.3700000000000001 109.449 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.413 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -48.16 -48.48 34.32 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.323 0.649 . . . . 1.22 111.463 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -78.56 -8.07 58.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.362 0.504 . . . . 2.3199999999999998 112.362 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -96.25 -12.86 23.95 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.237 -0.289 . . . . 0.92000000000000004 110.848 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 176.06 19.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.847 -0.692 . . . . 0.85999999999999999 112.36 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -41.49 97.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.916 0.388 . . . . 1.52 110.996 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.51 165.56 18.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.562 -0.827 . . . . 2.2999999999999998 112.447 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -72.51 -23.37 61.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.327 0.584 . . . . 5.8600000000000003 111.015 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -87.32 10.9 15.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.724 -0.671 . . . . 4.2699999999999996 110.742 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.43 -161.86 10.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.532 -0.842 . . . . 2.8999999999999999 112.227 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.1 m -72.31 126.31 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.788 0.328 . . . . 3.7799999999999998 110.326 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.6 142.58 16.05 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.874 -0.679 . . . . 1.47 111.914 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.18 -71.57 0.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.608 -0.516 . . . . 3.0800000000000001 109.608 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -104.86 -72.08 0.72 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.147 -0.686 . . . . 1.71 109.147 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -143.62 112.38 5.43 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.35 -0.387 . . . . 1.3700000000000001 110.095 175.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -83.06 -83.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.516 2.144 . . . . 1.5800000000000001 112.831 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.89 18.16 59.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.952 -0.36 . . . . 2.0499999999999998 113.694 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 52.65 35.39 18.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.006 0.431 . . . . 2.2999999999999998 111.181 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.3 m -107.77 179.49 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 1.5700000000000001 110.67 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.33 129.57 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.174 0.512 . . . . 1.1799999999999999 111.008 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.473 ' HG ' HD11 ' A' ' 48' ' ' LEU . 6.3 mp -127.21 174.82 8.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.297 -0.631 . . . . 1.25 109.297 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.611 ' HB3' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -147.01 133.04 19.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.29 0.567 . . . . 1.3500000000000001 110.578 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.483 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 43.6 m-85 -127.98 141.76 51.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.56000000000000005 110.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.3 mt-10 -76.26 127.15 32.32 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.062 -0.718 . . . . 1.46 109.062 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.7 mt -105.89 118.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.601 0.715 . . . . 1.1599999999999999 110.216 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -110.68 116.0 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.687 -1.142 . . . . 1.8799999999999999 110.458 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.447 HD23 ' HG3' ' A' ' 34' ' ' PRO . 30.3 tp -91.89 89.6 7.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 1.75 109.977 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.7 pt? -95.17 -33.32 12.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 1.78 111.042 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 13.8 m -135.12 128.18 31.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.024 -0.362 . . . . 1.53 110.024 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.25 171.16 11.01 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.559 -0.534 . . . . 0.90000000000000002 109.559 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -162.11 168.49 22.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.007 -0.368 . . . . 3.4700000000000002 110.007 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.78 152.15 40.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.139 -1.06 . . . . 3.3799999999999999 108.139 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.87 -37.67 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.407 0.521 . . . . 3.8199999999999998 112.407 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -108.5 98.33 7.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.05 -0.66 . . . . 5.3899999999999997 111.964 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -89.28 55.37 3.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.143 -0.935 . . . . 7.75 108.926 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -135.54 137.0 41.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.309 -0.859 . . . . 7.8499999999999996 110.098 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.96 119.26 32.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.901 0.381 . . . . 9.5500000000000007 110.729 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -75.66 127.47 33.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.8 -0.636 . . . . 10.23 109.33 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 21.4 p80 -65.3 -58.63 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.825 -0.35 . . . . 12.85 111.099 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 69.0 t60 . . . . . 0 C--O 1.243 0.72 0 CA-C-O 118.493 -0.765 . . . . 13.970000000000001 109.452 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.707 -0.479 . . . . 7.8200000000000003 109.707 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m 75.02 14.97 3.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.715 0.769 . . . . 6.2699999999999996 110.251 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.59 113.17 20.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 4.75 110.612 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.82 125.99 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.042 0.839 . . . . 4.4400000000000004 110.739 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -144.63 153.12 41.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.676 -0.693 . . . . 4.9000000000000004 111.144 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -85.45 44.05 1.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.627 -0.715 . . . . 3.6099999999999999 109.823 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -81.98 165.18 20.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 4.54 111.57 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -94.14 153.99 17.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.013 -0.994 . . . . 2.71 110.053 -175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 11.5 mptt -114.73 147.51 39.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.765 0.317 . . . . 2.4399999999999999 110.697 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.98 108.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.536 -0.542 . . . . 1.3100000000000001 109.536 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -89.45 125.06 35.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.237 0.542 . . . . 2.1600000000000001 111.421 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.432 ' H ' HD13 ' A' ' 19' ' ' ILE . 11.1 tp 54.76 64.38 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.953 -1.021 . . . . 2.04 111.027 174.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.549 HG21 HG23 ' A' ' 80' ' ' ILE . 9.0 t -59.16 156.03 12.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.636 -0.711 . . . . 1.26 111.61 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -19.86 64.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.743 -0.662 . . . . 1.3700000000000001 112.588 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.62 19.93 1.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.324 0.49 . . . . 2.3999999999999999 112.324 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.64 30.64 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.83999999999999997 114.429 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.85 83.6 0.06 OUTLIER Glycine 0 C--O 1.227 -0.334 0 N-CA-C 114.648 0.619 . . . . 0.62 114.648 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.0 t -141.21 140.1 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.38 -0.6 . . . . 1.1799999999999999 109.38 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 12' ' ' LEU . 10.0 mm -93.07 113.58 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.228 0.33 . . . . 1.1799999999999999 110.113 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -141.27 146.9 37.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.338 0.59 . . . . 1.96 111.616 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -109.68 138.65 45.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.106 -0.952 . . . . 1.21 110.113 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.84 132.3 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.234 -0.284 . . . . 1.3 110.234 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 92' ' ' LEU . 3.5 mm? -115.57 -51.58 2.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.456 -0.338 . . . . 1.3999999999999999 110.64 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 29.1 ttmt -122.9 135.07 54.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.726 -0.472 . . . . 2.0600000000000001 109.726 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -99.63 147.12 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 123.46 0.475 . . . . 3.25 110.785 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 171.4 52.15 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 116.028 -0.533 . . . . 1.3200000000000001 111.939 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.55 -65.92 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 2.77 110.768 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -151.7 153.05 33.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 2.6400000000000001 110.074 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.43 100.8 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.181 -1.009 . . . . 1.3 112.98 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -74.63 -42.33 58.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.574 . . . . 2.29 109.793 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -81.4 -23.31 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.377 -0.829 . . . . 2.6400000000000001 110.663 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.69 75.78 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.421 0.629 . . . . 1.49 109.611 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mm -146.4 118.78 4.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.735 -1.12 . . . . 1.3700000000000001 109.209 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.477 ' HG3' HD21 ' A' ' 122' ' ' LEU . 20.3 Cg_endo -60.78 124.73 15.57 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.799 2.333 . . . . 0.84999999999999998 111.716 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -116.37 149.54 39.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.601 -0.518 . . . . 3.1400000000000001 109.601 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.565 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -77.19 144.54 38.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.416 -0.514 . . . . 2.9100000000000001 110.633 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.34 -22.31 41.32 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.162 -0.775 . . . . 1.1899999999999999 111.162 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -99.33 169.96 8.98 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.079 -0.341 . . . . 1.3799999999999999 110.079 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.05 125.63 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.286 0.565 . . . . 2.2000000000000002 111.324 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 125' ' ' PHE . 19.0 m -135.12 160.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.598 -0.728 . . . . 1.3300000000000001 109.235 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 28.6 m -130.51 111.85 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.407 -0.59 . . . . 1.23 109.407 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.26 153.34 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 1.6200000000000001 111.751 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -116.18 130.25 56.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 3.5600000000000001 109.022 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 21.8 p90 -127.23 144.3 51.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.788 0.327 . . . . 0.88 110.143 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -167.82 158.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.892 -0.781 . . . . 1.1899999999999999 108.892 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.67 -130.35 1.98 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.841 -1.171 . . . . 0.37 113.05 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HG3' HD13 ' A' ' 117' ' ' LEU . 57.2 pttt -157.38 173.07 17.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.377 . . . . 1.96 110.682 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 66.7 tp -94.53 109.34 21.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 1.1200000000000001 110.28 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.517 ' HB2' HD12 ' A' ' 117' ' ' LEU . 24.2 tt0 -68.43 -20.69 64.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.204 0.526 . . . . 1.96 110.091 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.442 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 39.7 t -55.1 -43.27 73.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.154 -0.93 . . . . 1.1100000000000001 111.328 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.429 HG22 HD23 ' A' ' 48' ' ' LEU . 8.8 t -124.38 3.31 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 1.24 111.41 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.35 78.51 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 120.902 -0.666 . . . . 0.78000000000000003 113.039 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 67.0 mmtt -91.82 132.92 36.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 3.2999999999999998 110.917 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.649 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.8 p -75.84 166.84 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 1.3400000000000001 109.95 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.96 117.99 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.431 0.634 . . . . 0.96999999999999997 110.582 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.72 95.01 2.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.113 -0.949 . . . . 2.1800000000000002 109.42 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 m -137.4 171.2 14.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.933 0.397 . . . . 1.6799999999999999 110.337 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -70.41 -33.7 71.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.15 -0.477 . . . . 1.8600000000000001 110.9 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -92.33 -35.93 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.541 0.571 . . . . 2.1200000000000001 112.541 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -33.77 74.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.819 0.342 . . . . 2.1899999999999999 111.544 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.71 -12.15 51.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.051 0.453 . . . . 3.1899999999999999 110.941 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.81 HD21 HG21 ' A' ' 63' ' ' VAL . 6.9 t30 -112.24 -61.04 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.129 -0.487 . . . . 1.27 111.815 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.81 HG21 HD21 ' A' ' 62' ' ' ASN . 96.9 t -119.25 104.09 46.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.598 -0.274 . . . . 2.6099999999999999 110.289 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.42 147.83 47.44 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.086 2.524 . . . . 2.1299999999999999 112.035 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -101.99 150.39 23.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.295 -0.411 . . . . 1.6299999999999999 109.929 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.09 146.35 31.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 2.0099999999999998 109.792 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -127.59 -177.32 4.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.895 0.379 . . . . 0.68999999999999995 111.278 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -118.51 149.81 40.67 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.363 -0.606 . . . . 2.6600000000000001 109.363 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.625 HD12 HG21 ' A' ' 82' ' ' VAL . 15.9 tp -75.87 117.08 17.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.026 0.38 . . . . 1.5600000000000001 112.026 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 68.26 48.79 0.87 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.187 -0.915 . . . . 2.0800000000000001 112.395 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 1.3 pm0 -92.33 0.67 57.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.096 -0.705 . . . . 1.98 109.096 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.37 1.38 44.09 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.78000000000000003 113.091 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 7.9 mm-40 -99.04 -24.27 14.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.412 0.606 . . . . 0.96999999999999997 111.255 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.8 123.64 57.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 1.25 110.923 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.531 HD12 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -97.17 -62.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 1.3500000000000001 112.293 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.611 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 8.7 mmpt? -129.2 -61.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 2.5600000000000001 112.494 -172.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 -53.21 34.38 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.065 -0.588 . . . . 0.34000000000000002 113.459 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.563 ' O ' HG23 ' A' ' 82' ' ' VAL . 10.0 m-90 -75.24 -37.12 61.17 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.841 -0.211 . . . . 0.56000000000000005 110.644 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.75 -52.09 57.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.826 0.703 . . . . 1.1399999999999999 111.685 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.549 HG23 HG21 ' A' ' 13' ' ' THR . 2.4 mp -74.26 -41.89 50.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 1.3999999999999999 110.995 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.501 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 44.6 t -60.33 -51.03 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.98999999999999999 111.589 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.759 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 28.6 m -67.69 -43.1 86.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 111.975 0.361 . . . . 1.49 111.975 -174.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.418 ' OG ' HD22 ' A' ' 69' ' ' LEU . 21.6 m -70.16 -14.92 62.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.028 0.442 . . . . 1.9399999999999999 111.463 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -99.46 24.95 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.367 -0.379 . . . . 1.8700000000000001 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.759 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 37.2 mtm -118.83 -173.58 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.215 0.531 . . . . 2.79 111.214 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 53.5 mtm180 -142.2 175.46 9.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.155 -0.93 . . . . 4.9199999999999999 109.271 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -62.31 -16.88 56.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.563 0.579 . . . . 2.4300000000000002 112.563 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -135.32 29.4 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 1.4199999999999999 110.747 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 4.5 tt0 -113.91 153.95 28.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.527 -0.546 . . . . 1.6000000000000001 109.527 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 1.5 tmtp? -143.58 127.49 17.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.972 -0.291 . . . . 1.74 110.955 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 71.2 m -127.61 151.45 48.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.222 -0.445 . . . . 1.3600000000000001 111.425 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -107.29 118.96 38.1 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.151 -0.685 . . . . 2.2999999999999998 109.151 173.01 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.501 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.2 p -109.7 141.89 23.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.243 0.544 . . . . 1.46 111.43 -173.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -99.29 117.44 33.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 2.29 109.88 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.9 mp -96.92 104.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.462 . . . . 1.2 109.751 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 97' ' ' SER . 28.9 tt0 -83.76 170.87 13.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.787 -0.82 . . . . 1.3700000000000001 108.787 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.402 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 9.5 p -49.6 -49.9 44.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.526 0.33 . . . . 1.22 111.85 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.9 ptp -76.61 -13.5 60.06 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.236 -0.438 . . . . 2.3199999999999998 111.635 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 16.1 m-30 -84.54 -5.84 59.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.871 0.367 . . . . 0.92000000000000004 110.149 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.531 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -138.39 -161.2 8.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.55 -0.75 . . . . 0.85999999999999999 111.52 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -92.89 30.43 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 1.52 110.975 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.8 -31.94 82.58 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.045 -0.525 . . . . 2.2999999999999998 112.313 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.16 -35.53 75.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.151 0.5 . . . . 5.8600000000000003 110.738 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.51 -40.5 12.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.569 -0.741 . . . . 4.2699999999999996 110.533 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.99 15.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.781 -0.723 . . . . 2.8999999999999999 112.494 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -74.09 108.71 7.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.099 0.476 . . . . 3.7799999999999998 110.865 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.531 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -137.95 137.02 8.53 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.773 -0.649 . . . . 1.47 111.768 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -71.44 -46.35 60.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.925 0.393 . . . . 3.0800000000000001 110.988 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 t -110.99 -73.75 0.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.673 -0.491 . . . . 1.71 109.673 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.467 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -143.21 117.0 6.13 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 1.3700000000000001 110.452 176.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.531 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 7.0 Cg_endo -80.56 -68.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.015 1.81 . . . . 1.5800000000000001 111.717 170.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.87 1.25 17.2 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.176 -0.466 . . . . 2.0499999999999998 113.409 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 m120 60.88 27.71 17.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.192 0.52 . . . . 2.2999999999999998 110.917 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -119.7 -163.69 1.01 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.896 -0.593 . . . . 1.5700000000000001 110.307 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 7.6 p -108.17 130.05 61.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.309 0.576 . . . . 1.1799999999999999 111.775 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -112.94 161.89 16.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 1.25 109.79 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.715 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.28 116.82 28.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.494 -0.558 . . . . 1.3500000000000001 109.494 175.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.418 ' HD2' HD12 ' A' ' 95' ' ' ILE . 29.4 m-85 -113.87 125.0 53.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 0.56000000000000005 111.045 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 47.9 mt-10 -80.13 113.96 18.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.463 -0.789 . . . . 1.46 109.081 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.605 HG23 HG13 ' A' ' 82' ' ' VAL . 40.0 mt -107.93 123.94 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.028 0.442 . . . . 1.1599999999999999 110.352 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.515 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 18.3 mt-10 -127.87 130.33 48.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.646 -0.706 . . . . 1.8799999999999999 109.875 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.664 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 25.6 tp -91.82 100.4 13.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 1.75 110.341 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.74 -30.2 18.19 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.824 -0.351 . . . . 1.78 111.082 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 58.0 m -150.41 147.76 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 1.53 111.436 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.523 ' HB2' HG13 ' A' ' 40' ' ' VAL . 2.0 p90 -165.05 159.62 18.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.90000000000000002 109.352 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -158.63 113.72 2.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.95 0.405 . . . . 3.4700000000000002 111.352 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.16 139.92 30.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.363 -0.38 . . . . 3.3799999999999999 110.758 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.3 mt -140.3 52.88 1.65 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.572 -0.74 . . . . 3.8199999999999998 109.761 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.793 ' HB3' ' HE1' ' A' ' 132' ' ' HIS . 1.0 OUTLIER 76.27 -176.13 0.12 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.919 0.762 . . . . 5.3899999999999997 110.02 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -123.76 -49.28 1.88 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.842 0.682 . . . . 7.75 112.842 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -126.93 100.91 6.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 7.8499999999999996 111.72 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.793 ' HE1' ' HB3' ' A' ' 129' ' ' GLU . 15.1 m-70 -91.14 67.24 5.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.2 -0.454 . . . . 9.5500000000000007 110.157 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 24.6 m80 52.74 67.42 0.99 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.552 0.532 . . . . 10.23 111.636 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.7 134.09 20.74 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.689 -0.486 . . . . 12.85 109.689 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.369 -0.824 . . . . 13.970000000000001 110.438 -175.106 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.402 -0.221 . . . . 7.8200000000000003 110.402 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.1 p -72.22 99.09 2.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.998 0.427 . . . . 6.2699999999999996 110.256 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -112.36 113.27 25.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 4.75 111.98 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.72 150.68 22.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.817 -0.629 . . . . 4.4400000000000004 109.512 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -75.61 125.38 28.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.918 0.39 . . . . 4.9000000000000004 111.603 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -84.38 104.47 14.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 3.6099999999999999 109.999 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.15 136.68 54.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.267 0.556 . . . . 4.54 111.036 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.85 143.07 42.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 2.71 110.447 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.18 136.27 47.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 2.4399999999999999 109.84 -174.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.6 107.65 23.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.601 -0.518 . . . . 1.3100000000000001 109.601 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' HB2' HD13 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -102.58 134.95 45.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.138 -0.483 . . . . 2.1600000000000001 111.462 -176.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.495 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt 56.64 51.74 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.248 -0.887 . . . . 2.04 112.493 171.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -61.29 153.65 25.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.275 -0.42 . . . . 1.26 110.117 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.9 1.07 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.688 0.625 . . . . 1.3700000000000001 112.688 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.64 24.81 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 2.3999999999999999 111.264 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.47 10.42 5.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.378 -0.915 . . . . 0.83999999999999997 114.011 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 57.75 67.14 2.36 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.892 0.717 . . . . 0.62 114.892 170.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' HB ' ' A' ' 80' ' ' ILE . 25.6 t -116.83 139.21 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 122.285 -0.538 . . . . 1.1799999999999999 110.58 173.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 94' ' ' ARG . 5.6 mm -88.18 109.34 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.214 -0.661 . . . . 1.1799999999999999 109.214 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -125.66 146.23 49.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.393 0.616 . . . . 1.96 111.222 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 m -114.07 121.43 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.419 -0.81 . . . . 1.21 109.603 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 tp -72.43 125.96 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.883 0.373 . . . . 1.3 111.565 -174.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.03 -63.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.17 0.509 . . . . 1.3999999999999999 109.954 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 50.7 mtmt -117.6 134.9 54.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 2.0600000000000001 108.981 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -102.99 139.46 38.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.754 0.311 . . . . 3.25 110.985 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 134.26 12.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.77 -0.729 . . . . 1.3200000000000001 111.718 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.9 -65.32 1.02 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.827 -0.435 . . . . 2.77 109.827 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -96.0 144.17 26.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.0 -0.545 . . . . 2.6400000000000001 109.548 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -154.34 14.54 0.55 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.547 -0.835 . . . . 1.3 111.852 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.21 -21.05 62.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 2.29 110.406 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' C ' HD21 ' A' ' 32' ' ' ASN . 47.4 mt-10 -115.18 14.49 16.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.773 -0.649 . . . . 2.6400000000000001 109.927 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.533 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -138.78 80.86 1.81 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.083 -0.508 . . . . 1.49 111.4 -172.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.82 113.03 27.0 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.223 0.535 . . . . 1.3700000000000001 111.923 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.2 Cg_endo -91.04 111.08 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.963 2.442 . . . . 0.84999999999999998 112.384 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' C ' HD23 ' A' ' 69' ' ' LEU . 27.9 mmtp -136.64 -173.68 3.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 3.1400000000000001 110.951 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.36 152.94 20.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 2.9100000000000001 110.726 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.27 -5.19 38.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.744 . . . . 1.1899999999999999 111.904 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' OD1' HG12 ' A' ' 40' ' ' VAL . 31.4 p30 -135.24 -175.77 4.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.74 0.305 . . . . 1.3799999999999999 110.513 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -96.99 94.21 7.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 2.2000000000000002 110.743 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG12 ' OD1' ' A' ' 38' ' ' ASN . 9.6 m -97.85 122.22 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.903 -0.777 . . . . 1.3300000000000001 108.903 168.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.516 HG21 ' HD3' ' A' ' 66' ' ' LYS . 27.0 m -96.72 111.42 23.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.198 0.523 . . . . 1.23 109.96 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.456 ' CG1' HG21 ' A' ' 120' ' ' ILE . 54.1 t -117.24 130.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.499 -0.773 . . . . 1.6200000000000001 110.329 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -101.79 127.96 48.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.204 -0.665 . . . . 3.5600000000000001 109.204 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 6.6 p90 -128.23 144.5 51.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 0.88 111.105 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -166.38 144.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.557 -0.747 . . . . 1.1899999999999999 109.841 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 118' ' ' PHE . . . -171.02 -139.91 2.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.613 -0.803 . . . . 0.37 112.135 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 64.7 pttt -157.69 172.3 18.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 1.96 110.886 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 114' ' ' SER . 60.7 tp -85.55 101.15 12.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.046 -0.525 . . . . 1.1200000000000001 110.539 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 40.8 tt0 -68.42 -25.87 65.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.771 0.319 . . . . 1.96 110.935 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -54.38 -27.1 34.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 1.1100000000000001 111.543 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 53' ' ' LYS . 14.8 t -139.18 9.05 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.051 0.453 . . . . 1.24 110.482 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.13 41.59 98.18 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.635 -0.711 . . . . 0.78000000000000003 112.755 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.557 ' HB2' HG22 ' A' ' 51' ' ' THR . 4.3 tmtt? -102.83 118.34 36.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 3.2999999999999998 110.29 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.7 p -74.1 160.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 1.3400000000000001 109.856 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 13.0 m-30 -78.0 124.58 28.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.129 0.49 . . . . 0.96999999999999997 111.083 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.95 88.27 2.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.854 0.835 . . . . 2.1800000000000002 109.306 171.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.8 m -136.48 172.97 12.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.596 -0.729 . . . . 1.6799999999999999 111.19 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -71.6 -23.83 61.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.79 -0.641 . . . . 1.8600000000000001 110.865 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -93.83 -51.1 5.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.147 0.795 . . . . 2.1200000000000001 113.147 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.8 -43.23 85.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.335 0.397 . . . . 2.1899999999999999 111.996 -168.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -92.22 9.34 34.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.928 0.394 . . . . 3.1899999999999999 111.602 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -115.7 -64.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.283 -0.417 . . . . 1.27 111.597 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.8 m -105.01 127.56 28.48 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.384 0.611 . . . . 2.6099999999999999 111.997 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.5 Cg_endo -83.44 111.29 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.956 2.437 . . . . 2.1299999999999999 111.511 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -94.72 154.57 17.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 1.6299999999999999 110.888 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HD3' HG21 ' A' ' 41' ' ' THR . 1.7 pptp? -142.44 157.48 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.942 -0.572 . . . . 2.0099999999999998 110.01 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.09 172.65 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.68999999999999995 110.912 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -122.47 150.3 42.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.813 -0.63 . . . . 2.6600000000000001 109.641 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.492 HD21 HG23 ' A' ' 82' ' ' VAL . 35.2 tp -71.38 136.29 47.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.792 0.33 . . . . 1.5600000000000001 111.528 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 51.69 37.72 20.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.57 -0.741 . . . . 2.0800000000000001 112.205 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 73' ' ' GLU . 13.8 pt20 -77.49 -8.28 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.359 0.599 . . . . 1.98 109.597 169.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.21 46.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.78000000000000003 112.845 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB2' HE21 ' A' ' 71' ' ' GLN . 10.1 mm-40 -84.0 -21.92 31.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.883 0.342 . . . . 0.96999999999999997 110.754 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 m -113.61 135.11 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 1.25 110.379 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.465 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -96.02 -61.29 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.083 0.772 . . . . 1.3500000000000001 113.083 -172.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.721 ' HZ2' HD13 ' A' ' 80' ' ' ILE . 5.3 mmpt? -143.18 -44.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.957 0.725 . . . . 2.5600000000000001 112.957 -171.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.03 -53.0 36.14 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.651 -0.785 . . . . 0.34000000000000002 112.684 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.435 ' O ' HG21 ' A' ' 82' ' ' VAL . 4.2 m-90 -75.94 -30.94 58.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.853 0.359 . . . . 0.56000000000000005 110.501 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.24 -54.3 32.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.169 -0.923 . . . . 1.1399999999999999 112.148 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.721 HD13 ' HZ2' ' A' ' 76' ' ' LYS . 2.8 mp -75.38 -42.31 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 1.3999999999999999 110.985 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 85' ' ' MET . 20.7 t -56.99 -47.34 81.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.98999999999999999 111.182 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.492 HG23 HD21 ' A' ' 69' ' ' LEU . 27.1 m -72.91 -32.21 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 123.0 0.188 . . . . 1.49 110.979 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 66.2 m -65.79 -23.3 66.68 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.436 0.636 . . . . 1.9399999999999999 110.869 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -112.25 46.4 1.17 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 1.8700000000000001 110.455 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.765 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.6 mmt -125.41 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.281 0.562 . . . . 2.79 111.226 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.98 ' HD3' ' H ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -155.25 160.69 41.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.056 -1.09 . . . . 4.9199999999999999 108.056 174.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -46.97 -38.27 10.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.461 0.541 . . . . 2.4300000000000002 112.461 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.98 ' H ' ' HD3' ' A' ' 86' ' ' ARG . 16.5 m120 -109.54 6.24 23.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 1.4199999999999999 111.122 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 30.6 tt0 -105.38 140.85 37.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.161 -0.681 . . . . 1.6000000000000001 109.161 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.5 tttt -146.93 135.92 22.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.266 -0.424 . . . . 1.74 110.728 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 22' ' ' ILE . 83.9 m -136.06 159.19 42.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.234 0.54 . . . . 1.3600000000000001 110.825 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 117' ' ' LEU . 1.8 tp -91.34 142.18 27.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.25 -1.018 . . . . 2.2999999999999998 108.25 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.97 135.48 52.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 O-C-N 123.366 0.416 . . . . 1.46 110.36 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.433 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -107.28 111.86 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.638 -0.505 . . . . 2.29 109.638 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -96.4 107.1 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.898 -0.408 . . . . 1.2 109.898 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.612 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 9.7 tt0 -85.43 177.41 7.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.107 -0.701 . . . . 1.3700000000000001 109.107 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -57.32 -37.29 72.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.893 0.331 . . . . 1.22 111.893 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.4 ptp -77.62 -9.73 59.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.182 0.438 . . . . 2.3199999999999998 112.182 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.612 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.7 m-85 -103.62 6.33 37.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.017 -0.273 . . . . 0.92000000000000004 111.037 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.71 174.92 16.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.952 -0.642 . . . . 0.85999999999999999 112.468 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.449 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 50.4 m-85 -81.05 -6.9 59.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.941 0.401 . . . . 1.52 111.183 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.51 -149.68 51.51 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.577 -0.82 . . . . 2.2999999999999998 111.655 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.35 -6.52 57.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 5.8600000000000003 111.265 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -84.48 -46.14 11.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.309 -0.405 . . . . 4.2699999999999996 111.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -84.47 170.41 46.47 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.634 -0.793 . . . . 2.8999999999999999 112.323 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -82.08 95.06 7.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.108 0.48 . . . . 3.7799999999999998 110.484 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.531 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -68.34 152.79 52.67 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.68 -0.691 . . . . 1.47 112.347 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -71.71 -58.71 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.377 0.14 . . . . 3.0800000000000001 111.377 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -108.22 -75.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.631 -0.428 . . . . 1.71 111.33 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -148.23 104.16 3.56 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 1.3700000000000001 111.225 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.531 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 50.4 Cg_endo -97.42 179.89 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.076 2.517 . . . . 1.5800000000000001 112.274 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.61 66.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.267 -0.968 . . . . 2.0499999999999998 113.187 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 m120 55.48 23.84 6.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.954 0.406 . . . . 2.2999999999999998 111.835 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.547 ' HB3' HD12 ' A' ' 48' ' ' LEU . 30.1 m -110.03 150.71 28.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.942 -0.572 . . . . 1.5700000000000001 110.003 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.17 130.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 1.1799999999999999 110.206 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.6 mp -123.34 151.45 42.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.063 -0.517 . . . . 1.25 110.411 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.51 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -128.22 125.54 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.497 . . . . 1.3500000000000001 110.926 177.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.414 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 46.1 m-85 -126.14 153.22 44.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.745 -0.661 . . . . 0.56000000000000005 110.221 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.539 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 42.7 mt-10 -85.46 126.88 34.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.279 -0.638 . . . . 1.46 109.279 170.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.456 HG21 ' CG1' ' A' ' 42' ' ' VAL . 10.6 mt -108.58 118.18 55.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 1.1599999999999999 109.865 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.472 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 45.2 tt0 -132.96 132.29 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 1.8799999999999999 110.24 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.21 115.7 28.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 1.75 110.678 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.31 -21.4 13.84 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.757 -0.377 . . . . 1.78 112.016 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.51 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 29.3 t -155.63 149.61 25.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.003 -0.279 . . . . 1.53 110.393 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -168.19 172.66 8.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 0.90000000000000002 110.036 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -161.04 126.38 3.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 3.4700000000000002 110.177 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -89.4 139.09 30.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 3.3799999999999999 111.536 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 39.8 tp -99.92 -6.39 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.488 -0.778 . . . . 3.8199999999999998 110.786 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.67 158.87 0.21 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.524 -0.762 . . . . 5.3899999999999997 111.967 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -62.56 126.27 26.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.333 -0.848 . . . . 7.75 110.969 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -101.67 -21.6 14.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.414 -0.812 . . . . 7.8499999999999996 111.305 -171.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -84.58 135.12 34.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.838 -0.43 . . . . 9.5500000000000007 109.838 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -100.74 129.23 46.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.967 0.413 . . . . 10.23 111.212 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -93.32 -28.24 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.649 -0.871 . . . . 12.85 108.649 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 . . . . . 0 C--O 1.242 0.692 0 CA-C-N 114.79 -1.095 . . . . 13.970000000000001 108.987 177.701 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.81 0.338 . . . . 7.8200000000000003 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 p -129.81 -49.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.78 0.324 . . . . 6.2699999999999996 110.158 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m 57.94 78.34 0.24 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.761 0.791 . . . . 4.75 110.475 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -107.68 175.5 5.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.982 -1.008 . . . . 4.4400000000000004 110.061 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -68.14 101.83 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.523 . . . . 4.9000000000000004 110.438 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.56 46.08 1.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.61 -0.723 . . . . 3.6099999999999999 110.063 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -113.03 144.74 42.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.474 . . . . 4.54 110.887 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.39 157.07 17.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.51 0.672 . . . . 2.71 110.609 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -103.0 148.26 25.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.789 -1.096 . . . . 2.4399999999999999 111.052 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.41 106.92 20.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 1.3100000000000001 109.495 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 7.4 pt-20 -78.85 113.35 16.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.803 -0.635 . . . . 2.1600000000000001 111.542 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 19' ' ' ILE . 17.2 tp 58.25 65.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 2.04 111.215 169.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 t -61.73 144.9 53.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 1.26 110.076 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 0.72 7.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.95 0.352 . . . . 1.3700000000000001 111.95 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.48 25.73 1.01 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.532 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.09 2.64 9.16 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.83999999999999997 113.92 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.47 78.28 0.61 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.072 -0.585 . . . . 0.62 114.169 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 80' ' ' ILE . 53.7 t -140.78 143.82 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.935 -0.394 . . . . 1.1799999999999999 109.935 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 17.9 mm -86.27 116.31 28.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.595 -0.52 . . . . 1.1799999999999999 109.595 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -138.19 144.34 40.64 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.507 -0.477 . . . . 1.96 111.464 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 6.8 m -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.916 -0.583 . . . . 1.21 109.864 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.5 tp -84.82 118.91 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 1.3 110.585 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.18 -70.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 1.3999999999999999 110.605 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 36.9 ttpt -109.7 116.33 31.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.519 -0.31 . . . . 2.0600000000000001 110.531 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.55 137.62 42.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.033 -0.531 . . . . 3.25 110.171 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.44 162.35 54.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.735 -0.745 . . . . 1.3200000000000001 112.309 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.76 -68.26 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 2.77 110.74 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.37 132.61 15.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.095 0.474 . . . . 2.6400000000000001 109.781 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.08 33.33 0.94 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.498 -0.858 . . . . 1.3 111.492 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.26 -28.93 70.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.24 0.543 . . . . 2.29 110.402 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -94.88 -4.75 46.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.332 -0.849 . . . . 2.6400000000000001 110.381 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -138.81 91.46 2.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.051 0.453 . . . . 1.49 111.259 -173.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.09 123.98 28.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 1.3700000000000001 110.776 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 43.0 Cg_endo -69.96 92.54 0.53 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.644 2.229 . . . . 0.84999999999999998 111.807 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 53.5 mmtt -94.7 146.53 24.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.365 0.602 . . . . 3.1400000000000001 112.261 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.526 ' HZ2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -71.99 124.54 25.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.933 -1.031 . . . . 2.9100000000000001 110.0 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.89 -9.24 43.49 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.422 -0.671 . . . . 1.1899999999999999 111.422 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -101.09 154.65 18.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.343 . . . . 1.3799999999999999 110.219 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -79.3 106.21 11.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.329 0.585 . . . . 2.2000000000000002 111.123 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 68' ' ' HIS . 3.1 m -121.68 152.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.843 -0.799 . . . . 1.3300000000000001 108.843 174.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.2 m -117.75 119.42 34.86 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.651 -0.5 . . . . 1.23 109.651 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 120' ' ' ILE . 90.3 t -131.82 144.06 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.999 -0.546 . . . . 1.6200000000000001 110.764 -174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.457 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 24.5 m80 -99.96 145.29 28.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.044 -0.354 . . . . 3.5600000000000001 110.044 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 29.2 p90 -143.06 130.63 21.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.055 0.455 . . . . 0.88 110.934 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.57 159.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.224 -0.658 . . . . 1.1899999999999999 109.224 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.41 -121.0 0.7 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.041 -1.076 . . . . 0.37 112.751 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 50.1 pttt -150.9 168.06 25.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.666 0.27 . . . . 1.96 110.505 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 HD11 ' HG ' ' A' ' 116' ' ' LEU . 57.3 tp -85.02 98.37 10.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.031 -0.729 . . . . 1.1200000000000001 109.031 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 50.0 tp10 -62.55 -26.94 68.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 1.96 112.381 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 t -63.17 -18.56 63.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 1.1100000000000001 111.279 -177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -129.63 -26.12 2.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.034 0.445 . . . . 1.24 110.767 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.44 35.64 10.4 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.369 -0.443 . . . . 0.78000000000000003 112.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.38 128.86 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.715 0.293 . . . . 3.2999999999999998 110.362 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.8 p -71.77 158.35 6.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 1.3400000000000001 109.78 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.412 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 21.7 m-85 -73.93 98.49 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.315 0.579 . . . . 0.96999999999999997 111.784 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.72 86.15 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.13 -1.063 . . . . 2.1800000000000002 108.13 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -136.54 164.47 28.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.811 -0.631 . . . . 1.6799999999999999 110.571 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -57.97 -45.76 86.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 1.8600000000000001 112.046 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -93.32 -45.45 7.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.012 0.434 . . . . 2.1200000000000001 110.943 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -34.49 58.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.122 -0.944 . . . . 2.1899999999999999 111.655 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -77.52 -22.88 50.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 3.1899999999999999 111.801 -174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -100.66 -52.79 3.24 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.818 -0.353 . . . . 1.27 110.942 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.26 108.77 6.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.996 0.427 . . . . 2.6099999999999999 111.698 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.7 153.34 56.61 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.553 2.169 . . . . 2.1299999999999999 110.547 173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -93.47 149.14 21.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.007 0.432 . . . . 1.6299999999999999 110.515 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 3.0 pptp? -123.12 142.67 50.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.794 -0.639 . . . . 2.0099999999999998 109.587 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CZ ' HG12 ' A' ' 82' ' ' VAL . 42.5 p90 -128.86 171.42 12.3 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.985 0.421 . . . . 0.68999999999999995 110.999 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 98.0 m-70 -112.22 145.94 39.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.464 -0.789 . . . . 2.6600000000000001 109.113 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 36' ' ' LYS . 16.6 tp -72.62 120.42 18.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.315 0.579 . . . . 1.5600000000000001 110.371 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.526 ' HG2' ' HZ2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 66.56 54.59 0.86 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.447 -1.251 . . . . 2.0800000000000001 111.077 -176.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 73' ' ' GLU . 12.2 pt20 -96.07 10.01 38.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 1.98 109.414 169.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.07 -12.18 62.93 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.422 -0.808 . . . . 0.78000000000000003 112.801 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.402 ' HB2' HE21 ' A' ' 71' ' ' GLN . 13.3 mm-40 -96.18 -10.16 28.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.712 0.291 . . . . 0.96999999999999997 111.279 -174.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.07 125.11 67.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.006 0.431 . . . . 1.25 110.713 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.541 HG12 ' N ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -95.78 -59.13 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.921 0.711 . . . . 1.3500000000000001 112.921 -173.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 75' ' ' ILE . 6.6 mmpt? -140.0 -61.06 0.53 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.094 -0.378 . . . . 2.5600000000000001 111.401 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.42 -52.79 35.12 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.953 -0.567 . . . . 0.34000000000000002 113.656 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.541 ' O ' HG21 ' A' ' 82' ' ' VAL . 10.6 m-90 -74.98 -44.78 46.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.975 0.387 . . . . 0.56000000000000005 110.738 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -51.61 -51.83 52.48 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.039 0.837 . . . . 1.1399999999999999 111.933 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.479 ' HB ' HG22 ' A' ' 18' ' ' VAL . 2.1 mp -75.05 -38.64 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 1.3999999999999999 110.972 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.693 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 34.3 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.98999999999999999 110.68 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 78' ' ' TRP . 34.7 m -67.74 -32.64 57.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 1.49 110.738 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.0 t -62.38 -32.73 73.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.9399999999999999 110.886 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.7 t -96.09 31.18 2.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.141 -0.481 . . . . 1.8700000000000001 110.627 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.795 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 2.0 mmt -110.42 -173.33 2.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.386 0.613 . . . . 2.79 111.609 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 6.4 ttm180 -139.76 168.46 19.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.878 -1.156 . . . . 4.9199999999999999 107.878 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.0 -35.18 70.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.338 . . . . 2.4300000000000002 111.392 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -122.2 31.98 5.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 1.4199999999999999 110.862 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 23.6 tt0 -122.36 143.98 49.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.308 -0.405 . . . . 1.6000000000000001 110.452 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.87 137.9 35.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.716 0.293 . . . . 1.74 110.529 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 21' ' ' THR . 27.5 p -141.22 171.37 14.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 1.3600000000000001 111.194 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.09 123.05 49.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.68 . . . . 2.2999999999999998 109.533 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.693 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.0 p -99.92 137.48 27.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.255 0.55 . . . . 1.46 110.8 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.518 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 55.2 mmt-85 -91.11 112.38 24.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.633 -0.712 . . . . 2.29 110.086 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.458 HD12 HG12 ' A' ' 93' ' ' VAL . 2.9 mp -93.7 100.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.368 -0.604 . . . . 1.2 109.368 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 97' ' ' SER . 29.6 tt0 -81.05 170.25 16.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.484 -0.932 . . . . 1.3700000000000001 108.484 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.495 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 8.7 p -51.4 -44.13 62.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.767 0.284 . . . . 1.22 111.767 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.6 ptp -77.56 -8.43 57.81 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.128 0.418 . . . . 2.3199999999999998 112.128 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -103.88 -11.86 17.24 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 122.267 -0.271 . . . . 0.92000000000000004 110.941 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.06 164.61 17.12 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.734 -0.746 . . . . 0.85999999999999999 113.24 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.49 94.08 8.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.995 -0.372 . . . . 1.52 109.995 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.33 62.16 0.37 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.506 -0.854 . . . . 2.2999999999999998 112.695 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.495 ' OD1' ' HB2' ' A' ' 97' ' ' SER . 17.8 t70 -69.71 -30.21 67.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 5.8600000000000003 110.438 174.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.55 -46.43 86.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.346 -0.843 . . . . 4.2699999999999996 111.477 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -168.14 -128.04 0.96 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.391 -0.909 . . . . 2.8999999999999999 112.538 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.678 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 81.4 m -87.69 149.05 24.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.956 0.408 . . . . 3.7799999999999998 111.073 -175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.14 -101.74 0.33 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.297 -0.721 . . . . 1.47 111.297 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.63 -71.93 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.687 0.28 . . . . 3.0800000000000001 110.77 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -111.55 -75.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.71 110.666 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.03 83.66 4.22 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-O 120.814 0.34 . . . . 1.3700000000000001 111.844 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.678 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 52.1 Cg_endo -98.54 -160.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.228 2.618 . . . . 1.5800000000000001 111.457 171.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.38 91.48 2.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 2.0499999999999998 113.189 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.4 m120 56.66 27.13 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 2.2999999999999998 111.738 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.7 p -133.93 171.04 14.72 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.633 -0.258 . . . . 1.5700000000000001 110.875 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.24 133.43 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.198 0.523 . . . . 1.1799999999999999 110.348 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.6 mp -122.38 169.6 10.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 1.25 109.699 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.587 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -147.42 133.8 19.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.061 0.457 . . . . 1.3500000000000001 110.596 172.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.412 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 39.9 m-85 -122.41 142.29 50.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.89 -0.595 . . . . 0.56000000000000005 109.616 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 32.5 mt-10 -74.18 122.97 23.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.724 -0.843 . . . . 1.46 108.724 171.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.486 HG22 HG11 ' A' ' 42' ' ' VAL . 8.1 mt -105.95 115.42 47.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.422 0.63 . . . . 1.1599999999999999 109.739 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.08 116.59 17.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.098 -0.955 . . . . 1.8799999999999999 110.284 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 123' ' ' LEU . 6.8 tt -87.12 133.71 33.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 1.75 109.219 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 122' ' ' LEU . 1.1 pt? -117.1 -43.96 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.78 111.786 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.9 t -140.78 140.87 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.783 -0.451 . . . . 1.53 109.783 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.564 ' HB2' HG13 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -167.04 177.57 6.21 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.174 0.297 . . . . 0.90000000000000002 110.6 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -157.49 150.72 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 3.4700000000000002 111.051 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.21 116.84 31.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.582 -0.525 . . . . 3.3799999999999999 109.582 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 31.9 tp -150.62 157.69 43.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 3.8199999999999998 110.581 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.57 137.02 32.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 5.3899999999999997 110.953 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -83.91 53.28 2.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.126 -1.064 . . . . 7.75 108.126 165.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -79.53 53.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.348 -1.297 . . . . 7.8499999999999996 110.286 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 63.63 -168.71 0.2 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.007 -0.542 . . . . 9.5500000000000007 110.924 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.01 158.78 19.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.138 -0.689 . . . . 10.23 109.138 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -169.36 169.66 8.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.503 -0.317 . . . . 12.85 110.188 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 . . . . . 0 C--O 1.245 0.864 0 N-CA-C 109.244 -0.651 . . . . 13.970000000000001 109.244 176.603 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.421 0.153 . . . . 7.8200000000000003 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 t -71.9 111.85 7.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.585 . . . . 6.2699999999999996 109.422 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.28 10.37 15.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.141 0.496 . . . . 4.75 111.181 -172.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -105.25 124.12 49.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.879 -0.6 . . . . 4.4400000000000004 110.367 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -59.62 130.08 45.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 4.9000000000000004 109.834 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.67 84.76 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.157 0.503 . . . . 3.6099999999999999 111.24 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -141.57 163.13 33.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 4.54 109.607 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.34 148.83 29.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.11 0.481 . . . . 2.71 110.878 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.7 mppt? -91.96 143.17 26.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 2.4399999999999999 110.283 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG11 ' HB ' ' A' ' 13' ' ' THR . 5.1 t -108.94 108.55 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 110.054 -0.35 . . . . 1.3100000000000001 110.054 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.81 128.92 43.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.1600000000000001 110.974 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' H ' HD11 ' A' ' 19' ' ' ILE . 13.5 tp 55.76 46.26 22.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.689 0.757 . . . . 2.04 110.113 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.572 ' HB ' HG11 ' A' ' 10' ' ' VAL . 8.5 t -63.84 164.04 10.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.868 -1.06 . . . . 1.26 111.532 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.66 1.37 8.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 1.3700000000000001 111.253 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 80' ' ' ILE . 25.9 m-20 -80.65 14.19 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 2.3999999999999999 111.054 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.27 9.39 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.52 -0.847 . . . . 0.83999999999999997 113.598 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.25 64.07 1.81 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.803 -0.713 . . . . 0.62 114.045 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.529 ' HB ' HG21 ' A' ' 80' ' ' ILE . 3.3 t -145.35 154.23 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.894 -0.41 . . . . 1.1799999999999999 109.894 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.411 HD11 ' H ' ' A' ' 12' ' ' LEU . 4.7 mm -85.24 109.65 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.243 -0.28 . . . . 1.1799999999999999 110.243 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.532 ' HE3' HG22 ' A' ' 13' ' ' THR . 21.6 pttp -132.61 142.65 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.96 111.181 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -110.8 140.87 44.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.476 -0.784 . . . . 1.21 110.246 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' C ' HD22 ' A' ' 23' ' ' LEU . 7.6 tp -86.44 130.3 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.422 -0.354 . . . . 1.3 110.369 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.512 HD22 ' C ' ' A' ' 22' ' ' ILE . 3.5 mm? -132.72 -69.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.455 0.645 . . . . 1.3999999999999999 110.515 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 80.7 tttt -91.5 97.66 11.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.41 -0.814 . . . . 2.0600000000000001 109.53 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -73.74 127.29 32.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.068 -0.969 . . . . 3.25 110.21 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.7 -148.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.09 -0.505 . . . . 1.3200000000000001 113.33 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.5 -167.84 2.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.463 -0.94 . . . . 2.77 108.463 -172.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -85.46 127.3 34.35 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.739 -0.467 . . . . 2.6400000000000001 109.739 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -168.39 75.37 0.12 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.108 -0.797 . . . . 1.3 111.108 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.44 -32.99 69.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.749 0.278 . . . . 2.29 111.749 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.72 0.38 56.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.272 0.558 . . . . 2.6400000000000001 110.579 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.5 79.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 1.49 110.877 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.8 mm -131.37 122.04 18.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 1.3700000000000001 110.909 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.55 126.56 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.689 2.259 . . . . 0.84999999999999998 112.023 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 27.1 mmtp -132.92 161.92 32.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.905 0.383 . . . . 3.1400000000000001 110.77 177.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -71.77 150.21 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.969 -0.559 . . . . 2.9100000000000001 111.882 -172.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.43 -23.03 29.69 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.722 -0.672 . . . . 1.1899999999999999 111.799 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.438 ' OD1' ' HG ' ' A' ' 128' ' ' LEU . 85.1 m-20 -86.66 153.41 21.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.003 0.43 . . . . 1.3799999999999999 110.968 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.649 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 51.0 mt-10 -79.0 95.39 5.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.016 -0.538 . . . . 2.2000000000000002 110.481 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 125' ' ' PHE . 19.9 m -102.87 151.08 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.6 -0.519 . . . . 1.3300000000000001 109.6 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -111.95 106.51 15.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.167 -0.679 . . . . 1.23 109.167 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -126.33 138.99 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 1.6200000000000001 110.863 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 22.3 m-70 -104.16 142.91 33.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.521 -0.548 . . . . 3.5600000000000001 109.521 172.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.5 p90 -137.15 139.52 41.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 0.88 110.021 175.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.11 154.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 1.1899999999999999 109.146 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 179.77 -134.6 2.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.878 -1.153 . . . . 0.37 112.98 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -151.68 171.33 17.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.032 0.444 . . . . 1.96 110.671 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.62 HD12 ' HB3' ' A' ' 114' ' ' SER . 61.3 tp -85.58 107.38 17.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.621 . . . . 1.1200000000000001 109.758 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' HD12 ' A' ' 117' ' ' LEU . 3.6 tp10 -68.05 -31.19 70.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.031 0.443 . . . . 1.96 110.81 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 t -54.3 -43.04 70.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.342 -0.844 . . . . 1.1100000000000001 112.05 -173.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.472 HG23 HD23 ' A' ' 48' ' ' LEU . 15.4 t -119.96 -10.97 9.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 1.24 110.604 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 56.12 3.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.892 -0.671 . . . . 0.78000000000000003 111.648 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -125.03 130.02 51.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.175 -0.305 . . . . 3.2999999999999998 110.175 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.2 156.87 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.114 -0.328 . . . . 1.3400000000000001 110.114 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -74.6 99.33 3.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.386 . . . . 0.96999999999999997 111.763 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.83 91.84 3.82 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.485 -0.932 . . . . 2.1800000000000002 108.485 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 28.7 t -137.59 148.3 45.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.46 -0.791 . . . . 1.6799999999999999 109.985 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -53.8 -42.49 68.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.312 0.486 . . . . 1.8600000000000001 112.312 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -84.84 -46.15 11.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 2.1200000000000001 110.692 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -36.82 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 2.1899999999999999 111.629 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 57' ' ' SER . 14.8 ptm180 -81.56 4.11 22.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.697 0.284 . . . . 3.1899999999999999 111.542 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' ND2' HG13 ' A' ' 63' ' ' VAL . 14.3 t30 -121.29 -60.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.645 -0.252 . . . . 1.27 110.702 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG13 ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -133.32 133.7 23.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.692 0.282 . . . . 2.6099999999999999 111.598 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.0 Cg_exo -77.3 163.35 30.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.838 2.359 . . . . 2.1299999999999999 111.869 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -103.87 154.74 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.427 -0.351 . . . . 1.6299999999999999 110.302 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -137.49 151.36 48.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 2.0099999999999998 109.649 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -136.42 -175.55 4.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.756 0.313 . . . . 0.68999999999999995 110.819 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -121.03 150.05 41.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 2.6600000000000001 109.991 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -58.14 121.67 11.25 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.752 0.657 . . . . 1.5600000000000001 111.348 -174.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER 55.29 45.95 24.58 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.589 0.556 . . . . 2.0800000000000001 111.806 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.538 ' NE2' ' HB2' ' A' ' 73' ' ' GLU . 6.7 pm0 -78.96 -4.3 49.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.094 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.15 -9.13 50.02 Favored Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.78000000000000003 113.161 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 15.9 mm-40 -95.57 -17.08 21.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.96999999999999997 110.724 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.14 132.74 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.74 0.305 . . . . 1.25 110.695 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.476 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.5 -68.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.373 0.508 . . . . 1.3500000000000001 112.373 -178.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 5.6 mtpp -140.94 -41.26 0.4 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.449 0.537 . . . . 2.5600000000000001 112.449 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 93' ' ' VAL . . . -53.02 -46.73 61.08 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.34000000000000002 112.56 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.493 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.9 m-90 -76.13 -36.89 58.61 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.922 -0.163 . . . . 0.56000000000000005 111.127 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.62 ' OD2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -63.42 -40.43 97.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.033 0.383 . . . . 1.1399999999999999 112.033 -169.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.529 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -64.35 -39.45 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.013 0.435 . . . . 1.3999999999999999 110.631 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -72.3 -51.28 21.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.406 -0.361 . . . . 0.98999999999999999 110.891 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.0 m -64.63 -33.89 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.254 0.465 . . . . 1.49 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 t -80.19 -0.84 37.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.018 0.437 . . . . 1.9399999999999999 110.769 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 t -119.88 14.41 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.18 -0.464 . . . . 1.8700000000000001 110.387 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.868 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 4.0 mmt -98.95 179.18 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 2.79 110.809 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' NH1' ' HA3' ' A' ' 29' ' ' GLY . 22.3 ttp85 -143.6 174.05 11.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.133 -1.062 . . . . 4.9199999999999999 108.133 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 60.3 tttm -67.7 -6.09 19.1 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.8 0.334 . . . . 2.4300000000000002 111.832 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -141.56 21.2 2.19 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.581 0.229 . . . . 1.4199999999999999 110.594 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.5 tt0 -118.76 148.64 42.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.512 -0.313 . . . . 1.6000000000000001 110.66 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 24' ' ' LYS . 75.2 tttt -149.06 138.66 21.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 1.74 110.794 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.412 ' SG ' ' HE2' ' A' ' 85' ' ' MET . 87.5 m -134.02 164.33 27.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.44 -0.345 . . . . 1.3600000000000001 111.142 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.493 ' CD2' ' HG2' ' A' ' 119' ' ' GLU . 63.6 mt -100.53 111.62 23.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.037 -0.529 . . . . 2.2999999999999998 109.605 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 77' ' ' GLY . 7.1 p -100.98 135.95 34.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 1.46 109.994 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mmm-85 -100.45 111.43 23.69 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.115 -0.698 . . . . 2.29 109.115 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.425 HD11 HG12 ' A' ' 93' ' ' VAL . 3.2 mp -92.21 103.62 14.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.127 0.489 . . . . 1.2 109.833 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.537 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 32.5 tt0 -82.41 173.44 12.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.321 -0.854 . . . . 1.3700000000000001 109.02 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.535 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.6 p -51.54 -41.31 60.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.631 0.372 . . . . 1.22 111.898 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.0 ptm -77.21 -15.7 59.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 2.3199999999999998 111.771 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.7 m-30 -91.2 -13.96 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.92000000000000004 110.885 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.55 -172.54 15.54 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.348 -0.701 . . . . 0.85999999999999999 111.348 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -84.09 41.77 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 1.52 111.209 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.4 -21.98 76.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.804 -0.713 . . . . 2.2999999999999998 112.202 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -76.23 -46.29 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 5.8600000000000003 110.569 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -74.71 -43.04 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 4.2699999999999996 110.998 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.2 22.93 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.517 -0.849 . . . . 2.8999999999999999 112.425 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.3 m -75.07 139.36 42.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.22 -0.289 . . . . 3.7799999999999998 110.22 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.539 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -168.48 165.36 38.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.69 -0.767 . . . . 1.47 111.545 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -76.46 -70.93 0.42 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.823 0.311 . . . . 3.0800000000000001 110.881 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -93.35 -73.24 0.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.588 -0.278 . . . . 1.71 111.066 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.43 HG12 HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -146.13 100.2 4.22 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 121.143 0.496 . . . . 1.3700000000000001 111.285 177.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 61.0 Cg_endo -90.29 -166.33 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.874 2.383 . . . . 1.5800000000000001 111.856 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.82 -139.5 13.49 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.553 -0.832 . . . . 2.0499999999999998 112.748 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.4 m120 -93.42 6.11 49.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.124 0.488 . . . . 2.2999999999999998 110.349 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.62 ' HB3' HD12 ' A' ' 48' ' ' LEU . 47.1 m -94.44 146.95 23.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.74 -0.664 . . . . 1.5700000000000001 111.349 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 49' ' ' GLU . 7.2 p -95.02 138.82 19.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.2 -0.455 . . . . 1.1799999999999999 110.286 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.499 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.4 mp -126.36 174.27 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 1.25 110.622 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -132.78 124.4 28.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.157 -0.683 . . . . 1.3500000000000001 109.157 176.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -116.13 126.6 53.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.56000000000000005 110.546 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.588 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 37.8 mt-10 -81.18 107.66 14.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 1.46 109.504 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' HIS . 58.4 mt -107.85 124.46 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.061 -0.256 . . . . 1.1599999999999999 110.9 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 90' ' ' LYS . 34.3 mt-10 -121.5 131.02 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 1.8799999999999999 110.308 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 42' ' ' VAL . 6.9 tt -100.26 101.85 12.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 1.75 109.576 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -96.69 -16.23 21.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.904 0.335 . . . . 1.78 111.904 -175.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.5 m -153.19 150.76 29.37 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.454 -0.202 . . . . 1.53 110.454 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.496 ' HB3' HD21 ' A' ' 122' ' ' LEU . 1.5 p90 -164.85 178.74 6.96 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.963 -0.384 . . . . 0.90000000000000002 109.963 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.649 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.9 ptp180 -162.17 167.84 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.617 0.573 . . . . 3.4700000000000002 109.547 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.69 151.54 37.79 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.201 0.313 . . . . 3.3799999999999999 110.265 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.438 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 95.6 mt -101.76 138.22 39.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.46 -0.336 . . . . 3.8199999999999998 110.924 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.42 154.83 26.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 5.3899999999999997 108.88 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -83.64 -92.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.433 -0.349 . . . . 7.75 110.867 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.96 92.22 2.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.569 . . . . 7.8499999999999996 109.465 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -82.52 114.66 21.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 9.5500000000000007 109.433 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -59.33 140.21 56.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.041 0.448 . . . . 10.23 111.01 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -160.73 142.4 12.25 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.906 -0.776 . . . . 12.85 108.906 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.543 -0.741 . . . . 13.970000000000001 110.19 -177.215 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mmm . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.515 0.197 . . . . 7.8200000000000003 110.634 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.9 p -79.81 155.73 27.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.251 -0.431 . . . . 6.2699999999999996 110.142 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p -73.35 162.33 29.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.495 -0.32 . . . . 4.75 111.335 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 60.43 -149.15 0.43 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.59 0.556 . . . . 4.4400000000000004 110.636 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.52 139.23 36.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.306 -0.406 . . . . 4.9000000000000004 110.13 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.78 38.0 1.62 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.036 -0.529 . . . . 3.6099999999999999 110.481 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -101.28 113.89 27.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.21 -0.45 . . . . 4.54 110.224 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -89.44 156.08 18.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.444 -0.576 . . . . 2.71 109.444 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.28 153.85 24.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.405 -0.361 . . . . 2.4399999999999999 110.8 -171.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.38 104.83 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 1.3100000000000001 109.029 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.87 120.29 30.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 2.1600000000000001 110.612 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt 58.67 64.72 1.38 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.569 0.7 . . . . 2.04 110.727 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.505 HG22 ' HE2' ' A' ' 20' ' ' LYS . 9.2 t -65.79 160.84 22.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.936 -1.029 . . . . 1.26 111.115 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.33 -5.22 21.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.093 0.405 . . . . 1.3700000000000001 112.093 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -71.05 -0.36 9.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.407 -0.36 . . . . 2.3999999999999999 111.268 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.98 24.79 2.2 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.79 -0.719 . . . . 0.83999999999999997 113.321 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.14 72.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.011 -0.614 . . . . 0.62 113.576 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 80' ' ' ILE . 12.2 t -138.84 146.11 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.856 -0.424 . . . . 1.1799999999999999 109.856 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.0 mm -87.08 110.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.013 -0.365 . . . . 1.1799999999999999 110.013 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HE2' HG22 ' A' ' 13' ' ' THR . 58.3 pttt -125.27 145.53 49.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 1.96 111.096 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -126.01 120.49 30.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 1.21 109.8 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 25' ' ' LYS . 10.0 tp -76.01 145.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.386 . . . . 1.3 110.734 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.39 -34.85 2.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.431 -0.35 . . . . 1.3999999999999999 111.173 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 38.8 ttpt -150.78 118.32 6.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.637 -0.505 . . . . 2.0600000000000001 109.637 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HG3' HG12 ' A' ' 22' ' ' ILE . 88.8 mttt -101.0 154.28 18.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.188 0.518 . . . . 3.25 112.021 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.89 164.75 16.07 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 111.683 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.65 -95.12 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.045 0.422 . . . . 2.77 111.133 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -91.48 145.38 24.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.944 0.402 . . . . 2.6400000000000001 110.845 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 162.51 64.57 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.787 -0.642 . . . . 1.3 111.615 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.23 -35.0 72.86 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.072 0.463 . . . . 2.29 111.011 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -104.25 26.34 8.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 2.6400000000000001 111.539 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.48 74.9 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.753 -0.462 . . . . 1.49 109.753 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' HG2' ' A' ' 35' ' ' LYS . 27.6 mm -136.68 108.92 9.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 1.3700000000000001 110.829 -177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.6 Cg_endo -71.46 88.24 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.643 2.229 . . . . 0.84999999999999998 112.067 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HG2' HG23 ' A' ' 33' ' ' ILE . 29.7 mmtp -97.7 159.41 14.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.533 0.682 . . . . 3.1400000000000001 111.876 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HA ' HD22 ' A' ' 69' ' ' LEU . 8.8 ttmm -67.88 150.29 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.683 -1.144 . . . . 2.9100000000000001 111.531 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.68 -26.13 22.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.192 -0.528 . . . . 1.1899999999999999 112.119 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.13 158.45 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.698 0.285 . . . . 1.3799999999999999 110.726 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.76 97.75 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.19 0.519 . . . . 2.2000000000000002 111.721 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 125' ' ' PHE . 29.9 m -96.86 143.81 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.065 -0.717 . . . . 1.3300000000000001 109.065 170.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 20.1 m -111.62 113.63 26.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.877 0.37 . . . . 1.23 110.755 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -131.6 160.8 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.073 -0.512 . . . . 1.6200000000000001 111.599 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -117.18 153.99 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 3.5600000000000001 109.254 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.681 ' HH ' ' HG3' ' A' ' 108' ' ' GLU . 23.5 p90 -137.69 143.56 41.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.44 -0.345 . . . . 0.88 110.233 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.89 160.79 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.878 -0.786 . . . . 1.1899999999999999 108.878 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 167.08 -136.55 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.351 -0.928 . . . . 0.37 112.38 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.62 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 60.6 pttt -158.45 171.97 19.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.653 0.263 . . . . 1.96 110.995 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -88.86 105.25 17.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 1.1200000000000001 110.403 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.61 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 32.7 tt0 -64.04 -27.39 69.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.36 -0.382 . . . . 1.96 111.249 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.458 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.7 t -54.76 -40.59 69.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.894 -0.594 . . . . 1.1100000000000001 111.545 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.422 HG22 HD21 ' A' ' 48' ' ' LEU . 10.1 t -120.01 -12.47 9.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.583 0.23 . . . . 1.24 111.597 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.42 10.75 73.26 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.75 -0.738 . . . . 0.78000000000000003 112.896 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 33.7 mmtp -88.39 132.03 34.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.871 0.367 . . . . 3.2999999999999998 111.163 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.62 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.3 p -81.65 160.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.472 -0.786 . . . . 1.3400000000000001 109.963 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -74.53 114.56 13.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.021 0.439 . . . . 0.96999999999999997 111.249 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -129.03 91.23 3.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.145 -0.687 . . . . 2.1800000000000002 109.145 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -123.95 -173.55 2.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 1.6799999999999999 109.87 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.1 m -72.9 -47.3 47.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.772 0.32 . . . . 1.8600000000000001 111.49 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -95.15 -39.11 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.739 1.015 . . . . 2.1200000000000001 113.739 -171.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.28 -42.84 87.41 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.977 0.362 . . . . 2.1899999999999999 111.977 -168.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.75 11.28 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.39 0.614 . . . . 3.1899999999999999 111.277 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -106.08 -50.15 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 1.27 109.047 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.4 p -149.4 121.82 4.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 2.6099999999999999 110.223 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 10.5 Cg_exo -70.82 154.65 63.42 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.819 2.346 . . . . 2.1299999999999999 112.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -93.94 153.88 17.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.998 -0.546 . . . . 1.6299999999999999 109.717 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -125.99 161.39 27.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.352 -0.61 . . . . 2.0099999999999998 109.352 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.65 175.35 13.35 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.518 -0.473 . . . . 0.68999999999999995 111.489 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 75.1 m-70 -118.37 150.55 39.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.836 . . . . 2.6600000000000001 109.769 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.572 HD12 ' CG2' ' A' ' 82' ' ' VAL . 14.5 tp -66.13 127.43 32.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.366 -0.379 . . . . 1.5600000000000001 111.871 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 50.56 37.58 16.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.193 0.997 . . . . 2.0800000000000001 111.467 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 13.9 tt0 -72.11 -6.07 39.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.865 -1.516 . . . . 1.98 111.192 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.98 56.19 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 111.661 -0.576 . . . . 0.78000000000000003 111.661 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.19 -18.35 25.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.449 0.642 . . . . 0.96999999999999997 109.759 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.6 125.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.372 -0.831 . . . . 1.25 109.578 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.513 HG12 ' N ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -95.94 -58.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.7 1.0 . . . . 1.3500000000000001 113.7 -172.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.513 ' N ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.95 -50.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.79 -0.568 . . . . 2.5600000000000001 112.295 -169.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.13 -52.43 40.17 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.791 -0.719 . . . . 0.34000000000000002 112.707 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.451 ' O ' HG21 ' A' ' 82' ' ' VAL . 12.0 m-90 -75.94 -33.94 59.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.618 0.247 . . . . 0.56000000000000005 110.698 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' A' ' 69' ' ' LEU . 10.4 t70 -53.04 -51.69 60.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.703 -0.681 . . . . 1.1399999999999999 111.428 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.524 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.8 mp -65.83 -48.37 82.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.09 -0.505 . . . . 1.3999999999999999 110.75 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 120' ' ' ILE . 28.7 t -60.55 -48.24 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.98999999999999999 111.625 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.832 HG11 HG22 ' A' ' 120' ' ' ILE . 32.0 m -70.12 -33.23 54.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.962 -0.295 . . . . 1.49 111.295 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 32.6 t -79.17 0.25 29.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 1.9399999999999999 110.882 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -110.38 10.6 23.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.285 -0.416 . . . . 1.8700000000000001 111.19 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.655 ' HE1' ' HA ' ' A' ' 82' ' ' VAL . 47.9 mtm -102.3 -173.42 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.797 0.808 . . . . 2.79 112.054 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -140.9 -177.44 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.439 -1.255 . . . . 4.9199999999999999 108.5 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -67.06 -23.44 65.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 2.4300000000000002 111.273 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -126.68 17.93 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 1.4199999999999999 111.219 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 25.8 tt0 -112.2 131.85 55.24 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.695 -0.483 . . . . 1.6000000000000001 109.695 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 12.8 tmtt? -134.93 134.97 41.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.518 -0.765 . . . . 1.74 109.868 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.413 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.7 p -137.57 172.82 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.258 -0.428 . . . . 1.3600000000000001 110.683 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 93' ' ' VAL . 3.2 tt -119.43 140.27 50.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.281 -1.007 . . . . 2.2999999999999998 108.281 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 95' ' ' ILE . 6.1 p -121.39 141.57 41.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 120.958 0.409 . . . . 1.46 110.903 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -98.89 111.65 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.156 -0.683 . . . . 2.29 109.156 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 93' ' ' VAL . 3.2 mp -93.4 109.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.378 . . . . 1.2 110.187 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -84.81 166.04 17.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.579 -0.897 . . . . 1.3700000000000001 108.579 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.4 p -51.01 -40.68 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.29 0.369 . . . . 1.22 111.956 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.5 ptp -77.19 -16.27 59.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.33 -0.395 . . . . 2.3199999999999998 111.993 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -92.67 -16.27 25.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.945 0.402 . . . . 0.92000000000000004 110.432 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -115.24 -160.15 12.56 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.103 -0.799 . . . . 0.85999999999999999 111.103 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -94.54 29.55 2.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.722 0.296 . . . . 1.52 111.012 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.02 -28.81 73.35 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.931 -0.577 . . . . 2.2999999999999998 112.333 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -70.82 -31.79 68.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 5.8600000000000003 110.683 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.22 -32.1 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 4.2699999999999996 110.322 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.33 -7.26 39.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.829 -0.7 . . . . 2.8999999999999999 112.322 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 55.5 m -86.68 147.58 25.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.005 0.431 . . . . 3.7799999999999998 110.959 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.71 169.23 42.22 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.898 -0.668 . . . . 1.47 111.518 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.681 ' HG3' ' HH ' ' A' ' 44' ' ' TYR . 16.5 mm-40 -84.44 -69.84 0.62 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.682 0.277 . . . . 3.0800000000000001 111.171 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 m -90.85 -73.45 0.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.861 -0.336 . . . . 1.71 110.581 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.444 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.02 103.45 4.43 Favored Pre-proline 0 N--CA 1.465 0.277 0 N-CA-C 109.879 -0.415 . . . . 1.3700000000000001 109.879 176.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.21 -74.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.346 2.031 . . . . 1.5800000000000001 112.846 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.78 -134.78 44.0 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.805 -0.712 . . . . 2.0499999999999998 112.224 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -133.67 21.39 3.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.466 -0.568 . . . . 2.2999999999999998 109.466 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 22.4 m -105.77 179.19 4.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.76 -0.655 . . . . 1.5700000000000001 111.196 -173.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -97.53 138.57 22.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.128 0.489 . . . . 1.1799999999999999 111.006 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.4 mp -120.41 166.78 13.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.371 -0.377 . . . . 1.25 110.907 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 5.4 mt -116.14 110.21 18.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 1.3500000000000001 109.662 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.64 124.51 48.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.793 0.33 . . . . 0.56000000000000005 110.625 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -92.1 126.25 37.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.304 -0.628 . . . . 1.46 109.304 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.832 HG22 HG11 ' A' ' 82' ' ' VAL . 76.0 mt -120.06 131.62 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.471 -0.331 . . . . 1.1599999999999999 110.979 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -136.25 143.66 44.4 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.103 -0.499 . . . . 1.8799999999999999 110.447 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.53 ' HA ' HG13 ' A' ' 42' ' ' VAL . 24.7 tp -90.94 118.77 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 1.75 110.72 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.36 -27.89 10.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 1.78 111.239 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 39.9 m -151.69 149.8 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.374 . . . . 1.53 109.989 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' A' ' 40' ' ' VAL . 4.0 p90 -165.5 158.5 15.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.808 0.337 . . . . 0.90000000000000002 111.123 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -125.39 123.44 39.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.103 -0.498 . . . . 3.4700000000000002 110.052 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -103.05 114.39 28.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 3.3799999999999999 109.927 171.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.0 tp -134.38 150.22 50.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.385 -0.825 . . . . 3.8199999999999998 109.372 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.71 130.53 49.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.875 0.369 . . . . 5.3899999999999997 110.544 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -84.47 113.28 21.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 7.75 110.037 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.91 156.52 21.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.103 0.779 . . . . 7.8499999999999996 113.103 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -111.92 168.3 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.873 -1.058 . . . . 9.5500000000000007 109.52 168.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -143.84 123.84 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.55 0.214 . . . . 10.23 110.65 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -138.14 -178.16 5.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.148 -0.478 . . . . 12.85 109.836 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.6 -1.19 . . . . 13.970000000000001 109.26 174.856 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.238 -0.282 . . . . 7.8200000000000003 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -102.83 99.21 9.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.736 0.303 . . . . 6.2699999999999996 110.459 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.0 m -101.87 -43.6 5.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 4.75 110.264 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.92 137.07 34.5 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.946 -0.761 . . . . 4.4400000000000004 108.946 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -87.22 141.91 28.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.038 0.447 . . . . 4.9000000000000004 111.003 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.9 93.34 9.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.428 -0.582 . . . . 3.6099999999999999 109.428 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -119.41 141.53 49.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.035 -0.529 . . . . 4.54 110.099 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.1 137.77 45.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.529 -0.759 . . . . 2.71 111.262 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -100.39 128.78 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.307 -0.627 . . . . 2.4399999999999999 109.307 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 23.2 t -102.29 105.1 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.11 0.481 . . . . 1.3100000000000001 110.372 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.1 103.9 16.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.607 -0.724 . . . . 2.1600000000000001 110.663 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.6 tp 62.24 76.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.255 -0.884 . . . . 2.04 110.863 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.459 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -80.92 159.82 24.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.731 -0.668 . . . . 1.26 110.928 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.87 -5.09 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.29 0.567 . . . . 1.3700000000000001 111.023 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.523 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.9 t70 -78.17 30.3 0.18 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 2.3999999999999999 111.645 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' HA3' HG13 ' A' ' 80' ' ' ILE . . . 121.91 -26.17 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.754 -0.736 . . . . 0.83999999999999997 112.735 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.05 60.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.394 -0.908 . . . . 0.62 113.372 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 12.2 t -140.09 152.17 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.965 -0.383 . . . . 1.1799999999999999 109.965 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.4 mm -85.75 120.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.505 0.322 . . . . 1.1799999999999999 110.257 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 84' ' ' SER . 51.7 pttt -142.73 147.09 35.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.177 0.513 . . . . 1.96 111.461 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.38 135.29 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.509 -0.769 . . . . 1.21 109.891 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.4 112.97 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.102 0.477 . . . . 1.3 110.624 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 -52.83 3.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 1.3999999999999999 110.813 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -115.93 151.97 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.331 -0.618 . . . . 2.0600000000000001 109.331 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.89 110.97 19.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.823 -0.436 . . . . 3.25 109.823 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.87 163.18 10.46 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.535 -0.757 . . . . 1.3200000000000001 112.821 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 28' ' ' GLU . 12.5 t70 -104.96 -149.22 0.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.554 -0.536 . . . . 2.77 109.554 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 42.4 tt0 -59.27 125.1 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.15 0.5 . . . . 2.6400000000000001 110.793 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.85 52.37 0.24 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 111.215 -0.754 . . . . 1.3 111.215 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.91 -33.87 73.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.5 . . . . 2.29 110.619 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -98.46 18.3 16.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.583 -0.735 . . . . 2.6400000000000001 110.091 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -126.41 76.74 1.64 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.911 -0.586 . . . . 1.49 109.94 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 38.4 mm -129.14 119.98 19.95 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.398 0.618 . . . . 1.3700000000000001 111.886 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -87.05 100.75 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.148 3.232 . . . . 0.84999999999999998 112.186 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.569 ' HE2' ' HB3' ' A' ' 83' ' ' SER . 28.1 mmtp -135.95 178.44 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.15 0.5 . . . . 3.1400000000000001 112.264 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.53 139.51 57.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.145 -0.934 . . . . 2.9100000000000001 111.511 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.51 56.42 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.265 -0.734 . . . . 1.1899999999999999 111.265 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 45.6 m-20 -113.87 161.92 17.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.388 . . . . 1.3799999999999999 110.154 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.562 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 25.7 mt-10 -94.57 103.92 15.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.176 -0.465 . . . . 2.2000000000000002 110.613 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.86 132.2 49.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.63 -0.507 . . . . 1.3300000000000001 109.63 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -108.39 109.83 21.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.581 -0.526 . . . . 1.23 109.581 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' CG1' HD11 ' A' ' 122' ' ' LEU . 15.8 m -124.04 140.49 47.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.692 -0.685 . . . . 1.6200000000000001 111.009 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -105.6 140.7 38.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.676 -0.693 . . . . 3.5600000000000001 109.482 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -123.73 142.67 50.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.107 -0.331 . . . . 0.88 110.107 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 p -167.08 148.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.237 -0.653 . . . . 1.1899999999999999 109.237 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.6 1.77 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.127 -0.789 . . . . 0.37 111.127 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 63.7 pttt -157.8 171.39 20.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 1.96 111.499 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.853 ' HA ' HD22 ' A' ' 116' ' ' LEU . 63.8 tp -81.75 98.17 8.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.814 -0.63 . . . . 1.1200000000000001 110.253 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.608 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 33.6 tt0 -60.17 -27.75 67.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.756 0.312 . . . . 1.96 111.142 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 t -55.36 -27.2 45.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.955 -0.566 . . . . 1.1100000000000001 111.783 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 53' ' ' LYS . 11.8 t -139.96 4.61 2.09 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.286 0.565 . . . . 1.24 110.926 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.89 13.48 75.57 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.94 -0.573 . . . . 0.78000000000000003 113.077 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -77.8 118.34 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.606 0.241 . . . . 3.2999999999999998 111.141 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.9 p -76.84 159.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 1.3400000000000001 110.039 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 110' ' ' ILE . 18.3 m-30 -80.26 99.44 7.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.518 -0.31 . . . . 0.96999999999999997 110.675 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -124.51 84.72 2.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.889 0.852 . . . . 2.1800000000000002 111.28 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.519 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.9 m -136.92 -178.16 5.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.133 -0.94 . . . . 1.6799999999999999 108.81 175.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.9 p -67.36 -44.15 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 1.8600000000000001 111.104 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.35 -51.59 23.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.039 -0.528 . . . . 2.1200000000000001 110.141 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.7 OUTLIER -45.89 -43.81 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.745 -1.116 . . . . 2.1899999999999999 112.191 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.39 -11.9 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.501 . . . . 3.1899999999999999 112.351 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -103.9 -61.91 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.699 -0.401 . . . . 1.27 111.588 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 29.0 m -86.0 124.11 71.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.488 . . . . 2.6099999999999999 112.03 -169.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.7 Cg_endo -87.22 103.98 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.147 2.565 . . . . 2.1299999999999999 111.21 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -94.8 149.16 21.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.454 -0.339 . . . . 1.6299999999999999 110.519 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -141.41 165.88 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 2.0099999999999998 109.939 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CE2' HG11 ' A' ' 74' ' ' VAL . 54.4 p90 -149.86 -176.88 5.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.088 0.47 . . . . 0.68999999999999995 111.516 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 3.9 m-70 -120.03 150.93 39.77 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.477 -0.783 . . . . 2.6600000000000001 110.075 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.498 HD13 ' CG2' ' A' ' 82' ' ' VAL . 45.6 tp -68.76 134.98 50.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.552 0.215 . . . . 1.5600000000000001 110.46 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 53.21 31.22 11.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.504 0.669 . . . . 2.0800000000000001 111.518 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 16.5 tt0 -69.62 -12.04 61.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.076 -0.965 . . . . 1.98 111.033 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.52 -14.31 54.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.741 -0.743 . . . . 0.78000000000000003 111.744 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -104.07 0.02 29.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.96999999999999997 110.737 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.9 m -132.3 124.65 52.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 1.25 110.266 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.502 HG12 ' N ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -96.36 -60.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.03 0.752 . . . . 1.3500000000000001 113.03 -176.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 75' ' ' ILE . 35.6 mmtt -145.03 -41.49 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.285 0.846 . . . . 2.5600000000000001 113.285 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.36 -52.33 37.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.307 -0.949 . . . . 0.34000000000000002 112.212 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -76.48 -33.13 58.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.543 0.211 . . . . 0.56000000000000005 110.992 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 10.4 t70 -52.33 -53.33 45.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.77 -0.65 . . . . 1.1399999999999999 112.102 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.11 -33.13 59.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.441 0.638 . . . . 1.3999999999999999 111.22 -176.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.68 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 49.8 t -76.19 -39.52 54.56 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.896 -0.502 . . . . 0.98999999999999999 111.661 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.498 ' CG2' HD13 ' A' ' 69' ' ' LEU . 33.8 m -81.02 -32.82 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.452 0.167 . . . . 1.49 111.131 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.569 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 62.6 m -61.27 -40.71 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 1.9399999999999999 110.7 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.481 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 21.4 m -101.42 64.38 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 1.8700000000000001 111.038 174.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.68 ' HE1' ' HG ' ' A' ' 81' ' ' CYS . 11.4 mmt -120.9 172.47 7.89 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.149 -0.932 . . . . 2.79 110.074 171.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -142.96 162.83 34.41 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.69 -0.856 . . . . 4.9199999999999999 108.69 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HA ' HD23 ' A' ' 122' ' ' LEU . 3.4 tmtm? -56.11 -29.56 60.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.981 0.363 . . . . 2.4300000000000002 111.981 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -118.96 18.12 13.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.68 0.276 . . . . 1.4199999999999999 111.13 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.37 158.03 16.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.395 -0.366 . . . . 1.6000000000000001 110.578 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -152.29 124.06 7.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.283 -0.636 . . . . 1.74 109.283 -175.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.603 ' H ' ' HE2' ' A' ' 85' ' ' MET . 63.8 m -129.63 160.7 32.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.324 -0.398 . . . . 1.3600000000000001 110.9 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.17 118.21 36.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.058 -0.519 . . . . 2.2999999999999998 109.655 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 95' ' ' ILE . 7.5 p -100.63 138.17 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.822 0.344 . . . . 1.46 110.224 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 mmm-85 -107.42 111.44 23.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.571 -0.899 . . . . 2.29 108.571 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 93' ' ' VAL . 5.1 mp -104.28 107.17 21.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.181 -173.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.579 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 2.2 tt0 -83.46 176.01 9.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.153 -0.684 . . . . 1.3700000000000001 109.153 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.423 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -58.68 -30.99 67.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.253 -0.431 . . . . 1.22 110.783 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.14 -9.29 59.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.294 -0.412 . . . . 2.3199999999999998 111.983 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.579 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 17.7 m-85 -109.42 -0.69 18.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 0.92000000000000004 110.29 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.58 176.09 22.95 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.85999999999999999 112.134 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.706 ' HD1' ' HB3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -86.54 32.18 0.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.704 0.261 . . . . 1.52 111.704 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.92 -27.06 71.25 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.08 -0.581 . . . . 2.2999999999999998 111.767 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.42 -54.83 42.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.055 0.455 . . . . 5.8600000000000003 110.244 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.706 ' HB3' ' HD1' ' A' ' 101' ' ' TYR . 15.3 tp10 -64.99 -42.65 94.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 4.2699999999999996 110.544 175.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.21 22.03 7.72 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.915 -0.66 . . . . 2.8999999999999999 112.241 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 48.9 t -91.82 121.88 33.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.282 . . . . 3.7799999999999998 110.537 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.523 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -107.7 119.48 5.79 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.053 -0.594 . . . . 1.47 111.667 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -99.09 -71.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.05 -0.352 . . . . 3.0800000000000001 110.05 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -75.6 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.072 -0.251 . . . . 1.71 111.09 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.542 HD13 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -156.15 72.83 5.1 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 1.3700000000000001 110.95 175.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.523 ' HG2' ' HA2' ' A' ' 107' ' ' GLY . 19.4 Cg_endo -94.82 102.81 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.161 2.574 . . . . 1.5800000000000001 112.342 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.3 73.3 0.46 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.969 -0.853 . . . . 2.0499999999999998 110.969 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.02 31.33 0.33 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.92 0.888 . . . . 2.2999999999999998 111.26 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.434 ' HB2' HD12 ' A' ' 48' ' ' LEU . 6.8 p -104.27 -177.33 3.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.5700000000000001 111.018 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.82 137.64 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.07 -0.514 . . . . 1.1799999999999999 110.035 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.853 HD22 ' HA ' ' A' ' 48' ' ' LEU . 10.1 mt -124.55 156.4 37.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 1.25 110.72 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.608 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -125.56 119.67 28.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.829 -0.434 . . . . 1.3500000000000001 109.829 171.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.437 ' CD2' HD13 ' A' ' 95' ' ' ILE . 21.2 m-85 -114.52 137.93 51.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.962 -0.563 . . . . 0.56000000000000005 111.006 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 36.2 mt-10 -89.12 116.09 27.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.295 -0.866 . . . . 1.46 108.869 172.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.457 HG21 HG11 ' A' ' 82' ' ' VAL . 44.6 mt -106.78 127.82 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.705 0.288 . . . . 1.1599999999999999 110.258 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.26 125.82 50.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.806 -0.634 . . . . 1.8799999999999999 110.601 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 87' ' ' LYS . 4.4 tp -91.88 89.86 7.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.518 -0.549 . . . . 1.75 109.518 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -78.78 -37.07 41.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.895 -0.322 . . . . 1.78 111.43 -176.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.3 m -146.77 151.36 37.03 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.128 -0.229 . . . . 1.53 110.794 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -165.86 -177.71 4.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.507 -0.553 . . . . 0.90000000000000002 109.507 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.562 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -162.33 172.38 15.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 3.4700000000000002 109.786 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 26.8 mt-10 -135.18 121.71 20.62 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.366 0.416 . . . . 3.3799999999999999 110.94 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.4 mt -128.52 166.37 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.971 -0.559 . . . . 3.8199999999999998 110.006 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.79 137.01 36.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 5.3899999999999997 110.728 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -111.11 121.5 45.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.115 -0.493 . . . . 7.75 110.614 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -107.05 124.37 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.685 -0.487 . . . . 7.8499999999999996 109.685 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -140.77 118.66 11.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 9.5500000000000007 110.146 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -129.29 121.78 28.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.18 -0.464 . . . . 10.23 110.327 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -94.4 -62.72 1.28 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.905 0.383 . . . . 12.85 110.235 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 t60 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.333 -0.841 . . . . 13.970000000000001 109.682 178.821 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.824 0.345 . . . . 7.8200000000000003 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.4 m -85.12 153.71 22.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.576 -0.528 . . . . 6.2699999999999996 109.576 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 1.5 p -61.96 153.64 28.77 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.985 0.178 . . . . 4.75 111.247 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 3' ' ' THR . 42.0 mt-10 67.81 -162.73 0.21 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.063 -0.517 . . . . 4.4400000000000004 109.644 -173.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.555 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 35.7 tt0 -155.98 170.83 21.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 4.9000000000000004 110.608 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.52 80.52 3.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 3.6099999999999999 111.454 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 68.7 m-85 -106.04 164.84 11.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.877 -0.601 . . . . 4.54 110.354 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -112.35 136.53 51.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.018 -0.537 . . . . 2.71 110.178 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HG3' HG23 ' A' ' 21' ' ' THR . 7.1 mptt -111.34 125.82 54.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.722 -0.474 . . . . 2.4399999999999999 109.722 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.42 115.54 45.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.537 -0.301 . . . . 1.3100000000000001 110.349 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.04 126.67 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.095 -0.502 . . . . 2.1600000000000001 111.09 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.3 mt 57.26 53.31 7.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 2.04 110.04 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.524 HG23 ' HE2' ' A' ' 20' ' ' LYS . 11.7 t -59.23 157.72 10.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.948 -1.024 . . . . 1.26 111.169 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -2.76 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 1.3700000000000001 112.115 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.53 -4.41 36.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 2.3999999999999999 110.658 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.27 37.41 0.69 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.574 -0.822 . . . . 0.83999999999999997 113.107 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.29 0.85 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.906 -0.664 . . . . 0.62 113.489 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.455 HG22 ' HB ' ' A' ' 80' ' ' ILE . 38.6 t -141.13 141.36 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.272 -0.27 . . . . 1.1799999999999999 110.272 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 12' ' ' LEU . 14.3 mm -90.83 110.82 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 1.1799999999999999 109.753 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' HE2' HG23 ' A' ' 13' ' ' THR . 61.3 pttt -137.09 144.83 43.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.192 0.52 . . . . 1.96 111.076 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.427 HG23 ' HG3' ' A' ' 9' ' ' LYS . 25.2 m -116.77 131.37 56.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.811 . . . . 1.21 110.239 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 25' ' ' LYS . 4.9 tp -91.17 126.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.244 -0.435 . . . . 1.3 110.267 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.568 ' CD2' ' HG ' ' A' ' 92' ' ' LEU . 3.3 mm? -108.04 -72.85 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.38 0.609 . . . . 1.3999999999999999 110.135 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -108.07 103.28 12.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.146 -0.687 . . . . 2.0600000000000001 109.146 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.466 ' HA ' HD11 ' A' ' 22' ' ' ILE . 73.4 tttt -72.26 157.38 37.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.851 -0.425 . . . . 3.25 109.851 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.27 -136.83 0.12 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 114.559 0.583 . . . . 1.3200000000000001 114.559 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 28' ' ' GLU . 14.0 t70 -167.3 -162.98 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.556 -1.275 . . . . 2.77 107.556 -170.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.48 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 39.2 tt0 -77.81 125.38 29.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 2.6400000000000001 110.716 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.93 70.0 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.559 -1.016 . . . . 1.3 110.559 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.46 -22.43 59.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.043 0.449 . . . . 2.29 111.03 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.47 1.1 55.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.645 0.736 . . . . 2.6400000000000001 109.328 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -105.71 76.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.647 -0.706 . . . . 1.49 109.243 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.1 mm -137.07 130.42 17.44 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 1.3700000000000001 111.138 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.503 ' HG3' ' O ' ' A' ' 85' ' ' MET . 74.0 Cg_endo -74.74 133.86 17.55 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.031 2.488 . . . . 0.84999999999999998 111.424 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 29.9 mmmt -134.12 142.06 47.36 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.283 -0.261 . . . . 3.1400000000000001 110.539 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' HE3' ' HB3' ' A' ' 70' ' ' GLU . 17.3 tptm -56.14 127.51 31.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 2.9100000000000001 110.47 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.53 -25.25 23.61 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.474 -0.785 . . . . 1.1899999999999999 111.825 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 128' ' ' LEU . 78.9 m-20 -94.28 165.73 12.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 1.3799999999999999 110.305 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.27 132.26 34.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.142 0.496 . . . . 2.2000000000000002 111.857 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.8 150.8 35.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.496 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 25.6 m -125.55 106.41 9.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.861 -0.422 . . . . 1.23 109.861 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 122' ' ' LEU . 34.0 m -131.22 160.48 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.573 . . . . 1.6200000000000001 111.385 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -113.92 152.73 30.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.647 -0.872 . . . . 3.5600000000000001 108.647 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -128.06 132.64 49.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.88 110.253 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -165.14 158.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.807 -0.812 . . . . 1.1899999999999999 108.807 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.84 -127.35 1.51 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.038 -1.077 . . . . 0.37 112.372 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -150.42 166.63 29.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 1.96 110.471 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.569 HD23 HG13 ' A' ' 110' ' ' ILE . 66.3 tp -86.23 101.97 13.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 1.1200000000000001 109.694 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 18.9 tt0 -59.78 -24.54 64.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.807 0.337 . . . . 1.96 111.817 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 t -55.86 -25.35 41.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.188 -0.46 . . . . 1.1100000000000001 111.468 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.412 HG21 ' HG2' ' A' ' 53' ' ' LYS . 3.0 t -137.84 -31.62 0.77 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.933 0.396 . . . . 1.24 111.567 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.72 14.75 26.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.84 -0.695 . . . . 0.78000000000000003 112.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HG2' HG21 ' A' ' 51' ' ' THR . 70.2 mmtt -86.59 133.7 33.69 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.652 -0.499 . . . . 3.2999999999999998 109.652 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 p -83.06 155.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.211 -0.45 . . . . 1.3400000000000001 111.46 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 3.2 m-85 -74.33 102.11 4.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.96999999999999997 110.77 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.52 85.3 2.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.375 0.607 . . . . 2.1800000000000002 110.004 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.519 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 67.3 m -138.58 -177.61 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 1.6799999999999999 110.323 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -48.47 -47.0 38.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.887 0.699 . . . . 1.8600000000000001 112.887 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.89 -43.29 8.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 2.1200000000000001 110.339 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.8 OUTLIER -57.29 -30.5 64.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 2.1899999999999999 112.185 -174.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -19.91 21.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 3.1899999999999999 110.973 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.641 HD21 HG11 ' A' ' 63' ' ' VAL . 8.5 t30 -86.81 -61.02 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 1.27 110.94 -171.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.641 HG11 HD21 ' A' ' 62' ' ' ASN . 7.1 p -156.13 126.36 3.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 2.6099999999999999 111.121 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.02 152.74 57.44 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.694 2.262 . . . . 2.1299999999999999 111.326 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.71 146.41 23.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.676 0.274 . . . . 1.6299999999999999 110.328 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 2.7 pptp? -105.89 143.35 34.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.979 -0.378 . . . . 2.0099999999999998 109.979 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.31 170.44 15.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.01 0.433 . . . . 0.68999999999999995 111.131 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -103.96 149.58 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 2.6600000000000001 109.966 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD13 ' CG2' ' A' ' 82' ' ' VAL . 16.5 tp -64.19 119.46 10.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.94 0.4 . . . . 1.5600000000000001 110.928 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.636 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER 42.31 74.94 0.1 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 114.405 -1.271 . . . . 2.0800000000000001 111.767 -174.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -100.85 17.39 22.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.548 -1.206 . . . . 1.98 109.536 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.5 -16.6 59.62 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.604 -0.726 . . . . 0.78000000000000003 111.787 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.53 -41.56 11.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.466 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.87 135.36 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.651 0.262 . . . . 1.25 110.301 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.53 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.61 -68.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.455 0.539 . . . . 1.3500000000000001 112.455 -175.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' H ' HG12 ' A' ' 75' ' ' ILE . 41.7 mtpt -133.52 -51.09 0.86 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 122.026 -0.421 . . . . 2.5600000000000001 111.892 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.07 -53.41 34.22 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.049 -0.596 . . . . 0.34000000000000002 113.513 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.416 ' O ' HG21 ' A' ' 82' ' ' VAL . 17.7 m-90 -75.86 -37.72 58.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.652 0.263 . . . . 0.56000000000000005 110.632 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.01 -54.06 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 1.1399999999999999 111.791 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' HG22 ' A' ' 18' ' ' VAL . 1.9 mp -68.59 -35.31 69.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.129 0.49 . . . . 1.3999999999999999 110.559 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.58 ' SG ' HD13 ' A' ' 120' ' ' ILE . 44.2 t -69.43 -48.19 61.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.096 -0.502 . . . . 0.98999999999999999 111.083 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.596 ' CG2' HD13 ' A' ' 69' ' ' LEU . 34.0 m -66.7 -32.37 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 121.169 -0.212 . . . . 1.49 111.125 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -80.92 3.38 22.99 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.275 0.56 . . . . 1.9399999999999999 110.237 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 t -123.93 27.48 7.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.558 -0.746 . . . . 1.8700000000000001 109.001 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.746 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 40.7 mmm -123.79 116.45 23.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 2.79 111.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.502 HH21 ' HB2' ' A' ' 88' ' ' ASN . 18.0 ttp85 -82.41 162.06 22.27 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 4.9199999999999999 109.753 175.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -66.12 -13.68 60.53 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.108 0.41 . . . . 2.4300000000000002 112.108 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.502 ' HB2' HH21 ' A' ' 86' ' ' ARG . 37.0 m-80 -121.42 25.51 9.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.004 0.43 . . . . 1.4199999999999999 109.976 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -123.16 166.4 15.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.634 -0.712 . . . . 1.6000000000000001 109.737 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.746 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 79.2 tttt -157.28 121.03 4.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 1.74 111.405 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.27 160.96 25.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.522 -0.763 . . . . 1.3600000000000001 110.646 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.568 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 75.2 mt -115.13 126.22 54.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.544 -0.539 . . . . 2.2999999999999998 109.544 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.505 ' HB ' ' HG ' ' A' ' 81' ' ' CYS . 10.0 p -101.22 142.45 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 110.024 -0.362 . . . . 1.46 110.024 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -100.98 112.84 25.38 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.84 -0.8 . . . . 2.29 108.84 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 95' ' ' ILE . 3.3 mp -87.23 101.18 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 1.2 110.928 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.75 159.22 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.433 -0.951 . . . . 1.3700000000000001 108.433 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 p -55.37 -36.1 65.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.889 0.376 . . . . 1.22 111.499 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 22.2 ptp -76.95 -8.27 57.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.166 -0.47 . . . . 2.3199999999999998 111.021 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -96.08 -2.4 46.72 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.154 -0.313 . . . . 0.92000000000000004 110.154 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.53 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -133.72 -152.45 6.78 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.684 -0.689 . . . . 0.85999999999999999 112.335 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.604 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 36.0 m-85 -96.8 -0.12 48.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.926 0.343 . . . . 1.52 111.926 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.32 -137.28 45.25 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 2.2999999999999998 113.145 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.03 -32.45 17.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.156 0.503 . . . . 5.8600000000000003 110.588 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.09 -53.08 55.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 4.2699999999999996 112.193 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -76.68 161.11 51.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.091 -0.575 . . . . 2.8999999999999999 113.214 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 23.1 p -71.63 128.31 35.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 3.7799999999999998 110.347 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.564 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -102.89 173.88 22.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 1.47 112.862 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -96.32 -71.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.799 0.296 . . . . 3.0800000000000001 111.799 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.57 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 3.0 t -106.65 -73.25 0.69 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.305 -0.247 . . . . 1.71 110.751 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.569 HG13 HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.59 71.36 17.49 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.922 0.392 . . . . 1.3700000000000001 111.77 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.564 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 83.4 Cg_endo -92.23 -158.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.766 2.311 . . . . 1.5800000000000001 112.558 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.14 -133.0 9.65 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.336 -0.706 . . . . 2.0499999999999998 111.336 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -96.64 24.07 6.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.753 0.787 . . . . 2.2999999999999998 109.732 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -104.93 146.5 28.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.397 -0.82 . . . . 1.5700000000000001 109.737 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.19 132.06 34.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.158 0.504 . . . . 1.1799999999999999 110.66 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.428 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.7 mp -121.07 168.95 10.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.545 . . . . 1.25 109.624 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -138.97 122.83 17.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 1.3500000000000001 110.333 172.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -110.94 140.6 45.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.56000000000000005 111.453 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.42 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 34.3 mt-10 -80.45 119.58 23.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.274 -0.875 . . . . 1.46 108.903 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.582 HG22 HG12 ' A' ' 82' ' ' VAL . 47.8 mt -108.12 134.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.248 -0.649 . . . . 1.1599999999999999 109.248 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -134.93 114.38 12.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.529 . . . . 1.8799999999999999 110.7 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HA ' HG13 ' A' ' 42' ' ' VAL . 4.9 tp -84.0 91.72 7.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.852 -0.425 . . . . 1.75 109.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 41' ' ' THR . 2.8 pp -84.27 -36.81 22.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.1 -0.24 . . . . 1.78 111.279 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.4 m -143.14 150.66 39.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.047 -0.353 . . . . 1.53 110.047 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -165.91 -178.89 4.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.494 -0.558 . . . . 0.90000000000000002 109.494 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.86 138.92 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 3.4700000000000002 110.554 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -93.51 151.71 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.318 -0.623 . . . . 3.3799999999999999 109.318 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.489 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 19.8 tp -75.3 138.78 42.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.611 0.243 . . . . 3.8199999999999998 111.211 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -81.69 168.16 18.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.933 0.397 . . . . 5.3899999999999997 111.344 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.0 m80 59.36 -163.45 0.23 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.257 -0.883 . . . . 7.75 111.084 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -135.54 121.84 20.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.114 0.483 . . . . 7.8499999999999996 109.715 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -125.29 95.31 4.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 9.5500000000000007 110.689 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -169.59 127.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.82 -0.627 . . . . 10.23 109.481 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -91.94 126.58 37.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.245 -0.582 . . . . 12.85 109.845 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-N 115.311 -0.859 . . . . 13.970000000000001 110.689 -176.774 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.702 0.287 . . . . 7.8200000000000003 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -85.72 81.69 8.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.375 0.607 . . . . 6.2699999999999996 111.526 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.8 p -100.12 -25.82 14.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.675 0.75 . . . . 4.75 109.325 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.72 130.17 34.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.795 -1.093 . . . . 4.4400000000000004 108.867 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -151.31 162.85 40.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.685 0.278 . . . . 4.9000000000000004 110.333 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.31 86.73 2.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.012 0.434 . . . . 3.6099999999999999 110.403 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.62 122.64 22.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.818 -0.628 . . . . 4.54 109.754 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.35 154.13 39.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.263 0.554 . . . . 2.71 110.77 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.4 mppt? -94.42 152.04 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.039 -0.726 . . . . 2.4399999999999999 109.039 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.31 105.19 17.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.562 -0.533 . . . . 1.3100000000000001 109.562 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.8 99.75 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 2.1600000000000001 110.247 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt 66.75 78.63 0.25 Allowed 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.027 0.829 . . . . 2.04 110.858 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -68.3 156.07 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 1.26 110.366 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.27 -20.27 65.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.247 -0.433 . . . . 1.3700000000000001 111.902 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.51 30.69 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.87 0.367 . . . . 2.3999999999999999 111.83 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 11.38 5.32 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.043 -1.075 . . . . 0.83999999999999997 114.548 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.92 64.33 4.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.545 0.578 . . . . 0.62 114.545 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.411 HG21 ' HB ' ' A' ' 80' ' ' ILE . 69.0 t -127.14 147.55 32.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 1.1799999999999999 109.984 173.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.616 HG12 ' HH ' ' A' ' 99' ' ' TYR . 25.9 mm -85.5 111.17 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.789 -0.449 . . . . 1.1799999999999999 109.789 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 18.5 pttp -141.68 146.92 36.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.945 0.402 . . . . 1.96 110.769 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -102.79 132.02 49.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 1.21 110.034 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 tp -93.63 121.93 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.878 0.371 . . . . 1.3 110.194 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.88 -78.83 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 1.3999999999999999 110.419 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 108.69 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.579 -0.737 . . . . 2.0600000000000001 109.675 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HZ3' ' HB2' ' A' ' 25' ' ' LYS . 9.2 mtmp? -72.88 147.39 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.885 -0.598 . . . . 3.25 111.901 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.73 88.75 1.38 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.072 -1.211 . . . . 1.3200000000000001 110.072 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.33 -43.21 43.5 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.767 0.654 . . . . 2.77 112.767 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.32 144.38 34.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.924 0.392 . . . . 2.6400000000000001 110.709 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.81 51.8 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.977 -0.63 . . . . 1.3 111.643 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.95 -45.98 64.58 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.583 0.586 . . . . 2.29 112.583 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.47 27.65 8.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.962 0.411 . . . . 2.6400000000000001 111.035 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.435 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 30.9 m-80 -129.26 78.62 1.86 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 1.49 110.609 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.25 124.31 21.18 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.134 -0.485 . . . . 1.3700000000000001 111.066 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.517 ' HG3' HD23 ' A' ' 122' ' ' LEU . 42.8 Cg_endo -67.65 112.83 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.713 2.275 . . . . 0.84999999999999998 111.504 176.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.7 mmtp -133.39 172.78 12.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.364 0.875 . . . . 3.1400000000000001 113.364 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -43.42 126.48 4.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.02 -1.445 . . . . 2.9100000000000001 113.211 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 -16.01 45.1 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.935 -0.575 . . . . 1.1899999999999999 113.301 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 92.7 m-20 -83.58 146.99 28.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.057 0.456 . . . . 1.3799999999999999 110.913 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -78.5 110.23 13.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.292 0.568 . . . . 2.2000000000000002 110.252 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 125' ' ' PHE . 11.1 m -117.88 159.29 18.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.587 -0.733 . . . . 1.3300000000000001 109.819 175.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.49 HG21 ' HD3' ' A' ' 66' ' ' LYS . 23.7 m -125.55 105.61 9.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.383 -0.599 . . . . 1.23 109.383 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 122' ' ' LEU . 12.7 m -128.01 140.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.864 -0.607 . . . . 1.6200000000000001 110.185 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -100.43 147.64 25.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.06 -0.718 . . . . 3.5600000000000001 109.06 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -126.39 127.84 46.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.371 0.605 . . . . 0.88 110.326 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.22 157.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.355 -0.98 . . . . 1.1899999999999999 108.355 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.61 -128.49 1.71 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.258 -0.972 . . . . 0.37 111.454 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.67 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 59.2 pttt -157.81 170.92 21.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.993 0.425 . . . . 1.96 111.058 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD13 ' HG ' ' A' ' 116' ' ' LEU . 46.2 tp -89.52 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 1.1200000000000001 109.627 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 78.2 tt0 -64.36 -28.55 69.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 1.96 111.233 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 8.7 t -54.84 -29.78 55.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.532 . . . . 1.1100000000000001 111.543 -175.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -130.46 -2.45 4.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.656 0.265 . . . . 1.24 111.086 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 45.34 50.31 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.347 -0.454 . . . . 0.78000000000000003 113.032 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 68.8 mmtt -113.51 127.1 55.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 3.2999999999999998 110.584 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.67 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 14.4 p -72.76 152.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.622 -0.717 . . . . 1.3400000000000001 111.168 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 3.5 m-30 -74.48 115.45 14.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.998 0.428 . . . . 0.96999999999999997 110.749 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -146.21 85.7 1.67 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.655 -0.702 . . . . 2.1800000000000002 109.425 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 15.0 m -116.13 -177.5 3.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.544 -0.753 . . . . 1.6799999999999999 109.734 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -71.17 -37.98 72.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.947 0.404 . . . . 1.8600000000000001 111.212 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.42 -48.09 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.382 0.512 . . . . 2.1200000000000001 112.382 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -62.34 -45.57 92.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.926 0.713 . . . . 2.1899999999999999 112.926 -167.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 57' ' ' SER . 3.4 ptm180 -67.35 -23.25 65.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.776 0.322 . . . . 3.1899999999999999 111.326 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -87.71 -62.32 1.52 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 1.27 110.565 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.3 107.09 30.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.631 0.729 . . . . 2.6099999999999999 110.787 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.14 138.74 37.3 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.114 2.542 . . . . 2.1299999999999999 111.795 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.25 153.85 18.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.902 -0.407 . . . . 1.6299999999999999 109.902 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD3' HG21 ' A' ' 41' ' ' THR . 3.7 pptp? -130.02 146.76 51.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.303 -0.408 . . . . 2.0099999999999998 110.506 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 48.7 p90 -127.86 174.43 9.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.82 0.343 . . . . 0.68999999999999995 111.447 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -110.69 151.36 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 2.6600000000000001 110.664 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -65.18 117.67 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 1.5600000000000001 110.535 -176.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.76 90.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.203 1.001 . . . . 2.0800000000000001 110.228 -171.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.419 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 8.2 tt0 -127.73 8.24 6.32 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.399 -1.273 . . . . 1.98 109.585 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.1 -17.67 31.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.78000000000000003 112.472 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.412 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 9.0 mm-40 -90.4 -15.53 30.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.374 0.606 . . . . 0.96999999999999997 110.329 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.56 124.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.952 -0.567 . . . . 1.25 110.747 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -99.43 -57.07 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.74 0.644 . . . . 1.3500000000000001 112.74 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.499 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.0 mtpt -137.41 -61.18 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 2.5600000000000001 111.665 -171.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.452 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -52.99 -52.74 37.66 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.05 -0.595 . . . . 0.34000000000000002 112.78 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.574 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -74.87 -51.53 13.67 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.74 -0.384 . . . . 0.56000000000000005 110.431 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.41 -51.98 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.545 0.528 . . . . 1.1399999999999999 112.123 -171.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 76' ' ' LYS . 1.8 mp -65.42 -38.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.809 0.338 . . . . 1.3999999999999999 110.453 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.628 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.0 t -68.6 -46.1 70.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.284 . . . . 0.98999999999999999 110.765 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.6 m -67.98 -33.06 59.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 O-C-N 123.153 0.283 . . . . 1.49 110.856 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -61.1 -39.24 89.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 1.9399999999999999 110.58 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.505 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 22.4 m -92.67 31.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.474 . . . . 1.8700000000000001 111.15 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 85.6 mmm -104.52 175.13 5.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.615 -0.266 . . . . 2.79 110.385 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 70.4 mtt85 -144.89 165.71 27.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.465 -0.334 . . . . 4.9199999999999999 110.359 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -53.73 -35.14 60.87 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.618 0.573 . . . . 2.4300000000000002 112.316 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -125.19 41.4 3.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 1.4199999999999999 110.561 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 20.2 tt0 -117.34 154.25 31.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.392 -0.367 . . . . 1.6000000000000001 110.193 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.94 117.49 7.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.376 . . . . 1.74 109.986 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 74.5 m -124.52 162.21 24.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.092 0.472 . . . . 1.3600000000000001 112.018 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.44 114.67 27.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.369 -0.832 . . . . 2.2999999999999998 109.646 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.6 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.1 p -103.77 147.57 9.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.409 -0.359 . . . . 1.46 110.983 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 94' ' ' ARG . 9.5 mmt85 -105.51 112.38 25.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.587 -0.523 . . . . 2.29 109.587 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.519 HD12 ' HD2' ' A' ' 118' ' ' PHE . 2.1 mp -94.1 105.58 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.149 0.499 . . . . 1.2 109.67 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 97' ' ' SER . 23.0 tt0 -93.78 174.85 6.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.424 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -49.0 -45.87 43.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.76 0.424 . . . . 1.22 111.516 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.08 -8.29 58.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.948 -0.569 . . . . 2.3199999999999998 112.027 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.616 ' HH ' HG12 ' A' ' 19' ' ' ILE . 21.6 m-85 -102.28 -18.58 15.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.92000000000000004 110.578 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.487 ' C ' HD13 ' A' ' 75' ' ' ILE . . . -112.99 -174.41 19.13 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.304 -0.718 . . . . 0.85999999999999999 111.304 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . 5.7 m-85 -82.38 59.96 4.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 1.52 110.889 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -89.34 -0.32 80.04 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.397 -0.681 . . . . 2.2999999999999998 111.397 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.39 -55.22 4.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 5.8600000000000003 109.985 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -81.64 -54.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.571 -0.74 . . . . 4.2699999999999996 110.365 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.75 67.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.779 . . . . 2.8999999999999999 112.828 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . 43.9 t -123.32 136.71 54.81 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.653 -0.322 . . . . 3.7799999999999998 110.379 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -176.34 99.88 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.587 -0.605 . . . . 1.47 111.587 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.11 -34.35 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.274 . . . . 3.0800000000000001 111.604 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB2' HD12 ' A' ' 110' ' ' ILE . 4.7 p -93.94 -76.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.961 0.356 . . . . 1.71 111.961 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.504 HD12 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -160.25 87.67 1.87 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 122.892 0.477 . . . . 1.3700000000000001 110.848 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.567 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 87.1 Cg_endo -84.83 170.35 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.345 2.03 . . . . 1.5800000000000001 111.597 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.06 36.54 0.02 OUTLIER Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.39 -0.91 . . . . 2.0499999999999998 112.473 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.53 19.01 11.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.274 0.559 . . . . 2.2999999999999998 110.402 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.427 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 2.0 m -95.8 160.93 14.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.493 -0.776 . . . . 1.5700000000000001 110.33 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.22 122.21 45.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.375 0.607 . . . . 1.1799999999999999 110.452 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.0 mp -116.29 142.7 46.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.837 -0.62 . . . . 1.25 109.615 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.44 121.59 45.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.142 0.496 . . . . 1.3500000000000001 110.539 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.519 ' HD2' HD12 ' A' ' 95' ' ' ILE . 44.4 m-85 -112.88 137.95 50.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.747 . . . . 0.56000000000000005 111.219 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 38.7 mt-10 -78.2 122.37 25.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.81 -0.811 . . . . 1.46 108.81 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.484 HG21 HG12 ' A' ' 82' ' ' VAL . 49.9 mt -107.16 121.16 59.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.512 -0.551 . . . . 1.1599999999999999 109.512 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -127.68 112.88 15.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.514 -0.766 . . . . 1.8799999999999999 110.639 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HA ' HG13 ' A' ' 42' ' ' VAL . 24.6 tp -88.93 99.59 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 1.75 109.9 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.8 -31.42 16.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.872 -0.331 . . . . 1.78 111.308 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.3 m -151.21 146.21 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.713 -0.221 . . . . 1.53 110.571 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.555 ' HB2' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -168.39 -179.21 3.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.523 -0.308 . . . . 0.90000000000000002 110.294 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 6.0 ptp180 -155.74 142.22 18.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.055 -0.521 . . . . 3.4700000000000002 109.948 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.92 150.99 25.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.756 0.312 . . . . 3.3799999999999999 110.482 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.2 mt -101.27 127.77 47.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.032 0.444 . . . . 3.8199999999999998 110.454 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.34 168.86 13.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.694 -0.685 . . . . 5.3899999999999997 109.308 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -63.15 122.0 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.293 -0.262 . . . . 7.75 110.293 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -135.89 98.99 4.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.331 0.586 . . . . 7.8499999999999996 111.722 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -126.19 -76.63 0.58 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.386 -0.968 . . . . 9.5500000000000007 108.386 172.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 62.73 -6.96 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.38 1.622 . . . . 10.23 115.38 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -81.17 -20.69 40.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.932 -1.136 . . . . 12.85 107.932 167.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 70.3 t60 . . . . . 0 C--O 1.244 0.765 0 CA-C-N 114.101 -1.408 . . . . 13.970000000000001 107.977 173.921 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.721 0.296 . . . . 7.8200000000000003 111.082 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.4 t -82.41 -19.35 39.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.624 -0.262 . . . . 6.2699999999999996 110.95 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.771 HG23 ' H ' ' A' ' 4' ' ' GLU . 3.6 m 66.09 -174.2 0.18 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.344 -0.389 . . . . 4.75 110.577 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.771 ' H ' HG23 ' A' ' 3' ' ' THR . 18.6 tt0 -130.58 178.16 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.956 -0.465 . . . . 4.4400000000000004 109.82 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 49.8 mt-30 -76.8 149.99 36.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.996 0.427 . . . . 4.9000000000000004 111.457 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.67 79.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.649 -0.871 . . . . 3.6099999999999999 108.649 172.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.46 160.44 25.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.561 -0.745 . . . . 4.54 112.834 -171.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.72 154.26 19.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.9 -1.046 . . . . 2.71 110.025 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 3.2 mppt? -99.41 127.83 45.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.337 -0.616 . . . . 2.4399999999999999 109.337 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -102.53 105.42 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.421 -0.585 . . . . 1.3100000000000001 109.421 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.16 140.98 29.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.253 -0.43 . . . . 2.1600000000000001 110.993 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.511 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.2 mt 54.04 44.0 29.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 2.04 111.677 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 20' ' ' LYS . 9.1 t -55.92 157.3 4.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 1.26 110.817 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 1.16 5.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 1.3700000000000001 111.19 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -80.11 3.51 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 2.3999999999999999 110.592 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.86 25.41 1.9 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.839 -0.696 . . . . 0.83999999999999997 113.539 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 66.02 68.75 1.55 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.231 -0.509 . . . . 0.62 113.941 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' HB ' ' A' ' 80' ' ' ILE . 12.8 t -135.87 145.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.898 -0.408 . . . . 1.1799999999999999 109.898 176.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.769 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 8.8 mm -85.49 109.67 18.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.453 -0.573 . . . . 1.1799999999999999 109.453 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HD3' HG22 ' A' ' 13' ' ' THR . 4.1 ptmt -125.0 129.13 49.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.232 0.539 . . . . 1.96 111.158 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -101.07 114.62 28.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.644 -0.707 . . . . 1.21 109.801 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.497 HD11 ' CG ' ' A' ' 25' ' ' LYS . 10.5 tp -66.16 128.74 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.992 -0.549 . . . . 1.3 109.792 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 0.5 OUTLIER -122.57 -78.3 0.6 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.993 0.425 . . . . 1.3999999999999999 110.776 -177.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -124.55 119.03 27.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.753 -0.658 . . . . 2.0600000000000001 109.983 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 43.7 mtpt -107.09 163.73 12.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.024 0.44 . . . . 3.25 110.692 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.3 -124.67 5.24 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.428 -0.806 . . . . 1.3200000000000001 111.3 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -150.99 -86.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.129 0.49 . . . . 2.77 110.439 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -95.65 158.74 15.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.978 -0.556 . . . . 2.6400000000000001 110.526 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.37 53.79 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 111.218 -0.753 . . . . 1.3 111.218 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.43 -40.19 89.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.109 0.48 . . . . 2.29 110.2 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -106.51 27.18 9.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.493 0.663 . . . . 2.6400000000000001 109.802 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.5 ' OD1' ' HE3' ' A' ' 87' ' ' LYS . 36.1 m-80 -130.51 76.47 1.72 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.521 -0.763 . . . . 1.49 109.857 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.6 mm -130.48 120.53 18.89 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.066 -0.516 . . . . 1.3700000000000001 111.131 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.16 131.74 15.73 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.571 2.181 . . . . 0.84999999999999998 111.52 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -126.05 142.22 51.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.623 -0.262 . . . . 3.1400000000000001 110.5 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -71.22 138.64 49.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 2.9100000000000001 109.471 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.7 -27.15 13.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.809 -0.71 . . . . 1.1899999999999999 111.408 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -88.88 145.37 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.82 -0.437 . . . . 1.3799999999999999 109.82 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 42.8 mt-10 -69.53 98.75 1.17 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.846 -0.615 . . . . 2.2000000000000002 112.126 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 125' ' ' PHE . 22.6 m -116.13 152.23 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 1.3300000000000001 109.828 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.4 m -127.36 131.05 50.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.683 -0.488 . . . . 1.23 109.683 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 122' ' ' LEU . 10.7 m -137.12 152.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.276 0.56 . . . . 1.6200000000000001 112.436 -173.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -105.38 129.44 53.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 3.5600000000000001 109.58 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.694 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 8.7 p90 -134.27 140.13 46.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.854 0.359 . . . . 0.88 111.474 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.14 158.6 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.54 -0.911 . . . . 1.1899999999999999 108.54 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -177.39 -126.63 0.99 Allowed Glycine 0 C--O 1.228 -0.227 0 C-N-CA 119.847 -1.168 . . . . 0.37 113.019 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.559 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 20.6 pttp -155.45 170.68 21.38 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.575 -0.367 . . . . 1.96 111.478 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.448 HD11 ' HG ' ' A' ' 116' ' ' LEU . 66.0 tp -94.1 98.32 10.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 1.1200000000000001 109.683 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' HB2' HD13 ' A' ' 117' ' ' LEU . 2.4 tp10 -69.19 -20.65 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.309 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 5.5 t -55.31 -27.37 46.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 1.1100000000000001 111.504 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 t -138.18 9.22 2.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 1.24 110.452 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.73 55.61 27.6 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.847 -0.615 . . . . 0.78000000000000003 112.636 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -121.14 118.55 29.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.529 -0.175 . . . . 3.2999999999999998 110.529 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.5 p -69.6 153.99 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.864 0.364 . . . . 1.3400000000000001 110.973 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 7.7 m-30 -76.73 105.53 7.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.96999999999999997 110.624 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -130.82 85.58 2.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.549 0.69 . . . . 2.1800000000000002 109.81 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.32 156.17 28.29 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.587 -0.894 . . . . 1.6799999999999999 108.587 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -68.33 -21.32 64.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.177 0.513 . . . . 1.8600000000000001 110.77 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -94.62 -48.8 5.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 2.1200000000000001 112.21 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -42.92 82.75 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.984 0.364 . . . . 2.1899999999999999 111.984 -169.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -77.49 -3.52 40.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.016 0.436 . . . . 3.1899999999999999 111.063 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -90.7 -45.73 8.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 1.27 109.989 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.87 113.51 2.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 2.6099999999999999 110.52 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.22 171.4 17.85 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.798 2.332 . . . . 2.1299999999999999 112.197 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -102.4 142.44 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.176 -0.466 . . . . 1.6299999999999999 110.175 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HD3' ' CG2' ' A' ' 41' ' ' THR . 0.0 OUTLIER -119.14 143.65 47.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 2.0099999999999998 108.996 175.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CE2' HG12 ' A' ' 74' ' ' VAL . 55.8 p90 -133.44 169.89 16.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.68999999999999995 112.054 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' HE1' ' HB3' ' A' ' 39' ' ' GLU . 1.5 m-70 -104.96 148.97 26.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.676 -1.147 . . . . 2.6600000000000001 109.768 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 79' ' ' ASP . 25.3 tp -73.15 129.99 39.28 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.747 -0.381 . . . . 1.5600000000000001 110.144 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 65.72 31.77 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.929 0.768 . . . . 2.0800000000000001 111.165 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.442 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 12.2 pt20 -80.9 12.57 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 1.98 111.114 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.57 48.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.035 -0.602 . . . . 0.78000000000000003 112.828 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' HE21 ' A' ' 71' ' ' GLN . 17.1 mm-40 -87.5 -32.32 19.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.449 . . . . 0.96999999999999997 110.818 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.443 HG12 ' CE2' ' A' ' 67' ' ' PHE . 28.0 m -98.52 127.05 51.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.376 0.607 . . . . 1.25 110.62 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.652 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.65 -76.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 1.3500000000000001 112.27 -175.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.652 ' H ' HG12 ' A' ' 75' ' ' ILE . 4.2 mmpt? -121.15 -57.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.455 . . . . 2.5600000000000001 112.23 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.16 -52.31 36.66 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.292 0.37 . . . . 0.34000000000000002 113.693 -171.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.423 ' O ' HG23 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.63 -43.13 49.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.94 -0.153 . . . . 0.56000000000000005 111.373 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' HA ' ' CD1' ' A' ' 69' ' ' LEU . 23.2 t70 -51.87 -52.32 50.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.526 0.565 . . . . 1.1399999999999999 112.526 -171.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.472 ' HB ' HG23 ' A' ' 18' ' ' VAL . 1.7 mp -61.62 -50.97 78.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.451 . . . . 1.3999999999999999 111.296 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.501 ' HB3' HD13 ' A' ' 120' ' ' ILE . 47.6 t -71.21 -27.41 63.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.98999999999999999 111.734 -171.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.478 ' HB ' HD13 ' A' ' 69' ' ' LEU . 53.7 t -66.24 -40.12 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.281 . . . . 1.49 110.873 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 t -78.39 -7.84 57.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 1.9399999999999999 110.05 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.5 m -98.09 19.0 14.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 1.8700000000000001 110.76 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.841 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 6.0 mmt -98.26 -173.53 2.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 2.79 111.726 -176.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 38.1 ttm180 -157.43 163.49 38.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.957 -1.127 . . . . 4.9199999999999999 107.957 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HE3' ' OD1' ' A' ' 32' ' ' ASN . 5.3 tppp? -50.85 -40.51 56.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.032 0.382 . . . . 2.4300000000000002 112.032 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -118.96 34.17 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.237 . . . . 1.4199999999999999 110.563 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 4.3 tt0 -122.7 140.09 53.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.722 -0.391 . . . . 1.6000000000000001 110.781 -175.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.9 tmtp? -145.57 129.18 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 1.74 109.977 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 74.4 m -137.58 171.09 14.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.074 0.464 . . . . 1.3600000000000001 111.687 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 119' ' ' GLU . 58.0 mt -105.83 131.68 52.87 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.502 -0.772 . . . . 2.2999999999999998 109.983 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 95' ' ' ILE . 7.3 p -112.45 140.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.044 0.449 . . . . 1.46 110.994 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 8.3 mmm180 -99.13 112.81 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.577 . . . . 2.29 110.028 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 93' ' ' VAL . 3.2 mp -101.45 107.51 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 1.2 110.137 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 31.4 tt0 -84.51 171.81 12.21 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.856 -0.794 . . . . 1.3700000000000001 108.856 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.6 p -56.4 -38.21 71.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.645 0.259 . . . . 1.22 111.612 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -77.21 -7.85 56.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 2.3199999999999998 111.434 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.8 m-30 -97.29 1.96 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.34 -0.225 . . . . 0.92000000000000004 110.508 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.525 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -134.35 -152.59 6.69 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.94 -0.573 . . . . 0.85999999999999999 111.729 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.07 -70.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 1.52 110.746 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 111' ' ' PRO . . . 121.98 -175.42 16.3 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.2999999999999998 112.012 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -74.6 -6.92 51.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.913 0.387 . . . . 5.8600000000000003 110.41 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -61.96 -36.86 82.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 4.2699999999999996 111.155 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.48 -82.98 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.286 -0.959 . . . . 2.8999999999999999 112.539 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 86.1 m -81.8 113.48 19.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.272 0.558 . . . . 3.7799999999999998 111.168 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.491 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -117.08 83.8 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.411 -0.813 . . . . 1.47 111.228 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 108' ' ' GLU . 21.9 mp0 -53.77 -64.85 0.69 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.722 0.409 . . . . 3.0800000000000001 110.866 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m -112.21 -74.91 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.264 -0.426 . . . . 1.71 110.277 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -154.59 66.13 5.06 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 121.025 0.441 . . . . 1.3700000000000001 110.594 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.511 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 11.0 Cg_endo -91.71 53.79 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.203 2.602 . . . . 1.5800000000000001 112.972 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.33 63.8 4.09 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.732 -0.746 . . . . 2.0499999999999998 112.045 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 51.73 66.25 1.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.602 0.715 . . . . 2.2999999999999998 110.407 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 49.6 m -144.93 168.45 20.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.328 -0.851 . . . . 1.5700000000000001 110.097 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.86 128.42 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.182 -0.463 . . . . 1.1799999999999999 110.415 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.448 ' HG ' HD11 ' A' ' 48' ' ' LEU . 5.1 mp -123.07 169.18 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 1.25 110.293 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.16 131.64 37.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.448 -0.575 . . . . 1.3500000000000001 109.448 175.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 95' ' ' ILE . 37.9 m-85 -128.96 144.04 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.381 . . . . 0.56000000000000005 110.95 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.694 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 26.9 mt-10 -74.81 128.03 34.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.727 -0.842 . . . . 1.46 108.727 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' A' ' 81' ' ' CYS . 25.8 mt -107.17 120.32 58.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.178 -0.675 . . . . 1.1599999999999999 109.178 172.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -127.07 118.07 23.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.482 -0.781 . . . . 1.8799999999999999 110.51 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.61 ' HA ' HG13 ' A' ' 42' ' ' VAL . 35.8 tp -80.69 113.89 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 1.75 109.902 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.94 -13.41 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.967 -0.293 . . . . 1.78 111.716 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.4 m -155.63 137.84 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.985 -0.376 . . . . 1.53 109.985 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' HB2' HG13 ' A' ' 40' ' ' VAL . 9.0 p90 -160.81 175.0 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.90000000000000002 110.368 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.552 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.6 ptp180 -162.26 147.27 12.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 3.4700000000000002 110.38 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.54 152.14 33.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.779 0.323 . . . . 3.3799999999999999 110.279 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 tt -151.76 127.05 9.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.06 -1.089 . . . . 3.8199999999999998 108.06 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -96.79 167.2 11.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.02 0.438 . . . . 5.3899999999999997 112.022 -173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -69.07 -43.3 74.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.774 -0.648 . . . . 7.75 111.86 -172.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 56.14 89.8 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.948 0.78 . . . . 7.8499999999999996 111.975 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -108.4 127.81 54.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.653 -0.419 . . . . 9.5500000000000007 109.96 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -78.53 93.0 4.72 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.958 -0.564 . . . . 10.23 110.585 -176.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 7.1 p80 -82.38 124.21 29.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 12.85 109.372 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 29.6 m-70 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.687 -1.149 . . . . 13.970000000000001 111.211 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HB3' ' H ' ' A' ' 2' ' ' THR . 65.2 mtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.866 0.365 . . . . 7.8200000000000003 110.573 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 1' ' ' MET . 0.8 OUTLIER -69.57 120.57 15.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 6.2699999999999996 112.11 -178.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.2 p -95.28 12.04 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.286 0.565 . . . . 4.75 110.485 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -120.19 138.36 53.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.665 . . . . 4.4400000000000004 110.27 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -89.96 163.32 15.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.451 -0.341 . . . . 4.9000000000000004 110.512 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.34 2.68 34.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 3.6099999999999999 111.036 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.46 158.16 15.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.377 -0.374 . . . . 4.54 110.99 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -121.16 170.81 9.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.013 -0.54 . . . . 2.71 109.897 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 0.0 OUTLIER -90.86 157.24 17.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 2.4399999999999999 110.814 -175.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.93 115.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.328 -0.619 . . . . 1.3100000000000001 109.328 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -87.92 99.82 12.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.474 -0.33 . . . . 2.1600000000000001 111.259 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 66.1 mt 52.88 75.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 2.04 111.19 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -59.29 147.2 36.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 1.26 110.32 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.38 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 1.3700000000000001 111.084 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.15 29.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 2.3999999999999999 111.084 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.35 -5.39 10.15 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.631 -0.795 . . . . 0.83999999999999997 113.933 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.19 71.02 1.09 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.94 -0.648 . . . . 0.62 114.043 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.2 t -138.11 145.64 28.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.693 -0.484 . . . . 1.1799999999999999 109.693 173.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mm -85.61 110.72 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.294 -0.412 . . . . 1.1799999999999999 110.802 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.51 147.24 40.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.286 -0.415 . . . . 1.96 110.697 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 9' ' ' LYS . 26.4 m -112.98 139.46 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 1.21 110.392 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.403 HD12 ' SG ' ' A' ' 91' ' ' CYS . 7.9 tp -80.03 134.97 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.147 -0.479 . . . . 1.3 110.355 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.43 -71.16 0.72 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.086 0.47 . . . . 1.3999999999999999 110.503 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -105.47 97.54 7.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.291 -0.633 . . . . 2.0600000000000001 109.291 -177.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -75.21 138.82 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.884 0.373 . . . . 3.25 110.855 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.69 135.59 14.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.97 -0.633 . . . . 1.3200000000000001 111.681 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.71 -55.21 37.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 2.77 110.174 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.59 170.27 19.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.39 -0.823 . . . . 2.6400000000000001 109.579 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.83 43.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 1.3 111.369 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.52 -38.0 85.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.949 0.404 . . . . 2.29 111.143 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -94.57 -20.55 19.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.809 -0.632 . . . . 2.6400000000000001 110.509 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 38.8 m-80 -95.3 81.81 3.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.129 -0.487 . . . . 1.49 110.927 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.36 120.56 26.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 1.3700000000000001 111.377 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.4 Cg_endo -76.49 132.75 13.76 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.204 2.603 . . . . 0.84999999999999998 111.4 174.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' OG ' ' A' ' 83' ' ' SER . 34.3 mmtm -148.78 158.94 44.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.667 0.27 . . . . 3.1400000000000001 111.109 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.576 ' HZ2' ' CD ' ' A' ' 70' ' ' GLU . 19.1 tptm -55.75 128.47 35.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.961 -0.563 . . . . 2.9100000000000001 110.465 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.75 -26.59 20.65 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.9 -0.591 . . . . 1.1899999999999999 111.793 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -83.63 140.22 32.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.652 -0.499 . . . . 1.3799999999999999 109.652 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -76.91 101.59 6.01 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.325 -0.62 . . . . 2.2000000000000002 109.325 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.586 HG11 ' HB2' ' A' ' 125' ' ' PHE . 26.3 m -115.49 133.83 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.781 -0.645 . . . . 1.3300000000000001 111.309 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.48 HG23 ' HD3' ' A' ' 66' ' ' LYS . 17.4 m -103.26 106.93 17.57 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.5 -0.555 . . . . 1.23 109.5 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 m -119.34 141.66 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.551 0.691 . . . . 1.6200000000000001 112.582 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.42 148.67 25.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.944 -1.025 . . . . 3.5600000000000001 109.601 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.688 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 2.5 p90 -144.24 140.88 29.51 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.226 0.329 . . . . 0.88 110.596 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -168.04 160.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.377 -0.601 . . . . 1.1899999999999999 109.377 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 171.32 -137.87 4.6 Favored Glycine 0 C--N 1.329 0.15 0 C-N-CA 119.59 -1.29 . . . . 0.37 113.249 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.9 pttp -143.49 171.71 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 1.96 110.497 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.744 HD22 HG13 ' A' ' 110' ' ' ILE . 42.7 tp -95.0 101.93 13.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.155 -0.475 . . . . 1.1200000000000001 110.131 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.1 tp10 -61.68 -35.28 77.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 1.96 110.575 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 t -55.21 -32.08 61.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 1.1100000000000001 112.55 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -123.35 -4.05 8.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.885 0.374 . . . . 1.24 110.96 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.03 26.06 74.59 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.183 -0.532 . . . . 0.78000000000000003 113.189 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.18 140.01 43.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.168 0.509 . . . . 3.2999999999999998 110.616 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.549 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 p -84.59 159.99 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.883 -0.599 . . . . 1.3400000000000001 110.035 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -74.35 131.5 41.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.116 -0.327 . . . . 0.96999999999999997 110.116 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.57 89.9 1.6 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.313 0.577 . . . . 2.1800000000000002 109.535 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -136.95 168.08 20.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.879 -0.6 . . . . 1.6799999999999999 111.099 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -62.58 -29.14 70.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.8600000000000001 111.403 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -92.65 -44.54 8.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.147 0.425 . . . . 2.1200000000000001 112.147 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -32.45 72.79 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 2.1899999999999999 111.978 -169.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -94.2 -14.07 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.838 -0.345 . . . . 3.1899999999999999 111.21 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.452 HD21 HG13 ' A' ' 63' ' ' VAL . 11.3 t30 -100.32 -44.82 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.358 . . . . 1.27 111.467 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.452 HG13 HD21 ' A' ' 62' ' ' ASN . 3.5 m -129.31 98.82 22.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.669 0.747 . . . . 2.6099999999999999 111.794 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.98 128.48 14.96 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.206 1.938 . . . . 2.1299999999999999 111.52 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -95.86 148.29 22.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 1.6299999999999999 110.521 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HD3' HG23 ' A' ' 41' ' ' THR . 2.4 pptp? -133.07 143.66 49.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 2.0099999999999998 109.658 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -128.87 -178.72 4.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.68999999999999995 111.548 -173.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.537 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 18.5 m170 -114.04 149.68 35.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.659 . . . . 2.6600000000000001 110.437 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.697 HD13 ' HA ' ' A' ' 79' ' ' ASP . 22.9 tp -67.37 122.81 18.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 1.5600000000000001 111.787 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.576 ' CD ' ' HZ2' ' A' ' 36' ' ' LYS . 1.7 tt0 42.39 72.5 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.222 1.009 . . . . 2.0800000000000001 112.259 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -119.71 19.09 12.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.709 0.766 . . . . 1.98 110.587 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.5 -18.85 46.87 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.276 -0.874 . . . . 0.78000000000000003 112.835 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.83 -50.96 6.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.407 0.622 . . . . 0.96999999999999997 109.617 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -100.16 132.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.604 -0.726 . . . . 1.25 110.381 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.495 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.04 -74.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.799 0.666 . . . . 1.3500000000000001 112.799 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 75' ' ' ILE . 19.8 mtpp -128.82 -40.81 1.51 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.876 -0.515 . . . . 2.5600000000000001 112.174 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -49.51 52.58 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.824 -0.703 . . . . 0.34000000000000002 112.462 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.406 ' O ' HG21 ' A' ' 82' ' ' VAL . 14.7 m-90 -76.02 -41.09 52.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.626 0.25 . . . . 0.56000000000000005 110.858 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.697 ' HA ' HD13 ' A' ' 69' ' ' LEU . 35.0 t70 -56.02 -53.41 57.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.964 -0.562 . . . . 1.1399999999999999 112.329 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.75 -33.35 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 1.3999999999999999 110.873 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.548 ' HG ' HD11 ' A' ' 120' ' ' ILE . 48.7 t -69.25 -50.0 51.08 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.805 -0.358 . . . . 0.98999999999999999 110.243 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' A' ' 69' ' ' LEU . 89.4 t -63.29 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.496 -0.32 . . . . 1.49 111.338 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.431 ' OG ' ' HD3' ' A' ' 35' ' ' LYS . 23.3 t -71.69 -8.47 54.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.813 0.34 . . . . 1.9399999999999999 111.456 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 t -114.0 23.05 13.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.112 0.482 . . . . 1.8700000000000001 110.389 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.933 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 82.8 mmm -99.45 177.33 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 2.79 111.332 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HB2' ' CB ' ' A' ' 89' ' ' GLU . 97.1 mtt180 -141.08 159.4 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 4.9199999999999999 108.417 173.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 63.9 tttm -66.45 -21.68 66.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.093 0.473 . . . . 2.4300000000000002 111.087 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.77 12.13 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 1.4199999999999999 110.703 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.574 ' CB ' ' HB2' ' A' ' 86' ' ' ARG . 18.2 tt0 -122.64 156.26 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.443 -0.344 . . . . 1.6000000000000001 110.444 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.933 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 75.3 tttt -156.51 134.93 11.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.367 -0.379 . . . . 1.74 110.704 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.403 ' SG ' HD12 ' A' ' 22' ' ' ILE . 64.3 m -139.07 171.66 13.99 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.89 0.7 . . . . 1.3600000000000001 112.89 -173.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.33 125.75 53.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.23 -0.895 . . . . 2.2999999999999998 110.062 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.489 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 13.9 p -117.73 150.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.896 0.379 . . . . 1.46 111.101 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -108.27 115.54 30.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 2.29 110.226 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.86 103.8 13.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.163 -0.681 . . . . 1.2 109.163 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.62 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 22.1 tt0 -86.58 176.12 7.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.047 -0.979 . . . . 1.3700000000000001 109.293 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.406 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 20.6 p -49.93 -48.94 51.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.268 0.47 . . . . 1.22 112.268 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.04 -7.83 56.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.307 . . . . 2.3199999999999998 111.72 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.62 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.4 m-30 -94.68 -9.52 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.57 0.224 . . . . 0.92000000000000004 110.724 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 -171.74 14.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.044 -0.598 . . . . 0.85999999999999999 111.797 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.452 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 22.3 m-85 -88.45 -33.69 17.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 1.52 110.835 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.31 -154.42 33.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.643 -0.789 . . . . 2.2999999999999998 112.642 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.1 -30.28 34.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.984 0.421 . . . . 5.8600000000000003 111.224 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -87.38 11.25 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.45 0.643 . . . . 4.2699999999999996 110.533 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -133.96 -135.07 3.51 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.751 -0.659 . . . . 2.8999999999999999 111.645 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 68.9 m -104.54 120.6 41.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 3.7799999999999998 110.436 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.404 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -110.98 120.8 5.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.768 -0.73 . . . . 1.47 112.093 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.24 -70.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.782 0.325 . . . . 3.0800000000000001 111.257 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.401 ' CB ' HD11 ' A' ' 110' ' ' ILE . 14.4 m -105.41 -74.73 0.64 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.861 -0.336 . . . . 1.71 111.013 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.744 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.0 57.07 3.28 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-O 120.646 0.26 . . . . 1.3700000000000001 111.537 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 55.5 Cg_endo -97.7 59.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.115 2.543 . . . . 1.5800000000000001 112.538 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.6 56.14 4.16 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.729 -0.748 . . . . 2.0499999999999998 112.043 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 67.01 14.14 9.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.322 0.649 . . . . 2.2999999999999998 109.82 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -86.55 159.56 19.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.343 -0.844 . . . . 1.5700000000000001 110.406 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.87 128.07 43.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.017 0.437 . . . . 1.1799999999999999 110.694 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.6 mp -122.36 165.86 15.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.456 . . . . 1.25 110.544 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -116.56 113.1 22.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.409 -0.589 . . . . 1.3500000000000001 109.409 176.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -111.86 124.69 52.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.374 0.607 . . . . 0.56000000000000005 110.89 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.0 tm-20 -83.0 120.54 25.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.886 -1.052 . . . . 1.46 109.172 174.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.548 HD11 ' HG ' ' A' ' 81' ' ' CYS . 48.4 mt -109.34 130.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.223 0.535 . . . . 1.1599999999999999 111.098 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -126.01 121.66 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.347 -0.842 . . . . 1.8799999999999999 110.329 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.474 HD22 ' HG3' ' A' ' 34' ' ' PRO . 27.7 tp -87.03 89.7 8.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.948 -0.76 . . . . 1.75 108.948 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.71 -25.77 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.082 -0.508 . . . . 1.78 111.762 -172.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 m -154.13 142.26 20.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.758 0.313 . . . . 1.53 110.546 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.586 ' HB2' HG11 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -167.43 179.6 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.245 -0.65 . . . . 0.90000000000000002 109.245 175.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -159.64 158.99 32.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.983 0.421 . . . . 3.4700000000000002 110.682 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.21 115.54 28.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 3.3799999999999999 110.492 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -108.59 113.54 26.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.387 -0.37 . . . . 3.8199999999999998 110.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -96.28 145.09 25.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.199 -0.455 . . . . 5.3899999999999997 111.197 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -128.86 -58.23 1.16 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.377 -0.601 . . . . 7.75 109.377 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 69.26 152.73 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.754 0.659 . . . . 7.8499999999999996 110.802 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -116.07 -26.58 7.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.262 0.553 . . . . 9.5500000000000007 109.772 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -66.49 127.56 32.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.445 -0.798 . . . . 10.23 109.495 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -67.35 93.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.199 0.523 . . . . 12.85 110.524 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.252 1.218 0 CA-C-N 115.304 -0.862 . . . . 13.970000000000001 110.381 -177.29 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.275 -0.269 . . . . 7.8200000000000003 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.83 115.16 3.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.485 0.659 . . . . 6.2699999999999996 111.014 174.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.8 p -86.89 -68.04 0.77 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.185 -0.916 . . . . 4.75 109.114 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 47.12 92.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 O-C-N 124.097 0.873 . . . . 4.4400000000000004 112.202 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -52.13 151.31 3.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.26 -0.882 . . . . 4.9000000000000004 111.771 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -81.64 90.98 6.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 3.6099999999999999 111.109 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.94 144.93 26.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.037 0.446 . . . . 4.54 110.807 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.91 142.51 33.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.549 -0.751 . . . . 2.71 109.417 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -82.88 148.63 27.59 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 2.4399999999999999 109.475 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.2 t -101.87 104.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.759 . . . . 1.3100000000000001 108.952 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -91.25 110.37 21.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 2.1600000000000001 110.957 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 87.0 mt 64.38 67.63 0.57 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.082 -0.963 . . . . 2.04 110.574 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -74.45 167.66 21.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.03 -0.532 . . . . 1.26 110.696 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -0.82 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 1.3700000000000001 112.004 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.699 ' OD2' ' HA ' ' A' ' 80' ' ' ILE . 8.4 t70 -79.09 -0.61 32.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.248 0.546 . . . . 2.3999999999999999 110.423 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.16 22.94 2.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.598 -0.811 . . . . 0.83999999999999997 113.69 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 75.68 72.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.091 -0.576 . . . . 0.62 114.524 171.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 80' ' ' ILE . 38.8 t -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.937 -0.394 . . . . 1.1799999999999999 109.937 172.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.7 mm -89.75 112.64 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 1.1799999999999999 110.845 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -136.96 145.97 44.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 1.96 111.382 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -107.95 123.62 48.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 1.21 110.232 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 91' ' ' CYS . 8.2 tp -83.98 130.95 35.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 1.3 110.997 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.578 HD22 ' HG ' ' A' ' 92' ' ' LEU . 2.5 mm? -100.14 -60.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.339 0.59 . . . . 1.3999999999999999 109.733 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 24' ' ' LYS . 32.8 ttpt -122.26 122.71 39.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 2.0600000000000001 109.659 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -82.28 147.48 28.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.295 -0.412 . . . . 3.25 111.38 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.94 144.12 33.19 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.509 -1.036 . . . . 1.3200000000000001 110.509 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.13 -78.14 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.275 0.538 . . . . 2.77 109.62 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.58 164.83 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.218 -0.66 . . . . 2.6400000000000001 109.218 171.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.523 ' HA3' ' CZ ' ' A' ' 86' ' ' ARG . . . 157.24 70.35 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.957 -1.115 . . . . 1.3 113.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -75.36 -30.89 60.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.42 0.629 . . . . 2.29 110.14 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -86.39 -39.0 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.389 -0.823 . . . . 2.6400000000000001 111.419 -174.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.752 ' HB2' HH21 ' A' ' 86' ' ' ARG . 10.6 m120 -93.66 79.54 4.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.186 0.517 . . . . 1.49 111.096 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.09 125.63 21.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.073 -0.967 . . . . 1.3700000000000001 110.338 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HG3' HD22 ' A' ' 122' ' ' LEU . 67.5 Cg_endo -73.57 140.39 29.7 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.908 2.405 . . . . 0.84999999999999998 111.542 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 14.2 mmmm -127.41 147.68 50.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.426 -0.583 . . . . 3.1400000000000001 109.426 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.528 ' HA ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.31 149.14 48.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.774 -0.371 . . . . 2.9100000000000001 111.242 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.89 -17.29 53.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.836 -0.697 . . . . 1.1899999999999999 111.966 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 81.5 m-20 -85.68 175.89 8.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 1.3799999999999999 111.083 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.468 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -97.48 121.57 39.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.534 -0.757 . . . . 2.2000000000000002 109.747 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 HG11 HD23 ' A' ' 69' ' ' LEU . 6.9 m -140.99 166.64 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.767 0.318 . . . . 1.3300000000000001 110.446 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.531 HG21 ' HD3' ' A' ' 66' ' ' LYS . 21.0 m -133.97 116.94 16.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 1.23 110.408 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.681 HG11 ' HA ' ' A' ' 122' ' ' LEU . 34.9 m -134.87 145.25 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.437 -0.347 . . . . 1.6200000000000001 110.687 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -100.84 140.52 35.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.415 -0.587 . . . . 3.5600000000000001 109.415 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 42.6 p90 -125.75 135.47 52.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.88 111.397 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.87 155.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.391 -0.966 . . . . 1.1899999999999999 108.391 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 178.61 -130.03 1.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.744 -1.217 . . . . 0.37 113.27 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.557 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 57.2 pttt -147.06 171.32 15.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 1.96 110.313 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.541 HD21 HG13 ' A' ' 110' ' ' ILE . 61.7 tp -96.73 98.39 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 1.1200000000000001 109.914 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.569 ' HB2' HD13 ' A' ' 117' ' ' LEU . 3.3 tp10 -68.65 -22.41 64.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.248 0.546 . . . . 1.96 110.547 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -25.43 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.389 -0.823 . . . . 1.1100000000000001 111.407 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.599 HG21 ' HD3' ' A' ' 53' ' ' LYS . 7.9 t -132.97 -19.31 2.27 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.986 0.422 . . . . 1.24 111.072 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' C ' ' HD2' ' A' ' 53' ' ' LYS . . . 91.6 34.82 7.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.28 -0.486 . . . . 0.78000000000000003 112.853 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.599 ' HD3' HG21 ' A' ' 51' ' ' THR . 13.7 mptt -116.97 134.93 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.75 0.309 . . . . 3.2999999999999998 110.989 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.557 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.1 p -79.31 156.39 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.935 -0.575 . . . . 1.3400000000000001 110.838 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -74.25 131.15 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.96999999999999997 111.04 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.01 89.13 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.833 -0.621 . . . . 2.1800000000000002 109.882 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.2 m -124.99 147.03 49.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.533 -0.758 . . . . 1.6799999999999999 110.094 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 m -59.24 -20.4 53.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.987 -0.551 . . . . 1.8600000000000001 111.127 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -92.3 -50.85 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.171 -0.468 . . . . 2.1200000000000001 111.901 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -32.4 72.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.936 0.347 . . . . 2.1899999999999999 111.936 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -83.4 1.83 39.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.346 0.593 . . . . 3.1899999999999999 110.26 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.448 HD21 HG11 ' A' ' 63' ' ' VAL . 10.3 t30 -109.23 -48.64 3.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.37 -0.832 . . . . 1.27 110.448 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.448 HG11 HD21 ' A' ' 62' ' ' ASN . 7.6 p -152.13 126.15 4.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.036 0.446 . . . . 2.6099999999999999 111.085 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.53 162.06 19.4 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.78 2.32 . . . . 2.1299999999999999 112.327 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -104.09 154.83 19.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.752 -0.462 . . . . 1.6299999999999999 109.752 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HD3' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.15 136.12 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 2.0099999999999998 110.692 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -114.44 -174.23 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.553 -0.294 . . . . 0.68999999999999995 110.518 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.446 ' HB2' HE21 ' A' ' 71' ' ' GLN . 80.4 m-70 -126.45 153.05 45.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.269 -0.271 . . . . 2.6600000000000001 110.269 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -51.34 151.93 2.74 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.457 0.473 . . . . 1.5600000000000001 111.659 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -22.2 98.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 113.318 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -129.8 8.07 5.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.508 -1.224 . . . . 1.98 108.98 176.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.13 -10.45 43.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.78000000000000003 113.409 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -85.23 -46.56 10.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.804 0.802 . . . . 0.96999999999999997 109.248 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.55 134.06 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.031 -0.531 . . . . 1.25 110.575 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.588 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.6 -69.83 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.461 0.541 . . . . 1.3500000000000001 112.461 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.588 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -140.96 -45.66 0.39 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.563 0.579 . . . . 2.5600000000000001 112.563 -173.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 -53.12 34.79 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.944 -0.646 . . . . 0.34000000000000002 113.005 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 82' ' ' VAL . 18.3 m-90 -76.69 -31.01 56.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 0.56000000000000005 110.75 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -57.92 -49.14 77.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.46 -0.791 . . . . 1.1399999999999999 111.759 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.699 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . 1.6 mp -59.69 -31.32 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.124 0.487 . . . . 1.3999999999999999 111.051 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.777 ' HB2' HG21 ' A' ' 93' ' ' VAL . 14.9 t -77.05 -58.05 3.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.334 -0.546 . . . . 0.98999999999999999 110.713 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.976 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 15.5 m -62.13 -33.54 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.791 0.664 . . . . 1.49 112.791 -170.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t -92.12 5.66 49.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.079 0.466 . . . . 1.9399999999999999 110.974 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 32.0 t -137.73 30.09 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.228 0.537 . . . . 1.8700000000000001 110.083 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.976 ' HE3' ' HA ' ' A' ' 82' ' ' VAL . 45.3 mtm -106.59 -172.12 2.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 2.79 110.373 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.752 HH21 ' HB2' ' A' ' 32' ' ' ASN . 14.5 mtp-105 -138.73 170.74 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.515 . . . . 4.9199999999999999 110.212 171.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -64.12 -20.57 66.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.282 -0.417 . . . . 2.4300000000000002 111.621 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -127.05 16.57 7.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.36 -0.382 . . . . 1.4199999999999999 111.106 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 2.1 tm-20 -110.38 153.72 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -158.86 123.33 4.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.691 -0.231 . . . . 1.74 110.551 -173.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 1.6 p -136.53 159.05 42.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.437 -0.347 . . . . 1.3600000000000001 111.421 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.578 ' HG ' HD22 ' A' ' 23' ' ' LEU . 97.9 mt -105.2 127.17 52.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.12 -0.491 . . . . 2.2999999999999998 110.852 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.777 HG21 ' HB2' ' A' ' 81' ' ' CYS . 39.1 t -105.74 151.08 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.968 -0.56 . . . . 1.46 111.015 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.36 112.17 25.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.445 -0.576 . . . . 2.29 109.445 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.448 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.4 mp -90.3 105.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 1.2 110.43 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 97' ' ' SER . 34.0 tt0 -82.29 166.09 19.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 1.3700000000000001 109.12 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 3.6 p -52.99 -42.94 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.565 0.58 . . . . 1.22 112.565 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -76.99 -7.91 56.46 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.882 -0.327 . . . . 2.3199999999999998 111.5 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -89.03 -1.48 58.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.017 0.437 . . . . 0.92000000000000004 110.196 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.54 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -146.3 -165.42 11.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.681 -0.69 . . . . 0.85999999999999999 111.411 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -87.77 80.51 7.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.304 0.552 . . . . 1.52 110.336 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -91.53 -29.46 12.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 2.2999999999999998 112.427 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.64 -56.9 5.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.032 0.444 . . . . 5.8600000000000003 110.044 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.92 -40.36 79.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.69 -0.686 . . . . 4.2699999999999996 110.149 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 82.3 1.65 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.876 -0.678 . . . . 2.8999999999999999 112.786 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.2 t -93.66 118.81 31.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.406 -0.59 . . . . 3.7799999999999998 109.406 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.548 ' HA2' ' HG3' ' A' ' 111' ' ' PRO . . . -120.62 121.87 5.02 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.35 -0.928 . . . . 1.47 113.506 -175.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -111.51 -67.68 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.786 0.327 . . . . 3.0800000000000001 110.182 171.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 m -108.41 -74.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.921 -0.312 . . . . 1.71 111.241 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.541 HG13 HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.04 81.82 10.33 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 121.15 0.5 . . . . 1.3700000000000001 111.432 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.548 ' HG3' ' HA2' ' A' ' 107' ' ' GLY . 64.2 Cg_endo -102.7 -149.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.303 3.335 . . . . 1.5800000000000001 111.891 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.31 73.31 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.838 -0.696 . . . . 2.0499999999999998 112.288 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.534 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 15.6 m120 56.73 23.61 8.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.118 0.485 . . . . 2.2999999999999998 111.188 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 m -114.0 151.59 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.96 -0.564 . . . . 1.5700000000000001 109.594 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.13 132.63 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.599 . . . . 1.1799999999999999 111.295 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -125.02 165.29 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 1.25 109.999 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -124.83 124.74 42.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.178 -0.675 . . . . 1.3500000000000001 109.178 173.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.67 143.24 47.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.74 -0.209 . . . . 0.56000000000000005 110.553 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 38.5 mt-10 -62.63 136.49 57.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.738 -0.467 . . . . 1.46 109.738 168.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.541 ' HB ' ' HG ' ' A' ' 81' ' ' CYS . 22.3 mt -128.09 116.85 44.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.229 -1.026 . . . . 1.1599999999999999 108.229 169.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -135.17 111.47 9.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.692 -0.685 . . . . 1.8799999999999999 110.535 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.681 ' HA ' HG11 ' A' ' 42' ' ' VAL . 23.0 tp -81.47 100.09 9.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.361 -0.381 . . . . 1.75 110.788 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -104.81 -9.45 18.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.868 0.366 . . . . 1.78 111.167 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.506 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 67.5 m -155.28 139.52 16.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 1.53 110.524 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' HB3' HD13 ' A' ' 122' ' ' LEU . 7.8 p90 -165.74 150.29 8.44 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.29 0.369 . . . . 0.90000000000000002 110.222 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HE ' ' HB3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -146.24 127.33 14.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.943 0.401 . . . . 3.4700000000000002 110.922 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.24 122.91 29.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.511 -0.768 . . . . 3.3799999999999999 111.178 -176.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 50.7 tp -143.17 -103.2 0.13 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.691 -0.231 . . . . 3.8199999999999998 111.414 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 7.6 mt-10 171.57 -178.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.484 1.114 . . . . 5.3899999999999997 108.3 -172.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -95.38 -54.81 3.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.91 -0.404 . . . . 7.75 109.91 171.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -177.93 -29.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.248 -0.433 . . . . 7.8499999999999996 110.956 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.2 t60 46.18 79.56 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.908 0.755 . . . . 9.5500000000000007 111.685 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -176.76 94.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.752 -1.203 . . . . 10.23 107.752 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.53 -31.97 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 12.85 111.902 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.4 t60 . . . . . 0 C--O 1.243 0.719 0 CA-C-O 118.284 -0.865 . . . . 13.970000000000001 109.226 175.315 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttm . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.803 0.335 . . . . 7.8200000000000003 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -145.88 -30.67 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.426 -0.352 . . . . 6.2699999999999996 110.992 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.2 m 64.28 97.66 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.914 0.388 . . . . 4.75 111.051 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.47 103.57 2.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.772 -0.455 . . . . 4.4400000000000004 109.772 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.27 131.34 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.492 -0.777 . . . . 4.9000000000000004 111.087 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -81.39 99.83 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.422 -0.584 . . . . 3.6099999999999999 109.422 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.87 137.01 34.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.659 -0.7 . . . . 4.54 111.158 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -81.63 151.61 27.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.675 -0.693 . . . . 2.71 109.145 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.58 145.84 25.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.79 0.329 . . . . 2.4399999999999999 110.274 -177.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.504 HG12 ' HB ' ' A' ' 13' ' ' THR . 21.8 t -101.97 103.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.965 -1.124 . . . . 1.3100000000000001 107.965 170.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HG2' HG21 ' A' ' 19' ' ' ILE . 45.9 mt-10 -102.47 120.84 41.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.714 . . . . 2.1600000000000001 110.622 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.9 tp 65.54 50.93 1.58 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.241 -0.89 . . . . 2.04 109.436 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.504 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.9 t -62.97 159.46 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 1.26 111.617 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 2.11 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 1.3700000000000001 111.436 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.595 ' O ' HG13 ' A' ' 80' ' ' ILE . 40.3 m-20 -83.61 7.79 16.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.172 -0.467 . . . . 2.3999999999999999 111.367 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.36 22.6 2.29 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.394 -0.908 . . . . 0.83999999999999997 113.555 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.89 62.7 4.32 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.293 -0.48 . . . . 0.62 114.083 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 80' ' ' ILE . 39.4 t -137.62 152.77 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.081 0.44 . . . . 1.1799999999999999 110.224 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 11' ' ' GLU . 18.1 mm -85.36 109.7 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.474 -0.565 . . . . 1.1799999999999999 109.474 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -118.99 130.45 55.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 1.96 110.65 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 m -109.94 117.69 34.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.097 -0.502 . . . . 1.21 110.703 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.492 HD11 ' SG ' ' A' ' 91' ' ' CYS . 6.2 tp -74.77 131.71 34.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 1.3 111.356 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 2.6 mm? -120.76 -81.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 1.3999999999999999 111.362 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -89.44 134.3 34.15 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.928 0.394 . . . . 2.0600000000000001 110.309 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 41.3 mtmt -111.34 113.18 25.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.779 -0.646 . . . . 3.25 110.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.509 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -73.71 -151.74 2.08 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.219 -0.515 . . . . 1.3200000000000001 111.89 174.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.47 -97.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.104 -0.645 . . . . 2.77 111.725 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.72 126.45 36.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.46 0.647 . . . . 2.6400000000000001 110.934 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.51 47.79 0.86 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.582 -0.818 . . . . 1.3 112.611 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.15 -42.11 99.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 2.29 109.945 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.25 28.2 8.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.977 -1.01 . . . . 2.6400000000000001 109.4 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.79 76.87 1.63 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.49 110.89 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.485 HG21 ' HD3' ' A' ' 35' ' ' LYS . 30.8 mm -141.94 116.28 6.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 123.265 0.353 . . . . 1.3700000000000001 111.274 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 28.1 Cg_endo -63.41 138.69 67.03 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.058 2.505 . . . . 0.84999999999999998 111.065 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HD3' HG21 ' A' ' 33' ' ' ILE . 6.0 mmmm -126.54 155.07 42.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.106 0.479 . . . . 3.1400000000000001 111.713 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -70.38 117.54 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.17 -0.923 . . . . 2.9100000000000001 110.291 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.81 -26.88 22.82 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.99 -0.624 . . . . 1.1899999999999999 111.923 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.69 154.19 42.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 1.3799999999999999 110.179 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 40.8 mt-10 -76.99 99.9 5.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.113 0.482 . . . . 2.2000000000000002 110.822 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.3 m -118.64 143.61 29.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.335 -0.617 . . . . 1.3300000000000001 109.335 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.7 m -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.267 -0.642 . . . . 1.23 109.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.38 139.35 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.334 0.587 . . . . 1.6200000000000001 111.839 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -104.39 134.88 46.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 3.5600000000000001 110.39 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.484 ' HH ' ' HG3' ' A' ' 108' ' ' GLU . 14.4 p90 -123.87 136.82 54.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.88 110.464 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.45 153.23 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.488 -0.93 . . . . 1.1899999999999999 108.488 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.93 -124.44 0.91 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.775 -1.202 . . . . 0.37 113.231 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.7 pttp -157.61 170.12 23.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 1.96 111.0 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 69.8 tp -97.26 103.18 15.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.506 -0.77 . . . . 1.1200000000000001 110.145 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 117' ' ' LEU . 6.5 tp10 -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.873 0.368 . . . . 1.96 110.151 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' A' ' 115' ' ' VAL . 8.3 t -55.4 -28.92 57.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 1.1100000000000001 112.089 -174.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 t -140.26 14.55 2.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.285 0.564 . . . . 1.24 110.486 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.9 44.33 96.13 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.336 -0.847 . . . . 0.78000000000000003 113.065 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 12.2 mmmt -105.98 126.03 51.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.278 -0.267 . . . . 3.2999999999999998 110.278 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.1 p -83.99 159.48 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.509 -0.552 . . . . 1.3400000000000001 109.509 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -75.04 102.94 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 0.96999999999999997 110.984 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -125.58 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.604 0.716 . . . . 2.1800000000000002 109.835 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.8 m -126.11 169.22 13.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.959 -0.564 . . . . 1.6799999999999999 110.536 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -71.44 -26.31 62.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.088 0.47 . . . . 1.8600000000000001 110.818 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.2 -44.77 7.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.923 -0.58 . . . . 2.1200000000000001 112.371 -170.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -44.82 80.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.989 0.366 . . . . 2.1899999999999999 111.989 -169.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -77.1 -9.17 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.423 . . . . 3.1899999999999999 110.938 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -96.13 -61.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.018 -0.537 . . . . 1.27 109.978 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.23 109.77 7.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.446 0.641 . . . . 2.6099999999999999 110.474 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.07 158.18 38.08 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.58 2.187 . . . . 2.1299999999999999 112.543 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.56 154.07 19.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 1.6299999999999999 109.775 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -129.91 159.54 36.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 2.0099999999999998 109.999 178.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.69 173.35 11.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.68999999999999995 111.066 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -116.01 140.17 49.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.408 -0.815 . . . . 2.6600000000000001 109.609 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD22 HG21 ' A' ' 82' ' ' VAL . 26.4 tp -69.1 131.91 45.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.232 -0.284 . . . . 1.5600000000000001 110.232 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.56 79.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.92 0.867 . . . . 2.0800000000000001 109.232 -169.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.508 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 28.4 tt0 -131.64 -3.6 3.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.341 -1.3 . . . . 1.98 110.211 -174.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.6 -18.53 24.48 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.998 -0.62 . . . . 0.78000000000000003 112.353 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 2.1 mm-40 -93.64 -11.39 31.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.96999999999999997 109.954 -177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.17 124.48 64.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 1.25 109.702 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.458 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -97.1 -61.45 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 1.3500000000000001 112.925 -176.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 mmpt? -138.11 -48.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 2.5600000000000001 111.881 -173.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.08 -50.72 44.29 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.037 -0.601 . . . . 0.34000000000000002 113.12 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.471 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.12 -41.16 59.06 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.807 -0.231 . . . . 0.56000000000000005 110.433 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.63 -51.57 54.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.607 -0.724 . . . . 1.1399999999999999 112.041 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.7 mp -63.04 -42.97 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 1.3999999999999999 111.52 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.534 ' HB3' HD11 ' A' ' 120' ' ' ILE . 49.3 t -75.32 -42.34 54.75 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.848 0.314 . . . . 0.98999999999999999 111.848 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 69' ' ' LEU . 35.4 m -69.15 -34.41 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.779 0.288 . . . . 1.49 111.779 -175.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 p -72.03 -16.44 62.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.099 0.476 . . . . 1.9399999999999999 110.814 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.7 m -97.57 8.26 44.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.981 -0.554 . . . . 1.8700000000000001 110.928 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.715 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 20.1 mmt -93.94 -173.65 3.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 2.79 111.495 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 33.6 mtp-105 -143.2 -171.27 3.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.349 -0.841 . . . . 4.9199999999999999 109.002 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.42 -24.63 67.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.299 0.374 . . . . 2.4300000000000002 111.992 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -135.39 15.28 3.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 1.4199999999999999 111.309 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -79.87 159.94 26.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.889 0.376 . . . . 1.6000000000000001 110.683 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -158.36 132.45 7.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.089 -0.505 . . . . 1.74 110.354 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 99.9 m -150.7 170.93 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 1.3600000000000001 110.816 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.34 124.95 52.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.54 . . . . 2.2999999999999998 110.237 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 95' ' ' ILE . 6.3 p -100.76 146.22 9.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.15 -0.477 . . . . 1.46 110.264 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 12.3 mmt180 -98.63 112.06 24.23 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.177 -0.675 . . . . 2.29 109.177 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 93' ' ' VAL . 4.1 mp -98.04 103.87 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.131 0.491 . . . . 1.2 110.447 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.56 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 27.6 tt0 -86.49 170.73 11.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.336 -0.987 . . . . 1.3700000000000001 108.336 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.472 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.9 p -51.69 -38.32 54.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.826 0.306 . . . . 1.22 111.826 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -77.71 -8.72 58.35 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.042 0.386 . . . . 2.3199999999999998 112.042 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.56 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 20.6 m-85 -102.62 -16.36 16.09 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.752 0.31 . . . . 0.92000000000000004 110.607 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.36 -163.01 12.45 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.252 -0.739 . . . . 0.85999999999999999 111.252 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -99.07 90.86 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.52 110.992 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.28 -20.24 10.59 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.65 -0.786 . . . . 2.2999999999999998 111.559 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.88 -47.46 18.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.286 0.565 . . . . 5.8600000000000003 110.901 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -87.24 -17.81 31.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 4.2699999999999996 111.355 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.15 -11.68 68.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.643 -0.789 . . . . 2.8999999999999999 113.232 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.82 97.43 1.39 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.439 0.637 . . . . 3.7799999999999998 111.145 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.536 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -130.3 149.07 18.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.917 -0.659 . . . . 1.47 111.684 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.484 ' HG3' ' HH ' ' A' ' 44' ' ' TYR . 11.1 mm-40 -78.69 -69.39 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.872 0.323 . . . . 3.0800000000000001 111.872 -175.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 m -89.41 -74.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 1.71 111.426 -175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.45 96.75 4.13 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.059 0.457 . . . . 1.3700000000000001 111.45 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 62.1 Cg_endo -91.5 -164.1 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.833 2.355 . . . . 1.5800000000000001 111.888 173.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 121.7 50.26 0.25 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.382 -0.913 . . . . 2.0499999999999998 113.285 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.7 m120 62.8 17.21 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.068 0.461 . . . . 2.2999999999999998 111.336 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.3 p -94.83 175.68 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.833 -0.621 . . . . 1.5700000000000001 111.339 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.447 ' H ' ' HB2' ' A' ' 50' ' ' SER . 6.3 p -114.7 127.49 72.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 116.136 -0.483 . . . . 1.1799999999999999 110.203 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.9 mp -120.97 169.7 10.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.007 -0.542 . . . . 1.25 111.054 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -128.95 126.28 39.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.084 -0.71 . . . . 1.3500000000000001 109.084 175.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -118.8 123.96 46.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.075 0.464 . . . . 0.56000000000000005 111.151 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.86 119.44 16.04 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.186 -1.042 . . . . 1.46 108.186 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 81' ' ' CYS . 42.2 mt -106.41 116.14 49.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 1.1599999999999999 109.5 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -126.94 119.3 26.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.779 -1.1 . . . . 1.8799999999999999 109.466 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 tt -90.88 117.14 29.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.804 -0.635 . . . . 1.75 109.731 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.39 -23.81 15.02 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.019 -0.272 . . . . 1.78 111.668 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -164.05 153.45 14.11 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.004 0.431 . . . . 1.53 110.564 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.573 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -161.83 178.72 8.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.652 -0.704 . . . . 0.90000000000000002 109.618 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HD3' ' HB2' ' A' ' 39' ' ' GLU . 14.0 ptm180 -150.93 137.9 19.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 3.4700000000000002 110.053 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -100.22 152.83 19.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 3.3799999999999999 110.556 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 tt -159.14 116.85 2.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.711 -0.848 . . . . 3.8199999999999998 108.711 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.01 130.84 36.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.448 . . . . 5.3899999999999997 109.855 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 63.8 t60 -114.42 166.3 11.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.848 -0.614 . . . . 7.75 110.041 -172.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 130' ' ' HIS . 46.3 m80 74.99 -170.96 0.1 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.072 0.549 . . . . 7.8499999999999996 111.238 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -95.42 155.87 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 9.5500000000000007 109.499 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 82.45 4.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.773 -0.371 . . . . 10.23 110.899 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 72.97 118.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.26 -0.882 . . . . 12.85 112.055 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.183 -0.913 . . . . 13.970000000000001 109.811 173.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.802 0.334 . . . . 7.8200000000000003 110.772 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.5 m -81.34 -34.88 31.52 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.363 -0.606 . . . . 6.2699999999999996 109.363 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m 61.42 26.47 16.24 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.261 -0.881 . . . . 4.75 110.212 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 56.8 -160.11 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.291 -0.868 . . . . 4.4400000000000004 110.415 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -114.81 126.51 54.91 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.763 0.316 . . . . 4.9000000000000004 111.44 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.55 79.79 9.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.155 -1.054 . . . . 3.6099999999999999 108.155 168.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.26 140.91 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.36 -0.836 . . . . 4.54 111.3 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.86 144.12 32.23 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.876 -0.787 . . . . 2.71 108.876 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.15 139.07 35.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.219 -0.66 . . . . 2.4399999999999999 109.219 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.624 HG13 ' HB ' ' A' ' 13' ' ' THR . 32.9 t -100.99 104.43 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.528 -0.545 . . . . 1.3100000000000001 109.528 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -102.64 134.91 45.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.939 -0.573 . . . . 2.1600000000000001 111.566 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.83 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 81.8 mt 52.25 51.89 15.38 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.511 -0.768 . . . . 2.04 111.332 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.624 ' HB ' HG13 ' A' ' 10' ' ' VAL . 15.4 t -70.68 168.36 16.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.682 -0.69 . . . . 1.26 110.521 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.35 -12.56 61.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.837 0.68 . . . . 1.3700000000000001 112.837 -170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' ILE . 3.3 t70 -89.57 14.02 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.717 -0.393 . . . . 2.3999999999999999 111.638 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.44 29.93 1.04 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.589 -0.815 . . . . 0.83999999999999997 114.119 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.83 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 60.01 33.29 78.46 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.881 1.112 . . . . 0.62 115.881 166.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.529 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 30.6 t -104.06 142.48 17.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 117.886 0.843 . . . . 1.1799999999999999 110.727 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 2.3 mm -88.57 116.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.86 -0.609 . . . . 1.1799999999999999 110.013 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HE2' ' HB3' ' A' ' 84' ' ' SER . 21.4 pttp -138.75 136.02 35.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 1.96 111.021 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 m -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.163 -0.926 . . . . 1.21 109.923 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tp -88.7 127.62 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.087 0.47 . . . . 1.3 110.811 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -116.26 -52.13 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.427 0.632 . . . . 1.3999999999999999 110.499 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' HE2' ' CB ' ' A' ' 90' ' ' LYS . 29.6 ttpt -119.07 121.91 40.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.63 -0.714 . . . . 2.0600000000000001 110.047 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -99.98 126.19 46.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.392 -0.367 . . . . 3.25 111.14 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 155.64 32.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.972 -0.633 . . . . 1.3200000000000001 111.743 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.4 -81.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.646 0.26 . . . . 2.77 111.171 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.11 150.08 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 2.6400000000000001 110.426 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -156.68 51.05 0.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.308 -0.948 . . . . 1.3 112.854 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.3 -42.23 55.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.584 0.707 . . . . 2.29 109.299 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 -16.59 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 2.6400000000000001 110.562 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.464 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 19.3 m-80 -85.48 76.04 10.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.232 -0.44 . . . . 1.49 110.537 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 33.3 mm -140.87 119.7 8.27 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.857 -0.61 . . . . 1.3700000000000001 109.863 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 1.5 Cg_endo -82.15 111.05 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.84999999999999998 111.638 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -118.06 152.24 35.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.472 -0.566 . . . . 3.1400000000000001 109.472 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 148.97 46.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.977 0.418 . . . . 2.9100000000000001 110.278 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.91 -9.78 65.94 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.887 -0.885 . . . . 1.1899999999999999 110.887 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 95.5 m-20 -107.49 159.42 16.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.856 -0.672 . . . . 1.3799999999999999 109.511 174.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 102.32 14.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.497 -0.557 . . . . 2.2000000000000002 109.497 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -116.19 145.03 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.693 -0.685 . . . . 1.3300000000000001 109.579 175.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 108.63 13.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.047 -0.524 . . . . 1.23 110.263 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 122' ' ' LEU . 18.5 m -131.36 153.3 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.527 -0.306 . . . . 1.6200000000000001 111.544 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.516 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 36.7 m170 -105.24 162.51 13.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 3.5600000000000001 110.337 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 12.7 p90 -145.58 129.44 17.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.88 110.028 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -167.02 153.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.85 -0.426 . . . . 1.1899999999999999 109.85 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 55' ' ' PHE . . . 176.3 -111.57 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.717 -1.23 . . . . 0.37 112.968 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' HG3' HD11 ' A' ' 117' ' ' LEU . 51.7 pttt -157.23 166.95 31.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.987 0.423 . . . . 1.96 110.882 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.2 tp -92.56 102.07 14.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.963 -0.562 . . . . 1.1200000000000001 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 3.6 tp10 -58.71 -30.47 67.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.616 -0.72 . . . . 1.96 111.039 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -55.88 -32.43 63.69 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.563 -0.744 . . . . 1.1100000000000001 112.264 -173.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 53' ' ' LYS . 13.6 t -140.21 5.52 2.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.445 -0.502 . . . . 1.24 111.983 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.83 46.63 59.62 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 121.098 -0.572 . . . . 0.78000000000000003 112.394 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.45 ' HB2' HG23 ' A' ' 51' ' ' THR . 2.0 tmtp? -115.14 126.36 54.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.652 -0.499 . . . . 3.2999999999999998 109.652 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.07 153.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.454 -0.339 . . . . 1.3400000000000001 110.196 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 0.8 OUTLIER -74.45 106.4 6.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.403 . . . . 0.96999999999999997 110.722 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -121.7 103.57 8.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.87 0.843 . . . . 2.1800000000000002 110.324 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 34.8 m -136.81 150.53 48.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.119 -0.491 . . . . 1.6799999999999999 110.004 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.4 m -62.6 -36.09 81.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 1.8600000000000001 111.174 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.21 -33.9 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.348 -0.387 . . . . 2.1200000000000001 110.887 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 6.9 t70 -56.99 -52.48 65.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.934 0.397 . . . . 2.1899999999999999 111.993 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -77.25 2.6 15.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.368 -0.378 . . . . 3.1899999999999999 111.44 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -111.5 -52.85 2.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.42 -0.355 . . . . 1.27 110.845 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.7 p -133.04 117.18 14.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.197 0.522 . . . . 2.6099999999999999 111.167 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.4 Cg_exo -77.03 146.08 25.37 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.041 2.494 . . . . 2.1299999999999999 111.459 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -103.82 151.09 23.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.464 -0.335 . . . . 1.6299999999999999 110.251 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 1.7 pptp? -128.93 154.19 46.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.529 -0.305 . . . . 2.0099999999999998 110.911 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -137.21 174.49 10.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.524 -0.307 . . . . 0.68999999999999995 111.156 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.84 150.21 33.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.076 -0.712 . . . . 2.6600000000000001 109.076 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.749 HD12 HG22 ' A' ' 82' ' ' VAL . 16.8 tp -70.6 124.66 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.475 0.546 . . . . 1.5600000000000001 112.475 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' N ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER 42.4 63.29 1.44 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.388 -1.278 . . . . 2.0800000000000001 112.335 173.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -108.55 9.28 27.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.71 -1.132 . . . . 1.98 108.751 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.6 -16.38 48.06 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.971 -1.013 . . . . 0.78000000000000003 113.084 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -85.48 -39.43 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.457 0.629 . . . . 0.96999999999999997 110.501 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 m -97.9 135.41 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.389 -0.597 . . . . 1.25 109.389 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.762 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -94.55 -76.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.382 0.512 . . . . 1.3500000000000001 112.382 -172.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.762 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.25 -37.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.873 -0.517 . . . . 2.5600000000000001 112.315 -175.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.61 -54.29 31.17 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.449 -0.881 . . . . 0.34000000000000002 113.153 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.618 ' O ' HG23 ' A' ' 82' ' ' VAL . 23.3 m-90 -76.67 -31.52 57.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.736 -0.273 . . . . 0.56000000000000005 110.708 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -51.49 -53.35 38.32 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.019 0.824 . . . . 1.1399999999999999 111.843 -170.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.529 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 2.0 mp -68.77 -29.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.096 0.474 . . . . 1.3999999999999999 111.275 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.617 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 19.9 t -72.55 -38.23 68.05 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.603 -0.439 . . . . 0.98999999999999999 110.514 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG22 HD12 ' A' ' 69' ' ' LEU . 2.1 m -83.86 -33.95 9.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.791 -0.364 . . . . 1.49 111.498 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -65.66 -25.57 67.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.157 0.503 . . . . 1.9399999999999999 110.63 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.539 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 22.0 t -121.92 44.97 2.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.777 -0.647 . . . . 1.8700000000000001 110.489 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 82' ' ' VAL . 19.8 ptm -124.68 -175.89 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.989 -0.551 . . . . 2.79 109.688 173.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 64.3 mtt85 -142.95 162.86 34.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.123 -0.695 . . . . 4.9199999999999999 109.123 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.423 ' HG3' HD23 ' A' ' 122' ' ' LEU . 85.6 tttt -61.31 -43.06 99.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 2.4300000000000002 111.364 -175.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -97.29 24.7 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 1.4199999999999999 110.709 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 37.5 tt0 -114.87 163.68 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.037 -0.727 . . . . 1.6000000000000001 109.037 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.5 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 76.1 tttt -157.54 127.56 6.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.926 0.393 . . . . 1.74 110.439 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.1 p -134.7 148.11 50.24 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.785 -0.643 . . . . 1.3600000000000001 111.01 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.73 122.02 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 2.2999999999999998 109.357 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.617 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.4 p -100.65 143.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.159 0.504 . . . . 1.46 111.427 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.517 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 18.3 mmt180 -106.2 112.15 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.438 -0.801 . . . . 2.29 109.441 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 3.9 mp -93.96 100.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.828 -0.349 . . . . 1.2 110.111 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 9.6 tp10 -70.07 156.72 38.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 1.3700000000000001 109.183 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 p -50.12 -44.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.06 0.544 . . . . 1.22 111.761 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.1 ptp -74.76 -8.09 55.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 2.3199999999999998 111.721 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.476 ' CD2' ' HB3' ' A' ' 96' ' ' GLU . 21.8 m-30 -100.05 8.62 43.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.626 0.25 . . . . 0.92000000000000004 110.426 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -139.09 -176.28 14.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.21 -0.519 . . . . 0.85999999999999999 112.201 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -70.3 -70.03 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.14 0.495 . . . . 1.52 111.077 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.18 -170.1 21.93 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.731 -0.747 . . . . 2.2999999999999998 111.551 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.849 ' HB2' ' HA2' ' A' ' 112' ' ' GLY . 24.8 t70 -81.45 -25.23 36.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 5.8600000000000003 111.028 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.5 8.86 25.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.48 0.657 . . . . 4.2699999999999996 110.914 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -117.46 -116.85 2.83 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.461 -0.876 . . . . 2.8999999999999999 112.023 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.84 126.48 52.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.514 -0.55 . . . . 3.7799999999999998 109.514 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.607 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -151.21 105.41 0.29 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.511 -0.852 . . . . 1.47 112.41 -176.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -95.14 -61.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.267 0.469 . . . . 3.0800000000000001 112.267 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 m -78.5 -76.52 0.19 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.76 0.281 . . . . 1.71 111.76 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 89.99 3.36 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-O 121.146 0.498 . . . . 1.3700000000000001 110.296 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.607 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 72.4 Cg_endo -96.84 -155.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.488 2.792 . . . . 1.5800000000000001 111.663 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.849 ' HA2' ' HB2' ' A' ' 103' ' ' ASP . . . 127.83 31.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.461 -0.876 . . . . 2.0499999999999998 112.85 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.01 41.81 27.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.314 0.578 . . . . 2.2999999999999998 110.553 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 p -122.13 177.05 5.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.5 -0.773 . . . . 1.5700000000000001 110.38 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 5.3 p -93.94 125.47 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.256 0.55 . . . . 1.1799999999999999 110.889 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.83 162.1 15.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 1.25 110.103 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.582 HD11 ' HG3' ' A' ' 47' ' ' LYS . 36.8 mt -119.04 117.47 28.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 1.3500000000000001 110.228 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -125.81 138.0 53.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.259 0.552 . . . . 0.56000000000000005 112.321 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 50.5 mt-10 -79.16 132.77 36.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.226 -0.897 . . . . 1.46 108.981 167.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.523 HD11 HG11 ' A' ' 82' ' ' VAL . 19.5 mt -113.17 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.516 0.674 . . . . 1.1599999999999999 110.252 171.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 90' ' ' LYS . 5.1 tp10 -118.75 120.1 36.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 1.8799999999999999 109.597 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.749 ' HA ' HG13 ' A' ' 42' ' ' VAL . 4.9 tt -89.87 102.4 15.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.526 -0.546 . . . . 1.75 109.526 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.562 HD22 ' H ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -88.89 -35.63 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.577 -0.283 . . . . 1.78 111.486 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 t -152.26 144.79 24.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.598 -0.274 . . . . 1.53 110.755 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.568 ' HB2' HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -164.97 171.75 13.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.90000000000000002 109.799 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 14.0 ptp180 -150.07 124.6 9.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.579 -0.282 . . . . 3.4700000000000002 110.325 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -95.58 139.49 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.871 -0.418 . . . . 3.3799999999999999 109.871 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.877 ' HG ' ' H ' ' A' ' 129' ' ' GLU . 15.9 tp 66.33 -162.7 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.82 0.7 . . . . 3.8199999999999998 110.947 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.877 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 15.3 tp10 62.8 79.75 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.617 0.722 . . . . 5.3899999999999997 111.47 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -116.89 116.1 26.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.133 -0.692 . . . . 7.75 109.133 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -89.39 29.43 1.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.486 0.55 . . . . 7.8499999999999996 112.486 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -132.27 -67.54 0.65 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.58 -0.282 . . . . 9.5500000000000007 110.506 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 70.23 -72.29 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.784 0.677 . . . . 10.23 110.471 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.3 t60 52.55 79.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.327 0.651 . . . . 12.85 111.13 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.903 -1.046 . . . . 13.970000000000001 110.189 -177.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.167 0.508 . . . . 7.8200000000000003 110.577 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 p -114.36 120.22 39.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.854 -0.612 . . . . 6.2699999999999996 110.763 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.9 m -70.23 -48.3 57.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.591 -0.522 . . . . 4.75 109.591 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.09 158.11 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 4.4400000000000004 109.423 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.11 161.04 15.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.826 0.346 . . . . 4.9000000000000004 111.193 -174.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -82.05 32.03 0.38 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.947 0.404 . . . . 3.6099999999999999 111.093 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.87 128.4 36.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.457 0.646 . . . . 4.54 112.504 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.95 153.28 21.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.445 -0.798 . . . . 2.71 109.057 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 6.2 mptt -98.79 144.3 28.17 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.208 -0.664 . . . . 2.4399999999999999 109.208 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.11 112.83 38.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.886 -0.326 . . . . 1.3100000000000001 110.704 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 4.2 pt-20 -86.59 131.05 34.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.224 -0.287 . . . . 2.1600000000000001 110.224 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.543 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.9 mt 45.58 59.84 3.41 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.897 0.748 . . . . 2.04 111.869 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 t -59.01 153.75 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 1.26 110.757 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.82 43.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.48 0.548 . . . . 1.3700000000000001 112.48 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.6 t0 -85.39 18.27 2.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.706 0.289 . . . . 2.3999999999999999 111.406 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 2.7 9.22 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.422 -0.894 . . . . 0.83999999999999997 114.41 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 77.59 80.31 0.68 Allowed Glycine 0 C--O 1.224 -0.485 0 C-N-CA 121.021 -0.609 . . . . 0.62 114.172 170.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 t -142.7 145.04 23.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.696 -0.483 . . . . 1.1799999999999999 109.696 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.68 110.99 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 1.1799999999999999 110.244 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -136.09 147.12 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 1.96 111.281 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.6 m -117.95 144.25 45.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 1.21 110.469 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 25' ' ' LYS . 9.7 tp -93.39 135.3 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.9 0.381 . . . . 1.3 111.931 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.482 HD21 ' HG ' ' A' ' 92' ' ' LEU . 3.0 mm? -123.34 -71.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.383 0.611 . . . . 1.3999999999999999 109.369 174.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 2.2 mmmt -104.86 116.19 31.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.331 -0.85 . . . . 2.0600000000000001 109.378 176.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -112.9 150.86 31.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.844 -0.342 . . . . 3.25 110.294 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.85 163.25 47.55 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.923 -0.656 . . . . 1.3200000000000001 111.991 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.38 -57.59 2.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.252 0.548 . . . . 2.77 109.752 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -121.12 174.12 6.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.815 . . . . 2.6400000000000001 108.817 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.554 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 126.55 51.88 0.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.546 -0.835 . . . . 1.3 112.296 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.63 -41.29 98.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.809 0.358 . . . . 2.29 111.408 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -89.07 4.27 48.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.427 0.632 . . . . 2.6400000000000001 110.398 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.596 ' HB2' HH21 ' A' ' 86' ' ' ARG . 0.9 OUTLIER -116.59 78.64 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 1.49 109.617 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.6 mm -134.41 123.85 16.76 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.637 . . . . 1.3700000000000001 110.775 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' HG3' HD21 ' A' ' 122' ' ' LEU . 57.2 Cg_endo -70.18 138.45 36.51 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.876 2.384 . . . . 0.84999999999999998 111.457 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -145.66 156.71 43.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.007 0.432 . . . . 3.1400000000000001 111.871 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HG3' ' HB2' ' A' ' 70' ' ' GLU . 1.9 ttmp? -68.56 147.59 51.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.127 -0.942 . . . . 2.9100000000000001 111.111 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' N ' ' HG2' ' A' ' 36' ' ' LYS . . . 93.23 -18.48 56.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.56 -1.016 . . . . 1.1899999999999999 110.56 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 3.6 m-20 -99.18 163.38 12.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.778 -0.711 . . . . 1.3799999999999999 109.834 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.58 126.16 35.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 2.2000000000000002 110.529 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 125' ' ' PHE . 21.1 m -131.05 153.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 1.3300000000000001 109.691 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 29.7 m -113.61 106.07 14.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.374 -0.602 . . . . 1.23 109.374 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.48 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.195 0.522 . . . . 1.6200000000000001 111.341 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -100.34 136.03 40.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.622 -0.717 . . . . 3.5600000000000001 109.079 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.681 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 47.6 p90 -122.87 144.35 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.88 110.364 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -169.08 157.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.416 -0.957 . . . . 1.1899999999999999 108.416 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.91 -126.66 1.13 Allowed Glycine 0 CA--C 1.51 -0.244 0 C-N-CA 119.739 -1.22 . . . . 0.37 113.262 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 64.7 pttt -150.98 165.76 32.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.218 0.532 . . . . 1.96 111.033 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD11 ' HG ' ' A' ' 116' ' ' LEU . 63.5 tp -83.64 97.42 9.08 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.06 -0.719 . . . . 1.1200000000000001 109.06 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 48.4 tp10 -60.93 -25.76 67.0 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.017 -0.538 . . . . 1.96 111.856 -174.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 t -56.19 -27.17 53.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.426 -0.352 . . . . 1.1100000000000001 111.38 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.617 HG21 ' HD3' ' A' ' 53' ' ' LYS . 10.1 t -134.9 -13.93 2.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.835 0.35 . . . . 1.24 111.571 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.54 28.7 34.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.159 -0.543 . . . . 0.78000000000000003 112.957 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HD3' HG21 ' A' ' 51' ' ' THR . 13.9 mptt -100.42 122.57 43.37 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.604 -0.351 . . . . 3.2999999999999998 110.577 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 8.6 p -73.98 160.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 1.3400000000000001 110.407 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -74.77 147.86 40.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 0.96999999999999997 111.392 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -159.1 89.91 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.254 -0.885 . . . . 2.1800000000000002 108.939 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -136.72 -177.14 4.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 1.6799999999999999 110.815 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -71.56 -38.63 70.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.973 -0.558 . . . . 1.8600000000000001 111.425 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.86 -36.96 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.211 0.819 . . . . 2.1200000000000001 113.211 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -59.97 -33.01 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.878 0.325 . . . . 2.1899999999999999 111.878 -169.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -104.4 -0.94 27.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.282 0.475 . . . . 3.1899999999999999 112.282 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.489 HD21 HG21 ' A' ' 63' ' ' VAL . 20.4 t30 -114.19 -45.79 3.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.302 -0.559 . . . . 1.27 111.576 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 62' ' ' ASN . 95.2 t -132.08 97.81 17.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.918 0.39 . . . . 2.6099999999999999 110.05 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.29 141.73 43.81 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.988 2.459 . . . . 2.1299999999999999 112.599 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.58 146.55 25.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 1.6299999999999999 110.008 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -144.21 153.71 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.981 -0.377 . . . . 2.0099999999999998 109.981 177.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -133.99 175.07 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.68999999999999995 111.152 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -104.58 148.28 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.942 -0.762 . . . . 2.6600000000000001 108.942 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 82' ' ' VAL . 11.3 tp -69.4 119.47 13.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.034 0.445 . . . . 1.5600000000000001 110.584 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 57.55 66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.654 -1.157 . . . . 2.0800000000000001 110.646 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.01 17.78 23.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.947 -1.024 . . . . 1.98 109.063 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.04 -18.03 38.37 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.78000000000000003 112.479 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.86 -23.31 22.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.96999999999999997 110.984 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.8 126.24 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 1.25 110.353 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.526 HD12 ' HA2' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -95.75 -58.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 1.3500000000000001 113.437 -172.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.66 -48.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 2.5600000000000001 112.644 -170.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -52.4 38.13 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.917 -0.659 . . . . 0.34000000000000002 113.131 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.509 ' O ' HG21 ' A' ' 82' ' ' VAL . 9.0 m-90 -76.01 -32.22 59.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.672 0.273 . . . . 0.56000000000000005 110.702 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -53.86 -51.93 62.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.45 -0.795 . . . . 1.1399999999999999 112.179 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -69.29 -43.84 80.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 1.3999999999999999 110.82 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.652 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.8 t -62.21 -50.06 73.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.53 -0.304 . . . . 0.98999999999999999 111.009 -175.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 HD23 ' A' ' 69' ' ' LEU . 33.9 m -66.09 -32.81 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.652 0.263 . . . . 1.49 110.911 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 t -66.05 -40.12 90.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.931 0.396 . . . . 1.9399999999999999 110.131 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 m -89.69 36.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.579 . . . . 1.8700000000000001 111.08 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.856 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 4.4 mmt -112.81 -175.25 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 2.79 110.468 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.596 HH21 ' HB2' ' A' ' 32' ' ' ASN . 8.3 mtp-105 -149.87 175.4 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 4.9199999999999999 110.116 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.63 -22.24 66.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.654 -0.703 . . . . 2.4300000000000002 112.436 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -136.32 34.88 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 1.4199999999999999 110.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 25' ' ' LYS . 30.8 tt0 -120.51 154.06 35.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 1.6000000000000001 109.787 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.6 tttt -156.94 132.22 9.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.663 0.268 . . . . 1.74 111.359 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 93.8 m -135.2 165.35 25.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.111 0.481 . . . . 1.3600000000000001 111.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HG ' HD21 ' A' ' 23' ' ' LEU . 78.5 mt -106.34 114.95 29.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.461 -0.79 . . . . 2.2999999999999998 109.676 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.3 p -108.3 141.93 22.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.297 -0.41 . . . . 1.46 111.232 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.47 ' NE ' HD22 ' A' ' 117' ' ' LEU . 7.2 mpt_? -90.91 117.13 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 2.29 110.414 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.618 HD12 ' HD2' ' A' ' 118' ' ' PHE . 2.7 mp -96.64 101.08 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.28 -1.007 . . . . 1.2 108.28 172.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.565 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 8.1 tt0 -98.41 177.04 5.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.268 -0.878 . . . . 1.3700000000000001 109.434 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -55.36 -36.37 66.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 1.22 110.962 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 24.2 ptp -76.86 -7.64 55.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.036 -0.529 . . . . 2.3199999999999998 111.296 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.565 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.0 m-85 -112.65 4.85 17.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.606 0.241 . . . . 0.92000000000000004 110.952 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.526 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -138.7 -173.1 12.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.929 -0.653 . . . . 0.85999999999999999 112.285 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -88.73 7.69 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 1.52 111.356 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.25 -152.18 39.54 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 2.2999999999999998 112.672 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.432 ' CB ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 t70 -88.42 -17.08 31.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.18 0.514 . . . . 5.8600000000000003 110.449 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.64 -29.71 69.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.591 -0.732 . . . . 4.2699999999999996 111.267 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.68 159.84 36.88 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.783 -0.722 . . . . 2.8999999999999999 113.028 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.9 m -76.62 131.98 39.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.206 -0.294 . . . . 3.7799999999999998 110.206 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -119.44 164.81 13.3 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.448 -0.882 . . . . 1.47 112.432 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.51 -46.8 5.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 3.0800000000000001 110.741 -178.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.454 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 20.2 m -97.4 -74.7 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 1.71 110.085 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.443 HG12 HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -158.47 97.62 1.78 Allowed Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.124 -0.489 . . . . 1.3700000000000001 110.553 176.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 74.4 Cg_endo -85.16 177.95 4.94 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.509 2.139 . . . . 1.5800000000000001 111.384 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 103' ' ' ASP . . . 142.67 -162.73 27.35 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.11 -1.043 . . . . 2.0499999999999998 113.038 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -98.08 39.88 1.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 2.2999999999999998 109.086 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.9 m -125.2 158.31 34.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.797 -0.638 . . . . 1.5700000000000001 110.37 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.37 127.42 42.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.51 0.671 . . . . 1.1799999999999999 111.653 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' HG ' HD11 ' A' ' 48' ' ' LEU . 6.7 mp -123.55 167.63 13.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.681 -0.691 . . . . 1.25 109.873 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -138.3 131.89 30.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.006 0.431 . . . . 1.3500000000000001 110.518 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 95' ' ' ILE . 59.3 m-85 -121.6 145.76 47.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.961 -0.563 . . . . 0.56000000000000005 110.669 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.5 mt-10 -68.65 123.62 21.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.816 -0.809 . . . . 1.46 108.816 170.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 81' ' ' CYS . 10.2 mt -107.74 115.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.298 0.57 . . . . 1.1599999999999999 109.622 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -125.62 114.07 18.22 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.002 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 34' ' ' PRO . 14.9 tp -86.84 99.92 12.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 1.75 109.896 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 123' ' ' LEU . 1.1 pt? -98.63 -19.96 17.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.655 -0.418 . . . . 1.78 111.305 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 20.5 m -151.7 145.66 25.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.46 0.171 . . . . 1.53 110.802 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.412 ' HB2' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -166.92 156.98 11.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.448 -0.342 . . . . 0.90000000000000002 110.255 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.81 49.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.202 -0.454 . . . . 3.4700000000000002 110.704 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.433 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mp0 -96.71 115.05 26.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.137 -0.483 . . . . 3.3799999999999999 110.591 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 tp -150.47 110.62 4.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 3.8199999999999998 109.795 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.44 138.2 53.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.966 -0.561 . . . . 5.3899999999999997 111.966 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.96 115.69 24.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.479 -0.782 . . . . 7.75 110.042 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -131.77 163.13 28.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.313 -0.403 . . . . 7.8499999999999996 110.957 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.32 133.2 38.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.869 0.366 . . . . 9.5500000000000007 111.107 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -94.72 108.4 20.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 10.23 110.114 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -90.05 140.42 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.043 -0.526 . . . . 12.85 111.129 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.755 -0.641 . . . . 13.970000000000001 109.451 175.744 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.7 -0.481 . . . . 7.8200000000000003 109.7 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.0 p -74.69 105.92 6.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 6.2699999999999996 111.336 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.0 m -88.29 117.35 27.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 4.75 110.348 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.46 78.4 9.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.398 -0.593 . . . . 4.4400000000000004 109.398 175.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -66.16 126.91 30.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.716 . . . . 4.9000000000000004 110.156 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.54 73.11 6.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.609 0.719 . . . . 3.6099999999999999 110.219 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.4 169.8 16.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.242 -0.89 . . . . 4.54 110.852 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -116.14 158.42 23.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.783 -0.644 . . . . 2.71 110.013 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 6.4 mptt -102.37 148.16 25.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.048 -0.723 . . . . 2.4399999999999999 109.048 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 15.6 t -101.03 109.24 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.383 0.611 . . . . 1.3100000000000001 110.168 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -79.82 99.74 7.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.031 -0.986 . . . . 2.1600000000000001 111.475 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt 51.32 79.17 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.691 0.619 . . . . 2.04 111.328 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.642 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 11.6 t -89.93 177.17 6.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 1.26 110.903 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.93 -3.63 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.3700000000000001 111.828 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HB2' HG21 ' A' ' 80' ' ' ILE . 27.0 m-20 -75.93 2.33 12.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.533 0.206 . . . . 2.3999999999999999 110.652 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.3 8.92 6.86 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.612 -0.804 . . . . 0.83999999999999997 113.326 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.22 63.48 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.019 -0.61 . . . . 0.62 114.42 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HB ' ' CB ' ' A' ' 80' ' ' ILE . 23.5 t -134.42 148.39 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.929 -0.397 . . . . 1.1799999999999999 109.929 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.92 109.73 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.18 0.514 . . . . 1.1799999999999999 110.44 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.498 ' HE2' HG23 ' A' ' 13' ' ' THR . 47.7 pttt -123.32 148.28 46.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.99 -0.55 . . . . 1.96 110.368 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -109.43 124.33 50.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.828 -0.624 . . . . 1.21 110.332 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.484 HD11 ' SG ' ' A' ' 91' ' ' CYS . 5.1 tp -75.65 113.9 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 1.3 110.924 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 3.5 mm? -99.24 -60.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 1.3999999999999999 110.481 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -120.33 133.96 55.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 2.0600000000000001 110.076 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -106.46 124.17 49.18 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.491 . . . . 3.25 110.212 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 161.85 37.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.66 -0.781 . . . . 1.3200000000000001 111.788 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -68.07 -67.1 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 2.77 110.692 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.17 -177.81 4.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 2.6400000000000001 110.806 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.96 45.85 0.17 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.49 -0.777 . . . . 1.3 111.27 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.32 -41.5 89.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 2.29 110.552 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -113.83 26.03 10.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.309 0.576 . . . . 2.6400000000000001 109.817 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 79.81 1.79 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 1.49 110.07 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 HG23 ' HE3' ' A' ' 35' ' ' LYS . 36.1 mm -129.48 128.46 23.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 1.3700000000000001 111.084 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 1.1 Cg_endo -81.55 114.65 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.896 2.397 . . . . 0.84999999999999998 111.256 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.449 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 28.3 mmtp -120.46 146.45 46.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.21 -0.45 . . . . 3.1400000000000001 111.065 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 5.3 tmmm? -57.02 124.58 19.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.701 -0.681 . . . . 2.9100000000000001 109.783 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.58 37.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.752 -0.737 . . . . 1.1899999999999999 112.277 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 82.3 m-20 -79.39 142.57 35.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.964 0.412 . . . . 1.3799999999999999 110.122 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.513 ' HB3' ' CG ' ' A' ' 126' ' ' ARG . 37.6 tp10 -76.46 102.32 5.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.797 -0.638 . . . . 2.2000000000000002 109.797 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 125' ' ' PHE . 28.0 m -112.94 156.02 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.088 -0.505 . . . . 1.3300000000000001 110.868 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.8 m -132.6 110.87 10.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 1.23 109.709 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 122' ' ' LEU . 27.4 m -125.15 151.03 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 1.6200000000000001 111.405 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -101.17 149.28 24.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 3.5600000000000001 109.709 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 39.9 p90 -133.32 136.92 45.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.708 0.29 . . . . 0.88 110.233 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -164.89 146.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.58 -0.526 . . . . 1.1899999999999999 109.58 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -176.18 -127.86 1.07 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.325 -0.94 . . . . 0.37 112.513 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 63.6 pttt -157.77 171.94 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 1.96 110.831 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.738 HD22 HG13 ' A' ' 110' ' ' ILE . 58.2 tp -87.04 108.89 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 1.1200000000000001 110.794 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HB3' HG11 ' A' ' 115' ' ' VAL . 2.1 tp10 -61.46 -35.33 77.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.51 0.672 . . . . 1.96 110.615 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -55.71 -27.82 52.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 1.1100000000000001 112.792 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 53' ' ' LYS . 15.2 t -140.55 -23.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.178 -0.609 . . . . 1.24 112.35 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.69 34.65 4.89 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.502 -0.856 . . . . 0.78000000000000003 113.014 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 51' ' ' THR . 73.8 mmtt -102.84 125.51 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.132 -0.321 . . . . 3.2999999999999998 110.132 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.533 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.7 p -82.44 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.108 -0.33 . . . . 1.3400000000000001 110.108 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -78.69 127.23 31.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.387 0.514 . . . . 0.96999999999999997 112.387 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -161.24 85.74 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.025 -0.989 . . . . 2.1800000000000002 108.549 167.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.557 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 23.5 t -122.54 158.11 30.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.747 -0.66 . . . . 1.6799999999999999 109.986 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -50.0 -44.0 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.245 0.618 . . . . 1.8600000000000001 112.437 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -87.76 -33.67 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 2.1200000000000001 110.532 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -64.71 -52.0 59.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 2.1899999999999999 111.738 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.1 ptp180 -67.49 -20.49 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.352 . . . . 3.1899999999999999 111.309 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.516 ' ND2' HG22 ' A' ' 63' ' ' VAL . 8.3 t30 -75.58 -64.12 1.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.297 -0.411 . . . . 1.27 110.108 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG22 ' ND2' ' A' ' 62' ' ' ASN . 73.1 t -142.55 106.43 5.49 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.382 -0.372 . . . . 2.6099999999999999 111.007 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.37 140.16 92.24 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.287 1.991 . . . . 2.1299999999999999 110.818 171.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -93.3 151.0 20.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.917 0.389 . . . . 1.6299999999999999 110.582 -171.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 143.14 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.117 -0.697 . . . . 2.0099999999999998 109.117 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.408 ' CE1' HG13 ' A' ' 82' ' ' VAL . 30.0 p90 -124.39 153.85 41.27 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.968 -0.693 . . . . 0.68999999999999995 111.212 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . 41.7 t-80 -94.5 145.02 25.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.149 -0.932 . . . . 2.6600000000000001 109.788 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 ' CG2' ' A' ' 82' ' ' VAL . 38.3 tp -69.13 128.84 38.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.991 -0.744 . . . . 1.5600000000000001 108.991 173.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HG2' ' CG ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.49 78.75 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.146 0.974 . . . . 2.0800000000000001 110.403 -168.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 68' ' ' HIS . 26.2 tt0 -126.42 -5.66 6.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.13 -1.395 . . . . 1.98 109.994 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 -19.24 33.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.701 -0.681 . . . . 0.78000000000000003 112.681 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 42.3 mm-40 -87.73 -21.76 25.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.531 0.682 . . . . 0.96999999999999997 109.504 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.9 m -108.87 124.18 65.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.65 -0.705 . . . . 1.25 109.979 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.73 -59.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.179 0.437 . . . . 1.3500000000000001 112.179 -178.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -149.19 -38.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.307 -0.246 . . . . 2.5600000000000001 111.468 -174.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.7 -52.62 44.45 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.561 -0.828 . . . . 0.34000000000000002 112.857 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 82' ' ' VAL . 15.2 m-90 -76.18 -27.72 57.03 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.8 -0.235 . . . . 0.56000000000000005 110.895 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.12 -54.02 35.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.603 -0.726 . . . . 1.1399999999999999 111.37 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -68.16 -30.99 49.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.636 -0.711 . . . . 1.3999999999999999 111.586 -173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 85' ' ' MET . 34.8 t -76.08 -55.92 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.748 0.309 . . . . 0.98999999999999999 111.038 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.842 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 32.0 m -67.34 -33.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.324 0.861 . . . . 1.49 113.324 -169.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 62.2 p -79.64 -0.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.987 0.422 . . . . 1.9399999999999999 111.167 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -125.77 25.5 6.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 1.8700000000000001 110.384 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 31.4 mtm -114.78 142.37 46.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.95 0.405 . . . . 2.79 111.664 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 86' ' ' ARG . 51.2 mtt180 -90.88 164.62 13.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.538 -0.542 . . . . 4.9199999999999999 109.538 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.406 ' HA ' HD22 ' A' ' 122' ' ' LEU . 61.3 tttm -65.16 -21.66 66.81 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.641 0.608 . . . . 2.4300000000000002 112.641 -171.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -117.54 24.65 10.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.537 0.684 . . . . 1.4199999999999999 109.805 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 35.8 tt0 -117.85 132.71 56.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.995 -1.002 . . . . 1.6000000000000001 109.898 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 11.9 tmtt? -137.44 129.68 29.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.94 -0.573 . . . . 1.74 110.226 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 78.9 m -138.51 171.74 13.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.372 -0.377 . . . . 1.3600000000000001 111.269 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.931 HD22 ' HB3' ' A' ' 117' ' ' LEU . 6.1 tt -112.54 145.63 39.96 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.608 -0.886 . . . . 2.2999999999999998 108.608 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 92' ' ' LEU . 13.9 p -121.07 146.34 26.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 116.443 -0.344 . . . . 1.46 110.303 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -107.07 111.13 23.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.643 -1.243 . . . . 2.29 107.643 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.556 HD12 HG13 ' A' ' 93' ' ' VAL . 4.9 mp -93.36 99.8 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.08 -0.648 . . . . 1.2 110.459 -172.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.55 155.55 29.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.926 -1.033 . . . . 1.3700000000000001 109.82 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 6.4 p -53.34 -38.59 63.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.052 -0.522 . . . . 1.22 111.495 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.1 ptp -78.08 -11.18 59.89 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.562 -0.29 . . . . 2.3199999999999998 111.428 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -101.7 -2.66 29.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.877 0.37 . . . . 0.92000000000000004 110.145 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 -178.01 44.91 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.85999999999999999 111.795 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -40.52 10.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.886 0.374 . . . . 1.52 110.733 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.81 174.44 14.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.811 -0.709 . . . . 2.2999999999999998 112.471 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.1 -21.46 24.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.6 0.714 . . . . 5.8600000000000003 109.786 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.58 -7.84 42.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.849 -1.069 . . . . 4.2699999999999996 111.823 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.93 18.47 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.832 -0.699 . . . . 2.8999999999999999 112.399 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.3 m -103.23 154.29 19.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.576 0.227 . . . . 3.7799999999999998 110.605 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 111' ' ' PRO . . . -151.44 175.17 30.41 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.671 -0.776 . . . . 1.47 112.6 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.81 -70.49 0.7 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.942 0.349 . . . . 3.0800000000000001 111.942 -175.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.58 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 16.6 m -107.08 -73.17 0.7 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.42 0.152 . . . . 1.71 111.368 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.738 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -141.48 77.68 19.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.211 0.529 . . . . 1.3700000000000001 111.421 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.551 ' CG ' ' HA3' ' A' ' 107' ' ' GLY . 27.3 Cg_endo -93.74 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.25 2.633 . . . . 1.5800000000000001 111.649 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.37 -125.32 7.25 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.517 -0.849 . . . . 2.0499999999999998 111.958 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 97' ' ' SER . 3.3 t-20 -105.41 1.16 27.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.61 0.719 . . . . 2.2999999999999998 109.352 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.9 m -79.56 152.15 30.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.323 -0.853 . . . . 1.5700000000000001 110.632 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 49' ' ' GLU . 6.5 p -90.14 135.03 27.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.197 -0.456 . . . . 1.1799999999999999 110.686 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HA ' ' H ' ' A' ' 49' ' ' GLU . 6.2 mp -126.67 167.01 16.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.75 0.31 . . . . 1.25 110.991 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.931 ' HB3' HD22 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -117.26 114.53 23.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.184 -0.673 . . . . 1.3500000000000001 109.184 174.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -113.13 122.04 46.33 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.944 -0.303 . . . . 0.56000000000000005 110.721 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.537 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 33.6 mt-10 -86.12 130.05 34.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.003 -0.74 . . . . 1.46 109.003 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.656 HG21 HG12 ' A' ' 82' ' ' VAL . 70.7 mt -113.5 127.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.997 -0.547 . . . . 1.1599999999999999 111.504 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -115.91 115.34 26.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.462 -0.79 . . . . 1.8799999999999999 110.815 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.691 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 6.0 tt -91.35 102.24 14.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.871 -0.789 . . . . 1.75 108.871 173.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -97.85 -34.43 10.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.556 -0.293 . . . . 1.78 111.184 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.0 t -146.57 144.01 29.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.72 0.295 . . . . 1.53 110.759 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.536 ' HB2' HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -165.39 148.41 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.90000000000000002 109.873 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.513 ' CG ' ' HB3' ' A' ' 39' ' ' GLU . 7.8 ptp85 -127.49 129.48 47.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 3.4700000000000002 109.988 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -96.27 135.07 38.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 110.951 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.5 tp 74.97 105.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.283 0.989 . . . . 3.8199999999999998 111.974 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 130' ' ' HIS . 7.7 tp10 -125.49 154.91 41.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.205 -0.907 . . . . 5.3899999999999997 109.298 175.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 20.9 m80 74.83 172.29 0.27 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.016 0.822 . . . . 7.75 111.699 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 t60 52.02 69.95 0.61 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.13 -0.941 . . . . 7.8499999999999996 111.413 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -128.55 174.19 9.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.954 -0.566 . . . . 9.5500000000000007 109.973 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 171.1 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.497 -0.32 . . . . 10.23 110.758 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.7 m80 65.55 26.77 11.66 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.654 0.596 . . . . 12.85 110.672 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.597 -0.716 . . . . 13.970000000000001 109.362 177.57 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.744 0.307 . . . . 7.8200000000000003 110.395 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 p -86.29 141.19 29.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.448 -0.342 . . . . 6.2699999999999996 110.537 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m -93.63 12.46 25.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.632 0.729 . . . . 4.75 109.989 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -111.46 173.97 6.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.342 -0.844 . . . . 4.4400000000000004 110.995 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -85.98 133.93 33.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.748 -0.66 . . . . 4.9000000000000004 110.202 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -95.82 18.73 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.616 0.722 . . . . 3.6099999999999999 109.77 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -83.29 149.1 26.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.432 -0.804 . . . . 4.54 110.497 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.93 150.26 21.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 2.71 110.63 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -101.67 141.72 34.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 2.4399999999999999 109.129 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.661 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 16.9 t -102.47 109.57 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.092 0.472 . . . . 1.3100000000000001 111.217 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.13 108.79 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.73 -0.668 . . . . 2.1600000000000001 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.0 tp 53.05 72.54 0.42 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.638 0.586 . . . . 2.04 111.201 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.661 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 6.8 t -80.43 156.6 26.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.983 -0.553 . . . . 1.26 111.349 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 1.67 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 1.3700000000000001 111.972 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.6 3.38 3.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.577 0.227 . . . . 2.3999999999999999 110.835 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.26 6.82 8.02 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.091 -0.576 . . . . 0.83999999999999997 112.974 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.01 70.32 1.33 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.708 -0.758 . . . . 0.62 113.928 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' HB ' ' A' ' 80' ' ' ILE . 35.8 t -142.89 145.17 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.786 -0.45 . . . . 1.1799999999999999 109.786 174.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.1 mm -85.53 109.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 1.1799999999999999 110.323 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' HE3' HG23 ' A' ' 13' ' ' THR . 18.2 pttp -131.05 143.67 50.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.13 0.491 . . . . 1.96 111.011 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -110.73 121.73 46.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.609 -0.723 . . . . 1.21 110.237 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.83 134.87 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 1.3 110.15 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.4 -74.02 0.62 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.019 -0.363 . . . . 1.3999999999999999 110.019 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -88.26 153.17 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.833 -0.803 . . . . 2.0600000000000001 108.833 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -126.28 120.08 29.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.212 0.53 . . . . 3.25 111.001 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.45 27.31 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.124 -0.944 . . . . 1.3200000000000001 112.13 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.92 -65.81 0.97 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.766 0.317 . . . . 2.77 110.877 -176.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -99.69 139.07 35.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.848 0.356 . . . . 2.6400000000000001 110.493 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.669 ' HA3' ' HD3' ' A' ' 86' ' ' ARG . . . -157.17 36.77 0.56 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.567 -0.613 . . . . 1.3 111.567 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.519 0.676 . . . . 2.29 109.188 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -112.09 4.33 17.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.215 -0.902 . . . . 2.6400000000000001 110.353 176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.513 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 11.7 m120 -114.55 78.82 1.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.608 -0.437 . . . . 1.49 111.254 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.1 mm -128.33 114.99 19.89 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.61 -0.723 . . . . 1.3700000000000001 109.559 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.08 106.21 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.132 2.555 . . . . 0.84999999999999998 111.84 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 31.5 mmtp -118.7 158.21 25.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.749 0.309 . . . . 3.1400000000000001 110.671 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 1.043 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -80.56 150.65 29.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 2.9100000000000001 111.384 -175.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.64 -26.06 25.41 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.808 -0.633 . . . . 1.1899999999999999 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -93.46 157.7 16.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 1.3799999999999999 110.186 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -71.67 95.71 1.49 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 2.2000000000000002 110.805 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 125' ' ' PHE . 10.4 m -114.49 153.03 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.459 -0.337 . . . . 1.3300000000000001 110.351 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -128.27 107.09 9.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.447 -0.342 . . . . 1.23 110.406 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -123.75 143.37 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 1.6200000000000001 111.534 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -112.99 145.44 40.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.561 -0.745 . . . . 3.5600000000000001 110.236 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.678 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.2 p90 -132.94 141.42 48.34 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.18 0.3 . . . . 0.88 110.831 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p -168.24 154.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.271 -0.641 . . . . 1.1899999999999999 109.271 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 177.92 -120.31 0.71 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.83 -1.176 . . . . 0.37 113.225 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.754 ' HG3' HD13 ' A' ' 117' ' ' LEU . 21.0 pttp -157.53 173.28 17.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.545 0.212 . . . . 1.96 111.06 -178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.809 HD23 HG13 ' A' ' 110' ' ' ILE . 59.3 tp -90.9 106.66 18.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.688 -0.486 . . . . 1.1200000000000001 109.688 176.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.515 ' HB2' HD12 ' A' ' 117' ' ' LEU . 3.0 tp10 -68.73 -25.61 64.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 1.96 110.793 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 17.1 t -55.0 -35.1 64.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.118 -0.946 . . . . 1.1100000000000001 111.461 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.501 HG21 ' HG2' ' A' ' 53' ' ' LYS . 2.8 t -125.21 -20.64 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.346 -0.388 . . . . 1.24 111.083 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.25 11.58 51.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.78000000000000003 112.771 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.501 ' HG2' HG21 ' A' ' 51' ' ' THR . 29.0 mmmt -85.02 131.03 34.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.955 -0.387 . . . . 3.2999999999999998 109.955 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.662 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.5 p -79.1 164.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.315 -0.402 . . . . 1.3400000000000001 110.097 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 7.3 m-30 -73.61 98.47 2.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.367 0.603 . . . . 0.96999999999999997 110.791 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.32 85.7 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.454 -0.793 . . . . 2.1800000000000002 109.706 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.678 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 19.0 m -135.89 169.24 17.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.376 -0.829 . . . . 1.6799999999999999 109.54 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 m -57.91 -44.57 86.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.818 0.673 . . . . 1.8600000000000001 112.818 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -91.01 -48.26 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 2.1200000000000001 111.456 -171.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.678 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 1.6 m-20 -54.4 -44.74 72.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.985 -1.007 . . . . 2.1899999999999999 112.73 -169.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -83.83 0.7 46.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.851 -0.34 . . . . 3.1899999999999999 111.657 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.536 HD21 HG11 ' A' ' 63' ' ' VAL . 10.7 t30 -104.09 -42.25 5.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.447 -0.342 . . . . 1.27 110.807 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 62' ' ' ASN . 8.4 m -124.24 125.82 25.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.843 0.354 . . . . 2.6099999999999999 111.521 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 1.7 Cg_endo -85.57 139.57 6.81 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.256 2.637 . . . . 2.1299999999999999 112.451 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.79 148.95 32.44 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.891 0.377 . . . . 1.6299999999999999 111.179 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 157.62 46.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.998 -0.546 . . . . 2.0099999999999998 110.198 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -140.34 176.95 8.35 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.034 0.445 . . . . 0.68999999999999995 111.982 -175.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -107.75 148.46 29.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 2.6600000000000001 110.659 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 36' ' ' LYS . 24.0 tp -78.72 124.45 28.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.103 -0.703 . . . . 1.5600000000000001 109.103 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 1.043 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 1.4 mm-40 63.51 79.57 0.25 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.457 1.122 . . . . 2.0800000000000001 110.255 -168.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -130.61 -3.73 4.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.653 -1.612 . . . . 1.98 109.836 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.22 -11.06 61.64 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.557 -0.747 . . . . 0.78000000000000003 111.847 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.02 -18.77 16.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.96999999999999997 110.836 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -111.74 127.95 68.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 1.25 110.282 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.68 -76.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.299 0.481 . . . . 1.3500000000000001 112.299 -176.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' H ' HG12 ' A' ' 75' ' ' ILE . 37.2 mtpt -127.59 -49.87 1.38 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.472 0.545 . . . . 2.5600000000000001 112.472 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.4 -53.06 33.53 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.955 -0.64 . . . . 0.34000000000000002 113.342 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.414 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.6 m-90 -76.03 -44.27 40.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.639 0.257 . . . . 0.56000000000000005 110.571 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.14 -49.32 69.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.587 -0.733 . . . . 1.1399999999999999 112.026 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -73.37 -36.42 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.165 -0.47 . . . . 1.3999999999999999 111.413 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 46.3 t -72.46 -42.84 64.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.687 -0.233 . . . . 0.98999999999999999 111.426 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.874 HG13 HG21 ' A' ' 120' ' ' ILE . 27.4 m -64.06 -32.53 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.895 0.379 . . . . 1.49 111.121 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -79.11 5.1 12.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.062 0.458 . . . . 1.9399999999999999 110.863 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -113.38 5.73 16.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 1.8700000000000001 110.824 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.613 ' HA ' ' OE1' ' A' ' 89' ' ' GLU . 55.9 mtm -93.75 -172.73 2.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.519 0.676 . . . . 2.79 112.288 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.669 ' HD3' ' HA3' ' A' ' 29' ' ' GLY . 1.6 ttm180 -145.55 165.51 28.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.153 -1.054 . . . . 4.9199999999999999 108.153 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -63.2 -23.81 67.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.924 0.392 . . . . 2.4300000000000002 111.715 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -117.49 24.91 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.072 0.463 . . . . 1.4199999999999999 110.065 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 5.3 tm-20 -123.07 152.85 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 1.6000000000000001 109.629 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -155.23 124.67 6.37 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.146 -0.316 . . . . 1.74 110.146 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.69 171.17 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 1.3600000000000001 111.383 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.85 137.41 52.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 2.2999999999999998 110.32 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.696 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 6.2 p -111.73 149.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.89 -0.595 . . . . 1.46 111.075 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -104.14 112.56 25.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.566 -0.531 . . . . 2.29 109.566 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.487 HD11 HG13 ' A' ' 93' ' ' VAL . 2.6 mp -92.2 106.57 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 1.2 110.504 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 28.5 tt0 -90.48 168.29 11.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.393 -0.822 . . . . 1.3700000000000001 108.932 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.8 m -51.03 -39.32 55.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.312 0.486 . . . . 1.22 112.312 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.5 ptp -77.39 -7.91 56.85 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.61 0.243 . . . . 2.3199999999999998 111.487 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.508 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -99.05 -3.35 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.549 0.214 . . . . 0.92000000000000004 110.772 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HD13 ' A' ' 75' ' ' ILE . . . -135.01 -177.51 15.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.253 -0.499 . . . . 0.85999999999999999 112.015 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -76.32 -51.41 12.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.697 0.248 . . . . 1.52 111.175 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 -165.75 20.13 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.445 -0.883 . . . . 2.2999999999999998 112.84 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.95 -40.21 96.99 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.853 0.461 . . . . 5.8600000000000003 111.519 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.12 -11.57 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 4.2699999999999996 111.033 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.88 162.34 24.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.759 -0.734 . . . . 2.8999999999999999 112.354 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.3 m -67.74 127.97 34.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 3.7799999999999998 110.505 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.483 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -127.07 163.46 20.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.848 -0.691 . . . . 1.47 111.855 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -77.94 -72.51 0.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.99 0.424 . . . . 3.0800000000000001 111.23 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.511 ' HB2' HD13 ' A' ' 110' ' ' ILE . 3.4 m -104.5 -72.26 0.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.96 -0.564 . . . . 1.71 110.803 -176.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.809 HG13 HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.63 85.95 50.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 1.3700000000000001 110.818 178.502 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.483 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 83.1 Cg_endo -78.55 -175.59 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.292 1.995 . . . . 1.5800000000000001 111.905 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.53 -132.44 5.12 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.456 -0.878 . . . . 2.0499999999999998 112.117 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -122.77 36.53 4.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 2.2999999999999998 109.965 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 21.3 p -114.84 179.31 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.5700000000000001 110.819 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 49' ' ' GLU . 7.1 p -104.98 129.17 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.146 0.498 . . . . 1.1799999999999999 111.016 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -119.94 172.73 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 1.25 110.382 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.754 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -128.08 130.83 48.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.695 -0.483 . . . . 1.3500000000000001 109.695 177.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.658 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 34.7 m-85 -130.4 128.34 41.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.672 0.272 . . . . 0.56000000000000005 110.672 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.678 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 62.5 mt-10 -71.28 126.44 29.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.265 -1.013 . . . . 1.46 108.265 169.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.874 HG21 HG13 ' A' ' 82' ' ' VAL . 34.8 mt -107.67 123.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.212 -0.595 . . . . 1.1599999999999999 109.677 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.96 114.7 20.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.682 -0.69 . . . . 1.8799999999999999 110.678 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 35.9 tp -87.29 90.62 8.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.51 . . . . 1.75 109.753 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 124' ' ' SER . 3.5 pp -86.48 -25.26 25.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 1.78 111.741 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.416 ' N ' HD12 ' A' ' 123' ' ' LEU . 75.7 m -159.46 148.23 17.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.361 -0.381 . . . . 1.53 110.292 177.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.53 ' HB3' HD12 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -167.02 -176.22 3.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.90000000000000002 109.877 -178.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.88 170.54 22.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.524 -0.307 . . . . 3.4700000000000002 110.178 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.86 153.72 50.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.908 -1.145 . . . . 3.3799999999999999 107.908 171.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.38 74.88 1.55 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.639 -0.424 . . . . 3.8199999999999998 111.3 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.682 ' HG3' ' H ' ' A' ' 131' ' ' HIS . 9.3 tp10 -86.17 141.02 29.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.208 -0.451 . . . . 5.3899999999999997 110.053 173.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -103.73 10.52 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.298 -0.41 . . . . 7.75 110.338 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.682 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 5.7 t-160 -85.92 47.11 1.4 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 7.8499999999999996 111.23 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.99 -63.85 1.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.305 -0.628 . . . . 9.5500000000000007 109.305 174.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -171.48 79.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.48 0.657 . . . . 10.23 111.431 172.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -139.1 146.45 40.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.58 -0.896 . . . . 12.85 108.58 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.388 -0.815 . . . . 13.970000000000001 110.952 -173.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.166 -0.309 . . . . 7.8200000000000003 110.166 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 m -88.63 120.32 29.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.934 -0.395 . . . . 6.2699999999999996 109.934 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -94.52 -68.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.41 -0.359 . . . . 4.75 110.751 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -144.83 157.58 44.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.072 -0.344 . . . . 4.4400000000000004 110.072 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.9 88.93 5.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.611 0.243 . . . . 4.9000000000000004 111.531 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -96.92 85.75 3.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.386 -0.598 . . . . 3.6099999999999999 109.386 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.14 155.86 32.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.074 -0.512 . . . . 4.54 110.896 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.42 139.01 36.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 2.71 109.899 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -113.51 151.4 31.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 2.4399999999999999 110.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 21.6 t -114.0 120.55 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 1.3100000000000001 111.352 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.93 112.56 25.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 2.1600000000000001 111.138 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.2 mt 49.74 74.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.752 0.657 . . . . 2.04 112.022 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.515 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 3.5 t -86.34 163.01 17.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 1.26 110.739 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.03 -5.45 13.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.363 0.601 . . . . 1.3700000000000001 110.685 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HB3' HG22 ' A' ' 13' ' ' THR . 38.4 t70 -74.52 6.87 3.36 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.629 -0.714 . . . . 2.3999999999999999 111.084 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.28 16.52 3.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.67 -0.776 . . . . 0.83999999999999997 113.851 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.41 62.38 6.07 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.293 -0.479 . . . . 0.62 113.82 173.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.492 HG21 ' HB ' ' A' ' 80' ' ' ILE . 47.3 t -136.57 145.47 30.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.04 -0.356 . . . . 1.1799999999999999 110.04 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.6 mm -85.78 109.95 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 1.1799999999999999 110.372 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -138.38 146.78 42.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.206 -0.452 . . . . 1.96 110.835 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -119.63 137.56 53.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 1.21 110.524 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -80.27 126.9 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.051 0.453 . . . . 1.3 110.844 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 92' ' ' LEU . 4.5 mm? -118.03 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 1.3999999999999999 110.423 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 39.5 ttpt -116.63 106.44 13.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.56 -0.533 . . . . 2.0600000000000001 109.56 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -88.02 148.94 24.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.245 -0.434 . . . . 3.25 110.944 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.93 124.37 8.1 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.635 -0.986 . . . . 1.3200000000000001 110.635 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -61.99 -54.81 36.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.642 0.221 . . . . 2.77 111.493 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.9 151.71 40.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.107 0.48 . . . . 2.6400000000000001 110.719 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.3 34.12 0.11 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.274 -0.875 . . . . 1.3 110.937 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.11 -41.33 78.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 2.29 111.541 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -110.62 26.55 10.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.761 0.791 . . . . 2.6400000000000001 109.274 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.38 77.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.446 -0.797 . . . . 1.49 110.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -123.95 119.48 26.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.956 0.407 . . . . 1.3700000000000001 111.155 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.93 128.68 20.26 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.74 2.293 . . . . 0.84999999999999998 111.525 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mmmm -121.24 147.74 45.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.172 -0.467 . . . . 3.1400000000000001 111.442 -174.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.559 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 7.5 ttmm -76.61 129.72 36.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.617 -0.72 . . . . 2.9100000000000001 109.111 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.9 -21.67 44.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.784 -0.722 . . . . 1.1899999999999999 111.904 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -83.0 156.61 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.65 95.49 3.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.559 -0.534 . . . . 2.2000000000000002 109.559 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -125.06 147.69 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 1.3300000000000001 110.615 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.482 HG22 ' HD3' ' A' ' 66' ' ' LYS . 82.3 m -124.66 119.69 29.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.182 -0.463 . . . . 1.23 109.998 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.95 157.62 38.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 1.6200000000000001 111.576 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 9.8 t60 -110.17 131.04 55.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.347 -0.842 . . . . 3.5600000000000001 109.898 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 14.4 p90 -133.7 135.75 44.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.076 0.465 . . . . 0.88 111.221 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -168.32 151.73 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.295 -1.002 . . . . 1.1899999999999999 108.295 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.78 -126.83 0.98 Allowed Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.504 -1.331 . . . . 0.37 112.714 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.659 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 65.8 pttt -155.87 170.5 21.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.099 0.476 . . . . 1.96 111.441 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 114' ' ' SER . 54.4 tp -92.52 109.71 21.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.774 -0.648 . . . . 1.1200000000000001 110.392 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' HB3' HG13 ' A' ' 115' ' ' VAL . 7.8 tm-20 -66.44 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 1.96 109.942 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -55.29 -20.11 10.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.51 -0.768 . . . . 1.1100000000000001 112.444 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -136.52 -26.57 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.274 -0.266 . . . . 1.24 111.584 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.73 20.03 18.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 0.78000000000000003 112.004 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.9 mmtt -91.99 126.37 37.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.625 0.25 . . . . 3.2999999999999998 111.441 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.659 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.4 p -76.0 159.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 1.3400000000000001 109.956 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.545 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 4.8 m-30 -73.97 110.69 8.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.454 0.645 . . . . 0.96999999999999997 111.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -139.34 89.08 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.09 . . . . 2.1800000000000002 109.02 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.558 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 47.5 m -126.99 -171.01 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.801 -0.636 . . . . 1.6799999999999999 109.947 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -72.84 -48.0 41.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.478 0.547 . . . . 1.8600000000000001 112.478 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -95.64 -47.52 6.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.283 0.475 . . . . 2.1200000000000001 112.283 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.558 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 6.3 p-10 -57.51 -29.86 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.859 -0.61 . . . . 2.1899999999999999 111.878 -172.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -70.83 -14.35 62.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 3.1899999999999999 111.329 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -125.51 -56.4 1.5 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.788 0.328 . . . . 1.27 111.656 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -99.01 113.37 64.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 2.6099999999999999 110.538 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' HB3' ' CE1' ' A' ' 43' ' ' HIS . 22.4 Cg_exo -65.29 137.66 52.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.966 2.444 . . . . 2.1299999999999999 112.515 -177.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.99 127.28 39.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 1.6299999999999999 109.836 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HD3' HG22 ' A' ' 41' ' ' THR . 3.0 pptp? -125.22 158.2 34.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.947 -0.57 . . . . 2.0099999999999998 109.922 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -148.14 171.75 15.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.652 0.263 . . . . 0.68999999999999995 110.357 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.456 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 12.0 m170 -112.82 148.47 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 2.6600000000000001 108.888 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.623 HD13 ' CG2' ' A' ' 82' ' ' VAL . 10.5 tp -66.63 114.25 5.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.546 0.689 . . . . 1.5600000000000001 111.834 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.22 75.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 113.986 -1.461 . . . . 2.0800000000000001 111.081 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 68' ' ' HIS . 6.3 pt20 -113.16 20.98 15.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 1.98 109.748 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 -10.02 64.8 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.841 -0.618 . . . . 0.78000000000000003 111.908 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.41 -24.91 17.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.998 0.428 . . . . 0.96999999999999997 110.921 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.23 128.14 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.682 -0.488 . . . . 1.25 109.682 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.549 HD12 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -95.75 -64.49 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.536 0.939 . . . . 1.3500000000000001 113.536 -174.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.455 ' H ' HG12 ' A' ' 75' ' ' ILE . 27.5 mtpt -133.07 -48.58 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.214 0.82 . . . . 2.5600000000000001 113.214 -172.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' HA3' HG13 ' A' ' 95' ' ' ILE . . . -52.41 -53.03 33.73 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.815 -0.707 . . . . 0.34000000000000002 113.225 -171.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.494 ' O ' HG22 ' A' ' 82' ' ' VAL . 6.3 m-90 -76.76 -38.29 54.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.888 0.375 . . . . 0.56000000000000005 110.285 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.459 ' OD1' HD12 ' A' ' 69' ' ' LEU . 11.6 t70 -54.28 -53.59 51.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.103 -0.953 . . . . 1.1399999999999999 112.74 -172.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.492 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -66.34 -40.22 86.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 1.3999999999999999 110.629 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.9 t -62.66 -50.02 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.98999999999999999 111.117 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.623 ' CG2' HD13 ' A' ' 69' ' ' LEU . 30.6 m -71.59 -32.84 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.338 0.496 . . . . 1.49 112.338 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.485 ' HB3' HD21 ' A' ' 69' ' ' LEU . 32.8 p -74.61 -9.61 58.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.837 0.31 . . . . 1.9399999999999999 111.837 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 t -118.67 38.87 3.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.404 0.621 . . . . 1.8700000000000001 109.39 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.865 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 5.7 mmt -111.9 -173.93 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.83 . . . . 2.79 111.083 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -134.63 171.0 14.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.148 -1.056 . . . . 4.9199999999999999 108.148 171.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.482 ' HA ' HD22 ' A' ' 122' ' ' LEU . 58.8 tttm -62.7 -31.54 72.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.204 0.446 . . . . 2.4300000000000002 112.204 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.42 25.63 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 1.4199999999999999 110.741 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 26.4 tt0 -104.23 148.58 26.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 1.6000000000000001 110.525 -176.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 79.9 tttt -145.49 129.93 17.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.946 -0.57 . . . . 1.74 110.711 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.571 ' SG ' ' HE2' ' A' ' 85' ' ' MET . 98.1 m -136.23 162.87 31.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.053 0.454 . . . . 1.3600000000000001 111.267 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' A' ' 23' ' ' LEU . 3.8 mm? -102.22 119.79 39.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 2.2999999999999998 109.791 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.0 140.53 28.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.966 -0.561 . . . . 1.46 110.927 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.799 ' HE ' HD21 ' A' ' 117' ' ' LEU . 1.3 mpt_? -99.43 112.4 24.59 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.756 -0.461 . . . . 2.29 109.756 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.581 HD12 ' HD2' ' A' ' 118' ' ' PHE . 1.8 mp -88.38 105.66 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.237 0.541 . . . . 1.2 110.145 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 1.1 tm-20 -79.37 163.79 24.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.645 -1.162 . . . . 1.3700000000000001 107.933 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.9 p -58.74 -29.81 67.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.504 0.192 . . . . 1.22 110.778 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.404 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 17.4 ptm -75.93 -9.67 58.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.883 0.373 . . . . 2.3199999999999998 111.249 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.52 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.3 m-30 -100.93 -4.48 27.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.676 -0.238 . . . . 0.92000000000000004 111.422 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.549 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -141.55 171.36 24.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.638 . . . . 0.85999999999999999 112.371 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -75.12 -57.65 3.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.735 0.303 . . . . 1.52 110.614 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 -106.44 1.79 Allowed Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.798 -0.715 . . . . 2.2999999999999998 111.861 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.4 -23.4 34.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.314 0.578 . . . . 5.8600000000000003 110.23 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -82.06 11.3 5.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.568 0.699 . . . . 4.2699999999999996 110.649 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.23 -164.85 28.44 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.008 -0.837 . . . . 2.8999999999999999 111.008 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 81.8 m -90.93 104.38 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.173 0.486 . . . . 3.7799999999999998 110.415 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.83 146.17 37.92 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.959 -0.639 . . . . 1.47 112.266 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.97 -70.61 0.24 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.977 0.418 . . . . 3.0800000000000001 110.94 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.419 ' CB ' HD13 ' A' ' 110' ' ' ILE . 37.4 m -112.15 -74.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 1.71 111.788 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.602 HG13 HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.21 60.64 9.21 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.137 0.421 . . . . 1.3700000000000001 112.137 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 31.7 Cg_endo -96.04 93.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.963 2.442 . . . . 1.5800000000000001 111.992 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.36 82.47 0.19 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.273 -0.731 . . . . 2.0499999999999998 111.273 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.1 m120 63.11 21.84 13.09 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.919 0.866 . . . . 2.2999999999999998 109.468 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.8 ' HB2' HD13 ' A' ' 48' ' ' LEU . 8.0 p -118.7 131.75 56.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.726 -1.125 . . . . 1.5700000000000001 110.389 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.4 p -86.89 135.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 1.1799999999999999 110.419 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -123.03 168.3 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 1.25 110.763 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.799 HD21 ' HE ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -122.33 112.01 17.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.052 -0.722 . . . . 1.3500000000000001 109.052 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.581 ' HD2' HD12 ' A' ' 95' ' ' ILE . 45.3 m-85 -104.07 128.29 51.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.964 0.411 . . . . 0.56000000000000005 111.076 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.64 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 44.2 mt-10 -75.65 112.14 11.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 171.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.606 HG22 HG12 ' A' ' 82' ' ' VAL . 25.4 mt -105.88 120.85 57.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.062 0.458 . . . . 1.1599999999999999 110.254 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.33 -0.85 . . . . 1.8799999999999999 109.287 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 87' ' ' LYS . 7.9 tt -91.9 135.52 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.439 . . . . 1.75 109.813 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.97 -31.27 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.663 -0.415 . . . . 1.78 112.025 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m -149.99 139.38 21.42 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.124 -0.36 . . . . 1.53 111.399 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG12 ' A' ' 40' ' ' VAL . 3.4 p90 -167.62 171.34 10.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.905 -0.776 . . . . 0.90000000000000002 108.905 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.1 153.47 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.697 0.284 . . . . 3.4700000000000002 110.99 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.04 150.41 48.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 3.3799999999999999 110.36 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 23.9 tp -162.18 45.42 0.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.334 -0.988 . . . . 3.8199999999999998 108.334 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -91.29 90.22 7.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.898 -1.046 . . . . 5.3899999999999997 112.684 -167.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -160.14 5.22 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 7.75 111.247 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -93.4 5.5 51.36 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.34 -0.544 . . . . 7.8499999999999996 111.338 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -133.38 82.46 1.99 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.741 -0.384 . . . . 9.5500000000000007 110.912 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -172.84 136.61 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.697 -0.853 . . . . 10.23 108.697 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.3 t60 62.47 -141.73 0.41 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.269 -0.641 . . . . 12.85 109.269 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.681 -0.676 . . . . 13.970000000000001 110.278 176.456 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.792 0.329 . . . . 7.8200000000000003 110.536 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 p -144.42 145.67 32.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.75 -0.659 . . . . 6.2699999999999996 109.635 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -72.13 140.64 48.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.536 -0.913 . . . . 4.75 108.536 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -78.67 69.97 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.586 -0.279 . . . . 4.4400000000000004 111.707 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 63.82 115.93 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.226 -0.897 . . . . 4.9000000000000004 113.074 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.28 70.69 6.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.924 -0.58 . . . . 3.6099999999999999 109.65 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.12 138.6 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.028 -0.533 . . . . 4.54 110.959 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -96.62 156.98 16.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.888 -0.596 . . . . 2.71 109.605 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 7.0 mptt -101.64 142.63 32.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.344 -0.243 . . . . 2.4399999999999999 110.344 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.7 t -103.89 118.73 51.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.73 -0.47 . . . . 1.3100000000000001 109.73 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.88 126.99 46.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.419 -0.355 . . . . 2.1600000000000001 110.842 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt 50.1 51.15 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.589 -0.732 . . . . 2.04 112.12 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -55.51 151.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 1.26 110.967 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -8.54 13.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.363 0.505 . . . . 1.3700000000000001 112.363 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 80' ' ' ILE . 7.1 t70 -82.31 24.33 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.022 0.439 . . . . 2.3999999999999999 111.066 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.07 -7.42 9.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.026 -0.607 . . . . 0.83999999999999997 114.163 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.43 76.07 1.08 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.415 -0.898 . . . . 0.62 113.942 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 9.4 t -143.76 150.21 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.611 -0.514 . . . . 1.1799999999999999 109.611 175.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mm -85.27 109.89 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 123.237 0.335 . . . . 1.1799999999999999 110.162 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -123.64 147.08 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.272 0.558 . . . . 1.96 111.349 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.1 m -119.08 122.26 41.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.502 -0.772 . . . . 1.21 110.365 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.589 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.7 tp -71.7 131.95 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 1.3 111.315 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 1.6 mm? -121.94 -59.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 1.3999999999999999 110.916 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 88' ' ' ASN . 37.1 ttpt -128.65 154.82 45.88 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.217 -0.66 . . . . 2.0600000000000001 109.217 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -125.23 156.39 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.894 0.378 . . . . 3.25 111.106 -173.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.39 163.2 14.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.815 -0.914 . . . . 1.3200000000000001 110.815 170.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -87.51 -97.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.336 0.568 . . . . 2.77 110.648 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.94 155.99 18.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.515 -0.55 . . . . 2.6400000000000001 109.515 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.504 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 171.68 62.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.092 -1.051 . . . . 1.3 112.299 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.83 -41.65 99.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.009 0.433 . . . . 2.29 110.318 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.79 20.81 13.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.728 0.775 . . . . 2.6400000000000001 110.466 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HB3' HH21 ' A' ' 86' ' ' ARG . 0.2 OUTLIER -135.9 78.3 1.71 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 1.49 109.929 175.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG22 ' HG2' ' A' ' 35' ' ' LYS . 36.0 mm -136.58 123.87 14.34 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 1.3700000000000001 110.811 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 121.49 7.86 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.69 2.26 . . . . 0.84999999999999998 110.911 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -135.73 150.47 49.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.013 -0.429 . . . . 3.1400000000000001 111.263 -178.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -60.4 132.03 52.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.774 -0.648 . . . . 2.9100000000000001 109.857 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -22.36 31.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.475 -0.65 . . . . 1.1899999999999999 111.475 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -104.05 130.97 51.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.851 -0.425 . . . . 1.3799999999999999 109.851 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -69.07 109.21 3.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.051 -0.522 . . . . 2.2000000000000002 111.765 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 69' ' ' LEU . 22.3 m -99.56 154.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.886 -0.597 . . . . 1.3300000000000001 109.693 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -122.43 113.01 18.76 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.407 -0.59 . . . . 1.23 109.407 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.84 159.85 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.019 0.748 . . . . 1.6200000000000001 113.019 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -111.85 128.21 56.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 3.5600000000000001 108.901 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.691 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 55.0 p90 -131.25 139.34 49.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.205 0.526 . . . . 0.88 111.54 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -168.63 158.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.401 -0.962 . . . . 1.1899999999999999 108.401 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.53 -130.87 1.74 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.926 -1.13 . . . . 0.37 112.434 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.71 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 62.4 pttt -156.19 170.05 23.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.13 0.49 . . . . 1.96 111.028 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 tp -82.76 101.64 11.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.811 -0.632 . . . . 1.1200000000000001 110.079 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 44.5 tt0 -57.54 -33.1 67.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.88 0.371 . . . . 1.96 110.942 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -57.27 -19.62 22.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 1.1100000000000001 112.106 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 t -138.22 -8.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.792 -0.363 . . . . 1.24 111.709 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.07 83.14 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.217 -0.516 . . . . 0.78000000000000003 112.981 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 12.8 mmmm -87.99 120.96 29.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.707 0.289 . . . . 3.2999999999999998 110.99 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.71 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 13.6 p -75.56 151.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.591 . . . . 1.3400000000000001 110.195 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.469 ' CE1' HD13 ' A' ' 110' ' ' ILE . 17.7 m-30 -73.85 127.39 32.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.96999999999999997 111.015 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -141.39 85.76 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.868 0.842 . . . . 2.1800000000000002 110.2 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 m -122.57 -175.93 3.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.234 -0.654 . . . . 1.6799999999999999 109.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.4 m -72.31 -47.03 53.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.752 0.31 . . . . 1.8600000000000001 111.604 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -96.42 -36.76 10.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.964 0.727 . . . . 2.1200000000000001 112.964 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 47.7 p-10 -60.62 -45.38 94.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.586 0.587 . . . . 2.1899999999999999 112.586 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.89 15.38 5.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.214 0.531 . . . . 3.1899999999999999 110.775 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.05 -47.09 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 1.27 111.793 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 7.1 p -114.38 124.89 29.96 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 2.6099999999999999 110.947 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 2.8 Cg_exo -75.83 120.67 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.046 2.497 . . . . 2.1299999999999999 111.788 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.44 146.72 23.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.436 -0.579 . . . . 1.6299999999999999 109.436 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 162.08 37.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.331 -0.395 . . . . 2.0099999999999998 110.755 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CE1' HG13 ' A' ' 74' ' ' VAL . 41.0 p90 -144.74 175.63 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.68999999999999995 110.302 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.456 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.8 m-70 -111.4 147.79 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.296 -0.631 . . . . 2.6600000000000001 109.296 173.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.508 ' HB2' HG22 ' A' ' 40' ' ' VAL . 16.9 tp -72.02 127.02 31.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.403 . . . . 1.5600000000000001 109.911 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 64.44 72.78 0.44 Allowed 'General case' 0 C--N 1.331 -0.206 0 O-C-N 124.15 0.906 . . . . 2.0800000000000001 111.453 -175.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -130.35 14.71 5.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.326 -0.852 . . . . 1.98 109.597 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.92 -17.44 31.73 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.78000000000000003 113.11 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.36 -39.41 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.058 0.456 . . . . 0.96999999999999997 111.465 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 67' ' ' PHE . 18.1 m -97.97 127.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.108 -0.496 . . . . 1.25 110.456 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.698 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.61 -68.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.537 0.569 . . . . 1.3500000000000001 112.537 -175.049 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.698 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -139.95 -45.97 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.231 0.456 . . . . 2.5600000000000001 112.231 -175.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.75 -53.16 34.31 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.12 -0.562 . . . . 0.34000000000000002 113.275 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.443 ' O ' HG21 ' A' ' 82' ' ' VAL . 20.2 m-90 -75.8 -31.87 59.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.9 0.381 . . . . 0.56000000000000005 110.628 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' HD11 ' A' ' 69' ' ' LEU . 22.1 t0 -53.98 -52.88 59.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.201 -0.909 . . . . 1.1399999999999999 112.068 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.87 -41.07 81.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.903 0.383 . . . . 1.3999999999999999 111.191 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.655 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 25.4 t -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.712 -0.395 . . . . 0.98999999999999999 111.385 -176.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 HD12 ' A' ' 69' ' ' LEU . 34.9 m -67.96 -32.03 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.97 0.414 . . . . 1.49 110.173 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -64.76 -27.17 68.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 1.9399999999999999 110.802 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 t -101.43 24.66 9.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.815 -0.629 . . . . 1.8700000000000001 110.812 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.895 ' HA ' ' HE3' ' A' ' 85' ' ' MET . 5.1 mmt -104.98 -173.32 2.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.561 -0.29 . . . . 2.79 110.921 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 24.1 mtp-105 -151.99 175.01 12.95 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.937 -0.764 . . . . 4.9199999999999999 108.937 170.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -61.27 -24.32 66.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.061 0.458 . . . . 2.4300000000000002 111.254 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.45 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 35.3 m-80 -130.37 28.62 4.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.444 -0.344 . . . . 1.4199999999999999 110.966 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 28.4 tt0 -121.19 142.85 49.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.58 -0.526 . . . . 1.6000000000000001 109.58 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.551 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.32 130.24 16.23 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.713 -0.477 . . . . 1.74 109.713 -171.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.589 ' SG ' HD12 ' A' ' 22' ' ' ILE . 96.9 m -141.96 171.68 13.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 1.3600000000000001 111.996 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.7 134.76 46.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.36 -0.836 . . . . 2.2999999999999998 110.015 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.655 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.1 p -112.93 140.96 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.901 0.382 . . . . 1.46 111.165 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.594 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.09 112.48 25.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.919 -0.582 . . . . 2.29 110.263 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.459 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.8 mp -95.84 102.1 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 1.2 110.03 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 24.7 tt0 -83.89 168.74 15.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.43 -0.952 . . . . 1.3700000000000001 108.43 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.4 p -53.22 -36.05 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.0 0.37 . . . . 1.22 112.0 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.52 -7.47 54.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.366 -0.379 . . . . 2.3199999999999998 111.801 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -100.44 0.03 38.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.576 0.227 . . . . 0.92000000000000004 111.265 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.07 -165.15 11.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.891 -0.671 . . . . 0.85999999999999999 111.928 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -82.61 -48.7 10.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.876 0.338 . . . . 1.52 111.102 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.09 -168.48 21.4 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.096 -1.049 . . . . 2.2999999999999998 113.108 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.93 -36.26 79.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.038 0.535 . . . . 5.8600000000000003 111.647 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -87.08 7.25 28.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.763 -0.653 . . . . 4.2699999999999996 111.427 -171.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.93 164.71 12.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.765 -0.731 . . . . 2.8999999999999999 111.769 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.5 m -90.03 123.43 33.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.973 0.416 . . . . 3.7799999999999998 111.029 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.593 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -111.43 -158.55 15.05 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.927 -0.579 . . . . 1.47 111.826 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.35 -71.42 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.217 0.508 . . . . 3.0800000000000001 111.865 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.474 ' HB2' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -79.76 -76.02 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 1.71 111.985 -172.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -152.69 87.34 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.139 -0.689 . . . . 1.3700000000000001 109.139 175.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -95.73 -171.7 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.489 2.793 . . . . 1.5800000000000001 113.196 -174.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.87 -143.51 13.85 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.61 -0.596 . . . . 2.0499999999999998 111.61 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -101.14 1.52 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.907 0.384 . . . . 2.2999999999999998 110.599 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 p -82.43 158.27 23.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.928 -0.578 . . . . 1.5700000000000001 110.939 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.83 132.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 1.1799999999999999 111.095 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.18 155.13 32.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 1.25 109.695 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.644 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -124.67 127.64 47.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 1.3500000000000001 110.48 172.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -122.74 141.31 51.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.814 -0.63 . . . . 0.56000000000000005 110.589 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.691 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 40.3 mt-10 -76.54 121.5 23.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.846 -0.798 . . . . 1.46 108.846 169.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.542 ' HB ' ' HG ' ' A' ' 81' ' ' CYS . 13.1 mt -106.8 127.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.524 -0.547 . . . . 1.1599999999999999 109.524 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -134.16 111.02 9.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.051 -0.977 . . . . 1.8799999999999999 110.354 -169.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 24.9 tp -84.8 96.92 9.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 1.75 109.991 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.14 -21.9 24.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 1.78 111.349 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -173.17 163.54 4.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.503 -0.317 . . . . 1.53 110.203 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.24 174.12 8.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.90000000000000002 110.201 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -137.21 138.79 40.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.431 . . . . 3.4700000000000002 110.904 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -100.04 128.58 46.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.555 -0.748 . . . . 3.3799999999999999 110.207 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.5 tp -165.95 134.45 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 3.8199999999999998 111.157 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -92.34 -78.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.546 -0.538 . . . . 5.3899999999999997 109.546 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -173.29 155.26 2.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.627 -0.879 . . . . 7.75 108.627 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -111.36 151.1 28.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.604 0.24 . . . . 7.8499999999999996 111.323 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 70.96 158.17 0.18 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.195 0.935 . . . . 9.5500000000000007 112.822 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.0 m170 70.0 179.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.931 -1.031 . . . . 10.23 111.147 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 74.77 139.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.565 0.746 . . . . 12.85 111.156 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.4 p80 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.856 -0.593 . . . . 13.970000000000001 110.144 176.606 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.212 0.53 . . . . 3.6000000000000001 111.328 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.06 150.84 21.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.393 -0.821 . . . . 2.71 109.156 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -98.9 151.58 20.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.898 -0.408 . . . . 1.8799999999999999 109.898 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -101.42 104.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.545 -0.909 . . . . 0.58999999999999997 108.545 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.54 108.49 20.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.222 -0.899 . . . . 2.1600000000000001 110.825 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 84.1 mt 65.01 69.5 0.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 1.45 110.406 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -65.21 163.7 14.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.838 -0.619 . . . . 0.78000000000000003 110.571 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.37 -3.74 29.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.672 0.619 . . . . 0.81000000000000005 112.672 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.534 ' HB3' HG13 ' A' ' 80' ' ' ILE . 29.1 t70 -90.55 14.76 12.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.361 0.601 . . . . 2.3999999999999999 110.946 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.03 19.46 2.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.323 -0.942 . . . . 0.68000000000000005 114.241 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 69.03 76.64 0.45 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.639 0.615 . . . . 0.60999999999999999 114.639 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.534 ' HB ' HG21 ' A' ' 80' ' ' ILE . 96.9 t -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.85 -0.426 . . . . 0.48999999999999999 109.85 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 13.7 mm -91.86 116.02 32.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 O-C-N 123.385 0.428 . . . . 0.46999999999999997 110.594 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -135.12 146.46 48.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 1.3400000000000001 111.263 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 m -108.56 131.91 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.691 . . . . 0.5 110.356 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -80.44 120.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.109 0.48 . . . . 0.67000000000000004 111.188 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.38 -52.57 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.82999999999999996 110.632 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 39.5 ttmt -127.44 149.19 50.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.351 -0.611 . . . . 1.5600000000000001 109.351 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -115.15 140.83 48.75 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.134 0.271 . . . . 2.9500000000000002 110.325 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.03 121.7 25.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.956 -0.64 . . . . 1.3200000000000001 112.009 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.05 -60.29 4.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.342 . . . . 2.77 111.511 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -160.96 141.01 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 2.6400000000000001 110.407 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 32' ' ' ASN . . . 167.86 103.31 0.17 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.551 -0.833 . . . . 1.04 112.026 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.65 -41.62 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.598 0.714 . . . . 2.29 109.246 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -88.48 -10.4 49.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.521 -1.218 . . . . 2.6400000000000001 110.607 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.655 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.5 m-80 -84.86 75.52 10.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.989 -0.551 . . . . 1.45 111.036 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 31.8 mm -144.58 102.22 4.63 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.757 -0.656 . . . . 0.81000000000000005 110.262 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HG3' HD22 ' A' ' 122' ' ' LEU . 65.2 Cg_endo -71.81 111.33 3.12 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 123.329 2.686 . . . . 0.75 112.181 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -116.87 166.47 12.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.624 0.726 . . . . 2.6600000000000001 112.189 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 1.024 ' HE3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -70.11 153.88 42.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.891 -1.05 . . . . 2.5099999999999998 111.736 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' H ' ' HB2' ' A' ' 70' ' ' GLU . . . 86.68 -5.11 85.53 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.365 -0.834 . . . . 1.1200000000000001 111.49 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -119.85 163.8 16.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.163 0.506 . . . . 1.3799999999999999 111.119 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -87.54 121.79 30.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 2.2000000000000002 110.769 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 125' ' ' PHE . 17.8 m -132.73 156.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.217 -0.447 . . . . 0.67000000000000004 109.974 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 124' ' ' SER . 39.0 m -127.75 116.58 20.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.229 -0.442 . . . . 0.65000000000000002 109.916 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 122' ' ' LEU . 33.7 m -137.46 156.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.614 -0.266 . . . . 0.87 111.088 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.73 142.71 45.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.956 -0.757 . . . . 2.75 108.956 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -124.16 141.23 52.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.76000000000000001 110.71 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -168.77 161.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 109.251 -0.648 . . . . 0.48999999999999999 109.251 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.22 -128.61 1.79 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.312 -0.947 . . . . 0.35999999999999999 112.341 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.665 ' O ' HD12 ' A' ' 117' ' ' LEU . 18.6 pttm -156.69 173.16 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.929 0.395 . . . . 1.4299999999999999 110.805 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.627 HD22 HG13 ' A' ' 110' ' ' ILE . 65.9 tp -91.15 98.29 11.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.38 110.184 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.71 ' HB2' HD11 ' A' ' 117' ' ' LEU . 35.7 tt0 -66.58 -21.15 66.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.846 0.355 . . . . 1.96 110.704 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.518 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 23.2 t -55.89 -29.97 60.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.67000000000000004 111.48 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 53' ' ' LYS . 9.6 t -138.04 1.31 2.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.868 0.366 . . . . 0.72999999999999998 111.406 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.91 20.42 73.41 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.215 -0.517 . . . . 0.78000000000000003 112.869 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HB2' HG23 ' A' ' 51' ' ' THR . 0.2 OUTLIER -84.19 116.42 22.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.629 0.252 . . . . 2.8900000000000001 110.784 -178.155 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.2 p -70.57 150.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.58999999999999997 110.054 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 8.4 m-30 -74.92 124.52 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.971 0.415 . . . . 0.78000000000000003 111.425 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.63 85.25 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.504 0.669 . . . . 2.1800000000000002 110.674 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.409 ' HB3' ' OD1' ' A' ' 60' ' ' ASP . 46.8 t -126.53 166.59 17.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.656 -0.702 . . . . 1.24 109.227 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -71.18 -22.05 62.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.897 0.38 . . . . 1.49 111.082 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.566 ' O ' HG12 ' A' ' 63' ' ' VAL . 43.3 m-85 -95.02 -55.65 3.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.793 0.664 . . . . 1.8 112.793 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 5.5 p-10 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.548 0.573 . . . . 2.1899999999999999 112.548 -167.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -1.94 55.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.842 0.353 . . . . 2.7799999999999998 111.278 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -116.29 -53.99 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 1.1000000000000001 111.765 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 59' ' ' PHE . 13.0 p -87.09 127.27 59.99 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.441 0.638 . . . . 2.0299999999999998 111.858 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.6 Cg_exo -78.18 90.48 1.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.586 2.191 . . . . 1.76 111.027 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -94.39 132.61 38.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.148 -0.686 . . . . 1.3100000000000001 109.148 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -138.55 147.31 42.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.106 -0.497 . . . . 1.3600000000000001 110.206 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -115.47 178.35 4.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.56999999999999995 109.722 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -115.72 148.9 39.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.237 -1.023 . . . . 1.98 108.237 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.621 HD13 ' CG2' ' A' ' 82' ' ' VAL . 18.3 tp -74.36 128.91 36.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.995 0.426 . . . . 0.94999999999999996 111.226 -175.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 1.024 ' HG3' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 58.93 64.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.879 -1.055 . . . . 2.0800000000000001 112.229 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 73' ' ' GLU . 10.0 pt20 -115.84 10.13 15.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.3 -1.318 . . . . 1.98 108.967 172.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.8 -18.7 41.89 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.71999999999999997 112.772 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' HB2' HE21 ' A' ' 71' ' ' GLN . 19.9 mm-40 -76.63 -32.92 58.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.178 0.513 . . . . 0.96999999999999997 110.791 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.78 129.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.813 -0.631 . . . . 0.57999999999999996 109.725 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.657 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.93 -73.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.261 -0.427 . . . . 0.62 111.592 -175.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.657 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -138.16 -44.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.022 -0.424 . . . . 2.04 112.018 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -54.5 -53.87 35.93 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.792 -0.718 . . . . 0.32000000000000001 113.101 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.604 ' O ' HG22 ' A' ' 82' ' ' VAL . 11.4 m-90 -75.78 -36.59 59.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.439 -0.448 . . . . 0.48999999999999999 110.266 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -51.41 -53.79 33.2 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.063 0.852 . . . . 1.1399999999999999 111.951 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 15' ' ' ASP . 1.6 mp -65.23 -38.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.829 0.347 . . . . 0.78000000000000003 111.164 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.593 ' O ' ' HG2' ' A' ' 85' ' ' MET . 23.6 t -66.86 -55.85 12.94 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.888 -0.325 . . . . 0.55000000000000004 110.616 -176.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.621 ' CG2' HD13 ' A' ' 69' ' ' LEU . 29.9 m -71.76 -33.23 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.038 0.385 . . . . 0.83999999999999997 112.038 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 t -78.05 0.83 23.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.264 0.555 . . . . 1.4299999999999999 110.734 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 t -131.69 20.48 4.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.687 . . . . 1.23 109.843 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.661 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.1 mmt -90.81 -174.66 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 2.27 110.699 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 50.8 mtt85 -149.42 154.97 39.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.03 -1.1 . . . . 4.1900000000000004 108.03 172.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 62.2 tttm -65.27 -14.33 60.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.128 0.489 . . . . 1.9399999999999999 111.911 -173.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -124.06 25.08 8.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.96 0.41 . . . . 1.23 110.185 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 32.3 tt0 -123.61 166.66 15.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.862 -0.608 . . . . 1.6000000000000001 110.363 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -158.8 133.72 8.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.715 0.293 . . . . 1.1699999999999999 111.301 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.3 m -136.79 153.94 50.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.342 -0.39 . . . . 1.2 110.738 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -101.21 121.46 41.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.35 -0.611 . . . . 1.73 109.35 175.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 77' ' ' GLY . 12.6 p -106.44 145.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.453 -0.34 . . . . 0.73999999999999999 110.896 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.534 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 41.5 mmt-85 -96.5 118.14 32.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.976 -0.557 . . . . 1.71 110.497 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.2 mp -96.43 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.227 -0.657 . . . . 0.52000000000000002 109.227 175.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 99' ' ' TYR . 42.1 tt0 -92.63 173.29 7.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.975 -1.012 . . . . 1.3700000000000001 108.898 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 17.1 p -51.42 -50.05 60.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.765 0.283 . . . . 1.0 111.765 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.6 ptm -77.55 -16.82 58.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.074 0.398 . . . . 1.79 112.074 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.489 ' HB2' ' H ' ' A' ' 96' ' ' GLU . 21.7 m-30 -85.59 -17.17 37.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.177 -0.305 . . . . 0.75 110.177 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.85 -154.22 9.25 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.488 -0.778 . . . . 0.70999999999999996 111.463 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 1.52 111.847 -178.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.507 ' HB2' HD13 ' A' ' 110' ' ' ILE . 11.4 p . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 111.753 0.279 . . . . 1.52 111.753 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.627 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -144.43 84.27 9.36 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.617 0.722 . . . . 0.75 110.861 177.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -95.15 90.9 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.029 2.486 . . . . 1.5800000000000001 112.272 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.95 47.66 1.0 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.079 -1.058 . . . . 2.0499999999999998 112.302 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 3.6 m-20 60.34 21.68 11.2 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.534 0.683 . . . . 2.0299999999999998 110.76 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.518 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 7.4 m -96.46 156.55 16.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 1.1399999999999999 109.852 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -87.03 121.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.404 0.621 . . . . 0.47999999999999998 110.766 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -114.57 157.27 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.601 -0.727 . . . . 0.51000000000000001 110.159 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -116.77 129.19 55.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 110.0 -0.37 . . . . 0.69999999999999996 110.0 175.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.461 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 21.1 m-85 -122.33 122.0 38.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.598 -0.274 . . . . 0.42999999999999999 110.351 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.471 ' HG2' ' HG ' ' A' ' 92' ' ' LEU . 42.7 mt-10 -75.25 114.52 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.191 -0.67 . . . . 1.46 109.191 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.436 HD11 ' HD1' ' A' ' 78' ' ' TRP . 65.4 mt -106.76 122.29 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.913 0.387 . . . . 0.47999999999999998 110.005 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.29 115.66 22.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 109.5 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.86 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -86.0 94.43 9.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 1.1200000000000001 110.362 -176.186 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.678 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.2 pt? -86.08 -28.65 23.94 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.16 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.54 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 t -141.05 144.82 35.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.044 0.45 . . . . 1.1899999999999999 110.555 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 87' ' ' LYS . 6.1 p90 -164.47 168.16 18.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.931 -0.766 . . . . 0.71999999999999997 108.931 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -161.97 109.16 1.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 2.98 111.339 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.541 -0.754 . . . . 3.3799999999999999 110.365 176.658 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.822 0.344 . . . . 3.6000000000000001 110.466 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.28 150.07 49.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.038 0.447 . . . . 2.71 110.826 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.475 ' HG3' HG23 ' A' ' 21' ' ' THR . 3.6 mppt? -91.6 144.4 25.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 1.8799999999999999 109.605 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 41.4 t -101.34 103.85 15.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 0.58999999999999997 108.427 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -103.45 113.75 27.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.129 -0.941 . . . . 2.1600000000000001 110.66 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 19' ' ' ILE . 52.2 mt 60.67 54.65 3.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.962 0.789 . . . . 1.45 111.206 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.49 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -57.29 148.63 22.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.92 . . . . 0.78000000000000003 110.607 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.43 1.3 4.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.81000000000000005 110.502 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.1 16.64 4.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 2.3999999999999999 110.908 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.18 5.04 8.98 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.396 -0.907 . . . . 0.68000000000000005 114.114 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.34 72.26 0.9 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.226 -0.512 . . . . 0.60999999999999999 113.652 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' A' ' 80' ' ' ILE . 62.4 t -135.68 142.72 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.782 -0.451 . . . . 0.48999999999999999 109.782 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 12' ' ' LEU . 18.5 mm -88.11 114.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.721 -0.474 . . . . 0.46999999999999997 109.721 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HD2' ' SG ' ' A' ' 81' ' ' CYS . 12.1 pttp -142.4 138.51 31.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.314 0.578 . . . . 1.3400000000000001 111.418 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 24.6 m -100.02 123.81 44.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.5 110.126 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.557 HG12 ' HE2' ' A' ' 25' ' ' LYS . 8.9 tp -80.42 132.76 31.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.997 0.427 . . . . 0.67000000000000004 110.1 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' LEU . 3.9 mm? -113.68 -51.06 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.049 -0.523 . . . . 0.82999999999999996 110.983 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 117.19 19.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.454 -0.339 . . . . 1.5600000000000001 110.392 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 58.0 mttm -101.91 160.63 14.32 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.148 -0.478 . . . . 2.9500000000000002 110.312 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.42 -142.23 12.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.789 -0.719 . . . . 1.3200000000000001 111.919 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -76.0 0.56 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.961 0.41 . . . . 2.77 110.293 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.79 -178.58 3.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.136 -0.483 . . . . 2.6400000000000001 110.116 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 52.31 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.081 -0.807 . . . . 1.04 111.081 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.78 -40.64 93.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.983 0.42 . . . . 2.29 110.948 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -108.79 9.28 26.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.536 . . . . 2.6400000000000001 110.474 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -111.79 77.37 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 1.45 110.296 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.452 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 36.4 mm -132.87 120.69 16.57 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.398 -0.819 . . . . 0.81000000000000005 110.101 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.452 ' HG3' HD22 ' A' ' 122' ' ' LEU . 85.7 Cg_endo -87.04 115.9 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.815 2.343 . . . . 0.75 112.576 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HE2' ' CG2' ' A' ' 33' ' ' ILE . 71.3 mmtt -129.9 158.29 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 2.6600000000000001 111.444 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 12.1 ttmm -65.43 150.27 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.158 -0.928 . . . . 2.5099999999999998 111.365 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.2 -11.66 68.92 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.934 -0.867 . . . . 1.1200000000000001 110.934 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -105.05 155.71 18.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.517 . . . . 1.3799999999999999 110.878 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.25 104.25 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 2.2000000000000002 110.682 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 m -118.08 162.12 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 0.67000000000000004 110.655 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 31.5 m -133.45 120.91 21.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.797 -0.638 . . . . 0.65000000000000002 109.611 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.68 148.79 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.87 111.577 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.22 143.84 30.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.297 -0.631 . . . . 2.75 109.297 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 30.6 p90 -141.97 137.02 30.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.76000000000000001 110.505 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.55 160.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.125 -0.694 . . . . 0.48999999999999999 109.125 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.11 -118.88 0.68 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.539 -0.839 . . . . 0.35999999999999999 112.597 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HG3' HD11 ' A' ' 117' ' ' LEU . 55.5 pttt -149.94 171.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 1.4299999999999999 110.111 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.506 HD12 ' HG ' ' A' ' 116' ' ' LEU . 57.0 tp -87.23 98.01 11.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.879 -0.6 . . . . 0.38 109.533 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.577 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 4.9 tp10 -57.59 -35.09 69.94 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.46 0.541 . . . . 1.96 112.46 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -58.26 -20.06 39.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.372 0.508 . . . . 0.67000000000000004 112.372 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 53' ' ' LYS . 11.4 t -134.05 -30.81 1.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.971 0.415 . . . . 0.72999999999999998 110.773 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.26 15.84 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.254 -0.498 . . . . 0.78000000000000003 113.151 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' H ' HG23 ' A' ' 51' ' ' THR . 11.2 mmmm -81.49 125.33 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.932 0.366 . . . . 2.8900000000000001 110.67 177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.24 154.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.58999999999999997 110.03 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.485 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 22.0 m-30 -75.2 99.96 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.167 0.508 . . . . 0.78000000000000003 111.918 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -116.87 85.89 2.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.371 -0.974 . . . . 2.1800000000000002 108.371 168.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -135.33 158.06 45.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.62 -0.718 . . . . 1.24 110.248 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -48.67 -42.08 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.769 0.668 . . . . 1.49 112.496 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -93.88 -50.64 5.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.771 0.32 . . . . 1.8 110.609 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.66 -37.87 59.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 2.1899999999999999 112.626 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -84.53 -4.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 2.7799999999999998 111.267 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -115.49 -61.44 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.939 -0.305 . . . . 1.1000000000000001 110.569 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.19 109.61 6.96 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.32 -0.4 . . . . 2.0299999999999998 110.225 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.49 161.17 42.32 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.709 2.273 . . . . 1.76 112.137 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -94.03 154.12 17.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.079 -0.509 . . . . 1.3100000000000001 110.279 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.8 pptp? -134.47 151.1 50.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 1.3600000000000001 110.263 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.68 -171.85 2.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.37 -0.377 . . . . 0.56999999999999995 110.989 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -116.72 149.2 40.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.289 -0.634 . . . . 1.98 109.289 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 HG21 ' A' ' 82' ' ' VAL . 9.8 tp -67.81 112.86 5.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.94999999999999996 111.89 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.97 73.11 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.334 -1.303 . . . . 2.0800000000000001 111.63 176.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -113.44 17.43 18.43 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.187 -1.042 . . . . 1.98 108.187 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.99 -18.28 55.99 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.585 -1.189 . . . . 0.71999999999999997 113.062 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.25 -14.54 28.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.956 0.378 . . . . 0.96999999999999997 111.446 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.15 121.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.643 0.735 . . . . 0.57999999999999996 109.751 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.431 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -99.37 -62.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.08 -0.964 . . . . 0.62 112.774 -172.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -125.92 -66.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.278 0.473 . . . . 2.04 112.278 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.33 -52.6 35.82 Favored Glycine 0 C--N 1.333 0.384 0 O-C-N 123.56 0.538 . . . . 0.32000000000000001 113.59 -169.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.45 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.9 m-90 -75.39 -46.44 32.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.769 0.318 . . . . 0.48999999999999999 110.393 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.36 -48.26 65.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.026 -0.988 . . . . 1.1399999999999999 112.251 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.593 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -73.89 -45.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.488 -0.324 . . . . 0.78000000000000003 110.894 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.489 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 53.1 t -63.56 -41.8 98.4 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.591 0.219 . . . . 0.55000000000000004 111.591 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.607 HG21 HD13 ' A' ' 69' ' ' LEU . 34.4 m -67.66 -32.34 56.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.768 -0.373 . . . . 0.83999999999999997 110.805 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.1 m -79.48 -4.0 49.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.946 0.403 . . . . 1.4299999999999999 111.169 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.425 ' OG ' ' HE2' ' A' ' 20' ' ' LYS . 9.7 p -124.01 39.32 3.99 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.227 0.537 . . . . 1.23 111.096 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.497 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 0.1 OUTLIER -116.13 174.57 5.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 2.27 110.488 176.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 86' ' ' ARG . 6.1 ttm180 -127.51 163.36 24.31 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.36 -1.348 . . . . 4.1900000000000004 107.36 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -64.42 -17.55 63.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.238 0.542 . . . . 1.9399999999999999 110.846 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -122.81 16.73 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.069 -0.514 . . . . 1.23 110.703 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 25' ' ' LYS . 33.6 tt0 -123.7 129.38 51.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 1.6000000000000001 110.642 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.476 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 85.4 tttt -136.58 143.75 43.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 1.1699999999999999 109.894 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 21' ' ' THR . 28.8 p -149.79 165.26 33.0 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.001 0.429 . . . . 1.2 111.733 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.97 120.65 32.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.291 -0.868 . . . . 1.73 110.007 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.489 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.5 p -99.89 134.59 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.286 -0.415 . . . . 0.73999999999999999 110.096 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 26.2 mmm-85 -96.1 111.38 23.43 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.463 -0.569 . . . . 1.71 109.463 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.426 HD13 ' CD2' ' A' ' 118' ' ' PHE . 2.1 mp -91.44 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.019 -0.734 . . . . 0.52000000000000002 109.019 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 97' ' ' SER . 43.7 tt0 -79.7 168.52 19.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.313 -0.858 . . . . 1.3700000000000001 109.449 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -48.16 -48.48 34.32 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.323 0.649 . . . . 1.0 111.463 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -78.56 -8.07 58.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.362 0.504 . . . . 1.79 112.362 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -96.25 -12.86 23.95 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.237 -0.289 . . . . 0.75 110.848 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 176.06 19.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.847 -0.692 . . . . 0.70999999999999996 112.36 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.916 0.388 . . . . 1.52 110.996 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.147 -0.686 . . . . 1.52 109.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.449 HG13 HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -143.62 112.38 5.43 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.35 -0.387 . . . . 0.75 110.095 175.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -83.06 -83.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.516 2.144 . . . . 1.5800000000000001 112.831 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.89 18.16 59.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.952 -0.36 . . . . 2.0499999999999998 113.694 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 52.65 35.39 18.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.006 0.431 . . . . 2.0299999999999998 111.181 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.3 m -107.77 179.49 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 1.1399999999999999 110.67 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.33 129.57 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.174 0.512 . . . . 0.47999999999999998 111.008 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.506 ' HG ' HD12 ' A' ' 48' ' ' LEU . 6.3 mp -127.21 174.82 8.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.297 -0.631 . . . . 0.51000000000000001 109.297 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.631 ' HB3' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -147.01 133.04 19.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.29 0.567 . . . . 0.69999999999999996 110.578 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.485 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 43.6 m-85 -127.98 141.76 51.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.42999999999999999 110.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.3 mt-10 -76.26 127.15 32.32 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.062 -0.718 . . . . 1.46 109.062 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.7 mt -105.89 118.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.601 0.715 . . . . 0.47999999999999998 110.216 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -110.68 116.0 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.687 -1.142 . . . . 1.8799999999999999 110.458 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 34' ' ' PRO . 30.3 tp -91.89 89.6 7.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 1.1200000000000001 109.977 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.7 pt? -95.17 -33.32 12.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.042 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 13.8 m -135.12 128.18 31.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.024 -0.362 . . . . 1.1899999999999999 110.024 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.25 171.16 11.01 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.559 -0.534 . . . . 0.71999999999999997 109.559 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -162.11 168.49 22.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.007 -0.368 . . . . 2.98 110.007 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 108.139 -1.06 . . . . 3.3799999999999999 108.139 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.236 0.368 0 CA-C-O 121.271 0.558 . . . . 3.6000000000000001 111.57 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -94.14 153.99 17.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.013 -0.994 . . . . 2.71 110.053 -175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 11.5 mptt -114.73 147.51 39.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.765 0.317 . . . . 1.8799999999999999 110.697 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.98 108.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.536 -0.542 . . . . 0.58999999999999997 109.536 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -89.45 125.06 35.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.237 0.542 . . . . 2.1600000000000001 111.421 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' H ' HD13 ' A' ' 19' ' ' ILE . 11.1 tp 54.76 64.38 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.953 -1.021 . . . . 1.45 111.027 174.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 80' ' ' ILE . 9.0 t -59.16 156.03 12.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.636 -0.711 . . . . 0.78000000000000003 111.61 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -19.86 64.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.743 -0.662 . . . . 0.81000000000000005 112.588 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.62 19.93 1.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.324 0.49 . . . . 2.3999999999999999 112.324 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.64 30.64 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.68000000000000005 114.429 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.85 83.6 0.06 OUTLIER Glycine 0 C--O 1.227 -0.334 0 N-CA-C 114.648 0.619 . . . . 0.60999999999999999 114.648 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' THR . 55.0 t -141.21 140.1 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.38 -0.6 . . . . 0.48999999999999999 109.38 174.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 12' ' ' LEU . 10.0 mm -93.07 113.58 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.228 0.33 . . . . 0.46999999999999997 110.113 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -141.27 146.9 37.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.338 0.59 . . . . 1.3400000000000001 111.616 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -109.68 138.65 45.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.106 -0.952 . . . . 0.5 110.113 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.84 132.3 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.234 -0.284 . . . . 0.67000000000000004 110.234 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 92' ' ' LEU . 3.5 mm? -115.57 -51.58 2.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.456 -0.338 . . . . 0.82999999999999996 110.64 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 29.1 ttmt -122.9 135.07 54.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.726 -0.472 . . . . 1.5600000000000001 109.726 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -99.63 147.12 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 123.46 0.475 . . . . 2.9500000000000002 110.785 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 171.4 52.15 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 116.028 -0.533 . . . . 1.3200000000000001 111.939 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.55 -65.92 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 2.77 110.768 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -151.7 153.05 33.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 2.6400000000000001 110.074 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.43 100.8 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.181 -1.009 . . . . 1.04 112.98 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -74.63 -42.33 58.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.574 . . . . 2.29 109.793 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -81.4 -23.31 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.377 -0.829 . . . . 2.6400000000000001 110.663 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.69 75.78 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.421 0.629 . . . . 1.45 109.611 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mm -146.4 118.78 4.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.735 -1.12 . . . . 0.81000000000000005 109.209 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HG3' HD22 ' A' ' 122' ' ' LEU . 20.3 Cg_endo -60.78 124.73 15.57 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.799 2.333 . . . . 0.75 111.716 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -116.37 149.54 39.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.601 -0.518 . . . . 2.6600000000000001 109.601 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -77.19 144.54 38.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.416 -0.514 . . . . 2.5099999999999998 110.633 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.34 -22.31 41.32 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.162 -0.775 . . . . 1.1200000000000001 111.162 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -99.33 169.96 8.98 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.079 -0.341 . . . . 1.3799999999999999 110.079 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.05 125.63 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.286 0.565 . . . . 2.2000000000000002 111.324 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG12 ' HB2' ' A' ' 125' ' ' PHE . 19.0 m -135.12 160.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.598 -0.728 . . . . 0.67000000000000004 109.235 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 28.6 m -130.51 111.85 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.407 -0.59 . . . . 0.65000000000000002 109.407 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.26 153.34 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.87 111.751 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -116.18 130.25 56.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 2.75 109.022 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 21.8 p90 -127.23 144.3 51.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.788 0.327 . . . . 0.76000000000000001 110.143 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -167.82 158.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.892 -0.781 . . . . 0.48999999999999999 108.892 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.67 -130.35 1.98 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.841 -1.171 . . . . 0.35999999999999999 113.05 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.744 ' HG3' HD13 ' A' ' 117' ' ' LEU . 57.2 pttt -157.38 173.07 17.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.377 . . . . 1.4299999999999999 110.682 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.46 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 66.7 tp -94.53 109.34 21.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 0.38 110.28 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' HD11 ' A' ' 117' ' ' LEU . 24.2 tt0 -68.43 -20.69 64.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.204 0.526 . . . . 1.96 110.091 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.445 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 39.7 t -55.1 -43.27 73.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.154 -0.93 . . . . 0.67000000000000004 111.328 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.459 HG22 HD23 ' A' ' 48' ' ' LEU . 8.8 t -124.38 3.31 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.72999999999999998 111.41 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.35 78.51 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 120.902 -0.666 . . . . 0.78000000000000003 113.039 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 67.0 mmtt -91.82 132.92 36.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 2.8900000000000001 110.917 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.661 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.8 p -75.84 166.84 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 0.58999999999999997 109.95 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.96 117.99 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.431 0.634 . . . . 0.78000000000000003 110.582 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.72 95.01 2.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.113 -0.949 . . . . 2.1800000000000002 109.42 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 m -137.4 171.2 14.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.933 0.397 . . . . 1.24 110.337 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -70.41 -33.7 71.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.15 -0.477 . . . . 1.49 110.9 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -92.33 -35.93 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.541 0.571 . . . . 1.8 112.541 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -33.77 74.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.819 0.342 . . . . 2.1899999999999999 111.544 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.71 -12.15 51.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.051 0.453 . . . . 2.7799999999999998 110.941 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -112.24 -61.04 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.129 -0.487 . . . . 1.1000000000000001 111.815 -172.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -119.25 104.09 46.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.598 -0.274 . . . . 2.0299999999999998 110.289 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.42 147.83 47.44 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.086 2.524 . . . . 1.76 112.035 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -101.99 150.39 23.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.295 -0.411 . . . . 1.3100000000000001 109.929 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.09 146.35 31.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 1.3600000000000001 109.792 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -127.59 -177.32 4.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.895 0.379 . . . . 0.56999999999999995 111.278 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -118.51 149.81 40.67 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.363 -0.606 . . . . 1.98 109.363 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 82' ' ' VAL . 15.9 tp -75.87 117.08 17.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.026 0.38 . . . . 0.94999999999999996 112.026 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 68.26 48.79 0.87 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.187 -0.915 . . . . 2.0800000000000001 112.395 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 1.3 pm0 -92.33 0.67 57.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.096 -0.705 . . . . 1.98 109.096 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.37 1.38 44.09 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.71999999999999997 113.091 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 7.9 mm-40 -99.04 -24.27 14.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.412 0.606 . . . . 0.96999999999999997 111.255 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.8 123.64 57.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.923 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.539 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -97.17 -62.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 0.62 112.293 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.626 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 8.7 mmpt? -129.2 -61.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 2.04 112.494 -172.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 -53.21 34.38 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.065 -0.588 . . . . 0.32000000000000001 113.459 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.572 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.0 m-90 -75.24 -37.12 61.17 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.841 -0.211 . . . . 0.48999999999999999 110.644 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.75 -52.09 57.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.826 0.703 . . . . 1.1399999999999999 111.685 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.576 HG21 HG21 ' A' ' 13' ' ' THR . 2.4 mp -74.26 -41.89 50.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 0.78000000000000003 110.995 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.51 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 44.6 t -60.33 -51.03 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.55000000000000004 111.589 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 69' ' ' LEU . 28.6 m -67.69 -43.1 86.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 111.975 0.361 . . . . 0.83999999999999997 111.975 -174.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.429 ' OG ' HD21 ' A' ' 69' ' ' LEU . 21.6 m -70.16 -14.92 62.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.028 0.442 . . . . 1.4299999999999999 111.463 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -99.46 24.95 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.367 -0.379 . . . . 1.23 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.592 ' HE1' ' HA ' ' A' ' 82' ' ' VAL . 37.2 mtm -118.83 -173.58 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.215 0.531 . . . . 2.27 111.214 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.498 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 53.5 mtm180 -142.2 175.46 9.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.155 -0.93 . . . . 4.1900000000000004 109.271 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -62.31 -16.88 56.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.563 0.579 . . . . 1.9399999999999999 112.563 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -135.32 29.4 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 1.23 110.747 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 4.5 tt0 -113.91 153.95 28.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.527 -0.546 . . . . 1.6000000000000001 109.527 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.545 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 1.5 tmtp? -143.58 127.49 17.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.972 -0.291 . . . . 1.1699999999999999 110.955 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 71.2 m -127.61 151.45 48.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.222 -0.445 . . . . 1.2 111.425 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.457 ' HB2' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -107.29 118.96 38.1 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.151 -0.685 . . . . 1.73 109.151 173.01 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.2 p -109.7 141.89 23.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.243 0.544 . . . . 0.73999999999999999 111.43 -173.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -99.29 117.44 33.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 1.71 109.88 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.9 mp -96.92 104.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.462 . . . . 0.52000000000000002 109.751 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 97' ' ' SER . 28.9 tt0 -83.76 170.87 13.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.787 -0.82 . . . . 1.3700000000000001 108.787 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 9.5 p -49.6 -49.9 44.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.526 0.33 . . . . 1.0 111.85 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.9 ptp -76.61 -13.5 60.06 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.236 -0.438 . . . . 1.79 111.635 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 16.1 m-30 -84.54 -5.84 59.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.871 0.367 . . . . 0.75 110.149 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -138.39 -161.2 8.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.55 -0.75 . . . . 0.70999999999999996 111.52 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 1.52 110.975 179.615 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.673 -0.491 . . . . 1.52 109.673 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -143.21 117.0 6.13 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.75 110.452 176.327 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -80.56 -68.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.015 1.81 . . . . 1.5800000000000001 111.717 170.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.87 1.25 17.2 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.176 -0.466 . . . . 2.0499999999999998 113.409 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 m120 60.88 27.71 17.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.192 0.52 . . . . 2.0299999999999998 110.917 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -119.7 -163.69 1.01 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.896 -0.593 . . . . 1.1399999999999999 110.307 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 7.6 p -108.17 130.05 61.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.309 0.576 . . . . 0.47999999999999998 111.775 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -112.94 161.89 16.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 109.79 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.744 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.28 116.82 28.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.494 -0.558 . . . . 0.69999999999999996 109.494 175.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.425 ' HD2' HD13 ' A' ' 95' ' ' ILE . 29.4 m-85 -113.87 125.0 53.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 0.42999999999999999 111.045 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 47.9 mt-10 -80.13 113.96 18.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.463 -0.789 . . . . 1.46 109.081 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.599 HG21 HG12 ' A' ' 82' ' ' VAL . 40.0 mt -107.93 123.94 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.028 0.442 . . . . 0.47999999999999998 110.352 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 18.3 mt-10 -127.87 130.33 48.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.646 -0.706 . . . . 1.8799999999999999 109.875 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 34' ' ' PRO . 25.6 tp -91.82 100.4 13.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 1.1200000000000001 110.341 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.5 OUTLIER -89.74 -30.2 18.19 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.082 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.454 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 58.0 m -150.41 147.76 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.436 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' HB2' HG12 ' A' ' 40' ' ' VAL . 2.0 p90 -165.05 159.62 18.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.71999999999999997 109.352 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 126' ' ' ARG . 2.3 ptm180 -158.63 113.72 2.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.95 0.405 . . . . 2.98 111.352 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.363 -0.38 . . . . 3.3799999999999999 110.758 175.818 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.267 0.556 . . . . 3.6000000000000001 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.85 143.07 42.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 2.71 110.447 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.18 136.27 47.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 1.8799999999999999 109.84 -174.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.6 107.65 23.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.601 -0.518 . . . . 0.58999999999999997 109.601 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HB2' HD12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -102.58 134.95 45.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.138 -0.483 . . . . 2.1600000000000001 111.462 -176.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt 56.64 51.74 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.248 -0.887 . . . . 1.45 112.493 171.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -61.29 153.65 25.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.275 -0.42 . . . . 0.78000000000000003 110.117 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.9 1.07 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.688 0.625 . . . . 0.81000000000000005 112.688 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.64 24.81 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 2.3999999999999999 111.264 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.47 10.42 5.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.378 -0.915 . . . . 0.68000000000000005 114.011 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 57.75 67.14 2.36 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.892 0.717 . . . . 0.60999999999999999 114.892 170.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG21 ' HB ' ' A' ' 80' ' ' ILE . 25.6 t -116.83 139.21 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 122.285 -0.538 . . . . 0.48999999999999999 110.58 173.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 94' ' ' ARG . 5.6 mm -88.18 109.34 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.214 -0.661 . . . . 0.46999999999999997 109.214 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -125.66 146.23 49.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.393 0.616 . . . . 1.3400000000000001 111.222 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 m -114.07 121.43 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.419 -0.81 . . . . 0.5 109.603 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.522 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 tp -72.43 125.96 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.883 0.373 . . . . 0.67000000000000004 111.565 -174.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.03 -63.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.17 0.509 . . . . 0.82999999999999996 109.954 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 50.7 mtmt -117.6 134.9 54.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 1.5600000000000001 108.981 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -102.99 139.46 38.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.754 0.311 . . . . 2.9500000000000002 110.985 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 134.26 12.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.77 -0.729 . . . . 1.3200000000000001 111.718 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.9 -65.32 1.02 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.827 -0.435 . . . . 2.77 109.827 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -96.0 144.17 26.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.0 -0.545 . . . . 2.6400000000000001 109.548 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.556 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -154.34 14.54 0.55 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.547 -0.835 . . . . 1.04 111.852 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.21 -21.05 62.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 2.29 110.406 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' C ' HD22 ' A' ' 32' ' ' ASN . 47.4 mt-10 -115.18 14.49 16.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.773 -0.649 . . . . 2.6400000000000001 109.927 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.556 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -138.78 80.86 1.81 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.083 -0.508 . . . . 1.45 111.4 -172.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.82 113.03 27.0 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.223 0.535 . . . . 0.81000000000000005 111.923 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.2 Cg_endo -91.04 111.08 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.963 2.442 . . . . 0.75 112.384 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 27.9 mmtp -136.64 -173.68 3.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.6600000000000001 110.951 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.36 152.94 20.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 2.5099999999999998 110.726 -176.327 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.27 -5.19 38.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.744 . . . . 1.1200000000000001 111.904 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' HG13 ' A' ' 40' ' ' VAL . 31.4 p30 -135.24 -175.77 4.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.74 0.305 . . . . 1.3799999999999999 110.513 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -96.99 94.21 7.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 2.2000000000000002 110.743 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 ' OD1' ' A' ' 38' ' ' ASN . 9.6 m -97.85 122.22 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.903 -0.777 . . . . 0.67000000000000004 108.903 168.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.542 HG23 ' HD3' ' A' ' 66' ' ' LYS . 27.0 m -96.72 111.42 23.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.198 0.523 . . . . 0.65000000000000002 109.96 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 120' ' ' ILE . 54.1 t -117.24 130.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.499 -0.773 . . . . 0.87 110.329 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -101.79 127.96 48.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.204 -0.665 . . . . 2.75 109.204 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 6.6 p90 -128.23 144.5 51.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 0.76000000000000001 111.105 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -166.38 144.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.557 -0.747 . . . . 0.48999999999999999 109.841 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 118' ' ' PHE . . . -171.02 -139.91 2.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.613 -0.803 . . . . 0.35999999999999999 112.135 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 64.7 pttt -157.69 172.3 18.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 1.4299999999999999 110.886 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 114' ' ' SER . 60.7 tp -85.55 101.15 12.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.046 -0.525 . . . . 0.38 110.539 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 40.8 tt0 -68.42 -25.87 65.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.771 0.319 . . . . 1.96 110.935 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -54.38 -27.1 34.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 0.67000000000000004 111.543 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.576 HG23 ' HB2' ' A' ' 53' ' ' LYS . 14.8 t -139.18 9.05 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.051 0.453 . . . . 0.72999999999999998 110.482 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.13 41.59 98.18 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.635 -0.711 . . . . 0.78000000000000003 112.755 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.576 ' HB2' HG23 ' A' ' 51' ' ' THR . 4.3 tmtt? -102.83 118.34 36.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 2.8900000000000001 110.29 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.7 p -74.1 160.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.58999999999999997 109.856 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 13.0 m-30 -78.0 124.58 28.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 111.083 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.95 88.27 2.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.854 0.835 . . . . 2.1800000000000002 109.306 171.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.8 m -136.48 172.97 12.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.596 -0.729 . . . . 1.24 111.19 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -71.6 -23.83 61.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.79 -0.641 . . . . 1.49 110.865 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -93.83 -51.1 5.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.147 0.795 . . . . 1.8 113.147 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.8 -43.23 85.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.335 0.397 . . . . 2.1899999999999999 111.996 -168.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -92.22 9.34 34.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.928 0.394 . . . . 2.7799999999999998 111.602 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -115.7 -64.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.283 -0.417 . . . . 1.1000000000000001 111.597 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.8 m -105.01 127.56 28.48 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.384 0.611 . . . . 2.0299999999999998 111.997 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.5 Cg_endo -83.44 111.29 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.956 2.437 . . . . 1.76 111.511 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -94.72 154.57 17.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 1.3100000000000001 110.888 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.542 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.7 pptp? -142.44 157.48 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.942 -0.572 . . . . 1.3600000000000001 110.01 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.09 172.65 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.56999999999999995 110.912 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -122.47 150.3 42.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.813 -0.63 . . . . 1.98 109.641 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.505 HD22 HG23 ' A' ' 82' ' ' VAL . 35.2 tp -71.38 136.29 47.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.792 0.33 . . . . 0.94999999999999996 111.528 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 36.1 mt-10 51.69 37.72 20.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.57 -0.741 . . . . 2.0800000000000001 112.205 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.463 HE21 ' HB2' ' A' ' 73' ' ' GLU . 13.8 pt20 -77.49 -8.28 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.359 0.599 . . . . 1.98 109.597 169.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.21 46.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.71999999999999997 112.845 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' HE21 ' A' ' 71' ' ' GLN . 10.1 mm-40 -84.0 -21.92 31.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.883 0.342 . . . . 0.96999999999999997 110.754 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 m -113.61 135.11 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.57999999999999996 110.379 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.02 -61.29 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.083 0.772 . . . . 0.62 113.083 -172.478 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.3 mmpt? -143.18 -44.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.957 0.725 . . . . 2.04 112.957 -171.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.03 -53.0 36.14 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.651 -0.785 . . . . 0.32000000000000001 112.684 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.448 ' O ' HG22 ' A' ' 82' ' ' VAL . 4.2 m-90 -75.94 -30.94 58.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.853 0.359 . . . . 0.48999999999999999 110.501 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 21.7 t70 -52.24 -54.3 32.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.169 -0.923 . . . . 1.1399999999999999 112.148 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.544 ' HB ' HG21 ' A' ' 18' ' ' VAL . 2.8 mp -75.38 -42.31 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.78000000000000003 110.985 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.577 ' O ' ' HG2' ' A' ' 85' ' ' MET . 20.7 t -56.99 -47.34 81.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.55000000000000004 111.182 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.505 HG23 HD22 ' A' ' 69' ' ' LEU . 27.1 m -72.91 -32.21 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 123.0 0.188 . . . . 0.83999999999999997 110.979 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 66.2 m -65.79 -23.3 66.68 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.436 0.636 . . . . 1.4299999999999999 110.869 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -112.25 46.4 1.17 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 1.23 110.455 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.928 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.6 mmt -125.41 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.281 0.562 . . . . 2.27 111.226 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.966 ' HD3' ' H ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -155.25 160.69 41.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.056 -1.09 . . . . 4.1900000000000004 108.056 174.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -46.97 -38.27 10.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.461 0.541 . . . . 1.9399999999999999 112.461 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.966 ' H ' ' HD3' ' A' ' 86' ' ' ARG . 16.5 m120 -109.54 6.24 23.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 1.23 111.122 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 30.6 tt0 -105.38 140.85 37.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.161 -0.681 . . . . 1.6000000000000001 109.161 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.5 tttt -146.93 135.92 22.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.266 -0.424 . . . . 1.1699999999999999 110.728 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 22' ' ' ILE . 83.9 m -136.06 159.19 42.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.234 0.54 . . . . 1.2 110.825 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 117' ' ' LEU . 1.8 tp -91.34 142.18 27.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.25 -1.018 . . . . 1.73 108.25 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.97 135.48 52.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 O-C-N 123.366 0.416 . . . . 0.73999999999999999 110.36 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -107.28 111.86 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.638 -0.505 . . . . 1.71 109.638 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -96.4 107.1 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.898 -0.408 . . . . 0.52000000000000002 109.898 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.651 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 9.7 tt0 -85.43 177.41 7.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.107 -0.701 . . . . 1.3700000000000001 109.107 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -57.32 -37.29 72.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.4 ptp -77.62 -9.73 59.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.182 0.438 . . . . 1.79 112.182 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.7 m-85 -103.62 6.33 37.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.017 -0.273 . . . . 0.75 111.037 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.71 174.92 16.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.952 -0.642 . . . . 0.70999999999999996 112.468 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.941 0.401 . . . . 1.52 111.183 177.4 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 111.33 0.122 . . . . 1.52 111.33 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.407 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -148.23 104.16 3.56 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.75 111.225 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -97.42 179.89 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.076 2.517 . . . . 1.5800000000000001 112.274 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.61 66.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.267 -0.968 . . . . 2.0499999999999998 113.187 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 m120 55.48 23.84 6.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.954 0.406 . . . . 2.0299999999999998 111.835 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.579 ' HB3' HD11 ' A' ' 48' ' ' LEU . 30.1 m -110.03 150.71 28.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.942 -0.572 . . . . 1.1399999999999999 110.003 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.17 130.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.47999999999999998 110.206 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.433 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.6 mp -123.34 151.45 42.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.063 -0.517 . . . . 0.51000000000000001 110.411 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -128.22 125.54 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.497 . . . . 0.69999999999999996 110.926 177.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.444 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 46.1 m-85 -126.14 153.22 44.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.745 -0.661 . . . . 0.42999999999999999 110.221 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.578 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 42.7 mt-10 -85.46 126.88 34.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.279 -0.638 . . . . 1.46 109.279 170.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.481 HG23 HG11 ' A' ' 42' ' ' VAL . 10.6 mt -108.58 118.18 55.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 0.47999999999999998 109.865 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 45.2 tt0 -132.96 132.29 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 1.8799999999999999 110.24 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.21 115.7 28.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 1.1200000000000001 110.678 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.31 -21.4 13.84 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.757 -0.377 . . . . 1.0 112.016 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.507 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 29.3 t -155.63 149.61 25.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.003 -0.279 . . . . 1.1899999999999999 110.393 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -168.19 172.66 8.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 0.71999999999999997 110.036 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -161.04 126.38 3.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 2.98 110.177 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 3.3799999999999999 111.536 -173.972 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.39 . . . . 3.6000000000000001 110.887 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.39 157.07 17.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.51 0.672 . . . . 2.71 110.609 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -103.0 148.26 25.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.789 -1.096 . . . . 1.8799999999999999 111.052 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.41 106.92 20.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.58999999999999997 109.495 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 7.4 pt-20 -78.85 113.35 16.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.803 -0.635 . . . . 2.1600000000000001 111.542 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.47 ' H ' HD13 ' A' ' 19' ' ' ILE . 17.2 tp 58.25 65.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 1.45 111.215 169.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 t -61.73 144.9 53.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 0.78000000000000003 110.076 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 0.72 7.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.95 0.352 . . . . 0.81000000000000005 111.95 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.48 25.73 1.01 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.532 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.09 2.64 9.16 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.68000000000000005 113.92 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.47 78.28 0.61 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.072 -0.585 . . . . 0.60999999999999999 114.169 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 80' ' ' ILE . 53.7 t -140.78 143.82 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.935 -0.394 . . . . 0.48999999999999999 109.935 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 17.9 mm -86.27 116.31 28.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.595 -0.52 . . . . 0.46999999999999997 109.595 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -138.19 144.34 40.64 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.507 -0.477 . . . . 1.3400000000000001 111.464 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 6.8 m -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.916 -0.583 . . . . 0.5 109.864 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.5 tp -84.82 118.91 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.67000000000000004 110.585 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.18 -70.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.82999999999999996 110.605 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 36.9 ttpt -109.7 116.33 31.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.519 -0.31 . . . . 1.5600000000000001 110.531 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.55 137.62 42.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.033 -0.531 . . . . 2.9500000000000002 110.171 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.44 162.35 54.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.735 -0.745 . . . . 1.3200000000000001 112.309 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.76 -68.26 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 2.77 110.74 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.37 132.61 15.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.095 0.474 . . . . 2.6400000000000001 109.781 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.08 33.33 0.94 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.498 -0.858 . . . . 1.04 111.492 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.26 -28.93 70.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.24 0.543 . . . . 2.29 110.402 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -94.88 -4.75 46.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.332 -0.849 . . . . 2.6400000000000001 110.381 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -138.81 91.46 2.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.051 0.453 . . . . 1.45 111.259 -173.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.09 123.98 28.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.81000000000000005 110.776 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 43.0 Cg_endo -69.96 92.54 0.53 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.644 2.229 . . . . 0.75 111.807 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 53.5 mmtt -94.7 146.53 24.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.365 0.602 . . . . 2.6600000000000001 112.261 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -71.99 124.54 25.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.933 -1.031 . . . . 2.5099999999999998 110.0 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.89 -9.24 43.49 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.422 -0.671 . . . . 1.1200000000000001 111.422 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -101.09 154.65 18.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.343 . . . . 1.3799999999999999 110.219 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -79.3 106.21 11.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.329 0.585 . . . . 2.2000000000000002 111.123 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' HIS . 3.1 m -121.68 152.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.843 -0.799 . . . . 0.67000000000000004 108.843 174.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.2 m -117.75 119.42 34.86 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.651 -0.5 . . . . 0.65000000000000002 109.651 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.549 HG11 HG23 ' A' ' 120' ' ' ILE . 90.3 t -131.82 144.06 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.999 -0.546 . . . . 0.87 110.764 -174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.468 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 24.5 m80 -99.96 145.29 28.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.044 -0.354 . . . . 2.75 110.044 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 29.2 p90 -143.06 130.63 21.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.055 0.455 . . . . 0.76000000000000001 110.934 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.57 159.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.224 -0.658 . . . . 0.48999999999999999 109.224 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.41 -121.0 0.7 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.041 -1.076 . . . . 0.35999999999999999 112.751 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 50.1 pttt -150.9 168.06 25.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.666 0.27 . . . . 1.4299999999999999 110.505 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' HG ' ' A' ' 116' ' ' LEU . 57.3 tp -85.02 98.37 10.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.031 -0.729 . . . . 0.38 109.031 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 50.0 tp10 -62.55 -26.94 68.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 1.96 112.381 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 4.4 t -63.17 -18.56 63.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 0.67000000000000004 111.279 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -129.63 -26.12 2.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.034 0.445 . . . . 0.72999999999999998 110.767 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.44 35.64 10.4 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.369 -0.443 . . . . 0.78000000000000003 112.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.38 128.86 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.715 0.293 . . . . 2.8900000000000001 110.362 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.8 p -71.77 158.35 6.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.58999999999999997 109.78 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 21.7 m-85 -73.93 98.49 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.315 0.579 . . . . 0.78000000000000003 111.784 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.72 86.15 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.13 -1.063 . . . . 2.1800000000000002 108.13 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -136.54 164.47 28.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.811 -0.631 . . . . 1.24 110.571 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -57.97 -45.76 86.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 1.49 112.046 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -93.32 -45.45 7.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.012 0.434 . . . . 1.8 110.943 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -34.49 58.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.122 -0.944 . . . . 2.1899999999999999 111.655 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 61' ' ' ARG . 6.1 ptm85 -77.52 -22.88 50.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 2.7799999999999998 111.801 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -100.66 -52.79 3.24 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.818 -0.353 . . . . 1.1000000000000001 110.942 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.26 108.77 6.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.996 0.427 . . . . 2.0299999999999998 111.698 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.7 153.34 56.61 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.553 2.169 . . . . 1.76 110.547 173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -93.47 149.14 21.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.007 0.432 . . . . 1.3100000000000001 110.515 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 3.0 pptp? -123.12 142.67 50.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.794 -0.639 . . . . 1.3600000000000001 109.587 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -128.86 171.42 12.3 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.985 0.421 . . . . 0.56999999999999995 110.999 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 98.0 m-70 -112.22 145.94 39.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.464 -0.789 . . . . 1.98 109.113 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 36' ' ' LYS . 16.6 tp -72.62 120.42 18.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.315 0.579 . . . . 0.94999999999999996 110.371 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 66.56 54.59 0.86 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.447 -1.251 . . . . 2.0800000000000001 111.077 -176.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.444 HE21 ' HB2' ' A' ' 73' ' ' GLU . 12.2 pt20 -96.07 10.01 38.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 1.98 109.414 169.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.07 -12.18 62.93 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.422 -0.808 . . . . 0.71999999999999997 112.801 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HB2' HE21 ' A' ' 71' ' ' GLN . 13.3 mm-40 -96.18 -10.16 28.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.712 0.291 . . . . 0.96999999999999997 111.279 -174.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.07 125.11 67.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.006 0.431 . . . . 0.57999999999999996 110.713 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.762 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -95.78 -59.13 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.921 0.711 . . . . 0.62 112.921 -173.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 75' ' ' ILE . 6.6 mmpt? -140.0 -61.06 0.53 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.094 -0.378 . . . . 2.04 111.401 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.42 -52.79 35.12 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.953 -0.567 . . . . 0.32000000000000001 113.656 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.6 m-90 -74.98 -44.78 46.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.975 0.387 . . . . 0.48999999999999999 110.738 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -51.61 -51.83 52.48 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.039 0.837 . . . . 1.1399999999999999 111.933 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.513 ' HB ' HG21 ' A' ' 18' ' ' VAL . 2.1 mp -75.05 -38.64 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 0.78000000000000003 110.972 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.701 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 34.3 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.55000000000000004 110.68 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 78' ' ' TRP . 34.7 m -67.74 -32.64 57.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.738 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.0 t -62.38 -32.73 73.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.4299999999999999 110.886 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.7 t -96.09 31.18 2.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.141 -0.481 . . . . 1.23 110.627 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.579 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mmt -110.42 -173.33 2.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.386 0.613 . . . . 2.27 111.609 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 6.4 ttm180 -139.76 168.46 19.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.878 -1.156 . . . . 4.1900000000000004 107.878 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.0 -35.18 70.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.338 . . . . 1.9399999999999999 111.392 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -122.2 31.98 5.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 1.23 110.862 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 23.6 tt0 -122.36 143.98 49.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.308 -0.405 . . . . 1.6000000000000001 110.452 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.87 137.9 35.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.716 0.293 . . . . 1.1699999999999999 110.529 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' THR . 27.5 p -141.22 171.37 14.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 1.2 111.194 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.09 123.05 49.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.68 . . . . 1.73 109.533 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.701 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.0 p -99.92 137.48 27.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.255 0.55 . . . . 0.73999999999999999 110.8 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 55.2 mmt-85 -91.11 112.38 24.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.633 -0.712 . . . . 1.71 110.086 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.491 HD11 HG13 ' A' ' 93' ' ' VAL . 2.9 mp -93.7 100.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.368 -0.604 . . . . 0.52000000000000002 109.368 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 97' ' ' SER . 29.6 tt0 -81.05 170.25 16.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.484 -0.932 . . . . 1.3700000000000001 108.484 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 8.7 p -51.4 -44.13 62.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.767 0.284 . . . . 1.0 111.767 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.6 ptp -77.56 -8.43 57.81 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.128 0.418 . . . . 1.79 112.128 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -103.88 -11.86 17.24 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 122.267 -0.271 . . . . 0.75 110.941 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.06 164.61 17.12 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.734 -0.746 . . . . 0.70999999999999996 113.24 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.528 0 N-CA-C 109.995 -0.372 . . . . 1.52 109.995 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.429 0.157 . . . . 1.52 110.666 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.03 83.66 4.22 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-O 120.814 0.34 . . . . 0.75 111.844 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -98.54 -160.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.228 2.618 . . . . 1.5800000000000001 111.457 171.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.38 91.48 2.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 2.0499999999999998 113.189 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 56.66 27.13 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 2.0299999999999998 111.738 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 9.7 p -133.93 171.04 14.72 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.633 -0.258 . . . . 1.1399999999999999 110.875 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.24 133.43 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.198 0.523 . . . . 0.47999999999999998 110.348 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.6 mp -122.38 169.6 10.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.51000000000000001 109.699 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -147.42 133.8 19.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.061 0.457 . . . . 0.69999999999999996 110.596 172.238 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 39.9 m-85 -122.41 142.29 50.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.89 -0.595 . . . . 0.42999999999999999 109.616 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 32.5 mt-10 -74.18 122.97 23.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.724 -0.843 . . . . 1.46 108.724 171.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.549 HG23 HG11 ' A' ' 42' ' ' VAL . 8.1 mt -105.95 115.42 47.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.422 0.63 . . . . 0.47999999999999998 109.739 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.08 116.59 17.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.098 -0.955 . . . . 1.8799999999999999 110.284 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 123' ' ' LEU . 6.8 tt -87.12 133.71 33.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 1.1200000000000001 109.219 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 122' ' ' LEU . 1.1 pt? -117.1 -43.96 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.786 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.9 t -140.78 140.87 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.783 -0.451 . . . . 1.1899999999999999 109.783 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.584 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -167.04 177.57 6.21 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.174 0.297 . . . . 0.71999999999999997 110.6 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -157.49 150.72 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 2.98 111.051 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 C--N 1.329 -0.32 0 N-CA-C 109.582 -0.525 . . . . 3.3799999999999999 109.582 174.332 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 109.607 -0.516 . . . . 3.6000000000000001 109.607 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.34 148.83 29.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.11 0.481 . . . . 2.71 110.878 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.7 mppt? -91.96 143.17 26.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 110.283 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' A' ' 13' ' ' THR . 5.1 t -108.94 108.55 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 110.054 -0.35 . . . . 0.58999999999999997 110.054 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.81 128.92 43.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.1600000000000001 110.974 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 19' ' ' ILE . 13.5 tp 55.76 46.26 22.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.689 0.757 . . . . 1.45 110.113 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.5 t -63.84 164.04 10.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.868 -1.06 . . . . 0.78000000000000003 111.532 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.66 1.37 8.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.81000000000000005 111.253 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' O ' HG13 ' A' ' 80' ' ' ILE . 25.9 m-20 -80.65 14.19 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 2.3999999999999999 111.054 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.27 9.39 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.52 -0.847 . . . . 0.68000000000000005 113.598 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.25 64.07 1.81 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.803 -0.713 . . . . 0.60999999999999999 114.045 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.555 ' HB ' HG21 ' A' ' 80' ' ' ILE . 3.3 t -145.35 154.23 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.894 -0.41 . . . . 0.48999999999999999 109.894 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 12' ' ' LEU . 4.7 mm -85.24 109.65 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.243 -0.28 . . . . 0.46999999999999997 110.243 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HE3' HG21 ' A' ' 13' ' ' THR . 21.6 pttp -132.61 142.65 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.3400000000000001 111.181 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -110.8 140.87 44.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.476 -0.784 . . . . 0.5 110.246 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' C ' HD22 ' A' ' 23' ' ' LEU . 7.6 tp -86.44 130.3 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.422 -0.354 . . . . 0.67000000000000004 110.369 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 22' ' ' ILE . 3.5 mm? -132.72 -69.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.455 0.645 . . . . 0.82999999999999996 110.515 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 80.7 tttt -91.5 97.66 11.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.41 -0.814 . . . . 1.5600000000000001 109.53 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -73.74 127.29 32.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.068 -0.969 . . . . 2.9500000000000002 110.21 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.7 -148.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.09 -0.505 . . . . 1.3200000000000001 113.33 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.5 -167.84 2.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.463 -0.94 . . . . 2.77 108.463 -172.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -85.46 127.3 34.35 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.739 -0.467 . . . . 2.6400000000000001 109.739 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.469 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -168.39 75.37 0.12 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.108 -0.797 . . . . 1.04 111.108 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.44 -32.99 69.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.749 0.278 . . . . 2.29 111.749 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.72 0.38 56.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.272 0.558 . . . . 2.6400000000000001 110.579 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.406 ' HA ' ' HZ ' ' A' ' 125' ' ' PHE . 6.5 m-20 -105.5 79.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 1.45 110.877 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.8 mm -131.37 122.04 18.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.81000000000000005 110.909 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 69.6 Cg_endo -77.55 126.56 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.689 2.259 . . . . 0.75 112.023 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 27.1 mmtp -132.92 161.92 32.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.905 0.383 . . . . 2.6600000000000001 110.77 177.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -71.77 150.21 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.969 -0.559 . . . . 2.5099999999999998 111.882 -172.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.43 -23.03 29.69 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.722 -0.672 . . . . 1.1200000000000001 111.799 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.66 153.41 21.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.003 0.43 . . . . 1.3799999999999999 110.968 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 51.0 mt-10 -79.0 95.39 5.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.016 -0.538 . . . . 2.2000000000000002 110.481 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.502 HG21 HD23 ' A' ' 69' ' ' LEU . 19.9 m -102.87 151.08 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.6 -0.519 . . . . 0.67000000000000004 109.6 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -111.95 106.51 15.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.167 -0.679 . . . . 0.65000000000000002 109.167 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -126.33 138.99 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.87 110.863 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 22.3 m-70 -104.16 142.91 33.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.521 -0.548 . . . . 2.75 109.521 172.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.5 p90 -137.15 139.52 41.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 0.76000000000000001 110.021 175.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.11 154.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 0.48999999999999999 109.146 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 179.77 -134.6 2.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.878 -1.153 . . . . 0.35999999999999999 112.98 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 117' ' ' LEU . 22.8 pttp -151.68 171.33 17.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.032 0.444 . . . . 1.4299999999999999 110.671 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 114' ' ' SER . 61.3 tp -85.58 107.38 17.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.621 . . . . 0.38 109.758 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.6 tp10 -68.05 -31.19 70.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.031 0.443 . . . . 1.96 110.81 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 t -54.3 -43.04 70.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.342 -0.844 . . . . 0.67000000000000004 112.05 -173.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.498 HG22 HD23 ' A' ' 48' ' ' LEU . 15.4 t -119.96 -10.97 9.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.72999999999999998 110.604 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 56.12 3.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.892 -0.671 . . . . 0.78000000000000003 111.648 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -125.03 130.02 51.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.175 -0.305 . . . . 2.8900000000000001 110.175 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.2 156.87 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.114 -0.328 . . . . 0.58999999999999997 110.114 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -74.6 99.33 3.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.386 . . . . 0.78000000000000003 111.763 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.83 91.84 3.82 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.485 -0.932 . . . . 2.1800000000000002 108.485 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 28.7 t -137.59 148.3 45.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.46 -0.791 . . . . 1.24 109.985 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -53.8 -42.49 68.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.312 0.486 . . . . 1.49 112.312 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -84.84 -46.15 11.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 1.8 110.692 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -36.82 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 2.1899999999999999 111.629 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' SER . 14.8 ptm180 -81.56 4.11 22.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.697 0.284 . . . . 2.7799999999999998 111.542 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -121.29 -60.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.645 -0.252 . . . . 1.1000000000000001 110.702 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 5.3 m -133.32 133.7 23.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.692 0.282 . . . . 2.0299999999999998 111.598 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.0 Cg_exo -77.3 163.35 30.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.838 2.359 . . . . 1.76 111.869 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -103.87 154.74 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.427 -0.351 . . . . 1.3100000000000001 110.302 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -137.49 151.36 48.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 1.3600000000000001 109.649 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -136.42 -175.55 4.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.756 0.313 . . . . 0.56999999999999995 110.819 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -121.03 150.05 41.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 1.98 109.991 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -58.14 121.67 11.25 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.752 0.657 . . . . 0.94999999999999996 111.348 -174.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER 55.29 45.95 24.58 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.589 0.556 . . . . 2.0800000000000001 111.806 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 6.7 pm0 -78.96 -4.3 49.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.094 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.15 -9.13 50.02 Favored Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.71999999999999997 113.161 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 15.9 mm-40 -95.57 -17.08 21.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.96999999999999997 110.724 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.14 132.74 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.74 0.305 . . . . 0.57999999999999996 110.695 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.484 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.5 -68.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.373 0.508 . . . . 0.62 112.373 -178.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.618 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 5.6 mtpp -140.94 -41.26 0.4 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.449 0.537 . . . . 2.04 112.449 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.02 -46.73 61.08 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.32000000000000001 112.56 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.499 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.9 m-90 -76.13 -36.89 58.61 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.922 -0.163 . . . . 0.48999999999999999 111.127 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -63.42 -40.43 97.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.033 0.383 . . . . 1.1399999999999999 112.033 -169.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.555 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -64.35 -39.45 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.013 0.435 . . . . 0.78000000000000003 110.631 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -72.3 -51.28 21.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.406 -0.361 . . . . 0.55000000000000004 110.891 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.0 m -64.63 -33.89 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.254 0.465 . . . . 0.83999999999999997 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 t -80.19 -0.84 37.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.018 0.437 . . . . 1.4299999999999999 110.769 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 t -119.88 14.41 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.18 -0.464 . . . . 1.23 110.387 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.041 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 4.0 mmt -98.95 179.18 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 2.27 110.809 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.469 ' NH1' ' HA3' ' A' ' 29' ' ' GLY . 22.3 ttp85 -143.6 174.05 11.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.133 -1.062 . . . . 4.1900000000000004 108.133 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 60.3 tttm -67.7 -6.09 19.1 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.8 0.334 . . . . 1.9399999999999999 111.832 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -141.56 21.2 2.19 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.581 0.229 . . . . 1.23 110.594 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.5 tt0 -118.76 148.64 42.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.512 -0.313 . . . . 1.6000000000000001 110.66 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 24' ' ' LYS . 75.2 tttt -149.06 138.66 21.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 1.1699999999999999 110.794 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.5 m -134.02 164.33 27.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.44 -0.345 . . . . 1.2 111.142 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.508 ' CD2' ' HG2' ' A' ' 119' ' ' GLU . 63.6 mt -100.53 111.62 23.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.037 -0.529 . . . . 1.73 109.605 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 77' ' ' GLY . 7.1 p -100.98 135.95 34.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.73999999999999999 109.994 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mmm-85 -100.45 111.43 23.69 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.115 -0.698 . . . . 1.71 109.115 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 93' ' ' VAL . 3.2 mp -92.21 103.62 14.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.127 0.489 . . . . 0.52000000000000002 109.833 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.54 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 32.5 tt0 -82.41 173.44 12.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.321 -0.854 . . . . 1.3700000000000001 109.02 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.6 p -51.54 -41.31 60.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.631 0.372 . . . . 1.0 111.898 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.0 ptm -77.21 -15.7 59.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 1.79 111.771 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.7 m-30 -91.2 -13.96 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.75 110.885 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.55 -172.54 15.54 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.348 -0.701 . . . . 0.70999999999999996 111.348 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 1.52 111.209 178.395 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.226 0.06 . . . . 1.52 111.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.445 HG12 HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -146.13 100.2 4.22 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 121.143 0.496 . . . . 0.75 111.285 177.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -90.29 -166.33 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.874 2.383 . . . . 1.5800000000000001 111.856 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.82 -139.5 13.49 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.553 -0.832 . . . . 2.0499999999999998 112.748 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.4 m120 -93.42 6.11 49.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.124 0.488 . . . . 2.0299999999999998 110.349 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 48' ' ' LEU . 47.1 m -94.44 146.95 23.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.74 -0.664 . . . . 1.1399999999999999 111.349 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.2 p -95.02 138.82 19.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.2 -0.455 . . . . 0.47999999999999998 110.286 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.4 mp -126.36 174.27 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 0.51000000000000001 110.622 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -132.78 124.4 28.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.157 -0.683 . . . . 0.69999999999999996 109.157 176.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 22.2 m-85 -116.13 126.6 53.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.42999999999999999 110.546 178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.609 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 37.8 mt-10 -81.18 107.66 14.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 1.46 109.504 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' HIS . 58.4 mt -107.85 124.46 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.061 -0.256 . . . . 0.47999999999999998 110.9 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 90' ' ' LYS . 34.3 mt-10 -121.5 131.02 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 1.8799999999999999 110.308 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 42' ' ' VAL . 6.9 tt -100.26 101.85 12.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 1.1200000000000001 109.576 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -96.69 -16.23 21.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -175.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.5 m -153.19 150.76 29.37 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.454 -0.202 . . . . 1.1899999999999999 110.454 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.498 ' HB3' HD21 ' A' ' 122' ' ' LEU . 1.5 p90 -164.85 178.74 6.96 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.963 -0.384 . . . . 0.71999999999999997 109.963 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.635 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.9 ptp180 -162.17 167.84 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.617 0.573 . . . . 2.98 109.547 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.318 0 O-C-N 123.201 0.313 . . . . 3.3799999999999999 110.265 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 110.224 -0.287 . . . . 3.6000000000000001 110.224 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -89.44 156.08 18.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.444 -0.576 . . . . 2.71 109.444 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.28 153.85 24.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.405 -0.361 . . . . 1.8799999999999999 110.8 -171.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.38 104.83 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.58999999999999997 109.029 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.87 120.29 30.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 2.1600000000000001 110.612 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' H ' HD13 ' A' ' 19' ' ' ILE . 96.2 mt 58.67 64.72 1.38 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.569 0.7 . . . . 1.45 110.727 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.5 HG21 ' HE2' ' A' ' 20' ' ' LYS . 9.2 t -65.79 160.84 22.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.936 -1.029 . . . . 0.78000000000000003 111.115 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.33 -5.22 21.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.093 0.405 . . . . 0.81000000000000005 112.093 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -71.05 -0.36 9.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.407 -0.36 . . . . 2.3999999999999999 111.268 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.98 24.79 2.2 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.79 -0.719 . . . . 0.68000000000000005 113.321 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.14 72.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.011 -0.614 . . . . 0.60999999999999999 113.576 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.539 ' HB ' HG21 ' A' ' 80' ' ' ILE . 12.2 t -138.84 146.11 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.856 -0.424 . . . . 0.48999999999999999 109.856 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 12' ' ' LEU . 22.0 mm -87.08 110.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.013 -0.365 . . . . 0.46999999999999997 110.013 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.5 ' HE2' HG21 ' A' ' 13' ' ' THR . 58.3 pttt -125.27 145.53 49.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 1.3400000000000001 111.096 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -126.01 120.49 30.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 0.5 109.8 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.542 HG12 ' HG3' ' A' ' 25' ' ' LYS . 10.0 tp -76.01 145.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.386 . . . . 0.67000000000000004 110.734 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.39 -34.85 2.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.431 -0.35 . . . . 0.82999999999999996 111.173 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 38.8 ttpt -150.78 118.32 6.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.637 -0.505 . . . . 1.5600000000000001 109.637 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HG3' HG12 ' A' ' 22' ' ' ILE . 88.8 mttt -101.0 154.28 18.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.188 0.518 . . . . 2.9500000000000002 112.021 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.89 164.75 16.07 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 111.683 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.65 -95.12 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.045 0.422 . . . . 2.77 111.133 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -91.48 145.38 24.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.944 0.402 . . . . 2.6400000000000001 110.845 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 162.51 64.57 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.787 -0.642 . . . . 1.04 111.615 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.23 -35.0 72.86 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.072 0.463 . . . . 2.29 111.011 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -104.25 26.34 8.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 2.6400000000000001 111.539 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.48 74.9 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.753 -0.462 . . . . 1.45 109.753 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.528 HG22 ' HG2' ' A' ' 35' ' ' LYS . 27.6 mm -136.68 108.92 9.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 0.81000000000000005 110.829 -177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.6 Cg_endo -71.46 88.24 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.643 2.229 . . . . 0.75 112.067 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HG2' HG22 ' A' ' 33' ' ' ILE . 29.7 mmtp -97.7 159.41 14.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.533 0.682 . . . . 2.6600000000000001 111.876 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HA ' HD23 ' A' ' 69' ' ' LEU . 8.8 ttmm -67.88 150.29 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.683 -1.144 . . . . 2.5099999999999998 111.531 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.68 -26.13 22.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.192 -0.528 . . . . 1.1200000000000001 112.119 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.13 158.45 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.698 0.285 . . . . 1.3799999999999999 110.726 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.76 97.75 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.19 0.519 . . . . 2.2000000000000002 111.721 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.9 m -96.86 143.81 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.065 -0.717 . . . . 0.67000000000000004 109.065 170.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 20.1 m -111.62 113.63 26.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.877 0.37 . . . . 0.65000000000000002 110.755 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -131.6 160.8 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.073 -0.512 . . . . 0.87 111.599 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -117.18 153.99 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 2.75 109.254 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -137.69 143.56 41.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.44 -0.345 . . . . 0.76000000000000001 110.233 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.89 160.79 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.878 -0.786 . . . . 0.48999999999999999 108.878 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 167.08 -136.55 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.351 -0.928 . . . . 0.35999999999999999 112.38 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.626 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 60.6 pttt -158.45 171.97 19.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.653 0.263 . . . . 1.4299999999999999 110.995 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.494 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -88.86 105.25 17.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.38 110.403 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 32.7 tt0 -64.04 -27.39 69.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.36 -0.382 . . . . 1.96 111.249 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.7 t -54.76 -40.59 69.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.894 -0.594 . . . . 0.67000000000000004 111.545 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.452 HG22 HD23 ' A' ' 48' ' ' LEU . 10.1 t -120.01 -12.47 9.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.583 0.23 . . . . 0.72999999999999998 111.597 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.42 10.75 73.26 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.75 -0.738 . . . . 0.78000000000000003 112.896 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 33.7 mmtp -88.39 132.03 34.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.871 0.367 . . . . 2.8900000000000001 111.163 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.626 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.3 p -81.65 160.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.472 -0.786 . . . . 0.58999999999999997 109.963 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -74.53 114.56 13.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.021 0.439 . . . . 0.78000000000000003 111.249 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -129.03 91.23 3.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.145 -0.687 . . . . 2.1800000000000002 109.145 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -123.95 -173.55 2.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 1.24 109.87 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.1 m -72.9 -47.3 47.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.772 0.32 . . . . 1.49 111.49 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -95.15 -39.11 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.739 1.015 . . . . 1.8 113.739 -171.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.28 -42.84 87.41 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.977 0.362 . . . . 2.1899999999999999 111.977 -168.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -90.75 11.28 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.39 0.614 . . . . 2.7799999999999998 111.277 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -106.08 -50.15 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 1.1000000000000001 109.047 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.4 p -149.4 121.82 4.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 2.0299999999999998 110.223 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 10.5 Cg_exo -70.82 154.65 63.42 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.819 2.346 . . . . 1.76 112.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -93.94 153.88 17.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.998 -0.546 . . . . 1.3100000000000001 109.717 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -125.99 161.39 27.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.352 -0.61 . . . . 1.3600000000000001 109.352 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.65 175.35 13.35 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.518 -0.473 . . . . 0.56999999999999995 111.489 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 75.1 m-70 -118.37 150.55 39.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.836 . . . . 1.98 109.769 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.603 HD11 ' OD1' ' A' ' 79' ' ' ASP . 14.5 tp -66.13 127.43 32.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.366 -0.379 . . . . 0.94999999999999996 111.871 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 50.56 37.58 16.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.193 0.997 . . . . 2.0800000000000001 111.467 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 22.7 tt0 -72.11 -6.07 39.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.865 -1.516 . . . . 1.98 111.192 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.98 56.19 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 111.661 -0.576 . . . . 0.71999999999999997 111.661 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.19 -18.35 25.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.449 0.642 . . . . 0.96999999999999997 109.759 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.6 125.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.372 -0.831 . . . . 0.57999999999999996 109.578 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -95.94 -58.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.7 1.0 . . . . 0.62 113.7 -172.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.95 -50.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.79 -0.568 . . . . 2.04 112.295 -169.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.13 -52.43 40.17 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.791 -0.719 . . . . 0.32000000000000001 112.707 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.46 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -75.94 -33.94 59.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.618 0.247 . . . . 0.48999999999999999 110.698 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.603 ' OD1' HD11 ' A' ' 69' ' ' LEU . 10.4 t70 -53.04 -51.69 60.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.703 -0.681 . . . . 1.1399999999999999 111.428 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.539 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.8 mp -65.83 -48.37 82.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.09 -0.505 . . . . 0.78000000000000003 110.75 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 120' ' ' ILE . 28.7 t -60.55 -48.24 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.55000000000000004 111.625 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.833 HG12 HG21 ' A' ' 120' ' ' ILE . 32.0 m -70.12 -33.23 54.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.962 -0.295 . . . . 0.83999999999999997 111.295 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 32.6 t -79.17 0.25 29.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 1.4299999999999999 110.882 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -110.38 10.6 23.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.285 -0.416 . . . . 1.23 111.19 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.59 ' SD ' HG22 ' A' ' 120' ' ' ILE . 47.9 mtm -102.3 -173.42 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.797 0.808 . . . . 2.27 112.054 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.452 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 14.2 mtp180 -140.9 -177.44 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.439 -1.255 . . . . 4.1900000000000004 108.5 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -67.06 -23.44 65.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 1.9399999999999999 111.273 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -126.68 17.93 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 1.23 111.219 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 25.8 tt0 -112.2 131.85 55.24 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.695 -0.483 . . . . 1.6000000000000001 109.695 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 12.8 tmtt? -134.93 134.97 41.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.518 -0.765 . . . . 1.1699999999999999 109.868 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.457 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.7 p -137.57 172.82 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.258 -0.428 . . . . 1.2 110.683 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 93' ' ' VAL . 3.2 tt -119.43 140.27 50.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.281 -1.007 . . . . 1.73 108.281 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 95' ' ' ILE . 6.1 p -121.39 141.57 41.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 120.958 0.409 . . . . 0.73999999999999999 110.903 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -98.89 111.65 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.156 -0.683 . . . . 1.71 109.156 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.524 HD11 HG13 ' A' ' 93' ' ' VAL . 3.2 mp -93.4 109.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.378 . . . . 0.52000000000000002 110.187 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -84.81 166.04 17.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.579 -0.897 . . . . 1.3700000000000001 108.579 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.4 p -51.01 -40.68 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.29 0.369 . . . . 1.0 111.956 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.5 ptp -77.19 -16.27 59.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.33 -0.395 . . . . 1.79 111.993 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -92.67 -16.27 25.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.945 0.402 . . . . 0.75 110.432 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.437 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -115.24 -160.15 12.56 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.103 -0.799 . . . . 0.70999999999999996 111.103 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 120.722 0.296 . . . . 1.52 111.012 178.43 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.511 0.196 . . . . 1.52 110.581 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.469 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.02 103.45 4.43 Favored Pre-proline 0 N--CA 1.465 0.277 0 N-CA-C 109.879 -0.415 . . . . 0.75 109.879 176.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.21 -74.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.346 2.031 . . . . 1.5800000000000001 112.846 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.78 -134.78 44.0 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.805 -0.712 . . . . 2.0499999999999998 112.224 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -133.67 21.39 3.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.466 -0.568 . . . . 2.0299999999999998 109.466 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 22.4 m -105.77 179.19 4.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.76 -0.655 . . . . 1.1399999999999999 111.196 -173.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -97.53 138.57 22.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.128 0.489 . . . . 0.47999999999999998 111.006 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.4 mp -120.41 166.78 13.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.371 -0.377 . . . . 0.51000000000000001 110.907 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 5.4 mt -116.14 110.21 18.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.69999999999999996 109.662 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.64 124.51 48.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.793 0.33 . . . . 0.42999999999999999 110.625 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -92.1 126.25 37.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.304 -0.628 . . . . 1.46 109.304 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.833 HG21 HG12 ' A' ' 82' ' ' VAL . 76.0 mt -120.06 131.62 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.471 -0.331 . . . . 0.47999999999999998 110.979 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -136.25 143.66 44.4 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.103 -0.499 . . . . 1.8799999999999999 110.447 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.545 ' HA ' HG12 ' A' ' 42' ' ' VAL . 24.7 tp -90.94 118.77 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 1.1200000000000001 110.72 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.36 -27.89 10.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 1.0 111.239 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.5 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 39.9 m -151.69 149.8 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.374 . . . . 1.1899999999999999 109.989 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.56 ' HB2' HG12 ' A' ' 40' ' ' VAL . 4.0 p90 -165.5 158.5 15.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.808 0.337 . . . . 0.71999999999999997 111.123 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -125.39 123.44 39.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.103 -0.498 . . . . 2.98 110.052 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 3.3799999999999999 109.927 171.668 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.989 0.423 . . . . 3.6000000000000001 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.1 137.77 45.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.529 -0.759 . . . . 2.71 111.262 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -100.39 128.78 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.307 -0.627 . . . . 1.8799999999999999 109.307 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 23.2 t -102.29 105.1 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.11 0.481 . . . . 0.58999999999999997 110.372 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.1 103.9 16.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.607 -0.724 . . . . 2.1600000000000001 110.663 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 19' ' ' ILE . 21.6 tp 62.24 76.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.255 -0.884 . . . . 1.45 110.863 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -80.92 159.82 24.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.731 -0.668 . . . . 0.78000000000000003 110.928 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.87 -5.09 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.29 0.567 . . . . 0.81000000000000005 111.023 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.9 t70 -78.17 30.3 0.18 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 2.3999999999999999 111.645 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' HA3' HG13 ' A' ' 80' ' ' ILE . . . 121.91 -26.17 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.754 -0.736 . . . . 0.68000000000000005 112.735 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.05 60.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.394 -0.908 . . . . 0.60999999999999999 113.372 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.09 152.17 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.965 -0.383 . . . . 0.48999999999999999 109.965 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 12' ' ' LEU . 7.4 mm -85.75 120.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.505 0.322 . . . . 0.46999999999999997 110.257 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 84' ' ' SER . 51.7 pttt -142.73 147.09 35.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.177 0.513 . . . . 1.3400000000000001 111.461 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.38 135.29 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.509 -0.769 . . . . 0.5 109.891 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.4 112.97 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.102 0.477 . . . . 0.67000000000000004 110.624 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 -52.83 3.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.82999999999999996 110.813 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -115.93 151.97 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.331 -0.618 . . . . 1.5600000000000001 109.331 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.89 110.97 19.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.823 -0.436 . . . . 2.9500000000000002 109.823 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.87 163.18 10.46 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.535 -0.757 . . . . 1.3200000000000001 112.821 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 28' ' ' GLU . 12.5 t70 -104.96 -149.22 0.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.554 -0.536 . . . . 2.77 109.554 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 42.4 tt0 -59.27 125.1 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.15 0.5 . . . . 2.6400000000000001 110.793 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.85 52.37 0.24 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 111.215 -0.754 . . . . 1.04 111.215 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.91 -33.87 73.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.5 . . . . 2.29 110.619 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -98.46 18.3 16.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.583 -0.735 . . . . 2.6400000000000001 110.091 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.41 76.74 1.64 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.911 -0.586 . . . . 1.45 109.94 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 38.4 mm -129.14 119.98 19.95 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.398 0.618 . . . . 0.81000000000000005 111.886 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -87.05 100.75 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.148 3.232 . . . . 0.75 112.186 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.585 ' HE2' ' HB3' ' A' ' 83' ' ' SER . 28.1 mmtp -135.95 178.44 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.15 0.5 . . . . 2.6600000000000001 112.264 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.53 139.51 57.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.145 -0.934 . . . . 2.5099999999999998 111.511 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.51 56.42 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.265 -0.734 . . . . 1.1200000000000001 111.265 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -113.87 161.92 17.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.388 . . . . 1.3799999999999999 110.154 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 25.7 mt-10 -94.57 103.92 15.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.176 -0.465 . . . . 2.2000000000000002 110.613 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.86 132.2 49.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.63 -0.507 . . . . 0.67000000000000004 109.63 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -108.39 109.83 21.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.581 -0.526 . . . . 0.65000000000000002 109.581 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.507 ' CG1' HD12 ' A' ' 122' ' ' LEU . 15.8 m -124.04 140.49 47.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.692 -0.685 . . . . 0.87 111.009 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -105.6 140.7 38.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.676 -0.693 . . . . 2.75 109.482 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -123.73 142.67 50.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.107 -0.331 . . . . 0.76000000000000001 110.107 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 p -167.08 148.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.237 -0.653 . . . . 0.48999999999999999 109.237 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.6 1.77 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.127 -0.789 . . . . 0.35999999999999999 111.127 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 63.7 pttt -157.8 171.39 20.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 111.499 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.858 ' HA ' HD23 ' A' ' 116' ' ' LEU . 63.8 tp -81.75 98.17 8.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.814 -0.63 . . . . 0.38 110.253 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.616 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 33.6 tt0 -60.17 -27.75 67.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.756 0.312 . . . . 1.96 111.142 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 t -55.36 -27.2 45.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.955 -0.566 . . . . 0.67000000000000004 111.783 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 53' ' ' LYS . 11.8 t -139.96 4.61 2.09 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.286 0.565 . . . . 0.72999999999999998 110.926 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.89 13.48 75.57 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.94 -0.573 . . . . 0.78000000000000003 113.077 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -77.8 118.34 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.606 0.241 . . . . 2.8900000000000001 111.141 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.724 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.9 p -76.84 159.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.58999999999999997 110.039 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.55 ' CE1' HD11 ' A' ' 110' ' ' ILE . 18.3 m-30 -80.26 99.44 7.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.518 -0.31 . . . . 0.78000000000000003 110.675 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -124.51 84.72 2.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.889 0.852 . . . . 2.1800000000000002 111.28 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.513 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.9 m -136.92 -178.16 5.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.133 -0.94 . . . . 1.24 108.81 175.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.9 p -67.36 -44.15 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 1.49 111.104 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.35 -51.59 23.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.039 -0.528 . . . . 1.8 110.141 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.7 OUTLIER -45.89 -43.81 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.745 -1.116 . . . . 2.1899999999999999 112.191 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.39 -11.9 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.501 . . . . 2.7799999999999998 112.351 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -103.9 -61.91 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.699 -0.401 . . . . 1.1000000000000001 111.588 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 29.0 m -86.0 124.11 71.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.488 . . . . 2.0299999999999998 112.03 -169.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.7 Cg_endo -87.22 103.98 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.147 2.565 . . . . 1.76 111.21 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -94.8 149.16 21.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.454 -0.339 . . . . 1.3100000000000001 110.519 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -141.41 165.88 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 1.3600000000000001 109.939 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 74' ' ' VAL . 54.4 p90 -149.86 -176.88 5.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.088 0.47 . . . . 0.56999999999999995 111.516 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 3.9 m-70 -120.03 150.93 39.77 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.477 -0.783 . . . . 1.98 110.075 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 82' ' ' VAL . 45.6 tp -68.76 134.98 50.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.552 0.215 . . . . 0.94999999999999996 110.46 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 53.21 31.22 11.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.504 0.669 . . . . 2.0800000000000001 111.518 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 30.2 tt0 -69.62 -12.04 61.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.076 -0.965 . . . . 1.98 111.033 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.52 -14.31 54.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.741 -0.743 . . . . 0.71999999999999997 111.744 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -104.07 0.02 29.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.96999999999999997 110.737 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.9 m -132.3 124.65 52.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.57999999999999996 110.266 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.793 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -96.36 -60.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.03 0.752 . . . . 0.62 113.03 -176.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 75' ' ' ILE . 35.6 mmtt -145.03 -41.49 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.285 0.846 . . . . 2.04 113.285 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.36 -52.33 37.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.307 -0.949 . . . . 0.32000000000000001 112.212 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.417 ' O ' HG22 ' A' ' 82' ' ' VAL . 14.2 m-90 -76.48 -33.13 58.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.543 0.211 . . . . 0.48999999999999999 110.992 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 10.4 t70 -52.33 -53.33 45.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.77 -0.65 . . . . 1.1399999999999999 112.102 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.11 -33.13 59.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.441 0.638 . . . . 0.78000000000000003 111.22 -176.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.8 t -76.19 -39.52 54.56 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.896 -0.502 . . . . 0.55000000000000004 111.661 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 69' ' ' LEU . 33.8 m -81.02 -32.82 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.452 0.167 . . . . 0.83999999999999997 111.131 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.585 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 62.6 m -61.27 -40.71 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 1.4299999999999999 110.7 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 21.4 m -101.42 64.38 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 1.23 111.038 174.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 11.4 mmt -120.9 172.47 7.89 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.149 -0.932 . . . . 2.27 110.074 171.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -142.96 162.83 34.41 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.69 -0.856 . . . . 4.1900000000000004 108.69 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HA ' HD23 ' A' ' 122' ' ' LEU . 3.4 tmtm? -56.11 -29.56 60.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.981 0.363 . . . . 1.9399999999999999 111.981 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -118.96 18.12 13.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.68 0.276 . . . . 1.23 111.13 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.37 158.03 16.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.395 -0.366 . . . . 1.6000000000000001 110.578 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -152.29 124.06 7.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.283 -0.636 . . . . 1.1699999999999999 109.283 -175.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.8 m -129.63 160.7 32.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.324 -0.398 . . . . 1.2 110.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' CD2' ' HE2' ' A' ' 90' ' ' LYS . 2.6 mm? -103.17 118.21 36.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.73 109.655 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.737 HG13 HD11 ' A' ' 95' ' ' ILE . 7.5 p -100.63 138.17 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.822 0.344 . . . . 0.73999999999999999 110.224 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 mmm-85 -107.42 111.44 23.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.571 -0.899 . . . . 1.71 108.571 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.737 HD11 HG13 ' A' ' 93' ' ' VAL . 5.1 mp -104.28 107.17 21.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.155 -0.475 . . . . 0.52000000000000002 110.181 -173.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.595 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 2.2 tt0 -83.46 176.01 9.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.153 -0.684 . . . . 1.3700000000000001 109.153 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -30.99 67.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.14 -9.29 59.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.294 -0.412 . . . . 1.79 111.983 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.595 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 17.7 m-85 -109.42 -0.69 18.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 0.75 110.29 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.58 176.09 22.95 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.70999999999999996 112.134 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 111.704 0.261 . . . . 1.52 111.704 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.473 0.177 . . . . 1.52 111.09 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.55 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -156.15 72.83 5.1 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 0.75 110.95 175.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -94.82 102.81 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.161 2.574 . . . . 1.5800000000000001 112.342 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.3 73.3 0.46 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.969 -0.853 . . . . 2.0499999999999998 110.969 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.02 31.33 0.33 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.92 0.888 . . . . 2.0299999999999998 111.26 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 48' ' ' LEU . 6.8 p -104.27 -177.33 3.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.1399999999999999 111.018 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.82 137.64 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.07 -0.514 . . . . 0.47999999999999998 110.035 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.858 HD23 ' HA ' ' A' ' 48' ' ' LEU . 10.1 mt -124.55 156.4 37.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 0.51000000000000001 110.72 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.616 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -125.56 119.67 28.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.829 -0.434 . . . . 0.69999999999999996 109.829 171.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 95' ' ' ILE . 21.2 m-85 -114.52 137.93 51.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.962 -0.563 . . . . 0.42999999999999999 111.006 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.43 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 36.2 mt-10 -89.12 116.09 27.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.295 -0.866 . . . . 1.46 108.869 172.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.465 HG21 HG12 ' A' ' 82' ' ' VAL . 44.6 mt -106.78 127.82 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.705 0.288 . . . . 0.47999999999999998 110.258 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.26 125.82 50.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.806 -0.634 . . . . 1.8799999999999999 110.601 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 87' ' ' LYS . 4.4 tp -91.88 89.86 7.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.518 -0.549 . . . . 1.1200000000000001 109.518 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -78.78 -37.07 41.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.43 -176.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.3 m -146.77 151.36 37.03 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.128 -0.229 . . . . 1.1899999999999999 110.794 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -165.86 -177.71 4.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.507 -0.553 . . . . 0.71999999999999997 109.507 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.549 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -162.33 172.38 15.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 2.98 109.786 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 . . . . . 0 C--N 1.327 -0.409 0 O-C-N 123.366 0.416 . . . . 3.3799999999999999 110.94 175.165 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 C--O 1.233 0.237 0 CA-C-O 120.848 0.356 . . . . 3.6000000000000001 110.354 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -112.35 136.53 51.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.018 -0.537 . . . . 2.71 110.178 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HG3' HG23 ' A' ' 21' ' ' THR . 7.1 mptt -111.34 125.82 54.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.722 -0.474 . . . . 1.8799999999999999 109.722 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.42 115.54 45.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.537 -0.301 . . . . 0.58999999999999997 110.349 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.04 126.67 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.095 -0.502 . . . . 2.1600000000000001 111.09 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.3 mt 57.26 53.31 7.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 1.45 110.04 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.532 HG21 ' HE2' ' A' ' 20' ' ' LYS . 11.7 t -59.23 157.72 10.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.78000000000000003 111.169 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -2.76 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.81000000000000005 112.115 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.53 -4.41 36.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 2.3999999999999999 110.658 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.27 37.41 0.69 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.574 -0.822 . . . . 0.68000000000000005 113.107 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.29 0.85 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.906 -0.664 . . . . 0.60999999999999999 113.489 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.462 HG21 ' HB ' ' A' ' 80' ' ' ILE . 38.6 t -141.13 141.36 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.272 -0.27 . . . . 0.48999999999999999 110.272 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 12' ' ' LEU . 14.3 mm -90.83 110.82 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.46999999999999997 109.753 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.532 ' HE2' HG21 ' A' ' 13' ' ' THR . 61.3 pttt -137.09 144.83 43.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.192 0.52 . . . . 1.3400000000000001 111.076 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 9' ' ' LYS . 25.2 m -116.77 131.37 56.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.5 110.239 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.478 HD11 ' HA ' ' A' ' 25' ' ' LYS . 4.9 tp -91.17 126.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.67000000000000004 110.267 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.578 ' CD2' ' HG ' ' A' ' 92' ' ' LEU . 3.3 mm? -108.04 -72.85 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.38 0.609 . . . . 0.82999999999999996 110.135 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -108.07 103.28 12.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.146 -0.687 . . . . 1.5600000000000001 109.146 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HA ' HD11 ' A' ' 22' ' ' ILE . 73.4 tttt -72.26 157.38 37.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.851 -0.425 . . . . 2.9500000000000002 109.851 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.27 -136.83 0.12 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 114.559 0.583 . . . . 1.3200000000000001 114.559 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 14.0 t70 -167.3 -162.98 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.556 -1.275 . . . . 2.77 107.556 -170.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 39.2 tt0 -77.81 125.38 29.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 2.6400000000000001 110.716 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.93 70.0 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.559 -1.016 . . . . 1.04 110.559 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.46 -22.43 59.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.043 0.449 . . . . 2.29 111.03 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.47 1.1 55.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.645 0.736 . . . . 2.6400000000000001 109.328 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -105.71 76.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.647 -0.706 . . . . 1.45 109.243 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.1 mm -137.07 130.42 17.44 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.81000000000000005 111.138 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.501 ' HG3' ' O ' ' A' ' 85' ' ' MET . 74.0 Cg_endo -74.74 133.86 17.55 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.031 2.488 . . . . 0.75 111.424 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -134.12 142.06 47.36 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.283 -0.261 . . . . 2.6600000000000001 110.539 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.635 ' HE3' ' HB3' ' A' ' 70' ' ' GLU . 17.3 tptm -56.14 127.51 31.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 2.5099999999999998 110.47 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.53 -25.25 23.61 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.474 -0.785 . . . . 1.1200000000000001 111.825 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -94.28 165.73 12.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 1.3799999999999999 110.305 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.27 132.26 34.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.142 0.496 . . . . 2.2000000000000002 111.857 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.8 150.8 35.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.765 -0.828 . . . . 0.67000000000000004 108.765 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 25.6 m -125.55 106.41 9.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.861 -0.422 . . . . 0.65000000000000002 109.861 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 122' ' ' LEU . 34.0 m -131.22 160.48 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.573 . . . . 0.87 111.385 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -113.92 152.73 30.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.647 -0.872 . . . . 2.75 108.647 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -128.06 132.64 49.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.76000000000000001 110.253 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -165.14 158.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.807 -0.812 . . . . 0.48999999999999999 108.807 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.84 -127.35 1.51 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.038 -1.077 . . . . 0.35999999999999999 112.372 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 58.5 pttt -150.42 166.63 29.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 1.4299999999999999 110.471 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.579 HD22 HG13 ' A' ' 110' ' ' ILE . 66.3 tp -86.23 101.97 13.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 0.38 109.694 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 18.9 tt0 -59.78 -24.54 64.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.807 0.337 . . . . 1.96 111.817 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 t -55.86 -25.35 41.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.188 -0.46 . . . . 0.67000000000000004 111.468 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 53' ' ' LYS . 3.0 t -137.84 -31.62 0.77 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.933 0.396 . . . . 0.72999999999999998 111.567 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.72 14.75 26.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.84 -0.695 . . . . 0.78000000000000003 112.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' A' ' 51' ' ' THR . 70.2 mmtt -86.59 133.7 33.69 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.652 -0.499 . . . . 2.8900000000000001 109.652 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.3 p -83.06 155.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.211 -0.45 . . . . 0.58999999999999997 111.46 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 3.2 m-85 -74.33 102.11 4.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.78000000000000003 110.77 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.52 85.3 2.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.375 0.607 . . . . 2.1800000000000002 110.004 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.531 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 67.3 m -138.58 -177.61 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 1.24 110.323 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -48.47 -47.0 38.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.887 0.699 . . . . 1.49 112.887 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.89 -43.29 8.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 1.8 110.339 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.8 OUTLIER -57.29 -30.5 64.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 2.1899999999999999 112.185 -174.539 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -19.91 21.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 2.7799999999999998 110.973 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -86.81 -61.02 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 1.1000000000000001 110.94 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 7.1 p -156.13 126.36 3.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 2.0299999999999998 111.121 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 8.9 Cg_exo -72.02 152.74 57.44 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.694 2.262 . . . . 1.76 111.326 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.71 146.41 23.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.676 0.274 . . . . 1.3100000000000001 110.328 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 2.7 pptp? -105.89 143.35 34.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.979 -0.378 . . . . 1.3600000000000001 109.979 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 47.7 p90 -134.31 170.44 15.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.01 0.433 . . . . 0.56999999999999995 111.131 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -103.96 149.58 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 1.98 109.966 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.614 HD13 ' CG2' ' A' ' 82' ' ' VAL . 16.5 tp -64.19 119.46 10.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.94 0.4 . . . . 0.94999999999999996 110.928 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.635 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER 42.31 74.94 0.1 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 114.405 -1.271 . . . . 2.0800000000000001 111.767 -174.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 6.1 pt20 -100.85 17.39 22.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.548 -1.206 . . . . 1.98 109.536 174.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.5 -16.6 59.62 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.604 -0.726 . . . . 0.71999999999999997 111.787 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.53 -41.56 11.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.466 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.87 135.36 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.651 0.262 . . . . 0.57999999999999996 110.301 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.562 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.61 -68.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.455 0.539 . . . . 0.62 112.455 -175.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 75' ' ' ILE . 41.7 mtpt -133.52 -51.09 0.86 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 122.026 -0.421 . . . . 2.04 111.892 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.07 -53.41 34.22 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.049 -0.596 . . . . 0.32000000000000001 113.513 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.427 ' O ' HG22 ' A' ' 82' ' ' VAL . 17.7 m-90 -75.86 -37.72 58.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.652 0.263 . . . . 0.48999999999999999 110.632 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.01 -54.06 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 1.1399999999999999 111.791 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.462 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -68.59 -35.31 69.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 110.559 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 120' ' ' ILE . 44.2 t -69.43 -48.19 61.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.096 -0.502 . . . . 0.55000000000000004 111.083 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.614 ' CG2' HD13 ' A' ' 69' ' ' LEU . 34.0 m -66.7 -32.37 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 121.169 -0.212 . . . . 0.83999999999999997 111.125 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -80.92 3.38 22.99 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.275 0.56 . . . . 1.4299999999999999 110.237 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 t -123.93 27.48 7.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.558 -0.746 . . . . 1.23 109.001 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.63 ' HE1' ' HA ' ' A' ' 90' ' ' LYS . 40.7 mmm -123.79 116.45 23.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 2.27 111.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.534 HH21 ' HB2' ' A' ' 88' ' ' ASN . 18.0 ttp85 -82.41 162.06 22.27 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 4.1900000000000004 109.753 175.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -66.12 -13.68 60.53 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.108 0.41 . . . . 1.9399999999999999 112.108 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.534 ' HB2' HH21 ' A' ' 86' ' ' ARG . 37.0 m-80 -121.42 25.51 9.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.004 0.43 . . . . 1.23 109.976 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -123.16 166.4 15.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.634 -0.712 . . . . 1.6000000000000001 109.737 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.63 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 79.2 tttt -157.28 121.03 4.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 1.1699999999999999 111.405 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.27 160.96 25.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.522 -0.763 . . . . 1.2 110.646 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 75.2 mt -115.13 126.22 54.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.544 -0.539 . . . . 1.73 109.544 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 77' ' ' GLY . 10.0 p -101.22 142.45 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 110.024 -0.362 . . . . 0.73999999999999999 110.024 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 15.3 mmm-85 -100.98 112.84 25.38 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.84 -0.8 . . . . 1.71 108.84 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -87.23 101.18 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.52000000000000002 110.928 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 98' ' ' MET . 10.2 tp10 -79.75 159.22 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.433 -0.951 . . . . 1.3700000000000001 108.433 170.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.411 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 8.5 p -55.37 -36.1 65.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.889 0.376 . . . . 1.0 111.499 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 96' ' ' GLU . 22.2 ptp -76.95 -8.27 57.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.166 -0.47 . . . . 1.79 111.021 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -96.08 -2.4 46.72 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.154 -0.313 . . . . 0.75 110.154 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.562 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -133.72 -152.45 6.78 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.684 -0.689 . . . . 0.70999999999999996 112.335 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.926 0.343 . . . . 1.52 111.926 -177.845 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.506 ' HB3' HD13 ' A' ' 110' ' ' ILE . 3.0 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.751 -0.092 . . . . 1.52 110.751 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.579 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.59 71.36 17.49 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.922 0.392 . . . . 0.75 111.77 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -92.23 -158.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.766 2.311 . . . . 1.5800000000000001 112.558 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.14 -133.0 9.65 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.336 -0.706 . . . . 2.0499999999999998 111.336 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 67.0 t30 -96.64 24.07 6.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.753 0.787 . . . . 2.0299999999999998 109.732 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -104.93 146.5 28.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.397 -0.82 . . . . 1.1399999999999999 109.737 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.19 132.06 34.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.158 0.504 . . . . 0.47999999999999998 110.66 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.7 mp -121.07 168.95 10.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.545 . . . . 0.51000000000000001 109.624 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -138.97 122.83 17.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.69999999999999996 110.333 172.38 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -110.94 140.6 45.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.42999999999999999 111.453 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.434 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 34.3 mt-10 -80.45 119.58 23.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.274 -0.875 . . . . 1.46 108.903 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.587 HD12 ' SG ' ' A' ' 81' ' ' CYS . 47.8 mt -108.12 134.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.248 -0.649 . . . . 0.47999999999999998 109.248 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -134.93 114.38 12.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.529 . . . . 1.8799999999999999 110.7 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.71 ' HA ' HG12 ' A' ' 42' ' ' VAL . 4.9 tp -84.0 91.72 7.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.852 -0.425 . . . . 1.1200000000000001 109.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 41' ' ' THR . 2.8 pp -84.27 -36.81 22.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.279 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.4 m -143.14 150.66 39.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.047 -0.353 . . . . 1.1899999999999999 110.047 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -165.91 -178.89 4.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.494 -0.558 . . . . 0.71999999999999997 109.494 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.86 138.92 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 2.98 110.554 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.318 -0.623 . . . . 3.3799999999999999 109.318 177.726 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.754 -0.462 . . . . 3.6000000000000001 109.754 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.35 154.13 39.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.263 0.554 . . . . 2.71 110.77 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.4 mppt? -94.42 152.04 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.039 -0.726 . . . . 1.8799999999999999 109.039 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.31 105.19 17.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.562 -0.533 . . . . 0.58999999999999997 109.562 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.8 99.75 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 2.1600000000000001 110.247 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt 66.75 78.63 0.25 Allowed 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.027 0.829 . . . . 1.45 110.858 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -68.3 156.07 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.78000000000000003 110.366 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.27 -20.27 65.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.247 -0.433 . . . . 0.81000000000000005 111.902 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.51 30.69 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.87 0.367 . . . . 2.3999999999999999 111.83 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 11.38 5.32 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.043 -1.075 . . . . 0.68000000000000005 114.548 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.92 64.33 4.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.545 0.578 . . . . 0.60999999999999999 114.545 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.14 147.55 32.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 0.48999999999999999 109.984 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -85.5 111.17 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.789 -0.449 . . . . 0.46999999999999997 109.789 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 18.5 pttp -141.68 146.92 36.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.945 0.402 . . . . 1.3400000000000001 110.769 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -102.79 132.02 49.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.5 110.034 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 tp -93.63 121.93 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.878 0.371 . . . . 0.67000000000000004 110.194 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.88 -78.83 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.82999999999999996 110.419 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 108.69 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.579 -0.737 . . . . 1.5600000000000001 109.675 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -72.88 147.39 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.885 -0.598 . . . . 2.9500000000000002 111.901 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.73 88.75 1.38 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.072 -1.211 . . . . 1.3200000000000001 110.072 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.33 -43.21 43.5 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.767 0.654 . . . . 2.77 112.767 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.32 144.38 34.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.924 0.392 . . . . 2.6400000000000001 110.709 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.81 51.8 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.977 -0.63 . . . . 1.04 111.643 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.95 -45.98 64.58 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.583 0.586 . . . . 2.29 112.583 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.47 27.65 8.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.962 0.411 . . . . 2.6400000000000001 111.035 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 30.9 m-80 -129.26 78.62 1.86 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 1.45 110.609 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.25 124.31 21.18 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.134 -0.485 . . . . 0.81000000000000005 111.066 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HG3' HD22 ' A' ' 122' ' ' LEU . 42.8 Cg_endo -67.65 112.83 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.713 2.275 . . . . 0.75 111.504 176.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.7 mmtp -133.39 172.78 12.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.364 0.875 . . . . 2.6600000000000001 113.364 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -43.42 126.48 4.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.02 -1.445 . . . . 2.5099999999999998 113.211 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 -16.01 45.1 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.935 -0.575 . . . . 1.1200000000000001 113.301 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 92.7 m-20 -83.58 146.99 28.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.057 0.456 . . . . 1.3799999999999999 110.913 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -78.5 110.23 13.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.292 0.568 . . . . 2.2000000000000002 110.252 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 125' ' ' PHE . 11.1 m -117.88 159.29 18.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.587 -0.733 . . . . 0.67000000000000004 109.819 175.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' HD3' ' A' ' 66' ' ' LYS . 23.7 m -125.55 105.61 9.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.383 -0.599 . . . . 0.65000000000000002 109.383 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 122' ' ' LEU . 12.7 m -128.01 140.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.864 -0.607 . . . . 0.87 110.185 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -100.43 147.64 25.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.06 -0.718 . . . . 2.75 109.06 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -126.39 127.84 46.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.371 0.605 . . . . 0.76000000000000001 110.326 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.22 157.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.355 -0.98 . . . . 0.48999999999999999 108.355 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.61 -128.49 1.71 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.258 -0.972 . . . . 0.35999999999999999 111.454 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.679 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 59.2 pttt -157.81 170.92 21.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.993 0.425 . . . . 1.4299999999999999 111.058 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD13 ' HG ' ' A' ' 116' ' ' LEU . 46.2 tp -89.52 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.38 109.627 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 78.2 tt0 -64.36 -28.55 69.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 1.96 111.233 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.44 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 8.7 t -54.84 -29.78 55.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.532 . . . . 0.67000000000000004 111.543 -175.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -130.46 -2.45 4.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.656 0.265 . . . . 0.72999999999999998 111.086 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 45.34 50.31 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.347 -0.454 . . . . 0.78000000000000003 113.032 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 68.8 mmtt -113.51 127.1 55.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 2.8900000000000001 110.584 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.679 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 14.4 p -72.76 152.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.622 -0.717 . . . . 0.58999999999999997 111.168 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 3.5 m-30 -74.48 115.45 14.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.998 0.428 . . . . 0.78000000000000003 110.749 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -146.21 85.7 1.67 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.655 -0.702 . . . . 2.1800000000000002 109.425 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 15.0 m -116.13 -177.5 3.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.544 -0.753 . . . . 1.24 109.734 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -71.17 -37.98 72.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.947 0.404 . . . . 1.49 111.212 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.42 -48.09 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.382 0.512 . . . . 1.8 112.382 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -62.34 -45.57 92.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.926 0.713 . . . . 2.1899999999999999 112.926 -167.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 57' ' ' SER . 3.4 ptm180 -67.35 -23.25 65.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.776 0.322 . . . . 2.7799999999999998 111.326 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -87.71 -62.32 1.52 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 1.1000000000000001 110.565 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.3 107.09 30.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.631 0.729 . . . . 2.0299999999999998 110.787 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.14 138.74 37.3 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.114 2.542 . . . . 1.76 111.795 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.25 153.85 18.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.902 -0.407 . . . . 1.3100000000000001 109.902 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD3' HG23 ' A' ' 41' ' ' THR . 3.7 pptp? -130.02 146.76 51.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.303 -0.408 . . . . 1.3600000000000001 110.506 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.454 ' HB2' HE22 ' A' ' 71' ' ' GLN . 48.7 p90 -127.86 174.43 9.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.82 0.343 . . . . 0.56999999999999995 111.447 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -110.69 151.36 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 1.98 110.664 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.488 HD23 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -65.18 117.67 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.94999999999999996 110.535 -176.349 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.76 90.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.203 1.001 . . . . 2.0800000000000001 110.228 -171.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.454 HE22 ' HB2' ' A' ' 67' ' ' PHE . 8.2 tt0 -127.73 8.24 6.32 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.399 -1.273 . . . . 1.98 109.585 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.1 -17.67 31.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.71999999999999997 112.472 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 9.0 mm-40 -90.4 -15.53 30.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.374 0.606 . . . . 0.96999999999999997 110.329 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.56 124.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.952 -0.567 . . . . 0.57999999999999996 110.747 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -99.43 -57.07 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.74 0.644 . . . . 0.62 112.74 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.0 mtpt -137.41 -61.18 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 2.04 111.665 -171.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.46 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -52.99 -52.74 37.66 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.05 -0.595 . . . . 0.32000000000000001 112.78 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.571 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -74.87 -51.53 13.67 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.74 -0.384 . . . . 0.48999999999999999 110.431 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.41 -51.98 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.545 0.528 . . . . 1.1399999999999999 112.123 -171.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 76' ' ' LYS . 1.8 mp -65.42 -38.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.809 0.338 . . . . 0.78000000000000003 110.453 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.0 t -68.6 -46.1 70.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.284 . . . . 0.55000000000000004 110.765 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.6 m -67.98 -33.06 59.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 O-C-N 123.153 0.283 . . . . 0.83999999999999997 110.856 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -61.1 -39.24 89.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 1.4299999999999999 110.58 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.527 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 22.4 m -92.67 31.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.474 . . . . 1.23 111.15 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 85.6 mmm -104.52 175.13 5.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.615 -0.266 . . . . 2.27 110.385 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 70.4 mtt85 -144.89 165.71 27.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.465 -0.334 . . . . 4.1900000000000004 110.359 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -53.73 -35.14 60.87 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.618 0.573 . . . . 1.9399999999999999 112.316 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -125.19 41.4 3.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 1.23 110.561 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 20.2 tt0 -117.34 154.25 31.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.392 -0.367 . . . . 1.6000000000000001 110.193 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.94 117.49 7.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.376 . . . . 1.1699999999999999 109.986 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 74.5 m -124.52 162.21 24.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.092 0.472 . . . . 1.2 112.018 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.44 114.67 27.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.369 -0.832 . . . . 1.73 109.646 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.603 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.1 p -103.77 147.57 9.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.409 -0.359 . . . . 0.73999999999999999 110.983 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 94' ' ' ARG . 9.5 mmt85 -105.51 112.38 25.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.587 -0.523 . . . . 1.71 109.587 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.521 HD13 ' HD2' ' A' ' 118' ' ' PHE . 2.1 mp -94.1 105.58 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.149 0.499 . . . . 0.52000000000000002 109.67 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 97' ' ' SER . 23.0 tt0 -93.78 174.85 6.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -49.0 -45.87 43.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.76 0.424 . . . . 1.0 111.516 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.08 -8.29 58.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.948 -0.569 . . . . 1.79 112.027 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.412 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 21.6 m-85 -102.28 -18.58 15.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.75 110.578 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' C ' HD11 ' A' ' 75' ' ' ILE . . . -112.99 -174.41 19.13 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.304 -0.718 . . . . 0.70999999999999996 111.304 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 1.52 110.889 179.282 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.552 ' HB2' HD13 ' A' ' 110' ' ' ILE . 4.7 p . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 111.961 0.356 . . . . 1.52 111.961 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -160.25 87.67 1.87 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 122.892 0.477 . . . . 0.75 110.848 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.83 170.35 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.345 2.03 . . . . 1.5800000000000001 111.597 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.06 36.54 0.02 OUTLIER Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.39 -0.91 . . . . 2.0499999999999998 112.473 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.53 19.01 11.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.274 0.559 . . . . 2.0299999999999998 110.402 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 2.0 m -95.8 160.93 14.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.493 -0.776 . . . . 1.1399999999999999 110.33 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.22 122.21 45.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.375 0.607 . . . . 0.47999999999999998 110.452 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.0 mp -116.29 142.7 46.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.837 -0.62 . . . . 0.51000000000000001 109.615 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.44 121.59 45.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.142 0.496 . . . . 0.69999999999999996 110.539 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.521 ' HD2' HD13 ' A' ' 95' ' ' ILE . 44.4 m-85 -112.88 137.95 50.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.747 . . . . 0.42999999999999999 111.219 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.512 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 38.7 mt-10 -78.2 122.37 25.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.81 -0.811 . . . . 1.46 108.81 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.479 HG21 HG12 ' A' ' 82' ' ' VAL . 49.9 mt -107.16 121.16 59.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.512 -0.551 . . . . 0.47999999999999998 109.512 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -127.68 112.88 15.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.514 -0.766 . . . . 1.8799999999999999 110.639 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 42' ' ' VAL . 24.6 tp -88.93 99.59 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 1.1200000000000001 109.9 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -90.8 -31.42 16.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.872 -0.331 . . . . 1.0 111.308 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.3 m -151.21 146.21 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.713 -0.221 . . . . 1.1899999999999999 110.571 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.593 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -168.39 -179.21 3.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.523 -0.308 . . . . 0.71999999999999997 110.294 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 6.0 ptp180 -155.74 142.22 18.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.055 -0.521 . . . . 2.98 109.948 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.756 0.312 . . . . 3.3799999999999999 110.482 174.689 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 112.834 0.679 . . . . 3.6000000000000001 112.834 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.72 154.26 19.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.9 -1.046 . . . . 2.71 110.025 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 3.2 mppt? -99.41 127.83 45.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.337 -0.616 . . . . 1.8799999999999999 109.337 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -102.53 105.42 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.421 -0.585 . . . . 0.58999999999999997 109.421 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.16 140.98 29.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.253 -0.43 . . . . 2.1600000000000001 110.993 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.2 mt 54.04 44.0 29.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 1.45 111.677 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.587 HG21 ' HD3' ' A' ' 20' ' ' LYS . 9.1 t -55.92 157.3 4.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.78000000000000003 110.817 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 1.16 5.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.81000000000000005 111.19 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -80.11 3.51 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 2.3999999999999999 110.592 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.86 25.41 1.9 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.839 -0.696 . . . . 0.68000000000000005 113.539 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 66.02 68.75 1.55 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.231 -0.509 . . . . 0.60999999999999999 113.941 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.532 HG21 ' HB ' ' A' ' 80' ' ' ILE . 12.8 t -135.87 145.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.898 -0.408 . . . . 0.48999999999999999 109.898 176.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.783 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 8.8 mm -85.49 109.67 18.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.453 -0.573 . . . . 0.46999999999999997 109.453 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.587 ' HD3' HG21 ' A' ' 13' ' ' THR . 4.1 ptmt -125.0 129.13 49.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.232 0.539 . . . . 1.3400000000000001 111.158 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -101.07 114.62 28.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.644 -0.707 . . . . 0.5 109.801 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.505 HD11 ' CG ' ' A' ' 25' ' ' LYS . 10.5 tp -66.16 128.74 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.992 -0.549 . . . . 0.67000000000000004 109.792 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 0.5 OUTLIER -122.57 -78.3 0.6 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.993 0.425 . . . . 0.82999999999999996 110.776 -177.011 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -124.55 119.03 27.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.753 -0.658 . . . . 1.5600000000000001 109.983 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.591 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 43.7 mtpt -107.09 163.73 12.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.024 0.44 . . . . 2.9500000000000002 110.692 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.3 -124.67 5.24 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.428 -0.806 . . . . 1.3200000000000001 111.3 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -150.99 -86.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.129 0.49 . . . . 2.77 110.439 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -95.65 158.74 15.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.978 -0.556 . . . . 2.6400000000000001 110.526 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.37 53.79 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 111.218 -0.753 . . . . 1.04 111.218 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.43 -40.19 89.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.109 0.48 . . . . 2.29 110.2 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -106.51 27.18 9.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.493 0.663 . . . . 2.6400000000000001 109.802 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.504 ' OD1' ' HE3' ' A' ' 87' ' ' LYS . 36.1 m-80 -130.51 76.47 1.72 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.521 -0.763 . . . . 1.45 109.857 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.6 mm -130.48 120.53 18.89 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.066 -0.516 . . . . 0.81000000000000005 111.131 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.16 131.74 15.73 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.571 2.181 . . . . 0.75 111.52 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HB2' HD22 ' A' ' 38' ' ' ASN . 30.4 mmmt -126.05 142.22 51.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.623 -0.262 . . . . 2.6600000000000001 110.5 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 7.4 ttmm -71.22 138.64 49.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 2.5099999999999998 109.471 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.7 -27.15 13.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.809 -0.71 . . . . 1.1200000000000001 111.408 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.404 HD22 ' HB2' ' A' ' 35' ' ' LYS . 72.9 m-20 -88.88 145.37 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.82 -0.437 . . . . 1.3799999999999999 109.82 174.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 42.8 mt-10 -69.53 98.75 1.17 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.846 -0.615 . . . . 2.2000000000000002 112.126 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 125' ' ' PHE . 22.6 m -116.13 152.23 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 0.67000000000000004 109.828 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.4 m -127.36 131.05 50.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.683 -0.488 . . . . 0.65000000000000002 109.683 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 122' ' ' LEU . 10.7 m -137.12 152.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.276 0.56 . . . . 0.87 112.436 -173.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -105.38 129.44 53.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 2.75 109.58 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 8.7 p90 -134.27 140.13 46.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.854 0.359 . . . . 0.76000000000000001 111.474 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.14 158.6 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.54 -0.911 . . . . 0.48999999999999999 108.54 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -177.39 -126.63 0.99 Allowed Glycine 0 C--O 1.228 -0.227 0 C-N-CA 119.847 -1.168 . . . . 0.35999999999999999 113.019 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.573 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 20.6 pttp -155.45 170.68 21.38 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.575 -0.367 . . . . 1.4299999999999999 111.478 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HG ' ' A' ' 116' ' ' LEU . 66.0 tp -94.1 98.32 10.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.38 109.683 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 117' ' ' LEU . 2.4 tp10 -69.19 -20.65 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.309 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.543 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 5.5 t -55.31 -27.37 46.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.67000000000000004 111.504 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 t -138.18 9.22 2.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 0.72999999999999998 110.452 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.73 55.61 27.6 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.847 -0.615 . . . . 0.78000000000000003 112.636 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 27.1 mmmt -121.14 118.55 29.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.529 -0.175 . . . . 2.8900000000000001 110.529 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.573 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.5 p -69.6 153.99 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.864 0.364 . . . . 0.58999999999999997 110.973 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 7.7 m-30 -76.73 105.53 7.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.78000000000000003 110.624 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -130.82 85.58 2.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.549 0.69 . . . . 2.1800000000000002 109.81 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.32 156.17 28.29 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.587 -0.894 . . . . 1.24 108.587 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -68.33 -21.32 64.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.177 0.513 . . . . 1.49 110.77 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -94.62 -48.8 5.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 1.8 112.21 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -42.92 82.75 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.984 0.364 . . . . 2.1899999999999999 111.984 -169.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -77.49 -3.52 40.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.016 0.436 . . . . 2.7799999999999998 111.063 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.7 -45.73 8.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 1.1000000000000001 109.989 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.87 113.51 2.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 2.0299999999999998 110.52 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.22 171.4 17.85 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.798 2.332 . . . . 1.76 112.197 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -102.4 142.44 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.176 -0.466 . . . . 1.3100000000000001 110.175 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HD3' ' CG2' ' A' ' 41' ' ' THR . 0.0 OUTLIER -119.14 143.65 47.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 1.3600000000000001 108.996 175.476 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 55.8 p90 -133.44 169.89 16.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.56999999999999995 112.054 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.419 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 2.4 m80 -104.96 148.97 26.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.676 -1.147 . . . . 1.98 109.768 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 ' HB ' ' A' ' 82' ' ' VAL . 25.3 tp -73.15 129.99 39.28 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.747 -0.381 . . . . 0.94999999999999996 110.144 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 65.72 31.77 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.929 0.768 . . . . 2.0800000000000001 111.165 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 12.2 pt20 -80.9 12.57 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 1.98 111.114 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.57 48.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.035 -0.602 . . . . 0.71999999999999997 112.828 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HB2' HE21 ' A' ' 71' ' ' GLN . 17.1 mm-40 -87.5 -32.32 19.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.449 . . . . 0.96999999999999997 110.818 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.452 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.0 m -98.52 127.05 51.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.376 0.607 . . . . 0.57999999999999996 110.62 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.645 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.65 -76.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.62 112.27 -175.476 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.645 ' H ' HG12 ' A' ' 75' ' ' ILE . 4.2 mmpt? -121.15 -57.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.455 . . . . 2.04 112.23 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.16 -52.31 36.66 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.292 0.37 . . . . 0.32000000000000001 113.693 -171.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.63 -43.13 49.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.94 -0.153 . . . . 0.48999999999999999 111.373 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.491 ' HA ' ' CD1' ' A' ' 69' ' ' LEU . 23.2 t70 -51.87 -52.32 50.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.526 0.565 . . . . 1.1399999999999999 112.526 -171.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.532 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.7 mp -61.62 -50.97 78.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.451 . . . . 0.78000000000000003 111.296 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 120' ' ' ILE . 47.6 t -71.21 -27.41 63.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.55000000000000004 111.734 -171.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' HD13 ' A' ' 69' ' ' LEU . 53.7 t -66.24 -40.12 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.281 . . . . 0.83999999999999997 110.873 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 t -78.39 -7.84 57.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 1.4299999999999999 110.05 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.5 m -98.09 19.0 14.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 1.23 110.76 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 6.0 mmt -98.26 -173.53 2.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 2.27 111.726 -176.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 38.1 ttm180 -157.43 163.49 38.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.957 -1.127 . . . . 4.1900000000000004 107.957 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.504 ' HE3' ' OD1' ' A' ' 32' ' ' ASN . 5.3 tppp? -50.85 -40.51 56.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.032 0.382 . . . . 1.9399999999999999 112.032 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -118.96 34.17 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.237 . . . . 1.23 110.563 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 4.3 tt0 -122.7 140.09 53.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.722 -0.391 . . . . 1.6000000000000001 110.781 -175.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.9 tmtp? -145.57 129.18 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 1.1699999999999999 109.977 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 74.4 m -137.58 171.09 14.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.074 0.464 . . . . 1.2 111.687 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 119' ' ' GLU . 58.0 mt -105.83 131.68 52.87 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.502 -0.772 . . . . 1.73 109.983 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 95' ' ' ILE . 7.3 p -112.45 140.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.044 0.449 . . . . 0.73999999999999999 110.994 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.783 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 8.3 mmm180 -99.13 112.81 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.577 . . . . 1.71 110.028 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CD1' HG13 ' A' ' 93' ' ' VAL . 3.2 mp -101.45 107.51 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.52000000000000002 110.137 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 31.4 tt0 -84.51 171.81 12.21 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.856 -0.794 . . . . 1.3700000000000001 108.856 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.6 p -56.4 -38.21 71.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.645 0.259 . . . . 1.0 111.612 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -77.21 -7.85 56.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 1.79 111.434 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.502 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.8 m-30 -97.29 1.96 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.34 -0.225 . . . . 0.75 110.508 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.57 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -134.35 -152.59 6.69 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.94 -0.573 . . . . 0.70999999999999996 111.729 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 1.52 110.746 179.451 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 110.277 -0.268 . . . . 1.52 110.277 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -154.59 66.13 5.06 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 121.025 0.441 . . . . 0.75 110.594 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.71 53.79 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.203 2.602 . . . . 1.5800000000000001 112.972 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.33 63.8 4.09 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.732 -0.746 . . . . 2.0499999999999998 112.045 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 51.73 66.25 1.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.602 0.715 . . . . 2.0299999999999998 110.407 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 49.6 m -144.93 168.45 20.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.328 -0.851 . . . . 1.1399999999999999 110.097 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.86 128.42 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.182 -0.463 . . . . 0.47999999999999998 110.415 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.1 mp -123.07 169.18 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.51000000000000001 110.293 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.16 131.64 37.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.448 -0.575 . . . . 0.69999999999999996 109.448 175.178 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 95' ' ' ILE . 37.9 m-85 -128.96 144.04 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.381 . . . . 0.42999999999999999 110.95 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.705 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 26.9 mt-10 -74.81 128.03 34.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.727 -0.842 . . . . 1.46 108.727 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 81' ' ' CYS . 25.8 mt -107.17 120.32 58.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.178 -0.675 . . . . 0.47999999999999998 109.178 172.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -127.07 118.07 23.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.482 -0.781 . . . . 1.8799999999999999 110.51 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HA ' HG12 ' A' ' 42' ' ' VAL . 35.8 tp -80.69 113.89 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 1.1200000000000001 109.902 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.94 -13.41 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.716 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.4 m -155.63 137.84 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.985 -0.376 . . . . 1.1899999999999999 109.985 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG12 ' A' ' 40' ' ' VAL . 9.0 p90 -160.81 175.0 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.71999999999999997 110.368 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.6 ptp180 -162.26 147.27 12.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 2.98 110.38 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 120.779 0.323 . . . . 3.3799999999999999 110.279 176.828 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.759 0.314 . . . . 3.6000000000000001 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -121.16 170.81 9.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.013 -0.54 . . . . 2.71 109.897 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 0.0 OUTLIER -90.86 157.24 17.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 1.8799999999999999 110.814 -175.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.44 HG11 ' HB ' ' A' ' 13' ' ' THR . 58.9 t -103.93 115.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.328 -0.619 . . . . 0.58999999999999997 109.328 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -87.92 99.82 12.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.474 -0.33 . . . . 2.1600000000000001 111.259 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' H ' HD13 ' A' ' 19' ' ' ILE . 66.1 mt 52.88 75.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 1.45 111.19 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.44 ' HB ' HG11 ' A' ' 10' ' ' VAL . 4.9 t -59.29 147.2 36.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 0.78000000000000003 110.32 175.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.38 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 0.81000000000000005 111.084 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.15 29.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 2.3999999999999999 111.084 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.35 -5.39 10.15 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.631 -0.795 . . . . 0.68000000000000005 113.933 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.19 71.02 1.09 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.94 -0.648 . . . . 0.60999999999999999 114.043 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.2 t -138.11 145.64 28.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.693 -0.484 . . . . 0.48999999999999999 109.693 173.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.0 mm -85.61 110.72 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.294 -0.412 . . . . 0.46999999999999997 110.802 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.51 147.24 40.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.286 -0.415 . . . . 1.3400000000000001 110.697 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 9' ' ' LYS . 26.4 m -112.98 139.46 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 0.5 110.392 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -80.03 134.97 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.147 -0.479 . . . . 0.67000000000000004 110.355 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.43 -71.16 0.72 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.086 0.47 . . . . 0.82999999999999996 110.503 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -105.47 97.54 7.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.291 -0.633 . . . . 1.5600000000000001 109.291 -177.531 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -75.21 138.82 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.884 0.373 . . . . 2.9500000000000002 110.855 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.69 135.59 14.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.97 -0.633 . . . . 1.3200000000000001 111.681 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.71 -55.21 37.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 2.77 110.174 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.59 170.27 19.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.39 -0.823 . . . . 2.6400000000000001 109.579 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.83 43.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 1.04 111.369 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.52 -38.0 85.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.949 0.404 . . . . 2.29 111.143 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -94.57 -20.55 19.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.809 -0.632 . . . . 2.6400000000000001 110.509 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 38.8 m-80 -95.3 81.81 3.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.129 -0.487 . . . . 1.45 110.927 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.36 120.56 26.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.81000000000000005 111.377 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.4 Cg_endo -76.49 132.75 13.76 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.204 2.603 . . . . 0.75 111.4 174.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HD3' ' OG ' ' A' ' 83' ' ' SER . 34.3 mmtm -148.78 158.94 44.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.667 0.27 . . . . 2.6600000000000001 111.109 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -55.75 128.47 35.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.961 -0.563 . . . . 2.5099999999999998 110.465 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.75 -26.59 20.65 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.9 -0.591 . . . . 1.1200000000000001 111.793 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -83.63 140.22 32.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.652 -0.499 . . . . 1.3799999999999999 109.652 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' A' ' 68' ' ' HIS . 1.7 tm-20 -76.91 101.59 6.01 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.325 -0.62 . . . . 2.2000000000000002 109.325 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 125' ' ' PHE . 26.3 m -115.49 133.83 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.781 -0.645 . . . . 0.67000000000000004 111.309 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' HD3' ' A' ' 66' ' ' LYS . 17.4 m -103.26 106.93 17.57 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.5 -0.555 . . . . 0.65000000000000002 109.5 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 m -119.34 141.66 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.551 0.691 . . . . 0.87 112.582 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.42 148.67 25.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.944 -1.025 . . . . 2.75 109.601 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 2.5 p90 -144.24 140.88 29.51 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.226 0.329 . . . . 0.76000000000000001 110.596 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -168.04 160.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.377 -0.601 . . . . 0.48999999999999999 109.377 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 171.32 -137.87 4.6 Favored Glycine 0 C--N 1.329 0.15 0 C-N-CA 119.59 -1.29 . . . . 0.35999999999999999 113.249 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.9 pttp -143.49 171.71 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 1.4299999999999999 110.497 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD22 HG13 ' A' ' 110' ' ' ILE . 42.7 tp -95.0 101.93 13.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.155 -0.475 . . . . 0.38 110.131 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.1 tp10 -61.68 -35.28 77.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 1.96 110.575 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 t -55.21 -32.08 61.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 0.67000000000000004 112.55 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 53' ' ' LYS . 8.8 t -123.35 -4.05 8.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.885 0.374 . . . . 0.72999999999999998 110.96 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.03 26.06 74.59 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.183 -0.532 . . . . 0.78000000000000003 113.189 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HG2' HG23 ' A' ' 51' ' ' THR . 75.4 mmtt -109.18 140.01 43.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.168 0.509 . . . . 2.8900000000000001 110.616 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 p -84.59 159.99 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.883 -0.599 . . . . 0.58999999999999997 110.035 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -74.35 131.5 41.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.116 -0.327 . . . . 0.78000000000000003 110.116 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.57 89.9 1.6 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.313 0.577 . . . . 2.1800000000000002 109.535 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -136.95 168.08 20.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.879 -0.6 . . . . 1.24 111.099 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -62.58 -29.14 70.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.49 111.403 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -92.65 -44.54 8.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.147 0.425 . . . . 1.8 112.147 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -32.45 72.79 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 2.1899999999999999 111.978 -169.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -94.2 -14.07 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.838 -0.345 . . . . 2.7799999999999998 111.21 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -100.32 -44.82 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.358 . . . . 1.1000000000000001 111.467 -173.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 3.5 m -129.31 98.82 22.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.669 0.747 . . . . 2.0299999999999998 111.794 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 63' ' ' VAL . 46.5 Cg_endo -70.98 128.48 14.96 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.206 1.938 . . . . 1.76 111.52 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -95.86 148.29 22.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 1.3100000000000001 110.521 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD3' HG23 ' A' ' 41' ' ' THR . 2.4 pptp? -133.07 143.66 49.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 1.3600000000000001 109.658 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -128.87 -178.72 4.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.56999999999999995 111.548 -173.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' A' ' 39' ' ' GLU . 8.4 m-70 -114.04 149.68 35.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.659 . . . . 1.98 110.437 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.75 HD11 ' HA ' ' A' ' 79' ' ' ASP . 22.9 tp -67.37 122.81 18.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.94999999999999996 111.787 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 42.39 72.5 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.222 1.009 . . . . 2.0800000000000001 112.259 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -119.71 19.09 12.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.709 0.766 . . . . 1.98 110.587 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.5 -18.85 46.87 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.276 -0.874 . . . . 0.71999999999999997 112.835 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.83 -50.96 6.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.407 0.622 . . . . 0.96999999999999997 109.617 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -100.16 132.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.604 -0.726 . . . . 0.57999999999999996 110.381 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.501 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.04 -74.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.799 0.666 . . . . 0.62 112.799 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 75' ' ' ILE . 19.8 mtpp -128.82 -40.81 1.51 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.876 -0.515 . . . . 2.04 112.174 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -49.51 52.58 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.824 -0.703 . . . . 0.32000000000000001 112.462 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 82' ' ' VAL . 14.7 m-90 -76.02 -41.09 52.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.626 0.25 . . . . 0.48999999999999999 110.858 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.75 ' HA ' HD11 ' A' ' 69' ' ' LEU . 35.0 t70 -56.02 -53.41 57.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.964 -0.562 . . . . 1.1399999999999999 112.329 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.75 -33.35 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.78000000000000003 110.873 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -69.25 -50.0 51.08 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.805 -0.358 . . . . 0.55000000000000004 110.243 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 69' ' ' LEU . 89.4 t -63.29 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.496 -0.32 . . . . 0.83999999999999997 111.338 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.442 ' OG ' ' HD3' ' A' ' 35' ' ' LYS . 23.3 t -71.69 -8.47 54.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.813 0.34 . . . . 1.4299999999999999 111.456 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 t -114.0 23.05 13.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.112 0.482 . . . . 1.23 110.389 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.576 ' HE1' ' HA ' ' A' ' 90' ' ' LYS . 82.8 mmm -99.45 177.33 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 2.27 111.332 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.58 ' HB2' ' CB ' ' A' ' 89' ' ' GLU . 97.1 mtt180 -141.08 159.4 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 4.1900000000000004 108.417 173.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 63.9 tttm -66.45 -21.68 66.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.093 0.473 . . . . 1.9399999999999999 111.087 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.77 12.13 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 1.23 110.703 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.58 ' CB ' ' HB2' ' A' ' 86' ' ' ARG . 18.2 tt0 -122.64 156.26 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.443 -0.344 . . . . 1.6000000000000001 110.444 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.576 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 75.3 tttt -156.51 134.93 11.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.367 -0.379 . . . . 1.1699999999999999 110.704 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 64.3 m -139.07 171.66 13.99 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.89 0.7 . . . . 1.2 112.89 -173.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.33 125.75 53.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.23 -0.895 . . . . 1.73 110.062 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.492 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 13.9 p -117.73 150.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.896 0.379 . . . . 0.73999999999999999 111.101 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -108.27 115.54 30.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 1.71 110.226 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 118' ' ' PHE . 1.9 mp -87.86 103.8 13.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.163 -0.681 . . . . 0.52000000000000002 109.163 176.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.616 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 22.1 tt0 -86.58 176.12 7.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.047 -0.979 . . . . 1.3700000000000001 109.293 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 20.6 p -49.93 -48.94 51.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.268 0.47 . . . . 1.0 112.268 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.04 -7.83 56.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.307 . . . . 1.79 111.72 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.616 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.4 m-30 -94.68 -9.52 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.57 0.224 . . . . 0.75 110.724 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 -171.74 14.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.044 -0.598 . . . . 0.70999999999999996 111.797 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 1.52 110.835 176.86 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.414 ' CB ' HD13 ' A' ' 110' ' ' ILE . 14.4 m . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.371 0.129 . . . . 1.52 111.013 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.766 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.0 57.07 3.28 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-O 120.646 0.26 . . . . 0.75 111.537 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 55.5 Cg_endo -97.7 59.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.115 2.543 . . . . 1.5800000000000001 112.538 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.6 56.14 4.16 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.729 -0.748 . . . . 2.0499999999999998 112.043 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 67.01 14.14 9.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.322 0.649 . . . . 2.0299999999999998 109.82 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -86.55 159.56 19.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.343 -0.844 . . . . 1.1399999999999999 110.406 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.87 128.07 43.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.017 0.437 . . . . 0.47999999999999998 110.694 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.6 mp -122.36 165.86 15.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.456 . . . . 0.51000000000000001 110.544 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -116.56 113.1 22.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.409 -0.589 . . . . 0.69999999999999996 109.409 176.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 95' ' ' ILE . 13.4 m-85 -111.86 124.69 52.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.374 0.607 . . . . 0.42999999999999999 110.89 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.699 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.0 tm-20 -83.0 120.54 25.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.886 -1.052 . . . . 1.46 109.172 174.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.452 HG21 HG22 ' A' ' 82' ' ' VAL . 48.4 mt -109.34 130.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.223 0.535 . . . . 0.47999999999999998 111.098 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -126.01 121.66 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.347 -0.842 . . . . 1.8799999999999999 110.329 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' A' ' 34' ' ' PRO . 27.7 tp -87.03 89.7 8.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.948 -0.76 . . . . 1.1200000000000001 108.948 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 3.3 pp -91.71 -25.77 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.762 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 m -154.13 142.26 20.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.758 0.313 . . . . 1.1899999999999999 110.546 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.645 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -167.43 179.6 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.245 -0.65 . . . . 0.71999999999999997 109.245 175.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -159.64 158.99 32.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.983 0.421 . . . . 2.98 110.682 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 3.3799999999999999 110.492 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.037 0.446 . . . . 3.6000000000000001 110.807 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.91 142.51 33.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.549 -0.751 . . . . 2.71 109.417 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -82.88 148.63 27.59 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 1.8799999999999999 109.475 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.2 t -101.87 104.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.759 . . . . 0.58999999999999997 108.952 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -91.25 110.37 21.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 2.1600000000000001 110.957 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' H ' HD13 ' A' ' 19' ' ' ILE . 87.0 mt 64.38 67.63 0.57 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.082 -0.963 . . . . 1.45 110.574 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 15' ' ' ASP . 14.7 t -74.45 167.66 21.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.03 -0.532 . . . . 0.78000000000000003 110.696 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -0.82 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.81000000000000005 112.004 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.703 ' OD2' ' HA ' ' A' ' 80' ' ' ILE . 8.4 t70 -79.09 -0.61 32.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.248 0.546 . . . . 2.3999999999999999 110.423 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.16 22.94 2.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.598 -0.811 . . . . 0.68000000000000005 113.69 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 75.68 72.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.091 -0.576 . . . . 0.60999999999999999 114.524 171.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 80' ' ' ILE . 38.8 t -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.937 -0.394 . . . . 0.48999999999999999 109.937 172.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 12' ' ' LEU . 7.7 mm -89.75 112.64 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.46999999999999997 110.845 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' HG22 ' A' ' 93' ' ' VAL . 64.3 pttt -136.96 145.97 44.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 1.3400000000000001 111.382 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -107.95 123.62 48.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.5 110.232 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 91' ' ' CYS . 8.2 tp -83.98 130.95 35.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.67000000000000004 110.997 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD21 ' HG ' ' A' ' 92' ' ' LEU . 2.5 mm? -100.14 -60.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.339 0.59 . . . . 0.82999999999999996 109.733 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -122.26 122.71 39.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 1.5600000000000001 109.659 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -82.28 147.48 28.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.295 -0.412 . . . . 2.9500000000000002 111.38 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.94 144.12 33.19 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.509 -1.036 . . . . 1.3200000000000001 110.509 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.13 -78.14 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.275 0.538 . . . . 2.77 109.62 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.58 164.83 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.218 -0.66 . . . . 2.6400000000000001 109.218 171.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 86' ' ' ARG . . . 157.24 70.35 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.957 -1.115 . . . . 1.04 113.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -75.36 -30.89 60.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.42 0.629 . . . . 2.29 110.14 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -86.39 -39.0 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.389 -0.823 . . . . 2.6400000000000001 111.419 -174.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.772 ' HB2' HH21 ' A' ' 86' ' ' ARG . 93.9 m-20 -93.66 79.54 4.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.186 0.517 . . . . 1.45 111.096 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.09 125.63 21.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.073 -0.967 . . . . 0.81000000000000005 110.338 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.5 ' HG3' HD22 ' A' ' 122' ' ' LEU . 67.5 Cg_endo -73.57 140.39 29.7 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.908 2.405 . . . . 0.75 111.542 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 14.2 mmmm -127.41 147.68 50.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.426 -0.583 . . . . 2.6600000000000001 109.426 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.628 ' HA ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.31 149.14 48.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.774 -0.371 . . . . 2.5099999999999998 111.242 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.89 -17.29 53.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.836 -0.697 . . . . 1.1200000000000001 111.966 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.535 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 81.5 m-20 -85.68 175.89 8.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 1.3799999999999999 111.083 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -97.48 121.57 39.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.534 -0.757 . . . . 2.2000000000000002 109.747 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG11 HD23 ' A' ' 69' ' ' LEU . 6.9 m -140.99 166.64 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.767 0.318 . . . . 0.67000000000000004 110.446 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.547 HG23 ' HD3' ' A' ' 66' ' ' LYS . 21.0 m -133.97 116.94 16.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.65000000000000002 110.408 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 122' ' ' LEU . 34.9 m -134.87 145.25 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.437 -0.347 . . . . 0.87 110.687 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -100.84 140.52 35.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.415 -0.587 . . . . 2.75 109.415 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 42.6 p90 -125.75 135.47 52.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 111.397 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.87 155.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.391 -0.966 . . . . 0.48999999999999999 108.391 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 178.61 -130.03 1.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.744 -1.217 . . . . 0.35999999999999999 113.27 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 57.2 pttt -147.06 171.32 15.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 1.4299999999999999 110.313 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 110' ' ' ILE . 61.7 tp -96.73 98.39 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.38 109.914 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.736 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.3 tp10 -68.65 -22.41 64.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.248 0.546 . . . . 1.96 110.547 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -25.43 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.389 -0.823 . . . . 0.67000000000000004 111.407 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.616 HG23 ' HD3' ' A' ' 53' ' ' LYS . 7.9 t -132.97 -19.31 2.27 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.986 0.422 . . . . 0.72999999999999998 111.072 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 53' ' ' LYS . . . 91.6 34.82 7.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.28 -0.486 . . . . 0.78000000000000003 112.853 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HD3' HG23 ' A' ' 51' ' ' THR . 13.7 mptt -116.97 134.93 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.75 0.309 . . . . 2.8900000000000001 110.989 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.564 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.1 p -79.31 156.39 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.935 -0.575 . . . . 0.58999999999999997 110.838 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -74.25 131.15 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.78000000000000003 111.04 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.01 89.13 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.833 -0.621 . . . . 2.1800000000000002 109.882 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.2 m -124.99 147.03 49.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.533 -0.758 . . . . 1.24 110.094 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 m -59.24 -20.4 53.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.987 -0.551 . . . . 1.49 111.127 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -92.3 -50.85 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.171 -0.468 . . . . 1.8 111.901 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -32.4 72.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.936 0.347 . . . . 2.1899999999999999 111.936 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -83.4 1.83 39.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.346 0.593 . . . . 2.7799999999999998 110.26 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -109.23 -48.64 3.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.37 -0.832 . . . . 1.1000000000000001 110.448 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.13 126.15 4.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.036 0.446 . . . . 2.0299999999999998 111.085 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.53 162.06 19.4 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.78 2.32 . . . . 1.76 112.327 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -104.09 154.83 19.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.752 -0.462 . . . . 1.3100000000000001 109.752 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.15 136.12 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 1.3600000000000001 110.692 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -114.44 -174.23 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.553 -0.294 . . . . 0.56999999999999995 110.518 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.55 ' HB2' HE21 ' A' ' 71' ' ' GLN . 80.4 m-70 -126.45 153.05 45.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.269 -0.271 . . . . 1.98 110.269 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -51.34 151.93 2.74 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.457 0.473 . . . . 0.94999999999999996 111.659 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -22.2 98.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 113.318 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.55 HE21 ' HB2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -129.8 8.07 5.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.508 -1.224 . . . . 1.98 108.98 176.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.13 -10.45 43.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.71999999999999997 113.409 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -85.23 -46.56 10.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.804 0.802 . . . . 0.96999999999999997 109.248 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.55 134.06 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.031 -0.531 . . . . 0.57999999999999996 110.575 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.662 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.6 -69.83 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.461 0.541 . . . . 0.62 112.461 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.58 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -140.96 -45.66 0.39 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.563 0.579 . . . . 2.04 112.563 -173.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 99' ' ' TYR . . . -52.83 -53.12 34.79 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.944 -0.646 . . . . 0.32000000000000001 113.005 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.514 ' O ' HG22 ' A' ' 82' ' ' VAL . 18.3 m-90 -76.69 -31.01 56.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 0.48999999999999999 110.75 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -57.92 -49.14 77.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.46 -0.791 . . . . 1.1399999999999999 111.759 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.703 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . 1.6 mp -59.69 -31.32 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.124 0.487 . . . . 0.78000000000000003 111.051 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.767 ' HB2' HG21 ' A' ' 93' ' ' VAL . 14.9 t -77.05 -58.05 3.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.334 -0.546 . . . . 0.55000000000000004 110.713 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.67 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 15.5 m -62.13 -33.54 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.791 0.664 . . . . 0.83999999999999997 112.791 -170.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t -92.12 5.66 49.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.079 0.466 . . . . 1.4299999999999999 110.974 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 32.0 t -137.73 30.09 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.228 0.537 . . . . 1.23 110.083 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.67 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 45.3 mtm -106.59 -172.12 2.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 2.27 110.373 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.772 HH21 ' HB2' ' A' ' 32' ' ' ASN . 14.5 mtp-105 -138.73 170.74 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.515 . . . . 4.1900000000000004 110.212 171.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -64.12 -20.57 66.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.282 -0.417 . . . . 1.9399999999999999 111.621 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -127.05 16.57 7.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.36 -0.382 . . . . 1.23 111.106 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 2.1 tm-20 -110.38 153.72 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -158.86 123.33 4.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.691 -0.231 . . . . 1.1699999999999999 110.551 -173.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 1.6 p -136.53 159.05 42.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.437 -0.347 . . . . 1.2 111.421 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 23' ' ' LEU . 97.9 mt -105.2 127.17 52.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.12 -0.491 . . . . 1.73 110.852 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 81' ' ' CYS . 39.1 t -105.74 151.08 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.968 -0.56 . . . . 0.73999999999999999 111.015 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.36 112.17 25.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.445 -0.576 . . . . 1.71 109.445 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.4 mp -90.3 105.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.52000000000000002 110.43 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 97' ' ' SER . 34.0 tt0 -82.29 166.09 19.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 1.3700000000000001 109.12 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 3.6 p -52.99 -42.94 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.565 0.58 . . . . 1.0 112.565 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -76.99 -7.91 56.46 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.882 -0.327 . . . . 1.79 111.5 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.402 ' HB3' ' CA ' ' A' ' 77' ' ' GLY . 22.0 m-30 -89.03 -1.48 58.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.017 0.437 . . . . 0.75 110.196 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.662 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -146.3 -165.42 11.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.681 -0.69 . . . . 0.70999999999999996 111.411 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 117.304 0.552 . . . . 1.52 110.336 179.009 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.403 ' CB ' HD13 ' A' ' 110' ' ' ILE . 13.6 m . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.405 0.145 . . . . 1.52 111.241 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.556 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.04 81.82 10.33 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 121.15 0.5 . . . . 0.75 111.432 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -102.7 -149.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.303 3.335 . . . . 1.5800000000000001 111.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.31 73.31 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.838 -0.696 . . . . 2.0499999999999998 112.288 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 15.6 m120 56.73 23.61 8.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.118 0.485 . . . . 2.0299999999999998 111.188 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 m -114.0 151.59 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.96 -0.564 . . . . 1.1399999999999999 109.594 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.13 132.63 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.599 . . . . 0.47999999999999998 111.295 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -125.02 165.29 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.51000000000000001 109.999 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -124.83 124.74 42.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.178 -0.675 . . . . 0.69999999999999996 109.178 173.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.67 143.24 47.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.74 -0.209 . . . . 0.42999999999999999 110.553 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 38.5 mt-10 -62.63 136.49 57.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.738 -0.467 . . . . 1.46 109.738 168.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 ' SD ' ' A' ' 85' ' ' MET . 22.3 mt -128.09 116.85 44.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.229 -1.026 . . . . 0.47999999999999998 108.229 169.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -135.17 111.47 9.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.692 -0.685 . . . . 1.8799999999999999 110.535 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.688 ' HA ' HG12 ' A' ' 42' ' ' VAL . 23.0 tp -81.47 100.09 9.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.361 -0.381 . . . . 1.1200000000000001 110.788 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -104.81 -9.45 18.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.868 0.366 . . . . 1.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 67.5 m -155.28 139.52 16.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 1.1899999999999999 110.524 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.504 ' HB3' HD11 ' A' ' 122' ' ' LEU . 7.8 p90 -165.74 150.29 8.44 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.29 0.369 . . . . 0.71999999999999997 110.222 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.489 ' HE ' ' HB3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -146.24 127.33 14.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.943 0.401 . . . . 2.98 110.922 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.511 -0.768 . . . . 3.3799999999999999 111.178 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.03 0.443 . . . . 3.6000000000000001 111.158 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -81.63 151.61 27.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.675 -0.693 . . . . 2.71 109.145 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.58 145.84 25.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.79 0.329 . . . . 1.8799999999999999 110.274 -177.199 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 13' ' ' THR . 21.8 t -101.97 103.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.965 -1.124 . . . . 0.58999999999999997 107.965 170.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.558 ' HG2' HG23 ' A' ' 19' ' ' ILE . 45.9 mt-10 -102.47 120.84 41.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.714 . . . . 2.1600000000000001 110.622 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.9 tp 65.54 50.93 1.58 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.241 -0.89 . . . . 1.45 109.436 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.498 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.9 t -62.97 159.46 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.78000000000000003 111.617 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 2.11 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 0.81000000000000005 111.436 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.6 ' O ' HG13 ' A' ' 80' ' ' ILE . 40.3 m-20 -83.61 7.79 16.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.172 -0.467 . . . . 2.3999999999999999 111.367 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.36 22.6 2.29 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.394 -0.908 . . . . 0.68000000000000005 113.555 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.89 62.7 4.32 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.293 -0.48 . . . . 0.60999999999999999 114.083 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.475 ' HB ' HG21 ' A' ' 80' ' ' ILE . 39.4 t -137.62 152.77 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.081 0.44 . . . . 0.48999999999999999 110.224 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.558 HG23 ' HG2' ' A' ' 11' ' ' GLU . 18.1 mm -85.36 109.7 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.474 -0.565 . . . . 0.46999999999999997 109.474 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -118.99 130.45 55.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 110.65 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 m -109.94 117.69 34.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.097 -0.502 . . . . 0.5 110.703 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.509 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.2 tp -74.77 131.71 34.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.67000000000000004 111.356 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 2.6 mm? -120.76 -81.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.82999999999999996 111.362 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -89.44 134.3 34.15 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.928 0.394 . . . . 1.5600000000000001 110.309 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 41.3 mtmt -111.34 113.18 25.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.779 -0.646 . . . . 2.9500000000000002 110.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.526 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -73.71 -151.74 2.08 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.219 -0.515 . . . . 1.3200000000000001 111.89 174.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.47 -97.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.104 -0.645 . . . . 2.77 111.725 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.72 126.45 36.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.46 0.647 . . . . 2.6400000000000001 110.934 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -140.51 47.79 0.86 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.582 -0.818 . . . . 1.04 112.611 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.15 -42.11 99.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 2.29 109.945 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.25 28.2 8.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.977 -1.01 . . . . 2.6400000000000001 109.4 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.403 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -135.79 76.87 1.63 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.45 110.89 -179.171 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG22 ' HD3' ' A' ' 35' ' ' LYS . 30.8 mm -141.94 116.28 6.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 123.265 0.353 . . . . 0.81000000000000005 111.274 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 28.1 Cg_endo -63.41 138.69 67.03 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.058 2.505 . . . . 0.75 111.065 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HD3' HG22 ' A' ' 33' ' ' ILE . 6.0 mmmm -126.54 155.07 42.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.106 0.479 . . . . 2.6600000000000001 111.713 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -70.38 117.54 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.17 -0.923 . . . . 2.5099999999999998 110.291 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.81 -26.88 22.82 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.99 -0.624 . . . . 1.1200000000000001 111.923 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.69 154.19 42.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 1.3799999999999999 110.179 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 40.8 mt-10 -76.99 99.9 5.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.113 0.482 . . . . 2.2000000000000002 110.822 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.659 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.3 m -118.64 143.61 29.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.335 -0.617 . . . . 0.67000000000000004 109.335 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.7 m -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.267 -0.642 . . . . 0.65000000000000002 109.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.38 139.35 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.334 0.587 . . . . 0.87 111.839 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -104.39 134.88 46.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 2.75 110.39 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -123.87 136.82 54.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.76000000000000001 110.464 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.45 153.23 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.488 -0.93 . . . . 0.48999999999999999 108.488 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.93 -124.44 0.91 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.775 -1.202 . . . . 0.35999999999999999 113.231 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.7 pttp -157.61 170.12 23.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 1.4299999999999999 111.0 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 69.8 tp -97.26 103.18 15.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.506 -0.77 . . . . 0.38 110.145 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.854 ' HB2' HD11 ' A' ' 117' ' ' LEU . 6.5 tp10 -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.873 0.368 . . . . 1.96 110.151 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 115' ' ' VAL . 8.3 t -55.4 -28.92 57.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 0.67000000000000004 112.089 -174.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 t -140.26 14.55 2.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.285 0.564 . . . . 0.72999999999999998 110.486 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.9 44.33 96.13 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.336 -0.847 . . . . 0.78000000000000003 113.065 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 12.2 mmmt -105.98 126.03 51.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.278 -0.267 . . . . 2.8900000000000001 110.278 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.1 p -83.99 159.48 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.509 -0.552 . . . . 0.58999999999999997 109.509 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -75.04 102.94 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 0.78000000000000003 110.984 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -125.58 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.604 0.716 . . . . 2.1800000000000002 109.835 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.8 m -126.11 169.22 13.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.959 -0.564 . . . . 1.24 110.536 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -71.44 -26.31 62.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.088 0.47 . . . . 1.49 110.818 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.2 -44.77 7.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.923 -0.58 . . . . 1.8 112.371 -170.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -44.82 80.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.989 0.366 . . . . 2.1899999999999999 111.989 -169.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -77.1 -9.17 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.423 . . . . 2.7799999999999998 110.938 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.13 -61.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.018 -0.537 . . . . 1.1000000000000001 109.978 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.23 109.77 7.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.446 0.641 . . . . 2.0299999999999998 110.474 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.07 158.18 38.08 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.58 2.187 . . . . 1.76 112.543 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.56 154.07 19.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 1.3100000000000001 109.775 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -129.91 159.54 36.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 1.3600000000000001 109.999 178.417 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.69 173.35 11.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.56999999999999995 111.066 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -116.01 140.17 49.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.408 -0.815 . . . . 1.98 109.609 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 82' ' ' VAL . 26.4 tp -69.1 131.91 45.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.232 -0.284 . . . . 0.94999999999999996 110.232 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.56 79.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.92 0.867 . . . . 2.0800000000000001 109.232 -169.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.531 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 28.4 tt0 -131.64 -3.6 3.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.341 -1.3 . . . . 1.98 110.211 -174.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.6 -18.53 24.48 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.998 -0.62 . . . . 0.71999999999999997 112.353 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 2.1 mm-40 -93.64 -11.39 31.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.96999999999999997 109.954 -177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.17 124.48 64.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.57999999999999996 109.702 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.1 -61.45 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.62 112.925 -176.489 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 mmpt? -138.11 -48.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 2.04 111.881 -173.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.08 -50.72 44.29 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.037 -0.601 . . . . 0.32000000000000001 113.12 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.12 -41.16 59.06 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.807 -0.231 . . . . 0.48999999999999999 110.433 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.63 -51.57 54.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.607 -0.724 . . . . 1.1399999999999999 112.041 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.7 mp -63.04 -42.97 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.78000000000000003 111.52 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.558 ' HB3' HD12 ' A' ' 120' ' ' ILE . 49.3 t -75.32 -42.34 54.75 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.848 0.314 . . . . 0.55000000000000004 111.848 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 69' ' ' LEU . 35.4 m -69.15 -34.41 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.779 0.288 . . . . 0.83999999999999997 111.779 -175.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 p -72.03 -16.44 62.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 110.814 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.7 m -97.57 8.26 44.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.981 -0.554 . . . . 1.23 110.928 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 20.1 mmt -93.94 -173.65 3.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 2.27 111.495 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 33.6 mtp-105 -143.2 -171.27 3.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.349 -0.841 . . . . 4.1900000000000004 109.002 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.42 -24.63 67.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.299 0.374 . . . . 1.9399999999999999 111.992 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -135.39 15.28 3.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 1.23 111.309 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -79.87 159.94 26.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.889 0.376 . . . . 1.6000000000000001 110.683 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -158.36 132.45 7.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.089 -0.505 . . . . 1.1699999999999999 110.354 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 99.9 m -150.7 170.93 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 1.2 110.816 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.34 124.95 52.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.54 . . . . 1.73 110.237 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 95' ' ' ILE . 6.3 p -100.76 146.22 9.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.15 -0.477 . . . . 0.73999999999999999 110.264 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.541 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 12.3 mmt180 -98.63 112.06 24.23 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.177 -0.675 . . . . 1.71 109.177 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.628 HD11 HG13 ' A' ' 93' ' ' VAL . 4.1 mp -98.04 103.87 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.52000000000000002 110.447 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.557 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 27.6 tt0 -86.49 170.73 11.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.336 -0.987 . . . . 1.3700000000000001 108.336 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.9 p -51.69 -38.32 54.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.826 0.306 . . . . 1.0 111.826 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -77.71 -8.72 58.35 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.042 0.386 . . . . 1.79 112.042 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.557 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 20.6 m-85 -102.62 -16.36 16.09 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.752 0.31 . . . . 0.75 110.607 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.36 -163.01 12.45 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.252 -0.739 . . . . 0.70999999999999996 111.252 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.52 110.992 177.285 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.405 ' CB ' HD13 ' A' ' 110' ' ' ILE . 5.9 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 111.426 0.158 . . . . 1.52 111.426 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.405 HD13 ' CB ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -147.45 96.75 4.13 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.059 0.457 . . . . 0.75 111.45 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -91.5 -164.1 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.833 2.355 . . . . 1.5800000000000001 111.888 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 121.7 50.26 0.25 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.382 -0.913 . . . . 2.0499999999999998 113.285 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.7 m120 62.8 17.21 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.068 0.461 . . . . 2.0299999999999998 111.336 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.3 p -94.83 175.68 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.833 -0.621 . . . . 1.1399999999999999 111.339 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.484 ' H ' ' HB2' ' A' ' 50' ' ' SER . 6.3 p -114.7 127.49 72.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 116.136 -0.483 . . . . 0.47999999999999998 110.203 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.9 mp -120.97 169.7 10.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.007 -0.542 . . . . 0.51000000000000001 111.054 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.854 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -128.95 126.28 39.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.084 -0.71 . . . . 0.69999999999999996 109.084 175.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -118.8 123.96 46.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.075 0.464 . . . . 0.42999999999999999 111.151 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.86 119.44 16.04 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.186 -1.042 . . . . 1.46 108.186 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 81' ' ' CYS . 42.2 mt -106.41 116.14 49.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 0.47999999999999998 109.5 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -126.94 119.3 26.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.779 -1.1 . . . . 1.8799999999999999 109.466 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 tt -90.88 117.14 29.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.804 -0.635 . . . . 1.1200000000000001 109.731 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.39 -23.81 15.02 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.668 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -164.05 153.45 14.11 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.004 0.431 . . . . 1.1899999999999999 110.564 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.659 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -161.83 178.72 8.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.652 -0.704 . . . . 0.71999999999999997 109.618 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 39' ' ' GLU . 14.0 ptm180 -150.93 137.9 19.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 2.98 110.053 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 3.3799999999999999 110.556 179.189 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.056 0.455 . . . . 3.6000000000000001 111.3 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.86 144.12 32.23 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.876 -0.787 . . . . 2.71 108.876 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.15 139.07 35.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.219 -0.66 . . . . 1.8799999999999999 109.219 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.625 HG12 ' HB ' ' A' ' 13' ' ' THR . 32.9 t -100.99 104.43 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.528 -0.545 . . . . 0.58999999999999997 109.528 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -102.64 134.91 45.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.939 -0.573 . . . . 2.1600000000000001 111.566 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.856 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 81.8 mt 52.25 51.89 15.38 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.511 -0.768 . . . . 1.45 111.332 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.625 ' HB ' HG12 ' A' ' 10' ' ' VAL . 15.4 t -70.68 168.36 16.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.78000000000000003 110.521 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.35 -12.56 61.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.837 0.68 . . . . 0.81000000000000005 112.837 -170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 80' ' ' ILE . 3.3 t70 -89.57 14.02 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.717 -0.393 . . . . 2.3999999999999999 111.638 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.44 29.93 1.04 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.589 -0.815 . . . . 0.68000000000000005 114.119 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.856 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 60.01 33.29 78.46 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.881 1.112 . . . . 0.60999999999999999 115.881 166.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 30.6 t -104.06 142.48 17.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 117.886 0.843 . . . . 0.48999999999999999 110.727 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 2.3 mm -88.57 116.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.46999999999999997 110.013 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HE2' ' HB3' ' A' ' 84' ' ' SER . 21.4 pttp -138.75 136.02 35.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 1.3400000000000001 111.021 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 m -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.163 -0.926 . . . . 0.5 109.923 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tp -88.7 127.62 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.087 0.47 . . . . 0.67000000000000004 110.811 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -116.26 -52.13 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.427 0.632 . . . . 0.82999999999999996 110.499 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' CB ' ' A' ' 90' ' ' LYS . 29.6 ttpt -119.07 121.91 40.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.63 -0.714 . . . . 1.5600000000000001 110.047 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -99.98 126.19 46.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.392 -0.367 . . . . 2.9500000000000002 111.14 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 155.64 32.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.972 -0.633 . . . . 1.3200000000000001 111.743 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.4 -81.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.646 0.26 . . . . 2.77 111.171 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.11 150.08 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 2.6400000000000001 110.426 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -156.68 51.05 0.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.308 -0.948 . . . . 1.04 112.854 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.3 -42.23 55.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.584 0.707 . . . . 2.29 109.299 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 -16.59 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 2.6400000000000001 110.562 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 19.3 m-80 -85.48 76.04 10.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.232 -0.44 . . . . 1.45 110.537 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 33.3 mm -140.87 119.7 8.27 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.857 -0.61 . . . . 0.81000000000000005 109.863 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 1.5 Cg_endo -82.15 111.05 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.75 111.638 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -118.06 152.24 35.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.472 -0.566 . . . . 2.6600000000000001 109.472 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 148.97 46.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.977 0.418 . . . . 2.5099999999999998 110.278 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.91 -9.78 65.94 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.887 -0.885 . . . . 1.1200000000000001 110.887 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 95.5 m-20 -107.49 159.42 16.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.856 -0.672 . . . . 1.3799999999999999 109.511 174.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 102.32 14.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.497 -0.557 . . . . 2.2000000000000002 109.497 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -116.19 145.03 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.693 -0.685 . . . . 0.67000000000000004 109.579 175.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 108.63 13.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.047 -0.524 . . . . 0.65000000000000002 110.263 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 122' ' ' LEU . 18.5 m -131.36 153.3 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.527 -0.306 . . . . 0.87 111.544 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -105.24 162.51 13.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 2.75 110.337 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 12.7 p90 -145.58 129.44 17.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.76000000000000001 110.028 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -167.02 153.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.85 -0.426 . . . . 0.48999999999999999 109.85 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 55' ' ' PHE . . . 176.3 -111.57 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.717 -1.23 . . . . 0.35999999999999999 112.968 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG3' HD12 ' A' ' 117' ' ' LEU . 51.7 pttt -157.23 166.95 31.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.987 0.423 . . . . 1.4299999999999999 110.882 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.2 tp -92.56 102.07 14.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.963 -0.562 . . . . 0.38 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 3.6 tp10 -58.71 -30.47 67.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.616 -0.72 . . . . 1.96 111.039 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -55.88 -32.43 63.69 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.563 -0.744 . . . . 0.67000000000000004 112.264 -173.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 53' ' ' LYS . 13.6 t -140.21 5.52 2.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.445 -0.502 . . . . 0.72999999999999998 111.983 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.83 46.63 59.62 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 121.098 -0.572 . . . . 0.78000000000000003 112.394 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HB2' HG23 ' A' ' 51' ' ' THR . 2.0 tmtp? -115.14 126.36 54.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.652 -0.499 . . . . 2.8900000000000001 109.652 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.07 153.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.454 -0.339 . . . . 0.58999999999999997 110.196 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 0.8 OUTLIER -74.45 106.4 6.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.403 . . . . 0.78000000000000003 110.722 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -121.7 103.57 8.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.87 0.843 . . . . 2.1800000000000002 110.324 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 34.8 m -136.81 150.53 48.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.119 -0.491 . . . . 1.24 110.004 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.4 m -62.6 -36.09 81.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 1.49 111.174 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.21 -33.9 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.348 -0.387 . . . . 1.8 110.887 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 6.9 t70 -56.99 -52.48 65.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.934 0.397 . . . . 2.1899999999999999 111.993 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -77.25 2.6 15.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.368 -0.378 . . . . 2.7799999999999998 111.44 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -111.5 -52.85 2.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.42 -0.355 . . . . 1.1000000000000001 110.845 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.7 p -133.04 117.18 14.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.197 0.522 . . . . 2.0299999999999998 111.167 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.4 Cg_exo -77.03 146.08 25.37 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.041 2.494 . . . . 1.76 111.459 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -103.82 151.09 23.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.464 -0.335 . . . . 1.3100000000000001 110.251 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -128.93 154.19 46.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.529 -0.305 . . . . 1.3600000000000001 110.911 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -137.21 174.49 10.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.524 -0.307 . . . . 0.56999999999999995 111.156 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.84 150.21 33.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.076 -0.712 . . . . 1.98 109.076 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.757 HD13 HG23 ' A' ' 82' ' ' VAL . 16.8 tp -70.6 124.66 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.475 0.546 . . . . 0.94999999999999996 112.475 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER 42.4 63.29 1.44 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.388 -1.278 . . . . 2.0800000000000001 112.335 173.305 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -108.55 9.28 27.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.71 -1.132 . . . . 1.98 108.751 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.6 -16.38 48.06 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.971 -1.013 . . . . 0.71999999999999997 113.084 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -85.48 -39.43 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.457 0.629 . . . . 0.96999999999999997 110.501 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 m -97.9 135.41 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.389 -0.597 . . . . 0.57999999999999996 109.389 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.764 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -94.55 -76.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.382 0.512 . . . . 0.62 112.382 -172.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.764 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.25 -37.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.873 -0.517 . . . . 2.04 112.315 -175.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.61 -54.29 31.17 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.449 -0.881 . . . . 0.32000000000000001 113.153 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.626 ' O ' HG22 ' A' ' 82' ' ' VAL . 23.3 m-90 -76.67 -31.52 57.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.736 -0.273 . . . . 0.48999999999999999 110.708 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -51.49 -53.35 38.32 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.019 0.824 . . . . 1.1399999999999999 111.843 -170.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 2.0 mp -68.77 -29.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 111.275 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.627 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 19.9 t -72.55 -38.23 68.05 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.603 -0.439 . . . . 0.55000000000000004 110.514 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 HD13 ' A' ' 69' ' ' LEU . 2.1 m -83.86 -33.95 9.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.791 -0.364 . . . . 0.83999999999999997 111.498 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -65.66 -25.57 67.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.157 0.503 . . . . 1.4299999999999999 110.63 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.558 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 22.0 t -121.92 44.97 2.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.777 -0.647 . . . . 1.23 110.489 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 82' ' ' VAL . 19.8 ptm -124.68 -175.89 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.989 -0.551 . . . . 2.27 109.688 173.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 64.3 mtt85 -142.95 162.86 34.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.123 -0.695 . . . . 4.1900000000000004 109.123 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HG3' HD22 ' A' ' 122' ' ' LEU . 85.6 tttt -61.31 -43.06 99.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 1.9399999999999999 111.364 -175.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -97.29 24.7 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 1.23 110.709 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 37.5 tt0 -114.87 163.68 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.037 -0.727 . . . . 1.6000000000000001 109.037 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 76.1 tttt -157.54 127.56 6.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.926 0.393 . . . . 1.1699999999999999 110.439 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.1 p -134.7 148.11 50.24 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.785 -0.643 . . . . 1.2 111.01 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.73 122.02 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 1.73 109.357 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.627 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.4 p -100.65 143.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.159 0.504 . . . . 0.73999999999999999 111.427 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 18.3 mmt180 -106.2 112.15 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.438 -0.801 . . . . 1.71 109.441 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 3.9 mp -93.96 100.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.828 -0.349 . . . . 0.52000000000000002 110.111 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.493 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 9.6 tp10 -70.07 156.72 38.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 1.3700000000000001 109.183 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 p -50.12 -44.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.06 0.544 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.42 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 24.1 ptp -74.76 -8.09 55.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 1.79 111.721 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 96' ' ' GLU . 21.8 m-30 -100.05 8.62 43.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.626 0.25 . . . . 0.75 110.426 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.613 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -139.09 -176.28 14.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.21 -0.519 . . . . 0.70999999999999996 112.201 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 121.14 0.495 . . . . 1.52 111.077 179.02 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.76 0.281 . . . . 1.52 111.76 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 89.99 3.36 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-O 121.146 0.498 . . . . 0.75 110.296 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -96.84 -155.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.488 2.792 . . . . 1.5800000000000001 111.663 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.83 31.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.461 -0.876 . . . . 2.0499999999999998 112.85 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.01 41.81 27.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.314 0.578 . . . . 2.0299999999999998 110.553 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 p -122.13 177.05 5.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.5 -0.773 . . . . 1.1399999999999999 110.38 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 5.3 p -93.94 125.47 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.256 0.55 . . . . 0.47999999999999998 110.889 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.83 162.1 15.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.51000000000000001 110.103 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.608 HD12 ' HG3' ' A' ' 47' ' ' LYS . 36.8 mt -119.04 117.47 28.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.69999999999999996 110.228 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -125.81 138.0 53.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.259 0.552 . . . . 0.42999999999999999 112.321 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 50.5 mt-10 -79.16 132.77 36.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.226 -0.897 . . . . 1.46 108.981 167.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 82' ' ' VAL . 19.5 mt -113.17 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.516 0.674 . . . . 0.47999999999999998 110.252 171.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.43 ' OE1' ' HD2' ' A' ' 90' ' ' LYS . 5.1 tp10 -118.75 120.1 36.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 1.8799999999999999 109.597 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.745 ' HA ' HG12 ' A' ' 42' ' ' VAL . 4.9 tt -89.87 102.4 15.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.526 -0.546 . . . . 1.1200000000000001 109.526 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -88.89 -35.63 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.486 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 t -152.26 144.79 24.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.598 -0.274 . . . . 1.1899999999999999 110.755 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.606 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -164.97 171.75 13.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.71999999999999997 109.799 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 14.0 ptp180 -150.07 124.6 9.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.579 -0.282 . . . . 2.98 110.325 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--N 1.326 -0.451 0 N-CA-C 109.871 -0.418 . . . . 3.3799999999999999 109.871 176.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.457 0.646 . . . . 3.6000000000000001 112.504 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.95 153.28 21.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.445 -0.798 . . . . 2.71 109.057 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 6.2 mptt -98.79 144.3 28.17 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.208 -0.664 . . . . 1.8799999999999999 109.208 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.11 112.83 38.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.886 -0.326 . . . . 0.58999999999999997 110.704 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 4.2 pt-20 -86.59 131.05 34.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.224 -0.287 . . . . 2.1600000000000001 110.224 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.9 mt 45.58 59.84 3.41 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.897 0.748 . . . . 1.45 111.869 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 18' ' ' VAL . 7.5 t -59.01 153.75 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.78000000000000003 110.757 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.82 43.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.48 0.548 . . . . 0.81000000000000005 112.48 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.6 t0 -85.39 18.27 2.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.706 0.289 . . . . 2.3999999999999999 111.406 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 2.7 9.22 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.422 -0.894 . . . . 0.68000000000000005 114.41 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 77.59 80.31 0.68 Allowed Glycine 0 C--O 1.224 -0.485 0 C-N-CA 121.021 -0.609 . . . . 0.60999999999999999 114.172 170.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 13' ' ' THR . 11.8 t -142.7 145.04 23.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.696 -0.483 . . . . 0.48999999999999999 109.696 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.68 110.99 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.46999999999999997 110.244 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -136.09 147.12 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 1.3400000000000001 111.281 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.6 m -117.95 144.25 45.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 0.5 110.469 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 25' ' ' LYS . 9.7 tp -93.39 135.3 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.9 0.381 . . . . 0.67000000000000004 111.931 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.51 HD21 ' HG ' ' A' ' 92' ' ' LEU . 3.0 mm? -123.34 -71.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.383 0.611 . . . . 0.82999999999999996 109.369 174.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 2.2 mmmt -104.86 116.19 31.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.331 -0.85 . . . . 1.5600000000000001 109.378 176.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -112.9 150.86 31.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.844 -0.342 . . . . 2.9500000000000002 110.294 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.85 163.25 47.55 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.923 -0.656 . . . . 1.3200000000000001 111.991 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.38 -57.59 2.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.252 0.548 . . . . 2.77 109.752 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -121.12 174.12 6.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.815 . . . . 2.6400000000000001 108.817 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.568 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 126.55 51.88 0.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.546 -0.835 . . . . 1.04 112.296 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.63 -41.29 98.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.809 0.358 . . . . 2.29 111.408 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -89.07 4.27 48.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.427 0.632 . . . . 2.6400000000000001 110.398 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.631 ' HB2' HH21 ' A' ' 86' ' ' ARG . 6.7 m-20 -116.59 78.64 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 1.45 109.617 175.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.6 mm -134.41 123.85 16.76 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.637 . . . . 0.81000000000000005 110.775 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HG3' HD22 ' A' ' 122' ' ' LEU . 57.2 Cg_endo -70.18 138.45 36.51 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.876 2.384 . . . . 0.75 111.457 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -145.66 156.71 43.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.007 0.432 . . . . 2.6600000000000001 111.871 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 70' ' ' GLU . 1.9 ttmp? -68.56 147.59 51.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.127 -0.942 . . . . 2.5099999999999998 111.111 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 36' ' ' LYS . . . 93.23 -18.48 56.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.56 -1.016 . . . . 1.1200000000000001 110.56 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 3.6 m-20 -99.18 163.38 12.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.778 -0.711 . . . . 1.3799999999999999 109.834 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.58 126.16 35.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 2.2000000000000002 110.529 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 125' ' ' PHE . 21.1 m -131.05 153.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.67000000000000004 109.691 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 29.7 m -113.61 106.07 14.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.374 -0.602 . . . . 0.65000000000000002 109.374 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.48 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.195 0.522 . . . . 0.87 111.341 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -100.34 136.03 40.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.622 -0.717 . . . . 2.75 109.079 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.693 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 47.6 p90 -122.87 144.35 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.76000000000000001 110.364 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -169.08 157.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.416 -0.957 . . . . 0.48999999999999999 108.416 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.91 -126.66 1.13 Allowed Glycine 0 CA--C 1.51 -0.244 0 C-N-CA 119.739 -1.22 . . . . 0.35999999999999999 113.262 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 64.7 pttt -150.98 165.76 32.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.218 0.532 . . . . 1.4299999999999999 111.033 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD12 ' HG ' ' A' ' 116' ' ' LEU . 63.5 tp -83.64 97.42 9.08 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.06 -0.719 . . . . 0.38 109.06 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.594 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 48.4 tp10 -60.93 -25.76 67.0 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.017 -0.538 . . . . 1.96 111.856 -174.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 t -56.19 -27.17 53.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.426 -0.352 . . . . 0.67000000000000004 111.38 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.661 HG23 ' HD3' ' A' ' 53' ' ' LYS . 10.1 t -134.9 -13.93 2.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.835 0.35 . . . . 0.72999999999999998 111.571 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.54 28.7 34.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.159 -0.543 . . . . 0.78000000000000003 112.957 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.661 ' HD3' HG23 ' A' ' 51' ' ' THR . 13.9 mptt -100.42 122.57 43.37 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.604 -0.351 . . . . 2.8900000000000001 110.577 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 8.6 p -73.98 160.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 110.407 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.403 ' CE1' HD11 ' A' ' 110' ' ' ILE . 22.6 m-30 -74.77 147.86 40.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 0.78000000000000003 111.392 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -159.1 89.91 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.254 -0.885 . . . . 2.1800000000000002 108.939 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -136.72 -177.14 4.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 1.24 110.815 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -71.56 -38.63 70.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.973 -0.558 . . . . 1.49 111.425 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.86 -36.96 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.211 0.819 . . . . 1.8 113.211 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -59.97 -33.01 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.878 0.325 . . . . 2.1899999999999999 111.878 -169.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -104.4 -0.94 27.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.282 0.475 . . . . 2.7799999999999998 112.282 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -114.19 -45.79 3.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.302 -0.559 . . . . 1.1000000000000001 111.576 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.08 97.81 17.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.918 0.39 . . . . 2.0299999999999998 110.05 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.29 141.73 43.81 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.988 2.459 . . . . 1.76 112.599 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.58 146.55 25.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 1.3100000000000001 110.008 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -144.21 153.71 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.981 -0.377 . . . . 1.3600000000000001 109.981 177.234 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -133.99 175.07 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.56999999999999995 111.152 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -104.58 148.28 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.942 -0.762 . . . . 1.98 108.942 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.605 HD22 HG23 ' A' ' 82' ' ' VAL . 11.3 tp -69.4 119.47 13.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.034 0.445 . . . . 0.94999999999999996 110.584 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 57.55 66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.654 -1.157 . . . . 2.0800000000000001 110.646 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.01 17.78 23.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.947 -1.024 . . . . 1.98 109.063 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.04 -18.03 38.37 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.71999999999999997 112.479 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.86 -23.31 22.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.96999999999999997 110.984 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.8 126.24 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.57999999999999996 110.353 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.641 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -95.75 -58.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.62 113.437 -172.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.66 -48.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 2.04 112.644 -170.031 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -52.4 38.13 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.917 -0.659 . . . . 0.32000000000000001 113.131 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.5 ' O ' HG22 ' A' ' 82' ' ' VAL . 9.0 m-90 -76.01 -32.22 59.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.672 0.273 . . . . 0.48999999999999999 110.702 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -53.86 -51.93 62.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.45 -0.795 . . . . 1.1399999999999999 112.179 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -69.29 -43.84 80.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 0.78000000000000003 110.82 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.8 t -62.21 -50.06 73.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.53 -0.304 . . . . 0.55000000000000004 111.009 -175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG23 HD22 ' A' ' 69' ' ' LEU . 33.9 m -66.09 -32.81 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.652 0.263 . . . . 0.83999999999999997 110.911 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 t -66.05 -40.12 90.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.931 0.396 . . . . 1.4299999999999999 110.131 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 m -89.69 36.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.579 . . . . 1.23 111.08 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.967 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 4.4 mmt -112.81 -175.25 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 2.27 110.468 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.631 HH21 ' HB2' ' A' ' 32' ' ' ASN . 8.3 mtp-105 -149.87 175.4 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 4.1900000000000004 110.116 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.63 -22.24 66.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.654 -0.703 . . . . 1.9399999999999999 112.436 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -136.32 34.88 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 1.23 110.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 30.8 tt0 -120.51 154.06 35.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 1.6000000000000001 109.787 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.6 tttt -156.94 132.22 9.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.663 0.268 . . . . 1.1699999999999999 111.359 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.454 ' SG ' HD12 ' A' ' 22' ' ' ILE . 93.8 m -135.2 165.35 25.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.111 0.481 . . . . 1.2 111.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.51 ' HG ' HD21 ' A' ' 23' ' ' LEU . 78.5 mt -106.34 114.95 29.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.461 -0.79 . . . . 1.73 109.676 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.404 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.3 p -108.3 141.93 22.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.297 -0.41 . . . . 0.73999999999999999 111.232 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.477 ' NE ' HD23 ' A' ' 117' ' ' LEU . 7.2 mpt_? -90.91 117.13 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.414 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.621 HD13 ' HD2' ' A' ' 118' ' ' PHE . 2.7 mp -96.64 101.08 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.28 -1.007 . . . . 0.52000000000000002 108.28 172.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.572 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 8.1 tt0 -98.41 177.04 5.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.268 -0.878 . . . . 1.3700000000000001 109.434 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -55.36 -36.37 66.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 1.0 110.962 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.426 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 24.2 ptp -76.86 -7.64 55.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.036 -0.529 . . . . 1.79 111.296 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.572 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.0 m-85 -112.65 4.85 17.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.606 0.241 . . . . 0.75 110.952 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.641 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -138.7 -173.1 12.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.929 -0.653 . . . . 0.70999999999999996 112.285 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 1.52 111.356 179.635 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 110.085 -0.339 . . . . 1.52 110.085 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.483 HG12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -158.47 97.62 1.78 Allowed Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.124 -0.489 . . . . 0.75 110.553 176.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.16 177.95 4.94 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.509 2.139 . . . . 1.5800000000000001 111.384 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.67 -162.73 27.35 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.11 -1.043 . . . . 2.0499999999999998 113.038 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -98.08 39.88 1.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 2.0299999999999998 109.086 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.9 m -125.2 158.31 34.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.797 -0.638 . . . . 1.1399999999999999 110.37 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.37 127.42 42.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.51 0.671 . . . . 0.47999999999999998 111.653 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.483 HD21 HG12 ' A' ' 110' ' ' ILE . 6.7 mp -123.55 167.63 13.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.681 -0.691 . . . . 0.51000000000000001 109.873 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -138.3 131.89 30.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.006 0.431 . . . . 0.69999999999999996 110.518 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.621 ' HD2' HD13 ' A' ' 95' ' ' ILE . 59.3 m-85 -121.6 145.76 47.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.961 -0.563 . . . . 0.42999999999999999 110.669 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.5 mt-10 -68.65 123.62 21.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.816 -0.809 . . . . 1.46 108.816 170.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 81' ' ' CYS . 10.2 mt -107.74 115.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.298 0.57 . . . . 0.47999999999999998 109.622 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -125.62 114.07 18.22 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.002 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.52 HD22 ' HG3' ' A' ' 34' ' ' PRO . 14.9 tp -86.84 99.92 12.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 1.1200000000000001 109.896 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.1 pt? -98.63 -19.96 17.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.305 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.532 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 20.5 m -151.7 145.66 25.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.46 0.171 . . . . 1.1899999999999999 110.802 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.445 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -166.92 156.98 11.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.448 -0.342 . . . . 0.71999999999999997 110.255 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.81 49.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.202 -0.454 . . . . 2.98 110.704 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mp0 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.137 -0.483 . . . . 3.3799999999999999 110.591 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.075 0.464 . . . . 3.6000000000000001 110.852 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -116.14 158.42 23.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.783 -0.644 . . . . 2.71 110.013 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 6.4 mptt -102.37 148.16 25.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.048 -0.723 . . . . 1.8799999999999999 109.048 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.65 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 15.6 t -101.03 109.24 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.383 0.611 . . . . 0.58999999999999997 110.168 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -79.82 99.74 7.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.031 -0.986 . . . . 2.1600000000000001 111.475 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt 51.32 79.17 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.691 0.619 . . . . 1.45 111.328 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.65 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 11.6 t -89.93 177.17 6.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.78000000000000003 110.903 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.93 -3.63 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.81000000000000005 111.828 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.516 ' HB2' HG23 ' A' ' 80' ' ' ILE . 27.0 m-20 -75.93 2.33 12.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.533 0.206 . . . . 2.3999999999999999 110.652 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.3 8.92 6.86 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.612 -0.804 . . . . 0.68000000000000005 113.326 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.22 63.48 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.019 -0.61 . . . . 0.60999999999999999 114.42 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.537 ' HB ' ' CB ' ' A' ' 80' ' ' ILE . 23.5 t -134.42 148.39 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.929 -0.397 . . . . 0.48999999999999999 109.929 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.92 109.73 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.18 0.514 . . . . 0.46999999999999997 110.44 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.526 ' HE2' HG21 ' A' ' 13' ' ' THR . 47.7 pttt -123.32 148.28 46.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.99 -0.55 . . . . 1.3400000000000001 110.368 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -109.43 124.33 50.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.828 -0.624 . . . . 0.5 110.332 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.482 HD12 ' SG ' ' A' ' 91' ' ' CYS . 5.1 tp -75.65 113.9 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.67000000000000004 110.924 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 3.5 mm? -99.24 -60.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 0.82999999999999996 110.481 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -120.33 133.96 55.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.5600000000000001 110.076 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 37.7 pttt -106.46 124.17 49.18 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.491 . . . . 2.9500000000000002 110.212 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 161.85 37.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.66 -0.781 . . . . 1.3200000000000001 111.788 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -68.07 -67.1 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 2.77 110.692 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.17 -177.81 4.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 2.6400000000000001 110.806 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.96 45.85 0.17 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.49 -0.777 . . . . 1.04 111.27 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.32 -41.5 89.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 2.29 110.552 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -113.83 26.03 10.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.309 0.576 . . . . 2.6400000000000001 109.817 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 79.81 1.79 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 1.45 110.07 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.5 HG21 ' HE3' ' A' ' 35' ' ' LYS . 36.1 mm -129.48 128.46 23.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.81000000000000005 111.084 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 1.1 Cg_endo -81.55 114.65 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.896 2.397 . . . . 0.75 111.256 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 33' ' ' ILE . 28.3 mmtp -120.46 146.45 46.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.21 -0.45 . . . . 2.6600000000000001 111.065 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 5.3 tmmm? -57.02 124.58 19.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.701 -0.681 . . . . 2.5099999999999998 109.783 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.58 37.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.752 -0.737 . . . . 1.1200000000000001 112.277 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 82.3 m-20 -79.39 142.57 35.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.964 0.412 . . . . 1.3799999999999999 110.122 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.524 ' HB3' ' CG ' ' A' ' 126' ' ' ARG . 37.6 tp10 -76.46 102.32 5.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.797 -0.638 . . . . 2.2000000000000002 109.797 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 125' ' ' PHE . 28.0 m -112.94 156.02 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.088 -0.505 . . . . 0.67000000000000004 110.868 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.8 m -132.6 110.87 10.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.65000000000000002 109.709 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.685 HG12 ' HA ' ' A' ' 122' ' ' LEU . 27.4 m -125.15 151.03 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.87 111.405 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -101.17 149.28 24.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.75 109.709 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 39.9 p90 -133.32 136.92 45.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.708 0.29 . . . . 0.76000000000000001 110.233 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -164.89 146.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.58 -0.526 . . . . 0.48999999999999999 109.58 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -176.18 -127.86 1.07 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.325 -0.94 . . . . 0.35999999999999999 112.513 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.54 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 63.6 pttt -157.77 171.94 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 1.4299999999999999 110.831 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.754 HD22 HG13 ' A' ' 110' ' ' ILE . 58.2 tp -87.04 108.89 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.38 110.794 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.555 ' HB3' HG13 ' A' ' 115' ' ' VAL . 2.1 tp10 -61.46 -35.33 77.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.51 0.672 . . . . 1.96 110.615 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -55.71 -27.82 52.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.67000000000000004 112.792 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.497 HG22 HD23 ' A' ' 48' ' ' LEU . 15.2 t -140.55 -23.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.178 -0.609 . . . . 0.72999999999999998 112.35 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.69 34.65 4.89 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.502 -0.856 . . . . 0.78000000000000003 113.014 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HG2' HG23 ' A' ' 51' ' ' THR . 73.8 mmtt -102.84 125.51 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.132 -0.321 . . . . 2.8900000000000001 110.132 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.7 p -82.44 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.108 -0.33 . . . . 0.58999999999999997 110.108 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -78.69 127.23 31.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.387 0.514 . . . . 0.78000000000000003 112.387 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -161.24 85.74 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.025 -0.989 . . . . 2.1800000000000002 108.549 167.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 23.5 t -122.54 158.11 30.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.747 -0.66 . . . . 1.24 109.986 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -50.0 -44.0 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.245 0.618 . . . . 1.49 112.437 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -87.76 -33.67 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 1.8 110.532 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -64.71 -52.0 59.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 2.1899999999999999 111.738 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.1 ptp180 -67.49 -20.49 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.352 . . . . 2.7799999999999998 111.309 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -75.58 -64.12 1.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.297 -0.411 . . . . 1.1000000000000001 110.108 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.1 t -142.55 106.43 5.49 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.382 -0.372 . . . . 2.0299999999999998 111.007 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.37 140.16 92.24 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.287 1.991 . . . . 1.76 110.818 171.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -93.3 151.0 20.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.917 0.389 . . . . 1.3100000000000001 110.582 -171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 143.14 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.117 -0.697 . . . . 1.3600000000000001 109.117 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 82' ' ' VAL . 30.0 p90 -124.39 153.85 41.27 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.968 -0.693 . . . . 0.56999999999999995 111.212 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . 41.7 t-80 -94.5 145.02 25.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.149 -0.932 . . . . 1.98 109.788 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 HD13 ' CG2' ' A' ' 82' ' ' VAL . 38.3 tp -69.13 128.84 38.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.991 -0.744 . . . . 0.94999999999999996 108.991 173.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG2' ' CG ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.49 78.75 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.146 0.974 . . . . 2.0800000000000001 110.403 -168.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 68' ' ' HIS . 26.2 tt0 -126.42 -5.66 6.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.13 -1.395 . . . . 1.98 109.994 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 -19.24 33.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.701 -0.681 . . . . 0.71999999999999997 112.681 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 42.3 mm-40 -87.73 -21.76 25.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.531 0.682 . . . . 0.96999999999999997 109.504 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.9 m -108.87 124.18 65.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.65 -0.705 . . . . 0.57999999999999996 109.979 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.73 -59.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.179 0.437 . . . . 0.62 112.179 -178.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -149.19 -38.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.307 -0.246 . . . . 2.04 111.468 -174.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.7 -52.62 44.45 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.561 -0.828 . . . . 0.32000000000000001 112.857 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 82' ' ' VAL . 15.2 m-90 -76.18 -27.72 57.03 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.8 -0.235 . . . . 0.48999999999999999 110.895 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.12 -54.02 35.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.603 -0.726 . . . . 1.1399999999999999 111.37 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.537 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -68.16 -30.99 49.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.636 -0.711 . . . . 0.78000000000000003 111.586 -173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 85' ' ' MET . 34.8 t -76.08 -55.92 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.748 0.309 . . . . 0.55000000000000004 111.038 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.677 HG12 HG21 ' A' ' 120' ' ' ILE . 32.0 m -67.34 -33.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.324 0.861 . . . . 0.83999999999999997 113.324 -169.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 62.2 p -79.64 -0.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.987 0.422 . . . . 1.4299999999999999 111.167 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -125.77 25.5 6.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 1.23 110.384 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.789 ' HE3' ' HB2' ' A' ' 122' ' ' LEU . 31.4 mtm -114.78 142.37 46.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.95 0.405 . . . . 2.27 111.664 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.482 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 51.2 mtt180 -90.88 164.62 13.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.538 -0.542 . . . . 4.1900000000000004 109.538 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HA ' HD22 ' A' ' 122' ' ' LEU . 61.3 tttm -65.16 -21.66 66.81 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.641 0.608 . . . . 1.9399999999999999 112.641 -171.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -117.54 24.65 10.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.537 0.684 . . . . 1.23 109.805 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.482 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 35.8 tt0 -117.85 132.71 56.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.995 -1.002 . . . . 1.6000000000000001 109.898 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 11.9 tmtt? -137.44 129.68 29.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.94 -0.573 . . . . 1.1699999999999999 110.226 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 78.9 m -138.51 171.74 13.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.372 -0.377 . . . . 1.2 111.269 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.957 HD21 ' HB3' ' A' ' 117' ' ' LEU . 6.1 tt -112.54 145.63 39.96 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.608 -0.886 . . . . 1.73 108.608 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.561 ' N ' HD23 ' A' ' 92' ' ' LEU . 13.9 p -121.07 146.34 26.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 116.443 -0.344 . . . . 0.73999999999999999 110.303 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -107.07 111.13 23.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.643 -1.243 . . . . 1.71 107.643 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.555 HD11 HG13 ' A' ' 93' ' ' VAL . 4.9 mp -93.36 99.8 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.08 -0.648 . . . . 0.52000000000000002 110.459 -172.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 98' ' ' MET . 10.3 tp10 -63.55 155.55 29.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.926 -1.033 . . . . 1.3700000000000001 109.82 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.4 p -53.34 -38.59 63.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.495 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.426 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.1 ptp -78.08 -11.18 59.89 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.562 -0.29 . . . . 1.79 111.428 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -101.7 -2.66 29.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.877 0.37 . . . . 0.75 110.145 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 -178.01 44.91 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.70999999999999996 111.795 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.886 0.374 . . . . 1.52 110.733 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.468 ' CB ' HD13 ' A' ' 110' ' ' ILE . 16.6 m . . . . . 0 C--O 1.235 0.324 0 CA-C-O 120.42 0.152 . . . . 1.52 111.368 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.754 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -141.48 77.68 19.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.211 0.529 . . . . 0.75 111.421 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -93.74 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.25 2.633 . . . . 1.5800000000000001 111.649 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.37 -125.32 7.25 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.517 -0.849 . . . . 2.0499999999999998 111.958 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -105.41 1.16 27.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.61 0.719 . . . . 2.0299999999999998 109.352 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.9 m -79.56 152.15 30.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.323 -0.853 . . . . 1.1399999999999999 110.632 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.555 HG13 ' HB3' ' A' ' 49' ' ' GLU . 6.5 p -90.14 135.03 27.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.197 -0.456 . . . . 0.47999999999999998 110.686 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 49' ' ' GLU . 6.2 mp -126.67 167.01 16.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.75 0.31 . . . . 0.51000000000000001 110.991 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.957 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -117.26 114.53 23.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.184 -0.673 . . . . 0.69999999999999996 109.184 174.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -113.13 122.04 46.33 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.944 -0.303 . . . . 0.42999999999999999 110.721 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.57 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 33.6 mt-10 -86.12 130.05 34.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.003 -0.74 . . . . 1.46 109.003 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 82' ' ' VAL . 70.7 mt -113.5 127.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.997 -0.547 . . . . 0.47999999999999998 111.504 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -115.91 115.34 26.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.462 -0.79 . . . . 1.8799999999999999 110.815 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.789 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 6.0 tt -91.35 102.24 14.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.871 -0.789 . . . . 1.1200000000000001 108.871 173.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.2 pt? -97.85 -34.43 10.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.184 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.0 t -146.57 144.01 29.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.72 0.295 . . . . 1.1899999999999999 110.759 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.566 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -165.39 148.41 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.71999999999999997 109.873 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.524 ' CG ' ' HB3' ' A' ' 39' ' ' GLU . 7.8 ptp85 -127.49 129.48 47.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 2.98 109.988 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 110.951 -174.837 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 121.145 0.498 . . . . 3.6000000000000001 110.497 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.93 150.26 21.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 2.71 110.63 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -101.67 141.72 34.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 1.8799999999999999 109.129 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.67 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 16.9 t -102.47 109.57 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.092 0.472 . . . . 0.58999999999999997 111.217 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.13 108.79 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.73 -0.668 . . . . 2.1600000000000001 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.487 ' H ' HD13 ' A' ' 19' ' ' ILE . 23.0 tp 53.05 72.54 0.42 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.638 0.586 . . . . 1.45 111.201 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.67 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 6.8 t -80.43 156.6 26.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.78000000000000003 111.349 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 1.67 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.81000000000000005 111.972 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.6 3.38 3.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.577 0.227 . . . . 2.3999999999999999 110.835 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.26 6.82 8.02 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.091 -0.576 . . . . 0.68000000000000005 112.974 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.01 70.32 1.33 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.708 -0.758 . . . . 0.60999999999999999 113.928 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.89 145.17 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.786 -0.45 . . . . 0.48999999999999999 109.786 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.1 mm -85.53 109.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.46999999999999997 110.323 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 13' ' ' THR . 18.2 pttp -131.05 143.67 50.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.13 0.491 . . . . 1.3400000000000001 111.011 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -110.73 121.73 46.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.609 -0.723 . . . . 0.5 110.237 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.83 134.87 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 0.67000000000000004 110.15 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.4 -74.02 0.62 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.019 -0.363 . . . . 0.82999999999999996 110.019 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -88.26 153.17 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.833 -0.803 . . . . 1.5600000000000001 108.833 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -126.28 120.08 29.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.212 0.53 . . . . 2.9500000000000002 111.001 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.45 27.31 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.124 -0.944 . . . . 1.3200000000000001 112.13 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.92 -65.81 0.97 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.766 0.317 . . . . 2.77 110.877 -176.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 2.7 pp20? -99.69 139.07 35.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.848 0.356 . . . . 2.6400000000000001 110.493 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.679 ' HA3' ' HD3' ' A' ' 86' ' ' ARG . . . -157.17 36.77 0.56 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.567 -0.613 . . . . 1.04 111.567 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.519 0.676 . . . . 2.29 109.188 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -112.09 4.33 17.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.215 -0.902 . . . . 2.6400000000000001 110.353 176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.531 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 90.3 m-20 -114.55 78.82 1.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.608 -0.437 . . . . 1.45 111.254 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.1 mm -128.33 114.99 19.89 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.61 -0.723 . . . . 0.81000000000000005 109.559 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.08 106.21 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.132 2.555 . . . . 0.75 111.84 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 31.5 mmtp -118.7 158.21 25.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.749 0.309 . . . . 2.6600000000000001 110.671 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 1.018 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -80.56 150.65 29.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 2.5099999999999998 111.384 -175.241 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.64 -26.06 25.41 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.808 -0.633 . . . . 1.1200000000000001 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -93.46 157.7 16.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 1.3799999999999999 110.186 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -71.67 95.71 1.49 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 2.2000000000000002 110.805 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 125' ' ' PHE . 10.4 m -114.49 153.03 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.459 -0.337 . . . . 0.67000000000000004 110.351 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 ' HD2' ' A' ' 66' ' ' LYS . 9.1 m -128.27 107.09 9.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.447 -0.342 . . . . 0.65000000000000002 110.406 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -123.75 143.37 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.87 111.534 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -112.99 145.44 40.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.561 -0.745 . . . . 2.75 110.236 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.688 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.2 p90 -132.94 141.42 48.34 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.18 0.3 . . . . 0.76000000000000001 110.831 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p -168.24 154.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.271 -0.641 . . . . 0.48999999999999999 109.271 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 177.92 -120.31 0.71 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.83 -1.176 . . . . 0.35999999999999999 113.225 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.826 ' HG3' HD13 ' A' ' 117' ' ' LEU . 21.0 pttp -157.53 173.28 17.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.545 0.212 . . . . 1.4299999999999999 111.06 -178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.835 HD22 HG13 ' A' ' 110' ' ' ILE . 59.3 tp -90.9 106.66 18.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.688 -0.486 . . . . 0.38 109.688 176.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.0 tp10 -68.73 -25.61 64.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 1.96 110.793 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 17.1 t -55.0 -35.1 64.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.118 -0.946 . . . . 0.67000000000000004 111.461 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 53' ' ' LYS . 2.8 t -125.21 -20.64 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.346 -0.388 . . . . 0.72999999999999998 111.083 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.25 11.58 51.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.78000000000000003 112.771 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 51' ' ' THR . 29.0 mmmt -85.02 131.03 34.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.955 -0.387 . . . . 2.8900000000000001 109.955 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.671 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.5 p -79.1 164.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.315 -0.402 . . . . 0.58999999999999997 110.097 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.449 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 7.3 m-30 -73.61 98.47 2.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.367 0.603 . . . . 0.78000000000000003 110.791 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.32 85.7 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.454 -0.793 . . . . 2.1800000000000002 109.706 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.693 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 19.0 m -135.89 169.24 17.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.376 -0.829 . . . . 1.24 109.54 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 m -57.91 -44.57 86.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.818 0.673 . . . . 1.49 112.818 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -91.01 -48.26 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 1.8 111.456 -171.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.693 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 1.6 m-20 -54.4 -44.74 72.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.985 -1.007 . . . . 2.1899999999999999 112.73 -169.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -83.83 0.7 46.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.851 -0.34 . . . . 2.7799999999999998 111.657 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -104.09 -42.25 5.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.447 -0.342 . . . . 1.1000000000000001 110.807 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 8.4 m -124.24 125.82 25.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.843 0.354 . . . . 2.0299999999999998 111.521 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 1.7 Cg_endo -85.57 139.57 6.81 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.256 2.637 . . . . 1.76 112.451 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.79 148.95 32.44 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.891 0.377 . . . . 1.3100000000000001 111.179 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HD2' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -136.51 157.62 46.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.998 -0.546 . . . . 1.3600000000000001 110.198 177.19 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -140.34 176.95 8.35 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.034 0.445 . . . . 0.56999999999999995 111.982 -175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 55.4 m80 -107.75 148.46 29.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.98 110.659 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 36' ' ' LYS . 24.0 tp -78.72 124.45 28.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.103 -0.703 . . . . 0.94999999999999996 109.103 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 1.018 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 1.4 mm-40 63.51 79.57 0.25 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.457 1.122 . . . . 2.0800000000000001 110.255 -168.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 27.6 tt0 -130.61 -3.73 4.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.653 -1.612 . . . . 1.98 109.836 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.22 -11.06 61.64 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.557 -0.747 . . . . 0.71999999999999997 111.847 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.02 -18.77 16.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.96999999999999997 110.836 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -111.74 127.95 68.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 0.57999999999999996 110.282 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.68 -76.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.299 0.481 . . . . 0.62 112.299 -176.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' H ' HG12 ' A' ' 75' ' ' ILE . 37.2 mtpt -127.59 -49.87 1.38 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.472 0.545 . . . . 2.04 112.472 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.4 -53.06 33.53 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.955 -0.64 . . . . 0.32000000000000001 113.342 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.6 m-90 -76.03 -44.27 40.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.639 0.257 . . . . 0.48999999999999999 110.571 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.14 -49.32 69.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.587 -0.733 . . . . 1.1399999999999999 112.026 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -73.37 -36.42 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.165 -0.47 . . . . 0.78000000000000003 111.413 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.703 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 46.3 t -72.46 -42.84 64.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.687 -0.233 . . . . 0.55000000000000004 111.426 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.885 HG12 HG21 ' A' ' 120' ' ' ILE . 27.4 m -64.06 -32.53 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.895 0.379 . . . . 0.83999999999999997 111.121 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -79.11 5.1 12.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.062 0.458 . . . . 1.4299999999999999 110.863 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -113.38 5.73 16.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 1.23 110.824 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.751 ' HE1' ' HB2' ' A' ' 122' ' ' LEU . 55.9 mtm -93.75 -172.73 2.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.519 0.676 . . . . 2.27 112.288 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.679 ' HD3' ' HA3' ' A' ' 29' ' ' GLY . 1.6 ttm180 -145.55 165.51 28.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.153 -1.054 . . . . 4.1900000000000004 108.153 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -63.2 -23.81 67.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.924 0.392 . . . . 1.9399999999999999 111.715 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -117.49 24.91 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.072 0.463 . . . . 1.23 110.065 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.603 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 5.3 tm-20 -123.07 152.85 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 1.6000000000000001 109.629 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -155.23 124.67 6.37 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.146 -0.316 . . . . 1.1699999999999999 110.146 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.69 171.17 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 1.2 111.383 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.85 137.41 52.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.73 110.32 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.703 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 6.2 p -111.73 149.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.89 -0.595 . . . . 0.73999999999999999 111.075 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -104.14 112.56 25.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.566 -0.531 . . . . 1.71 109.566 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.515 HD11 HG13 ' A' ' 93' ' ' VAL . 2.6 mp -92.2 106.57 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.52000000000000002 110.504 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.526 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 28.5 tt0 -90.48 168.29 11.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.393 -0.822 . . . . 1.3700000000000001 108.932 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.419 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 8.8 m -51.03 -39.32 55.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.5 ptp -77.39 -7.91 56.85 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.61 0.243 . . . . 1.79 111.487 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.526 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -99.05 -3.35 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.549 0.214 . . . . 0.75 110.772 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.504 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -135.01 -177.51 15.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.253 -0.499 . . . . 0.70999999999999996 112.015 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.697 0.248 . . . . 1.52 111.175 -179.225 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.552 ' HB2' HD13 ' A' ' 110' ' ' ILE . 3.4 m . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.17 0.51 . . . . 1.52 110.803 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.835 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.63 85.95 50.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.75 110.818 178.502 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.55 -175.59 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.292 1.995 . . . . 1.5800000000000001 111.905 175.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.53 -132.44 5.12 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.456 -0.878 . . . . 2.0499999999999998 112.117 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -122.77 36.53 4.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 2.0299999999999998 109.965 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 21.3 p -114.84 179.31 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.1399999999999999 110.819 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.1 p -104.98 129.17 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.146 0.498 . . . . 0.47999999999999998 111.016 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -119.94 172.73 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.51000000000000001 110.382 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.826 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -128.08 130.83 48.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.695 -0.483 . . . . 0.69999999999999996 109.695 177.399 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.678 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 34.7 m-85 -130.4 128.34 41.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.672 0.272 . . . . 0.42999999999999999 110.672 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 62.5 mt-10 -71.28 126.44 29.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.265 -1.013 . . . . 1.46 108.265 169.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.885 HG21 HG12 ' A' ' 82' ' ' VAL . 34.8 mt -107.67 123.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.212 -0.595 . . . . 0.47999999999999998 109.677 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.96 114.7 20.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.682 -0.69 . . . . 1.8799999999999999 110.678 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.751 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 35.9 tp -87.29 90.62 8.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.51 . . . . 1.1200000000000001 109.753 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 124' ' ' SER . 3.5 pp -86.48 -25.26 25.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.741 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.425 ' N ' HD12 ' A' ' 123' ' ' LEU . 75.7 m -159.46 148.23 17.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.361 -0.381 . . . . 1.1899999999999999 110.292 177.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.596 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -167.02 -176.22 3.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.71999999999999997 109.877 -178.258 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.88 170.54 22.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.524 -0.307 . . . . 2.98 110.178 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 107.908 -1.145 . . . . 3.3799999999999999 107.908 171.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 121.04 0.448 . . . . 3.6000000000000001 110.896 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.42 139.01 36.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 2.71 109.899 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -113.51 151.4 31.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 1.8799999999999999 110.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.518 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 21.6 t -114.0 120.55 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.58999999999999997 111.352 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.93 112.56 25.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 2.1600000000000001 111.138 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.419 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.2 mt 49.74 74.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.752 0.657 . . . . 1.45 112.022 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.518 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 3.5 t -86.34 163.01 17.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.78000000000000003 110.739 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.03 -5.45 13.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.363 0.601 . . . . 0.81000000000000005 110.685 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB3' HG23 ' A' ' 13' ' ' THR . 38.4 t70 -74.52 6.87 3.36 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.629 -0.714 . . . . 2.3999999999999999 111.084 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.28 16.52 3.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.67 -0.776 . . . . 0.68000000000000005 113.851 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.41 62.38 6.07 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.293 -0.479 . . . . 0.60999999999999999 113.82 173.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 80' ' ' ILE . 47.3 t -136.57 145.47 30.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.04 -0.356 . . . . 0.48999999999999999 110.04 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.6 mm -85.78 109.95 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.46999999999999997 110.372 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -138.38 146.78 42.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 110.835 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -119.63 137.56 53.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.5 110.524 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -80.27 126.9 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.051 0.453 . . . . 0.67000000000000004 110.844 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' HD23 ' A' ' 92' ' ' LEU . 4.5 mm? -118.03 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.82999999999999996 110.423 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 39.5 ttpt -116.63 106.44 13.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.56 -0.533 . . . . 1.5600000000000001 109.56 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -88.02 148.94 24.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.245 -0.434 . . . . 2.9500000000000002 110.944 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.93 124.37 8.1 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.635 -0.986 . . . . 1.3200000000000001 110.635 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -61.99 -54.81 36.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.642 0.221 . . . . 2.77 111.493 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.9 151.71 40.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.107 0.48 . . . . 2.6400000000000001 110.719 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.3 34.12 0.11 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.274 -0.875 . . . . 1.04 110.937 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.11 -41.33 78.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 2.29 111.541 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -110.62 26.55 10.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.761 0.791 . . . . 2.6400000000000001 109.274 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.38 77.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.446 -0.797 . . . . 1.45 110.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -123.95 119.48 26.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.956 0.407 . . . . 0.81000000000000005 111.155 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.93 128.68 20.26 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.74 2.293 . . . . 0.75 111.525 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB2' ' CG ' ' A' ' 38' ' ' ASN . 7.9 mmmm -121.24 147.74 45.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.172 -0.467 . . . . 2.6600000000000001 111.442 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.583 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 7.5 ttmm -76.61 129.72 36.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.617 -0.72 . . . . 2.5099999999999998 109.111 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.9 -21.67 44.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.784 -0.722 . . . . 1.1200000000000001 111.904 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.406 ' CG ' ' HB2' ' A' ' 35' ' ' LYS . 3.2 m-20 -83.0 156.61 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.65 95.49 3.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.559 -0.534 . . . . 2.2000000000000002 109.559 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.603 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -125.06 147.69 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.67000000000000004 110.615 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.497 HG23 ' HD3' ' A' ' 66' ' ' LYS . 82.3 m -124.66 119.69 29.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.182 -0.463 . . . . 0.65000000000000002 109.998 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 122' ' ' LEU . 15.5 m -126.95 157.62 38.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.87 111.576 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.17 131.04 55.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.347 -0.842 . . . . 2.75 109.898 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 14.4 p90 -133.7 135.75 44.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.076 0.465 . . . . 0.76000000000000001 111.221 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -168.32 151.73 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.295 -1.002 . . . . 0.48999999999999999 108.295 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.78 -126.83 0.98 Allowed Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.504 -1.331 . . . . 0.35999999999999999 112.714 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.666 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 65.8 pttt -155.87 170.5 21.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 111.441 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 114' ' ' SER . 54.4 tp -92.52 109.71 21.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.774 -0.648 . . . . 0.38 110.392 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB3' HG13 ' A' ' 115' ' ' VAL . 7.8 tm-20 -66.44 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 1.96 109.942 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -55.29 -20.11 10.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.67000000000000004 112.444 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -136.52 -26.57 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.274 -0.266 . . . . 0.72999999999999998 111.584 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.73 20.03 18.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 0.78000000000000003 112.004 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.9 mmtt -91.99 126.37 37.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.625 0.25 . . . . 2.8900000000000001 111.441 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.666 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.4 p -76.0 159.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.58999999999999997 109.956 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.555 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 4.8 m-30 -73.97 110.69 8.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.454 0.645 . . . . 0.78000000000000003 111.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -139.34 89.08 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.09 . . . . 2.1800000000000002 109.02 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.552 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 47.5 m -126.99 -171.01 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.801 -0.636 . . . . 1.24 109.947 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -72.84 -48.0 41.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.478 0.547 . . . . 1.49 112.478 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -95.64 -47.52 6.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.283 0.475 . . . . 1.8 112.283 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 6.3 p-10 -57.51 -29.86 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.859 -0.61 . . . . 2.1899999999999999 111.878 -172.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -70.83 -14.35 62.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 2.7799999999999998 111.329 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -125.51 -56.4 1.5 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.788 0.328 . . . . 1.1000000000000001 111.656 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -99.01 113.37 64.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 2.0299999999999998 110.538 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.29 137.66 52.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.966 2.444 . . . . 1.76 112.515 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.99 127.28 39.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 1.3100000000000001 109.836 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HD3' HG23 ' A' ' 41' ' ' THR . 3.0 pptp? -125.22 158.2 34.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.947 -0.57 . . . . 1.3600000000000001 109.922 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -148.14 171.75 15.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.652 0.263 . . . . 0.56999999999999995 110.357 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 12.0 m170 -112.82 148.47 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 1.98 108.888 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.62 HD13 ' CG2' ' A' ' 82' ' ' VAL . 10.5 tp -66.63 114.25 5.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.546 0.689 . . . . 0.94999999999999996 111.834 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.22 75.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 113.986 -1.461 . . . . 2.0800000000000001 111.081 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 68' ' ' HIS . 6.3 pt20 -113.16 20.98 15.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 1.98 109.748 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 -10.02 64.8 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.841 -0.618 . . . . 0.71999999999999997 111.908 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.41 -24.91 17.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.998 0.428 . . . . 0.96999999999999997 110.921 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.23 128.14 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.682 -0.488 . . . . 0.57999999999999996 109.682 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.593 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -95.75 -64.49 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.536 0.939 . . . . 0.62 113.536 -174.179 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.461 ' H ' HG12 ' A' ' 75' ' ' ILE . 27.5 mtpt -133.07 -48.58 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.214 0.82 . . . . 2.04 113.214 -172.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.452 ' HA3' HG13 ' A' ' 95' ' ' ILE . . . -52.41 -53.03 33.73 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.815 -0.707 . . . . 0.32000000000000001 113.225 -171.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.513 ' O ' HG22 ' A' ' 82' ' ' VAL . 6.3 m-90 -76.76 -38.29 54.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.888 0.375 . . . . 0.48999999999999999 110.285 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' HD11 ' A' ' 69' ' ' LEU . 11.6 t70 -54.28 -53.59 51.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.103 -0.953 . . . . 1.1399999999999999 112.74 -172.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.461 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -66.34 -40.22 86.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 0.78000000000000003 110.629 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.9 t -62.66 -50.02 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.55000000000000004 111.117 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.62 ' CG2' HD13 ' A' ' 69' ' ' LEU . 30.6 m -71.59 -32.84 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.338 0.496 . . . . 0.83999999999999997 112.338 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.509 ' HB3' HD21 ' A' ' 69' ' ' LEU . 32.8 p -74.61 -9.61 58.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.837 0.31 . . . . 1.4299999999999999 111.837 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 t -118.67 38.87 3.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.404 0.621 . . . . 1.23 109.39 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.902 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 5.7 mmt -111.9 -173.93 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.83 . . . . 2.27 111.083 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.514 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -134.63 171.0 14.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.148 -1.056 . . . . 4.1900000000000004 108.148 171.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HA ' HD22 ' A' ' 122' ' ' LEU . 58.8 tttm -62.7 -31.54 72.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.204 0.446 . . . . 1.9399999999999999 112.204 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.42 25.63 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 1.23 110.741 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 26.4 tt0 -104.23 148.58 26.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 1.6000000000000001 110.525 -176.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.671 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 79.9 tttt -145.49 129.93 17.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.946 -0.57 . . . . 1.1699999999999999 110.711 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 98.1 m -136.23 162.87 31.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.053 0.454 . . . . 1.2 111.267 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.537 HD23 ' HG ' ' A' ' 23' ' ' LEU . 3.8 mm? -102.22 119.79 39.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.73 109.791 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.0 140.53 28.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.966 -0.561 . . . . 0.73999999999999999 110.927 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.836 ' HE ' HD23 ' A' ' 117' ' ' LEU . 1.3 mpt_? -99.43 112.4 24.59 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.756 -0.461 . . . . 1.71 109.756 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.616 HD13 ' HD2' ' A' ' 118' ' ' PHE . 1.8 mp -88.38 105.66 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.237 0.541 . . . . 0.52000000000000002 110.145 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 1.1 tm-20 -79.37 163.79 24.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.645 -1.162 . . . . 1.3700000000000001 107.933 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.9 p -58.74 -29.81 67.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.504 0.192 . . . . 1.0 110.778 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 17.4 ptm -75.93 -9.67 58.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.883 0.373 . . . . 1.79 111.249 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.3 m-30 -100.93 -4.48 27.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.676 -0.238 . . . . 0.75 111.422 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.593 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -141.55 171.36 24.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.638 . . . . 0.70999999999999996 112.371 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.735 0.303 . . . . 1.52 110.614 179.9 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' HD13 ' A' ' 110' ' ' ILE . 37.4 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 111.788 0.292 . . . . 1.52 111.788 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.641 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.21 60.64 9.21 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.137 0.421 . . . . 0.75 112.137 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 31.7 Cg_endo -96.04 93.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.963 2.442 . . . . 1.5800000000000001 111.992 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.36 82.47 0.19 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.273 -0.731 . . . . 2.0499999999999998 111.273 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.1 m120 63.11 21.84 13.09 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.919 0.866 . . . . 2.0299999999999998 109.468 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.817 ' HB2' HD11 ' A' ' 48' ' ' LEU . 8.0 p -118.7 131.75 56.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.726 -1.125 . . . . 1.1399999999999999 110.389 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.4 p -86.89 135.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 0.47999999999999998 110.419 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.488 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -123.03 168.3 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.51000000000000001 110.763 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.836 HD23 ' HE ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -122.33 112.01 17.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.052 -0.722 . . . . 0.69999999999999996 109.052 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.616 ' HD2' HD13 ' A' ' 95' ' ' ILE . 45.3 m-85 -104.07 128.29 51.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.076 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.671 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 44.2 mt-10 -75.65 112.14 11.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 171.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.581 HG21 HG12 ' A' ' 82' ' ' VAL . 25.4 mt -105.88 120.85 57.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.062 0.458 . . . . 0.47999999999999998 110.254 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.33 -0.85 . . . . 1.8799999999999999 109.287 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 87' ' ' LYS . 7.9 tt -91.9 135.52 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.439 . . . . 1.1200000000000001 109.813 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.97 -31.27 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.663 -0.415 . . . . 1.0 112.025 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m -149.99 139.38 21.42 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.124 -0.36 . . . . 1.1899999999999999 111.399 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.603 ' HB2' HG12 ' A' ' 40' ' ' VAL . 3.4 p90 -167.62 171.34 10.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.905 -0.776 . . . . 0.71999999999999997 108.905 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.1 153.47 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.697 0.284 . . . . 2.98 110.99 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 3.3799999999999999 110.36 176.563 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.105 0.479 . . . . 3.6000000000000001 110.959 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -96.62 156.98 16.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.888 -0.596 . . . . 2.71 109.605 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 7.0 mptt -101.64 142.63 32.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.344 -0.243 . . . . 1.8799999999999999 110.344 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.7 t -103.89 118.73 51.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.73 -0.47 . . . . 0.58999999999999997 109.73 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.88 126.99 46.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.419 -0.355 . . . . 2.1600000000000001 110.842 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt 50.1 51.15 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.589 -0.732 . . . . 1.45 112.12 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -55.51 151.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.78000000000000003 110.967 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -8.54 13.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.363 0.505 . . . . 0.81000000000000005 112.363 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 80' ' ' ILE . 7.1 t70 -82.31 24.33 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.022 0.439 . . . . 2.3999999999999999 111.066 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.07 -7.42 9.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.026 -0.607 . . . . 0.68000000000000005 114.163 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.43 76.07 1.08 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.415 -0.898 . . . . 0.60999999999999999 113.942 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 t -143.76 150.21 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.611 -0.514 . . . . 0.48999999999999999 109.611 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mm -85.27 109.89 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 123.237 0.335 . . . . 0.46999999999999997 110.162 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -123.64 147.08 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.272 0.558 . . . . 1.3400000000000001 111.349 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.1 m -119.08 122.26 41.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.502 -0.772 . . . . 0.5 110.365 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.599 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.7 tp -71.7 131.95 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 0.67000000000000004 111.315 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 1.6 mm? -121.94 -59.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.82999999999999996 110.916 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 88' ' ' ASN . 37.1 ttpt -128.65 154.82 45.88 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.217 -0.66 . . . . 1.5600000000000001 109.217 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -125.23 156.39 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.894 0.378 . . . . 2.9500000000000002 111.106 -173.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.39 163.2 14.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.815 -0.914 . . . . 1.3200000000000001 110.815 170.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -87.51 -97.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.336 0.568 . . . . 2.77 110.648 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.94 155.99 18.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.515 -0.55 . . . . 2.6400000000000001 109.515 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 171.68 62.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.092 -1.051 . . . . 1.04 112.299 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.83 -41.65 99.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.009 0.433 . . . . 2.29 110.318 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.79 20.81 13.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.728 0.775 . . . . 2.6400000000000001 110.466 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.456 ' HB3' HH21 ' A' ' 86' ' ' ARG . 0.2 OUTLIER -135.9 78.3 1.71 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 1.45 109.929 175.542 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 35' ' ' LYS . 36.0 mm -136.58 123.87 14.34 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.81000000000000005 110.811 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 121.49 7.86 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.69 2.26 . . . . 0.75 110.911 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -135.73 150.47 49.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.013 -0.429 . . . . 2.6600000000000001 111.263 -178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.596 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -60.4 132.03 52.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.774 -0.648 . . . . 2.5099999999999998 109.857 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -22.36 31.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.475 -0.65 . . . . 1.1200000000000001 111.475 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -104.05 130.97 51.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.851 -0.425 . . . . 1.3799999999999999 109.851 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -69.07 109.21 3.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.051 -0.522 . . . . 2.2000000000000002 111.765 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 69' ' ' LEU . 22.3 m -99.56 154.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.693 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -122.43 113.01 18.76 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.407 -0.59 . . . . 0.65000000000000002 109.407 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.84 159.85 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.019 0.748 . . . . 0.87 113.019 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -111.85 128.21 56.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 2.75 108.901 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 55.0 p90 -131.25 139.34 49.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.205 0.526 . . . . 0.76000000000000001 111.54 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -168.63 158.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.401 -0.962 . . . . 0.48999999999999999 108.401 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.53 -130.87 1.74 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.926 -1.13 . . . . 0.35999999999999999 112.434 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.717 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 62.4 pttt -156.19 170.05 23.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.13 0.49 . . . . 1.4299999999999999 111.028 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -82.76 101.64 11.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.811 -0.632 . . . . 0.38 110.079 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.65 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 44.5 tt0 -57.54 -33.1 67.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.88 0.371 . . . . 1.96 110.942 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -57.27 -19.62 22.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.67000000000000004 112.106 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 53' ' ' LYS . 7.5 t -138.22 -8.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.792 -0.363 . . . . 0.72999999999999998 111.709 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.07 83.14 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.217 -0.516 . . . . 0.78000000000000003 112.981 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 12.8 mmmm -87.99 120.96 29.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.707 0.289 . . . . 2.8900000000000001 110.99 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.717 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 13.6 p -75.56 151.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.591 . . . . 0.58999999999999997 110.195 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.48 ' CE1' HD11 ' A' ' 110' ' ' ILE . 17.7 m-30 -73.85 127.39 32.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.78000000000000003 111.015 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -141.39 85.76 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.868 0.842 . . . . 2.1800000000000002 110.2 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 m -122.57 -175.93 3.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.234 -0.654 . . . . 1.24 109.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.4 m -72.31 -47.03 53.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.752 0.31 . . . . 1.49 111.604 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -96.42 -36.76 10.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.964 0.727 . . . . 1.8 112.964 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 47.7 p-10 -60.62 -45.38 94.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.586 0.587 . . . . 2.1899999999999999 112.586 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.4 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -86.89 15.38 5.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.214 0.531 . . . . 2.7799999999999998 110.775 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.05 -47.09 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 1.1000000000000001 111.793 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 7.1 p -114.38 124.89 29.96 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 2.0299999999999998 110.947 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 2.8 Cg_exo -75.83 120.67 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.046 2.497 . . . . 1.76 111.788 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.44 146.72 23.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.436 -0.579 . . . . 1.3100000000000001 109.436 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 162.08 37.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.331 -0.395 . . . . 1.3600000000000001 110.755 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CE1' HG11 ' A' ' 74' ' ' VAL . 41.0 p90 -144.74 175.63 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.56999999999999995 110.302 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.8 m-70 -111.4 147.79 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.296 -0.631 . . . . 1.98 109.296 173.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HB2' HG22 ' A' ' 40' ' ' VAL . 16.9 tp -72.02 127.02 31.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.403 . . . . 0.94999999999999996 109.911 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.596 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 64.44 72.78 0.44 Allowed 'General case' 0 C--N 1.331 -0.206 0 O-C-N 124.15 0.906 . . . . 2.0800000000000001 111.453 -175.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 73' ' ' GLU . 11.9 pt20 -130.35 14.71 5.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.326 -0.852 . . . . 1.98 109.597 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.92 -17.44 31.73 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.71999999999999997 113.11 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HB2' HE21 ' A' ' 71' ' ' GLN . 14.2 mm-40 -84.36 -39.41 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.058 0.456 . . . . 0.96999999999999997 111.465 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 67' ' ' PHE . 18.1 m -97.97 127.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.108 -0.496 . . . . 0.57999999999999996 110.456 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.689 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.61 -68.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.537 0.569 . . . . 0.62 112.537 -175.049 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.689 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -139.95 -45.97 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.231 0.456 . . . . 2.04 112.231 -175.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.75 -53.16 34.31 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.12 -0.562 . . . . 0.32000000000000001 113.275 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.463 ' O ' HG22 ' A' ' 82' ' ' VAL . 20.2 m-90 -75.8 -31.87 59.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.9 0.381 . . . . 0.48999999999999999 110.628 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.487 ' OD1' HD11 ' A' ' 69' ' ' LEU . 22.1 t0 -53.98 -52.88 59.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.201 -0.909 . . . . 1.1399999999999999 112.068 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.87 -41.07 81.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.903 0.383 . . . . 0.78000000000000003 111.191 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.664 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 25.4 t -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.712 -0.395 . . . . 0.55000000000000004 111.385 -176.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 69' ' ' LEU . 34.9 m -67.96 -32.03 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.97 0.414 . . . . 0.83999999999999997 110.173 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -64.76 -27.17 68.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 1.4299999999999999 110.802 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 t -101.43 24.66 9.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.815 -0.629 . . . . 1.23 110.812 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.046 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 5.1 mmt -104.98 -173.32 2.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.561 -0.29 . . . . 2.27 110.921 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 24.1 mtp-105 -151.99 175.01 12.95 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.937 -0.764 . . . . 4.1900000000000004 108.937 170.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -61.27 -24.32 66.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.061 0.458 . . . . 1.9399999999999999 111.254 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.465 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 35.3 m-80 -130.37 28.62 4.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.444 -0.344 . . . . 1.23 110.966 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 28.4 tt0 -121.19 142.85 49.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.58 -0.526 . . . . 1.6000000000000001 109.58 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.556 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.32 130.24 16.23 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.713 -0.477 . . . . 1.1699999999999999 109.713 -171.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.599 ' SG ' HD12 ' A' ' 22' ' ' ILE . 96.9 m -141.96 171.68 13.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 1.2 111.996 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.7 134.76 46.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.36 -0.836 . . . . 1.73 110.015 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.664 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.1 p -112.93 140.96 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.901 0.382 . . . . 0.73999999999999999 111.165 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.625 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.09 112.48 25.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.919 -0.582 . . . . 1.71 110.263 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.8 mp -95.84 102.1 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.52000000000000002 110.03 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.425 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 24.7 tt0 -83.89 168.74 15.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.43 -0.952 . . . . 1.3700000000000001 108.43 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.4 p -53.22 -36.05 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.52 -7.47 54.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.366 -0.379 . . . . 1.79 111.801 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.425 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -100.44 0.03 38.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.576 0.227 . . . . 0.75 111.265 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -127.07 -165.15 11.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.891 -0.671 . . . . 0.70999999999999996 111.928 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.876 0.338 . . . . 1.52 111.102 179.144 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 N-CA-C 111.985 0.365 . . . . 1.52 111.985 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.48 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -152.69 87.34 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.139 -0.689 . . . . 0.75 109.139 175.521 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.73 -171.7 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.489 2.793 . . . . 1.5800000000000001 113.196 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.87 -143.51 13.85 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.61 -0.596 . . . . 2.0499999999999998 111.61 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -101.14 1.52 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.907 0.384 . . . . 2.0299999999999998 110.599 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 p -82.43 158.27 23.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.928 -0.578 . . . . 1.1399999999999999 110.939 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.83 132.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.47999999999999998 111.095 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -119.18 155.13 32.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.51000000000000001 109.695 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.65 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -124.67 127.64 47.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 0.69999999999999996 110.48 172.214 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -122.74 141.31 51.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.814 -0.63 . . . . 0.42999999999999999 110.589 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.7 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 40.3 mt-10 -76.54 121.5 23.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.846 -0.798 . . . . 1.46 108.846 169.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.535 HD12 ' HB3' ' A' ' 81' ' ' CYS . 13.1 mt -106.8 127.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.524 -0.547 . . . . 0.47999999999999998 109.524 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -134.16 111.02 9.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.051 -0.977 . . . . 1.8799999999999999 110.354 -169.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.459 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 24.9 tp -84.8 96.92 9.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 1.1200000000000001 109.991 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.14 -21.9 24.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.349 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -173.17 163.54 4.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.503 -0.317 . . . . 1.1899999999999999 110.203 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.24 174.12 8.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.71999999999999997 110.201 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -137.21 138.79 40.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.431 . . . . 2.98 110.904 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.555 -0.748 . . . . 3.3799999999999999 110.207 -177.636 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.831 0.348 . . . . 7.4800000000000004 110.52 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.34 122.74 24.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.322 -0.399 . . . . 5.9000000000000004 110.767 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 4' ' ' GLU . 13.0 t -91.93 -33.79 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.27 -0.641 . . . . 4.4400000000000004 109.27 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.565 ' HG2' HG23 ' A' ' 3' ' ' THR . 23.4 mm-40 -109.13 95.94 5.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.509 -0.769 . . . . 4.4400000000000004 108.94 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -67.41 131.65 46.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 4.1500000000000004 111.249 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.78 79.16 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.816 -0.629 . . . . 3.6099999999999999 109.77 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.34 150.47 21.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.212 0.53 . . . . 3.6000000000000001 111.328 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.06 150.84 21.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.393 -0.821 . . . . 2.71 109.156 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -98.9 151.58 20.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.898 -0.408 . . . . 1.8799999999999999 109.898 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -101.42 104.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.545 -0.909 . . . . 0.58999999999999997 108.545 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.54 108.49 20.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.222 -0.899 . . . . 2.1600000000000001 110.825 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 84.1 mt 65.01 69.5 0.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 1.45 110.406 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -65.21 163.7 14.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.838 -0.619 . . . . 0.78000000000000003 110.571 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.37 -3.74 29.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.672 0.619 . . . . 0.81000000000000005 112.672 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.534 ' HB3' HG13 ' A' ' 80' ' ' ILE . 29.1 t70 -90.55 14.76 12.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.361 0.601 . . . . 2.3999999999999999 110.946 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.03 19.46 2.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.323 -0.942 . . . . 0.68000000000000005 114.241 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 69.03 76.64 0.45 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.639 0.615 . . . . 0.60999999999999999 114.639 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.534 ' HB ' HG21 ' A' ' 80' ' ' ILE . 96.9 t -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.85 -0.426 . . . . 0.48999999999999999 109.85 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 13.7 mm -91.86 116.02 32.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 O-C-N 123.385 0.428 . . . . 0.46999999999999997 110.594 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -135.12 146.46 48.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 1.3400000000000001 111.263 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 m -108.56 131.91 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.691 . . . . 0.5 110.356 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -80.44 120.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.109 0.48 . . . . 0.67000000000000004 111.188 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.38 -52.57 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.82999999999999996 110.632 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 39.5 ttmt -127.44 149.19 50.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.351 -0.611 . . . . 1.5600000000000001 109.351 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -115.15 140.83 48.75 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.134 0.271 . . . . 2.9500000000000002 110.325 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.03 121.7 25.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.956 -0.64 . . . . 1.3200000000000001 112.009 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.05 -60.29 4.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.342 . . . . 2.77 111.511 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -160.96 141.01 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 2.6400000000000001 110.407 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 32' ' ' ASN . . . 167.86 103.31 0.17 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.551 -0.833 . . . . 1.04 112.026 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.65 -41.62 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.598 0.714 . . . . 2.29 109.246 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -88.48 -10.4 49.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.521 -1.218 . . . . 2.6400000000000001 110.607 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.655 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.5 m-80 -84.86 75.52 10.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.989 -0.551 . . . . 1.45 111.036 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 31.8 mm -144.58 102.22 4.63 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.757 -0.656 . . . . 0.81000000000000005 110.262 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HG3' HD22 ' A' ' 122' ' ' LEU . 65.2 Cg_endo -71.81 111.33 3.12 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 123.329 2.686 . . . . 0.75 112.181 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -116.87 166.47 12.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.624 0.726 . . . . 2.6600000000000001 112.189 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 1.024 ' HE3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -70.11 153.88 42.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.891 -1.05 . . . . 2.5099999999999998 111.736 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' H ' ' HB2' ' A' ' 70' ' ' GLU . . . 86.68 -5.11 85.53 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.365 -0.834 . . . . 1.1200000000000001 111.49 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -119.85 163.8 16.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.163 0.506 . . . . 1.3799999999999999 111.119 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -87.54 121.79 30.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 2.2000000000000002 110.769 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 125' ' ' PHE . 17.8 m -132.73 156.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.217 -0.447 . . . . 0.67000000000000004 109.974 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 124' ' ' SER . 39.0 m -127.75 116.58 20.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.229 -0.442 . . . . 0.65000000000000002 109.916 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 122' ' ' LEU . 33.7 m -137.46 156.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.614 -0.266 . . . . 0.87 111.088 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.73 142.71 45.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.956 -0.757 . . . . 2.75 108.956 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -124.16 141.23 52.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.76000000000000001 110.71 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -168.77 161.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 109.251 -0.648 . . . . 0.48999999999999999 109.251 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.22 -128.61 1.79 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.312 -0.947 . . . . 0.35999999999999999 112.341 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.665 ' O ' HD12 ' A' ' 117' ' ' LEU . 18.6 pttm -156.69 173.16 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.929 0.395 . . . . 1.4299999999999999 110.805 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.627 HD22 HG13 ' A' ' 110' ' ' ILE . 65.9 tp -91.15 98.29 11.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.38 110.184 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.71 ' HB2' HD11 ' A' ' 117' ' ' LEU . 35.7 tt0 -66.58 -21.15 66.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.846 0.355 . . . . 1.96 110.704 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.518 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 23.2 t -55.89 -29.97 60.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.67000000000000004 111.48 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 53' ' ' LYS . 9.6 t -138.04 1.31 2.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.868 0.366 . . . . 0.72999999999999998 111.406 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.91 20.42 73.41 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.215 -0.517 . . . . 0.78000000000000003 112.869 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HB2' HG23 ' A' ' 51' ' ' THR . 0.2 OUTLIER -84.19 116.42 22.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.629 0.252 . . . . 2.8900000000000001 110.784 -178.155 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.2 p -70.57 150.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.58999999999999997 110.054 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 8.4 m-30 -74.92 124.52 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.971 0.415 . . . . 0.78000000000000003 111.425 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.63 85.25 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.504 0.669 . . . . 2.1800000000000002 110.674 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.409 ' HB3' ' OD1' ' A' ' 60' ' ' ASP . 46.8 t -126.53 166.59 17.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.656 -0.702 . . . . 1.24 109.227 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -71.18 -22.05 62.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.897 0.38 . . . . 1.49 111.082 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.566 ' O ' HG12 ' A' ' 63' ' ' VAL . 43.3 m-85 -95.02 -55.65 3.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.793 0.664 . . . . 1.8 112.793 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 5.5 p-10 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.548 0.573 . . . . 2.1899999999999999 112.548 -167.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -1.94 55.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.842 0.353 . . . . 2.7799999999999998 111.278 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -116.29 -53.99 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 1.1000000000000001 111.765 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 59' ' ' PHE . 13.0 p -87.09 127.27 59.99 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.441 0.638 . . . . 2.0299999999999998 111.858 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.6 Cg_exo -78.18 90.48 1.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.586 2.191 . . . . 1.76 111.027 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -94.39 132.61 38.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.148 -0.686 . . . . 1.3100000000000001 109.148 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -138.55 147.31 42.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.106 -0.497 . . . . 1.3600000000000001 110.206 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -115.47 178.35 4.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.56999999999999995 109.722 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -115.72 148.9 39.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.237 -1.023 . . . . 1.98 108.237 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.621 HD13 ' CG2' ' A' ' 82' ' ' VAL . 18.3 tp -74.36 128.91 36.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.995 0.426 . . . . 0.94999999999999996 111.226 -175.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 1.024 ' HG3' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 58.93 64.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.879 -1.055 . . . . 2.0800000000000001 112.229 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 73' ' ' GLU . 10.0 pt20 -115.84 10.13 15.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.3 -1.318 . . . . 1.98 108.967 172.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.8 -18.7 41.89 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.71999999999999997 112.772 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' HB2' HE21 ' A' ' 71' ' ' GLN . 19.9 mm-40 -76.63 -32.92 58.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.178 0.513 . . . . 0.96999999999999997 110.791 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.78 129.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.813 -0.631 . . . . 0.57999999999999996 109.725 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.657 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.93 -73.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.261 -0.427 . . . . 0.62 111.592 -175.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.657 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -138.16 -44.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.022 -0.424 . . . . 2.04 112.018 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -54.5 -53.87 35.93 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.792 -0.718 . . . . 0.32000000000000001 113.101 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.604 ' O ' HG22 ' A' ' 82' ' ' VAL . 11.4 m-90 -75.78 -36.59 59.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.439 -0.448 . . . . 0.48999999999999999 110.266 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -51.41 -53.79 33.2 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.063 0.852 . . . . 1.1399999999999999 111.951 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 15' ' ' ASP . 1.6 mp -65.23 -38.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.829 0.347 . . . . 0.78000000000000003 111.164 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.593 ' O ' ' HG2' ' A' ' 85' ' ' MET . 23.6 t -66.86 -55.85 12.94 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.888 -0.325 . . . . 0.55000000000000004 110.616 -176.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.621 ' CG2' HD13 ' A' ' 69' ' ' LEU . 29.9 m -71.76 -33.23 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.038 0.385 . . . . 0.83999999999999997 112.038 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 t -78.05 0.83 23.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.264 0.555 . . . . 1.4299999999999999 110.734 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 t -131.69 20.48 4.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.687 . . . . 1.23 109.843 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.661 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.1 mmt -90.81 -174.66 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 2.27 110.699 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 50.8 mtt85 -149.42 154.97 39.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.03 -1.1 . . . . 4.1900000000000004 108.03 172.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 62.2 tttm -65.27 -14.33 60.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.128 0.489 . . . . 1.9399999999999999 111.911 -173.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -124.06 25.08 8.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.96 0.41 . . . . 1.23 110.185 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 32.3 tt0 -123.61 166.66 15.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.862 -0.608 . . . . 1.6000000000000001 110.363 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -158.8 133.72 8.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.715 0.293 . . . . 1.1699999999999999 111.301 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.3 m -136.79 153.94 50.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.342 -0.39 . . . . 1.2 110.738 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -101.21 121.46 41.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.35 -0.611 . . . . 1.73 109.35 175.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 77' ' ' GLY . 12.6 p -106.44 145.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.453 -0.34 . . . . 0.73999999999999999 110.896 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.534 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 41.5 mmt-85 -96.5 118.14 32.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.976 -0.557 . . . . 1.71 110.497 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.2 mp -96.43 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.227 -0.657 . . . . 0.52000000000000002 109.227 175.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 99' ' ' TYR . 42.1 tt0 -92.63 173.29 7.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.975 -1.012 . . . . 1.3700000000000001 108.898 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 17.1 p -51.42 -50.05 60.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.765 0.283 . . . . 1.0 111.765 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.6 ptm -77.55 -16.82 58.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.074 0.398 . . . . 1.79 112.074 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.489 ' HB2' ' H ' ' A' ' 96' ' ' GLU . 21.7 m-30 -85.59 -17.17 37.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.177 -0.305 . . . . 0.75 110.177 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.85 -154.22 9.25 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.488 -0.778 . . . . 0.70999999999999996 111.463 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -93.36 47.31 1.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 1.52 111.847 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.53 -10.39 79.34 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.821 . . . . 2.2999999999999998 111.344 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.34 -59.15 2.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.91 0.386 . . . . 5.8600000000000003 110.837 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.29 -33.5 43.29 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.877 -0.601 . . . . 4.2699999999999996 110.878 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 99.62 -5.21 58.37 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.617 -0.801 . . . . 2.1600000000000001 113.169 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.0 t -82.64 97.45 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.178 0.513 . . . . 3.3399999999999999 110.846 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -122.89 -168.14 13.06 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.857 -0.687 . . . . 1.2 111.594 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.47 -68.82 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.248 0.524 . . . . 3.0800000000000001 111.837 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.507 ' HB2' HD13 ' A' ' 110' ' ' ILE . 11.4 p -79.65 -74.99 0.27 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.959 -0.296 . . . . 1.52 111.753 -174.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.627 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -144.43 84.27 9.36 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.617 0.722 . . . . 0.75 110.861 177.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.566 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 68.5 Cg_endo -95.15 90.9 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.029 2.486 . . . . 1.5800000000000001 112.272 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.95 47.66 1.0 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.079 -1.058 . . . . 2.0499999999999998 112.302 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 3.6 m-20 60.34 21.68 11.2 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.534 0.683 . . . . 2.0299999999999998 110.76 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.518 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 7.4 m -96.46 156.55 16.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 1.1399999999999999 109.852 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -87.03 121.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.404 0.621 . . . . 0.47999999999999998 110.766 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -114.57 157.27 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.601 -0.727 . . . . 0.51000000000000001 110.159 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -116.77 129.19 55.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 110.0 -0.37 . . . . 0.69999999999999996 110.0 175.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.461 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 21.1 m-85 -122.33 122.0 38.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.598 -0.274 . . . . 0.42999999999999999 110.351 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.471 ' HG2' ' HG ' ' A' ' 92' ' ' LEU . 42.7 mt-10 -75.25 114.52 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.191 -0.67 . . . . 1.46 109.191 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.436 HD11 ' HD1' ' A' ' 78' ' ' TRP . 65.4 mt -106.76 122.29 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.913 0.387 . . . . 0.47999999999999998 110.005 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.29 115.66 22.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 109.5 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.86 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -86.0 94.43 9.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 1.1200000000000001 110.362 -176.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.678 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.2 pt? -86.08 -28.65 23.94 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.16 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.54 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 t -141.05 144.82 35.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.044 0.45 . . . . 1.1899999999999999 110.555 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 87' ' ' LYS . 6.1 p90 -164.47 168.16 18.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.931 -0.766 . . . . 0.71999999999999997 108.931 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -161.97 109.16 1.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 2.98 111.339 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -71.33 115.44 10.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.541 -0.754 . . . . 3.3799999999999999 110.365 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.7 tp -108.87 122.55 47.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.278 -0.638 . . . . 3.3500000000000001 109.278 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -80.62 91.33 5.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.252 0.548 . . . . 5.3899999999999997 110.874 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -108.78 73.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.862 0.839 . . . . 7.04 110.628 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -156.9 155.69 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.446 -1.252 . . . . 7.21 108.0 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -67.77 139.7 56.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.59 -0.444 . . . . 9.0199999999999996 110.842 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.18 110.71 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 9.75 110.398 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -61.37 -39.76 91.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.136 0.493 . . . . 12.26 110.291 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.915 -0.772 . . . . 13.35 108.915 170.93 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.652 0.263 . . . . 7.4800000000000004 110.809 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -70.9 159.69 34.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.139 -0.319 . . . . 5.9000000000000004 110.139 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.0 m -150.68 -66.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 4.4400000000000004 110.836 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -117.19 176.55 5.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.893 0.378 . . . . 4.4400000000000004 110.377 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -76.14 101.28 5.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 4.1500000000000004 110.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.88 34.8 0.98 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.698 0.761 . . . . 3.6099999999999999 109.355 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.13 -170.86 1.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.303 -0.862 . . . . 3.6000000000000001 110.466 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.28 150.07 49.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.038 0.447 . . . . 2.71 110.826 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.475 ' HG3' HG23 ' A' ' 21' ' ' THR . 3.6 mppt? -91.6 144.4 25.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 1.8799999999999999 109.605 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 41.4 t -101.34 103.85 15.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 0.58999999999999997 108.427 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -103.45 113.75 27.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.129 -0.941 . . . . 2.1600000000000001 110.66 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 19' ' ' ILE . 52.2 mt 60.67 54.65 3.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.962 0.789 . . . . 1.45 111.206 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.49 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -57.29 148.63 22.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.92 . . . . 0.78000000000000003 110.607 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.43 1.3 4.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.81000000000000005 110.502 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.1 16.64 4.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 2.3999999999999999 110.908 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.18 5.04 8.98 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.396 -0.907 . . . . 0.68000000000000005 114.114 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.34 72.26 0.9 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.226 -0.512 . . . . 0.60999999999999999 113.652 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' A' ' 80' ' ' ILE . 62.4 t -135.68 142.72 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.782 -0.451 . . . . 0.48999999999999999 109.782 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 12' ' ' LEU . 18.5 mm -88.11 114.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.721 -0.474 . . . . 0.46999999999999997 109.721 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HD2' ' SG ' ' A' ' 81' ' ' CYS . 12.1 pttp -142.4 138.51 31.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.314 0.578 . . . . 1.3400000000000001 111.418 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 24.6 m -100.02 123.81 44.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.5 110.126 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.557 HG12 ' HE2' ' A' ' 25' ' ' LYS . 8.9 tp -80.42 132.76 31.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.997 0.427 . . . . 0.67000000000000004 110.1 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' LEU . 3.9 mm? -113.68 -51.06 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.049 -0.523 . . . . 0.82999999999999996 110.983 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 117.19 19.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.454 -0.339 . . . . 1.5600000000000001 110.392 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 58.0 mttm -101.91 160.63 14.32 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.148 -0.478 . . . . 2.9500000000000002 110.312 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.42 -142.23 12.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.789 -0.719 . . . . 1.3200000000000001 111.919 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -76.0 0.56 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.961 0.41 . . . . 2.77 110.293 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.79 -178.58 3.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.136 -0.483 . . . . 2.6400000000000001 110.116 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 52.31 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.081 -0.807 . . . . 1.04 111.081 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.78 -40.64 93.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.983 0.42 . . . . 2.29 110.948 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -108.79 9.28 26.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.536 . . . . 2.6400000000000001 110.474 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -111.79 77.37 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 1.45 110.296 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.452 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 36.4 mm -132.87 120.69 16.57 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.398 -0.819 . . . . 0.81000000000000005 110.101 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.452 ' HG3' HD22 ' A' ' 122' ' ' LEU . 85.7 Cg_endo -87.04 115.9 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.815 2.343 . . . . 0.75 112.576 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HE2' ' CG2' ' A' ' 33' ' ' ILE . 71.3 mmtt -129.9 158.29 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 2.6600000000000001 111.444 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 12.1 ttmm -65.43 150.27 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.158 -0.928 . . . . 2.5099999999999998 111.365 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.2 -11.66 68.92 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.934 -0.867 . . . . 1.1200000000000001 110.934 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -105.05 155.71 18.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.517 . . . . 1.3799999999999999 110.878 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.25 104.25 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 2.2000000000000002 110.682 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 m -118.08 162.12 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 0.67000000000000004 110.655 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 31.5 m -133.45 120.91 21.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.797 -0.638 . . . . 0.65000000000000002 109.611 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.68 148.79 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.87 111.577 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.22 143.84 30.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.297 -0.631 . . . . 2.75 109.297 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 30.6 p90 -141.97 137.02 30.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.76000000000000001 110.505 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.55 160.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.125 -0.694 . . . . 0.48999999999999999 109.125 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.11 -118.88 0.68 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.539 -0.839 . . . . 0.35999999999999999 112.597 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HG3' HD11 ' A' ' 117' ' ' LEU . 55.5 pttt -149.94 171.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 1.4299999999999999 110.111 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.506 HD12 ' HG ' ' A' ' 116' ' ' LEU . 57.0 tp -87.23 98.01 11.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.879 -0.6 . . . . 0.38 109.533 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.577 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 4.9 tp10 -57.59 -35.09 69.94 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.46 0.541 . . . . 1.96 112.46 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -58.26 -20.06 39.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.372 0.508 . . . . 0.67000000000000004 112.372 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 53' ' ' LYS . 11.4 t -134.05 -30.81 1.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.971 0.415 . . . . 0.72999999999999998 110.773 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.26 15.84 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.254 -0.498 . . . . 0.78000000000000003 113.151 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' H ' HG23 ' A' ' 51' ' ' THR . 11.2 mmmm -81.49 125.33 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.932 0.366 . . . . 2.8900000000000001 110.67 177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.24 154.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.58999999999999997 110.03 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 22.0 m-30 -75.2 99.96 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.167 0.508 . . . . 0.78000000000000003 111.918 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -116.87 85.89 2.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.371 -0.974 . . . . 2.1800000000000002 108.371 168.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -135.33 158.06 45.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.62 -0.718 . . . . 1.24 110.248 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -48.67 -42.08 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.769 0.668 . . . . 1.49 112.496 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -93.88 -50.64 5.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.771 0.32 . . . . 1.8 110.609 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.66 -37.87 59.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 2.1899999999999999 112.626 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -84.53 -4.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 2.7799999999999998 111.267 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -115.49 -61.44 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.939 -0.305 . . . . 1.1000000000000001 110.569 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.19 109.61 6.96 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.32 -0.4 . . . . 2.0299999999999998 110.225 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.49 161.17 42.32 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.709 2.273 . . . . 1.76 112.137 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -94.03 154.12 17.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.079 -0.509 . . . . 1.3100000000000001 110.279 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.8 pptp? -134.47 151.1 50.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 1.3600000000000001 110.263 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.68 -171.85 2.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.37 -0.377 . . . . 0.56999999999999995 110.989 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -116.72 149.2 40.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.289 -0.634 . . . . 1.98 109.289 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 HG21 ' A' ' 82' ' ' VAL . 9.8 tp -67.81 112.86 5.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.94999999999999996 111.89 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.97 73.11 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.334 -1.303 . . . . 2.0800000000000001 111.63 176.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -113.44 17.43 18.43 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.187 -1.042 . . . . 1.98 108.187 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.99 -18.28 55.99 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.585 -1.189 . . . . 0.71999999999999997 113.062 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.25 -14.54 28.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.956 0.378 . . . . 0.96999999999999997 111.446 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.15 121.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.643 0.735 . . . . 0.57999999999999996 109.751 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.431 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -99.37 -62.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.08 -0.964 . . . . 0.62 112.774 -172.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -125.92 -66.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.278 0.473 . . . . 2.04 112.278 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.33 -52.6 35.82 Favored Glycine 0 C--N 1.333 0.384 0 O-C-N 123.56 0.538 . . . . 0.32000000000000001 113.59 -169.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.45 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.9 m-90 -75.39 -46.44 32.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.769 0.318 . . . . 0.48999999999999999 110.393 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.36 -48.26 65.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.026 -0.988 . . . . 1.1399999999999999 112.251 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.593 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -73.89 -45.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.488 -0.324 . . . . 0.78000000000000003 110.894 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.489 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 53.1 t -63.56 -41.8 98.4 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.591 0.219 . . . . 0.55000000000000004 111.591 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.607 HG21 HD13 ' A' ' 69' ' ' LEU . 34.4 m -67.66 -32.34 56.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.768 -0.373 . . . . 0.83999999999999997 110.805 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.1 m -79.48 -4.0 49.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.946 0.403 . . . . 1.4299999999999999 111.169 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.425 ' OG ' ' HE2' ' A' ' 20' ' ' LYS . 9.7 p -124.01 39.32 3.99 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.227 0.537 . . . . 1.23 111.096 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.497 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 0.1 OUTLIER -116.13 174.57 5.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 2.27 110.488 176.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 86' ' ' ARG . 6.1 ttm180 -127.51 163.36 24.31 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.36 -1.348 . . . . 4.1900000000000004 107.36 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -64.42 -17.55 63.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.238 0.542 . . . . 1.9399999999999999 110.846 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -122.81 16.73 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.069 -0.514 . . . . 1.23 110.703 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 25' ' ' LYS . 33.6 tt0 -123.7 129.38 51.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 1.6000000000000001 110.642 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 85.4 tttt -136.58 143.75 43.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 1.1699999999999999 109.894 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 21' ' ' THR . 28.8 p -149.79 165.26 33.0 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.001 0.429 . . . . 1.2 111.733 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.97 120.65 32.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.291 -0.868 . . . . 1.73 110.007 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.489 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.5 p -99.89 134.59 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.286 -0.415 . . . . 0.73999999999999999 110.096 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 26.2 mmm-85 -96.1 111.38 23.43 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.463 -0.569 . . . . 1.71 109.463 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.426 HD13 ' CD2' ' A' ' 118' ' ' PHE . 2.1 mp -91.44 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.019 -0.734 . . . . 0.52000000000000002 109.019 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 97' ' ' SER . 43.7 tt0 -79.7 168.52 19.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.313 -0.858 . . . . 1.3700000000000001 109.449 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -48.16 -48.48 34.32 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.323 0.649 . . . . 1.0 111.463 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -78.56 -8.07 58.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.362 0.504 . . . . 1.79 112.362 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -96.25 -12.86 23.95 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.237 -0.289 . . . . 0.75 110.848 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 176.06 19.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.847 -0.692 . . . . 0.70999999999999996 112.36 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -41.49 97.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.916 0.388 . . . . 1.52 110.996 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.51 165.56 18.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.562 -0.827 . . . . 2.2999999999999998 112.447 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -72.51 -23.37 61.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.327 0.584 . . . . 5.8600000000000003 111.015 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -87.32 10.9 15.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.724 -0.671 . . . . 4.2699999999999996 110.742 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.43 -161.86 10.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.532 -0.842 . . . . 2.1600000000000001 112.227 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.1 m -72.31 126.31 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.788 0.328 . . . . 3.3399999999999999 110.326 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.6 142.58 16.05 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.874 -0.679 . . . . 1.2 111.914 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.18 -71.57 0.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.608 -0.516 . . . . 3.0800000000000001 109.608 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -104.86 -72.08 0.72 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.147 -0.686 . . . . 1.52 109.147 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.449 HG13 HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -143.62 112.38 5.43 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.35 -0.387 . . . . 0.75 110.095 175.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -83.06 -83.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.516 2.144 . . . . 1.5800000000000001 112.831 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.89 18.16 59.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.952 -0.36 . . . . 2.0499999999999998 113.694 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 52.65 35.39 18.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.006 0.431 . . . . 2.0299999999999998 111.181 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.3 m -107.77 179.49 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 1.1399999999999999 110.67 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.33 129.57 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.174 0.512 . . . . 0.47999999999999998 111.008 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.506 ' HG ' HD12 ' A' ' 48' ' ' LEU . 6.3 mp -127.21 174.82 8.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.297 -0.631 . . . . 0.51000000000000001 109.297 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.631 ' HB3' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -147.01 133.04 19.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.29 0.567 . . . . 0.69999999999999996 110.578 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.485 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 43.6 m-85 -127.98 141.76 51.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.42999999999999999 110.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.3 mt-10 -76.26 127.15 32.32 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.062 -0.718 . . . . 1.46 109.062 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.7 mt -105.89 118.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.601 0.715 . . . . 0.47999999999999998 110.216 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -110.68 116.0 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.687 -1.142 . . . . 1.8799999999999999 110.458 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 34' ' ' PRO . 30.3 tp -91.89 89.6 7.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 1.1200000000000001 109.977 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.7 pt? -95.17 -33.32 12.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.042 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 13.8 m -135.12 128.18 31.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.024 -0.362 . . . . 1.1899999999999999 110.024 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.25 171.16 11.01 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.559 -0.534 . . . . 0.71999999999999997 109.559 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -162.11 168.49 22.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.007 -0.368 . . . . 2.98 110.007 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.78 152.15 40.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.139 -1.06 . . . . 3.3799999999999999 108.139 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.87 -37.67 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.407 0.521 . . . . 3.3500000000000001 112.407 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -108.5 98.33 7.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.05 -0.66 . . . . 5.3899999999999997 111.964 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -89.28 55.37 3.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.143 -0.935 . . . . 7.04 108.926 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -135.54 137.0 41.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.309 -0.859 . . . . 7.21 110.098 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.96 119.26 32.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.901 0.381 . . . . 9.0199999999999996 110.729 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -75.66 127.47 33.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.8 -0.636 . . . . 9.75 109.33 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 21.4 p80 -65.3 -58.63 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.825 -0.35 . . . . 12.26 111.099 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 69.0 t60 . . . . . 0 C--O 1.243 0.72 0 CA-C-O 118.493 -0.765 . . . . 13.35 109.452 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.707 -0.479 . . . . 7.4800000000000004 109.707 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m 75.02 14.97 3.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.715 0.769 . . . . 5.9000000000000004 110.251 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.59 113.17 20.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 4.4400000000000004 110.612 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.82 125.99 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.042 0.839 . . . . 4.4400000000000004 110.739 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -144.63 153.12 41.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.676 -0.693 . . . . 4.1500000000000004 111.144 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -85.45 44.05 1.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.627 -0.715 . . . . 3.6099999999999999 109.823 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -81.98 165.18 20.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 3.6000000000000001 111.57 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -94.14 153.99 17.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.013 -0.994 . . . . 2.71 110.053 -175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 11.5 mptt -114.73 147.51 39.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.765 0.317 . . . . 1.8799999999999999 110.697 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.98 108.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.536 -0.542 . . . . 0.58999999999999997 109.536 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -89.45 125.06 35.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.237 0.542 . . . . 2.1600000000000001 111.421 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' H ' HD13 ' A' ' 19' ' ' ILE . 11.1 tp 54.76 64.38 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.953 -1.021 . . . . 1.45 111.027 174.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 80' ' ' ILE . 9.0 t -59.16 156.03 12.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.636 -0.711 . . . . 0.78000000000000003 111.61 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -19.86 64.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.743 -0.662 . . . . 0.81000000000000005 112.588 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.62 19.93 1.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.324 0.49 . . . . 2.3999999999999999 112.324 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.64 30.64 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.68000000000000005 114.429 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.85 83.6 0.06 OUTLIER Glycine 0 C--O 1.227 -0.334 0 N-CA-C 114.648 0.619 . . . . 0.60999999999999999 114.648 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' THR . 55.0 t -141.21 140.1 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.38 -0.6 . . . . 0.48999999999999999 109.38 174.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 12' ' ' LEU . 10.0 mm -93.07 113.58 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.228 0.33 . . . . 0.46999999999999997 110.113 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -141.27 146.9 37.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.338 0.59 . . . . 1.3400000000000001 111.616 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -109.68 138.65 45.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.106 -0.952 . . . . 0.5 110.113 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.84 132.3 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.234 -0.284 . . . . 0.67000000000000004 110.234 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 92' ' ' LEU . 3.5 mm? -115.57 -51.58 2.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.456 -0.338 . . . . 0.82999999999999996 110.64 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 29.1 ttmt -122.9 135.07 54.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.726 -0.472 . . . . 1.5600000000000001 109.726 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -99.63 147.12 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 123.46 0.475 . . . . 2.9500000000000002 110.785 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 171.4 52.15 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 116.028 -0.533 . . . . 1.3200000000000001 111.939 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.55 -65.92 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 2.77 110.768 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -151.7 153.05 33.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 2.6400000000000001 110.074 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.43 100.8 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.181 -1.009 . . . . 1.04 112.98 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -74.63 -42.33 58.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.574 . . . . 2.29 109.793 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -81.4 -23.31 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.377 -0.829 . . . . 2.6400000000000001 110.663 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.69 75.78 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.421 0.629 . . . . 1.45 109.611 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mm -146.4 118.78 4.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.735 -1.12 . . . . 0.81000000000000005 109.209 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HG3' HD22 ' A' ' 122' ' ' LEU . 20.3 Cg_endo -60.78 124.73 15.57 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.799 2.333 . . . . 0.75 111.716 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -116.37 149.54 39.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.601 -0.518 . . . . 2.6600000000000001 109.601 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -77.19 144.54 38.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.416 -0.514 . . . . 2.5099999999999998 110.633 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.34 -22.31 41.32 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.162 -0.775 . . . . 1.1200000000000001 111.162 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -99.33 169.96 8.98 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.079 -0.341 . . . . 1.3799999999999999 110.079 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.05 125.63 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.286 0.565 . . . . 2.2000000000000002 111.324 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG12 ' HB2' ' A' ' 125' ' ' PHE . 19.0 m -135.12 160.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.598 -0.728 . . . . 0.67000000000000004 109.235 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 28.6 m -130.51 111.85 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.407 -0.59 . . . . 0.65000000000000002 109.407 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.26 153.34 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.87 111.751 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -116.18 130.25 56.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 2.75 109.022 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 21.8 p90 -127.23 144.3 51.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.788 0.327 . . . . 0.76000000000000001 110.143 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -167.82 158.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.892 -0.781 . . . . 0.48999999999999999 108.892 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.67 -130.35 1.98 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.841 -1.171 . . . . 0.35999999999999999 113.05 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.744 ' HG3' HD13 ' A' ' 117' ' ' LEU . 57.2 pttt -157.38 173.07 17.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.377 . . . . 1.4299999999999999 110.682 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 66.7 tp -94.53 109.34 21.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 0.38 110.28 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' HD11 ' A' ' 117' ' ' LEU . 24.2 tt0 -68.43 -20.69 64.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.204 0.526 . . . . 1.96 110.091 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.445 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 39.7 t -55.1 -43.27 73.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.154 -0.93 . . . . 0.67000000000000004 111.328 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.459 HG22 HD23 ' A' ' 48' ' ' LEU . 8.8 t -124.38 3.31 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.72999999999999998 111.41 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.35 78.51 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 120.902 -0.666 . . . . 0.78000000000000003 113.039 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 67.0 mmtt -91.82 132.92 36.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 2.8900000000000001 110.917 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.661 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.8 p -75.84 166.84 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 0.58999999999999997 109.95 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.96 117.99 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.431 0.634 . . . . 0.78000000000000003 110.582 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.72 95.01 2.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.113 -0.949 . . . . 2.1800000000000002 109.42 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 m -137.4 171.2 14.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.933 0.397 . . . . 1.24 110.337 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -70.41 -33.7 71.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.15 -0.477 . . . . 1.49 110.9 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -92.33 -35.93 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.541 0.571 . . . . 1.8 112.541 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -33.77 74.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.819 0.342 . . . . 2.1899999999999999 111.544 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.71 -12.15 51.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.051 0.453 . . . . 2.7799999999999998 110.941 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -112.24 -61.04 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.129 -0.487 . . . . 1.1000000000000001 111.815 -172.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -119.25 104.09 46.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.598 -0.274 . . . . 2.0299999999999998 110.289 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.42 147.83 47.44 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.086 2.524 . . . . 1.76 112.035 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -101.99 150.39 23.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.295 -0.411 . . . . 1.3100000000000001 109.929 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.09 146.35 31.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 1.3600000000000001 109.792 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -127.59 -177.32 4.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.895 0.379 . . . . 0.56999999999999995 111.278 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -118.51 149.81 40.67 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.363 -0.606 . . . . 1.98 109.363 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 82' ' ' VAL . 15.9 tp -75.87 117.08 17.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.026 0.38 . . . . 0.94999999999999996 112.026 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 68.26 48.79 0.87 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.187 -0.915 . . . . 2.0800000000000001 112.395 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 1.3 pm0 -92.33 0.67 57.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.096 -0.705 . . . . 1.98 109.096 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.37 1.38 44.09 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.71999999999999997 113.091 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 7.9 mm-40 -99.04 -24.27 14.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.412 0.606 . . . . 0.96999999999999997 111.255 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.8 123.64 57.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.923 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.539 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -97.17 -62.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 0.62 112.293 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.626 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 8.7 mmpt? -129.2 -61.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 2.04 112.494 -172.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 -53.21 34.38 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.065 -0.588 . . . . 0.32000000000000001 113.459 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.572 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.0 m-90 -75.24 -37.12 61.17 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.841 -0.211 . . . . 0.48999999999999999 110.644 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.75 -52.09 57.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.826 0.703 . . . . 1.1399999999999999 111.685 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.576 HG21 HG21 ' A' ' 13' ' ' THR . 2.4 mp -74.26 -41.89 50.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 0.78000000000000003 110.995 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.51 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 44.6 t -60.33 -51.03 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.55000000000000004 111.589 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 69' ' ' LEU . 28.6 m -67.69 -43.1 86.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 111.975 0.361 . . . . 0.83999999999999997 111.975 -174.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.429 ' OG ' HD21 ' A' ' 69' ' ' LEU . 21.6 m -70.16 -14.92 62.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.028 0.442 . . . . 1.4299999999999999 111.463 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -99.46 24.95 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.367 -0.379 . . . . 1.23 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.592 ' HE1' ' HA ' ' A' ' 82' ' ' VAL . 37.2 mtm -118.83 -173.58 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.215 0.531 . . . . 2.27 111.214 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.498 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 53.5 mtm180 -142.2 175.46 9.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.155 -0.93 . . . . 4.1900000000000004 109.271 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -62.31 -16.88 56.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.563 0.579 . . . . 1.9399999999999999 112.563 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -135.32 29.4 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 1.23 110.747 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 4.5 tt0 -113.91 153.95 28.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.527 -0.546 . . . . 1.6000000000000001 109.527 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.545 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 1.5 tmtp? -143.58 127.49 17.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.972 -0.291 . . . . 1.1699999999999999 110.955 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 71.2 m -127.61 151.45 48.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.222 -0.445 . . . . 1.2 111.425 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.457 ' HB2' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -107.29 118.96 38.1 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.151 -0.685 . . . . 1.73 109.151 173.01 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.2 p -109.7 141.89 23.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.243 0.544 . . . . 0.73999999999999999 111.43 -173.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -99.29 117.44 33.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 1.71 109.88 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.9 mp -96.92 104.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.462 . . . . 0.52000000000000002 109.751 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 97' ' ' SER . 28.9 tt0 -83.76 170.87 13.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.787 -0.82 . . . . 1.3700000000000001 108.787 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 9.5 p -49.6 -49.9 44.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.526 0.33 . . . . 1.0 111.85 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.9 ptp -76.61 -13.5 60.06 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.236 -0.438 . . . . 1.79 111.635 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 16.1 m-30 -84.54 -5.84 59.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.871 0.367 . . . . 0.75 110.149 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -138.39 -161.2 8.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.55 -0.75 . . . . 0.70999999999999996 111.52 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -92.89 30.43 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 1.52 110.975 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.8 -31.94 82.58 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.045 -0.525 . . . . 2.2999999999999998 112.313 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.16 -35.53 75.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.151 0.5 . . . . 5.8600000000000003 110.738 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.51 -40.5 12.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.569 -0.741 . . . . 4.2699999999999996 110.533 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.99 15.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.781 -0.723 . . . . 2.1600000000000001 112.494 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -74.09 108.71 7.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.099 0.476 . . . . 3.3399999999999999 110.865 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -137.95 137.02 8.53 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.773 -0.649 . . . . 1.2 111.768 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -71.44 -46.35 60.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.925 0.393 . . . . 3.0800000000000001 110.988 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 t -110.99 -73.75 0.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.673 -0.491 . . . . 1.52 109.673 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -143.21 117.0 6.13 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.75 110.452 176.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 7.0 Cg_endo -80.56 -68.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.015 1.81 . . . . 1.5800000000000001 111.717 170.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.87 1.25 17.2 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.176 -0.466 . . . . 2.0499999999999998 113.409 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 m120 60.88 27.71 17.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.192 0.52 . . . . 2.0299999999999998 110.917 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -119.7 -163.69 1.01 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.896 -0.593 . . . . 1.1399999999999999 110.307 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 7.6 p -108.17 130.05 61.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.309 0.576 . . . . 0.47999999999999998 111.775 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -112.94 161.89 16.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 109.79 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.744 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.28 116.82 28.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.494 -0.558 . . . . 0.69999999999999996 109.494 175.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.425 ' HD2' HD13 ' A' ' 95' ' ' ILE . 29.4 m-85 -113.87 125.0 53.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 0.42999999999999999 111.045 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 47.9 mt-10 -80.13 113.96 18.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.463 -0.789 . . . . 1.46 109.081 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.599 HG21 HG12 ' A' ' 82' ' ' VAL . 40.0 mt -107.93 123.94 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.028 0.442 . . . . 0.47999999999999998 110.352 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 18.3 mt-10 -127.87 130.33 48.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.646 -0.706 . . . . 1.8799999999999999 109.875 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 34' ' ' PRO . 25.6 tp -91.82 100.4 13.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 1.1200000000000001 110.341 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.5 OUTLIER -89.74 -30.2 18.19 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.082 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.454 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 58.0 m -150.41 147.76 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.436 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' HB2' HG12 ' A' ' 40' ' ' VAL . 2.0 p90 -165.05 159.62 18.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.71999999999999997 109.352 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 126' ' ' ARG . 2.3 ptm180 -158.63 113.72 2.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.95 0.405 . . . . 2.98 111.352 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.16 139.92 30.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.363 -0.38 . . . . 3.3799999999999999 110.758 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.3 mt -140.3 52.88 1.65 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.572 -0.74 . . . . 3.3500000000000001 109.761 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.814 ' HB3' ' HE1' ' A' ' 132' ' ' HIS . 1.0 OUTLIER 76.27 -176.13 0.12 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.919 0.762 . . . . 5.3899999999999997 110.02 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -123.76 -49.28 1.88 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.842 0.682 . . . . 7.04 112.842 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -126.93 100.91 6.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 7.21 111.72 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.814 ' HE1' ' HB3' ' A' ' 129' ' ' GLU . 15.1 m-70 -91.14 67.24 5.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.2 -0.454 . . . . 9.0199999999999996 110.157 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 24.6 m80 52.74 67.42 0.99 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.552 0.532 . . . . 9.75 111.636 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.7 134.09 20.74 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.689 -0.486 . . . . 12.26 109.689 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.369 -0.824 . . . . 13.35 110.438 -175.106 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.402 -0.221 . . . . 7.4800000000000004 110.402 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.1 p -72.22 99.09 2.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.998 0.427 . . . . 5.9000000000000004 110.256 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -112.36 113.27 25.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 4.4400000000000004 111.98 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.72 150.68 22.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.817 -0.629 . . . . 4.4400000000000004 109.512 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -75.61 125.38 28.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.918 0.39 . . . . 4.1500000000000004 111.603 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -84.38 104.47 14.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 3.6099999999999999 109.999 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.15 136.68 54.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.267 0.556 . . . . 3.6000000000000001 111.036 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.85 143.07 42.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 2.71 110.447 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.18 136.27 47.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 1.8799999999999999 109.84 -174.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.6 107.65 23.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.601 -0.518 . . . . 0.58999999999999997 109.601 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HB2' HD12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -102.58 134.95 45.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.138 -0.483 . . . . 2.1600000000000001 111.462 -176.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt 56.64 51.74 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.248 -0.887 . . . . 1.45 112.493 171.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -61.29 153.65 25.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.275 -0.42 . . . . 0.78000000000000003 110.117 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.9 1.07 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.688 0.625 . . . . 0.81000000000000005 112.688 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.64 24.81 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 2.3999999999999999 111.264 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.47 10.42 5.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.378 -0.915 . . . . 0.68000000000000005 114.011 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 57.75 67.14 2.36 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.892 0.717 . . . . 0.60999999999999999 114.892 170.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG21 ' HB ' ' A' ' 80' ' ' ILE . 25.6 t -116.83 139.21 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 122.285 -0.538 . . . . 0.48999999999999999 110.58 173.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 94' ' ' ARG . 5.6 mm -88.18 109.34 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.214 -0.661 . . . . 0.46999999999999997 109.214 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -125.66 146.23 49.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.393 0.616 . . . . 1.3400000000000001 111.222 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 m -114.07 121.43 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.419 -0.81 . . . . 0.5 109.603 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.522 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 tp -72.43 125.96 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.883 0.373 . . . . 0.67000000000000004 111.565 -174.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.03 -63.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.17 0.509 . . . . 0.82999999999999996 109.954 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 50.7 mtmt -117.6 134.9 54.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 1.5600000000000001 108.981 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -102.99 139.46 38.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.754 0.311 . . . . 2.9500000000000002 110.985 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 134.26 12.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.77 -0.729 . . . . 1.3200000000000001 111.718 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.9 -65.32 1.02 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.827 -0.435 . . . . 2.77 109.827 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -96.0 144.17 26.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.0 -0.545 . . . . 2.6400000000000001 109.548 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.556 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -154.34 14.54 0.55 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.547 -0.835 . . . . 1.04 111.852 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.21 -21.05 62.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 2.29 110.406 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' C ' HD22 ' A' ' 32' ' ' ASN . 47.4 mt-10 -115.18 14.49 16.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.773 -0.649 . . . . 2.6400000000000001 109.927 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.556 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -138.78 80.86 1.81 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.083 -0.508 . . . . 1.45 111.4 -172.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.82 113.03 27.0 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.223 0.535 . . . . 0.81000000000000005 111.923 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.2 Cg_endo -91.04 111.08 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.963 2.442 . . . . 0.75 112.384 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 27.9 mmtp -136.64 -173.68 3.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.6600000000000001 110.951 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.36 152.94 20.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 2.5099999999999998 110.726 -176.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.27 -5.19 38.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.744 . . . . 1.1200000000000001 111.904 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' HG13 ' A' ' 40' ' ' VAL . 31.4 p30 -135.24 -175.77 4.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.74 0.305 . . . . 1.3799999999999999 110.513 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -96.99 94.21 7.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 2.2000000000000002 110.743 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 ' OD1' ' A' ' 38' ' ' ASN . 9.6 m -97.85 122.22 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.903 -0.777 . . . . 0.67000000000000004 108.903 168.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.542 HG23 ' HD3' ' A' ' 66' ' ' LYS . 27.0 m -96.72 111.42 23.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.198 0.523 . . . . 0.65000000000000002 109.96 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 120' ' ' ILE . 54.1 t -117.24 130.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.499 -0.773 . . . . 0.87 110.329 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -101.79 127.96 48.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.204 -0.665 . . . . 2.75 109.204 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 6.6 p90 -128.23 144.5 51.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 0.76000000000000001 111.105 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -166.38 144.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.557 -0.747 . . . . 0.48999999999999999 109.841 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 118' ' ' PHE . . . -171.02 -139.91 2.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.613 -0.803 . . . . 0.35999999999999999 112.135 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 64.7 pttt -157.69 172.3 18.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 1.4299999999999999 110.886 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 114' ' ' SER . 60.7 tp -85.55 101.15 12.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.046 -0.525 . . . . 0.38 110.539 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 40.8 tt0 -68.42 -25.87 65.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.771 0.319 . . . . 1.96 110.935 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -54.38 -27.1 34.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 0.67000000000000004 111.543 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.576 HG23 ' HB2' ' A' ' 53' ' ' LYS . 14.8 t -139.18 9.05 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.051 0.453 . . . . 0.72999999999999998 110.482 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.13 41.59 98.18 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.635 -0.711 . . . . 0.78000000000000003 112.755 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.576 ' HB2' HG23 ' A' ' 51' ' ' THR . 4.3 tmtt? -102.83 118.34 36.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 2.8900000000000001 110.29 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.7 p -74.1 160.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.58999999999999997 109.856 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 13.0 m-30 -78.0 124.58 28.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 111.083 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.95 88.27 2.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.854 0.835 . . . . 2.1800000000000002 109.306 171.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.8 m -136.48 172.97 12.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.596 -0.729 . . . . 1.24 111.19 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -71.6 -23.83 61.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.79 -0.641 . . . . 1.49 110.865 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -93.83 -51.1 5.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.147 0.795 . . . . 1.8 113.147 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.8 -43.23 85.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.335 0.397 . . . . 2.1899999999999999 111.996 -168.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -92.22 9.34 34.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.928 0.394 . . . . 2.7799999999999998 111.602 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -115.7 -64.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.283 -0.417 . . . . 1.1000000000000001 111.597 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.8 m -105.01 127.56 28.48 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.384 0.611 . . . . 2.0299999999999998 111.997 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.5 Cg_endo -83.44 111.29 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.956 2.437 . . . . 1.76 111.511 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -94.72 154.57 17.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 1.3100000000000001 110.888 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.542 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.7 pptp? -142.44 157.48 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.942 -0.572 . . . . 1.3600000000000001 110.01 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.09 172.65 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.56999999999999995 110.912 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -122.47 150.3 42.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.813 -0.63 . . . . 1.98 109.641 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.505 HD22 HG23 ' A' ' 82' ' ' VAL . 35.2 tp -71.38 136.29 47.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.792 0.33 . . . . 0.94999999999999996 111.528 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 36.1 mt-10 51.69 37.72 20.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.57 -0.741 . . . . 2.0800000000000001 112.205 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.463 HE21 ' HB2' ' A' ' 73' ' ' GLU . 13.8 pt20 -77.49 -8.28 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.359 0.599 . . . . 1.98 109.597 169.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.21 46.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.71999999999999997 112.845 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' HE21 ' A' ' 71' ' ' GLN . 10.1 mm-40 -84.0 -21.92 31.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.883 0.342 . . . . 0.96999999999999997 110.754 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 m -113.61 135.11 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.57999999999999996 110.379 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.02 -61.29 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.083 0.772 . . . . 0.62 113.083 -172.478 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.3 mmpt? -143.18 -44.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.957 0.725 . . . . 2.04 112.957 -171.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.03 -53.0 36.14 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.651 -0.785 . . . . 0.32000000000000001 112.684 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.448 ' O ' HG22 ' A' ' 82' ' ' VAL . 4.2 m-90 -75.94 -30.94 58.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.853 0.359 . . . . 0.48999999999999999 110.501 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 21.7 t70 -52.24 -54.3 32.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.169 -0.923 . . . . 1.1399999999999999 112.148 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.544 ' HB ' HG21 ' A' ' 18' ' ' VAL . 2.8 mp -75.38 -42.31 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.78000000000000003 110.985 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.577 ' O ' ' HG2' ' A' ' 85' ' ' MET . 20.7 t -56.99 -47.34 81.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.55000000000000004 111.182 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.505 HG23 HD22 ' A' ' 69' ' ' LEU . 27.1 m -72.91 -32.21 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 123.0 0.188 . . . . 0.83999999999999997 110.979 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 66.2 m -65.79 -23.3 66.68 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.436 0.636 . . . . 1.4299999999999999 110.869 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -112.25 46.4 1.17 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 1.23 110.455 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.928 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.6 mmt -125.41 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.281 0.562 . . . . 2.27 111.226 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.966 ' HD3' ' H ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -155.25 160.69 41.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.056 -1.09 . . . . 4.1900000000000004 108.056 174.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -46.97 -38.27 10.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.461 0.541 . . . . 1.9399999999999999 112.461 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.966 ' H ' ' HD3' ' A' ' 86' ' ' ARG . 16.5 m120 -109.54 6.24 23.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 1.23 111.122 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 30.6 tt0 -105.38 140.85 37.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.161 -0.681 . . . . 1.6000000000000001 109.161 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.5 tttt -146.93 135.92 22.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.266 -0.424 . . . . 1.1699999999999999 110.728 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 22' ' ' ILE . 83.9 m -136.06 159.19 42.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.234 0.54 . . . . 1.2 110.825 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 117' ' ' LEU . 1.8 tp -91.34 142.18 27.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.25 -1.018 . . . . 1.73 108.25 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.97 135.48 52.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 O-C-N 123.366 0.416 . . . . 0.73999999999999999 110.36 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -107.28 111.86 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.638 -0.505 . . . . 1.71 109.638 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -96.4 107.1 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.898 -0.408 . . . . 0.52000000000000002 109.898 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.651 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 9.7 tt0 -85.43 177.41 7.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.107 -0.701 . . . . 1.3700000000000001 109.107 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -57.32 -37.29 72.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.4 ptp -77.62 -9.73 59.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.182 0.438 . . . . 1.79 112.182 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.7 m-85 -103.62 6.33 37.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.017 -0.273 . . . . 0.75 111.037 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.71 174.92 16.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.952 -0.642 . . . . 0.70999999999999996 112.468 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.438 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 50.4 m-85 -81.05 -6.9 59.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.941 0.401 . . . . 1.52 111.183 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.51 -149.68 51.51 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.577 -0.82 . . . . 2.2999999999999998 111.655 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.35 -6.52 57.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 5.8600000000000003 111.265 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -84.48 -46.14 11.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.309 -0.405 . . . . 4.2699999999999996 111.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -84.47 170.41 46.47 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.634 -0.793 . . . . 2.1600000000000001 112.323 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -82.08 95.06 7.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.108 0.48 . . . . 3.3399999999999999 110.484 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.538 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -68.34 152.79 52.67 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.68 -0.691 . . . . 1.2 112.347 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -71.71 -58.71 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.377 0.14 . . . . 3.0800000000000001 111.377 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -108.22 -75.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.631 -0.428 . . . . 1.52 111.33 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.407 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -148.23 104.16 3.56 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.75 111.225 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.538 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 50.4 Cg_endo -97.42 179.89 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.076 2.517 . . . . 1.5800000000000001 112.274 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.61 66.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.267 -0.968 . . . . 2.0499999999999998 113.187 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 m120 55.48 23.84 6.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.954 0.406 . . . . 2.0299999999999998 111.835 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.579 ' HB3' HD11 ' A' ' 48' ' ' LEU . 30.1 m -110.03 150.71 28.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.942 -0.572 . . . . 1.1399999999999999 110.003 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.17 130.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.47999999999999998 110.206 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.433 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.6 mp -123.34 151.45 42.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.063 -0.517 . . . . 0.51000000000000001 110.411 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -128.22 125.54 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.497 . . . . 0.69999999999999996 110.926 177.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.444 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 46.1 m-85 -126.14 153.22 44.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.745 -0.661 . . . . 0.42999999999999999 110.221 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.578 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 42.7 mt-10 -85.46 126.88 34.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.279 -0.638 . . . . 1.46 109.279 170.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.481 HG23 HG11 ' A' ' 42' ' ' VAL . 10.6 mt -108.58 118.18 55.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 0.47999999999999998 109.865 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 45.2 tt0 -132.96 132.29 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 1.8799999999999999 110.24 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.21 115.7 28.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 1.1200000000000001 110.678 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.31 -21.4 13.84 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.757 -0.377 . . . . 1.0 112.016 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.507 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 29.3 t -155.63 149.61 25.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.003 -0.279 . . . . 1.1899999999999999 110.393 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -168.19 172.66 8.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 0.71999999999999997 110.036 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -161.04 126.38 3.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 2.98 110.177 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -89.4 139.09 30.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 3.3799999999999999 111.536 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 39.8 tp -99.92 -6.39 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.488 -0.778 . . . . 3.3500000000000001 110.786 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.67 158.87 0.21 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.524 -0.762 . . . . 5.3899999999999997 111.967 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -62.56 126.27 26.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.333 -0.848 . . . . 7.04 110.969 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -101.67 -21.6 14.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.414 -0.812 . . . . 7.21 111.305 -171.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -84.58 135.12 34.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.838 -0.43 . . . . 9.0199999999999996 109.838 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -100.74 129.23 46.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.967 0.413 . . . . 9.75 111.212 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -93.32 -28.24 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.649 -0.871 . . . . 12.26 108.649 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 . . . . . 0 C--O 1.242 0.692 0 CA-C-N 114.79 -1.095 . . . . 13.35 108.987 177.701 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.81 0.338 . . . . 7.4800000000000004 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 p -129.81 -49.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.78 0.324 . . . . 5.9000000000000004 110.158 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m 57.94 78.34 0.24 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.761 0.791 . . . . 4.4400000000000004 110.475 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -107.68 175.5 5.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.982 -1.008 . . . . 4.4400000000000004 110.061 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -68.14 101.83 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.523 . . . . 4.1500000000000004 110.438 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.56 46.08 1.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.61 -0.723 . . . . 3.6099999999999999 110.063 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -113.03 144.74 42.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.474 . . . . 3.6000000000000001 110.887 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.39 157.07 17.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.51 0.672 . . . . 2.71 110.609 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -103.0 148.26 25.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.789 -1.096 . . . . 1.8799999999999999 111.052 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.41 106.92 20.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.58999999999999997 109.495 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 7.4 pt-20 -78.85 113.35 16.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.803 -0.635 . . . . 2.1600000000000001 111.542 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.47 ' H ' HD13 ' A' ' 19' ' ' ILE . 17.2 tp 58.25 65.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 1.45 111.215 169.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 t -61.73 144.9 53.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 0.78000000000000003 110.076 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 0.72 7.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.95 0.352 . . . . 0.81000000000000005 111.95 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.48 25.73 1.01 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.532 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.09 2.64 9.16 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.68000000000000005 113.92 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.47 78.28 0.61 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.072 -0.585 . . . . 0.60999999999999999 114.169 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 80' ' ' ILE . 53.7 t -140.78 143.82 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.935 -0.394 . . . . 0.48999999999999999 109.935 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 17.9 mm -86.27 116.31 28.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.595 -0.52 . . . . 0.46999999999999997 109.595 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -138.19 144.34 40.64 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.507 -0.477 . . . . 1.3400000000000001 111.464 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 6.8 m -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.916 -0.583 . . . . 0.5 109.864 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.5 tp -84.82 118.91 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.67000000000000004 110.585 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.18 -70.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.82999999999999996 110.605 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 36.9 ttpt -109.7 116.33 31.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.519 -0.31 . . . . 1.5600000000000001 110.531 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.55 137.62 42.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.033 -0.531 . . . . 2.9500000000000002 110.171 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.44 162.35 54.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.735 -0.745 . . . . 1.3200000000000001 112.309 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.76 -68.26 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 2.77 110.74 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.37 132.61 15.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.095 0.474 . . . . 2.6400000000000001 109.781 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.08 33.33 0.94 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.498 -0.858 . . . . 1.04 111.492 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.26 -28.93 70.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.24 0.543 . . . . 2.29 110.402 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -94.88 -4.75 46.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.332 -0.849 . . . . 2.6400000000000001 110.381 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -138.81 91.46 2.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.051 0.453 . . . . 1.45 111.259 -173.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.09 123.98 28.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.81000000000000005 110.776 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 43.0 Cg_endo -69.96 92.54 0.53 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.644 2.229 . . . . 0.75 111.807 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 53.5 mmtt -94.7 146.53 24.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.365 0.602 . . . . 2.6600000000000001 112.261 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -71.99 124.54 25.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.933 -1.031 . . . . 2.5099999999999998 110.0 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.89 -9.24 43.49 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.422 -0.671 . . . . 1.1200000000000001 111.422 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -101.09 154.65 18.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.343 . . . . 1.3799999999999999 110.219 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -79.3 106.21 11.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.329 0.585 . . . . 2.2000000000000002 111.123 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' HIS . 3.1 m -121.68 152.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.843 -0.799 . . . . 0.67000000000000004 108.843 174.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.2 m -117.75 119.42 34.86 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.651 -0.5 . . . . 0.65000000000000002 109.651 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.549 HG11 HG23 ' A' ' 120' ' ' ILE . 90.3 t -131.82 144.06 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.999 -0.546 . . . . 0.87 110.764 -174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.468 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 24.5 m80 -99.96 145.29 28.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.044 -0.354 . . . . 2.75 110.044 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 29.2 p90 -143.06 130.63 21.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.055 0.455 . . . . 0.76000000000000001 110.934 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.57 159.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.224 -0.658 . . . . 0.48999999999999999 109.224 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.41 -121.0 0.7 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.041 -1.076 . . . . 0.35999999999999999 112.751 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 50.1 pttt -150.9 168.06 25.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.666 0.27 . . . . 1.4299999999999999 110.505 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' HG ' ' A' ' 116' ' ' LEU . 57.3 tp -85.02 98.37 10.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.031 -0.729 . . . . 0.38 109.031 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 50.0 tp10 -62.55 -26.94 68.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 1.96 112.381 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 4.4 t -63.17 -18.56 63.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 0.67000000000000004 111.279 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -129.63 -26.12 2.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.034 0.445 . . . . 0.72999999999999998 110.767 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.44 35.64 10.4 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.369 -0.443 . . . . 0.78000000000000003 112.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.38 128.86 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.715 0.293 . . . . 2.8900000000000001 110.362 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.8 p -71.77 158.35 6.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.58999999999999997 109.78 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 21.7 m-85 -73.93 98.49 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.315 0.579 . . . . 0.78000000000000003 111.784 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.72 86.15 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.13 -1.063 . . . . 2.1800000000000002 108.13 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -136.54 164.47 28.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.811 -0.631 . . . . 1.24 110.571 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -57.97 -45.76 86.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 1.49 112.046 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -93.32 -45.45 7.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.012 0.434 . . . . 1.8 110.943 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -34.49 58.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.122 -0.944 . . . . 2.1899999999999999 111.655 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 61' ' ' ARG . 6.1 ptm85 -77.52 -22.88 50.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 2.7799999999999998 111.801 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -100.66 -52.79 3.24 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.818 -0.353 . . . . 1.1000000000000001 110.942 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.26 108.77 6.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.996 0.427 . . . . 2.0299999999999998 111.698 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.7 153.34 56.61 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.553 2.169 . . . . 1.76 110.547 173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -93.47 149.14 21.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.007 0.432 . . . . 1.3100000000000001 110.515 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 3.0 pptp? -123.12 142.67 50.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.794 -0.639 . . . . 1.3600000000000001 109.587 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -128.86 171.42 12.3 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.985 0.421 . . . . 0.56999999999999995 110.999 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 98.0 m-70 -112.22 145.94 39.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.464 -0.789 . . . . 1.98 109.113 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 36' ' ' LYS . 16.6 tp -72.62 120.42 18.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.315 0.579 . . . . 0.94999999999999996 110.371 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 66.56 54.59 0.86 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.447 -1.251 . . . . 2.0800000000000001 111.077 -176.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.444 HE21 ' HB2' ' A' ' 73' ' ' GLU . 12.2 pt20 -96.07 10.01 38.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 1.98 109.414 169.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.07 -12.18 62.93 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.422 -0.808 . . . . 0.71999999999999997 112.801 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HB2' HE21 ' A' ' 71' ' ' GLN . 13.3 mm-40 -96.18 -10.16 28.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.712 0.291 . . . . 0.96999999999999997 111.279 -174.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.07 125.11 67.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.006 0.431 . . . . 0.57999999999999996 110.713 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.762 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -95.78 -59.13 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.921 0.711 . . . . 0.62 112.921 -173.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 75' ' ' ILE . 6.6 mmpt? -140.0 -61.06 0.53 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.094 -0.378 . . . . 2.04 111.401 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.42 -52.79 35.12 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.953 -0.567 . . . . 0.32000000000000001 113.656 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.6 m-90 -74.98 -44.78 46.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.975 0.387 . . . . 0.48999999999999999 110.738 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -51.61 -51.83 52.48 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.039 0.837 . . . . 1.1399999999999999 111.933 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.513 ' HB ' HG21 ' A' ' 18' ' ' VAL . 2.1 mp -75.05 -38.64 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 0.78000000000000003 110.972 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.701 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 34.3 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.55000000000000004 110.68 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 78' ' ' TRP . 34.7 m -67.74 -32.64 57.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.738 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.0 t -62.38 -32.73 73.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.4299999999999999 110.886 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.7 t -96.09 31.18 2.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.141 -0.481 . . . . 1.23 110.627 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.579 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mmt -110.42 -173.33 2.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.386 0.613 . . . . 2.27 111.609 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 6.4 ttm180 -139.76 168.46 19.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.878 -1.156 . . . . 4.1900000000000004 107.878 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.0 -35.18 70.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.338 . . . . 1.9399999999999999 111.392 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -122.2 31.98 5.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 1.23 110.862 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 23.6 tt0 -122.36 143.98 49.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.308 -0.405 . . . . 1.6000000000000001 110.452 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.87 137.9 35.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.716 0.293 . . . . 1.1699999999999999 110.529 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' THR . 27.5 p -141.22 171.37 14.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 1.2 111.194 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.09 123.05 49.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.68 . . . . 1.73 109.533 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.701 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.0 p -99.92 137.48 27.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.255 0.55 . . . . 0.73999999999999999 110.8 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 55.2 mmt-85 -91.11 112.38 24.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.633 -0.712 . . . . 1.71 110.086 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.491 HD11 HG13 ' A' ' 93' ' ' VAL . 2.9 mp -93.7 100.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.368 -0.604 . . . . 0.52000000000000002 109.368 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 97' ' ' SER . 29.6 tt0 -81.05 170.25 16.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.484 -0.932 . . . . 1.3700000000000001 108.484 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.517 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 8.7 p -51.4 -44.13 62.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.767 0.284 . . . . 1.0 111.767 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.6 ptp -77.56 -8.43 57.81 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.128 0.418 . . . . 1.79 112.128 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -103.88 -11.86 17.24 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 122.267 -0.271 . . . . 0.75 110.941 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.06 164.61 17.12 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.734 -0.746 . . . . 0.70999999999999996 113.24 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.49 94.08 8.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.995 -0.372 . . . . 1.52 109.995 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.33 62.16 0.37 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.506 -0.854 . . . . 2.2999999999999998 112.695 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 97' ' ' SER . 17.8 t70 -69.71 -30.21 67.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 5.8600000000000003 110.438 174.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.55 -46.43 86.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.346 -0.843 . . . . 4.2699999999999996 111.477 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -168.14 -128.04 0.96 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.391 -0.909 . . . . 2.1600000000000001 112.538 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.706 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 81.4 m -87.69 149.05 24.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.956 0.408 . . . . 3.3399999999999999 111.073 -175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.14 -101.74 0.33 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.297 -0.721 . . . . 1.2 111.297 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.63 -71.93 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.687 0.28 . . . . 3.0800000000000001 110.77 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -111.55 -75.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.52 110.666 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.03 83.66 4.22 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-O 120.814 0.34 . . . . 0.75 111.844 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.706 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 52.1 Cg_endo -98.54 -160.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.228 2.618 . . . . 1.5800000000000001 111.457 171.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.38 91.48 2.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 2.0499999999999998 113.189 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.4 m120 56.66 27.13 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 2.0299999999999998 111.738 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 9.7 p -133.93 171.04 14.72 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.633 -0.258 . . . . 1.1399999999999999 110.875 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.24 133.43 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.198 0.523 . . . . 0.47999999999999998 110.348 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.6 mp -122.38 169.6 10.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.51000000000000001 109.699 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -147.42 133.8 19.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.061 0.457 . . . . 0.69999999999999996 110.596 172.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 39.9 m-85 -122.41 142.29 50.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.89 -0.595 . . . . 0.42999999999999999 109.616 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 32.5 mt-10 -74.18 122.97 23.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.724 -0.843 . . . . 1.46 108.724 171.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.549 HG23 HG11 ' A' ' 42' ' ' VAL . 8.1 mt -105.95 115.42 47.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.422 0.63 . . . . 0.47999999999999998 109.739 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.08 116.59 17.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.098 -0.955 . . . . 1.8799999999999999 110.284 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 123' ' ' LEU . 6.8 tt -87.12 133.71 33.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 1.1200000000000001 109.219 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 122' ' ' LEU . 1.1 pt? -117.1 -43.96 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.786 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.9 t -140.78 140.87 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.783 -0.451 . . . . 1.1899999999999999 109.783 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.584 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -167.04 177.57 6.21 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.174 0.297 . . . . 0.71999999999999997 110.6 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -157.49 150.72 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 2.98 111.051 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.21 116.84 31.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.582 -0.525 . . . . 3.3799999999999999 109.582 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 31.9 tp -150.62 157.69 43.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 3.3500000000000001 110.581 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.57 137.02 32.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 5.3899999999999997 110.953 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -83.91 53.28 2.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.126 -1.064 . . . . 7.04 108.126 165.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -79.53 53.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.348 -1.297 . . . . 7.21 110.286 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 63.63 -168.71 0.2 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.007 -0.542 . . . . 9.0199999999999996 110.924 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.01 158.78 19.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.138 -0.689 . . . . 9.75 109.138 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -169.36 169.66 8.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.503 -0.317 . . . . 12.26 110.188 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 . . . . . 0 C--O 1.245 0.864 0 N-CA-C 109.244 -0.651 . . . . 13.35 109.244 176.603 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.421 0.153 . . . . 7.4800000000000004 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 t -71.9 111.85 7.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.585 . . . . 5.9000000000000004 109.422 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.28 10.37 15.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.141 0.496 . . . . 4.4400000000000004 111.181 -172.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -105.25 124.12 49.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.879 -0.6 . . . . 4.4400000000000004 110.367 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -59.62 130.08 45.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 4.1500000000000004 109.834 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.67 84.76 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.157 0.503 . . . . 3.6099999999999999 111.24 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -141.57 163.13 33.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 3.6000000000000001 109.607 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.34 148.83 29.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.11 0.481 . . . . 2.71 110.878 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.7 mppt? -91.96 143.17 26.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 110.283 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' A' ' 13' ' ' THR . 5.1 t -108.94 108.55 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 110.054 -0.35 . . . . 0.58999999999999997 110.054 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.81 128.92 43.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.1600000000000001 110.974 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 19' ' ' ILE . 13.5 tp 55.76 46.26 22.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.689 0.757 . . . . 1.45 110.113 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.5 t -63.84 164.04 10.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.868 -1.06 . . . . 0.78000000000000003 111.532 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.66 1.37 8.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.81000000000000005 111.253 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' O ' HG13 ' A' ' 80' ' ' ILE . 25.9 m-20 -80.65 14.19 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 2.3999999999999999 111.054 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.27 9.39 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.52 -0.847 . . . . 0.68000000000000005 113.598 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.25 64.07 1.81 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.803 -0.713 . . . . 0.60999999999999999 114.045 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.555 ' HB ' HG21 ' A' ' 80' ' ' ILE . 3.3 t -145.35 154.23 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.894 -0.41 . . . . 0.48999999999999999 109.894 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 12' ' ' LEU . 4.7 mm -85.24 109.65 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.243 -0.28 . . . . 0.46999999999999997 110.243 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HE3' HG21 ' A' ' 13' ' ' THR . 21.6 pttp -132.61 142.65 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.3400000000000001 111.181 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -110.8 140.87 44.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.476 -0.784 . . . . 0.5 110.246 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' C ' HD22 ' A' ' 23' ' ' LEU . 7.6 tp -86.44 130.3 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.422 -0.354 . . . . 0.67000000000000004 110.369 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 22' ' ' ILE . 3.5 mm? -132.72 -69.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.455 0.645 . . . . 0.82999999999999996 110.515 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 80.7 tttt -91.5 97.66 11.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.41 -0.814 . . . . 1.5600000000000001 109.53 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -73.74 127.29 32.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.068 -0.969 . . . . 2.9500000000000002 110.21 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.7 -148.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.09 -0.505 . . . . 1.3200000000000001 113.33 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.5 -167.84 2.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.463 -0.94 . . . . 2.77 108.463 -172.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -85.46 127.3 34.35 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.739 -0.467 . . . . 2.6400000000000001 109.739 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -168.39 75.37 0.12 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.108 -0.797 . . . . 1.04 111.108 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.44 -32.99 69.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.749 0.278 . . . . 2.29 111.749 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.72 0.38 56.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.272 0.558 . . . . 2.6400000000000001 110.579 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.406 ' HA ' ' HZ ' ' A' ' 125' ' ' PHE . 6.5 m-20 -105.5 79.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 1.45 110.877 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.8 mm -131.37 122.04 18.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.81000000000000005 110.909 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 69.6 Cg_endo -77.55 126.56 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.689 2.259 . . . . 0.75 112.023 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 27.1 mmtp -132.92 161.92 32.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.905 0.383 . . . . 2.6600000000000001 110.77 177.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -71.77 150.21 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.969 -0.559 . . . . 2.5099999999999998 111.882 -172.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.43 -23.03 29.69 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.722 -0.672 . . . . 1.1200000000000001 111.799 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.447 ' OD1' ' HG ' ' A' ' 128' ' ' LEU . 85.1 m-20 -86.66 153.41 21.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.003 0.43 . . . . 1.3799999999999999 110.968 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 51.0 mt-10 -79.0 95.39 5.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.016 -0.538 . . . . 2.2000000000000002 110.481 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG21 HD23 ' A' ' 69' ' ' LEU . 19.9 m -102.87 151.08 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.6 -0.519 . . . . 0.67000000000000004 109.6 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -111.95 106.51 15.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.167 -0.679 . . . . 0.65000000000000002 109.167 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -126.33 138.99 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.87 110.863 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 22.3 m-70 -104.16 142.91 33.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.521 -0.548 . . . . 2.75 109.521 172.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.5 p90 -137.15 139.52 41.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 0.76000000000000001 110.021 175.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.11 154.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 0.48999999999999999 109.146 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 179.77 -134.6 2.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.878 -1.153 . . . . 0.35999999999999999 112.98 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 117' ' ' LEU . 22.8 pttp -151.68 171.33 17.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.032 0.444 . . . . 1.4299999999999999 110.671 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 114' ' ' SER . 61.3 tp -85.58 107.38 17.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.621 . . . . 0.38 109.758 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.6 tp10 -68.05 -31.19 70.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.031 0.443 . . . . 1.96 110.81 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 t -54.3 -43.04 70.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.342 -0.844 . . . . 0.67000000000000004 112.05 -173.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.498 HG22 HD23 ' A' ' 48' ' ' LEU . 15.4 t -119.96 -10.97 9.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.72999999999999998 110.604 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 56.12 3.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.892 -0.671 . . . . 0.78000000000000003 111.648 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -125.03 130.02 51.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.175 -0.305 . . . . 2.8900000000000001 110.175 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.2 156.87 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.114 -0.328 . . . . 0.58999999999999997 110.114 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -74.6 99.33 3.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.386 . . . . 0.78000000000000003 111.763 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.83 91.84 3.82 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.485 -0.932 . . . . 2.1800000000000002 108.485 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 28.7 t -137.59 148.3 45.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.46 -0.791 . . . . 1.24 109.985 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -53.8 -42.49 68.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.312 0.486 . . . . 1.49 112.312 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -84.84 -46.15 11.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 1.8 110.692 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -36.82 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 2.1899999999999999 111.629 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' SER . 14.8 ptm180 -81.56 4.11 22.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.697 0.284 . . . . 2.7799999999999998 111.542 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -121.29 -60.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.645 -0.252 . . . . 1.1000000000000001 110.702 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 5.3 m -133.32 133.7 23.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.692 0.282 . . . . 2.0299999999999998 111.598 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.0 Cg_exo -77.3 163.35 30.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.838 2.359 . . . . 1.76 111.869 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -103.87 154.74 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.427 -0.351 . . . . 1.3100000000000001 110.302 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -137.49 151.36 48.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 1.3600000000000001 109.649 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -136.42 -175.55 4.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.756 0.313 . . . . 0.56999999999999995 110.819 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -121.03 150.05 41.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 1.98 109.991 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -58.14 121.67 11.25 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.752 0.657 . . . . 0.94999999999999996 111.348 -174.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER 55.29 45.95 24.58 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.589 0.556 . . . . 2.0800000000000001 111.806 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 6.7 pm0 -78.96 -4.3 49.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.094 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.15 -9.13 50.02 Favored Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.71999999999999997 113.161 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 15.9 mm-40 -95.57 -17.08 21.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.96999999999999997 110.724 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.14 132.74 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.74 0.305 . . . . 0.57999999999999996 110.695 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.484 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.5 -68.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.373 0.508 . . . . 0.62 112.373 -178.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.618 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 5.6 mtpp -140.94 -41.26 0.4 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.449 0.537 . . . . 2.04 112.449 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.02 -46.73 61.08 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.32000000000000001 112.56 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.499 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.9 m-90 -76.13 -36.89 58.61 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.922 -0.163 . . . . 0.48999999999999999 111.127 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -63.42 -40.43 97.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.033 0.383 . . . . 1.1399999999999999 112.033 -169.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.555 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -64.35 -39.45 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.013 0.435 . . . . 0.78000000000000003 110.631 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -72.3 -51.28 21.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.406 -0.361 . . . . 0.55000000000000004 110.891 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.0 m -64.63 -33.89 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.254 0.465 . . . . 0.83999999999999997 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 t -80.19 -0.84 37.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.018 0.437 . . . . 1.4299999999999999 110.769 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 t -119.88 14.41 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.18 -0.464 . . . . 1.23 110.387 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.041 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 4.0 mmt -98.95 179.18 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 2.27 110.809 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.469 ' NH1' ' HA3' ' A' ' 29' ' ' GLY . 22.3 ttp85 -143.6 174.05 11.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.133 -1.062 . . . . 4.1900000000000004 108.133 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 60.3 tttm -67.7 -6.09 19.1 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.8 0.334 . . . . 1.9399999999999999 111.832 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -141.56 21.2 2.19 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.581 0.229 . . . . 1.23 110.594 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.5 tt0 -118.76 148.64 42.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.512 -0.313 . . . . 1.6000000000000001 110.66 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 24' ' ' LYS . 75.2 tttt -149.06 138.66 21.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 1.1699999999999999 110.794 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.5 m -134.02 164.33 27.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.44 -0.345 . . . . 1.2 111.142 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.508 ' CD2' ' HG2' ' A' ' 119' ' ' GLU . 63.6 mt -100.53 111.62 23.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.037 -0.529 . . . . 1.73 109.605 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 77' ' ' GLY . 7.1 p -100.98 135.95 34.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.73999999999999999 109.994 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mmm-85 -100.45 111.43 23.69 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.115 -0.698 . . . . 1.71 109.115 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 93' ' ' VAL . 3.2 mp -92.21 103.62 14.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.127 0.489 . . . . 0.52000000000000002 109.833 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.54 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 32.5 tt0 -82.41 173.44 12.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.321 -0.854 . . . . 1.3700000000000001 109.02 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.6 p -51.54 -41.31 60.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.631 0.372 . . . . 1.0 111.898 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.0 ptm -77.21 -15.7 59.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 1.79 111.771 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.7 m-30 -91.2 -13.96 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.75 110.885 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.55 -172.54 15.54 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.348 -0.701 . . . . 0.70999999999999996 111.348 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -84.09 41.77 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 1.52 111.209 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.4 -21.98 76.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.804 -0.713 . . . . 2.2999999999999998 112.202 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -76.23 -46.29 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 5.8600000000000003 110.569 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -74.71 -43.04 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 4.2699999999999996 110.998 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.2 22.93 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.517 -0.849 . . . . 2.1600000000000001 112.425 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.3 m -75.07 139.36 42.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.22 -0.289 . . . . 3.3399999999999999 110.22 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.523 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -168.48 165.36 38.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.69 -0.767 . . . . 1.2 111.545 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -76.46 -70.93 0.42 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.823 0.311 . . . . 3.0800000000000001 110.881 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -93.35 -73.24 0.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.588 -0.278 . . . . 1.52 111.066 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.445 HG12 HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -146.13 100.2 4.22 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 121.143 0.496 . . . . 0.75 111.285 177.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.523 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 61.0 Cg_endo -90.29 -166.33 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.874 2.383 . . . . 1.5800000000000001 111.856 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.82 -139.5 13.49 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.553 -0.832 . . . . 2.0499999999999998 112.748 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.4 m120 -93.42 6.11 49.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.124 0.488 . . . . 2.0299999999999998 110.349 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 48' ' ' LEU . 47.1 m -94.44 146.95 23.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.74 -0.664 . . . . 1.1399999999999999 111.349 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.2 p -95.02 138.82 19.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.2 -0.455 . . . . 0.47999999999999998 110.286 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.4 mp -126.36 174.27 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 0.51000000000000001 110.622 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -132.78 124.4 28.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.157 -0.683 . . . . 0.69999999999999996 109.157 176.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 22.2 m-85 -116.13 126.6 53.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.42999999999999999 110.546 178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.609 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 37.8 mt-10 -81.18 107.66 14.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 1.46 109.504 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' HIS . 58.4 mt -107.85 124.46 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.061 -0.256 . . . . 0.47999999999999998 110.9 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 90' ' ' LYS . 34.3 mt-10 -121.5 131.02 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 1.8799999999999999 110.308 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 42' ' ' VAL . 6.9 tt -100.26 101.85 12.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 1.1200000000000001 109.576 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -96.69 -16.23 21.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -175.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.5 m -153.19 150.76 29.37 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.454 -0.202 . . . . 1.1899999999999999 110.454 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.498 ' HB3' HD21 ' A' ' 122' ' ' LEU . 1.5 p90 -164.85 178.74 6.96 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.963 -0.384 . . . . 0.71999999999999997 109.963 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.635 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.9 ptp180 -162.17 167.84 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.617 0.573 . . . . 2.98 109.547 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.69 151.54 37.79 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.201 0.313 . . . . 3.3799999999999999 110.265 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.447 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 95.6 mt -101.76 138.22 39.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.46 -0.336 . . . . 3.3500000000000001 110.924 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.42 154.83 26.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 5.3899999999999997 108.88 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -83.64 -92.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.433 -0.349 . . . . 7.04 110.867 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.96 92.22 2.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.569 . . . . 7.21 109.465 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -82.52 114.66 21.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 9.0199999999999996 109.433 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -59.33 140.21 56.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.041 0.448 . . . . 9.75 111.01 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -160.73 142.4 12.25 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.906 -0.776 . . . . 12.26 108.906 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.543 -0.741 . . . . 13.35 110.19 -177.215 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mmm . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.515 0.197 . . . . 7.4800000000000004 110.634 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.9 p -79.81 155.73 27.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.251 -0.431 . . . . 5.9000000000000004 110.142 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p -73.35 162.33 29.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.495 -0.32 . . . . 4.4400000000000004 111.335 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 60.43 -149.15 0.43 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.59 0.556 . . . . 4.4400000000000004 110.636 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.52 139.23 36.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.306 -0.406 . . . . 4.1500000000000004 110.13 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.78 38.0 1.62 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.036 -0.529 . . . . 3.6099999999999999 110.481 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -101.28 113.89 27.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 110.224 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -89.44 156.08 18.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.444 -0.576 . . . . 2.71 109.444 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.28 153.85 24.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.405 -0.361 . . . . 1.8799999999999999 110.8 -171.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.38 104.83 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.58999999999999997 109.029 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.87 120.29 30.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 2.1600000000000001 110.612 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' H ' HD13 ' A' ' 19' ' ' ILE . 96.2 mt 58.67 64.72 1.38 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.569 0.7 . . . . 1.45 110.727 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.5 HG21 ' HE2' ' A' ' 20' ' ' LYS . 9.2 t -65.79 160.84 22.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.936 -1.029 . . . . 0.78000000000000003 111.115 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.33 -5.22 21.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.093 0.405 . . . . 0.81000000000000005 112.093 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -71.05 -0.36 9.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.407 -0.36 . . . . 2.3999999999999999 111.268 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.98 24.79 2.2 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.79 -0.719 . . . . 0.68000000000000005 113.321 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.14 72.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.011 -0.614 . . . . 0.60999999999999999 113.576 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.539 ' HB ' HG21 ' A' ' 80' ' ' ILE . 12.2 t -138.84 146.11 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.856 -0.424 . . . . 0.48999999999999999 109.856 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 12' ' ' LEU . 22.0 mm -87.08 110.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.013 -0.365 . . . . 0.46999999999999997 110.013 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.5 ' HE2' HG21 ' A' ' 13' ' ' THR . 58.3 pttt -125.27 145.53 49.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 1.3400000000000001 111.096 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -126.01 120.49 30.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 0.5 109.8 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.542 HG12 ' HG3' ' A' ' 25' ' ' LYS . 10.0 tp -76.01 145.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.386 . . . . 0.67000000000000004 110.734 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.39 -34.85 2.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.431 -0.35 . . . . 0.82999999999999996 111.173 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 38.8 ttpt -150.78 118.32 6.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.637 -0.505 . . . . 1.5600000000000001 109.637 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HG3' HG12 ' A' ' 22' ' ' ILE . 88.8 mttt -101.0 154.28 18.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.188 0.518 . . . . 2.9500000000000002 112.021 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.89 164.75 16.07 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 111.683 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.65 -95.12 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.045 0.422 . . . . 2.77 111.133 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -91.48 145.38 24.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.944 0.402 . . . . 2.6400000000000001 110.845 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 162.51 64.57 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.787 -0.642 . . . . 1.04 111.615 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.23 -35.0 72.86 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.072 0.463 . . . . 2.29 111.011 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -104.25 26.34 8.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 2.6400000000000001 111.539 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.48 74.9 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.753 -0.462 . . . . 1.45 109.753 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.528 HG22 ' HG2' ' A' ' 35' ' ' LYS . 27.6 mm -136.68 108.92 9.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 0.81000000000000005 110.829 -177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.6 Cg_endo -71.46 88.24 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.643 2.229 . . . . 0.75 112.067 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HG2' HG22 ' A' ' 33' ' ' ILE . 29.7 mmtp -97.7 159.41 14.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.533 0.682 . . . . 2.6600000000000001 111.876 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HA ' HD23 ' A' ' 69' ' ' LEU . 8.8 ttmm -67.88 150.29 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.683 -1.144 . . . . 2.5099999999999998 111.531 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.68 -26.13 22.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.192 -0.528 . . . . 1.1200000000000001 112.119 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -111.13 158.45 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.698 0.285 . . . . 1.3799999999999999 110.726 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.76 97.75 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.19 0.519 . . . . 2.2000000000000002 111.721 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.9 m -96.86 143.81 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.065 -0.717 . . . . 0.67000000000000004 109.065 170.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 20.1 m -111.62 113.63 26.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.877 0.37 . . . . 0.65000000000000002 110.755 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -131.6 160.8 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.073 -0.512 . . . . 0.87 111.599 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -117.18 153.99 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 2.75 109.254 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -137.69 143.56 41.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.44 -0.345 . . . . 0.76000000000000001 110.233 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.89 160.79 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.878 -0.786 . . . . 0.48999999999999999 108.878 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 167.08 -136.55 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.351 -0.928 . . . . 0.35999999999999999 112.38 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.626 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 60.6 pttt -158.45 171.97 19.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.653 0.263 . . . . 1.4299999999999999 110.995 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.494 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -88.86 105.25 17.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.38 110.403 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 32.7 tt0 -64.04 -27.39 69.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.36 -0.382 . . . . 1.96 111.249 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.7 t -54.76 -40.59 69.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.894 -0.594 . . . . 0.67000000000000004 111.545 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.452 HG22 HD23 ' A' ' 48' ' ' LEU . 10.1 t -120.01 -12.47 9.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.583 0.23 . . . . 0.72999999999999998 111.597 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.42 10.75 73.26 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.75 -0.738 . . . . 0.78000000000000003 112.896 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 33.7 mmtp -88.39 132.03 34.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.871 0.367 . . . . 2.8900000000000001 111.163 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.626 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.3 p -81.65 160.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.472 -0.786 . . . . 0.58999999999999997 109.963 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -74.53 114.56 13.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.021 0.439 . . . . 0.78000000000000003 111.249 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -129.03 91.23 3.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.145 -0.687 . . . . 2.1800000000000002 109.145 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -123.95 -173.55 2.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 1.24 109.87 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.1 m -72.9 -47.3 47.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.772 0.32 . . . . 1.49 111.49 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -95.15 -39.11 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.739 1.015 . . . . 1.8 113.739 -171.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.28 -42.84 87.41 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.977 0.362 . . . . 2.1899999999999999 111.977 -168.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -90.75 11.28 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.39 0.614 . . . . 2.7799999999999998 111.277 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -106.08 -50.15 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 1.1000000000000001 109.047 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.4 p -149.4 121.82 4.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 2.0299999999999998 110.223 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 10.5 Cg_exo -70.82 154.65 63.42 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.819 2.346 . . . . 1.76 112.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -93.94 153.88 17.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.998 -0.546 . . . . 1.3100000000000001 109.717 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -125.99 161.39 27.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.352 -0.61 . . . . 1.3600000000000001 109.352 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.65 175.35 13.35 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.518 -0.473 . . . . 0.56999999999999995 111.489 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 75.1 m-70 -118.37 150.55 39.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.836 . . . . 1.98 109.769 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.603 HD11 ' OD1' ' A' ' 79' ' ' ASP . 14.5 tp -66.13 127.43 32.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.366 -0.379 . . . . 0.94999999999999996 111.871 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 50.56 37.58 16.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.193 0.997 . . . . 2.0800000000000001 111.467 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 22.7 tt0 -72.11 -6.07 39.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.865 -1.516 . . . . 1.98 111.192 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.98 56.19 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 111.661 -0.576 . . . . 0.71999999999999997 111.661 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.19 -18.35 25.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.449 0.642 . . . . 0.96999999999999997 109.759 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.6 125.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.372 -0.831 . . . . 0.57999999999999996 109.578 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -95.94 -58.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.7 1.0 . . . . 0.62 113.7 -172.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.95 -50.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.79 -0.568 . . . . 2.04 112.295 -169.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.13 -52.43 40.17 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.791 -0.719 . . . . 0.32000000000000001 112.707 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.46 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -75.94 -33.94 59.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.618 0.247 . . . . 0.48999999999999999 110.698 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.603 ' OD1' HD11 ' A' ' 69' ' ' LEU . 10.4 t70 -53.04 -51.69 60.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.703 -0.681 . . . . 1.1399999999999999 111.428 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.539 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.8 mp -65.83 -48.37 82.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.09 -0.505 . . . . 0.78000000000000003 110.75 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 120' ' ' ILE . 28.7 t -60.55 -48.24 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.55000000000000004 111.625 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.833 HG12 HG21 ' A' ' 120' ' ' ILE . 32.0 m -70.12 -33.23 54.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.962 -0.295 . . . . 0.83999999999999997 111.295 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 32.6 t -79.17 0.25 29.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 1.4299999999999999 110.882 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -110.38 10.6 23.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.285 -0.416 . . . . 1.23 111.19 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.59 ' SD ' HG22 ' A' ' 120' ' ' ILE . 47.9 mtm -102.3 -173.42 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.797 0.808 . . . . 2.27 112.054 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.452 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 14.2 mtp180 -140.9 -177.44 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.439 -1.255 . . . . 4.1900000000000004 108.5 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -67.06 -23.44 65.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 1.9399999999999999 111.273 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -126.68 17.93 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 1.23 111.219 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 25.8 tt0 -112.2 131.85 55.24 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.695 -0.483 . . . . 1.6000000000000001 109.695 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 12.8 tmtt? -134.93 134.97 41.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.518 -0.765 . . . . 1.1699999999999999 109.868 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.457 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.7 p -137.57 172.82 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.258 -0.428 . . . . 1.2 110.683 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 93' ' ' VAL . 3.2 tt -119.43 140.27 50.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.281 -1.007 . . . . 1.73 108.281 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 95' ' ' ILE . 6.1 p -121.39 141.57 41.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 120.958 0.409 . . . . 0.73999999999999999 110.903 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -98.89 111.65 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.156 -0.683 . . . . 1.71 109.156 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.524 HD11 HG13 ' A' ' 93' ' ' VAL . 3.2 mp -93.4 109.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.378 . . . . 0.52000000000000002 110.187 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -84.81 166.04 17.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.579 -0.897 . . . . 1.3700000000000001 108.579 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.4 p -51.01 -40.68 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.29 0.369 . . . . 1.0 111.956 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.5 ptp -77.19 -16.27 59.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.33 -0.395 . . . . 1.79 111.993 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -92.67 -16.27 25.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.945 0.402 . . . . 0.75 110.432 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.437 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -115.24 -160.15 12.56 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.103 -0.799 . . . . 0.70999999999999996 111.103 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -94.54 29.55 2.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.722 0.296 . . . . 1.52 111.012 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.02 -28.81 73.35 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.931 -0.577 . . . . 2.2999999999999998 112.333 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -70.82 -31.79 68.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 5.8600000000000003 110.683 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.22 -32.1 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 4.2699999999999996 110.322 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.33 -7.26 39.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.829 -0.7 . . . . 2.1600000000000001 112.322 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 55.5 m -86.68 147.58 25.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.005 0.431 . . . . 3.3399999999999999 110.959 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.71 169.23 42.22 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.898 -0.668 . . . . 1.2 111.518 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -84.44 -69.84 0.62 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.682 0.277 . . . . 3.0800000000000001 111.171 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 m -90.85 -73.45 0.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.861 -0.336 . . . . 1.52 110.581 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.469 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.02 103.45 4.43 Favored Pre-proline 0 N--CA 1.465 0.277 0 N-CA-C 109.879 -0.415 . . . . 0.75 109.879 176.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.21 -74.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.346 2.031 . . . . 1.5800000000000001 112.846 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.78 -134.78 44.0 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.805 -0.712 . . . . 2.0499999999999998 112.224 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -133.67 21.39 3.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.466 -0.568 . . . . 2.0299999999999998 109.466 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 22.4 m -105.77 179.19 4.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.76 -0.655 . . . . 1.1399999999999999 111.196 -173.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -97.53 138.57 22.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.128 0.489 . . . . 0.47999999999999998 111.006 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.4 mp -120.41 166.78 13.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.371 -0.377 . . . . 0.51000000000000001 110.907 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 5.4 mt -116.14 110.21 18.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.69999999999999996 109.662 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.64 124.51 48.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.793 0.33 . . . . 0.42999999999999999 110.625 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -92.1 126.25 37.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.304 -0.628 . . . . 1.46 109.304 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.833 HG21 HG12 ' A' ' 82' ' ' VAL . 76.0 mt -120.06 131.62 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.471 -0.331 . . . . 0.47999999999999998 110.979 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -136.25 143.66 44.4 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.103 -0.499 . . . . 1.8799999999999999 110.447 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.545 ' HA ' HG12 ' A' ' 42' ' ' VAL . 24.7 tp -90.94 118.77 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 1.1200000000000001 110.72 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.36 -27.89 10.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 1.0 111.239 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.5 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 39.9 m -151.69 149.8 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.374 . . . . 1.1899999999999999 109.989 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.56 ' HB2' HG12 ' A' ' 40' ' ' VAL . 4.0 p90 -165.5 158.5 15.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.808 0.337 . . . . 0.71999999999999997 111.123 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -125.39 123.44 39.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.103 -0.498 . . . . 2.98 110.052 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -103.05 114.39 28.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 3.3799999999999999 109.927 171.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.0 tp -134.38 150.22 50.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.385 -0.825 . . . . 3.3500000000000001 109.372 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.71 130.53 49.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.875 0.369 . . . . 5.3899999999999997 110.544 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -84.47 113.28 21.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 7.04 110.037 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.91 156.52 21.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.103 0.779 . . . . 7.21 113.103 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -111.92 168.3 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.873 -1.058 . . . . 9.0199999999999996 109.52 168.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -143.84 123.84 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.55 0.214 . . . . 9.75 110.65 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -138.14 -178.16 5.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.148 -0.478 . . . . 12.26 109.836 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.6 -1.19 . . . . 13.35 109.26 174.856 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.238 -0.282 . . . . 7.4800000000000004 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -102.83 99.21 9.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.736 0.303 . . . . 5.9000000000000004 110.459 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.0 m -101.87 -43.6 5.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 4.4400000000000004 110.264 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.92 137.07 34.5 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.946 -0.761 . . . . 4.4400000000000004 108.946 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -87.22 141.91 28.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.038 0.447 . . . . 4.1500000000000004 111.003 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.9 93.34 9.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.428 -0.582 . . . . 3.6099999999999999 109.428 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -119.41 141.53 49.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.035 -0.529 . . . . 3.6000000000000001 110.099 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.1 137.77 45.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.529 -0.759 . . . . 2.71 111.262 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -100.39 128.78 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.307 -0.627 . . . . 1.8799999999999999 109.307 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 23.2 t -102.29 105.1 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.11 0.481 . . . . 0.58999999999999997 110.372 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.1 103.9 16.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.607 -0.724 . . . . 2.1600000000000001 110.663 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 19' ' ' ILE . 21.6 tp 62.24 76.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.255 -0.884 . . . . 1.45 110.863 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -80.92 159.82 24.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.731 -0.668 . . . . 0.78000000000000003 110.928 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.87 -5.09 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.29 0.567 . . . . 0.81000000000000005 111.023 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.9 t70 -78.17 30.3 0.18 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 2.3999999999999999 111.645 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' HA3' HG13 ' A' ' 80' ' ' ILE . . . 121.91 -26.17 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.754 -0.736 . . . . 0.68000000000000005 112.735 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.05 60.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.394 -0.908 . . . . 0.60999999999999999 113.372 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.09 152.17 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.965 -0.383 . . . . 0.48999999999999999 109.965 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 12' ' ' LEU . 7.4 mm -85.75 120.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.505 0.322 . . . . 0.46999999999999997 110.257 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 84' ' ' SER . 51.7 pttt -142.73 147.09 35.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.177 0.513 . . . . 1.3400000000000001 111.461 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.38 135.29 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.509 -0.769 . . . . 0.5 109.891 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.4 112.97 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.102 0.477 . . . . 0.67000000000000004 110.624 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 -52.83 3.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.82999999999999996 110.813 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -115.93 151.97 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.331 -0.618 . . . . 1.5600000000000001 109.331 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.89 110.97 19.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.823 -0.436 . . . . 2.9500000000000002 109.823 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.87 163.18 10.46 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.535 -0.757 . . . . 1.3200000000000001 112.821 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 28' ' ' GLU . 12.5 t70 -104.96 -149.22 0.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.554 -0.536 . . . . 2.77 109.554 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 42.4 tt0 -59.27 125.1 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.15 0.5 . . . . 2.6400000000000001 110.793 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.85 52.37 0.24 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 111.215 -0.754 . . . . 1.04 111.215 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.91 -33.87 73.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.5 . . . . 2.29 110.619 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -98.46 18.3 16.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.583 -0.735 . . . . 2.6400000000000001 110.091 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.41 76.74 1.64 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.911 -0.586 . . . . 1.45 109.94 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 38.4 mm -129.14 119.98 19.95 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.398 0.618 . . . . 0.81000000000000005 111.886 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -87.05 100.75 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.148 3.232 . . . . 0.75 112.186 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.585 ' HE2' ' HB3' ' A' ' 83' ' ' SER . 28.1 mmtp -135.95 178.44 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.15 0.5 . . . . 2.6600000000000001 112.264 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.53 139.51 57.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.145 -0.934 . . . . 2.5099999999999998 111.511 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.51 56.42 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.265 -0.734 . . . . 1.1200000000000001 111.265 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 45.6 m-20 -113.87 161.92 17.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.388 . . . . 1.3799999999999999 110.154 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 25.7 mt-10 -94.57 103.92 15.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.176 -0.465 . . . . 2.2000000000000002 110.613 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.86 132.2 49.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.63 -0.507 . . . . 0.67000000000000004 109.63 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -108.39 109.83 21.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.581 -0.526 . . . . 0.65000000000000002 109.581 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' CG1' HD12 ' A' ' 122' ' ' LEU . 15.8 m -124.04 140.49 47.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.692 -0.685 . . . . 0.87 111.009 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -105.6 140.7 38.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.676 -0.693 . . . . 2.75 109.482 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -123.73 142.67 50.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.107 -0.331 . . . . 0.76000000000000001 110.107 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 p -167.08 148.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.237 -0.653 . . . . 0.48999999999999999 109.237 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.6 1.77 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.127 -0.789 . . . . 0.35999999999999999 111.127 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 63.7 pttt -157.8 171.39 20.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 111.499 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.858 ' HA ' HD23 ' A' ' 116' ' ' LEU . 63.8 tp -81.75 98.17 8.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.814 -0.63 . . . . 0.38 110.253 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.616 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 33.6 tt0 -60.17 -27.75 67.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.756 0.312 . . . . 1.96 111.142 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 t -55.36 -27.2 45.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.955 -0.566 . . . . 0.67000000000000004 111.783 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 53' ' ' LYS . 11.8 t -139.96 4.61 2.09 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.286 0.565 . . . . 0.72999999999999998 110.926 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.89 13.48 75.57 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.94 -0.573 . . . . 0.78000000000000003 113.077 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -77.8 118.34 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.606 0.241 . . . . 2.8900000000000001 111.141 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.724 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.9 p -76.84 159.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.58999999999999997 110.039 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.55 ' CE1' HD11 ' A' ' 110' ' ' ILE . 18.3 m-30 -80.26 99.44 7.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.518 -0.31 . . . . 0.78000000000000003 110.675 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -124.51 84.72 2.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.889 0.852 . . . . 2.1800000000000002 111.28 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.513 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.9 m -136.92 -178.16 5.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.133 -0.94 . . . . 1.24 108.81 175.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.9 p -67.36 -44.15 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 1.49 111.104 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.35 -51.59 23.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.039 -0.528 . . . . 1.8 110.141 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.7 OUTLIER -45.89 -43.81 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.745 -1.116 . . . . 2.1899999999999999 112.191 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.39 -11.9 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.501 . . . . 2.7799999999999998 112.351 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -103.9 -61.91 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.699 -0.401 . . . . 1.1000000000000001 111.588 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 29.0 m -86.0 124.11 71.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.488 . . . . 2.0299999999999998 112.03 -169.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.7 Cg_endo -87.22 103.98 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.147 2.565 . . . . 1.76 111.21 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -94.8 149.16 21.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.454 -0.339 . . . . 1.3100000000000001 110.519 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -141.41 165.88 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 1.3600000000000001 109.939 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 74' ' ' VAL . 54.4 p90 -149.86 -176.88 5.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.088 0.47 . . . . 0.56999999999999995 111.516 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 3.9 m-70 -120.03 150.93 39.77 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.477 -0.783 . . . . 1.98 110.075 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 82' ' ' VAL . 45.6 tp -68.76 134.98 50.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.552 0.215 . . . . 0.94999999999999996 110.46 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 53.21 31.22 11.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.504 0.669 . . . . 2.0800000000000001 111.518 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 30.2 tt0 -69.62 -12.04 61.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.076 -0.965 . . . . 1.98 111.033 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.52 -14.31 54.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.741 -0.743 . . . . 0.71999999999999997 111.744 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -104.07 0.02 29.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.96999999999999997 110.737 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.9 m -132.3 124.65 52.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.57999999999999996 110.266 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.793 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -96.36 -60.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.03 0.752 . . . . 0.62 113.03 -176.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 75' ' ' ILE . 35.6 mmtt -145.03 -41.49 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.285 0.846 . . . . 2.04 113.285 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.36 -52.33 37.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.307 -0.949 . . . . 0.32000000000000001 112.212 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.417 ' O ' HG22 ' A' ' 82' ' ' VAL . 14.2 m-90 -76.48 -33.13 58.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.543 0.211 . . . . 0.48999999999999999 110.992 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 10.4 t70 -52.33 -53.33 45.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.77 -0.65 . . . . 1.1399999999999999 112.102 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.11 -33.13 59.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.441 0.638 . . . . 0.78000000000000003 111.22 -176.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.8 t -76.19 -39.52 54.56 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.896 -0.502 . . . . 0.55000000000000004 111.661 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 69' ' ' LEU . 33.8 m -81.02 -32.82 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.452 0.167 . . . . 0.83999999999999997 111.131 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.585 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 62.6 m -61.27 -40.71 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 1.4299999999999999 110.7 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 21.4 m -101.42 64.38 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 1.23 111.038 174.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 11.4 mmt -120.9 172.47 7.89 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.149 -0.932 . . . . 2.27 110.074 171.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -142.96 162.83 34.41 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.69 -0.856 . . . . 4.1900000000000004 108.69 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HA ' HD23 ' A' ' 122' ' ' LEU . 3.4 tmtm? -56.11 -29.56 60.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.981 0.363 . . . . 1.9399999999999999 111.981 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -118.96 18.12 13.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.68 0.276 . . . . 1.23 111.13 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.37 158.03 16.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.395 -0.366 . . . . 1.6000000000000001 110.578 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -152.29 124.06 7.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.283 -0.636 . . . . 1.1699999999999999 109.283 -175.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.8 m -129.63 160.7 32.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.324 -0.398 . . . . 1.2 110.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' CD2' ' HE2' ' A' ' 90' ' ' LYS . 2.6 mm? -103.17 118.21 36.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.73 109.655 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.737 HG13 HD11 ' A' ' 95' ' ' ILE . 7.5 p -100.63 138.17 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.822 0.344 . . . . 0.73999999999999999 110.224 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 mmm-85 -107.42 111.44 23.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.571 -0.899 . . . . 1.71 108.571 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.737 HD11 HG13 ' A' ' 93' ' ' VAL . 5.1 mp -104.28 107.17 21.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.155 -0.475 . . . . 0.52000000000000002 110.181 -173.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.595 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 2.2 tt0 -83.46 176.01 9.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.153 -0.684 . . . . 1.3700000000000001 109.153 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -30.99 67.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.14 -9.29 59.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.294 -0.412 . . . . 1.79 111.983 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.595 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 17.7 m-85 -109.42 -0.69 18.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 0.75 110.29 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.58 176.09 22.95 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.70999999999999996 112.134 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.716 ' HD1' ' HB3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -86.54 32.18 0.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.704 0.261 . . . . 1.52 111.704 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.92 -27.06 71.25 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.08 -0.581 . . . . 2.2999999999999998 111.767 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.42 -54.83 42.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.055 0.455 . . . . 5.8600000000000003 110.244 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.716 ' HB3' ' HD1' ' A' ' 101' ' ' TYR . 15.3 tp10 -64.99 -42.65 94.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 4.2699999999999996 110.544 175.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.21 22.03 7.72 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.915 -0.66 . . . . 2.1600000000000001 112.241 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 48.9 t -91.82 121.88 33.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.282 . . . . 3.3399999999999999 110.537 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -107.7 119.48 5.79 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.053 -0.594 . . . . 1.2 111.667 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -99.09 -71.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.05 -0.352 . . . . 3.0800000000000001 110.05 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -75.6 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.072 -0.251 . . . . 1.52 111.09 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.55 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -156.15 72.83 5.1 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 0.75 110.95 175.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.566 ' HG2' ' HA2' ' A' ' 107' ' ' GLY . 19.4 Cg_endo -94.82 102.81 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.161 2.574 . . . . 1.5800000000000001 112.342 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.3 73.3 0.46 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.969 -0.853 . . . . 2.0499999999999998 110.969 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.02 31.33 0.33 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.92 0.888 . . . . 2.0299999999999998 111.26 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 48' ' ' LEU . 6.8 p -104.27 -177.33 3.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.1399999999999999 111.018 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.82 137.64 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.07 -0.514 . . . . 0.47999999999999998 110.035 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.858 HD23 ' HA ' ' A' ' 48' ' ' LEU . 10.1 mt -124.55 156.4 37.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 0.51000000000000001 110.72 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.616 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -125.56 119.67 28.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.829 -0.434 . . . . 0.69999999999999996 109.829 171.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 95' ' ' ILE . 21.2 m-85 -114.52 137.93 51.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.962 -0.563 . . . . 0.42999999999999999 111.006 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.43 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 36.2 mt-10 -89.12 116.09 27.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.295 -0.866 . . . . 1.46 108.869 172.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.465 HG21 HG12 ' A' ' 82' ' ' VAL . 44.6 mt -106.78 127.82 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.705 0.288 . . . . 0.47999999999999998 110.258 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.26 125.82 50.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.806 -0.634 . . . . 1.8799999999999999 110.601 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 87' ' ' LYS . 4.4 tp -91.88 89.86 7.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.518 -0.549 . . . . 1.1200000000000001 109.518 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -78.78 -37.07 41.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.43 -176.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.3 m -146.77 151.36 37.03 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.128 -0.229 . . . . 1.1899999999999999 110.794 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -165.86 -177.71 4.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.507 -0.553 . . . . 0.71999999999999997 109.507 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.549 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -162.33 172.38 15.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 2.98 109.786 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.435 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 26.8 mt-10 -135.18 121.71 20.62 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.366 0.416 . . . . 3.3799999999999999 110.94 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.4 mt -128.52 166.37 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.971 -0.559 . . . . 3.3500000000000001 110.006 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.79 137.01 36.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 5.3899999999999997 110.728 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -111.11 121.5 45.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.115 -0.493 . . . . 7.04 110.614 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -107.05 124.37 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.685 -0.487 . . . . 7.21 109.685 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -140.77 118.66 11.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 9.0199999999999996 110.146 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -129.29 121.78 28.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.18 -0.464 . . . . 9.75 110.327 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -94.4 -62.72 1.28 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.905 0.383 . . . . 12.26 110.235 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 t60 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.333 -0.841 . . . . 13.35 109.682 178.821 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.824 0.345 . . . . 7.4800000000000004 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.4 m -85.12 153.71 22.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.576 -0.528 . . . . 5.9000000000000004 109.576 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p -61.96 153.64 28.77 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.985 0.178 . . . . 4.4400000000000004 111.247 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 67.81 -162.73 0.21 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.063 -0.517 . . . . 4.4400000000000004 109.644 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.57 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 35.7 tt0 -155.98 170.83 21.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 4.1500000000000004 110.608 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 6.4 pt-20 -94.52 80.52 3.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 3.6099999999999999 111.454 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 68.7 m-85 -106.04 164.84 11.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.877 -0.601 . . . . 3.6000000000000001 110.354 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -112.35 136.53 51.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.018 -0.537 . . . . 2.71 110.178 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HG3' HG23 ' A' ' 21' ' ' THR . 7.1 mptt -111.34 125.82 54.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.722 -0.474 . . . . 1.8799999999999999 109.722 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.42 115.54 45.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.537 -0.301 . . . . 0.58999999999999997 110.349 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.04 126.67 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.095 -0.502 . . . . 2.1600000000000001 111.09 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.3 mt 57.26 53.31 7.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 1.45 110.04 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.532 HG21 ' HE2' ' A' ' 20' ' ' LYS . 11.7 t -59.23 157.72 10.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.78000000000000003 111.169 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -2.76 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.81000000000000005 112.115 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.53 -4.41 36.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 2.3999999999999999 110.658 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.27 37.41 0.69 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.574 -0.822 . . . . 0.68000000000000005 113.107 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.29 0.85 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.906 -0.664 . . . . 0.60999999999999999 113.489 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG21 ' HB ' ' A' ' 80' ' ' ILE . 38.6 t -141.13 141.36 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.272 -0.27 . . . . 0.48999999999999999 110.272 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 12' ' ' LEU . 14.3 mm -90.83 110.82 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.46999999999999997 109.753 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.532 ' HE2' HG21 ' A' ' 13' ' ' THR . 61.3 pttt -137.09 144.83 43.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.192 0.52 . . . . 1.3400000000000001 111.076 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 9' ' ' LYS . 25.2 m -116.77 131.37 56.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.5 110.239 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.478 HD11 ' HA ' ' A' ' 25' ' ' LYS . 4.9 tp -91.17 126.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.67000000000000004 110.267 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.578 ' CD2' ' HG ' ' A' ' 92' ' ' LEU . 3.3 mm? -108.04 -72.85 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.38 0.609 . . . . 0.82999999999999996 110.135 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -108.07 103.28 12.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.146 -0.687 . . . . 1.5600000000000001 109.146 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HA ' HD11 ' A' ' 22' ' ' ILE . 73.4 tttt -72.26 157.38 37.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.851 -0.425 . . . . 2.9500000000000002 109.851 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.27 -136.83 0.12 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 114.559 0.583 . . . . 1.3200000000000001 114.559 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 14.0 t70 -167.3 -162.98 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.556 -1.275 . . . . 2.77 107.556 -170.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 39.2 tt0 -77.81 125.38 29.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 2.6400000000000001 110.716 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.93 70.0 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.559 -1.016 . . . . 1.04 110.559 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.46 -22.43 59.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.043 0.449 . . . . 2.29 111.03 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.47 1.1 55.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.645 0.736 . . . . 2.6400000000000001 109.328 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -105.71 76.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.647 -0.706 . . . . 1.45 109.243 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.1 mm -137.07 130.42 17.44 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.81000000000000005 111.138 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.501 ' HG3' ' O ' ' A' ' 85' ' ' MET . 74.0 Cg_endo -74.74 133.86 17.55 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.031 2.488 . . . . 0.75 111.424 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 29.9 mmmt -134.12 142.06 47.36 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.283 -0.261 . . . . 2.6600000000000001 110.539 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.635 ' HE3' ' HB3' ' A' ' 70' ' ' GLU . 17.3 tptm -56.14 127.51 31.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 2.5099999999999998 110.47 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.53 -25.25 23.61 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.474 -0.785 . . . . 1.1200000000000001 111.825 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 128' ' ' LEU . 78.9 m-20 -94.28 165.73 12.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 1.3799999999999999 110.305 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.27 132.26 34.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.142 0.496 . . . . 2.2000000000000002 111.857 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.8 150.8 35.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.765 -0.828 . . . . 0.67000000000000004 108.765 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 25.6 m -125.55 106.41 9.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.861 -0.422 . . . . 0.65000000000000002 109.861 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 122' ' ' LEU . 34.0 m -131.22 160.48 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.573 . . . . 0.87 111.385 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -113.92 152.73 30.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.647 -0.872 . . . . 2.75 108.647 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -128.06 132.64 49.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.76000000000000001 110.253 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -165.14 158.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.807 -0.812 . . . . 0.48999999999999999 108.807 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.84 -127.35 1.51 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.038 -1.077 . . . . 0.35999999999999999 112.372 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 58.5 pttt -150.42 166.63 29.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 1.4299999999999999 110.471 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.579 HD22 HG13 ' A' ' 110' ' ' ILE . 66.3 tp -86.23 101.97 13.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 0.38 109.694 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 18.9 tt0 -59.78 -24.54 64.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.807 0.337 . . . . 1.96 111.817 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 t -55.86 -25.35 41.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.188 -0.46 . . . . 0.67000000000000004 111.468 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 53' ' ' LYS . 3.0 t -137.84 -31.62 0.77 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.933 0.396 . . . . 0.72999999999999998 111.567 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.72 14.75 26.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.84 -0.695 . . . . 0.78000000000000003 112.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' A' ' 51' ' ' THR . 70.2 mmtt -86.59 133.7 33.69 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.652 -0.499 . . . . 2.8900000000000001 109.652 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.3 p -83.06 155.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.211 -0.45 . . . . 0.58999999999999997 111.46 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 3.2 m-85 -74.33 102.11 4.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.78000000000000003 110.77 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.52 85.3 2.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.375 0.607 . . . . 2.1800000000000002 110.004 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.531 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 67.3 m -138.58 -177.61 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 1.24 110.323 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -48.47 -47.0 38.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.887 0.699 . . . . 1.49 112.887 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.89 -43.29 8.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 1.8 110.339 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.8 OUTLIER -57.29 -30.5 64.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 2.1899999999999999 112.185 -174.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -19.91 21.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 2.7799999999999998 110.973 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -86.81 -61.02 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 1.1000000000000001 110.94 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 7.1 p -156.13 126.36 3.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 2.0299999999999998 111.121 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 8.9 Cg_exo -72.02 152.74 57.44 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.694 2.262 . . . . 1.76 111.326 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.71 146.41 23.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.676 0.274 . . . . 1.3100000000000001 110.328 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 2.7 pptp? -105.89 143.35 34.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.979 -0.378 . . . . 1.3600000000000001 109.979 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 47.7 p90 -134.31 170.44 15.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.01 0.433 . . . . 0.56999999999999995 111.131 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -103.96 149.58 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 1.98 109.966 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.614 HD13 ' CG2' ' A' ' 82' ' ' VAL . 16.5 tp -64.19 119.46 10.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.94 0.4 . . . . 0.94999999999999996 110.928 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.635 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER 42.31 74.94 0.1 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 114.405 -1.271 . . . . 2.0800000000000001 111.767 -174.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 6.1 pt20 -100.85 17.39 22.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.548 -1.206 . . . . 1.98 109.536 174.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.5 -16.6 59.62 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.604 -0.726 . . . . 0.71999999999999997 111.787 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.53 -41.56 11.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.466 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.87 135.36 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.651 0.262 . . . . 0.57999999999999996 110.301 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.562 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.61 -68.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.455 0.539 . . . . 0.62 112.455 -175.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 75' ' ' ILE . 41.7 mtpt -133.52 -51.09 0.86 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 122.026 -0.421 . . . . 2.04 111.892 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.07 -53.41 34.22 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.049 -0.596 . . . . 0.32000000000000001 113.513 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.427 ' O ' HG22 ' A' ' 82' ' ' VAL . 17.7 m-90 -75.86 -37.72 58.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.652 0.263 . . . . 0.48999999999999999 110.632 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.01 -54.06 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 1.1399999999999999 111.791 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.462 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -68.59 -35.31 69.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 110.559 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 120' ' ' ILE . 44.2 t -69.43 -48.19 61.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.096 -0.502 . . . . 0.55000000000000004 111.083 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.614 ' CG2' HD13 ' A' ' 69' ' ' LEU . 34.0 m -66.7 -32.37 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 121.169 -0.212 . . . . 0.83999999999999997 111.125 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -80.92 3.38 22.99 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.275 0.56 . . . . 1.4299999999999999 110.237 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 t -123.93 27.48 7.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.558 -0.746 . . . . 1.23 109.001 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.63 ' HE1' ' HA ' ' A' ' 90' ' ' LYS . 40.7 mmm -123.79 116.45 23.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 2.27 111.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.534 HH21 ' HB2' ' A' ' 88' ' ' ASN . 18.0 ttp85 -82.41 162.06 22.27 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 4.1900000000000004 109.753 175.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -66.12 -13.68 60.53 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.108 0.41 . . . . 1.9399999999999999 112.108 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.534 ' HB2' HH21 ' A' ' 86' ' ' ARG . 37.0 m-80 -121.42 25.51 9.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.004 0.43 . . . . 1.23 109.976 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -123.16 166.4 15.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.634 -0.712 . . . . 1.6000000000000001 109.737 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.63 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 79.2 tttt -157.28 121.03 4.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 1.1699999999999999 111.405 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.27 160.96 25.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.522 -0.763 . . . . 1.2 110.646 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 75.2 mt -115.13 126.22 54.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.544 -0.539 . . . . 1.73 109.544 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 77' ' ' GLY . 10.0 p -101.22 142.45 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 110.024 -0.362 . . . . 0.73999999999999999 110.024 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 15.3 mmm-85 -100.98 112.84 25.38 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.84 -0.8 . . . . 1.71 108.84 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -87.23 101.18 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.52000000000000002 110.928 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 98' ' ' MET . 10.2 tp10 -79.75 159.22 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.433 -0.951 . . . . 1.3700000000000001 108.433 170.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.411 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 8.5 p -55.37 -36.1 65.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.889 0.376 . . . . 1.0 111.499 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 96' ' ' GLU . 22.2 ptp -76.95 -8.27 57.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.166 -0.47 . . . . 1.79 111.021 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -96.08 -2.4 46.72 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.154 -0.313 . . . . 0.75 110.154 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.562 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -133.72 -152.45 6.78 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.684 -0.689 . . . . 0.70999999999999996 112.335 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.609 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 36.0 m-85 -96.8 -0.12 48.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.926 0.343 . . . . 1.52 111.926 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.32 -137.28 45.25 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 2.2999999999999998 113.145 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.03 -32.45 17.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.156 0.503 . . . . 5.8600000000000003 110.588 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.09 -53.08 55.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 4.2699999999999996 112.193 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.609 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -76.68 161.11 51.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.091 -0.575 . . . . 2.1600000000000001 113.214 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 23.1 p -71.63 128.31 35.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 3.3399999999999999 110.347 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.62 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -102.89 173.88 22.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 1.2 112.862 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -96.32 -71.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.799 0.296 . . . . 3.0800000000000001 111.799 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.568 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 3.0 t -106.65 -73.25 0.69 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.305 -0.247 . . . . 1.52 110.751 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.579 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.59 71.36 17.49 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.922 0.392 . . . . 0.75 111.77 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.62 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 83.4 Cg_endo -92.23 -158.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.766 2.311 . . . . 1.5800000000000001 112.558 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.14 -133.0 9.65 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.336 -0.706 . . . . 2.0499999999999998 111.336 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 67.0 t30 -96.64 24.07 6.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.753 0.787 . . . . 2.0299999999999998 109.732 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -104.93 146.5 28.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.397 -0.82 . . . . 1.1399999999999999 109.737 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.19 132.06 34.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.158 0.504 . . . . 0.47999999999999998 110.66 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.7 mp -121.07 168.95 10.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.545 . . . . 0.51000000000000001 109.624 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -138.97 122.83 17.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.69999999999999996 110.333 172.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -110.94 140.6 45.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.42999999999999999 111.453 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.434 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 34.3 mt-10 -80.45 119.58 23.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.274 -0.875 . . . . 1.46 108.903 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.587 HD12 ' SG ' ' A' ' 81' ' ' CYS . 47.8 mt -108.12 134.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.248 -0.649 . . . . 0.47999999999999998 109.248 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -134.93 114.38 12.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.529 . . . . 1.8799999999999999 110.7 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.71 ' HA ' HG12 ' A' ' 42' ' ' VAL . 4.9 tp -84.0 91.72 7.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.852 -0.425 . . . . 1.1200000000000001 109.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 41' ' ' THR . 2.8 pp -84.27 -36.81 22.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.279 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.4 m -143.14 150.66 39.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.047 -0.353 . . . . 1.1899999999999999 110.047 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -165.91 -178.89 4.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.494 -0.558 . . . . 0.71999999999999997 109.494 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.86 138.92 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 2.98 110.554 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -93.51 151.71 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.318 -0.623 . . . . 3.3799999999999999 109.318 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.499 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 19.8 tp -75.3 138.78 42.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.611 0.243 . . . . 3.3500000000000001 111.211 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -81.69 168.16 18.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.933 0.397 . . . . 5.3899999999999997 111.344 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.0 m80 59.36 -163.45 0.23 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.257 -0.883 . . . . 7.04 111.084 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -135.54 121.84 20.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.114 0.483 . . . . 7.21 109.715 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -125.29 95.31 4.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 9.0199999999999996 110.689 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -169.59 127.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.82 -0.627 . . . . 9.75 109.481 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -91.94 126.58 37.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.245 -0.582 . . . . 12.26 109.845 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-N 115.311 -0.859 . . . . 13.35 110.689 -176.774 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.702 0.287 . . . . 7.4800000000000004 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -85.72 81.69 8.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.375 0.607 . . . . 5.9000000000000004 111.526 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.8 p -100.12 -25.82 14.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.675 0.75 . . . . 4.4400000000000004 109.325 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.72 130.17 34.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.795 -1.093 . . . . 4.4400000000000004 108.867 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -151.31 162.85 40.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.685 0.278 . . . . 4.1500000000000004 110.333 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.31 86.73 2.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.012 0.434 . . . . 3.6099999999999999 110.403 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.62 122.64 22.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.818 -0.628 . . . . 3.6000000000000001 109.754 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.35 154.13 39.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.263 0.554 . . . . 2.71 110.77 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.4 mppt? -94.42 152.04 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.039 -0.726 . . . . 1.8799999999999999 109.039 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.31 105.19 17.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.562 -0.533 . . . . 0.58999999999999997 109.562 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.8 99.75 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 2.1600000000000001 110.247 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt 66.75 78.63 0.25 Allowed 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.027 0.829 . . . . 1.45 110.858 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -68.3 156.07 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.78000000000000003 110.366 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.27 -20.27 65.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.247 -0.433 . . . . 0.81000000000000005 111.902 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.51 30.69 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.87 0.367 . . . . 2.3999999999999999 111.83 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 11.38 5.32 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.043 -1.075 . . . . 0.68000000000000005 114.548 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.92 64.33 4.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.545 0.578 . . . . 0.60999999999999999 114.545 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.14 147.55 32.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 0.48999999999999999 109.984 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -85.5 111.17 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.789 -0.449 . . . . 0.46999999999999997 109.789 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 18.5 pttp -141.68 146.92 36.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.945 0.402 . . . . 1.3400000000000001 110.769 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -102.79 132.02 49.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.5 110.034 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 tp -93.63 121.93 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.878 0.371 . . . . 0.67000000000000004 110.194 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.88 -78.83 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.82999999999999996 110.419 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 108.69 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.579 -0.737 . . . . 1.5600000000000001 109.675 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -72.88 147.39 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.885 -0.598 . . . . 2.9500000000000002 111.901 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.73 88.75 1.38 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.072 -1.211 . . . . 1.3200000000000001 110.072 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.33 -43.21 43.5 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.767 0.654 . . . . 2.77 112.767 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.32 144.38 34.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.924 0.392 . . . . 2.6400000000000001 110.709 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.81 51.8 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.977 -0.63 . . . . 1.04 111.643 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.95 -45.98 64.58 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.583 0.586 . . . . 2.29 112.583 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.47 27.65 8.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.962 0.411 . . . . 2.6400000000000001 111.035 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 30.9 m-80 -129.26 78.62 1.86 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 1.45 110.609 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.25 124.31 21.18 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.134 -0.485 . . . . 0.81000000000000005 111.066 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HG3' HD22 ' A' ' 122' ' ' LEU . 42.8 Cg_endo -67.65 112.83 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.713 2.275 . . . . 0.75 111.504 176.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.7 mmtp -133.39 172.78 12.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.364 0.875 . . . . 2.6600000000000001 113.364 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -43.42 126.48 4.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.02 -1.445 . . . . 2.5099999999999998 113.211 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 -16.01 45.1 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.935 -0.575 . . . . 1.1200000000000001 113.301 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 92.7 m-20 -83.58 146.99 28.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.057 0.456 . . . . 1.3799999999999999 110.913 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -78.5 110.23 13.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.292 0.568 . . . . 2.2000000000000002 110.252 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 125' ' ' PHE . 11.1 m -117.88 159.29 18.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.587 -0.733 . . . . 0.67000000000000004 109.819 175.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' HD3' ' A' ' 66' ' ' LYS . 23.7 m -125.55 105.61 9.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.383 -0.599 . . . . 0.65000000000000002 109.383 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 122' ' ' LEU . 12.7 m -128.01 140.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.864 -0.607 . . . . 0.87 110.185 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -100.43 147.64 25.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.06 -0.718 . . . . 2.75 109.06 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -126.39 127.84 46.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.371 0.605 . . . . 0.76000000000000001 110.326 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.22 157.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.355 -0.98 . . . . 0.48999999999999999 108.355 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.61 -128.49 1.71 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.258 -0.972 . . . . 0.35999999999999999 111.454 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.679 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 59.2 pttt -157.81 170.92 21.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.993 0.425 . . . . 1.4299999999999999 111.058 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD13 ' HG ' ' A' ' 116' ' ' LEU . 46.2 tp -89.52 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.38 109.627 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 78.2 tt0 -64.36 -28.55 69.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 1.96 111.233 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.44 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 8.7 t -54.84 -29.78 55.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.532 . . . . 0.67000000000000004 111.543 -175.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -130.46 -2.45 4.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.656 0.265 . . . . 0.72999999999999998 111.086 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 45.34 50.31 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.347 -0.454 . . . . 0.78000000000000003 113.032 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 68.8 mmtt -113.51 127.1 55.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 2.8900000000000001 110.584 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.679 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 14.4 p -72.76 152.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.622 -0.717 . . . . 0.58999999999999997 111.168 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 3.5 m-30 -74.48 115.45 14.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.998 0.428 . . . . 0.78000000000000003 110.749 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -146.21 85.7 1.67 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.655 -0.702 . . . . 2.1800000000000002 109.425 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 15.0 m -116.13 -177.5 3.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.544 -0.753 . . . . 1.24 109.734 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -71.17 -37.98 72.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.947 0.404 . . . . 1.49 111.212 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.42 -48.09 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.382 0.512 . . . . 1.8 112.382 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -62.34 -45.57 92.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.926 0.713 . . . . 2.1899999999999999 112.926 -167.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 57' ' ' SER . 3.4 ptm180 -67.35 -23.25 65.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.776 0.322 . . . . 2.7799999999999998 111.326 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -87.71 -62.32 1.52 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 1.1000000000000001 110.565 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.3 107.09 30.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.631 0.729 . . . . 2.0299999999999998 110.787 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.14 138.74 37.3 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.114 2.542 . . . . 1.76 111.795 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.25 153.85 18.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.902 -0.407 . . . . 1.3100000000000001 109.902 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD3' HG23 ' A' ' 41' ' ' THR . 3.7 pptp? -130.02 146.76 51.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.303 -0.408 . . . . 1.3600000000000001 110.506 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.454 ' HB2' HE22 ' A' ' 71' ' ' GLN . 48.7 p90 -127.86 174.43 9.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.82 0.343 . . . . 0.56999999999999995 111.447 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -110.69 151.36 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 1.98 110.664 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.488 HD23 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -65.18 117.67 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.94999999999999996 110.535 -176.349 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.76 90.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.203 1.001 . . . . 2.0800000000000001 110.228 -171.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.454 HE22 ' HB2' ' A' ' 67' ' ' PHE . 8.2 tt0 -127.73 8.24 6.32 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.399 -1.273 . . . . 1.98 109.585 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.1 -17.67 31.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.71999999999999997 112.472 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 9.0 mm-40 -90.4 -15.53 30.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.374 0.606 . . . . 0.96999999999999997 110.329 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.56 124.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.952 -0.567 . . . . 0.57999999999999996 110.747 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -99.43 -57.07 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.74 0.644 . . . . 0.62 112.74 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.0 mtpt -137.41 -61.18 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 2.04 111.665 -171.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.46 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -52.99 -52.74 37.66 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.05 -0.595 . . . . 0.32000000000000001 112.78 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.571 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -74.87 -51.53 13.67 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.74 -0.384 . . . . 0.48999999999999999 110.431 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.41 -51.98 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.545 0.528 . . . . 1.1399999999999999 112.123 -171.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 76' ' ' LYS . 1.8 mp -65.42 -38.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.809 0.338 . . . . 0.78000000000000003 110.453 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.0 t -68.6 -46.1 70.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.284 . . . . 0.55000000000000004 110.765 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.6 m -67.98 -33.06 59.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 O-C-N 123.153 0.283 . . . . 0.83999999999999997 110.856 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -61.1 -39.24 89.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 1.4299999999999999 110.58 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.527 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 22.4 m -92.67 31.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.474 . . . . 1.23 111.15 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 85.6 mmm -104.52 175.13 5.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.615 -0.266 . . . . 2.27 110.385 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 70.4 mtt85 -144.89 165.71 27.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.465 -0.334 . . . . 4.1900000000000004 110.359 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -53.73 -35.14 60.87 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.618 0.573 . . . . 1.9399999999999999 112.316 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -125.19 41.4 3.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 1.23 110.561 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 20.2 tt0 -117.34 154.25 31.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.392 -0.367 . . . . 1.6000000000000001 110.193 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.94 117.49 7.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.376 . . . . 1.1699999999999999 109.986 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 74.5 m -124.52 162.21 24.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.092 0.472 . . . . 1.2 112.018 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.44 114.67 27.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.369 -0.832 . . . . 1.73 109.646 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.603 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.1 p -103.77 147.57 9.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.409 -0.359 . . . . 0.73999999999999999 110.983 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 94' ' ' ARG . 9.5 mmt85 -105.51 112.38 25.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.587 -0.523 . . . . 1.71 109.587 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.521 HD13 ' HD2' ' A' ' 118' ' ' PHE . 2.1 mp -94.1 105.58 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.149 0.499 . . . . 0.52000000000000002 109.67 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 97' ' ' SER . 23.0 tt0 -93.78 174.85 6.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -49.0 -45.87 43.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.76 0.424 . . . . 1.0 111.516 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.08 -8.29 58.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.948 -0.569 . . . . 1.79 112.027 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.412 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 21.6 m-85 -102.28 -18.58 15.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.75 110.578 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' C ' HD11 ' A' ' 75' ' ' ILE . . . -112.99 -174.41 19.13 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.304 -0.718 . . . . 0.70999999999999996 111.304 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.47 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . 5.7 m-85 -82.38 59.96 4.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 1.52 110.889 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -89.34 -0.32 80.04 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.397 -0.681 . . . . 2.2999999999999998 111.397 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.39 -55.22 4.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 5.8600000000000003 109.985 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -81.64 -54.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.571 -0.74 . . . . 4.2699999999999996 110.365 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.75 67.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.779 . . . . 2.1600000000000001 112.828 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . 43.9 t -123.32 136.71 54.81 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.653 -0.322 . . . . 3.3399999999999999 110.379 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.555 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -176.34 99.88 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.587 -0.605 . . . . 1.2 111.587 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 1.7 mp0 -66.11 -34.35 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.274 . . . . 3.0800000000000001 111.604 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.552 ' HB2' HD13 ' A' ' 110' ' ' ILE . 4.7 p -93.94 -76.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.961 0.356 . . . . 1.52 111.961 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -160.25 87.67 1.87 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 122.892 0.477 . . . . 0.75 110.848 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.555 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 87.1 Cg_endo -84.83 170.35 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.345 2.03 . . . . 1.5800000000000001 111.597 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.06 36.54 0.02 OUTLIER Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.39 -0.91 . . . . 2.0499999999999998 112.473 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.53 19.01 11.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.274 0.559 . . . . 2.0299999999999998 110.402 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 2.0 m -95.8 160.93 14.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.493 -0.776 . . . . 1.1399999999999999 110.33 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.22 122.21 45.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.375 0.607 . . . . 0.47999999999999998 110.452 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.0 mp -116.29 142.7 46.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.837 -0.62 . . . . 0.51000000000000001 109.615 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.44 121.59 45.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.142 0.496 . . . . 0.69999999999999996 110.539 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.521 ' HD2' HD13 ' A' ' 95' ' ' ILE . 44.4 m-85 -112.88 137.95 50.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.747 . . . . 0.42999999999999999 111.219 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.512 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 38.7 mt-10 -78.2 122.37 25.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.81 -0.811 . . . . 1.46 108.81 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.479 HG21 HG12 ' A' ' 82' ' ' VAL . 49.9 mt -107.16 121.16 59.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.512 -0.551 . . . . 0.47999999999999998 109.512 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -127.68 112.88 15.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.514 -0.766 . . . . 1.8799999999999999 110.639 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 42' ' ' VAL . 24.6 tp -88.93 99.59 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 1.1200000000000001 109.9 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -90.8 -31.42 16.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.872 -0.331 . . . . 1.0 111.308 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.3 m -151.21 146.21 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.713 -0.221 . . . . 1.1899999999999999 110.571 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.593 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -168.39 -179.21 3.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.523 -0.308 . . . . 0.71999999999999997 110.294 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 6.0 ptp180 -155.74 142.22 18.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.055 -0.521 . . . . 2.98 109.948 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.92 150.99 25.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.756 0.312 . . . . 3.3799999999999999 110.482 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.2 mt -101.27 127.77 47.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.032 0.444 . . . . 3.3500000000000001 110.454 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.34 168.86 13.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.694 -0.685 . . . . 5.3899999999999997 109.308 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -63.15 122.0 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.293 -0.262 . . . . 7.04 110.293 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -135.89 98.99 4.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.331 0.586 . . . . 7.21 111.722 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -126.19 -76.63 0.58 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.386 -0.968 . . . . 9.0199999999999996 108.386 172.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 62.73 -6.96 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.38 1.622 . . . . 9.75 115.38 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -81.17 -20.69 40.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.932 -1.136 . . . . 12.26 107.932 167.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 70.3 t60 . . . . . 0 C--O 1.244 0.765 0 CA-C-N 114.101 -1.408 . . . . 13.35 107.977 173.921 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.721 0.296 . . . . 7.4800000000000004 111.082 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.4 t -82.41 -19.35 39.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.624 -0.262 . . . . 5.9000000000000004 110.95 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.791 HG22 ' H ' ' A' ' 4' ' ' GLU . 3.6 m 66.09 -174.2 0.18 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.344 -0.389 . . . . 4.4400000000000004 110.577 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.791 ' H ' HG22 ' A' ' 3' ' ' THR . 18.6 tt0 -130.58 178.16 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.956 -0.465 . . . . 4.4400000000000004 109.82 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 49.8 mt-30 -76.8 149.99 36.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.996 0.427 . . . . 4.1500000000000004 111.457 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.67 79.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.649 -0.871 . . . . 3.6099999999999999 108.649 172.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.46 160.44 25.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.561 -0.745 . . . . 3.6000000000000001 112.834 -171.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.72 154.26 19.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.9 -1.046 . . . . 2.71 110.025 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 3.2 mppt? -99.41 127.83 45.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.337 -0.616 . . . . 1.8799999999999999 109.337 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -102.53 105.42 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.421 -0.585 . . . . 0.58999999999999997 109.421 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.16 140.98 29.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.253 -0.43 . . . . 2.1600000000000001 110.993 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.2 mt 54.04 44.0 29.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 1.45 111.677 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.587 HG21 ' HD3' ' A' ' 20' ' ' LYS . 9.1 t -55.92 157.3 4.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.78000000000000003 110.817 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 1.16 5.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.81000000000000005 111.19 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -80.11 3.51 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 2.3999999999999999 110.592 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.86 25.41 1.9 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.839 -0.696 . . . . 0.68000000000000005 113.539 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 66.02 68.75 1.55 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.231 -0.509 . . . . 0.60999999999999999 113.941 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.532 HG21 ' HB ' ' A' ' 80' ' ' ILE . 12.8 t -135.87 145.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.898 -0.408 . . . . 0.48999999999999999 109.898 176.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.783 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 8.8 mm -85.49 109.67 18.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.453 -0.573 . . . . 0.46999999999999997 109.453 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.587 ' HD3' HG21 ' A' ' 13' ' ' THR . 4.1 ptmt -125.0 129.13 49.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.232 0.539 . . . . 1.3400000000000001 111.158 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -101.07 114.62 28.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.644 -0.707 . . . . 0.5 109.801 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.505 HD11 ' CG ' ' A' ' 25' ' ' LYS . 10.5 tp -66.16 128.74 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.992 -0.549 . . . . 0.67000000000000004 109.792 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 0.5 OUTLIER -122.57 -78.3 0.6 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.993 0.425 . . . . 0.82999999999999996 110.776 -177.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -124.55 119.03 27.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.753 -0.658 . . . . 1.5600000000000001 109.983 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.591 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 43.7 mtpt -107.09 163.73 12.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.024 0.44 . . . . 2.9500000000000002 110.692 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.3 -124.67 5.24 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.428 -0.806 . . . . 1.3200000000000001 111.3 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -150.99 -86.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.129 0.49 . . . . 2.77 110.439 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -95.65 158.74 15.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.978 -0.556 . . . . 2.6400000000000001 110.526 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.37 53.79 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 111.218 -0.753 . . . . 1.04 111.218 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.43 -40.19 89.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.109 0.48 . . . . 2.29 110.2 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -106.51 27.18 9.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.493 0.663 . . . . 2.6400000000000001 109.802 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' OD1' ' HE3' ' A' ' 87' ' ' LYS . 36.1 m-80 -130.51 76.47 1.72 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.521 -0.763 . . . . 1.45 109.857 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.6 mm -130.48 120.53 18.89 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.066 -0.516 . . . . 0.81000000000000005 111.131 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.16 131.74 15.73 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.571 2.181 . . . . 0.75 111.52 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HB2' HD22 ' A' ' 38' ' ' ASN . 30.4 mmmt -126.05 142.22 51.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.623 -0.262 . . . . 2.6600000000000001 110.5 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 7.4 ttmm -71.22 138.64 49.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 2.5099999999999998 109.471 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.7 -27.15 13.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.809 -0.71 . . . . 1.1200000000000001 111.408 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.404 HD22 ' HB2' ' A' ' 35' ' ' LYS . 72.9 m-20 -88.88 145.37 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.82 -0.437 . . . . 1.3799999999999999 109.82 174.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 42.8 mt-10 -69.53 98.75 1.17 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.846 -0.615 . . . . 2.2000000000000002 112.126 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 125' ' ' PHE . 22.6 m -116.13 152.23 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 0.67000000000000004 109.828 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.4 m -127.36 131.05 50.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.683 -0.488 . . . . 0.65000000000000002 109.683 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 122' ' ' LEU . 10.7 m -137.12 152.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.276 0.56 . . . . 0.87 112.436 -173.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -105.38 129.44 53.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 2.75 109.58 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 8.7 p90 -134.27 140.13 46.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.854 0.359 . . . . 0.76000000000000001 111.474 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.14 158.6 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.54 -0.911 . . . . 0.48999999999999999 108.54 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -177.39 -126.63 0.99 Allowed Glycine 0 C--O 1.228 -0.227 0 C-N-CA 119.847 -1.168 . . . . 0.35999999999999999 113.019 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.573 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 20.6 pttp -155.45 170.68 21.38 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.575 -0.367 . . . . 1.4299999999999999 111.478 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HG ' ' A' ' 116' ' ' LEU . 66.0 tp -94.1 98.32 10.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.38 109.683 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 117' ' ' LEU . 2.4 tp10 -69.19 -20.65 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.309 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.543 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 5.5 t -55.31 -27.37 46.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.67000000000000004 111.504 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 t -138.18 9.22 2.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 0.72999999999999998 110.452 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.73 55.61 27.6 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.847 -0.615 . . . . 0.78000000000000003 112.636 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 27.1 mmmt -121.14 118.55 29.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.529 -0.175 . . . . 2.8900000000000001 110.529 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.573 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.5 p -69.6 153.99 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.864 0.364 . . . . 0.58999999999999997 110.973 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 7.7 m-30 -76.73 105.53 7.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.78000000000000003 110.624 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -130.82 85.58 2.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.549 0.69 . . . . 2.1800000000000002 109.81 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.32 156.17 28.29 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.587 -0.894 . . . . 1.24 108.587 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -68.33 -21.32 64.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.177 0.513 . . . . 1.49 110.77 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -94.62 -48.8 5.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 1.8 112.21 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -42.92 82.75 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.984 0.364 . . . . 2.1899999999999999 111.984 -169.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -77.49 -3.52 40.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.016 0.436 . . . . 2.7799999999999998 111.063 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.7 -45.73 8.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 1.1000000000000001 109.989 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.87 113.51 2.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 2.0299999999999998 110.52 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.22 171.4 17.85 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.798 2.332 . . . . 1.76 112.197 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -102.4 142.44 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.176 -0.466 . . . . 1.3100000000000001 110.175 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HD3' ' CG2' ' A' ' 41' ' ' THR . 0.0 OUTLIER -119.14 143.65 47.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 1.3600000000000001 108.996 175.476 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 55.8 p90 -133.44 169.89 16.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.56999999999999995 112.054 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.419 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 2.4 m80 -104.96 148.97 26.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.676 -1.147 . . . . 1.98 109.768 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 ' HB ' ' A' ' 82' ' ' VAL . 25.3 tp -73.15 129.99 39.28 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.747 -0.381 . . . . 0.94999999999999996 110.144 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 65.72 31.77 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.929 0.768 . . . . 2.0800000000000001 111.165 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 12.2 pt20 -80.9 12.57 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 1.98 111.114 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.57 48.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.035 -0.602 . . . . 0.71999999999999997 112.828 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HB2' HE21 ' A' ' 71' ' ' GLN . 17.1 mm-40 -87.5 -32.32 19.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.449 . . . . 0.96999999999999997 110.818 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.452 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.0 m -98.52 127.05 51.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.376 0.607 . . . . 0.57999999999999996 110.62 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.645 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.65 -76.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.62 112.27 -175.476 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.645 ' H ' HG12 ' A' ' 75' ' ' ILE . 4.2 mmpt? -121.15 -57.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.455 . . . . 2.04 112.23 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.16 -52.31 36.66 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.292 0.37 . . . . 0.32000000000000001 113.693 -171.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.63 -43.13 49.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.94 -0.153 . . . . 0.48999999999999999 111.373 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.491 ' HA ' ' CD1' ' A' ' 69' ' ' LEU . 23.2 t70 -51.87 -52.32 50.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.526 0.565 . . . . 1.1399999999999999 112.526 -171.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.532 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.7 mp -61.62 -50.97 78.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.451 . . . . 0.78000000000000003 111.296 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 120' ' ' ILE . 47.6 t -71.21 -27.41 63.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.55000000000000004 111.734 -171.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' HD13 ' A' ' 69' ' ' LEU . 53.7 t -66.24 -40.12 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.281 . . . . 0.83999999999999997 110.873 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 t -78.39 -7.84 57.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 1.4299999999999999 110.05 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.5 m -98.09 19.0 14.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 1.23 110.76 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 6.0 mmt -98.26 -173.53 2.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 2.27 111.726 -176.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 38.1 ttm180 -157.43 163.49 38.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.957 -1.127 . . . . 4.1900000000000004 107.957 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.504 ' HE3' ' OD1' ' A' ' 32' ' ' ASN . 5.3 tppp? -50.85 -40.51 56.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.032 0.382 . . . . 1.9399999999999999 112.032 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -118.96 34.17 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.237 . . . . 1.23 110.563 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 4.3 tt0 -122.7 140.09 53.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.722 -0.391 . . . . 1.6000000000000001 110.781 -175.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.9 tmtp? -145.57 129.18 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 1.1699999999999999 109.977 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 74.4 m -137.58 171.09 14.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.074 0.464 . . . . 1.2 111.687 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 119' ' ' GLU . 58.0 mt -105.83 131.68 52.87 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.502 -0.772 . . . . 1.73 109.983 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 95' ' ' ILE . 7.3 p -112.45 140.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.044 0.449 . . . . 0.73999999999999999 110.994 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.783 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 8.3 mmm180 -99.13 112.81 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.577 . . . . 1.71 110.028 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CD1' HG13 ' A' ' 93' ' ' VAL . 3.2 mp -101.45 107.51 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.52000000000000002 110.137 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 31.4 tt0 -84.51 171.81 12.21 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.856 -0.794 . . . . 1.3700000000000001 108.856 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.6 p -56.4 -38.21 71.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.645 0.259 . . . . 1.0 111.612 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -77.21 -7.85 56.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 1.79 111.434 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.502 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.8 m-30 -97.29 1.96 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.34 -0.225 . . . . 0.75 110.508 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.57 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -134.35 -152.59 6.69 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.94 -0.573 . . . . 0.70999999999999996 111.729 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.07 -70.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 1.52 110.746 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 111' ' ' PRO . . . 121.98 -175.42 16.3 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.2999999999999998 112.012 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -74.6 -6.92 51.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.913 0.387 . . . . 5.8600000000000003 110.41 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -61.96 -36.86 82.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 4.2699999999999996 111.155 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.48 -82.98 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.286 -0.959 . . . . 2.1600000000000001 112.539 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 86.1 m -81.8 113.48 19.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.272 0.558 . . . . 3.3399999999999999 111.168 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -117.08 83.8 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.411 -0.813 . . . . 1.2 111.228 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 108' ' ' GLU . 21.9 mp0 -53.77 -64.85 0.69 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.722 0.409 . . . . 3.0800000000000001 110.866 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m -112.21 -74.91 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.264 -0.426 . . . . 1.52 110.277 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -154.59 66.13 5.06 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 121.025 0.441 . . . . 0.75 110.594 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.513 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 11.0 Cg_endo -91.71 53.79 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.203 2.602 . . . . 1.5800000000000001 112.972 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.33 63.8 4.09 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.732 -0.746 . . . . 2.0499999999999998 112.045 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 51.73 66.25 1.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.602 0.715 . . . . 2.0299999999999998 110.407 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 49.6 m -144.93 168.45 20.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.328 -0.851 . . . . 1.1399999999999999 110.097 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.86 128.42 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.182 -0.463 . . . . 0.47999999999999998 110.415 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.1 mp -123.07 169.18 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.51000000000000001 110.293 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.16 131.64 37.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.448 -0.575 . . . . 0.69999999999999996 109.448 175.178 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 95' ' ' ILE . 37.9 m-85 -128.96 144.04 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.381 . . . . 0.42999999999999999 110.95 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.705 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 26.9 mt-10 -74.81 128.03 34.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.727 -0.842 . . . . 1.46 108.727 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 81' ' ' CYS . 25.8 mt -107.17 120.32 58.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.178 -0.675 . . . . 0.47999999999999998 109.178 172.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -127.07 118.07 23.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.482 -0.781 . . . . 1.8799999999999999 110.51 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HA ' HG12 ' A' ' 42' ' ' VAL . 35.8 tp -80.69 113.89 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 1.1200000000000001 109.902 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.94 -13.41 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.716 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.4 m -155.63 137.84 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.985 -0.376 . . . . 1.1899999999999999 109.985 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG12 ' A' ' 40' ' ' VAL . 9.0 p90 -160.81 175.0 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.71999999999999997 110.368 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.6 ptp180 -162.26 147.27 12.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 2.98 110.38 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.54 152.14 33.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.779 0.323 . . . . 3.3799999999999999 110.279 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 tt -151.76 127.05 9.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.06 -1.089 . . . . 3.3500000000000001 108.06 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.42 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 2.1 pp20? -96.79 167.2 11.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.02 0.438 . . . . 5.3899999999999997 112.022 -173.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -69.07 -43.3 74.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.774 -0.648 . . . . 7.04 111.86 -172.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 56.14 89.8 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.948 0.78 . . . . 7.21 111.975 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -108.4 127.81 54.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.653 -0.419 . . . . 9.0199999999999996 109.96 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -78.53 93.0 4.72 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.958 -0.564 . . . . 9.75 110.585 -176.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 36.9 p-80 -82.38 124.21 29.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 12.26 109.372 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 29.6 m-70 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.687 -1.149 . . . . 13.35 111.211 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.866 0.365 . . . . 7.4800000000000004 110.573 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.57 120.57 15.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 5.9000000000000004 112.11 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.2 p -95.28 12.04 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.286 0.565 . . . . 4.4400000000000004 110.485 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -120.19 138.36 53.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.665 . . . . 4.4400000000000004 110.27 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -89.96 163.32 15.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.451 -0.341 . . . . 4.1500000000000004 110.512 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.34 2.68 34.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 3.6099999999999999 111.036 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.46 158.16 15.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.377 -0.374 . . . . 3.6000000000000001 110.99 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -121.16 170.81 9.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.013 -0.54 . . . . 2.71 109.897 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 0.0 OUTLIER -90.86 157.24 17.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 1.8799999999999999 110.814 -175.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.44 HG11 ' HB ' ' A' ' 13' ' ' THR . 58.9 t -103.93 115.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.328 -0.619 . . . . 0.58999999999999997 109.328 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -87.92 99.82 12.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.474 -0.33 . . . . 2.1600000000000001 111.259 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' H ' HD13 ' A' ' 19' ' ' ILE . 66.1 mt 52.88 75.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 1.45 111.19 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.44 ' HB ' HG11 ' A' ' 10' ' ' VAL . 4.9 t -59.29 147.2 36.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 0.78000000000000003 110.32 175.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.38 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 0.81000000000000005 111.084 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.15 29.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 2.3999999999999999 111.084 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.35 -5.39 10.15 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.631 -0.795 . . . . 0.68000000000000005 113.933 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.19 71.02 1.09 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.94 -0.648 . . . . 0.60999999999999999 114.043 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.2 t -138.11 145.64 28.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.693 -0.484 . . . . 0.48999999999999999 109.693 173.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.0 mm -85.61 110.72 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.294 -0.412 . . . . 0.46999999999999997 110.802 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.51 147.24 40.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.286 -0.415 . . . . 1.3400000000000001 110.697 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 9' ' ' LYS . 26.4 m -112.98 139.46 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 0.5 110.392 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -80.03 134.97 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.147 -0.479 . . . . 0.67000000000000004 110.355 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.43 -71.16 0.72 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.086 0.47 . . . . 0.82999999999999996 110.503 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -105.47 97.54 7.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.291 -0.633 . . . . 1.5600000000000001 109.291 -177.531 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -75.21 138.82 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.884 0.373 . . . . 2.9500000000000002 110.855 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.69 135.59 14.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.97 -0.633 . . . . 1.3200000000000001 111.681 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.71 -55.21 37.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 2.77 110.174 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.59 170.27 19.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.39 -0.823 . . . . 2.6400000000000001 109.579 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.83 43.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 1.04 111.369 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.52 -38.0 85.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.949 0.404 . . . . 2.29 111.143 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -94.57 -20.55 19.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.809 -0.632 . . . . 2.6400000000000001 110.509 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 38.8 m-80 -95.3 81.81 3.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.129 -0.487 . . . . 1.45 110.927 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.36 120.56 26.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.81000000000000005 111.377 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.4 Cg_endo -76.49 132.75 13.76 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.204 2.603 . . . . 0.75 111.4 174.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HD3' ' OG ' ' A' ' 83' ' ' SER . 34.3 mmtm -148.78 158.94 44.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.667 0.27 . . . . 2.6600000000000001 111.109 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -55.75 128.47 35.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.961 -0.563 . . . . 2.5099999999999998 110.465 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.75 -26.59 20.65 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.9 -0.591 . . . . 1.1200000000000001 111.793 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -83.63 140.22 32.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.652 -0.499 . . . . 1.3799999999999999 109.652 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' A' ' 68' ' ' HIS . 1.7 tm-20 -76.91 101.59 6.01 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.325 -0.62 . . . . 2.2000000000000002 109.325 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 125' ' ' PHE . 26.3 m -115.49 133.83 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.781 -0.645 . . . . 0.67000000000000004 111.309 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' HD3' ' A' ' 66' ' ' LYS . 17.4 m -103.26 106.93 17.57 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.5 -0.555 . . . . 0.65000000000000002 109.5 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 m -119.34 141.66 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.551 0.691 . . . . 0.87 112.582 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.42 148.67 25.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.944 -1.025 . . . . 2.75 109.601 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 2.5 p90 -144.24 140.88 29.51 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.226 0.329 . . . . 0.76000000000000001 110.596 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -168.04 160.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.377 -0.601 . . . . 0.48999999999999999 109.377 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 171.32 -137.87 4.6 Favored Glycine 0 C--N 1.329 0.15 0 C-N-CA 119.59 -1.29 . . . . 0.35999999999999999 113.249 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.9 pttp -143.49 171.71 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 1.4299999999999999 110.497 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD22 HG13 ' A' ' 110' ' ' ILE . 42.7 tp -95.0 101.93 13.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.155 -0.475 . . . . 0.38 110.131 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.1 tp10 -61.68 -35.28 77.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 1.96 110.575 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 t -55.21 -32.08 61.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 0.67000000000000004 112.55 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 53' ' ' LYS . 8.8 t -123.35 -4.05 8.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.885 0.374 . . . . 0.72999999999999998 110.96 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.03 26.06 74.59 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.183 -0.532 . . . . 0.78000000000000003 113.189 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HG2' HG23 ' A' ' 51' ' ' THR . 75.4 mmtt -109.18 140.01 43.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.168 0.509 . . . . 2.8900000000000001 110.616 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 p -84.59 159.99 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.883 -0.599 . . . . 0.58999999999999997 110.035 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -74.35 131.5 41.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.116 -0.327 . . . . 0.78000000000000003 110.116 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.57 89.9 1.6 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.313 0.577 . . . . 2.1800000000000002 109.535 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -136.95 168.08 20.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.879 -0.6 . . . . 1.24 111.099 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -62.58 -29.14 70.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.49 111.403 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -92.65 -44.54 8.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.147 0.425 . . . . 1.8 112.147 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -32.45 72.79 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 2.1899999999999999 111.978 -169.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -94.2 -14.07 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.838 -0.345 . . . . 2.7799999999999998 111.21 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -100.32 -44.82 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.358 . . . . 1.1000000000000001 111.467 -173.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 3.5 m -129.31 98.82 22.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.669 0.747 . . . . 2.0299999999999998 111.794 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 63' ' ' VAL . 46.5 Cg_endo -70.98 128.48 14.96 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.206 1.938 . . . . 1.76 111.52 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -95.86 148.29 22.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 1.3100000000000001 110.521 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD3' HG23 ' A' ' 41' ' ' THR . 2.4 pptp? -133.07 143.66 49.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 1.3600000000000001 109.658 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -128.87 -178.72 4.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.56999999999999995 111.548 -173.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' A' ' 39' ' ' GLU . 8.4 m-70 -114.04 149.68 35.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.659 . . . . 1.98 110.437 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.75 HD11 ' HA ' ' A' ' 79' ' ' ASP . 22.9 tp -67.37 122.81 18.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.94999999999999996 111.787 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 42.39 72.5 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.222 1.009 . . . . 2.0800000000000001 112.259 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -119.71 19.09 12.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.709 0.766 . . . . 1.98 110.587 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.5 -18.85 46.87 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.276 -0.874 . . . . 0.71999999999999997 112.835 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.83 -50.96 6.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.407 0.622 . . . . 0.96999999999999997 109.617 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -100.16 132.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.604 -0.726 . . . . 0.57999999999999996 110.381 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.501 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.04 -74.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.799 0.666 . . . . 0.62 112.799 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 75' ' ' ILE . 19.8 mtpp -128.82 -40.81 1.51 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.876 -0.515 . . . . 2.04 112.174 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -49.51 52.58 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.824 -0.703 . . . . 0.32000000000000001 112.462 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 82' ' ' VAL . 14.7 m-90 -76.02 -41.09 52.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.626 0.25 . . . . 0.48999999999999999 110.858 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.75 ' HA ' HD11 ' A' ' 69' ' ' LEU . 35.0 t70 -56.02 -53.41 57.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.964 -0.562 . . . . 1.1399999999999999 112.329 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.75 -33.35 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.78000000000000003 110.873 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -69.25 -50.0 51.08 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.805 -0.358 . . . . 0.55000000000000004 110.243 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 69' ' ' LEU . 89.4 t -63.29 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.496 -0.32 . . . . 0.83999999999999997 111.338 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.442 ' OG ' ' HD3' ' A' ' 35' ' ' LYS . 23.3 t -71.69 -8.47 54.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.813 0.34 . . . . 1.4299999999999999 111.456 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 t -114.0 23.05 13.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.112 0.482 . . . . 1.23 110.389 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.576 ' HE1' ' HA ' ' A' ' 90' ' ' LYS . 82.8 mmm -99.45 177.33 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 2.27 111.332 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.58 ' HB2' ' CB ' ' A' ' 89' ' ' GLU . 97.1 mtt180 -141.08 159.4 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 4.1900000000000004 108.417 173.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 63.9 tttm -66.45 -21.68 66.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.093 0.473 . . . . 1.9399999999999999 111.087 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.77 12.13 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 1.23 110.703 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.58 ' CB ' ' HB2' ' A' ' 86' ' ' ARG . 18.2 tt0 -122.64 156.26 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.443 -0.344 . . . . 1.6000000000000001 110.444 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.576 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 75.3 tttt -156.51 134.93 11.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.367 -0.379 . . . . 1.1699999999999999 110.704 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 64.3 m -139.07 171.66 13.99 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.89 0.7 . . . . 1.2 112.89 -173.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.33 125.75 53.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.23 -0.895 . . . . 1.73 110.062 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.492 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 13.9 p -117.73 150.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.896 0.379 . . . . 0.73999999999999999 111.101 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -108.27 115.54 30.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 1.71 110.226 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 118' ' ' PHE . 1.9 mp -87.86 103.8 13.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.163 -0.681 . . . . 0.52000000000000002 109.163 176.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.616 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 22.1 tt0 -86.58 176.12 7.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.047 -0.979 . . . . 1.3700000000000001 109.293 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 20.6 p -49.93 -48.94 51.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.268 0.47 . . . . 1.0 112.268 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.04 -7.83 56.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.307 . . . . 1.79 111.72 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.616 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.4 m-30 -94.68 -9.52 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.57 0.224 . . . . 0.75 110.724 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 -171.74 14.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.044 -0.598 . . . . 0.70999999999999996 111.797 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.446 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 22.3 m-85 -88.45 -33.69 17.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 1.52 110.835 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.31 -154.42 33.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.643 -0.789 . . . . 2.2999999999999998 112.642 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.1 -30.28 34.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.984 0.421 . . . . 5.8600000000000003 111.224 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -87.38 11.25 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.45 0.643 . . . . 4.2699999999999996 110.533 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -133.96 -135.07 3.51 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.751 -0.659 . . . . 2.1600000000000001 111.645 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 68.9 m -104.54 120.6 41.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 3.3399999999999999 110.436 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -110.98 120.8 5.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.768 -0.73 . . . . 1.2 112.093 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.24 -70.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.782 0.325 . . . . 3.0800000000000001 111.257 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.414 ' CB ' HD13 ' A' ' 110' ' ' ILE . 14.4 m -105.41 -74.73 0.64 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.861 -0.336 . . . . 1.52 111.013 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.766 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.0 57.07 3.28 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-O 120.646 0.26 . . . . 0.75 111.537 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 55.5 Cg_endo -97.7 59.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.115 2.543 . . . . 1.5800000000000001 112.538 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.6 56.14 4.16 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.729 -0.748 . . . . 2.0499999999999998 112.043 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 67.01 14.14 9.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.322 0.649 . . . . 2.0299999999999998 109.82 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -86.55 159.56 19.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.343 -0.844 . . . . 1.1399999999999999 110.406 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.87 128.07 43.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.017 0.437 . . . . 0.47999999999999998 110.694 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.6 mp -122.36 165.86 15.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.456 . . . . 0.51000000000000001 110.544 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -116.56 113.1 22.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.409 -0.589 . . . . 0.69999999999999996 109.409 176.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 95' ' ' ILE . 13.4 m-85 -111.86 124.69 52.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.374 0.607 . . . . 0.42999999999999999 110.89 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.699 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.0 tm-20 -83.0 120.54 25.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.886 -1.052 . . . . 1.46 109.172 174.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.452 HG21 HG22 ' A' ' 82' ' ' VAL . 48.4 mt -109.34 130.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.223 0.535 . . . . 0.47999999999999998 111.098 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -126.01 121.66 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.347 -0.842 . . . . 1.8799999999999999 110.329 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' A' ' 34' ' ' PRO . 27.7 tp -87.03 89.7 8.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.948 -0.76 . . . . 1.1200000000000001 108.948 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 3.3 pp -91.71 -25.77 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.762 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 m -154.13 142.26 20.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.758 0.313 . . . . 1.1899999999999999 110.546 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.645 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -167.43 179.6 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.245 -0.65 . . . . 0.71999999999999997 109.245 175.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -159.64 158.99 32.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.983 0.421 . . . . 2.98 110.682 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.21 115.54 28.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 3.3799999999999999 110.492 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -108.59 113.54 26.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.387 -0.37 . . . . 3.3500000000000001 110.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -96.28 145.09 25.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.199 -0.455 . . . . 5.3899999999999997 111.197 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -128.86 -58.23 1.16 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.377 -0.601 . . . . 7.04 109.377 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 69.26 152.73 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.754 0.659 . . . . 7.21 110.802 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -116.07 -26.58 7.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.262 0.553 . . . . 9.0199999999999996 109.772 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -66.49 127.56 32.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.445 -0.798 . . . . 9.75 109.495 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -67.35 93.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.199 0.523 . . . . 12.26 110.524 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.252 1.218 0 CA-C-N 115.304 -0.862 . . . . 13.35 110.381 -177.29 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.275 -0.269 . . . . 7.4800000000000004 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.83 115.16 3.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.485 0.659 . . . . 5.9000000000000004 111.014 174.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.8 p -86.89 -68.04 0.77 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.185 -0.916 . . . . 4.4400000000000004 109.114 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 47.12 92.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 O-C-N 124.097 0.873 . . . . 4.4400000000000004 112.202 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -52.13 151.31 3.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.26 -0.882 . . . . 4.1500000000000004 111.771 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -81.64 90.98 6.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 3.6099999999999999 111.109 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.94 144.93 26.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.037 0.446 . . . . 3.6000000000000001 110.807 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.91 142.51 33.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.549 -0.751 . . . . 2.71 109.417 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -82.88 148.63 27.59 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 1.8799999999999999 109.475 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.2 t -101.87 104.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.759 . . . . 0.58999999999999997 108.952 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -91.25 110.37 21.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 2.1600000000000001 110.957 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' H ' HD13 ' A' ' 19' ' ' ILE . 87.0 mt 64.38 67.63 0.57 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.082 -0.963 . . . . 1.45 110.574 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 15' ' ' ASP . 14.7 t -74.45 167.66 21.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.03 -0.532 . . . . 0.78000000000000003 110.696 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -0.82 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.81000000000000005 112.004 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.703 ' OD2' ' HA ' ' A' ' 80' ' ' ILE . 8.4 t70 -79.09 -0.61 32.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.248 0.546 . . . . 2.3999999999999999 110.423 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.16 22.94 2.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.598 -0.811 . . . . 0.68000000000000005 113.69 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 75.68 72.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.091 -0.576 . . . . 0.60999999999999999 114.524 171.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 80' ' ' ILE . 38.8 t -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.937 -0.394 . . . . 0.48999999999999999 109.937 172.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 12' ' ' LEU . 7.7 mm -89.75 112.64 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.46999999999999997 110.845 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' HG22 ' A' ' 93' ' ' VAL . 64.3 pttt -136.96 145.97 44.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 1.3400000000000001 111.382 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -107.95 123.62 48.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.5 110.232 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 91' ' ' CYS . 8.2 tp -83.98 130.95 35.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.67000000000000004 110.997 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD21 ' HG ' ' A' ' 92' ' ' LEU . 2.5 mm? -100.14 -60.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.339 0.59 . . . . 0.82999999999999996 109.733 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -122.26 122.71 39.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 1.5600000000000001 109.659 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -82.28 147.48 28.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.295 -0.412 . . . . 2.9500000000000002 111.38 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.94 144.12 33.19 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.509 -1.036 . . . . 1.3200000000000001 110.509 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.13 -78.14 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.275 0.538 . . . . 2.77 109.62 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.58 164.83 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.218 -0.66 . . . . 2.6400000000000001 109.218 171.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 86' ' ' ARG . . . 157.24 70.35 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.957 -1.115 . . . . 1.04 113.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -75.36 -30.89 60.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.42 0.629 . . . . 2.29 110.14 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -86.39 -39.0 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.389 -0.823 . . . . 2.6400000000000001 111.419 -174.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.772 ' HB2' HH21 ' A' ' 86' ' ' ARG . 93.9 m-20 -93.66 79.54 4.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.186 0.517 . . . . 1.45 111.096 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.09 125.63 21.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.073 -0.967 . . . . 0.81000000000000005 110.338 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.5 ' HG3' HD22 ' A' ' 122' ' ' LEU . 67.5 Cg_endo -73.57 140.39 29.7 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.908 2.405 . . . . 0.75 111.542 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 14.2 mmmm -127.41 147.68 50.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.426 -0.583 . . . . 2.6600000000000001 109.426 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.628 ' HA ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.31 149.14 48.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.774 -0.371 . . . . 2.5099999999999998 111.242 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.89 -17.29 53.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.836 -0.697 . . . . 1.1200000000000001 111.966 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.535 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 81.5 m-20 -85.68 175.89 8.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 1.3799999999999999 111.083 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -97.48 121.57 39.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.534 -0.757 . . . . 2.2000000000000002 109.747 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG11 HD23 ' A' ' 69' ' ' LEU . 6.9 m -140.99 166.64 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.767 0.318 . . . . 0.67000000000000004 110.446 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.547 HG23 ' HD3' ' A' ' 66' ' ' LYS . 21.0 m -133.97 116.94 16.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.65000000000000002 110.408 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 122' ' ' LEU . 34.9 m -134.87 145.25 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.437 -0.347 . . . . 0.87 110.687 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -100.84 140.52 35.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.415 -0.587 . . . . 2.75 109.415 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 42.6 p90 -125.75 135.47 52.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 111.397 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.87 155.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.391 -0.966 . . . . 0.48999999999999999 108.391 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 178.61 -130.03 1.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.744 -1.217 . . . . 0.35999999999999999 113.27 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 57.2 pttt -147.06 171.32 15.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 1.4299999999999999 110.313 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 110' ' ' ILE . 61.7 tp -96.73 98.39 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.38 109.914 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.736 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.3 tp10 -68.65 -22.41 64.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.248 0.546 . . . . 1.96 110.547 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -25.43 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.389 -0.823 . . . . 0.67000000000000004 111.407 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.616 HG23 ' HD3' ' A' ' 53' ' ' LYS . 7.9 t -132.97 -19.31 2.27 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.986 0.422 . . . . 0.72999999999999998 111.072 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 53' ' ' LYS . . . 91.6 34.82 7.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.28 -0.486 . . . . 0.78000000000000003 112.853 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HD3' HG23 ' A' ' 51' ' ' THR . 13.7 mptt -116.97 134.93 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.75 0.309 . . . . 2.8900000000000001 110.989 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.564 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.1 p -79.31 156.39 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.935 -0.575 . . . . 0.58999999999999997 110.838 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -74.25 131.15 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.78000000000000003 111.04 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.01 89.13 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.833 -0.621 . . . . 2.1800000000000002 109.882 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.2 m -124.99 147.03 49.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.533 -0.758 . . . . 1.24 110.094 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 m -59.24 -20.4 53.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.987 -0.551 . . . . 1.49 111.127 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -92.3 -50.85 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.171 -0.468 . . . . 1.8 111.901 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -32.4 72.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.936 0.347 . . . . 2.1899999999999999 111.936 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -83.4 1.83 39.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.346 0.593 . . . . 2.7799999999999998 110.26 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -109.23 -48.64 3.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.37 -0.832 . . . . 1.1000000000000001 110.448 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.13 126.15 4.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.036 0.446 . . . . 2.0299999999999998 111.085 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.53 162.06 19.4 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.78 2.32 . . . . 1.76 112.327 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -104.09 154.83 19.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.752 -0.462 . . . . 1.3100000000000001 109.752 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.15 136.12 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 1.3600000000000001 110.692 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -114.44 -174.23 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.553 -0.294 . . . . 0.56999999999999995 110.518 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.55 ' HB2' HE21 ' A' ' 71' ' ' GLN . 80.4 m-70 -126.45 153.05 45.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.269 -0.271 . . . . 1.98 110.269 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -51.34 151.93 2.74 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.457 0.473 . . . . 0.94999999999999996 111.659 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -22.2 98.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 113.318 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.55 HE21 ' HB2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -129.8 8.07 5.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.508 -1.224 . . . . 1.98 108.98 176.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.13 -10.45 43.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.71999999999999997 113.409 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -85.23 -46.56 10.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.804 0.802 . . . . 0.96999999999999997 109.248 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.55 134.06 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.031 -0.531 . . . . 0.57999999999999996 110.575 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.662 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.6 -69.83 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.461 0.541 . . . . 0.62 112.461 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.58 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -140.96 -45.66 0.39 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.563 0.579 . . . . 2.04 112.563 -173.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 99' ' ' TYR . . . -52.83 -53.12 34.79 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.944 -0.646 . . . . 0.32000000000000001 113.005 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.514 ' O ' HG22 ' A' ' 82' ' ' VAL . 18.3 m-90 -76.69 -31.01 56.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 0.48999999999999999 110.75 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -57.92 -49.14 77.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.46 -0.791 . . . . 1.1399999999999999 111.759 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.703 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . 1.6 mp -59.69 -31.32 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.124 0.487 . . . . 0.78000000000000003 111.051 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.767 ' HB2' HG21 ' A' ' 93' ' ' VAL . 14.9 t -77.05 -58.05 3.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.334 -0.546 . . . . 0.55000000000000004 110.713 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.67 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 15.5 m -62.13 -33.54 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.791 0.664 . . . . 0.83999999999999997 112.791 -170.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t -92.12 5.66 49.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.079 0.466 . . . . 1.4299999999999999 110.974 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 32.0 t -137.73 30.09 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.228 0.537 . . . . 1.23 110.083 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.67 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 45.3 mtm -106.59 -172.12 2.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 2.27 110.373 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.772 HH21 ' HB2' ' A' ' 32' ' ' ASN . 14.5 mtp-105 -138.73 170.74 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.515 . . . . 4.1900000000000004 110.212 171.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -64.12 -20.57 66.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.282 -0.417 . . . . 1.9399999999999999 111.621 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -127.05 16.57 7.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.36 -0.382 . . . . 1.23 111.106 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 2.1 tm-20 -110.38 153.72 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -158.86 123.33 4.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.691 -0.231 . . . . 1.1699999999999999 110.551 -173.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 1.6 p -136.53 159.05 42.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.437 -0.347 . . . . 1.2 111.421 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 23' ' ' LEU . 97.9 mt -105.2 127.17 52.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.12 -0.491 . . . . 1.73 110.852 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 81' ' ' CYS . 39.1 t -105.74 151.08 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.968 -0.56 . . . . 0.73999999999999999 111.015 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.36 112.17 25.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.445 -0.576 . . . . 1.71 109.445 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.4 mp -90.3 105.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.52000000000000002 110.43 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 97' ' ' SER . 34.0 tt0 -82.29 166.09 19.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 1.3700000000000001 109.12 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 3.6 p -52.99 -42.94 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.565 0.58 . . . . 1.0 112.565 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -76.99 -7.91 56.46 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.882 -0.327 . . . . 1.79 111.5 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.402 ' HB3' ' CA ' ' A' ' 77' ' ' GLY . 22.0 m-30 -89.03 -1.48 58.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.017 0.437 . . . . 0.75 110.196 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.662 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -146.3 -165.42 11.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.681 -0.69 . . . . 0.70999999999999996 111.411 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -87.77 80.51 7.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.304 0.552 . . . . 1.52 110.336 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -91.53 -29.46 12.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 2.2999999999999998 112.427 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.64 -56.9 5.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.032 0.444 . . . . 5.8600000000000003 110.044 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.92 -40.36 79.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.69 -0.686 . . . . 4.2699999999999996 110.149 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 82.3 1.65 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.876 -0.678 . . . . 2.1600000000000001 112.786 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.2 t -93.66 118.81 31.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.406 -0.59 . . . . 3.3399999999999999 109.406 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.594 ' HA2' ' HG3' ' A' ' 111' ' ' PRO . . . -120.62 121.87 5.02 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.35 -0.928 . . . . 1.2 113.506 -175.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -111.51 -67.68 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.786 0.327 . . . . 3.0800000000000001 110.182 171.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.403 ' CB ' HD13 ' A' ' 110' ' ' ILE . 13.6 m -108.41 -74.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.921 -0.312 . . . . 1.52 111.241 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.556 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.04 81.82 10.33 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 121.15 0.5 . . . . 0.75 111.432 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.594 ' HG3' ' HA2' ' A' ' 107' ' ' GLY . 64.2 Cg_endo -102.7 -149.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.303 3.335 . . . . 1.5800000000000001 111.891 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.31 73.31 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.838 -0.696 . . . . 2.0499999999999998 112.288 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 15.6 m120 56.73 23.61 8.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.118 0.485 . . . . 2.0299999999999998 111.188 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 m -114.0 151.59 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.96 -0.564 . . . . 1.1399999999999999 109.594 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.13 132.63 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.599 . . . . 0.47999999999999998 111.295 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -125.02 165.29 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.51000000000000001 109.999 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -124.83 124.74 42.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.178 -0.675 . . . . 0.69999999999999996 109.178 173.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.67 143.24 47.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.74 -0.209 . . . . 0.42999999999999999 110.553 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 38.5 mt-10 -62.63 136.49 57.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.738 -0.467 . . . . 1.46 109.738 168.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 ' SD ' ' A' ' 85' ' ' MET . 22.3 mt -128.09 116.85 44.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.229 -1.026 . . . . 0.47999999999999998 108.229 169.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -135.17 111.47 9.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.692 -0.685 . . . . 1.8799999999999999 110.535 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.688 ' HA ' HG12 ' A' ' 42' ' ' VAL . 23.0 tp -81.47 100.09 9.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.361 -0.381 . . . . 1.1200000000000001 110.788 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -104.81 -9.45 18.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.868 0.366 . . . . 1.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 67.5 m -155.28 139.52 16.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 1.1899999999999999 110.524 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.504 ' HB3' HD11 ' A' ' 122' ' ' LEU . 7.8 p90 -165.74 150.29 8.44 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.29 0.369 . . . . 0.71999999999999997 110.222 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.489 ' HE ' ' HB3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -146.24 127.33 14.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.943 0.401 . . . . 2.98 110.922 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.24 122.91 29.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.511 -0.768 . . . . 3.3799999999999999 111.178 -176.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.541 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 50.7 tp -143.17 -103.2 0.13 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.691 -0.231 . . . . 3.3500000000000001 111.414 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 7.6 mt-10 171.57 -178.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.484 1.114 . . . . 5.3899999999999997 108.3 -172.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -95.38 -54.81 3.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.91 -0.404 . . . . 7.04 109.91 171.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -177.93 -29.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.248 -0.433 . . . . 7.21 110.956 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.2 t60 46.18 79.56 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.908 0.755 . . . . 9.0199999999999996 111.685 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -176.76 94.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.752 -1.203 . . . . 9.75 107.752 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.53 -31.97 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 12.26 111.902 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.4 t60 . . . . . 0 C--O 1.243 0.719 0 CA-C-O 118.284 -0.865 . . . . 13.35 109.226 175.315 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttm . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.803 0.335 . . . . 7.4800000000000004 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -145.88 -30.67 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.426 -0.352 . . . . 5.9000000000000004 110.992 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.2 m 64.28 97.66 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.914 0.388 . . . . 4.4400000000000004 111.051 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.47 103.57 2.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.772 -0.455 . . . . 4.4400000000000004 109.772 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.27 131.34 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.492 -0.777 . . . . 4.1500000000000004 111.087 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -81.39 99.83 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.422 -0.584 . . . . 3.6099999999999999 109.422 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.87 137.01 34.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.659 -0.7 . . . . 3.6000000000000001 111.158 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -81.63 151.61 27.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.675 -0.693 . . . . 2.71 109.145 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.58 145.84 25.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.79 0.329 . . . . 1.8799999999999999 110.274 -177.199 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 13' ' ' THR . 21.8 t -101.97 103.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.965 -1.124 . . . . 0.58999999999999997 107.965 170.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.558 ' HG2' HG23 ' A' ' 19' ' ' ILE . 45.9 mt-10 -102.47 120.84 41.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.714 . . . . 2.1600000000000001 110.622 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.9 tp 65.54 50.93 1.58 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.241 -0.89 . . . . 1.45 109.436 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.498 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.9 t -62.97 159.46 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.78000000000000003 111.617 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 2.11 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 0.81000000000000005 111.436 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.6 ' O ' HG13 ' A' ' 80' ' ' ILE . 40.3 m-20 -83.61 7.79 16.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.172 -0.467 . . . . 2.3999999999999999 111.367 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.36 22.6 2.29 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.394 -0.908 . . . . 0.68000000000000005 113.555 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.89 62.7 4.32 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.293 -0.48 . . . . 0.60999999999999999 114.083 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.475 ' HB ' HG21 ' A' ' 80' ' ' ILE . 39.4 t -137.62 152.77 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.081 0.44 . . . . 0.48999999999999999 110.224 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.558 HG23 ' HG2' ' A' ' 11' ' ' GLU . 18.1 mm -85.36 109.7 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.474 -0.565 . . . . 0.46999999999999997 109.474 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -118.99 130.45 55.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 110.65 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 m -109.94 117.69 34.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.097 -0.502 . . . . 0.5 110.703 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.509 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.2 tp -74.77 131.71 34.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.67000000000000004 111.356 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 2.6 mm? -120.76 -81.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.82999999999999996 111.362 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -89.44 134.3 34.15 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.928 0.394 . . . . 1.5600000000000001 110.309 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 41.3 mtmt -111.34 113.18 25.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.779 -0.646 . . . . 2.9500000000000002 110.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.526 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -73.71 -151.74 2.08 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.219 -0.515 . . . . 1.3200000000000001 111.89 174.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.47 -97.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.104 -0.645 . . . . 2.77 111.725 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.72 126.45 36.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.46 0.647 . . . . 2.6400000000000001 110.934 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -140.51 47.79 0.86 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.582 -0.818 . . . . 1.04 112.611 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.15 -42.11 99.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 2.29 109.945 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.25 28.2 8.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.977 -1.01 . . . . 2.6400000000000001 109.4 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.403 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -135.79 76.87 1.63 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.45 110.89 -179.171 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.54 HG22 ' HD3' ' A' ' 35' ' ' LYS . 30.8 mm -141.94 116.28 6.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 123.265 0.353 . . . . 0.81000000000000005 111.274 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 28.1 Cg_endo -63.41 138.69 67.03 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.058 2.505 . . . . 0.75 111.065 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HD3' HG22 ' A' ' 33' ' ' ILE . 6.0 mmmm -126.54 155.07 42.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.106 0.479 . . . . 2.6600000000000001 111.713 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -70.38 117.54 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.17 -0.923 . . . . 2.5099999999999998 110.291 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.81 -26.88 22.82 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.99 -0.624 . . . . 1.1200000000000001 111.923 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.69 154.19 42.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 1.3799999999999999 110.179 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 40.8 mt-10 -76.99 99.9 5.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.113 0.482 . . . . 2.2000000000000002 110.822 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.659 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.3 m -118.64 143.61 29.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.335 -0.617 . . . . 0.67000000000000004 109.335 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.7 m -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.267 -0.642 . . . . 0.65000000000000002 109.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.38 139.35 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.334 0.587 . . . . 0.87 111.839 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -104.39 134.88 46.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 2.75 110.39 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -123.87 136.82 54.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.76000000000000001 110.464 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.45 153.23 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.488 -0.93 . . . . 0.48999999999999999 108.488 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.93 -124.44 0.91 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.775 -1.202 . . . . 0.35999999999999999 113.231 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.7 pttp -157.61 170.12 23.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 1.4299999999999999 111.0 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 69.8 tp -97.26 103.18 15.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.506 -0.77 . . . . 0.38 110.145 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.854 ' HB2' HD11 ' A' ' 117' ' ' LEU . 6.5 tp10 -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.873 0.368 . . . . 1.96 110.151 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 115' ' ' VAL . 8.3 t -55.4 -28.92 57.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 0.67000000000000004 112.089 -174.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 t -140.26 14.55 2.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.285 0.564 . . . . 0.72999999999999998 110.486 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.9 44.33 96.13 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.336 -0.847 . . . . 0.78000000000000003 113.065 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 12.2 mmmt -105.98 126.03 51.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.278 -0.267 . . . . 2.8900000000000001 110.278 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.1 p -83.99 159.48 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.509 -0.552 . . . . 0.58999999999999997 109.509 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -75.04 102.94 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 0.78000000000000003 110.984 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -125.58 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.604 0.716 . . . . 2.1800000000000002 109.835 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.8 m -126.11 169.22 13.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.959 -0.564 . . . . 1.24 110.536 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -71.44 -26.31 62.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.088 0.47 . . . . 1.49 110.818 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.2 -44.77 7.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.923 -0.58 . . . . 1.8 112.371 -170.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -44.82 80.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.989 0.366 . . . . 2.1899999999999999 111.989 -169.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -77.1 -9.17 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.423 . . . . 2.7799999999999998 110.938 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.13 -61.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.018 -0.537 . . . . 1.1000000000000001 109.978 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.23 109.77 7.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.446 0.641 . . . . 2.0299999999999998 110.474 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.07 158.18 38.08 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.58 2.187 . . . . 1.76 112.543 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.56 154.07 19.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 1.3100000000000001 109.775 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -129.91 159.54 36.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 1.3600000000000001 109.999 178.417 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.69 173.35 11.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.56999999999999995 111.066 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -116.01 140.17 49.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.408 -0.815 . . . . 1.98 109.609 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 82' ' ' VAL . 26.4 tp -69.1 131.91 45.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.232 -0.284 . . . . 0.94999999999999996 110.232 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.56 79.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.92 0.867 . . . . 2.0800000000000001 109.232 -169.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.531 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 28.4 tt0 -131.64 -3.6 3.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.341 -1.3 . . . . 1.98 110.211 -174.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.6 -18.53 24.48 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.998 -0.62 . . . . 0.71999999999999997 112.353 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 2.1 mm-40 -93.64 -11.39 31.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.96999999999999997 109.954 -177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.17 124.48 64.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.57999999999999996 109.702 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.1 -61.45 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.62 112.925 -176.489 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 mmpt? -138.11 -48.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 2.04 111.881 -173.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.08 -50.72 44.29 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.037 -0.601 . . . . 0.32000000000000001 113.12 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.12 -41.16 59.06 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.807 -0.231 . . . . 0.48999999999999999 110.433 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.63 -51.57 54.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.607 -0.724 . . . . 1.1399999999999999 112.041 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.7 mp -63.04 -42.97 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.78000000000000003 111.52 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.558 ' HB3' HD12 ' A' ' 120' ' ' ILE . 49.3 t -75.32 -42.34 54.75 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.848 0.314 . . . . 0.55000000000000004 111.848 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 69' ' ' LEU . 35.4 m -69.15 -34.41 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.779 0.288 . . . . 0.83999999999999997 111.779 -175.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 p -72.03 -16.44 62.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 110.814 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.7 m -97.57 8.26 44.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.981 -0.554 . . . . 1.23 110.928 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 20.1 mmt -93.94 -173.65 3.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 2.27 111.495 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 33.6 mtp-105 -143.2 -171.27 3.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.349 -0.841 . . . . 4.1900000000000004 109.002 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.42 -24.63 67.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.299 0.374 . . . . 1.9399999999999999 111.992 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -135.39 15.28 3.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 1.23 111.309 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -79.87 159.94 26.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.889 0.376 . . . . 1.6000000000000001 110.683 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -158.36 132.45 7.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.089 -0.505 . . . . 1.1699999999999999 110.354 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 99.9 m -150.7 170.93 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 1.2 110.816 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.34 124.95 52.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.54 . . . . 1.73 110.237 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 95' ' ' ILE . 6.3 p -100.76 146.22 9.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.15 -0.477 . . . . 0.73999999999999999 110.264 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.541 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 12.3 mmt180 -98.63 112.06 24.23 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.177 -0.675 . . . . 1.71 109.177 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.628 HD11 HG13 ' A' ' 93' ' ' VAL . 4.1 mp -98.04 103.87 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.52000000000000002 110.447 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.557 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 27.6 tt0 -86.49 170.73 11.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.336 -0.987 . . . . 1.3700000000000001 108.336 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.9 p -51.69 -38.32 54.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.826 0.306 . . . . 1.0 111.826 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -77.71 -8.72 58.35 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.042 0.386 . . . . 1.79 112.042 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.557 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 20.6 m-85 -102.62 -16.36 16.09 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.752 0.31 . . . . 0.75 110.607 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.36 -163.01 12.45 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.252 -0.739 . . . . 0.70999999999999996 111.252 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -99.07 90.86 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.52 110.992 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.28 -20.24 10.59 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.65 -0.786 . . . . 2.2999999999999998 111.559 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.88 -47.46 18.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.286 0.565 . . . . 5.8600000000000003 110.901 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -87.24 -17.81 31.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 4.2699999999999996 111.355 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.15 -11.68 68.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.643 -0.789 . . . . 2.1600000000000001 113.232 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.82 97.43 1.39 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.439 0.637 . . . . 3.3399999999999999 111.145 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -130.3 149.07 18.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.917 -0.659 . . . . 1.2 111.684 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -78.69 -69.39 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.872 0.323 . . . . 3.0800000000000001 111.872 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.405 ' CB ' HD13 ' A' ' 110' ' ' ILE . 5.9 m -89.41 -74.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 1.52 111.426 -175.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.405 HD13 ' CB ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -147.45 96.75 4.13 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.059 0.457 . . . . 0.75 111.45 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.532 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 62.1 Cg_endo -91.5 -164.1 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.833 2.355 . . . . 1.5800000000000001 111.888 173.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 121.7 50.26 0.25 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.382 -0.913 . . . . 2.0499999999999998 113.285 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.7 m120 62.8 17.21 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.068 0.461 . . . . 2.0299999999999998 111.336 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.3 p -94.83 175.68 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.833 -0.621 . . . . 1.1399999999999999 111.339 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.484 ' H ' ' HB2' ' A' ' 50' ' ' SER . 6.3 p -114.7 127.49 72.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 116.136 -0.483 . . . . 0.47999999999999998 110.203 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.9 mp -120.97 169.7 10.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.007 -0.542 . . . . 0.51000000000000001 111.054 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.854 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -128.95 126.28 39.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.084 -0.71 . . . . 0.69999999999999996 109.084 175.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -118.8 123.96 46.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.075 0.464 . . . . 0.42999999999999999 111.151 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.86 119.44 16.04 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.186 -1.042 . . . . 1.46 108.186 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 81' ' ' CYS . 42.2 mt -106.41 116.14 49.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 0.47999999999999998 109.5 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -126.94 119.3 26.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.779 -1.1 . . . . 1.8799999999999999 109.466 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 tt -90.88 117.14 29.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.804 -0.635 . . . . 1.1200000000000001 109.731 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.39 -23.81 15.02 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.668 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -164.05 153.45 14.11 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.004 0.431 . . . . 1.1899999999999999 110.564 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.659 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -161.83 178.72 8.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.652 -0.704 . . . . 0.71999999999999997 109.618 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 39' ' ' GLU . 14.0 ptm180 -150.93 137.9 19.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 2.98 110.053 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -100.22 152.83 19.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 3.3799999999999999 110.556 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 tt -159.14 116.85 2.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.711 -0.848 . . . . 3.3500000000000001 108.711 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.01 130.84 36.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.448 . . . . 5.3899999999999997 109.855 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 63.8 t60 -114.42 166.3 11.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.848 -0.614 . . . . 7.04 110.041 -172.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' HIS . 46.3 m80 74.99 -170.96 0.1 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.072 0.549 . . . . 7.21 111.238 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -95.42 155.87 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 9.0199999999999996 109.499 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 82.45 4.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.773 -0.371 . . . . 9.75 110.899 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 72.97 118.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.26 -0.882 . . . . 12.26 112.055 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.183 -0.913 . . . . 13.35 109.811 173.916 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.802 0.334 . . . . 7.4800000000000004 110.772 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.5 m -81.34 -34.88 31.52 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.363 -0.606 . . . . 5.9000000000000004 109.363 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m 61.42 26.47 16.24 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.261 -0.881 . . . . 4.4400000000000004 110.212 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 56.8 -160.11 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.291 -0.868 . . . . 4.4400000000000004 110.415 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -114.81 126.51 54.91 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.763 0.316 . . . . 4.1500000000000004 111.44 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.55 79.79 9.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.155 -1.054 . . . . 3.6099999999999999 108.155 168.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.26 140.91 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.36 -0.836 . . . . 3.6000000000000001 111.3 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.86 144.12 32.23 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.876 -0.787 . . . . 2.71 108.876 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.15 139.07 35.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.219 -0.66 . . . . 1.8799999999999999 109.219 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.625 HG12 ' HB ' ' A' ' 13' ' ' THR . 32.9 t -100.99 104.43 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.528 -0.545 . . . . 0.58999999999999997 109.528 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -102.64 134.91 45.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.939 -0.573 . . . . 2.1600000000000001 111.566 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.856 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 81.8 mt 52.25 51.89 15.38 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.511 -0.768 . . . . 1.45 111.332 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.625 ' HB ' HG12 ' A' ' 10' ' ' VAL . 15.4 t -70.68 168.36 16.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.78000000000000003 110.521 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.35 -12.56 61.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.837 0.68 . . . . 0.81000000000000005 112.837 -170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 80' ' ' ILE . 3.3 t70 -89.57 14.02 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.717 -0.393 . . . . 2.3999999999999999 111.638 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.44 29.93 1.04 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.589 -0.815 . . . . 0.68000000000000005 114.119 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.856 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 60.01 33.29 78.46 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.881 1.112 . . . . 0.60999999999999999 115.881 166.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 30.6 t -104.06 142.48 17.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 117.886 0.843 . . . . 0.48999999999999999 110.727 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 2.3 mm -88.57 116.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.46999999999999997 110.013 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HE2' ' HB3' ' A' ' 84' ' ' SER . 21.4 pttp -138.75 136.02 35.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 1.3400000000000001 111.021 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 m -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.163 -0.926 . . . . 0.5 109.923 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tp -88.7 127.62 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.087 0.47 . . . . 0.67000000000000004 110.811 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -116.26 -52.13 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.427 0.632 . . . . 0.82999999999999996 110.499 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' CB ' ' A' ' 90' ' ' LYS . 29.6 ttpt -119.07 121.91 40.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.63 -0.714 . . . . 1.5600000000000001 110.047 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -99.98 126.19 46.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.392 -0.367 . . . . 2.9500000000000002 111.14 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 155.64 32.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.972 -0.633 . . . . 1.3200000000000001 111.743 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.4 -81.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.646 0.26 . . . . 2.77 111.171 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.11 150.08 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 2.6400000000000001 110.426 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -156.68 51.05 0.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.308 -0.948 . . . . 1.04 112.854 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.3 -42.23 55.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.584 0.707 . . . . 2.29 109.299 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 -16.59 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 2.6400000000000001 110.562 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 19.3 m-80 -85.48 76.04 10.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.232 -0.44 . . . . 1.45 110.537 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 33.3 mm -140.87 119.7 8.27 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.857 -0.61 . . . . 0.81000000000000005 109.863 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 1.5 Cg_endo -82.15 111.05 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.75 111.638 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -118.06 152.24 35.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.472 -0.566 . . . . 2.6600000000000001 109.472 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 148.97 46.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.977 0.418 . . . . 2.5099999999999998 110.278 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.91 -9.78 65.94 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.887 -0.885 . . . . 1.1200000000000001 110.887 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 95.5 m-20 -107.49 159.42 16.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.856 -0.672 . . . . 1.3799999999999999 109.511 174.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 102.32 14.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.497 -0.557 . . . . 2.2000000000000002 109.497 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -116.19 145.03 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.693 -0.685 . . . . 0.67000000000000004 109.579 175.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 108.63 13.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.047 -0.524 . . . . 0.65000000000000002 110.263 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 122' ' ' LEU . 18.5 m -131.36 153.3 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.527 -0.306 . . . . 0.87 111.544 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -105.24 162.51 13.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 2.75 110.337 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 12.7 p90 -145.58 129.44 17.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.76000000000000001 110.028 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -167.02 153.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.85 -0.426 . . . . 0.48999999999999999 109.85 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 55' ' ' PHE . . . 176.3 -111.57 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.717 -1.23 . . . . 0.35999999999999999 112.968 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG3' HD12 ' A' ' 117' ' ' LEU . 51.7 pttt -157.23 166.95 31.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.987 0.423 . . . . 1.4299999999999999 110.882 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.2 tp -92.56 102.07 14.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.963 -0.562 . . . . 0.38 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 3.6 tp10 -58.71 -30.47 67.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.616 -0.72 . . . . 1.96 111.039 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -55.88 -32.43 63.69 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.563 -0.744 . . . . 0.67000000000000004 112.264 -173.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 53' ' ' LYS . 13.6 t -140.21 5.52 2.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.445 -0.502 . . . . 0.72999999999999998 111.983 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.83 46.63 59.62 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 121.098 -0.572 . . . . 0.78000000000000003 112.394 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HB2' HG23 ' A' ' 51' ' ' THR . 2.0 tmtp? -115.14 126.36 54.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.652 -0.499 . . . . 2.8900000000000001 109.652 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.07 153.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.454 -0.339 . . . . 0.58999999999999997 110.196 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 0.8 OUTLIER -74.45 106.4 6.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.403 . . . . 0.78000000000000003 110.722 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -121.7 103.57 8.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.87 0.843 . . . . 2.1800000000000002 110.324 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 34.8 m -136.81 150.53 48.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.119 -0.491 . . . . 1.24 110.004 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.4 m -62.6 -36.09 81.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 1.49 111.174 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.21 -33.9 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.348 -0.387 . . . . 1.8 110.887 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 6.9 t70 -56.99 -52.48 65.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.934 0.397 . . . . 2.1899999999999999 111.993 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -77.25 2.6 15.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.368 -0.378 . . . . 2.7799999999999998 111.44 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -111.5 -52.85 2.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.42 -0.355 . . . . 1.1000000000000001 110.845 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.7 p -133.04 117.18 14.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.197 0.522 . . . . 2.0299999999999998 111.167 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.4 Cg_exo -77.03 146.08 25.37 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.041 2.494 . . . . 1.76 111.459 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -103.82 151.09 23.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.464 -0.335 . . . . 1.3100000000000001 110.251 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -128.93 154.19 46.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.529 -0.305 . . . . 1.3600000000000001 110.911 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -137.21 174.49 10.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.524 -0.307 . . . . 0.56999999999999995 111.156 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.84 150.21 33.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.076 -0.712 . . . . 1.98 109.076 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.757 HD13 HG23 ' A' ' 82' ' ' VAL . 16.8 tp -70.6 124.66 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.475 0.546 . . . . 0.94999999999999996 112.475 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER 42.4 63.29 1.44 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.388 -1.278 . . . . 2.0800000000000001 112.335 173.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -108.55 9.28 27.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.71 -1.132 . . . . 1.98 108.751 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.6 -16.38 48.06 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.971 -1.013 . . . . 0.71999999999999997 113.084 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -85.48 -39.43 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.457 0.629 . . . . 0.96999999999999997 110.501 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 m -97.9 135.41 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.389 -0.597 . . . . 0.57999999999999996 109.389 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.764 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -94.55 -76.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.382 0.512 . . . . 0.62 112.382 -172.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.764 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.25 -37.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.873 -0.517 . . . . 2.04 112.315 -175.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.61 -54.29 31.17 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.449 -0.881 . . . . 0.32000000000000001 113.153 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.626 ' O ' HG22 ' A' ' 82' ' ' VAL . 23.3 m-90 -76.67 -31.52 57.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.736 -0.273 . . . . 0.48999999999999999 110.708 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -51.49 -53.35 38.32 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.019 0.824 . . . . 1.1399999999999999 111.843 -170.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 2.0 mp -68.77 -29.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 111.275 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.627 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 19.9 t -72.55 -38.23 68.05 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.603 -0.439 . . . . 0.55000000000000004 110.514 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 HD13 ' A' ' 69' ' ' LEU . 2.1 m -83.86 -33.95 9.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.791 -0.364 . . . . 0.83999999999999997 111.498 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -65.66 -25.57 67.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.157 0.503 . . . . 1.4299999999999999 110.63 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.558 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 22.0 t -121.92 44.97 2.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.777 -0.647 . . . . 1.23 110.489 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 82' ' ' VAL . 19.8 ptm -124.68 -175.89 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.989 -0.551 . . . . 2.27 109.688 173.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 64.3 mtt85 -142.95 162.86 34.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.123 -0.695 . . . . 4.1900000000000004 109.123 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HG3' HD22 ' A' ' 122' ' ' LEU . 85.6 tttt -61.31 -43.06 99.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 1.9399999999999999 111.364 -175.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -97.29 24.7 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 1.23 110.709 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 37.5 tt0 -114.87 163.68 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.037 -0.727 . . . . 1.6000000000000001 109.037 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 76.1 tttt -157.54 127.56 6.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.926 0.393 . . . . 1.1699999999999999 110.439 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.1 p -134.7 148.11 50.24 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.785 -0.643 . . . . 1.2 111.01 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.73 122.02 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 1.73 109.357 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.627 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.4 p -100.65 143.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.159 0.504 . . . . 0.73999999999999999 111.427 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 18.3 mmt180 -106.2 112.15 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.438 -0.801 . . . . 1.71 109.441 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 3.9 mp -93.96 100.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.828 -0.349 . . . . 0.52000000000000002 110.111 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.493 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 9.6 tp10 -70.07 156.72 38.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 1.3700000000000001 109.183 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 p -50.12 -44.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.06 0.544 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.42 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 24.1 ptp -74.76 -8.09 55.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 1.79 111.721 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 96' ' ' GLU . 21.8 m-30 -100.05 8.62 43.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.626 0.25 . . . . 0.75 110.426 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.613 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -139.09 -176.28 14.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.21 -0.519 . . . . 0.70999999999999996 112.201 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -70.3 -70.03 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.14 0.495 . . . . 1.52 111.077 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.18 -170.1 21.93 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.731 -0.747 . . . . 2.2999999999999998 111.551 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.865 ' HB2' ' HA2' ' A' ' 112' ' ' GLY . 24.8 t70 -81.45 -25.23 36.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 5.8600000000000003 111.028 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.5 8.86 25.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.48 0.657 . . . . 4.2699999999999996 110.914 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -117.46 -116.85 2.83 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.461 -0.876 . . . . 2.1600000000000001 112.023 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.84 126.48 52.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.514 -0.55 . . . . 3.3399999999999999 109.514 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.66 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -151.21 105.41 0.29 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.511 -0.852 . . . . 1.2 112.41 -176.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -95.14 -61.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.267 0.469 . . . . 3.0800000000000001 112.267 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 m -78.5 -76.52 0.19 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.76 0.281 . . . . 1.52 111.76 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 89.99 3.36 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-O 121.146 0.498 . . . . 0.75 110.296 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.66 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 72.4 Cg_endo -96.84 -155.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.488 2.792 . . . . 1.5800000000000001 111.663 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.865 ' HA2' ' HB2' ' A' ' 103' ' ' ASP . . . 127.83 31.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.461 -0.876 . . . . 2.0499999999999998 112.85 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.01 41.81 27.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.314 0.578 . . . . 2.0299999999999998 110.553 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 p -122.13 177.05 5.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.5 -0.773 . . . . 1.1399999999999999 110.38 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 5.3 p -93.94 125.47 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.256 0.55 . . . . 0.47999999999999998 110.889 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.83 162.1 15.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.51000000000000001 110.103 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.608 HD12 ' HG3' ' A' ' 47' ' ' LYS . 36.8 mt -119.04 117.47 28.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.69999999999999996 110.228 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -125.81 138.0 53.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.259 0.552 . . . . 0.42999999999999999 112.321 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 50.5 mt-10 -79.16 132.77 36.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.226 -0.897 . . . . 1.46 108.981 167.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 82' ' ' VAL . 19.5 mt -113.17 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.516 0.674 . . . . 0.47999999999999998 110.252 171.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.43 ' OE1' ' HD2' ' A' ' 90' ' ' LYS . 5.1 tp10 -118.75 120.1 36.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 1.8799999999999999 109.597 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.745 ' HA ' HG12 ' A' ' 42' ' ' VAL . 4.9 tt -89.87 102.4 15.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.526 -0.546 . . . . 1.1200000000000001 109.526 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -88.89 -35.63 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.486 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 t -152.26 144.79 24.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.598 -0.274 . . . . 1.1899999999999999 110.755 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.606 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -164.97 171.75 13.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.71999999999999997 109.799 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 14.0 ptp180 -150.07 124.6 9.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.579 -0.282 . . . . 2.98 110.325 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -95.58 139.49 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.871 -0.418 . . . . 3.3799999999999999 109.871 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.9 ' HG ' ' H ' ' A' ' 129' ' ' GLU . 15.9 tp 66.33 -162.7 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.82 0.7 . . . . 3.3500000000000001 110.947 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.9 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 15.3 tp10 62.8 79.75 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.617 0.722 . . . . 5.3899999999999997 111.47 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -116.89 116.1 26.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.133 -0.692 . . . . 7.04 109.133 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -89.39 29.43 1.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.486 0.55 . . . . 7.21 112.486 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -132.27 -67.54 0.65 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.58 -0.282 . . . . 9.0199999999999996 110.506 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 70.23 -72.29 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.784 0.677 . . . . 9.75 110.471 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.3 t60 52.55 79.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.327 0.651 . . . . 12.26 111.13 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.903 -1.046 . . . . 13.35 110.189 -177.934 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.167 0.508 . . . . 7.4800000000000004 110.577 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 p -114.36 120.22 39.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.854 -0.612 . . . . 5.9000000000000004 110.763 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.9 m -70.23 -48.3 57.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.591 -0.522 . . . . 4.4400000000000004 109.591 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.09 158.11 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 4.4400000000000004 109.423 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.11 161.04 15.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.826 0.346 . . . . 4.1500000000000004 111.193 -174.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -82.05 32.03 0.38 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.947 0.404 . . . . 3.6099999999999999 111.093 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.87 128.4 36.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.457 0.646 . . . . 3.6000000000000001 112.504 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.95 153.28 21.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.445 -0.798 . . . . 2.71 109.057 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 6.2 mptt -98.79 144.3 28.17 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.208 -0.664 . . . . 1.8799999999999999 109.208 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.11 112.83 38.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.886 -0.326 . . . . 0.58999999999999997 110.704 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 4.2 pt-20 -86.59 131.05 34.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.224 -0.287 . . . . 2.1600000000000001 110.224 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.9 mt 45.58 59.84 3.41 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.897 0.748 . . . . 1.45 111.869 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 18' ' ' VAL . 7.5 t -59.01 153.75 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.78000000000000003 110.757 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.82 43.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.48 0.548 . . . . 0.81000000000000005 112.48 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.6 t0 -85.39 18.27 2.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.706 0.289 . . . . 2.3999999999999999 111.406 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 2.7 9.22 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.422 -0.894 . . . . 0.68000000000000005 114.41 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 77.59 80.31 0.68 Allowed Glycine 0 C--O 1.224 -0.485 0 C-N-CA 121.021 -0.609 . . . . 0.60999999999999999 114.172 170.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 13' ' ' THR . 11.8 t -142.7 145.04 23.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.696 -0.483 . . . . 0.48999999999999999 109.696 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.68 110.99 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.46999999999999997 110.244 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -136.09 147.12 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 1.3400000000000001 111.281 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.6 m -117.95 144.25 45.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 0.5 110.469 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 25' ' ' LYS . 9.7 tp -93.39 135.3 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.9 0.381 . . . . 0.67000000000000004 111.931 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD21 ' HG ' ' A' ' 92' ' ' LEU . 3.0 mm? -123.34 -71.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.383 0.611 . . . . 0.82999999999999996 109.369 174.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 2.2 mmmt -104.86 116.19 31.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.331 -0.85 . . . . 1.5600000000000001 109.378 176.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -112.9 150.86 31.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.844 -0.342 . . . . 2.9500000000000002 110.294 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.85 163.25 47.55 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.923 -0.656 . . . . 1.3200000000000001 111.991 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.38 -57.59 2.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.252 0.548 . . . . 2.77 109.752 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -121.12 174.12 6.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.815 . . . . 2.6400000000000001 108.817 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.568 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 126.55 51.88 0.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.546 -0.835 . . . . 1.04 112.296 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.63 -41.29 98.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.809 0.358 . . . . 2.29 111.408 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -89.07 4.27 48.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.427 0.632 . . . . 2.6400000000000001 110.398 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.631 ' HB2' HH21 ' A' ' 86' ' ' ARG . 6.7 m-20 -116.59 78.64 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 1.45 109.617 175.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.6 mm -134.41 123.85 16.76 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.637 . . . . 0.81000000000000005 110.775 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HG3' HD22 ' A' ' 122' ' ' LEU . 57.2 Cg_endo -70.18 138.45 36.51 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.876 2.384 . . . . 0.75 111.457 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -145.66 156.71 43.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.007 0.432 . . . . 2.6600000000000001 111.871 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 70' ' ' GLU . 1.9 ttmp? -68.56 147.59 51.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.127 -0.942 . . . . 2.5099999999999998 111.111 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 36' ' ' LYS . . . 93.23 -18.48 56.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.56 -1.016 . . . . 1.1200000000000001 110.56 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 3.6 m-20 -99.18 163.38 12.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.778 -0.711 . . . . 1.3799999999999999 109.834 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.58 126.16 35.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 2.2000000000000002 110.529 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 125' ' ' PHE . 21.1 m -131.05 153.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.67000000000000004 109.691 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 29.7 m -113.61 106.07 14.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.374 -0.602 . . . . 0.65000000000000002 109.374 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.48 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.195 0.522 . . . . 0.87 111.341 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -100.34 136.03 40.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.622 -0.717 . . . . 2.75 109.079 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.693 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 47.6 p90 -122.87 144.35 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.76000000000000001 110.364 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -169.08 157.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.416 -0.957 . . . . 0.48999999999999999 108.416 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.91 -126.66 1.13 Allowed Glycine 0 CA--C 1.51 -0.244 0 C-N-CA 119.739 -1.22 . . . . 0.35999999999999999 113.262 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 64.7 pttt -150.98 165.76 32.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.218 0.532 . . . . 1.4299999999999999 111.033 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD12 ' HG ' ' A' ' 116' ' ' LEU . 63.5 tp -83.64 97.42 9.08 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.06 -0.719 . . . . 0.38 109.06 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.594 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 48.4 tp10 -60.93 -25.76 67.0 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.017 -0.538 . . . . 1.96 111.856 -174.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 t -56.19 -27.17 53.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.426 -0.352 . . . . 0.67000000000000004 111.38 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.661 HG23 ' HD3' ' A' ' 53' ' ' LYS . 10.1 t -134.9 -13.93 2.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.835 0.35 . . . . 0.72999999999999998 111.571 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.54 28.7 34.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.159 -0.543 . . . . 0.78000000000000003 112.957 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.661 ' HD3' HG23 ' A' ' 51' ' ' THR . 13.9 mptt -100.42 122.57 43.37 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.604 -0.351 . . . . 2.8900000000000001 110.577 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 8.6 p -73.98 160.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 110.407 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.403 ' CE1' HD11 ' A' ' 110' ' ' ILE . 22.6 m-30 -74.77 147.86 40.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 0.78000000000000003 111.392 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -159.1 89.91 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.254 -0.885 . . . . 2.1800000000000002 108.939 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -136.72 -177.14 4.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 1.24 110.815 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -71.56 -38.63 70.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.973 -0.558 . . . . 1.49 111.425 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.86 -36.96 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.211 0.819 . . . . 1.8 113.211 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -59.97 -33.01 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.878 0.325 . . . . 2.1899999999999999 111.878 -169.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -104.4 -0.94 27.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.282 0.475 . . . . 2.7799999999999998 112.282 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -114.19 -45.79 3.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.302 -0.559 . . . . 1.1000000000000001 111.576 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.08 97.81 17.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.918 0.39 . . . . 2.0299999999999998 110.05 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.29 141.73 43.81 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.988 2.459 . . . . 1.76 112.599 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.58 146.55 25.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 1.3100000000000001 110.008 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -144.21 153.71 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.981 -0.377 . . . . 1.3600000000000001 109.981 177.234 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -133.99 175.07 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.56999999999999995 111.152 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -104.58 148.28 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.942 -0.762 . . . . 1.98 108.942 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD22 HG23 ' A' ' 82' ' ' VAL . 11.3 tp -69.4 119.47 13.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.034 0.445 . . . . 0.94999999999999996 110.584 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 57.55 66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.654 -1.157 . . . . 2.0800000000000001 110.646 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.01 17.78 23.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.947 -1.024 . . . . 1.98 109.063 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.04 -18.03 38.37 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.71999999999999997 112.479 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.86 -23.31 22.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.96999999999999997 110.984 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.8 126.24 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.57999999999999996 110.353 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.641 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -95.75 -58.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.62 113.437 -172.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.66 -48.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 2.04 112.644 -170.031 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -52.4 38.13 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.917 -0.659 . . . . 0.32000000000000001 113.131 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.5 ' O ' HG22 ' A' ' 82' ' ' VAL . 9.0 m-90 -76.01 -32.22 59.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.672 0.273 . . . . 0.48999999999999999 110.702 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -53.86 -51.93 62.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.45 -0.795 . . . . 1.1399999999999999 112.179 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -69.29 -43.84 80.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 0.78000000000000003 110.82 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.8 t -62.21 -50.06 73.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.53 -0.304 . . . . 0.55000000000000004 111.009 -175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG23 HD22 ' A' ' 69' ' ' LEU . 33.9 m -66.09 -32.81 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.652 0.263 . . . . 0.83999999999999997 110.911 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 t -66.05 -40.12 90.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.931 0.396 . . . . 1.4299999999999999 110.131 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 m -89.69 36.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.579 . . . . 1.23 111.08 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.967 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 4.4 mmt -112.81 -175.25 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 2.27 110.468 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.631 HH21 ' HB2' ' A' ' 32' ' ' ASN . 8.3 mtp-105 -149.87 175.4 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 4.1900000000000004 110.116 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.63 -22.24 66.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.654 -0.703 . . . . 1.9399999999999999 112.436 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -136.32 34.88 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 1.23 110.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 30.8 tt0 -120.51 154.06 35.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 1.6000000000000001 109.787 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.6 tttt -156.94 132.22 9.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.663 0.268 . . . . 1.1699999999999999 111.359 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.454 ' SG ' HD12 ' A' ' 22' ' ' ILE . 93.8 m -135.2 165.35 25.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.111 0.481 . . . . 1.2 111.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.51 ' HG ' HD21 ' A' ' 23' ' ' LEU . 78.5 mt -106.34 114.95 29.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.461 -0.79 . . . . 1.73 109.676 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.404 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.3 p -108.3 141.93 22.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.297 -0.41 . . . . 0.73999999999999999 111.232 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.477 ' NE ' HD23 ' A' ' 117' ' ' LEU . 7.2 mpt_? -90.91 117.13 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.414 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.621 HD13 ' HD2' ' A' ' 118' ' ' PHE . 2.7 mp -96.64 101.08 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.28 -1.007 . . . . 0.52000000000000002 108.28 172.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.572 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 8.1 tt0 -98.41 177.04 5.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.268 -0.878 . . . . 1.3700000000000001 109.434 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -55.36 -36.37 66.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 1.0 110.962 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.426 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 24.2 ptp -76.86 -7.64 55.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.036 -0.529 . . . . 1.79 111.296 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.572 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.0 m-85 -112.65 4.85 17.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.606 0.241 . . . . 0.75 110.952 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.641 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -138.7 -173.1 12.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.929 -0.653 . . . . 0.70999999999999996 112.285 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -88.73 7.69 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 1.52 111.356 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.25 -152.18 39.54 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 2.2999999999999998 112.672 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' CB ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 t70 -88.42 -17.08 31.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.18 0.514 . . . . 5.8600000000000003 110.449 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.64 -29.71 69.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.591 -0.732 . . . . 4.2699999999999996 111.267 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.68 159.84 36.88 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.783 -0.722 . . . . 2.1600000000000001 113.028 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.9 m -76.62 131.98 39.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.206 -0.294 . . . . 3.3399999999999999 110.206 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -119.44 164.81 13.3 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.448 -0.882 . . . . 1.2 112.432 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.51 -46.8 5.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 3.0800000000000001 110.741 -178.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.438 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 20.2 m -97.4 -74.7 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 1.52 110.085 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.483 HG12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -158.47 97.62 1.78 Allowed Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.124 -0.489 . . . . 0.75 110.553 176.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 74.4 Cg_endo -85.16 177.95 4.94 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.509 2.139 . . . . 1.5800000000000001 111.384 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 103' ' ' ASP . . . 142.67 -162.73 27.35 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.11 -1.043 . . . . 2.0499999999999998 113.038 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -98.08 39.88 1.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 2.0299999999999998 109.086 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.9 m -125.2 158.31 34.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.797 -0.638 . . . . 1.1399999999999999 110.37 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.37 127.42 42.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.51 0.671 . . . . 0.47999999999999998 111.653 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.483 HD21 HG12 ' A' ' 110' ' ' ILE . 6.7 mp -123.55 167.63 13.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.681 -0.691 . . . . 0.51000000000000001 109.873 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -138.3 131.89 30.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.006 0.431 . . . . 0.69999999999999996 110.518 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.621 ' HD2' HD13 ' A' ' 95' ' ' ILE . 59.3 m-85 -121.6 145.76 47.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.961 -0.563 . . . . 0.42999999999999999 110.669 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.5 mt-10 -68.65 123.62 21.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.816 -0.809 . . . . 1.46 108.816 170.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 81' ' ' CYS . 10.2 mt -107.74 115.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.298 0.57 . . . . 0.47999999999999998 109.622 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -125.62 114.07 18.22 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.002 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.52 HD22 ' HG3' ' A' ' 34' ' ' PRO . 14.9 tp -86.84 99.92 12.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 1.1200000000000001 109.896 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.1 pt? -98.63 -19.96 17.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.305 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.532 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 20.5 m -151.7 145.66 25.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.46 0.171 . . . . 1.1899999999999999 110.802 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.445 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -166.92 156.98 11.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.448 -0.342 . . . . 0.71999999999999997 110.255 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.81 49.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.202 -0.454 . . . . 2.98 110.704 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mp0 -96.71 115.05 26.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.137 -0.483 . . . . 3.3799999999999999 110.591 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 tp -150.47 110.62 4.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 3.3500000000000001 109.795 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.44 138.2 53.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.966 -0.561 . . . . 5.3899999999999997 111.966 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -86.96 115.69 24.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.479 -0.782 . . . . 7.04 110.042 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -131.77 163.13 28.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.313 -0.403 . . . . 7.21 110.957 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.32 133.2 38.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.869 0.366 . . . . 9.0199999999999996 111.107 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -94.72 108.4 20.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 9.75 110.114 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -90.05 140.42 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.043 -0.526 . . . . 12.26 111.129 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.755 -0.641 . . . . 13.35 109.451 175.744 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.7 -0.481 . . . . 7.4800000000000004 109.7 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.0 p -74.69 105.92 6.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 5.9000000000000004 111.336 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.0 m -88.29 117.35 27.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 4.4400000000000004 110.348 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.46 78.4 9.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.398 -0.593 . . . . 4.4400000000000004 109.398 175.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -66.16 126.91 30.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.716 . . . . 4.1500000000000004 110.156 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.54 73.11 6.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.609 0.719 . . . . 3.6099999999999999 110.219 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.4 169.8 16.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.242 -0.89 . . . . 3.6000000000000001 110.852 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -116.14 158.42 23.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.783 -0.644 . . . . 2.71 110.013 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 6.4 mptt -102.37 148.16 25.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.048 -0.723 . . . . 1.8799999999999999 109.048 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.65 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 15.6 t -101.03 109.24 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.383 0.611 . . . . 0.58999999999999997 110.168 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -79.82 99.74 7.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.031 -0.986 . . . . 2.1600000000000001 111.475 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt 51.32 79.17 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.691 0.619 . . . . 1.45 111.328 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.65 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 11.6 t -89.93 177.17 6.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.78000000000000003 110.903 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.93 -3.63 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.81000000000000005 111.828 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.516 ' HB2' HG23 ' A' ' 80' ' ' ILE . 27.0 m-20 -75.93 2.33 12.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.533 0.206 . . . . 2.3999999999999999 110.652 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.3 8.92 6.86 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.612 -0.804 . . . . 0.68000000000000005 113.326 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.22 63.48 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.019 -0.61 . . . . 0.60999999999999999 114.42 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.537 ' HB ' ' CB ' ' A' ' 80' ' ' ILE . 23.5 t -134.42 148.39 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.929 -0.397 . . . . 0.48999999999999999 109.929 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.92 109.73 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.18 0.514 . . . . 0.46999999999999997 110.44 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.526 ' HE2' HG21 ' A' ' 13' ' ' THR . 47.7 pttt -123.32 148.28 46.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.99 -0.55 . . . . 1.3400000000000001 110.368 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -109.43 124.33 50.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.828 -0.624 . . . . 0.5 110.332 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.482 HD12 ' SG ' ' A' ' 91' ' ' CYS . 5.1 tp -75.65 113.9 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.67000000000000004 110.924 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 3.5 mm? -99.24 -60.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 0.82999999999999996 110.481 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -120.33 133.96 55.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.5600000000000001 110.076 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 37.7 pttt -106.46 124.17 49.18 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.491 . . . . 2.9500000000000002 110.212 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 161.85 37.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.66 -0.781 . . . . 1.3200000000000001 111.788 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -68.07 -67.1 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 2.77 110.692 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.17 -177.81 4.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 2.6400000000000001 110.806 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.96 45.85 0.17 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.49 -0.777 . . . . 1.04 111.27 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.32 -41.5 89.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 2.29 110.552 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -113.83 26.03 10.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.309 0.576 . . . . 2.6400000000000001 109.817 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 79.81 1.79 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 1.45 110.07 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.5 HG21 ' HE3' ' A' ' 35' ' ' LYS . 36.1 mm -129.48 128.46 23.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.81000000000000005 111.084 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 1.1 Cg_endo -81.55 114.65 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.896 2.397 . . . . 0.75 111.256 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 33' ' ' ILE . 28.3 mmtp -120.46 146.45 46.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.21 -0.45 . . . . 2.6600000000000001 111.065 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 5.3 tmmm? -57.02 124.58 19.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.701 -0.681 . . . . 2.5099999999999998 109.783 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.58 37.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.752 -0.737 . . . . 1.1200000000000001 112.277 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 82.3 m-20 -79.39 142.57 35.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.964 0.412 . . . . 1.3799999999999999 110.122 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.524 ' HB3' ' CG ' ' A' ' 126' ' ' ARG . 37.6 tp10 -76.46 102.32 5.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.797 -0.638 . . . . 2.2000000000000002 109.797 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 125' ' ' PHE . 28.0 m -112.94 156.02 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.088 -0.505 . . . . 0.67000000000000004 110.868 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.8 m -132.6 110.87 10.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.65000000000000002 109.709 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.685 HG12 ' HA ' ' A' ' 122' ' ' LEU . 27.4 m -125.15 151.03 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.87 111.405 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -101.17 149.28 24.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.75 109.709 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 39.9 p90 -133.32 136.92 45.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.708 0.29 . . . . 0.76000000000000001 110.233 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -164.89 146.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.58 -0.526 . . . . 0.48999999999999999 109.58 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -176.18 -127.86 1.07 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.325 -0.94 . . . . 0.35999999999999999 112.513 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.54 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 63.6 pttt -157.77 171.94 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 1.4299999999999999 110.831 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.754 HD22 HG13 ' A' ' 110' ' ' ILE . 58.2 tp -87.04 108.89 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.38 110.794 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.555 ' HB3' HG13 ' A' ' 115' ' ' VAL . 2.1 tp10 -61.46 -35.33 77.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.51 0.672 . . . . 1.96 110.615 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -55.71 -27.82 52.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.67000000000000004 112.792 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.497 HG22 HD23 ' A' ' 48' ' ' LEU . 15.2 t -140.55 -23.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.178 -0.609 . . . . 0.72999999999999998 112.35 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.69 34.65 4.89 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.502 -0.856 . . . . 0.78000000000000003 113.014 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HG2' HG23 ' A' ' 51' ' ' THR . 73.8 mmtt -102.84 125.51 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.132 -0.321 . . . . 2.8900000000000001 110.132 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.7 p -82.44 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.108 -0.33 . . . . 0.58999999999999997 110.108 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -78.69 127.23 31.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.387 0.514 . . . . 0.78000000000000003 112.387 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -161.24 85.74 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.025 -0.989 . . . . 2.1800000000000002 108.549 167.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 23.5 t -122.54 158.11 30.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.747 -0.66 . . . . 1.24 109.986 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -50.0 -44.0 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.245 0.618 . . . . 1.49 112.437 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -87.76 -33.67 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 1.8 110.532 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -64.71 -52.0 59.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 2.1899999999999999 111.738 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.1 ptp180 -67.49 -20.49 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.352 . . . . 2.7799999999999998 111.309 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -75.58 -64.12 1.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.297 -0.411 . . . . 1.1000000000000001 110.108 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.1 t -142.55 106.43 5.49 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.382 -0.372 . . . . 2.0299999999999998 111.007 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.37 140.16 92.24 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.287 1.991 . . . . 1.76 110.818 171.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -93.3 151.0 20.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.917 0.389 . . . . 1.3100000000000001 110.582 -171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 143.14 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.117 -0.697 . . . . 1.3600000000000001 109.117 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 82' ' ' VAL . 30.0 p90 -124.39 153.85 41.27 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.968 -0.693 . . . . 0.56999999999999995 111.212 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . 41.7 t-80 -94.5 145.02 25.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.149 -0.932 . . . . 1.98 109.788 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 HD13 ' CG2' ' A' ' 82' ' ' VAL . 38.3 tp -69.13 128.84 38.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.991 -0.744 . . . . 0.94999999999999996 108.991 173.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG2' ' CG ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.49 78.75 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.146 0.974 . . . . 2.0800000000000001 110.403 -168.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 68' ' ' HIS . 26.2 tt0 -126.42 -5.66 6.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.13 -1.395 . . . . 1.98 109.994 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 -19.24 33.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.701 -0.681 . . . . 0.71999999999999997 112.681 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 42.3 mm-40 -87.73 -21.76 25.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.531 0.682 . . . . 0.96999999999999997 109.504 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.9 m -108.87 124.18 65.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.65 -0.705 . . . . 0.57999999999999996 109.979 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.73 -59.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.179 0.437 . . . . 0.62 112.179 -178.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -149.19 -38.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.307 -0.246 . . . . 2.04 111.468 -174.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.7 -52.62 44.45 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.561 -0.828 . . . . 0.32000000000000001 112.857 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 82' ' ' VAL . 15.2 m-90 -76.18 -27.72 57.03 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.8 -0.235 . . . . 0.48999999999999999 110.895 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.12 -54.02 35.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.603 -0.726 . . . . 1.1399999999999999 111.37 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.537 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -68.16 -30.99 49.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.636 -0.711 . . . . 0.78000000000000003 111.586 -173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 85' ' ' MET . 34.8 t -76.08 -55.92 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.748 0.309 . . . . 0.55000000000000004 111.038 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.677 HG12 HG21 ' A' ' 120' ' ' ILE . 32.0 m -67.34 -33.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.324 0.861 . . . . 0.83999999999999997 113.324 -169.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 62.2 p -79.64 -0.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.987 0.422 . . . . 1.4299999999999999 111.167 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -125.77 25.5 6.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 1.23 110.384 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.789 ' HE3' ' HB2' ' A' ' 122' ' ' LEU . 31.4 mtm -114.78 142.37 46.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.95 0.405 . . . . 2.27 111.664 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.482 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 51.2 mtt180 -90.88 164.62 13.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.538 -0.542 . . . . 4.1900000000000004 109.538 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HA ' HD22 ' A' ' 122' ' ' LEU . 61.3 tttm -65.16 -21.66 66.81 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.641 0.608 . . . . 1.9399999999999999 112.641 -171.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -117.54 24.65 10.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.537 0.684 . . . . 1.23 109.805 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.482 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 35.8 tt0 -117.85 132.71 56.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.995 -1.002 . . . . 1.6000000000000001 109.898 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 11.9 tmtt? -137.44 129.68 29.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.94 -0.573 . . . . 1.1699999999999999 110.226 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 78.9 m -138.51 171.74 13.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.372 -0.377 . . . . 1.2 111.269 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.957 HD21 ' HB3' ' A' ' 117' ' ' LEU . 6.1 tt -112.54 145.63 39.96 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.608 -0.886 . . . . 1.73 108.608 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.561 ' N ' HD23 ' A' ' 92' ' ' LEU . 13.9 p -121.07 146.34 26.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 116.443 -0.344 . . . . 0.73999999999999999 110.303 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -107.07 111.13 23.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.643 -1.243 . . . . 1.71 107.643 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.555 HD11 HG13 ' A' ' 93' ' ' VAL . 4.9 mp -93.36 99.8 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.08 -0.648 . . . . 0.52000000000000002 110.459 -172.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 98' ' ' MET . 10.3 tp10 -63.55 155.55 29.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.926 -1.033 . . . . 1.3700000000000001 109.82 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.4 p -53.34 -38.59 63.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.495 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.426 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.1 ptp -78.08 -11.18 59.89 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.562 -0.29 . . . . 1.79 111.428 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -101.7 -2.66 29.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.877 0.37 . . . . 0.75 110.145 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 -178.01 44.91 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.70999999999999996 111.795 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -40.52 10.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.886 0.374 . . . . 1.52 110.733 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.81 174.44 14.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.811 -0.709 . . . . 2.2999999999999998 112.471 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.1 -21.46 24.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.6 0.714 . . . . 5.8600000000000003 109.786 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.58 -7.84 42.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.849 -1.069 . . . . 4.2699999999999996 111.823 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.93 18.47 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.832 -0.699 . . . . 2.1600000000000001 112.399 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.3 m -103.23 154.29 19.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.576 0.227 . . . . 3.3399999999999999 110.605 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.586 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -151.44 175.17 30.41 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.671 -0.776 . . . . 1.2 112.6 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.81 -70.49 0.7 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.942 0.349 . . . . 3.0800000000000001 111.942 -175.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.575 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 16.6 m -107.08 -73.17 0.7 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.42 0.152 . . . . 1.52 111.368 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.754 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -141.48 77.68 19.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.211 0.529 . . . . 0.75 111.421 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 27.3 Cg_endo -93.74 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.25 2.633 . . . . 1.5800000000000001 111.649 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.37 -125.32 7.25 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.517 -0.849 . . . . 2.0499999999999998 111.958 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -105.41 1.16 27.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.61 0.719 . . . . 2.0299999999999998 109.352 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.9 m -79.56 152.15 30.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.323 -0.853 . . . . 1.1399999999999999 110.632 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.555 HG13 ' HB3' ' A' ' 49' ' ' GLU . 6.5 p -90.14 135.03 27.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.197 -0.456 . . . . 0.47999999999999998 110.686 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 49' ' ' GLU . 6.2 mp -126.67 167.01 16.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.75 0.31 . . . . 0.51000000000000001 110.991 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.957 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -117.26 114.53 23.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.184 -0.673 . . . . 0.69999999999999996 109.184 174.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -113.13 122.04 46.33 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.944 -0.303 . . . . 0.42999999999999999 110.721 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.57 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 33.6 mt-10 -86.12 130.05 34.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.003 -0.74 . . . . 1.46 109.003 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 82' ' ' VAL . 70.7 mt -113.5 127.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.997 -0.547 . . . . 0.47999999999999998 111.504 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -115.91 115.34 26.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.462 -0.79 . . . . 1.8799999999999999 110.815 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.789 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 6.0 tt -91.35 102.24 14.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.871 -0.789 . . . . 1.1200000000000001 108.871 173.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.2 pt? -97.85 -34.43 10.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.184 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.0 t -146.57 144.01 29.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.72 0.295 . . . . 1.1899999999999999 110.759 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.566 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -165.39 148.41 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.71999999999999997 109.873 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.524 ' CG ' ' HB3' ' A' ' 39' ' ' GLU . 7.8 ptp85 -127.49 129.48 47.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 2.98 109.988 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -96.27 135.07 38.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 110.951 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.5 tp 74.97 105.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.283 0.989 . . . . 3.3500000000000001 111.974 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 130' ' ' HIS . 7.7 tp10 -125.49 154.91 41.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.205 -0.907 . . . . 5.3899999999999997 109.298 175.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 20.9 m80 74.83 172.29 0.27 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.016 0.822 . . . . 7.04 111.699 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 t60 52.02 69.95 0.61 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.13 -0.941 . . . . 7.21 111.413 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -128.55 174.19 9.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.954 -0.566 . . . . 9.0199999999999996 109.973 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 171.1 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.497 -0.32 . . . . 9.75 110.758 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.7 m80 65.55 26.77 11.66 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.654 0.596 . . . . 12.26 110.672 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.597 -0.716 . . . . 13.35 109.362 177.57 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.744 0.307 . . . . 7.4800000000000004 110.395 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 p -86.29 141.19 29.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.448 -0.342 . . . . 5.9000000000000004 110.537 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m -93.63 12.46 25.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.632 0.729 . . . . 4.4400000000000004 109.989 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -111.46 173.97 6.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.342 -0.844 . . . . 4.4400000000000004 110.995 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -85.98 133.93 33.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.748 -0.66 . . . . 4.1500000000000004 110.202 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -95.82 18.73 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.616 0.722 . . . . 3.6099999999999999 109.77 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -83.29 149.1 26.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.432 -0.804 . . . . 3.6000000000000001 110.497 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.93 150.26 21.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 2.71 110.63 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -101.67 141.72 34.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 1.8799999999999999 109.129 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.67 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 16.9 t -102.47 109.57 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.092 0.472 . . . . 0.58999999999999997 111.217 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.13 108.79 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.73 -0.668 . . . . 2.1600000000000001 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.487 ' H ' HD13 ' A' ' 19' ' ' ILE . 23.0 tp 53.05 72.54 0.42 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.638 0.586 . . . . 1.45 111.201 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.67 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 6.8 t -80.43 156.6 26.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.78000000000000003 111.349 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 1.67 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.81000000000000005 111.972 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.6 3.38 3.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.577 0.227 . . . . 2.3999999999999999 110.835 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.26 6.82 8.02 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.091 -0.576 . . . . 0.68000000000000005 112.974 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.01 70.32 1.33 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.708 -0.758 . . . . 0.60999999999999999 113.928 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.89 145.17 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.786 -0.45 . . . . 0.48999999999999999 109.786 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.1 mm -85.53 109.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.46999999999999997 110.323 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 13' ' ' THR . 18.2 pttp -131.05 143.67 50.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.13 0.491 . . . . 1.3400000000000001 111.011 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -110.73 121.73 46.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.609 -0.723 . . . . 0.5 110.237 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.83 134.87 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 0.67000000000000004 110.15 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.4 -74.02 0.62 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.019 -0.363 . . . . 0.82999999999999996 110.019 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -88.26 153.17 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.833 -0.803 . . . . 1.5600000000000001 108.833 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -126.28 120.08 29.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.212 0.53 . . . . 2.9500000000000002 111.001 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.45 27.31 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.124 -0.944 . . . . 1.3200000000000001 112.13 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.92 -65.81 0.97 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.766 0.317 . . . . 2.77 110.877 -176.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 2.7 pp20? -99.69 139.07 35.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.848 0.356 . . . . 2.6400000000000001 110.493 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.679 ' HA3' ' HD3' ' A' ' 86' ' ' ARG . . . -157.17 36.77 0.56 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.567 -0.613 . . . . 1.04 111.567 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.519 0.676 . . . . 2.29 109.188 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -112.09 4.33 17.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.215 -0.902 . . . . 2.6400000000000001 110.353 176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.531 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 90.3 m-20 -114.55 78.82 1.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.608 -0.437 . . . . 1.45 111.254 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.1 mm -128.33 114.99 19.89 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.61 -0.723 . . . . 0.81000000000000005 109.559 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.08 106.21 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.132 2.555 . . . . 0.75 111.84 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 31.5 mmtp -118.7 158.21 25.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.749 0.309 . . . . 2.6600000000000001 110.671 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 1.018 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -80.56 150.65 29.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 2.5099999999999998 111.384 -175.241 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.64 -26.06 25.41 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.808 -0.633 . . . . 1.1200000000000001 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -93.46 157.7 16.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 1.3799999999999999 110.186 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -71.67 95.71 1.49 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 2.2000000000000002 110.805 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 125' ' ' PHE . 10.4 m -114.49 153.03 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.459 -0.337 . . . . 0.67000000000000004 110.351 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 ' HD2' ' A' ' 66' ' ' LYS . 9.1 m -128.27 107.09 9.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.447 -0.342 . . . . 0.65000000000000002 110.406 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -123.75 143.37 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.87 111.534 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -112.99 145.44 40.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.561 -0.745 . . . . 2.75 110.236 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.688 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.2 p90 -132.94 141.42 48.34 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.18 0.3 . . . . 0.76000000000000001 110.831 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p -168.24 154.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.271 -0.641 . . . . 0.48999999999999999 109.271 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 177.92 -120.31 0.71 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.83 -1.176 . . . . 0.35999999999999999 113.225 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.826 ' HG3' HD13 ' A' ' 117' ' ' LEU . 21.0 pttp -157.53 173.28 17.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.545 0.212 . . . . 1.4299999999999999 111.06 -178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.835 HD22 HG13 ' A' ' 110' ' ' ILE . 59.3 tp -90.9 106.66 18.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.688 -0.486 . . . . 0.38 109.688 176.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.0 tp10 -68.73 -25.61 64.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 1.96 110.793 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 17.1 t -55.0 -35.1 64.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.118 -0.946 . . . . 0.67000000000000004 111.461 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 53' ' ' LYS . 2.8 t -125.21 -20.64 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.346 -0.388 . . . . 0.72999999999999998 111.083 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.25 11.58 51.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.78000000000000003 112.771 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 51' ' ' THR . 29.0 mmmt -85.02 131.03 34.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.955 -0.387 . . . . 2.8900000000000001 109.955 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.671 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.5 p -79.1 164.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.315 -0.402 . . . . 0.58999999999999997 110.097 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.449 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 7.3 m-30 -73.61 98.47 2.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.367 0.603 . . . . 0.78000000000000003 110.791 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.32 85.7 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.454 -0.793 . . . . 2.1800000000000002 109.706 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.693 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 19.0 m -135.89 169.24 17.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.376 -0.829 . . . . 1.24 109.54 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 m -57.91 -44.57 86.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.818 0.673 . . . . 1.49 112.818 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -91.01 -48.26 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 1.8 111.456 -171.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.693 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 1.6 m-20 -54.4 -44.74 72.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.985 -1.007 . . . . 2.1899999999999999 112.73 -169.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -83.83 0.7 46.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.851 -0.34 . . . . 2.7799999999999998 111.657 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -104.09 -42.25 5.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.447 -0.342 . . . . 1.1000000000000001 110.807 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 8.4 m -124.24 125.82 25.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.843 0.354 . . . . 2.0299999999999998 111.521 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 1.7 Cg_endo -85.57 139.57 6.81 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.256 2.637 . . . . 1.76 112.451 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.79 148.95 32.44 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.891 0.377 . . . . 1.3100000000000001 111.179 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HD2' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -136.51 157.62 46.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.998 -0.546 . . . . 1.3600000000000001 110.198 177.19 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -140.34 176.95 8.35 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.034 0.445 . . . . 0.56999999999999995 111.982 -175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 55.4 m80 -107.75 148.46 29.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.98 110.659 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 36' ' ' LYS . 24.0 tp -78.72 124.45 28.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.103 -0.703 . . . . 0.94999999999999996 109.103 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 1.018 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 1.4 mm-40 63.51 79.57 0.25 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.457 1.122 . . . . 2.0800000000000001 110.255 -168.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 27.6 tt0 -130.61 -3.73 4.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.653 -1.612 . . . . 1.98 109.836 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.22 -11.06 61.64 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.557 -0.747 . . . . 0.71999999999999997 111.847 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.02 -18.77 16.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.96999999999999997 110.836 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -111.74 127.95 68.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 0.57999999999999996 110.282 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.68 -76.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.299 0.481 . . . . 0.62 112.299 -176.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' H ' HG12 ' A' ' 75' ' ' ILE . 37.2 mtpt -127.59 -49.87 1.38 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.472 0.545 . . . . 2.04 112.472 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.4 -53.06 33.53 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.955 -0.64 . . . . 0.32000000000000001 113.342 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.6 m-90 -76.03 -44.27 40.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.639 0.257 . . . . 0.48999999999999999 110.571 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.14 -49.32 69.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.587 -0.733 . . . . 1.1399999999999999 112.026 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -73.37 -36.42 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.165 -0.47 . . . . 0.78000000000000003 111.413 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.703 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 46.3 t -72.46 -42.84 64.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.687 -0.233 . . . . 0.55000000000000004 111.426 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.885 HG12 HG21 ' A' ' 120' ' ' ILE . 27.4 m -64.06 -32.53 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.895 0.379 . . . . 0.83999999999999997 111.121 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -79.11 5.1 12.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.062 0.458 . . . . 1.4299999999999999 110.863 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -113.38 5.73 16.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 1.23 110.824 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.751 ' HE1' ' HB2' ' A' ' 122' ' ' LEU . 55.9 mtm -93.75 -172.73 2.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.519 0.676 . . . . 2.27 112.288 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.679 ' HD3' ' HA3' ' A' ' 29' ' ' GLY . 1.6 ttm180 -145.55 165.51 28.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.153 -1.054 . . . . 4.1900000000000004 108.153 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -63.2 -23.81 67.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.924 0.392 . . . . 1.9399999999999999 111.715 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -117.49 24.91 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.072 0.463 . . . . 1.23 110.065 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.603 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 5.3 tm-20 -123.07 152.85 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 1.6000000000000001 109.629 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -155.23 124.67 6.37 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.146 -0.316 . . . . 1.1699999999999999 110.146 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.69 171.17 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 1.2 111.383 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.85 137.41 52.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.73 110.32 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.703 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 6.2 p -111.73 149.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.89 -0.595 . . . . 0.73999999999999999 111.075 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -104.14 112.56 25.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.566 -0.531 . . . . 1.71 109.566 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.515 HD11 HG13 ' A' ' 93' ' ' VAL . 2.6 mp -92.2 106.57 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.52000000000000002 110.504 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.526 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 28.5 tt0 -90.48 168.29 11.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.393 -0.822 . . . . 1.3700000000000001 108.932 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.419 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 8.8 m -51.03 -39.32 55.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.5 ptp -77.39 -7.91 56.85 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.61 0.243 . . . . 1.79 111.487 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.526 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -99.05 -3.35 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.549 0.214 . . . . 0.75 110.772 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.504 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -135.01 -177.51 15.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.253 -0.499 . . . . 0.70999999999999996 112.015 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -76.32 -51.41 12.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.697 0.248 . . . . 1.52 111.175 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 -165.75 20.13 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.445 -0.883 . . . . 2.2999999999999998 112.84 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.95 -40.21 96.99 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.853 0.461 . . . . 5.8600000000000003 111.519 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.12 -11.57 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 4.2699999999999996 111.033 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.88 162.34 24.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.759 -0.734 . . . . 2.1600000000000001 112.354 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.3 m -67.74 127.97 34.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 3.3399999999999999 110.505 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.452 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -127.07 163.46 20.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.848 -0.691 . . . . 1.2 111.855 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -77.94 -72.51 0.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.99 0.424 . . . . 3.0800000000000001 111.23 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.552 ' HB2' HD13 ' A' ' 110' ' ' ILE . 3.4 m -104.5 -72.26 0.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.96 -0.564 . . . . 1.52 110.803 -176.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.835 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.63 85.95 50.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.75 110.818 178.502 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.452 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 83.1 Cg_endo -78.55 -175.59 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.292 1.995 . . . . 1.5800000000000001 111.905 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.53 -132.44 5.12 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.456 -0.878 . . . . 2.0499999999999998 112.117 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -122.77 36.53 4.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 2.0299999999999998 109.965 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 21.3 p -114.84 179.31 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.1399999999999999 110.819 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.1 p -104.98 129.17 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.146 0.498 . . . . 0.47999999999999998 111.016 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -119.94 172.73 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.51000000000000001 110.382 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.826 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -128.08 130.83 48.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.695 -0.483 . . . . 0.69999999999999996 109.695 177.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.678 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 34.7 m-85 -130.4 128.34 41.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.672 0.272 . . . . 0.42999999999999999 110.672 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 62.5 mt-10 -71.28 126.44 29.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.265 -1.013 . . . . 1.46 108.265 169.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.885 HG21 HG12 ' A' ' 82' ' ' VAL . 34.8 mt -107.67 123.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.212 -0.595 . . . . 0.47999999999999998 109.677 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.96 114.7 20.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.682 -0.69 . . . . 1.8799999999999999 110.678 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.751 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 35.9 tp -87.29 90.62 8.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.51 . . . . 1.1200000000000001 109.753 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 124' ' ' SER . 3.5 pp -86.48 -25.26 25.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.741 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.425 ' N ' HD12 ' A' ' 123' ' ' LEU . 75.7 m -159.46 148.23 17.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.361 -0.381 . . . . 1.1899999999999999 110.292 177.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.596 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -167.02 -176.22 3.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.71999999999999997 109.877 -178.258 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.88 170.54 22.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.524 -0.307 . . . . 2.98 110.178 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.86 153.72 50.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.908 -1.145 . . . . 3.3799999999999999 107.908 171.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.38 74.88 1.55 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.639 -0.424 . . . . 3.3500000000000001 111.3 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.754 ' HG3' ' H ' ' A' ' 131' ' ' HIS . 9.3 tp10 -86.17 141.02 29.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.208 -0.451 . . . . 5.3899999999999997 110.053 173.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -103.73 10.52 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.298 -0.41 . . . . 7.04 110.338 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.754 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 5.7 t-160 -85.92 47.11 1.4 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 7.21 111.23 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.99 -63.85 1.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.305 -0.628 . . . . 9.0199999999999996 109.305 174.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -171.48 79.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.48 0.657 . . . . 9.75 111.431 172.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -139.1 146.45 40.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.58 -0.896 . . . . 12.26 108.58 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.388 -0.815 . . . . 13.35 110.952 -173.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.166 -0.309 . . . . 7.4800000000000004 110.166 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 m -88.63 120.32 29.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.934 -0.395 . . . . 5.9000000000000004 109.934 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -94.52 -68.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.41 -0.359 . . . . 4.4400000000000004 110.751 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -144.83 157.58 44.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.072 -0.344 . . . . 4.4400000000000004 110.072 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.9 88.93 5.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.611 0.243 . . . . 4.1500000000000004 111.531 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -96.92 85.75 3.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.386 -0.598 . . . . 3.6099999999999999 109.386 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.14 155.86 32.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.074 -0.512 . . . . 3.6000000000000001 110.896 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.42 139.01 36.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 2.71 109.899 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -113.51 151.4 31.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 1.8799999999999999 110.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.518 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 21.6 t -114.0 120.55 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.58999999999999997 111.352 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.93 112.56 25.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 2.1600000000000001 111.138 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.419 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.2 mt 49.74 74.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.752 0.657 . . . . 1.45 112.022 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.518 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 3.5 t -86.34 163.01 17.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.78000000000000003 110.739 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.03 -5.45 13.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.363 0.601 . . . . 0.81000000000000005 110.685 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB3' HG23 ' A' ' 13' ' ' THR . 38.4 t70 -74.52 6.87 3.36 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.629 -0.714 . . . . 2.3999999999999999 111.084 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.28 16.52 3.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.67 -0.776 . . . . 0.68000000000000005 113.851 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.41 62.38 6.07 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.293 -0.479 . . . . 0.60999999999999999 113.82 173.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 80' ' ' ILE . 47.3 t -136.57 145.47 30.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.04 -0.356 . . . . 0.48999999999999999 110.04 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.6 mm -85.78 109.95 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.46999999999999997 110.372 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -138.38 146.78 42.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 110.835 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -119.63 137.56 53.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.5 110.524 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -80.27 126.9 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.051 0.453 . . . . 0.67000000000000004 110.844 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' HD23 ' A' ' 92' ' ' LEU . 4.5 mm? -118.03 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.82999999999999996 110.423 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 39.5 ttpt -116.63 106.44 13.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.56 -0.533 . . . . 1.5600000000000001 109.56 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -88.02 148.94 24.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.245 -0.434 . . . . 2.9500000000000002 110.944 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.93 124.37 8.1 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.635 -0.986 . . . . 1.3200000000000001 110.635 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -61.99 -54.81 36.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.642 0.221 . . . . 2.77 111.493 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.9 151.71 40.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.107 0.48 . . . . 2.6400000000000001 110.719 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.3 34.12 0.11 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.274 -0.875 . . . . 1.04 110.937 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.11 -41.33 78.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 2.29 111.541 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -110.62 26.55 10.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.761 0.791 . . . . 2.6400000000000001 109.274 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.38 77.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.446 -0.797 . . . . 1.45 110.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -123.95 119.48 26.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.956 0.407 . . . . 0.81000000000000005 111.155 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.93 128.68 20.26 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.74 2.293 . . . . 0.75 111.525 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB2' ' CG ' ' A' ' 38' ' ' ASN . 7.9 mmmm -121.24 147.74 45.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.172 -0.467 . . . . 2.6600000000000001 111.442 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.583 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 7.5 ttmm -76.61 129.72 36.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.617 -0.72 . . . . 2.5099999999999998 109.111 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.9 -21.67 44.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.784 -0.722 . . . . 1.1200000000000001 111.904 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.406 ' CG ' ' HB2' ' A' ' 35' ' ' LYS . 3.2 m-20 -83.0 156.61 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.65 95.49 3.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.559 -0.534 . . . . 2.2000000000000002 109.559 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.603 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -125.06 147.69 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.67000000000000004 110.615 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.497 HG23 ' HD3' ' A' ' 66' ' ' LYS . 82.3 m -124.66 119.69 29.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.182 -0.463 . . . . 0.65000000000000002 109.998 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 122' ' ' LEU . 15.5 m -126.95 157.62 38.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.87 111.576 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.17 131.04 55.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.347 -0.842 . . . . 2.75 109.898 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 14.4 p90 -133.7 135.75 44.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.076 0.465 . . . . 0.76000000000000001 111.221 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -168.32 151.73 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.295 -1.002 . . . . 0.48999999999999999 108.295 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.78 -126.83 0.98 Allowed Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.504 -1.331 . . . . 0.35999999999999999 112.714 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.666 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 65.8 pttt -155.87 170.5 21.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 111.441 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 114' ' ' SER . 54.4 tp -92.52 109.71 21.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.774 -0.648 . . . . 0.38 110.392 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB3' HG13 ' A' ' 115' ' ' VAL . 7.8 tm-20 -66.44 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 1.96 109.942 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -55.29 -20.11 10.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.67000000000000004 112.444 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -136.52 -26.57 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.274 -0.266 . . . . 0.72999999999999998 111.584 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.73 20.03 18.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 0.78000000000000003 112.004 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.9 mmtt -91.99 126.37 37.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.625 0.25 . . . . 2.8900000000000001 111.441 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.666 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.4 p -76.0 159.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.58999999999999997 109.956 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.555 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 4.8 m-30 -73.97 110.69 8.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.454 0.645 . . . . 0.78000000000000003 111.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -139.34 89.08 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.09 . . . . 2.1800000000000002 109.02 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.552 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 47.5 m -126.99 -171.01 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.801 -0.636 . . . . 1.24 109.947 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -72.84 -48.0 41.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.478 0.547 . . . . 1.49 112.478 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -95.64 -47.52 6.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.283 0.475 . . . . 1.8 112.283 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 6.3 p-10 -57.51 -29.86 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.859 -0.61 . . . . 2.1899999999999999 111.878 -172.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -70.83 -14.35 62.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 2.7799999999999998 111.329 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -125.51 -56.4 1.5 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.788 0.328 . . . . 1.1000000000000001 111.656 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -99.01 113.37 64.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 2.0299999999999998 110.538 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.29 137.66 52.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.966 2.444 . . . . 1.76 112.515 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.99 127.28 39.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 1.3100000000000001 109.836 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HD3' HG23 ' A' ' 41' ' ' THR . 3.0 pptp? -125.22 158.2 34.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.947 -0.57 . . . . 1.3600000000000001 109.922 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -148.14 171.75 15.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.652 0.263 . . . . 0.56999999999999995 110.357 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 12.0 m170 -112.82 148.47 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 1.98 108.888 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.62 HD13 ' CG2' ' A' ' 82' ' ' VAL . 10.5 tp -66.63 114.25 5.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.546 0.689 . . . . 0.94999999999999996 111.834 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.22 75.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 113.986 -1.461 . . . . 2.0800000000000001 111.081 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 68' ' ' HIS . 6.3 pt20 -113.16 20.98 15.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 1.98 109.748 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 -10.02 64.8 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.841 -0.618 . . . . 0.71999999999999997 111.908 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.41 -24.91 17.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.998 0.428 . . . . 0.96999999999999997 110.921 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.23 128.14 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.682 -0.488 . . . . 0.57999999999999996 109.682 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.593 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -95.75 -64.49 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.536 0.939 . . . . 0.62 113.536 -174.179 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.461 ' H ' HG12 ' A' ' 75' ' ' ILE . 27.5 mtpt -133.07 -48.58 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.214 0.82 . . . . 2.04 113.214 -172.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.452 ' HA3' HG13 ' A' ' 95' ' ' ILE . . . -52.41 -53.03 33.73 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.815 -0.707 . . . . 0.32000000000000001 113.225 -171.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.513 ' O ' HG22 ' A' ' 82' ' ' VAL . 6.3 m-90 -76.76 -38.29 54.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.888 0.375 . . . . 0.48999999999999999 110.285 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' HD11 ' A' ' 69' ' ' LEU . 11.6 t70 -54.28 -53.59 51.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.103 -0.953 . . . . 1.1399999999999999 112.74 -172.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.461 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -66.34 -40.22 86.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 0.78000000000000003 110.629 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.9 t -62.66 -50.02 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.55000000000000004 111.117 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.62 ' CG2' HD13 ' A' ' 69' ' ' LEU . 30.6 m -71.59 -32.84 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.338 0.496 . . . . 0.83999999999999997 112.338 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.509 ' HB3' HD21 ' A' ' 69' ' ' LEU . 32.8 p -74.61 -9.61 58.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.837 0.31 . . . . 1.4299999999999999 111.837 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 t -118.67 38.87 3.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.404 0.621 . . . . 1.23 109.39 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.902 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 5.7 mmt -111.9 -173.93 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.83 . . . . 2.27 111.083 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.514 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -134.63 171.0 14.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.148 -1.056 . . . . 4.1900000000000004 108.148 171.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HA ' HD22 ' A' ' 122' ' ' LEU . 58.8 tttm -62.7 -31.54 72.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.204 0.446 . . . . 1.9399999999999999 112.204 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.42 25.63 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 1.23 110.741 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 26.4 tt0 -104.23 148.58 26.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 1.6000000000000001 110.525 -176.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.671 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 79.9 tttt -145.49 129.93 17.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.946 -0.57 . . . . 1.1699999999999999 110.711 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 98.1 m -136.23 162.87 31.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.053 0.454 . . . . 1.2 111.267 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.537 HD23 ' HG ' ' A' ' 23' ' ' LEU . 3.8 mm? -102.22 119.79 39.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.73 109.791 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.0 140.53 28.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.966 -0.561 . . . . 0.73999999999999999 110.927 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.836 ' HE ' HD23 ' A' ' 117' ' ' LEU . 1.3 mpt_? -99.43 112.4 24.59 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.756 -0.461 . . . . 1.71 109.756 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.616 HD13 ' HD2' ' A' ' 118' ' ' PHE . 1.8 mp -88.38 105.66 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.237 0.541 . . . . 0.52000000000000002 110.145 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 1.1 tm-20 -79.37 163.79 24.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.645 -1.162 . . . . 1.3700000000000001 107.933 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.9 p -58.74 -29.81 67.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.504 0.192 . . . . 1.0 110.778 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 17.4 ptm -75.93 -9.67 58.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.883 0.373 . . . . 1.79 111.249 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.3 m-30 -100.93 -4.48 27.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.676 -0.238 . . . . 0.75 111.422 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.593 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -141.55 171.36 24.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.638 . . . . 0.70999999999999996 112.371 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -75.12 -57.65 3.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.735 0.303 . . . . 1.52 110.614 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 -106.44 1.79 Allowed Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.798 -0.715 . . . . 2.2999999999999998 111.861 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.4 -23.4 34.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.314 0.578 . . . . 5.8600000000000003 110.23 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -82.06 11.3 5.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.568 0.699 . . . . 4.2699999999999996 110.649 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.23 -164.85 28.44 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.008 -0.837 . . . . 2.1600000000000001 111.008 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 81.8 m -90.93 104.38 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.173 0.486 . . . . 3.3399999999999999 110.415 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 111' ' ' PRO . . . -72.83 146.17 37.92 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.959 -0.639 . . . . 1.2 112.266 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 1.0 OUTLIER -66.97 -70.61 0.24 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.977 0.418 . . . . 3.0800000000000001 110.94 -176.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' HD13 ' A' ' 110' ' ' ILE . 37.4 m -112.15 -74.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 1.52 111.788 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.641 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.21 60.64 9.21 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.137 0.421 . . . . 0.75 112.137 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 31.7 Cg_endo -96.04 93.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.963 2.442 . . . . 1.5800000000000001 111.992 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.36 82.47 0.19 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.273 -0.731 . . . . 2.0499999999999998 111.273 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.1 m120 63.11 21.84 13.09 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.919 0.866 . . . . 2.0299999999999998 109.468 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.817 ' HB2' HD11 ' A' ' 48' ' ' LEU . 8.0 p -118.7 131.75 56.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.726 -1.125 . . . . 1.1399999999999999 110.389 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.4 p -86.89 135.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 0.47999999999999998 110.419 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.488 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -123.03 168.3 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.51000000000000001 110.763 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.836 HD23 ' HE ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -122.33 112.01 17.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.052 -0.722 . . . . 0.69999999999999996 109.052 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.616 ' HD2' HD13 ' A' ' 95' ' ' ILE . 45.3 m-85 -104.07 128.29 51.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.076 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.671 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 44.2 mt-10 -75.65 112.14 11.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 171.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.581 HG21 HG12 ' A' ' 82' ' ' VAL . 25.4 mt -105.88 120.85 57.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.062 0.458 . . . . 0.47999999999999998 110.254 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.33 -0.85 . . . . 1.8799999999999999 109.287 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 87' ' ' LYS . 7.9 tt -91.9 135.52 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.439 . . . . 1.1200000000000001 109.813 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.97 -31.27 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.663 -0.415 . . . . 1.0 112.025 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m -149.99 139.38 21.42 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.124 -0.36 . . . . 1.1899999999999999 111.399 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.603 ' HB2' HG12 ' A' ' 40' ' ' VAL . 3.4 p90 -167.62 171.34 10.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.905 -0.776 . . . . 0.71999999999999997 108.905 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.1 153.47 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.697 0.284 . . . . 2.98 110.99 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.04 150.41 48.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 3.3799999999999999 110.36 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 23.9 tp -162.18 45.42 0.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.334 -0.988 . . . . 3.3500000000000001 108.334 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -91.29 90.22 7.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.898 -1.046 . . . . 5.3899999999999997 112.684 -167.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -160.14 5.22 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 7.04 111.247 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -93.4 5.5 51.36 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.34 -0.544 . . . . 7.21 111.338 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -133.38 82.46 1.99 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.741 -0.384 . . . . 9.0199999999999996 110.912 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -172.84 136.61 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.697 -0.853 . . . . 9.75 108.697 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.3 t60 62.47 -141.73 0.41 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.269 -0.641 . . . . 12.26 109.269 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.681 -0.676 . . . . 13.35 110.278 176.456 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.792 0.329 . . . . 7.4800000000000004 110.536 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 p -144.42 145.67 32.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.75 -0.659 . . . . 5.9000000000000004 109.635 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -72.13 140.64 48.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.536 -0.913 . . . . 4.4400000000000004 108.536 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -78.67 69.97 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.586 -0.279 . . . . 4.4400000000000004 111.707 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 63.82 115.93 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.226 -0.897 . . . . 4.1500000000000004 113.074 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.28 70.69 6.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.924 -0.58 . . . . 3.6099999999999999 109.65 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.12 138.6 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.028 -0.533 . . . . 3.6000000000000001 110.959 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -96.62 156.98 16.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.888 -0.596 . . . . 2.71 109.605 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 7.0 mptt -101.64 142.63 32.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.344 -0.243 . . . . 1.8799999999999999 110.344 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.7 t -103.89 118.73 51.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.73 -0.47 . . . . 0.58999999999999997 109.73 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.88 126.99 46.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.419 -0.355 . . . . 2.1600000000000001 110.842 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt 50.1 51.15 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.589 -0.732 . . . . 1.45 112.12 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -55.51 151.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.78000000000000003 110.967 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -8.54 13.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.363 0.505 . . . . 0.81000000000000005 112.363 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 80' ' ' ILE . 7.1 t70 -82.31 24.33 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.022 0.439 . . . . 2.3999999999999999 111.066 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.07 -7.42 9.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.026 -0.607 . . . . 0.68000000000000005 114.163 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.43 76.07 1.08 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.415 -0.898 . . . . 0.60999999999999999 113.942 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 t -143.76 150.21 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.611 -0.514 . . . . 0.48999999999999999 109.611 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mm -85.27 109.89 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 123.237 0.335 . . . . 0.46999999999999997 110.162 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -123.64 147.08 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.272 0.558 . . . . 1.3400000000000001 111.349 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.1 m -119.08 122.26 41.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.502 -0.772 . . . . 0.5 110.365 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.599 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.7 tp -71.7 131.95 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 0.67000000000000004 111.315 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 1.6 mm? -121.94 -59.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.82999999999999996 110.916 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 88' ' ' ASN . 37.1 ttpt -128.65 154.82 45.88 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.217 -0.66 . . . . 1.5600000000000001 109.217 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -125.23 156.39 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.894 0.378 . . . . 2.9500000000000002 111.106 -173.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.39 163.2 14.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.815 -0.914 . . . . 1.3200000000000001 110.815 170.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -87.51 -97.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.336 0.568 . . . . 2.77 110.648 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.94 155.99 18.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.515 -0.55 . . . . 2.6400000000000001 109.515 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 171.68 62.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.092 -1.051 . . . . 1.04 112.299 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.83 -41.65 99.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.009 0.433 . . . . 2.29 110.318 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.79 20.81 13.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.728 0.775 . . . . 2.6400000000000001 110.466 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.456 ' HB3' HH21 ' A' ' 86' ' ' ARG . 0.2 OUTLIER -135.9 78.3 1.71 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 1.45 109.929 175.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 35' ' ' LYS . 36.0 mm -136.58 123.87 14.34 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.81000000000000005 110.811 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 121.49 7.86 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.69 2.26 . . . . 0.75 110.911 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -135.73 150.47 49.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.013 -0.429 . . . . 2.6600000000000001 111.263 -178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.596 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -60.4 132.03 52.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.774 -0.648 . . . . 2.5099999999999998 109.857 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -22.36 31.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.475 -0.65 . . . . 1.1200000000000001 111.475 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -104.05 130.97 51.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.851 -0.425 . . . . 1.3799999999999999 109.851 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -69.07 109.21 3.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.051 -0.522 . . . . 2.2000000000000002 111.765 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 69' ' ' LEU . 22.3 m -99.56 154.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.693 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -122.43 113.01 18.76 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.407 -0.59 . . . . 0.65000000000000002 109.407 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.84 159.85 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.019 0.748 . . . . 0.87 113.019 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -111.85 128.21 56.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 2.75 108.901 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 55.0 p90 -131.25 139.34 49.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.205 0.526 . . . . 0.76000000000000001 111.54 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -168.63 158.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.401 -0.962 . . . . 0.48999999999999999 108.401 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.53 -130.87 1.74 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.926 -1.13 . . . . 0.35999999999999999 112.434 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.717 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 62.4 pttt -156.19 170.05 23.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.13 0.49 . . . . 1.4299999999999999 111.028 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -82.76 101.64 11.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.811 -0.632 . . . . 0.38 110.079 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.65 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 44.5 tt0 -57.54 -33.1 67.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.88 0.371 . . . . 1.96 110.942 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -57.27 -19.62 22.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.67000000000000004 112.106 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 53' ' ' LYS . 7.5 t -138.22 -8.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.792 -0.363 . . . . 0.72999999999999998 111.709 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.07 83.14 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.217 -0.516 . . . . 0.78000000000000003 112.981 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 12.8 mmmm -87.99 120.96 29.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.707 0.289 . . . . 2.8900000000000001 110.99 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.717 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 13.6 p -75.56 151.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.591 . . . . 0.58999999999999997 110.195 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.48 ' CE1' HD11 ' A' ' 110' ' ' ILE . 17.7 m-30 -73.85 127.39 32.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.78000000000000003 111.015 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -141.39 85.76 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.868 0.842 . . . . 2.1800000000000002 110.2 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 m -122.57 -175.93 3.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.234 -0.654 . . . . 1.24 109.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.4 m -72.31 -47.03 53.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.752 0.31 . . . . 1.49 111.604 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -96.42 -36.76 10.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.964 0.727 . . . . 1.8 112.964 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 47.7 p-10 -60.62 -45.38 94.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.586 0.587 . . . . 2.1899999999999999 112.586 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -86.89 15.38 5.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.214 0.531 . . . . 2.7799999999999998 110.775 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.05 -47.09 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 1.1000000000000001 111.793 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 7.1 p -114.38 124.89 29.96 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 2.0299999999999998 110.947 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 2.8 Cg_exo -75.83 120.67 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.046 2.497 . . . . 1.76 111.788 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.44 146.72 23.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.436 -0.579 . . . . 1.3100000000000001 109.436 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 162.08 37.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.331 -0.395 . . . . 1.3600000000000001 110.755 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CE1' HG11 ' A' ' 74' ' ' VAL . 41.0 p90 -144.74 175.63 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.56999999999999995 110.302 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.8 m-70 -111.4 147.79 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.296 -0.631 . . . . 1.98 109.296 173.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HB2' HG22 ' A' ' 40' ' ' VAL . 16.9 tp -72.02 127.02 31.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.403 . . . . 0.94999999999999996 109.911 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.596 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 64.44 72.78 0.44 Allowed 'General case' 0 C--N 1.331 -0.206 0 O-C-N 124.15 0.906 . . . . 2.0800000000000001 111.453 -175.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 73' ' ' GLU . 11.9 pt20 -130.35 14.71 5.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.326 -0.852 . . . . 1.98 109.597 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.92 -17.44 31.73 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.71999999999999997 113.11 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HB2' HE21 ' A' ' 71' ' ' GLN . 14.2 mm-40 -84.36 -39.41 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.058 0.456 . . . . 0.96999999999999997 111.465 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 67' ' ' PHE . 18.1 m -97.97 127.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.108 -0.496 . . . . 0.57999999999999996 110.456 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.689 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.61 -68.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.537 0.569 . . . . 0.62 112.537 -175.049 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.689 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -139.95 -45.97 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.231 0.456 . . . . 2.04 112.231 -175.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.75 -53.16 34.31 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.12 -0.562 . . . . 0.32000000000000001 113.275 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.463 ' O ' HG22 ' A' ' 82' ' ' VAL . 20.2 m-90 -75.8 -31.87 59.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.9 0.381 . . . . 0.48999999999999999 110.628 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.487 ' OD1' HD11 ' A' ' 69' ' ' LEU . 22.1 t0 -53.98 -52.88 59.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.201 -0.909 . . . . 1.1399999999999999 112.068 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.87 -41.07 81.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.903 0.383 . . . . 0.78000000000000003 111.191 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.664 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 25.4 t -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.712 -0.395 . . . . 0.55000000000000004 111.385 -176.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 69' ' ' LEU . 34.9 m -67.96 -32.03 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.97 0.414 . . . . 0.83999999999999997 110.173 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -64.76 -27.17 68.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 1.4299999999999999 110.802 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 t -101.43 24.66 9.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.815 -0.629 . . . . 1.23 110.812 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.046 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 5.1 mmt -104.98 -173.32 2.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.561 -0.29 . . . . 2.27 110.921 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 24.1 mtp-105 -151.99 175.01 12.95 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.937 -0.764 . . . . 4.1900000000000004 108.937 170.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -61.27 -24.32 66.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.061 0.458 . . . . 1.9399999999999999 111.254 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.465 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 35.3 m-80 -130.37 28.62 4.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.444 -0.344 . . . . 1.23 110.966 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 28.4 tt0 -121.19 142.85 49.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.58 -0.526 . . . . 1.6000000000000001 109.58 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.556 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.32 130.24 16.23 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.713 -0.477 . . . . 1.1699999999999999 109.713 -171.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.599 ' SG ' HD12 ' A' ' 22' ' ' ILE . 96.9 m -141.96 171.68 13.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 1.2 111.996 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.7 134.76 46.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.36 -0.836 . . . . 1.73 110.015 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.664 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.1 p -112.93 140.96 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.901 0.382 . . . . 0.73999999999999999 111.165 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.625 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.09 112.48 25.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.919 -0.582 . . . . 1.71 110.263 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.8 mp -95.84 102.1 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.52000000000000002 110.03 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.425 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 24.7 tt0 -83.89 168.74 15.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.43 -0.952 . . . . 1.3700000000000001 108.43 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.4 p -53.22 -36.05 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.52 -7.47 54.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.366 -0.379 . . . . 1.79 111.801 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.425 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -100.44 0.03 38.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.576 0.227 . . . . 0.75 111.265 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -127.07 -165.15 11.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.891 -0.671 . . . . 0.70999999999999996 111.928 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -82.61 -48.7 10.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.876 0.338 . . . . 1.52 111.102 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.09 -168.48 21.4 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.096 -1.049 . . . . 2.2999999999999998 113.108 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.93 -36.26 79.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.038 0.535 . . . . 5.8600000000000003 111.647 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -87.08 7.25 28.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.763 -0.653 . . . . 4.2699999999999996 111.427 -171.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.93 164.71 12.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.765 -0.731 . . . . 2.1600000000000001 111.769 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.5 m -90.03 123.43 33.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.973 0.416 . . . . 3.3399999999999999 111.029 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -111.43 -158.55 15.05 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.927 -0.579 . . . . 1.2 111.826 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.35 -71.42 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.217 0.508 . . . . 3.0800000000000001 111.865 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -79.76 -76.02 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 1.52 111.985 -172.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.48 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -152.69 87.34 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.139 -0.689 . . . . 0.75 109.139 175.521 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.612 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -95.73 -171.7 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.489 2.793 . . . . 1.5800000000000001 113.196 -174.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.87 -143.51 13.85 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.61 -0.596 . . . . 2.0499999999999998 111.61 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -101.14 1.52 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.907 0.384 . . . . 2.0299999999999998 110.599 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 p -82.43 158.27 23.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.928 -0.578 . . . . 1.1399999999999999 110.939 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.83 132.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.47999999999999998 111.095 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -119.18 155.13 32.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.51000000000000001 109.695 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.65 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -124.67 127.64 47.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 0.69999999999999996 110.48 172.214 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -122.74 141.31 51.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.814 -0.63 . . . . 0.42999999999999999 110.589 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.7 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 40.3 mt-10 -76.54 121.5 23.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.846 -0.798 . . . . 1.46 108.846 169.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.535 HD12 ' HB3' ' A' ' 81' ' ' CYS . 13.1 mt -106.8 127.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.524 -0.547 . . . . 0.47999999999999998 109.524 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -134.16 111.02 9.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.051 -0.977 . . . . 1.8799999999999999 110.354 -169.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.459 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 24.9 tp -84.8 96.92 9.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 1.1200000000000001 109.991 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.14 -21.9 24.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.349 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -173.17 163.54 4.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.503 -0.317 . . . . 1.1899999999999999 110.203 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.24 174.12 8.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.71999999999999997 110.201 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -137.21 138.79 40.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.431 . . . . 2.98 110.904 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -100.04 128.58 46.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.555 -0.748 . . . . 3.3799999999999999 110.207 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.5 tp -165.95 134.45 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 3.3500000000000001 111.157 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -92.34 -78.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.546 -0.538 . . . . 5.3899999999999997 109.546 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -173.29 155.26 2.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.627 -0.879 . . . . 7.04 108.627 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -111.36 151.1 28.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.604 0.24 . . . . 7.21 111.323 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.3 m80 70.96 158.17 0.18 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.195 0.935 . . . . 9.0199999999999996 112.822 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.0 m170 70.0 179.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.931 -1.031 . . . . 9.75 111.147 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 74.77 139.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.565 0.746 . . . . 12.26 111.156 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.4 p80 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.856 -0.593 . . . . 13.35 110.144 176.606 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.212 0.53 . . . . 3.6000000000000001 111.328 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.06 150.84 21.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.393 -0.821 . . . . 2.71 109.156 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -98.9 151.58 20.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.898 -0.408 . . . . 1.8799999999999999 109.898 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -101.42 104.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.545 -0.909 . . . . 0.58999999999999997 108.545 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.54 108.49 20.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.222 -0.899 . . . . 2.1600000000000001 110.825 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 84.1 mt 65.01 69.5 0.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 1.45 110.406 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -65.21 163.7 14.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.838 -0.619 . . . . 0.78000000000000003 110.571 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.37 -3.74 29.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.672 0.619 . . . . 0.81000000000000005 112.672 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.534 ' HB3' HG13 ' A' ' 80' ' ' ILE . 29.1 t70 -90.55 14.76 12.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.361 0.601 . . . . 2.3999999999999999 110.946 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.03 19.46 2.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.323 -0.942 . . . . 0.68000000000000005 114.241 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 69.03 76.64 0.45 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.639 0.615 . . . . 0.60999999999999999 114.639 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.534 ' HB ' HG21 ' A' ' 80' ' ' ILE . 96.9 t -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.85 -0.426 . . . . 0.48999999999999999 109.85 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 13.7 mm -91.86 116.02 32.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 O-C-N 123.385 0.428 . . . . 0.46999999999999997 110.594 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -135.12 146.46 48.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 1.3400000000000001 111.263 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 m -108.56 131.91 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.691 . . . . 0.5 110.356 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -80.44 120.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.109 0.48 . . . . 0.67000000000000004 111.188 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.38 -52.57 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.82999999999999996 110.632 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 39.5 ttmt -127.44 149.19 50.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.351 -0.611 . . . . 1.5600000000000001 109.351 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -115.15 140.83 48.75 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.134 0.271 . . . . 2.9500000000000002 110.325 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.03 121.7 25.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.956 -0.64 . . . . 1.3200000000000001 112.009 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.05 -60.29 4.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.342 . . . . 2.77 111.511 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -160.96 141.01 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 2.6400000000000001 110.407 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 32' ' ' ASN . . . 167.86 103.31 0.17 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.551 -0.833 . . . . 1.04 112.026 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.65 -41.62 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.598 0.714 . . . . 2.29 109.246 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -88.48 -10.4 49.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.521 -1.218 . . . . 2.6400000000000001 110.607 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.655 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.5 m-80 -84.86 75.52 10.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.989 -0.551 . . . . 1.45 111.036 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 31.8 mm -144.58 102.22 4.63 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.757 -0.656 . . . . 0.81000000000000005 110.262 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HG3' HD22 ' A' ' 122' ' ' LEU . 65.2 Cg_endo -71.81 111.33 3.12 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 123.329 2.686 . . . . 0.75 112.181 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -116.87 166.47 12.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.624 0.726 . . . . 2.6600000000000001 112.189 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 1.024 ' HE3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -70.11 153.88 42.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.891 -1.05 . . . . 2.5099999999999998 111.736 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' H ' ' HB2' ' A' ' 70' ' ' GLU . . . 86.68 -5.11 85.53 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.365 -0.834 . . . . 1.1200000000000001 111.49 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -119.85 163.8 16.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.163 0.506 . . . . 1.3799999999999999 111.119 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -87.54 121.79 30.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 2.2000000000000002 110.769 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 125' ' ' PHE . 17.8 m -132.73 156.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.217 -0.447 . . . . 0.67000000000000004 109.974 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 124' ' ' SER . 39.0 m -127.75 116.58 20.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.229 -0.442 . . . . 0.65000000000000002 109.916 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 122' ' ' LEU . 33.7 m -137.46 156.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.614 -0.266 . . . . 0.87 111.088 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.73 142.71 45.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.956 -0.757 . . . . 2.75 108.956 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -124.16 141.23 52.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.76000000000000001 110.71 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -168.77 161.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 109.251 -0.648 . . . . 0.48999999999999999 109.251 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.22 -128.61 1.79 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.312 -0.947 . . . . 0.35999999999999999 112.341 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.665 ' O ' HD12 ' A' ' 117' ' ' LEU . 18.6 pttm -156.69 173.16 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.929 0.395 . . . . 1.4299999999999999 110.805 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.627 HD22 HG13 ' A' ' 110' ' ' ILE . 65.9 tp -91.15 98.29 11.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.38 110.184 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.71 ' HB2' HD11 ' A' ' 117' ' ' LEU . 35.7 tt0 -66.58 -21.15 66.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.846 0.355 . . . . 1.96 110.704 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.518 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 23.2 t -55.89 -29.97 60.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.67000000000000004 111.48 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 53' ' ' LYS . 9.6 t -138.04 1.31 2.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.868 0.366 . . . . 0.72999999999999998 111.406 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.91 20.42 73.41 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.215 -0.517 . . . . 0.78000000000000003 112.869 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HB2' HG23 ' A' ' 51' ' ' THR . 0.2 OUTLIER -84.19 116.42 22.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.629 0.252 . . . . 2.8900000000000001 110.784 -178.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.2 p -70.57 150.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.58999999999999997 110.054 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 8.4 m-30 -74.92 124.52 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.971 0.415 . . . . 0.78000000000000003 111.425 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.63 85.25 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.504 0.669 . . . . 2.1800000000000002 110.674 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.409 ' HB3' ' OD1' ' A' ' 60' ' ' ASP . 46.8 t -126.53 166.59 17.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.656 -0.702 . . . . 1.24 109.227 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -71.18 -22.05 62.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.897 0.38 . . . . 1.49 111.082 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.566 ' O ' HG12 ' A' ' 63' ' ' VAL . 43.3 m-85 -95.02 -55.65 3.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.793 0.664 . . . . 1.8 112.793 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 5.5 p-10 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.548 0.573 . . . . 2.1899999999999999 112.548 -167.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -1.94 55.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.842 0.353 . . . . 2.7799999999999998 111.278 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -116.29 -53.99 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 1.1000000000000001 111.765 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 59' ' ' PHE . 13.0 p -87.09 127.27 59.99 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.441 0.638 . . . . 2.0299999999999998 111.858 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.6 Cg_exo -78.18 90.48 1.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.586 2.191 . . . . 1.76 111.027 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -94.39 132.61 38.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.148 -0.686 . . . . 1.3100000000000001 109.148 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -138.55 147.31 42.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.106 -0.497 . . . . 1.3600000000000001 110.206 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -115.47 178.35 4.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.56999999999999995 109.722 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -115.72 148.9 39.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.237 -1.023 . . . . 1.98 108.237 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.621 HD13 ' CG2' ' A' ' 82' ' ' VAL . 18.3 tp -74.36 128.91 36.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.995 0.426 . . . . 0.94999999999999996 111.226 -175.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 1.024 ' HG3' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 58.93 64.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.879 -1.055 . . . . 2.0800000000000001 112.229 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 73' ' ' GLU . 10.0 pt20 -115.84 10.13 15.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.3 -1.318 . . . . 1.98 108.967 172.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.8 -18.7 41.89 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.71999999999999997 112.772 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' HB2' HE21 ' A' ' 71' ' ' GLN . 19.9 mm-40 -76.63 -32.92 58.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.178 0.513 . . . . 0.96999999999999997 110.791 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.78 129.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.813 -0.631 . . . . 0.57999999999999996 109.725 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.657 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.93 -73.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.261 -0.427 . . . . 0.62 111.592 -175.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.657 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -138.16 -44.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.022 -0.424 . . . . 2.04 112.018 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -54.5 -53.87 35.93 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.792 -0.718 . . . . 0.32000000000000001 113.101 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.604 ' O ' HG22 ' A' ' 82' ' ' VAL . 11.4 m-90 -75.78 -36.59 59.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.439 -0.448 . . . . 0.48999999999999999 110.266 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -51.41 -53.79 33.2 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.063 0.852 . . . . 1.1399999999999999 111.951 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 15' ' ' ASP . 1.6 mp -65.23 -38.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.829 0.347 . . . . 0.78000000000000003 111.164 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.593 ' O ' ' HG2' ' A' ' 85' ' ' MET . 23.6 t -66.86 -55.85 12.94 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.888 -0.325 . . . . 0.55000000000000004 110.616 -176.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.621 ' CG2' HD13 ' A' ' 69' ' ' LEU . 29.9 m -71.76 -33.23 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.038 0.385 . . . . 0.83999999999999997 112.038 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 t -78.05 0.83 23.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.264 0.555 . . . . 1.4299999999999999 110.734 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 t -131.69 20.48 4.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.687 . . . . 1.23 109.843 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.661 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.1 mmt -90.81 -174.66 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 2.27 110.699 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 50.8 mtt85 -149.42 154.97 39.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.03 -1.1 . . . . 4.1900000000000004 108.03 172.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 62.2 tttm -65.27 -14.33 60.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.128 0.489 . . . . 1.9399999999999999 111.911 -173.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -124.06 25.08 8.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.96 0.41 . . . . 1.23 110.185 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 32.3 tt0 -123.61 166.66 15.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.862 -0.608 . . . . 1.6000000000000001 110.363 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -158.8 133.72 8.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.715 0.293 . . . . 1.1699999999999999 111.301 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.3 m -136.79 153.94 50.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.342 -0.39 . . . . 1.2 110.738 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -101.21 121.46 41.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.35 -0.611 . . . . 1.73 109.35 175.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 77' ' ' GLY . 12.6 p -106.44 145.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.453 -0.34 . . . . 0.73999999999999999 110.896 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.534 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 41.5 mmt-85 -96.5 118.14 32.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.976 -0.557 . . . . 1.71 110.497 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.2 mp -96.43 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.227 -0.657 . . . . 0.52000000000000002 109.227 175.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 99' ' ' TYR . 42.1 tt0 -92.63 173.29 7.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.975 -1.012 . . . . 1.3700000000000001 108.898 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 17.1 p -51.42 -50.05 60.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.765 0.283 . . . . 1.0 111.765 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.6 ptm -77.55 -16.82 58.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.074 0.398 . . . . 1.79 112.074 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.489 ' HB2' ' H ' ' A' ' 96' ' ' GLU . 21.7 m-30 -85.59 -17.17 37.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.177 -0.305 . . . . 0.75 110.177 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.85 -154.22 9.25 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.488 -0.778 . . . . 0.70999999999999996 111.463 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 1.52 111.847 -178.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.507 ' HB2' HD13 ' A' ' 110' ' ' ILE . 11.4 p . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 111.753 0.279 . . . . 1.52 111.753 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.627 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -144.43 84.27 9.36 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.617 0.722 . . . . 0.75 110.861 177.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -95.15 90.9 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.029 2.486 . . . . 1.5800000000000001 112.272 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.95 47.66 1.0 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.079 -1.058 . . . . 2.0499999999999998 112.302 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 3.6 m-20 60.34 21.68 11.2 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.534 0.683 . . . . 2.0299999999999998 110.76 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.518 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 7.4 m -96.46 156.55 16.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 1.1399999999999999 109.852 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -87.03 121.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.404 0.621 . . . . 0.47999999999999998 110.766 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -114.57 157.27 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.601 -0.727 . . . . 0.51000000000000001 110.159 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -116.77 129.19 55.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 110.0 -0.37 . . . . 0.69999999999999996 110.0 175.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.461 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 21.1 m-85 -122.33 122.0 38.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.598 -0.274 . . . . 0.42999999999999999 110.351 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.471 ' HG2' ' HG ' ' A' ' 92' ' ' LEU . 42.7 mt-10 -75.25 114.52 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.191 -0.67 . . . . 1.46 109.191 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.436 HD11 ' HD1' ' A' ' 78' ' ' TRP . 65.4 mt -106.76 122.29 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.913 0.387 . . . . 0.47999999999999998 110.005 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.29 115.66 22.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 109.5 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.86 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -86.0 94.43 9.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 1.1200000000000001 110.362 -176.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.678 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.2 pt? -86.08 -28.65 23.94 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.16 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.54 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 t -141.05 144.82 35.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.044 0.45 . . . . 1.1899999999999999 110.555 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 87' ' ' LYS . 6.1 p90 -164.47 168.16 18.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.931 -0.766 . . . . 0.71999999999999997 108.931 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -161.97 109.16 1.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 2.98 111.339 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.541 -0.754 . . . . 3.3799999999999999 110.365 176.658 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.822 0.344 . . . . 3.6000000000000001 110.466 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.28 150.07 49.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.038 0.447 . . . . 2.71 110.826 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.475 ' HG3' HG23 ' A' ' 21' ' ' THR . 3.6 mppt? -91.6 144.4 25.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 1.8799999999999999 109.605 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 41.4 t -101.34 103.85 15.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 0.58999999999999997 108.427 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -103.45 113.75 27.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.129 -0.941 . . . . 2.1600000000000001 110.66 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 19' ' ' ILE . 52.2 mt 60.67 54.65 3.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.962 0.789 . . . . 1.45 111.206 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.49 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -57.29 148.63 22.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.92 . . . . 0.78000000000000003 110.607 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.43 1.3 4.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.81000000000000005 110.502 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.1 16.64 4.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 2.3999999999999999 110.908 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.18 5.04 8.98 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.396 -0.907 . . . . 0.68000000000000005 114.114 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.34 72.26 0.9 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.226 -0.512 . . . . 0.60999999999999999 113.652 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' A' ' 80' ' ' ILE . 62.4 t -135.68 142.72 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.782 -0.451 . . . . 0.48999999999999999 109.782 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 12' ' ' LEU . 18.5 mm -88.11 114.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.721 -0.474 . . . . 0.46999999999999997 109.721 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HD2' ' SG ' ' A' ' 81' ' ' CYS . 12.1 pttp -142.4 138.51 31.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.314 0.578 . . . . 1.3400000000000001 111.418 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 24.6 m -100.02 123.81 44.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.5 110.126 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.557 HG12 ' HE2' ' A' ' 25' ' ' LYS . 8.9 tp -80.42 132.76 31.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.997 0.427 . . . . 0.67000000000000004 110.1 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' LEU . 3.9 mm? -113.68 -51.06 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.049 -0.523 . . . . 0.82999999999999996 110.983 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 117.19 19.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.454 -0.339 . . . . 1.5600000000000001 110.392 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 58.0 mttm -101.91 160.63 14.32 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.148 -0.478 . . . . 2.9500000000000002 110.312 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.42 -142.23 12.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.789 -0.719 . . . . 1.3200000000000001 111.919 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -76.0 0.56 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.961 0.41 . . . . 2.77 110.293 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.79 -178.58 3.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.136 -0.483 . . . . 2.6400000000000001 110.116 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 52.31 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.081 -0.807 . . . . 1.04 111.081 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.78 -40.64 93.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.983 0.42 . . . . 2.29 110.948 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -108.79 9.28 26.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.536 . . . . 2.6400000000000001 110.474 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -111.79 77.37 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 1.45 110.296 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.452 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 36.4 mm -132.87 120.69 16.57 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.398 -0.819 . . . . 0.81000000000000005 110.101 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.452 ' HG3' HD22 ' A' ' 122' ' ' LEU . 85.7 Cg_endo -87.04 115.9 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.815 2.343 . . . . 0.75 112.576 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HE2' ' CG2' ' A' ' 33' ' ' ILE . 71.3 mmtt -129.9 158.29 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 2.6600000000000001 111.444 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 12.1 ttmm -65.43 150.27 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.158 -0.928 . . . . 2.5099999999999998 111.365 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.2 -11.66 68.92 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.934 -0.867 . . . . 1.1200000000000001 110.934 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -105.05 155.71 18.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.517 . . . . 1.3799999999999999 110.878 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.25 104.25 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 2.2000000000000002 110.682 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 m -118.08 162.12 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 0.67000000000000004 110.655 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 31.5 m -133.45 120.91 21.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.797 -0.638 . . . . 0.65000000000000002 109.611 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.68 148.79 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.87 111.577 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.22 143.84 30.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.297 -0.631 . . . . 2.75 109.297 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 30.6 p90 -141.97 137.02 30.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.76000000000000001 110.505 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.55 160.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.125 -0.694 . . . . 0.48999999999999999 109.125 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.11 -118.88 0.68 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.539 -0.839 . . . . 0.35999999999999999 112.597 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HG3' HD11 ' A' ' 117' ' ' LEU . 55.5 pttt -149.94 171.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 1.4299999999999999 110.111 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.506 HD12 ' HG ' ' A' ' 116' ' ' LEU . 57.0 tp -87.23 98.01 11.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.879 -0.6 . . . . 0.38 109.533 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.577 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 4.9 tp10 -57.59 -35.09 69.94 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.46 0.541 . . . . 1.96 112.46 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -58.26 -20.06 39.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.372 0.508 . . . . 0.67000000000000004 112.372 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 53' ' ' LYS . 11.4 t -134.05 -30.81 1.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.971 0.415 . . . . 0.72999999999999998 110.773 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.26 15.84 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.254 -0.498 . . . . 0.78000000000000003 113.151 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' H ' HG23 ' A' ' 51' ' ' THR . 11.2 mmmm -81.49 125.33 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.932 0.366 . . . . 2.8900000000000001 110.67 177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.24 154.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.58999999999999997 110.03 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.485 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 22.0 m-30 -75.2 99.96 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.167 0.508 . . . . 0.78000000000000003 111.918 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -116.87 85.89 2.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.371 -0.974 . . . . 2.1800000000000002 108.371 168.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -135.33 158.06 45.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.62 -0.718 . . . . 1.24 110.248 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -48.67 -42.08 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.769 0.668 . . . . 1.49 112.496 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -93.88 -50.64 5.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.771 0.32 . . . . 1.8 110.609 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.66 -37.87 59.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 2.1899999999999999 112.626 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -84.53 -4.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 2.7799999999999998 111.267 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -115.49 -61.44 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.939 -0.305 . . . . 1.1000000000000001 110.569 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.19 109.61 6.96 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.32 -0.4 . . . . 2.0299999999999998 110.225 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.49 161.17 42.32 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.709 2.273 . . . . 1.76 112.137 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -94.03 154.12 17.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.079 -0.509 . . . . 1.3100000000000001 110.279 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.8 pptp? -134.47 151.1 50.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 1.3600000000000001 110.263 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.68 -171.85 2.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.37 -0.377 . . . . 0.56999999999999995 110.989 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -116.72 149.2 40.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.289 -0.634 . . . . 1.98 109.289 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 HG21 ' A' ' 82' ' ' VAL . 9.8 tp -67.81 112.86 5.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.94999999999999996 111.89 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.97 73.11 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.334 -1.303 . . . . 2.0800000000000001 111.63 176.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -113.44 17.43 18.43 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.187 -1.042 . . . . 1.98 108.187 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.99 -18.28 55.99 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.585 -1.189 . . . . 0.71999999999999997 113.062 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.25 -14.54 28.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.956 0.378 . . . . 0.96999999999999997 111.446 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.15 121.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.643 0.735 . . . . 0.57999999999999996 109.751 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.431 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -99.37 -62.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.08 -0.964 . . . . 0.62 112.774 -172.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -125.92 -66.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.278 0.473 . . . . 2.04 112.278 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.33 -52.6 35.82 Favored Glycine 0 C--N 1.333 0.384 0 O-C-N 123.56 0.538 . . . . 0.32000000000000001 113.59 -169.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.45 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.9 m-90 -75.39 -46.44 32.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.769 0.318 . . . . 0.48999999999999999 110.393 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.36 -48.26 65.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.026 -0.988 . . . . 1.1399999999999999 112.251 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.593 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -73.89 -45.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.488 -0.324 . . . . 0.78000000000000003 110.894 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.489 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 53.1 t -63.56 -41.8 98.4 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.591 0.219 . . . . 0.55000000000000004 111.591 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.607 HG21 HD13 ' A' ' 69' ' ' LEU . 34.4 m -67.66 -32.34 56.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.768 -0.373 . . . . 0.83999999999999997 110.805 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.1 m -79.48 -4.0 49.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.946 0.403 . . . . 1.4299999999999999 111.169 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.425 ' OG ' ' HE2' ' A' ' 20' ' ' LYS . 9.7 p -124.01 39.32 3.99 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.227 0.537 . . . . 1.23 111.096 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.497 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 0.1 OUTLIER -116.13 174.57 5.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 2.27 110.488 176.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 86' ' ' ARG . 6.1 ttm180 -127.51 163.36 24.31 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.36 -1.348 . . . . 4.1900000000000004 107.36 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -64.42 -17.55 63.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.238 0.542 . . . . 1.9399999999999999 110.846 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -122.81 16.73 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.069 -0.514 . . . . 1.23 110.703 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 25' ' ' LYS . 33.6 tt0 -123.7 129.38 51.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 1.6000000000000001 110.642 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.476 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 85.4 tttt -136.58 143.75 43.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 1.1699999999999999 109.894 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 21' ' ' THR . 28.8 p -149.79 165.26 33.0 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.001 0.429 . . . . 1.2 111.733 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.97 120.65 32.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.291 -0.868 . . . . 1.73 110.007 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.489 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.5 p -99.89 134.59 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.286 -0.415 . . . . 0.73999999999999999 110.096 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 26.2 mmm-85 -96.1 111.38 23.43 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.463 -0.569 . . . . 1.71 109.463 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.426 HD13 ' CD2' ' A' ' 118' ' ' PHE . 2.1 mp -91.44 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.019 -0.734 . . . . 0.52000000000000002 109.019 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 97' ' ' SER . 43.7 tt0 -79.7 168.52 19.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.313 -0.858 . . . . 1.3700000000000001 109.449 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -48.16 -48.48 34.32 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.323 0.649 . . . . 1.0 111.463 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -78.56 -8.07 58.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.362 0.504 . . . . 1.79 112.362 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -96.25 -12.86 23.95 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.237 -0.289 . . . . 0.75 110.848 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 176.06 19.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.847 -0.692 . . . . 0.70999999999999996 112.36 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.916 0.388 . . . . 1.52 110.996 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.147 -0.686 . . . . 1.52 109.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.449 HG13 HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -143.62 112.38 5.43 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.35 -0.387 . . . . 0.75 110.095 175.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -83.06 -83.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.516 2.144 . . . . 1.5800000000000001 112.831 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.89 18.16 59.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.952 -0.36 . . . . 2.0499999999999998 113.694 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 52.65 35.39 18.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.006 0.431 . . . . 2.0299999999999998 111.181 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.3 m -107.77 179.49 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 1.1399999999999999 110.67 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.33 129.57 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.174 0.512 . . . . 0.47999999999999998 111.008 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.506 ' HG ' HD12 ' A' ' 48' ' ' LEU . 6.3 mp -127.21 174.82 8.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.297 -0.631 . . . . 0.51000000000000001 109.297 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.631 ' HB3' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -147.01 133.04 19.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.29 0.567 . . . . 0.69999999999999996 110.578 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.485 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 43.6 m-85 -127.98 141.76 51.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.42999999999999999 110.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.3 mt-10 -76.26 127.15 32.32 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.062 -0.718 . . . . 1.46 109.062 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.7 mt -105.89 118.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.601 0.715 . . . . 0.47999999999999998 110.216 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -110.68 116.0 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.687 -1.142 . . . . 1.8799999999999999 110.458 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 34' ' ' PRO . 30.3 tp -91.89 89.6 7.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 1.1200000000000001 109.977 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.7 pt? -95.17 -33.32 12.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.042 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 13.8 m -135.12 128.18 31.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.024 -0.362 . . . . 1.1899999999999999 110.024 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.25 171.16 11.01 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.559 -0.534 . . . . 0.71999999999999997 109.559 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -162.11 168.49 22.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.007 -0.368 . . . . 2.98 110.007 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 108.139 -1.06 . . . . 3.3799999999999999 108.139 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.236 0.368 0 CA-C-O 121.271 0.558 . . . . 3.6000000000000001 111.57 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -94.14 153.99 17.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.013 -0.994 . . . . 2.71 110.053 -175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 11.5 mptt -114.73 147.51 39.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.765 0.317 . . . . 1.8799999999999999 110.697 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.98 108.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.536 -0.542 . . . . 0.58999999999999997 109.536 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -89.45 125.06 35.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.237 0.542 . . . . 2.1600000000000001 111.421 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' H ' HD13 ' A' ' 19' ' ' ILE . 11.1 tp 54.76 64.38 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.953 -1.021 . . . . 1.45 111.027 174.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 80' ' ' ILE . 9.0 t -59.16 156.03 12.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.636 -0.711 . . . . 0.78000000000000003 111.61 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -19.86 64.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.743 -0.662 . . . . 0.81000000000000005 112.588 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.62 19.93 1.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.324 0.49 . . . . 2.3999999999999999 112.324 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.64 30.64 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.68000000000000005 114.429 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.85 83.6 0.06 OUTLIER Glycine 0 C--O 1.227 -0.334 0 N-CA-C 114.648 0.619 . . . . 0.60999999999999999 114.648 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' THR . 55.0 t -141.21 140.1 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.38 -0.6 . . . . 0.48999999999999999 109.38 174.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 12' ' ' LEU . 10.0 mm -93.07 113.58 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.228 0.33 . . . . 0.46999999999999997 110.113 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -141.27 146.9 37.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.338 0.59 . . . . 1.3400000000000001 111.616 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -109.68 138.65 45.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.106 -0.952 . . . . 0.5 110.113 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.84 132.3 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.234 -0.284 . . . . 0.67000000000000004 110.234 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 92' ' ' LEU . 3.5 mm? -115.57 -51.58 2.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.456 -0.338 . . . . 0.82999999999999996 110.64 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 29.1 ttmt -122.9 135.07 54.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.726 -0.472 . . . . 1.5600000000000001 109.726 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -99.63 147.12 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 123.46 0.475 . . . . 2.9500000000000002 110.785 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 171.4 52.15 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 116.028 -0.533 . . . . 1.3200000000000001 111.939 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.55 -65.92 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 2.77 110.768 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -151.7 153.05 33.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 2.6400000000000001 110.074 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.43 100.8 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.181 -1.009 . . . . 1.04 112.98 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -74.63 -42.33 58.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.574 . . . . 2.29 109.793 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -81.4 -23.31 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.377 -0.829 . . . . 2.6400000000000001 110.663 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.69 75.78 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.421 0.629 . . . . 1.45 109.611 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mm -146.4 118.78 4.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.735 -1.12 . . . . 0.81000000000000005 109.209 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HG3' HD22 ' A' ' 122' ' ' LEU . 20.3 Cg_endo -60.78 124.73 15.57 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.799 2.333 . . . . 0.75 111.716 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -116.37 149.54 39.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.601 -0.518 . . . . 2.6600000000000001 109.601 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -77.19 144.54 38.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.416 -0.514 . . . . 2.5099999999999998 110.633 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.34 -22.31 41.32 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.162 -0.775 . . . . 1.1200000000000001 111.162 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -99.33 169.96 8.98 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.079 -0.341 . . . . 1.3799999999999999 110.079 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.05 125.63 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.286 0.565 . . . . 2.2000000000000002 111.324 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG12 ' HB2' ' A' ' 125' ' ' PHE . 19.0 m -135.12 160.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.598 -0.728 . . . . 0.67000000000000004 109.235 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 28.6 m -130.51 111.85 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.407 -0.59 . . . . 0.65000000000000002 109.407 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.26 153.34 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.87 111.751 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -116.18 130.25 56.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 2.75 109.022 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 21.8 p90 -127.23 144.3 51.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.788 0.327 . . . . 0.76000000000000001 110.143 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -167.82 158.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.892 -0.781 . . . . 0.48999999999999999 108.892 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.67 -130.35 1.98 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.841 -1.171 . . . . 0.35999999999999999 113.05 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.744 ' HG3' HD13 ' A' ' 117' ' ' LEU . 57.2 pttt -157.38 173.07 17.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.377 . . . . 1.4299999999999999 110.682 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.46 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 66.7 tp -94.53 109.34 21.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 0.38 110.28 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' HD11 ' A' ' 117' ' ' LEU . 24.2 tt0 -68.43 -20.69 64.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.204 0.526 . . . . 1.96 110.091 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.445 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 39.7 t -55.1 -43.27 73.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.154 -0.93 . . . . 0.67000000000000004 111.328 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.459 HG22 HD23 ' A' ' 48' ' ' LEU . 8.8 t -124.38 3.31 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.72999999999999998 111.41 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.35 78.51 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 120.902 -0.666 . . . . 0.78000000000000003 113.039 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 67.0 mmtt -91.82 132.92 36.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 2.8900000000000001 110.917 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.661 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.8 p -75.84 166.84 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 0.58999999999999997 109.95 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.96 117.99 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.431 0.634 . . . . 0.78000000000000003 110.582 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.72 95.01 2.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.113 -0.949 . . . . 2.1800000000000002 109.42 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 m -137.4 171.2 14.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.933 0.397 . . . . 1.24 110.337 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -70.41 -33.7 71.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.15 -0.477 . . . . 1.49 110.9 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -92.33 -35.93 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.541 0.571 . . . . 1.8 112.541 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -33.77 74.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.819 0.342 . . . . 2.1899999999999999 111.544 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.71 -12.15 51.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.051 0.453 . . . . 2.7799999999999998 110.941 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.864 HD22 HG23 ' A' ' 63' ' ' VAL . 6.9 t30 -112.24 -61.04 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.129 -0.487 . . . . 1.1000000000000001 111.815 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.864 HG23 HD22 ' A' ' 62' ' ' ASN . 96.9 t -119.25 104.09 46.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.598 -0.274 . . . . 2.0299999999999998 110.289 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.42 147.83 47.44 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.086 2.524 . . . . 1.76 112.035 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -101.99 150.39 23.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.295 -0.411 . . . . 1.3100000000000001 109.929 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.09 146.35 31.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 1.3600000000000001 109.792 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -127.59 -177.32 4.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.895 0.379 . . . . 0.56999999999999995 111.278 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -118.51 149.81 40.67 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.363 -0.606 . . . . 1.98 109.363 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 82' ' ' VAL . 15.9 tp -75.87 117.08 17.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.026 0.38 . . . . 0.94999999999999996 112.026 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 68.26 48.79 0.87 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.187 -0.915 . . . . 2.0800000000000001 112.395 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 1.3 pm0 -92.33 0.67 57.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.096 -0.705 . . . . 1.98 109.096 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.37 1.38 44.09 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.71999999999999997 113.091 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 7.9 mm-40 -99.04 -24.27 14.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.412 0.606 . . . . 0.96999999999999997 111.255 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.8 123.64 57.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.923 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.539 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -97.17 -62.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 0.62 112.293 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.626 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 8.7 mmpt? -129.2 -61.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 2.04 112.494 -172.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 -53.21 34.38 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.065 -0.588 . . . . 0.32000000000000001 113.459 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.572 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.0 m-90 -75.24 -37.12 61.17 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.841 -0.211 . . . . 0.48999999999999999 110.644 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.75 -52.09 57.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.826 0.703 . . . . 1.1399999999999999 111.685 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.576 HG21 HG21 ' A' ' 13' ' ' THR . 2.4 mp -74.26 -41.89 50.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 0.78000000000000003 110.995 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.51 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 44.6 t -60.33 -51.03 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.55000000000000004 111.589 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 69' ' ' LEU . 28.6 m -67.69 -43.1 86.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 111.975 0.361 . . . . 0.83999999999999997 111.975 -174.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.429 ' OG ' HD21 ' A' ' 69' ' ' LEU . 21.6 m -70.16 -14.92 62.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.028 0.442 . . . . 1.4299999999999999 111.463 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -99.46 24.95 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.367 -0.379 . . . . 1.23 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.592 ' HE1' ' HA ' ' A' ' 82' ' ' VAL . 37.2 mtm -118.83 -173.58 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.215 0.531 . . . . 2.27 111.214 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.498 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 53.5 mtm180 -142.2 175.46 9.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.155 -0.93 . . . . 4.1900000000000004 109.271 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -62.31 -16.88 56.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.563 0.579 . . . . 1.9399999999999999 112.563 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -135.32 29.4 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 1.23 110.747 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 4.5 tt0 -113.91 153.95 28.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.527 -0.546 . . . . 1.6000000000000001 109.527 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.545 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 1.5 tmtp? -143.58 127.49 17.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.972 -0.291 . . . . 1.1699999999999999 110.955 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 71.2 m -127.61 151.45 48.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.222 -0.445 . . . . 1.2 111.425 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.457 ' HB2' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -107.29 118.96 38.1 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.151 -0.685 . . . . 1.73 109.151 173.01 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.2 p -109.7 141.89 23.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.243 0.544 . . . . 0.73999999999999999 111.43 -173.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -99.29 117.44 33.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 1.71 109.88 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.9 mp -96.92 104.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.462 . . . . 0.52000000000000002 109.751 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 97' ' ' SER . 28.9 tt0 -83.76 170.87 13.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.787 -0.82 . . . . 1.3700000000000001 108.787 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 9.5 p -49.6 -49.9 44.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.526 0.33 . . . . 1.0 111.85 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.9 ptp -76.61 -13.5 60.06 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.236 -0.438 . . . . 1.79 111.635 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 16.1 m-30 -84.54 -5.84 59.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.871 0.367 . . . . 0.75 110.149 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -138.39 -161.2 8.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.55 -0.75 . . . . 0.70999999999999996 111.52 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 1.52 110.975 179.615 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.673 -0.491 . . . . 1.52 109.673 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -143.21 117.0 6.13 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.75 110.452 176.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -80.56 -68.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.015 1.81 . . . . 1.5800000000000001 111.717 170.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.87 1.25 17.2 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.176 -0.466 . . . . 2.0499999999999998 113.409 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 m120 60.88 27.71 17.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.192 0.52 . . . . 2.0299999999999998 110.917 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -119.7 -163.69 1.01 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.896 -0.593 . . . . 1.1399999999999999 110.307 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 7.6 p -108.17 130.05 61.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.309 0.576 . . . . 0.47999999999999998 111.775 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -112.94 161.89 16.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 109.79 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.744 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.28 116.82 28.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.494 -0.558 . . . . 0.69999999999999996 109.494 175.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.425 ' HD2' HD13 ' A' ' 95' ' ' ILE . 29.4 m-85 -113.87 125.0 53.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 0.42999999999999999 111.045 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 47.9 mt-10 -80.13 113.96 18.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.463 -0.789 . . . . 1.46 109.081 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.599 HG21 HG12 ' A' ' 82' ' ' VAL . 40.0 mt -107.93 123.94 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.028 0.442 . . . . 0.47999999999999998 110.352 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 18.3 mt-10 -127.87 130.33 48.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.646 -0.706 . . . . 1.8799999999999999 109.875 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 34' ' ' PRO . 25.6 tp -91.82 100.4 13.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 1.1200000000000001 110.341 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.5 OUTLIER -89.74 -30.2 18.19 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.082 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.454 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 58.0 m -150.41 147.76 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.436 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' HB2' HG12 ' A' ' 40' ' ' VAL . 2.0 p90 -165.05 159.62 18.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.71999999999999997 109.352 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 126' ' ' ARG . 2.3 ptm180 -158.63 113.72 2.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.95 0.405 . . . . 2.98 111.352 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.363 -0.38 . . . . 3.3799999999999999 110.758 175.818 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.267 0.556 . . . . 3.6000000000000001 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.85 143.07 42.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 2.71 110.447 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.18 136.27 47.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 1.8799999999999999 109.84 -174.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.6 107.65 23.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.601 -0.518 . . . . 0.58999999999999997 109.601 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HB2' HD12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -102.58 134.95 45.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.138 -0.483 . . . . 2.1600000000000001 111.462 -176.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt 56.64 51.74 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.248 -0.887 . . . . 1.45 112.493 171.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -61.29 153.65 25.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.275 -0.42 . . . . 0.78000000000000003 110.117 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.9 1.07 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.688 0.625 . . . . 0.81000000000000005 112.688 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.64 24.81 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 2.3999999999999999 111.264 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.47 10.42 5.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.378 -0.915 . . . . 0.68000000000000005 114.011 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 57.75 67.14 2.36 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.892 0.717 . . . . 0.60999999999999999 114.892 170.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG21 ' HB ' ' A' ' 80' ' ' ILE . 25.6 t -116.83 139.21 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 122.285 -0.538 . . . . 0.48999999999999999 110.58 173.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 94' ' ' ARG . 5.6 mm -88.18 109.34 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.214 -0.661 . . . . 0.46999999999999997 109.214 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -125.66 146.23 49.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.393 0.616 . . . . 1.3400000000000001 111.222 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 m -114.07 121.43 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.419 -0.81 . . . . 0.5 109.603 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.522 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 tp -72.43 125.96 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.883 0.373 . . . . 0.67000000000000004 111.565 -174.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.03 -63.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.17 0.509 . . . . 0.82999999999999996 109.954 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 50.7 mtmt -117.6 134.9 54.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 1.5600000000000001 108.981 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -102.99 139.46 38.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.754 0.311 . . . . 2.9500000000000002 110.985 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 134.26 12.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.77 -0.729 . . . . 1.3200000000000001 111.718 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.9 -65.32 1.02 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.827 -0.435 . . . . 2.77 109.827 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -96.0 144.17 26.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.0 -0.545 . . . . 2.6400000000000001 109.548 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.556 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -154.34 14.54 0.55 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.547 -0.835 . . . . 1.04 111.852 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.21 -21.05 62.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 2.29 110.406 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' C ' HD22 ' A' ' 32' ' ' ASN . 47.4 mt-10 -115.18 14.49 16.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.773 -0.649 . . . . 2.6400000000000001 109.927 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.556 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -138.78 80.86 1.81 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.083 -0.508 . . . . 1.45 111.4 -172.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.82 113.03 27.0 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.223 0.535 . . . . 0.81000000000000005 111.923 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.2 Cg_endo -91.04 111.08 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.963 2.442 . . . . 0.75 112.384 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 27.9 mmtp -136.64 -173.68 3.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.6600000000000001 110.951 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.36 152.94 20.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 2.5099999999999998 110.726 -176.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.27 -5.19 38.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.744 . . . . 1.1200000000000001 111.904 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' HG13 ' A' ' 40' ' ' VAL . 31.4 p30 -135.24 -175.77 4.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.74 0.305 . . . . 1.3799999999999999 110.513 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -96.99 94.21 7.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 2.2000000000000002 110.743 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 ' OD1' ' A' ' 38' ' ' ASN . 9.6 m -97.85 122.22 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.903 -0.777 . . . . 0.67000000000000004 108.903 168.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.542 HG23 ' HD3' ' A' ' 66' ' ' LYS . 27.0 m -96.72 111.42 23.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.198 0.523 . . . . 0.65000000000000002 109.96 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 120' ' ' ILE . 54.1 t -117.24 130.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.499 -0.773 . . . . 0.87 110.329 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -101.79 127.96 48.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.204 -0.665 . . . . 2.75 109.204 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 6.6 p90 -128.23 144.5 51.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 0.76000000000000001 111.105 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -166.38 144.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.557 -0.747 . . . . 0.48999999999999999 109.841 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 118' ' ' PHE . . . -171.02 -139.91 2.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.613 -0.803 . . . . 0.35999999999999999 112.135 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 64.7 pttt -157.69 172.3 18.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 1.4299999999999999 110.886 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 114' ' ' SER . 60.7 tp -85.55 101.15 12.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.046 -0.525 . . . . 0.38 110.539 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 40.8 tt0 -68.42 -25.87 65.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.771 0.319 . . . . 1.96 110.935 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -54.38 -27.1 34.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 0.67000000000000004 111.543 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.576 HG23 ' HB2' ' A' ' 53' ' ' LYS . 14.8 t -139.18 9.05 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.051 0.453 . . . . 0.72999999999999998 110.482 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.13 41.59 98.18 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.635 -0.711 . . . . 0.78000000000000003 112.755 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.576 ' HB2' HG23 ' A' ' 51' ' ' THR . 4.3 tmtt? -102.83 118.34 36.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 2.8900000000000001 110.29 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.7 p -74.1 160.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.58999999999999997 109.856 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 13.0 m-30 -78.0 124.58 28.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 111.083 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.95 88.27 2.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.854 0.835 . . . . 2.1800000000000002 109.306 171.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.8 m -136.48 172.97 12.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.596 -0.729 . . . . 1.24 111.19 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -71.6 -23.83 61.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.79 -0.641 . . . . 1.49 110.865 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -93.83 -51.1 5.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.147 0.795 . . . . 1.8 113.147 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.8 -43.23 85.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.335 0.397 . . . . 2.1899999999999999 111.996 -168.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -92.22 9.34 34.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.928 0.394 . . . . 2.7799999999999998 111.602 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -115.7 -64.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.283 -0.417 . . . . 1.1000000000000001 111.597 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.8 m -105.01 127.56 28.48 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.384 0.611 . . . . 2.0299999999999998 111.997 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.5 Cg_endo -83.44 111.29 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.956 2.437 . . . . 1.76 111.511 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -94.72 154.57 17.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 1.3100000000000001 110.888 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.542 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.7 pptp? -142.44 157.48 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.942 -0.572 . . . . 1.3600000000000001 110.01 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.09 172.65 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.56999999999999995 110.912 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -122.47 150.3 42.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.813 -0.63 . . . . 1.98 109.641 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.505 HD22 HG23 ' A' ' 82' ' ' VAL . 35.2 tp -71.38 136.29 47.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.792 0.33 . . . . 0.94999999999999996 111.528 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 36.1 mt-10 51.69 37.72 20.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.57 -0.741 . . . . 2.0800000000000001 112.205 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.463 HE21 ' HB2' ' A' ' 73' ' ' GLU . 13.8 pt20 -77.49 -8.28 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.359 0.599 . . . . 1.98 109.597 169.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.21 46.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.71999999999999997 112.845 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' HE21 ' A' ' 71' ' ' GLN . 10.1 mm-40 -84.0 -21.92 31.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.883 0.342 . . . . 0.96999999999999997 110.754 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 m -113.61 135.11 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.57999999999999996 110.379 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.02 -61.29 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.083 0.772 . . . . 0.62 113.083 -172.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.3 mmpt? -143.18 -44.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.957 0.725 . . . . 2.04 112.957 -171.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.03 -53.0 36.14 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.651 -0.785 . . . . 0.32000000000000001 112.684 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.448 ' O ' HG22 ' A' ' 82' ' ' VAL . 4.2 m-90 -75.94 -30.94 58.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.853 0.359 . . . . 0.48999999999999999 110.501 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 21.7 t70 -52.24 -54.3 32.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.169 -0.923 . . . . 1.1399999999999999 112.148 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.544 ' HB ' HG21 ' A' ' 18' ' ' VAL . 2.8 mp -75.38 -42.31 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.78000000000000003 110.985 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.577 ' O ' ' HG2' ' A' ' 85' ' ' MET . 20.7 t -56.99 -47.34 81.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.55000000000000004 111.182 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.505 HG23 HD22 ' A' ' 69' ' ' LEU . 27.1 m -72.91 -32.21 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 123.0 0.188 . . . . 0.83999999999999997 110.979 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 66.2 m -65.79 -23.3 66.68 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.436 0.636 . . . . 1.4299999999999999 110.869 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -112.25 46.4 1.17 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 1.23 110.455 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.928 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.6 mmt -125.41 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.281 0.562 . . . . 2.27 111.226 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.966 ' HD3' ' H ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -155.25 160.69 41.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.056 -1.09 . . . . 4.1900000000000004 108.056 174.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -46.97 -38.27 10.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.461 0.541 . . . . 1.9399999999999999 112.461 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.966 ' H ' ' HD3' ' A' ' 86' ' ' ARG . 16.5 m120 -109.54 6.24 23.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 1.23 111.122 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 30.6 tt0 -105.38 140.85 37.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.161 -0.681 . . . . 1.6000000000000001 109.161 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.5 tttt -146.93 135.92 22.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.266 -0.424 . . . . 1.1699999999999999 110.728 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 22' ' ' ILE . 83.9 m -136.06 159.19 42.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.234 0.54 . . . . 1.2 110.825 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 117' ' ' LEU . 1.8 tp -91.34 142.18 27.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.25 -1.018 . . . . 1.73 108.25 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.97 135.48 52.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 O-C-N 123.366 0.416 . . . . 0.73999999999999999 110.36 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -107.28 111.86 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.638 -0.505 . . . . 1.71 109.638 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -96.4 107.1 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.898 -0.408 . . . . 0.52000000000000002 109.898 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.651 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 9.7 tt0 -85.43 177.41 7.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.107 -0.701 . . . . 1.3700000000000001 109.107 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -57.32 -37.29 72.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.4 ptp -77.62 -9.73 59.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.182 0.438 . . . . 1.79 112.182 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.7 m-85 -103.62 6.33 37.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.017 -0.273 . . . . 0.75 111.037 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.71 174.92 16.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.952 -0.642 . . . . 0.70999999999999996 112.468 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.941 0.401 . . . . 1.52 111.183 177.4 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 111.33 0.122 . . . . 1.52 111.33 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.407 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -148.23 104.16 3.56 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.75 111.225 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -97.42 179.89 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.076 2.517 . . . . 1.5800000000000001 112.274 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.61 66.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.267 -0.968 . . . . 2.0499999999999998 113.187 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 m120 55.48 23.84 6.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.954 0.406 . . . . 2.0299999999999998 111.835 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.579 ' HB3' HD11 ' A' ' 48' ' ' LEU . 30.1 m -110.03 150.71 28.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.942 -0.572 . . . . 1.1399999999999999 110.003 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.17 130.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.47999999999999998 110.206 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.433 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.6 mp -123.34 151.45 42.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.063 -0.517 . . . . 0.51000000000000001 110.411 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -128.22 125.54 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.497 . . . . 0.69999999999999996 110.926 177.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.444 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 46.1 m-85 -126.14 153.22 44.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.745 -0.661 . . . . 0.42999999999999999 110.221 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.578 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 42.7 mt-10 -85.46 126.88 34.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.279 -0.638 . . . . 1.46 109.279 170.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.481 HG23 HG11 ' A' ' 42' ' ' VAL . 10.6 mt -108.58 118.18 55.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 0.47999999999999998 109.865 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 45.2 tt0 -132.96 132.29 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 1.8799999999999999 110.24 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.21 115.7 28.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 1.1200000000000001 110.678 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.31 -21.4 13.84 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.757 -0.377 . . . . 1.0 112.016 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.507 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 29.3 t -155.63 149.61 25.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.003 -0.279 . . . . 1.1899999999999999 110.393 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -168.19 172.66 8.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 0.71999999999999997 110.036 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -161.04 126.38 3.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 2.98 110.177 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 3.3799999999999999 111.536 -173.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.39 . . . . 3.6000000000000001 110.887 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.39 157.07 17.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.51 0.672 . . . . 2.71 110.609 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -103.0 148.26 25.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.789 -1.096 . . . . 1.8799999999999999 111.052 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.41 106.92 20.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.58999999999999997 109.495 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 7.4 pt-20 -78.85 113.35 16.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.803 -0.635 . . . . 2.1600000000000001 111.542 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.47 ' H ' HD13 ' A' ' 19' ' ' ILE . 17.2 tp 58.25 65.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 1.45 111.215 169.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 t -61.73 144.9 53.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 0.78000000000000003 110.076 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 0.72 7.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.95 0.352 . . . . 0.81000000000000005 111.95 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.48 25.73 1.01 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.532 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.09 2.64 9.16 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.68000000000000005 113.92 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.47 78.28 0.61 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.072 -0.585 . . . . 0.60999999999999999 114.169 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 80' ' ' ILE . 53.7 t -140.78 143.82 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.935 -0.394 . . . . 0.48999999999999999 109.935 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 17.9 mm -86.27 116.31 28.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.595 -0.52 . . . . 0.46999999999999997 109.595 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -138.19 144.34 40.64 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.507 -0.477 . . . . 1.3400000000000001 111.464 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 6.8 m -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.916 -0.583 . . . . 0.5 109.864 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.5 tp -84.82 118.91 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.67000000000000004 110.585 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.18 -70.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.82999999999999996 110.605 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 36.9 ttpt -109.7 116.33 31.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.519 -0.31 . . . . 1.5600000000000001 110.531 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.55 137.62 42.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.033 -0.531 . . . . 2.9500000000000002 110.171 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.44 162.35 54.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.735 -0.745 . . . . 1.3200000000000001 112.309 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.76 -68.26 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 2.77 110.74 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.37 132.61 15.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.095 0.474 . . . . 2.6400000000000001 109.781 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.08 33.33 0.94 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.498 -0.858 . . . . 1.04 111.492 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.26 -28.93 70.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.24 0.543 . . . . 2.29 110.402 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -94.88 -4.75 46.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.332 -0.849 . . . . 2.6400000000000001 110.381 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -138.81 91.46 2.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.051 0.453 . . . . 1.45 111.259 -173.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.09 123.98 28.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.81000000000000005 110.776 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 43.0 Cg_endo -69.96 92.54 0.53 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.644 2.229 . . . . 0.75 111.807 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 53.5 mmtt -94.7 146.53 24.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.365 0.602 . . . . 2.6600000000000001 112.261 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -71.99 124.54 25.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.933 -1.031 . . . . 2.5099999999999998 110.0 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.89 -9.24 43.49 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.422 -0.671 . . . . 1.1200000000000001 111.422 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -101.09 154.65 18.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.343 . . . . 1.3799999999999999 110.219 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -79.3 106.21 11.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.329 0.585 . . . . 2.2000000000000002 111.123 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' HIS . 3.1 m -121.68 152.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.843 -0.799 . . . . 0.67000000000000004 108.843 174.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.2 m -117.75 119.42 34.86 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.651 -0.5 . . . . 0.65000000000000002 109.651 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.549 HG11 HG23 ' A' ' 120' ' ' ILE . 90.3 t -131.82 144.06 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.999 -0.546 . . . . 0.87 110.764 -174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.468 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 24.5 m80 -99.96 145.29 28.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.044 -0.354 . . . . 2.75 110.044 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 29.2 p90 -143.06 130.63 21.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.055 0.455 . . . . 0.76000000000000001 110.934 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.57 159.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.224 -0.658 . . . . 0.48999999999999999 109.224 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.41 -121.0 0.7 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.041 -1.076 . . . . 0.35999999999999999 112.751 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 50.1 pttt -150.9 168.06 25.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.666 0.27 . . . . 1.4299999999999999 110.505 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' HG ' ' A' ' 116' ' ' LEU . 57.3 tp -85.02 98.37 10.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.031 -0.729 . . . . 0.38 109.031 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 50.0 tp10 -62.55 -26.94 68.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 1.96 112.381 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 4.4 t -63.17 -18.56 63.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 0.67000000000000004 111.279 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -129.63 -26.12 2.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.034 0.445 . . . . 0.72999999999999998 110.767 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.44 35.64 10.4 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.369 -0.443 . . . . 0.78000000000000003 112.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.38 128.86 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.715 0.293 . . . . 2.8900000000000001 110.362 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.8 p -71.77 158.35 6.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.58999999999999997 109.78 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 21.7 m-85 -73.93 98.49 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.315 0.579 . . . . 0.78000000000000003 111.784 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.72 86.15 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.13 -1.063 . . . . 2.1800000000000002 108.13 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -136.54 164.47 28.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.811 -0.631 . . . . 1.24 110.571 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -57.97 -45.76 86.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 1.49 112.046 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -93.32 -45.45 7.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.012 0.434 . . . . 1.8 110.943 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -34.49 58.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.122 -0.944 . . . . 2.1899999999999999 111.655 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 61' ' ' ARG . 6.1 ptm85 -77.52 -22.88 50.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 2.7799999999999998 111.801 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -100.66 -52.79 3.24 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.818 -0.353 . . . . 1.1000000000000001 110.942 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.26 108.77 6.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.996 0.427 . . . . 2.0299999999999998 111.698 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.7 153.34 56.61 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.553 2.169 . . . . 1.76 110.547 173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -93.47 149.14 21.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.007 0.432 . . . . 1.3100000000000001 110.515 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 3.0 pptp? -123.12 142.67 50.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.794 -0.639 . . . . 1.3600000000000001 109.587 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -128.86 171.42 12.3 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.985 0.421 . . . . 0.56999999999999995 110.999 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 98.0 m-70 -112.22 145.94 39.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.464 -0.789 . . . . 1.98 109.113 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 36' ' ' LYS . 16.6 tp -72.62 120.42 18.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.315 0.579 . . . . 0.94999999999999996 110.371 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 66.56 54.59 0.86 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.447 -1.251 . . . . 2.0800000000000001 111.077 -176.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.444 HE21 ' HB2' ' A' ' 73' ' ' GLU . 12.2 pt20 -96.07 10.01 38.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 1.98 109.414 169.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.07 -12.18 62.93 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.422 -0.808 . . . . 0.71999999999999997 112.801 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HB2' HE21 ' A' ' 71' ' ' GLN . 13.3 mm-40 -96.18 -10.16 28.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.712 0.291 . . . . 0.96999999999999997 111.279 -174.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.07 125.11 67.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.006 0.431 . . . . 0.57999999999999996 110.713 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.762 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -95.78 -59.13 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.921 0.711 . . . . 0.62 112.921 -173.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 75' ' ' ILE . 6.6 mmpt? -140.0 -61.06 0.53 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.094 -0.378 . . . . 2.04 111.401 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.42 -52.79 35.12 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.953 -0.567 . . . . 0.32000000000000001 113.656 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.6 m-90 -74.98 -44.78 46.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.975 0.387 . . . . 0.48999999999999999 110.738 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -51.61 -51.83 52.48 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.039 0.837 . . . . 1.1399999999999999 111.933 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.513 ' HB ' HG21 ' A' ' 18' ' ' VAL . 2.1 mp -75.05 -38.64 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 0.78000000000000003 110.972 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.701 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 34.3 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.55000000000000004 110.68 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 78' ' ' TRP . 34.7 m -67.74 -32.64 57.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.738 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.0 t -62.38 -32.73 73.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.4299999999999999 110.886 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.7 t -96.09 31.18 2.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.141 -0.481 . . . . 1.23 110.627 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.579 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mmt -110.42 -173.33 2.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.386 0.613 . . . . 2.27 111.609 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 6.4 ttm180 -139.76 168.46 19.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.878 -1.156 . . . . 4.1900000000000004 107.878 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.0 -35.18 70.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.338 . . . . 1.9399999999999999 111.392 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -122.2 31.98 5.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 1.23 110.862 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 23.6 tt0 -122.36 143.98 49.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.308 -0.405 . . . . 1.6000000000000001 110.452 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.87 137.9 35.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.716 0.293 . . . . 1.1699999999999999 110.529 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' THR . 27.5 p -141.22 171.37 14.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 1.2 111.194 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.09 123.05 49.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.68 . . . . 1.73 109.533 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.701 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.0 p -99.92 137.48 27.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.255 0.55 . . . . 0.73999999999999999 110.8 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 55.2 mmt-85 -91.11 112.38 24.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.633 -0.712 . . . . 1.71 110.086 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.491 HD11 HG13 ' A' ' 93' ' ' VAL . 2.9 mp -93.7 100.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.368 -0.604 . . . . 0.52000000000000002 109.368 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 97' ' ' SER . 29.6 tt0 -81.05 170.25 16.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.484 -0.932 . . . . 1.3700000000000001 108.484 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 8.7 p -51.4 -44.13 62.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.767 0.284 . . . . 1.0 111.767 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.6 ptp -77.56 -8.43 57.81 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.128 0.418 . . . . 1.79 112.128 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -103.88 -11.86 17.24 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 122.267 -0.271 . . . . 0.75 110.941 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.06 164.61 17.12 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.734 -0.746 . . . . 0.70999999999999996 113.24 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.528 0 N-CA-C 109.995 -0.372 . . . . 1.52 109.995 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.429 0.157 . . . . 1.52 110.666 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.03 83.66 4.22 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-O 120.814 0.34 . . . . 0.75 111.844 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -98.54 -160.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.228 2.618 . . . . 1.5800000000000001 111.457 171.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.38 91.48 2.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 2.0499999999999998 113.189 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.4 m120 56.66 27.13 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 2.0299999999999998 111.738 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 9.7 p -133.93 171.04 14.72 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.633 -0.258 . . . . 1.1399999999999999 110.875 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.24 133.43 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.198 0.523 . . . . 0.47999999999999998 110.348 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.6 mp -122.38 169.6 10.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.51000000000000001 109.699 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -147.42 133.8 19.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.061 0.457 . . . . 0.69999999999999996 110.596 172.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 39.9 m-85 -122.41 142.29 50.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.89 -0.595 . . . . 0.42999999999999999 109.616 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 32.5 mt-10 -74.18 122.97 23.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.724 -0.843 . . . . 1.46 108.724 171.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.549 HG23 HG11 ' A' ' 42' ' ' VAL . 8.1 mt -105.95 115.42 47.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.422 0.63 . . . . 0.47999999999999998 109.739 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.08 116.59 17.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.098 -0.955 . . . . 1.8799999999999999 110.284 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 123' ' ' LEU . 6.8 tt -87.12 133.71 33.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 1.1200000000000001 109.219 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 122' ' ' LEU . 1.1 pt? -117.1 -43.96 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.786 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.9 t -140.78 140.87 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.783 -0.451 . . . . 1.1899999999999999 109.783 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.584 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -167.04 177.57 6.21 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.174 0.297 . . . . 0.71999999999999997 110.6 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -157.49 150.72 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 2.98 111.051 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 C--N 1.329 -0.32 0 N-CA-C 109.582 -0.525 . . . . 3.3799999999999999 109.582 174.332 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 109.607 -0.516 . . . . 3.6000000000000001 109.607 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.34 148.83 29.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.11 0.481 . . . . 2.71 110.878 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.7 mppt? -91.96 143.17 26.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 110.283 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' A' ' 13' ' ' THR . 5.1 t -108.94 108.55 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 110.054 -0.35 . . . . 0.58999999999999997 110.054 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.81 128.92 43.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.1600000000000001 110.974 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 19' ' ' ILE . 13.5 tp 55.76 46.26 22.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.689 0.757 . . . . 1.45 110.113 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.5 t -63.84 164.04 10.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.868 -1.06 . . . . 0.78000000000000003 111.532 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.66 1.37 8.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.81000000000000005 111.253 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' O ' HG13 ' A' ' 80' ' ' ILE . 25.9 m-20 -80.65 14.19 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 2.3999999999999999 111.054 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.27 9.39 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.52 -0.847 . . . . 0.68000000000000005 113.598 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.25 64.07 1.81 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.803 -0.713 . . . . 0.60999999999999999 114.045 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.555 ' HB ' HG21 ' A' ' 80' ' ' ILE . 3.3 t -145.35 154.23 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.894 -0.41 . . . . 0.48999999999999999 109.894 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 12' ' ' LEU . 4.7 mm -85.24 109.65 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.243 -0.28 . . . . 0.46999999999999997 110.243 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HE3' HG21 ' A' ' 13' ' ' THR . 21.6 pttp -132.61 142.65 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.3400000000000001 111.181 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -110.8 140.87 44.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.476 -0.784 . . . . 0.5 110.246 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' C ' HD22 ' A' ' 23' ' ' LEU . 7.6 tp -86.44 130.3 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.422 -0.354 . . . . 0.67000000000000004 110.369 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 22' ' ' ILE . 3.5 mm? -132.72 -69.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.455 0.645 . . . . 0.82999999999999996 110.515 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 80.7 tttt -91.5 97.66 11.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.41 -0.814 . . . . 1.5600000000000001 109.53 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -73.74 127.29 32.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.068 -0.969 . . . . 2.9500000000000002 110.21 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.7 -148.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.09 -0.505 . . . . 1.3200000000000001 113.33 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.5 -167.84 2.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.463 -0.94 . . . . 2.77 108.463 -172.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -85.46 127.3 34.35 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.739 -0.467 . . . . 2.6400000000000001 109.739 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.469 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -168.39 75.37 0.12 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.108 -0.797 . . . . 1.04 111.108 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.44 -32.99 69.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.749 0.278 . . . . 2.29 111.749 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.72 0.38 56.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.272 0.558 . . . . 2.6400000000000001 110.579 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.406 ' HA ' ' HZ ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -105.5 79.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 1.45 110.877 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.8 mm -131.37 122.04 18.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.81000000000000005 110.909 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 69.6 Cg_endo -77.55 126.56 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.689 2.259 . . . . 0.75 112.023 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 27.1 mmtp -132.92 161.92 32.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.905 0.383 . . . . 2.6600000000000001 110.77 177.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -71.77 150.21 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.969 -0.559 . . . . 2.5099999999999998 111.882 -172.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.43 -23.03 29.69 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.722 -0.672 . . . . 1.1200000000000001 111.799 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.66 153.41 21.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.003 0.43 . . . . 1.3799999999999999 110.968 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 51.0 mt-10 -79.0 95.39 5.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.016 -0.538 . . . . 2.2000000000000002 110.481 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.502 HG21 HD23 ' A' ' 69' ' ' LEU . 19.9 m -102.87 151.08 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.6 -0.519 . . . . 0.67000000000000004 109.6 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -111.95 106.51 15.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.167 -0.679 . . . . 0.65000000000000002 109.167 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -126.33 138.99 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.87 110.863 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 22.3 m-70 -104.16 142.91 33.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.521 -0.548 . . . . 2.75 109.521 172.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.5 p90 -137.15 139.52 41.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 0.76000000000000001 110.021 175.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.11 154.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 0.48999999999999999 109.146 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 179.77 -134.6 2.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.878 -1.153 . . . . 0.35999999999999999 112.98 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 117' ' ' LEU . 22.8 pttp -151.68 171.33 17.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.032 0.444 . . . . 1.4299999999999999 110.671 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 114' ' ' SER . 61.3 tp -85.58 107.38 17.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.621 . . . . 0.38 109.758 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.6 tp10 -68.05 -31.19 70.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.031 0.443 . . . . 1.96 110.81 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 t -54.3 -43.04 70.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.342 -0.844 . . . . 0.67000000000000004 112.05 -173.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.498 HG22 HD23 ' A' ' 48' ' ' LEU . 15.4 t -119.96 -10.97 9.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.72999999999999998 110.604 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 56.12 3.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.892 -0.671 . . . . 0.78000000000000003 111.648 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -125.03 130.02 51.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.175 -0.305 . . . . 2.8900000000000001 110.175 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.2 156.87 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.114 -0.328 . . . . 0.58999999999999997 110.114 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -74.6 99.33 3.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.386 . . . . 0.78000000000000003 111.763 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.83 91.84 3.82 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.485 -0.932 . . . . 2.1800000000000002 108.485 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 28.7 t -137.59 148.3 45.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.46 -0.791 . . . . 1.24 109.985 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -53.8 -42.49 68.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.312 0.486 . . . . 1.49 112.312 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -84.84 -46.15 11.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 1.8 110.692 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -36.82 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 2.1899999999999999 111.629 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' SER . 14.8 ptm180 -81.56 4.11 22.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.697 0.284 . . . . 2.7799999999999998 111.542 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' A' ' 63' ' ' VAL . 14.3 t30 -121.29 -60.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.645 -0.252 . . . . 1.1000000000000001 110.702 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG13 ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -133.32 133.7 23.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.692 0.282 . . . . 2.0299999999999998 111.598 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.0 Cg_exo -77.3 163.35 30.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.838 2.359 . . . . 1.76 111.869 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -103.87 154.74 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.427 -0.351 . . . . 1.3100000000000001 110.302 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -137.49 151.36 48.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 1.3600000000000001 109.649 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -136.42 -175.55 4.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.756 0.313 . . . . 0.56999999999999995 110.819 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -121.03 150.05 41.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 1.98 109.991 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -58.14 121.67 11.25 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.752 0.657 . . . . 0.94999999999999996 111.348 -174.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER 55.29 45.95 24.58 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.589 0.556 . . . . 2.0800000000000001 111.806 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 6.7 pm0 -78.96 -4.3 49.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.094 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.15 -9.13 50.02 Favored Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.71999999999999997 113.161 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 15.9 mm-40 -95.57 -17.08 21.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.96999999999999997 110.724 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.14 132.74 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.74 0.305 . . . . 0.57999999999999996 110.695 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.484 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.5 -68.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.373 0.508 . . . . 0.62 112.373 -178.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.618 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 5.6 mtpp -140.94 -41.26 0.4 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.449 0.537 . . . . 2.04 112.449 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.02 -46.73 61.08 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.32000000000000001 112.56 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.499 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.9 m-90 -76.13 -36.89 58.61 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.922 -0.163 . . . . 0.48999999999999999 111.127 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -63.42 -40.43 97.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.033 0.383 . . . . 1.1399999999999999 112.033 -169.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.555 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -64.35 -39.45 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.013 0.435 . . . . 0.78000000000000003 110.631 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -72.3 -51.28 21.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.406 -0.361 . . . . 0.55000000000000004 110.891 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.0 m -64.63 -33.89 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.254 0.465 . . . . 0.83999999999999997 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 t -80.19 -0.84 37.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.018 0.437 . . . . 1.4299999999999999 110.769 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 t -119.88 14.41 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.18 -0.464 . . . . 1.23 110.387 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.041 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 4.0 mmt -98.95 179.18 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 2.27 110.809 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.469 ' NH1' ' HA3' ' A' ' 29' ' ' GLY . 22.3 ttp85 -143.6 174.05 11.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.133 -1.062 . . . . 4.1900000000000004 108.133 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 60.3 tttm -67.7 -6.09 19.1 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.8 0.334 . . . . 1.9399999999999999 111.832 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -141.56 21.2 2.19 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.581 0.229 . . . . 1.23 110.594 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.5 tt0 -118.76 148.64 42.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.512 -0.313 . . . . 1.6000000000000001 110.66 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 24' ' ' LYS . 75.2 tttt -149.06 138.66 21.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 1.1699999999999999 110.794 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.5 m -134.02 164.33 27.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.44 -0.345 . . . . 1.2 111.142 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.508 ' CD2' ' HG2' ' A' ' 119' ' ' GLU . 63.6 mt -100.53 111.62 23.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.037 -0.529 . . . . 1.73 109.605 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 77' ' ' GLY . 7.1 p -100.98 135.95 34.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.73999999999999999 109.994 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mmm-85 -100.45 111.43 23.69 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.115 -0.698 . . . . 1.71 109.115 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 93' ' ' VAL . 3.2 mp -92.21 103.62 14.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.127 0.489 . . . . 0.52000000000000002 109.833 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.54 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 32.5 tt0 -82.41 173.44 12.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.321 -0.854 . . . . 1.3700000000000001 109.02 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.6 p -51.54 -41.31 60.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.631 0.372 . . . . 1.0 111.898 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.0 ptm -77.21 -15.7 59.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 1.79 111.771 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.7 m-30 -91.2 -13.96 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.75 110.885 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.55 -172.54 15.54 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.348 -0.701 . . . . 0.70999999999999996 111.348 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 1.52 111.209 178.395 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.226 0.06 . . . . 1.52 111.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.445 HG12 HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -146.13 100.2 4.22 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 121.143 0.496 . . . . 0.75 111.285 177.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -90.29 -166.33 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.874 2.383 . . . . 1.5800000000000001 111.856 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.82 -139.5 13.49 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.553 -0.832 . . . . 2.0499999999999998 112.748 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.4 m120 -93.42 6.11 49.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.124 0.488 . . . . 2.0299999999999998 110.349 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 48' ' ' LEU . 47.1 m -94.44 146.95 23.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.74 -0.664 . . . . 1.1399999999999999 111.349 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.2 p -95.02 138.82 19.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.2 -0.455 . . . . 0.47999999999999998 110.286 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.4 mp -126.36 174.27 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 0.51000000000000001 110.622 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -132.78 124.4 28.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.157 -0.683 . . . . 0.69999999999999996 109.157 176.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 22.2 m-85 -116.13 126.6 53.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.42999999999999999 110.546 178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.609 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 37.8 mt-10 -81.18 107.66 14.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 1.46 109.504 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' HIS . 58.4 mt -107.85 124.46 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.061 -0.256 . . . . 0.47999999999999998 110.9 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 90' ' ' LYS . 34.3 mt-10 -121.5 131.02 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 1.8799999999999999 110.308 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 42' ' ' VAL . 6.9 tt -100.26 101.85 12.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 1.1200000000000001 109.576 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -96.69 -16.23 21.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -175.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.5 m -153.19 150.76 29.37 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.454 -0.202 . . . . 1.1899999999999999 110.454 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.498 ' HB3' HD21 ' A' ' 122' ' ' LEU . 1.5 p90 -164.85 178.74 6.96 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.963 -0.384 . . . . 0.71999999999999997 109.963 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.635 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.9 ptp180 -162.17 167.84 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.617 0.573 . . . . 2.98 109.547 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.318 0 O-C-N 123.201 0.313 . . . . 3.3799999999999999 110.265 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 110.224 -0.287 . . . . 3.6000000000000001 110.224 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -89.44 156.08 18.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.444 -0.576 . . . . 2.71 109.444 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.28 153.85 24.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.405 -0.361 . . . . 1.8799999999999999 110.8 -171.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.38 104.83 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.58999999999999997 109.029 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.87 120.29 30.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 2.1600000000000001 110.612 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' H ' HD13 ' A' ' 19' ' ' ILE . 96.2 mt 58.67 64.72 1.38 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.569 0.7 . . . . 1.45 110.727 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.5 HG21 ' HE2' ' A' ' 20' ' ' LYS . 9.2 t -65.79 160.84 22.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.936 -1.029 . . . . 0.78000000000000003 111.115 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.33 -5.22 21.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.093 0.405 . . . . 0.81000000000000005 112.093 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -71.05 -0.36 9.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.407 -0.36 . . . . 2.3999999999999999 111.268 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.98 24.79 2.2 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.79 -0.719 . . . . 0.68000000000000005 113.321 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.14 72.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.011 -0.614 . . . . 0.60999999999999999 113.576 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.539 ' HB ' HG21 ' A' ' 80' ' ' ILE . 12.2 t -138.84 146.11 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.856 -0.424 . . . . 0.48999999999999999 109.856 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 12' ' ' LEU . 22.0 mm -87.08 110.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.013 -0.365 . . . . 0.46999999999999997 110.013 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.5 ' HE2' HG21 ' A' ' 13' ' ' THR . 58.3 pttt -125.27 145.53 49.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 1.3400000000000001 111.096 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -126.01 120.49 30.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 0.5 109.8 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.542 HG12 ' HG3' ' A' ' 25' ' ' LYS . 10.0 tp -76.01 145.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.386 . . . . 0.67000000000000004 110.734 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.39 -34.85 2.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.431 -0.35 . . . . 0.82999999999999996 111.173 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 38.8 ttpt -150.78 118.32 6.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.637 -0.505 . . . . 1.5600000000000001 109.637 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HG3' HG12 ' A' ' 22' ' ' ILE . 88.8 mttt -101.0 154.28 18.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.188 0.518 . . . . 2.9500000000000002 112.021 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.89 164.75 16.07 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 111.683 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.65 -95.12 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.045 0.422 . . . . 2.77 111.133 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -91.48 145.38 24.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.944 0.402 . . . . 2.6400000000000001 110.845 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 162.51 64.57 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.787 -0.642 . . . . 1.04 111.615 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.23 -35.0 72.86 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.072 0.463 . . . . 2.29 111.011 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -104.25 26.34 8.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 2.6400000000000001 111.539 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.48 74.9 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.753 -0.462 . . . . 1.45 109.753 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.528 HG22 ' HG2' ' A' ' 35' ' ' LYS . 27.6 mm -136.68 108.92 9.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 0.81000000000000005 110.829 -177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.6 Cg_endo -71.46 88.24 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.643 2.229 . . . . 0.75 112.067 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HG2' HG22 ' A' ' 33' ' ' ILE . 29.7 mmtp -97.7 159.41 14.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.533 0.682 . . . . 2.6600000000000001 111.876 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HA ' HD23 ' A' ' 69' ' ' LEU . 8.8 ttmm -67.88 150.29 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.683 -1.144 . . . . 2.5099999999999998 111.531 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.68 -26.13 22.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.192 -0.528 . . . . 1.1200000000000001 112.119 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -111.13 158.45 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.698 0.285 . . . . 1.3799999999999999 110.726 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.76 97.75 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.19 0.519 . . . . 2.2000000000000002 111.721 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.9 m -96.86 143.81 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.065 -0.717 . . . . 0.67000000000000004 109.065 170.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 20.1 m -111.62 113.63 26.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.877 0.37 . . . . 0.65000000000000002 110.755 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -131.6 160.8 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.073 -0.512 . . . . 0.87 111.599 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -117.18 153.99 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 2.75 109.254 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -137.69 143.56 41.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.44 -0.345 . . . . 0.76000000000000001 110.233 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.89 160.79 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.878 -0.786 . . . . 0.48999999999999999 108.878 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 167.08 -136.55 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.351 -0.928 . . . . 0.35999999999999999 112.38 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.626 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 60.6 pttt -158.45 171.97 19.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.653 0.263 . . . . 1.4299999999999999 110.995 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.494 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -88.86 105.25 17.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.38 110.403 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 32.7 tt0 -64.04 -27.39 69.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.36 -0.382 . . . . 1.96 111.249 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.7 t -54.76 -40.59 69.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.894 -0.594 . . . . 0.67000000000000004 111.545 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.452 HG22 HD23 ' A' ' 48' ' ' LEU . 10.1 t -120.01 -12.47 9.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.583 0.23 . . . . 0.72999999999999998 111.597 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.42 10.75 73.26 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.75 -0.738 . . . . 0.78000000000000003 112.896 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 33.7 mmtp -88.39 132.03 34.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.871 0.367 . . . . 2.8900000000000001 111.163 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.626 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.3 p -81.65 160.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.472 -0.786 . . . . 0.58999999999999997 109.963 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -74.53 114.56 13.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.021 0.439 . . . . 0.78000000000000003 111.249 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -129.03 91.23 3.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.145 -0.687 . . . . 2.1800000000000002 109.145 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -123.95 -173.55 2.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 1.24 109.87 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.1 m -72.9 -47.3 47.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.772 0.32 . . . . 1.49 111.49 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -95.15 -39.11 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.739 1.015 . . . . 1.8 113.739 -171.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.28 -42.84 87.41 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.977 0.362 . . . . 2.1899999999999999 111.977 -168.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -90.75 11.28 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.39 0.614 . . . . 2.7799999999999998 111.277 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -106.08 -50.15 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 1.1000000000000001 109.047 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.4 p -149.4 121.82 4.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 2.0299999999999998 110.223 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 10.5 Cg_exo -70.82 154.65 63.42 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.819 2.346 . . . . 1.76 112.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -93.94 153.88 17.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.998 -0.546 . . . . 1.3100000000000001 109.717 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -125.99 161.39 27.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.352 -0.61 . . . . 1.3600000000000001 109.352 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.65 175.35 13.35 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.518 -0.473 . . . . 0.56999999999999995 111.489 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 75.1 m-70 -118.37 150.55 39.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.836 . . . . 1.98 109.769 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.603 HD11 ' OD1' ' A' ' 79' ' ' ASP . 14.5 tp -66.13 127.43 32.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.366 -0.379 . . . . 0.94999999999999996 111.871 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 50.56 37.58 16.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.193 0.997 . . . . 2.0800000000000001 111.467 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 13.9 tt0 -72.11 -6.07 39.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.865 -1.516 . . . . 1.98 111.192 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.98 56.19 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 111.661 -0.576 . . . . 0.71999999999999997 111.661 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.19 -18.35 25.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.449 0.642 . . . . 0.96999999999999997 109.759 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.6 125.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.372 -0.831 . . . . 0.57999999999999996 109.578 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -95.94 -58.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.7 1.0 . . . . 0.62 113.7 -172.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.95 -50.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.79 -0.568 . . . . 2.04 112.295 -169.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.13 -52.43 40.17 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.791 -0.719 . . . . 0.32000000000000001 112.707 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.46 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -75.94 -33.94 59.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.618 0.247 . . . . 0.48999999999999999 110.698 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.603 ' OD1' HD11 ' A' ' 69' ' ' LEU . 10.4 t70 -53.04 -51.69 60.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.703 -0.681 . . . . 1.1399999999999999 111.428 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.539 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.8 mp -65.83 -48.37 82.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.09 -0.505 . . . . 0.78000000000000003 110.75 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 120' ' ' ILE . 28.7 t -60.55 -48.24 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.55000000000000004 111.625 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.833 HG12 HG21 ' A' ' 120' ' ' ILE . 32.0 m -70.12 -33.23 54.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.962 -0.295 . . . . 0.83999999999999997 111.295 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 32.6 t -79.17 0.25 29.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 1.4299999999999999 110.882 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -110.38 10.6 23.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.285 -0.416 . . . . 1.23 111.19 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.59 ' SD ' HG22 ' A' ' 120' ' ' ILE . 47.9 mtm -102.3 -173.42 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.797 0.808 . . . . 2.27 112.054 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.452 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 14.2 mtp180 -140.9 -177.44 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.439 -1.255 . . . . 4.1900000000000004 108.5 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -67.06 -23.44 65.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 1.9399999999999999 111.273 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -126.68 17.93 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 1.23 111.219 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 25.8 tt0 -112.2 131.85 55.24 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.695 -0.483 . . . . 1.6000000000000001 109.695 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 12.8 tmtt? -134.93 134.97 41.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.518 -0.765 . . . . 1.1699999999999999 109.868 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.457 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.7 p -137.57 172.82 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.258 -0.428 . . . . 1.2 110.683 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 93' ' ' VAL . 3.2 tt -119.43 140.27 50.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.281 -1.007 . . . . 1.73 108.281 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 95' ' ' ILE . 6.1 p -121.39 141.57 41.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 120.958 0.409 . . . . 0.73999999999999999 110.903 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -98.89 111.65 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.156 -0.683 . . . . 1.71 109.156 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.524 HD11 HG13 ' A' ' 93' ' ' VAL . 3.2 mp -93.4 109.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.378 . . . . 0.52000000000000002 110.187 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -84.81 166.04 17.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.579 -0.897 . . . . 1.3700000000000001 108.579 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.4 p -51.01 -40.68 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.29 0.369 . . . . 1.0 111.956 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.5 ptp -77.19 -16.27 59.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.33 -0.395 . . . . 1.79 111.993 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -92.67 -16.27 25.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.945 0.402 . . . . 0.75 110.432 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.437 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -115.24 -160.15 12.56 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.103 -0.799 . . . . 0.70999999999999996 111.103 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 120.722 0.296 . . . . 1.52 111.012 178.43 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.511 0.196 . . . . 1.52 110.581 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.469 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.02 103.45 4.43 Favored Pre-proline 0 N--CA 1.465 0.277 0 N-CA-C 109.879 -0.415 . . . . 0.75 109.879 176.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.21 -74.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.346 2.031 . . . . 1.5800000000000001 112.846 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.78 -134.78 44.0 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.805 -0.712 . . . . 2.0499999999999998 112.224 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -133.67 21.39 3.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.466 -0.568 . . . . 2.0299999999999998 109.466 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 22.4 m -105.77 179.19 4.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.76 -0.655 . . . . 1.1399999999999999 111.196 -173.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -97.53 138.57 22.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.128 0.489 . . . . 0.47999999999999998 111.006 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.4 mp -120.41 166.78 13.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.371 -0.377 . . . . 0.51000000000000001 110.907 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 5.4 mt -116.14 110.21 18.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.69999999999999996 109.662 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.64 124.51 48.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.793 0.33 . . . . 0.42999999999999999 110.625 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -92.1 126.25 37.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.304 -0.628 . . . . 1.46 109.304 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.833 HG21 HG12 ' A' ' 82' ' ' VAL . 76.0 mt -120.06 131.62 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.471 -0.331 . . . . 0.47999999999999998 110.979 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -136.25 143.66 44.4 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.103 -0.499 . . . . 1.8799999999999999 110.447 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.545 ' HA ' HG12 ' A' ' 42' ' ' VAL . 24.7 tp -90.94 118.77 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 1.1200000000000001 110.72 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.36 -27.89 10.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 1.0 111.239 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.5 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 39.9 m -151.69 149.8 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.374 . . . . 1.1899999999999999 109.989 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.56 ' HB2' HG12 ' A' ' 40' ' ' VAL . 4.0 p90 -165.5 158.5 15.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.808 0.337 . . . . 0.71999999999999997 111.123 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -125.39 123.44 39.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.103 -0.498 . . . . 2.98 110.052 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 3.3799999999999999 109.927 171.668 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.989 0.423 . . . . 3.6000000000000001 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.1 137.77 45.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.529 -0.759 . . . . 2.71 111.262 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -100.39 128.78 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.307 -0.627 . . . . 1.8799999999999999 109.307 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 23.2 t -102.29 105.1 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.11 0.481 . . . . 0.58999999999999997 110.372 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.1 103.9 16.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.607 -0.724 . . . . 2.1600000000000001 110.663 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 19' ' ' ILE . 21.6 tp 62.24 76.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.255 -0.884 . . . . 1.45 110.863 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -80.92 159.82 24.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.731 -0.668 . . . . 0.78000000000000003 110.928 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.87 -5.09 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.29 0.567 . . . . 0.81000000000000005 111.023 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.9 t70 -78.17 30.3 0.18 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 2.3999999999999999 111.645 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' HA3' HG13 ' A' ' 80' ' ' ILE . . . 121.91 -26.17 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.754 -0.736 . . . . 0.68000000000000005 112.735 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.05 60.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.394 -0.908 . . . . 0.60999999999999999 113.372 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.09 152.17 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.965 -0.383 . . . . 0.48999999999999999 109.965 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 12' ' ' LEU . 7.4 mm -85.75 120.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.505 0.322 . . . . 0.46999999999999997 110.257 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 84' ' ' SER . 51.7 pttt -142.73 147.09 35.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.177 0.513 . . . . 1.3400000000000001 111.461 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.38 135.29 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.509 -0.769 . . . . 0.5 109.891 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.4 112.97 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.102 0.477 . . . . 0.67000000000000004 110.624 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 -52.83 3.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.82999999999999996 110.813 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -115.93 151.97 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.331 -0.618 . . . . 1.5600000000000001 109.331 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.89 110.97 19.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.823 -0.436 . . . . 2.9500000000000002 109.823 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.87 163.18 10.46 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.535 -0.757 . . . . 1.3200000000000001 112.821 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 28' ' ' GLU . 12.5 t70 -104.96 -149.22 0.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.554 -0.536 . . . . 2.77 109.554 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 42.4 tt0 -59.27 125.1 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.15 0.5 . . . . 2.6400000000000001 110.793 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.85 52.37 0.24 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 111.215 -0.754 . . . . 1.04 111.215 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.91 -33.87 73.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.5 . . . . 2.29 110.619 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -98.46 18.3 16.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.583 -0.735 . . . . 2.6400000000000001 110.091 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -126.41 76.74 1.64 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.911 -0.586 . . . . 1.45 109.94 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 38.4 mm -129.14 119.98 19.95 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.398 0.618 . . . . 0.81000000000000005 111.886 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -87.05 100.75 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.148 3.232 . . . . 0.75 112.186 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.585 ' HE2' ' HB3' ' A' ' 83' ' ' SER . 28.1 mmtp -135.95 178.44 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.15 0.5 . . . . 2.6600000000000001 112.264 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.53 139.51 57.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.145 -0.934 . . . . 2.5099999999999998 111.511 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.51 56.42 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.265 -0.734 . . . . 1.1200000000000001 111.265 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 45.6 m-20 -113.87 161.92 17.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.388 . . . . 1.3799999999999999 110.154 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 25.7 mt-10 -94.57 103.92 15.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.176 -0.465 . . . . 2.2000000000000002 110.613 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.86 132.2 49.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.63 -0.507 . . . . 0.67000000000000004 109.63 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -108.39 109.83 21.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.581 -0.526 . . . . 0.65000000000000002 109.581 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.507 ' CG1' HD12 ' A' ' 122' ' ' LEU . 15.8 m -124.04 140.49 47.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.692 -0.685 . . . . 0.87 111.009 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -105.6 140.7 38.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.676 -0.693 . . . . 2.75 109.482 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -123.73 142.67 50.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.107 -0.331 . . . . 0.76000000000000001 110.107 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 p -167.08 148.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.237 -0.653 . . . . 0.48999999999999999 109.237 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.6 1.77 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.127 -0.789 . . . . 0.35999999999999999 111.127 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 63.7 pttt -157.8 171.39 20.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 111.499 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.858 ' HA ' HD23 ' A' ' 116' ' ' LEU . 63.8 tp -81.75 98.17 8.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.814 -0.63 . . . . 0.38 110.253 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.616 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 33.6 tt0 -60.17 -27.75 67.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.756 0.312 . . . . 1.96 111.142 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 t -55.36 -27.2 45.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.955 -0.566 . . . . 0.67000000000000004 111.783 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 53' ' ' LYS . 11.8 t -139.96 4.61 2.09 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.286 0.565 . . . . 0.72999999999999998 110.926 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.89 13.48 75.57 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.94 -0.573 . . . . 0.78000000000000003 113.077 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -77.8 118.34 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.606 0.241 . . . . 2.8900000000000001 111.141 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.724 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.9 p -76.84 159.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.58999999999999997 110.039 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.55 ' CE1' HD11 ' A' ' 110' ' ' ILE . 18.3 m-30 -80.26 99.44 7.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.518 -0.31 . . . . 0.78000000000000003 110.675 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -124.51 84.72 2.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.889 0.852 . . . . 2.1800000000000002 111.28 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.513 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.9 m -136.92 -178.16 5.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.133 -0.94 . . . . 1.24 108.81 175.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.9 p -67.36 -44.15 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 1.49 111.104 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.35 -51.59 23.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.039 -0.528 . . . . 1.8 110.141 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.7 OUTLIER -45.89 -43.81 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.745 -1.116 . . . . 2.1899999999999999 112.191 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.39 -11.9 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.501 . . . . 2.7799999999999998 112.351 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -103.9 -61.91 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.699 -0.401 . . . . 1.1000000000000001 111.588 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 29.0 m -86.0 124.11 71.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.488 . . . . 2.0299999999999998 112.03 -169.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.7 Cg_endo -87.22 103.98 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.147 2.565 . . . . 1.76 111.21 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -94.8 149.16 21.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.454 -0.339 . . . . 1.3100000000000001 110.519 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -141.41 165.88 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 1.3600000000000001 109.939 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 74' ' ' VAL . 54.4 p90 -149.86 -176.88 5.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.088 0.47 . . . . 0.56999999999999995 111.516 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 3.9 m-70 -120.03 150.93 39.77 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.477 -0.783 . . . . 1.98 110.075 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 82' ' ' VAL . 45.6 tp -68.76 134.98 50.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.552 0.215 . . . . 0.94999999999999996 110.46 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 53.21 31.22 11.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.504 0.669 . . . . 2.0800000000000001 111.518 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 16.5 tt0 -69.62 -12.04 61.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.076 -0.965 . . . . 1.98 111.033 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.52 -14.31 54.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.741 -0.743 . . . . 0.71999999999999997 111.744 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB2' HE21 ' A' ' 71' ' ' GLN . 18.3 mm-40 -104.07 0.02 29.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.96999999999999997 110.737 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.9 m -132.3 124.65 52.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.57999999999999996 110.266 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.793 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -96.36 -60.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.03 0.752 . . . . 0.62 113.03 -176.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 75' ' ' ILE . 35.6 mmtt -145.03 -41.49 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.285 0.846 . . . . 2.04 113.285 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.36 -52.33 37.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.307 -0.949 . . . . 0.32000000000000001 112.212 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.417 ' O ' HG22 ' A' ' 82' ' ' VAL . 14.2 m-90 -76.48 -33.13 58.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.543 0.211 . . . . 0.48999999999999999 110.992 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 10.4 t70 -52.33 -53.33 45.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.77 -0.65 . . . . 1.1399999999999999 112.102 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.11 -33.13 59.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.441 0.638 . . . . 0.78000000000000003 111.22 -176.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.8 t -76.19 -39.52 54.56 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.896 -0.502 . . . . 0.55000000000000004 111.661 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 69' ' ' LEU . 33.8 m -81.02 -32.82 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.452 0.167 . . . . 0.83999999999999997 111.131 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.585 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 62.6 m -61.27 -40.71 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 1.4299999999999999 110.7 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 21.4 m -101.42 64.38 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 1.23 111.038 174.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 11.4 mmt -120.9 172.47 7.89 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.149 -0.932 . . . . 2.27 110.074 171.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -142.96 162.83 34.41 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.69 -0.856 . . . . 4.1900000000000004 108.69 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HA ' HD23 ' A' ' 122' ' ' LEU . 3.4 tmtm? -56.11 -29.56 60.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.981 0.363 . . . . 1.9399999999999999 111.981 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -118.96 18.12 13.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.68 0.276 . . . . 1.23 111.13 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.37 158.03 16.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.395 -0.366 . . . . 1.6000000000000001 110.578 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -152.29 124.06 7.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.283 -0.636 . . . . 1.1699999999999999 109.283 -175.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.8 m -129.63 160.7 32.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.324 -0.398 . . . . 1.2 110.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' CD2' ' HE2' ' A' ' 90' ' ' LYS . 2.6 mm? -103.17 118.21 36.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.73 109.655 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.737 HG13 HD11 ' A' ' 95' ' ' ILE . 7.5 p -100.63 138.17 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.822 0.344 . . . . 0.73999999999999999 110.224 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 mmm-85 -107.42 111.44 23.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.571 -0.899 . . . . 1.71 108.571 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.737 HD11 HG13 ' A' ' 93' ' ' VAL . 5.1 mp -104.28 107.17 21.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.155 -0.475 . . . . 0.52000000000000002 110.181 -173.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.595 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 2.2 tt0 -83.46 176.01 9.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.153 -0.684 . . . . 1.3700000000000001 109.153 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -30.99 67.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.14 -9.29 59.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.294 -0.412 . . . . 1.79 111.983 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.595 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 17.7 m-85 -109.42 -0.69 18.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 0.75 110.29 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.58 176.09 22.95 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.70999999999999996 112.134 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 111.704 0.261 . . . . 1.52 111.704 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.473 0.177 . . . . 1.52 111.09 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.55 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -156.15 72.83 5.1 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 0.75 110.95 175.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -94.82 102.81 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.161 2.574 . . . . 1.5800000000000001 112.342 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.3 73.3 0.46 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.969 -0.853 . . . . 2.0499999999999998 110.969 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.02 31.33 0.33 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.92 0.888 . . . . 2.0299999999999998 111.26 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 48' ' ' LEU . 6.8 p -104.27 -177.33 3.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.1399999999999999 111.018 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.82 137.64 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.07 -0.514 . . . . 0.47999999999999998 110.035 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.858 HD23 ' HA ' ' A' ' 48' ' ' LEU . 10.1 mt -124.55 156.4 37.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 0.51000000000000001 110.72 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.616 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -125.56 119.67 28.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.829 -0.434 . . . . 0.69999999999999996 109.829 171.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 95' ' ' ILE . 21.2 m-85 -114.52 137.93 51.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.962 -0.563 . . . . 0.42999999999999999 111.006 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.43 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 36.2 mt-10 -89.12 116.09 27.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.295 -0.866 . . . . 1.46 108.869 172.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.465 HG21 HG12 ' A' ' 82' ' ' VAL . 44.6 mt -106.78 127.82 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.705 0.288 . . . . 0.47999999999999998 110.258 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.26 125.82 50.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.806 -0.634 . . . . 1.8799999999999999 110.601 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 87' ' ' LYS . 4.4 tp -91.88 89.86 7.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.518 -0.549 . . . . 1.1200000000000001 109.518 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -78.78 -37.07 41.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.43 -176.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.3 m -146.77 151.36 37.03 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.128 -0.229 . . . . 1.1899999999999999 110.794 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -165.86 -177.71 4.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.507 -0.553 . . . . 0.71999999999999997 109.507 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.549 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -162.33 172.38 15.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 2.98 109.786 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.435 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 26.8 mt-10 . . . . . 0 C--N 1.327 -0.409 0 O-C-N 123.366 0.416 . . . . 3.3799999999999999 110.94 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 C--O 1.233 0.237 0 CA-C-O 120.848 0.356 . . . . 3.6000000000000001 110.354 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -112.35 136.53 51.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.018 -0.537 . . . . 2.71 110.178 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HG3' HG23 ' A' ' 21' ' ' THR . 7.1 mptt -111.34 125.82 54.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.722 -0.474 . . . . 1.8799999999999999 109.722 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.42 115.54 45.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.537 -0.301 . . . . 0.58999999999999997 110.349 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.04 126.67 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.095 -0.502 . . . . 2.1600000000000001 111.09 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.3 mt 57.26 53.31 7.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 1.45 110.04 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.532 HG21 ' HE2' ' A' ' 20' ' ' LYS . 11.7 t -59.23 157.72 10.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.78000000000000003 111.169 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -2.76 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.81000000000000005 112.115 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.53 -4.41 36.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 2.3999999999999999 110.658 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.27 37.41 0.69 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.574 -0.822 . . . . 0.68000000000000005 113.107 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.29 0.85 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.906 -0.664 . . . . 0.60999999999999999 113.489 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.462 HG21 ' HB ' ' A' ' 80' ' ' ILE . 38.6 t -141.13 141.36 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.272 -0.27 . . . . 0.48999999999999999 110.272 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 12' ' ' LEU . 14.3 mm -90.83 110.82 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.46999999999999997 109.753 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.532 ' HE2' HG21 ' A' ' 13' ' ' THR . 61.3 pttt -137.09 144.83 43.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.192 0.52 . . . . 1.3400000000000001 111.076 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 9' ' ' LYS . 25.2 m -116.77 131.37 56.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.5 110.239 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.478 HD11 ' HA ' ' A' ' 25' ' ' LYS . 4.9 tp -91.17 126.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.67000000000000004 110.267 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.578 ' CD2' ' HG ' ' A' ' 92' ' ' LEU . 3.3 mm? -108.04 -72.85 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.38 0.609 . . . . 0.82999999999999996 110.135 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -108.07 103.28 12.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.146 -0.687 . . . . 1.5600000000000001 109.146 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HA ' HD11 ' A' ' 22' ' ' ILE . 73.4 tttt -72.26 157.38 37.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.851 -0.425 . . . . 2.9500000000000002 109.851 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.27 -136.83 0.12 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 114.559 0.583 . . . . 1.3200000000000001 114.559 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 14.0 t70 -167.3 -162.98 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.556 -1.275 . . . . 2.77 107.556 -170.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 39.2 tt0 -77.81 125.38 29.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 2.6400000000000001 110.716 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.93 70.0 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.559 -1.016 . . . . 1.04 110.559 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.46 -22.43 59.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.043 0.449 . . . . 2.29 111.03 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.47 1.1 55.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.645 0.736 . . . . 2.6400000000000001 109.328 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -105.71 76.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.647 -0.706 . . . . 1.45 109.243 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.1 mm -137.07 130.42 17.44 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.81000000000000005 111.138 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.501 ' HG3' ' O ' ' A' ' 85' ' ' MET . 74.0 Cg_endo -74.74 133.86 17.55 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.031 2.488 . . . . 0.75 111.424 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 29.9 mmmt -134.12 142.06 47.36 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.283 -0.261 . . . . 2.6600000000000001 110.539 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.635 ' HE3' ' HB3' ' A' ' 70' ' ' GLU . 17.3 tptm -56.14 127.51 31.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 2.5099999999999998 110.47 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.53 -25.25 23.61 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.474 -0.785 . . . . 1.1200000000000001 111.825 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 78.9 m-20 -94.28 165.73 12.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 1.3799999999999999 110.305 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.27 132.26 34.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.142 0.496 . . . . 2.2000000000000002 111.857 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.8 150.8 35.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.765 -0.828 . . . . 0.67000000000000004 108.765 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 25.6 m -125.55 106.41 9.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.861 -0.422 . . . . 0.65000000000000002 109.861 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 122' ' ' LEU . 34.0 m -131.22 160.48 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.573 . . . . 0.87 111.385 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -113.92 152.73 30.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.647 -0.872 . . . . 2.75 108.647 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -128.06 132.64 49.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.76000000000000001 110.253 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -165.14 158.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.807 -0.812 . . . . 0.48999999999999999 108.807 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.84 -127.35 1.51 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.038 -1.077 . . . . 0.35999999999999999 112.372 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 58.5 pttt -150.42 166.63 29.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 1.4299999999999999 110.471 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.579 HD22 HG13 ' A' ' 110' ' ' ILE . 66.3 tp -86.23 101.97 13.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 0.38 109.694 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 18.9 tt0 -59.78 -24.54 64.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.807 0.337 . . . . 1.96 111.817 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 t -55.86 -25.35 41.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.188 -0.46 . . . . 0.67000000000000004 111.468 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 53' ' ' LYS . 3.0 t -137.84 -31.62 0.77 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.933 0.396 . . . . 0.72999999999999998 111.567 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.72 14.75 26.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.84 -0.695 . . . . 0.78000000000000003 112.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' A' ' 51' ' ' THR . 70.2 mmtt -86.59 133.7 33.69 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.652 -0.499 . . . . 2.8900000000000001 109.652 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.3 p -83.06 155.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.211 -0.45 . . . . 0.58999999999999997 111.46 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 3.2 m-85 -74.33 102.11 4.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.78000000000000003 110.77 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.52 85.3 2.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.375 0.607 . . . . 2.1800000000000002 110.004 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.531 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 67.3 m -138.58 -177.61 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 1.24 110.323 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -48.47 -47.0 38.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.887 0.699 . . . . 1.49 112.887 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.89 -43.29 8.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 1.8 110.339 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.8 OUTLIER -57.29 -30.5 64.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 2.1899999999999999 112.185 -174.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -19.91 21.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 2.7799999999999998 110.973 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.673 HD22 HG12 ' A' ' 63' ' ' VAL . 8.5 t30 -86.81 -61.02 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 1.1000000000000001 110.94 -171.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.673 HG12 HD22 ' A' ' 62' ' ' ASN . 7.1 p -156.13 126.36 3.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 2.0299999999999998 111.121 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 8.9 Cg_exo -72.02 152.74 57.44 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.694 2.262 . . . . 1.76 111.326 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.71 146.41 23.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.676 0.274 . . . . 1.3100000000000001 110.328 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 2.7 pptp? -105.89 143.35 34.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.979 -0.378 . . . . 1.3600000000000001 109.979 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 47.7 p90 -134.31 170.44 15.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.01 0.433 . . . . 0.56999999999999995 111.131 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -103.96 149.58 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 1.98 109.966 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.614 HD13 ' CG2' ' A' ' 82' ' ' VAL . 16.5 tp -64.19 119.46 10.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.94 0.4 . . . . 0.94999999999999996 110.928 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.635 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER 42.31 74.94 0.1 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 114.405 -1.271 . . . . 2.0800000000000001 111.767 -174.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 6.1 pt20 -100.85 17.39 22.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.548 -1.206 . . . . 1.98 109.536 174.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.5 -16.6 59.62 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.604 -0.726 . . . . 0.71999999999999997 111.787 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.53 -41.56 11.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.466 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.87 135.36 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.651 0.262 . . . . 0.57999999999999996 110.301 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.562 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.61 -68.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.455 0.539 . . . . 0.62 112.455 -175.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 75' ' ' ILE . 41.7 mtpt -133.52 -51.09 0.86 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 122.026 -0.421 . . . . 2.04 111.892 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.07 -53.41 34.22 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.049 -0.596 . . . . 0.32000000000000001 113.513 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.427 ' O ' HG22 ' A' ' 82' ' ' VAL . 17.7 m-90 -75.86 -37.72 58.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.652 0.263 . . . . 0.48999999999999999 110.632 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.01 -54.06 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 1.1399999999999999 111.791 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.462 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -68.59 -35.31 69.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 110.559 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 120' ' ' ILE . 44.2 t -69.43 -48.19 61.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.096 -0.502 . . . . 0.55000000000000004 111.083 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.614 ' CG2' HD13 ' A' ' 69' ' ' LEU . 34.0 m -66.7 -32.37 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 121.169 -0.212 . . . . 0.83999999999999997 111.125 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -80.92 3.38 22.99 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.275 0.56 . . . . 1.4299999999999999 110.237 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 t -123.93 27.48 7.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.558 -0.746 . . . . 1.23 109.001 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.63 ' HE1' ' HA ' ' A' ' 90' ' ' LYS . 40.7 mmm -123.79 116.45 23.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 2.27 111.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.534 HH21 ' HB2' ' A' ' 88' ' ' ASN . 18.0 ttp85 -82.41 162.06 22.27 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 4.1900000000000004 109.753 175.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -66.12 -13.68 60.53 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.108 0.41 . . . . 1.9399999999999999 112.108 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.534 ' HB2' HH21 ' A' ' 86' ' ' ARG . 37.0 m-80 -121.42 25.51 9.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.004 0.43 . . . . 1.23 109.976 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -123.16 166.4 15.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.634 -0.712 . . . . 1.6000000000000001 109.737 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.63 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 79.2 tttt -157.28 121.03 4.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 1.1699999999999999 111.405 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.27 160.96 25.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.522 -0.763 . . . . 1.2 110.646 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 75.2 mt -115.13 126.22 54.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.544 -0.539 . . . . 1.73 109.544 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 77' ' ' GLY . 10.0 p -101.22 142.45 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 110.024 -0.362 . . . . 0.73999999999999999 110.024 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 15.3 mmm-85 -100.98 112.84 25.38 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.84 -0.8 . . . . 1.71 108.84 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -87.23 101.18 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.52000000000000002 110.928 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 98' ' ' MET . 10.2 tp10 -79.75 159.22 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.433 -0.951 . . . . 1.3700000000000001 108.433 170.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.411 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 8.5 p -55.37 -36.1 65.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.889 0.376 . . . . 1.0 111.499 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 96' ' ' GLU . 22.2 ptp -76.95 -8.27 57.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.166 -0.47 . . . . 1.79 111.021 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -96.08 -2.4 46.72 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.154 -0.313 . . . . 0.75 110.154 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.562 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -133.72 -152.45 6.78 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.684 -0.689 . . . . 0.70999999999999996 112.335 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.926 0.343 . . . . 1.52 111.926 -177.845 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.506 ' HB3' HD13 ' A' ' 110' ' ' ILE . 3.0 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.751 -0.092 . . . . 1.52 110.751 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.579 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.59 71.36 17.49 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.922 0.392 . . . . 0.75 111.77 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -92.23 -158.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.766 2.311 . . . . 1.5800000000000001 112.558 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.14 -133.0 9.65 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.336 -0.706 . . . . 2.0499999999999998 111.336 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 2.3 t-20 -96.64 24.07 6.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.753 0.787 . . . . 2.0299999999999998 109.732 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -104.93 146.5 28.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.397 -0.82 . . . . 1.1399999999999999 109.737 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.19 132.06 34.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.158 0.504 . . . . 0.47999999999999998 110.66 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.7 mp -121.07 168.95 10.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.545 . . . . 0.51000000000000001 109.624 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -138.97 122.83 17.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.69999999999999996 110.333 172.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -110.94 140.6 45.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.42999999999999999 111.453 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.434 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 34.3 mt-10 -80.45 119.58 23.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.274 -0.875 . . . . 1.46 108.903 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.587 HD12 ' SG ' ' A' ' 81' ' ' CYS . 47.8 mt -108.12 134.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.248 -0.649 . . . . 0.47999999999999998 109.248 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -134.93 114.38 12.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.529 . . . . 1.8799999999999999 110.7 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.71 ' HA ' HG12 ' A' ' 42' ' ' VAL . 4.9 tp -84.0 91.72 7.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.852 -0.425 . . . . 1.1200000000000001 109.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 41' ' ' THR . 2.8 pp -84.27 -36.81 22.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.279 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.4 m -143.14 150.66 39.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.047 -0.353 . . . . 1.1899999999999999 110.047 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -165.91 -178.89 4.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.494 -0.558 . . . . 0.71999999999999997 109.494 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.86 138.92 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 2.98 110.554 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.318 -0.623 . . . . 3.3799999999999999 109.318 177.726 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.754 -0.462 . . . . 3.6000000000000001 109.754 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.35 154.13 39.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.263 0.554 . . . . 2.71 110.77 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.4 mppt? -94.42 152.04 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.039 -0.726 . . . . 1.8799999999999999 109.039 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.31 105.19 17.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.562 -0.533 . . . . 0.58999999999999997 109.562 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.8 99.75 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 2.1600000000000001 110.247 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt 66.75 78.63 0.25 Allowed 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.027 0.829 . . . . 1.45 110.858 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -68.3 156.07 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.78000000000000003 110.366 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.27 -20.27 65.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.247 -0.433 . . . . 0.81000000000000005 111.902 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.51 30.69 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.87 0.367 . . . . 2.3999999999999999 111.83 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 11.38 5.32 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.043 -1.075 . . . . 0.68000000000000005 114.548 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.92 64.33 4.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.545 0.578 . . . . 0.60999999999999999 114.545 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.14 147.55 32.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 0.48999999999999999 109.984 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -85.5 111.17 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.789 -0.449 . . . . 0.46999999999999997 109.789 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 18.5 pttp -141.68 146.92 36.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.945 0.402 . . . . 1.3400000000000001 110.769 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -102.79 132.02 49.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.5 110.034 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 tp -93.63 121.93 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.878 0.371 . . . . 0.67000000000000004 110.194 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.88 -78.83 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.82999999999999996 110.419 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 108.69 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.579 -0.737 . . . . 1.5600000000000001 109.675 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -72.88 147.39 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.885 -0.598 . . . . 2.9500000000000002 111.901 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.73 88.75 1.38 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.072 -1.211 . . . . 1.3200000000000001 110.072 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.33 -43.21 43.5 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.767 0.654 . . . . 2.77 112.767 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.32 144.38 34.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.924 0.392 . . . . 2.6400000000000001 110.709 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.81 51.8 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.977 -0.63 . . . . 1.04 111.643 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.95 -45.98 64.58 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.583 0.586 . . . . 2.29 112.583 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.47 27.65 8.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.962 0.411 . . . . 2.6400000000000001 111.035 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 30.9 m-80 -129.26 78.62 1.86 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 1.45 110.609 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.25 124.31 21.18 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.134 -0.485 . . . . 0.81000000000000005 111.066 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HG3' HD22 ' A' ' 122' ' ' LEU . 42.8 Cg_endo -67.65 112.83 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.713 2.275 . . . . 0.75 111.504 176.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.7 mmtp -133.39 172.78 12.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.364 0.875 . . . . 2.6600000000000001 113.364 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -43.42 126.48 4.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.02 -1.445 . . . . 2.5099999999999998 113.211 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 -16.01 45.1 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.935 -0.575 . . . . 1.1200000000000001 113.301 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 92.7 m-20 -83.58 146.99 28.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.057 0.456 . . . . 1.3799999999999999 110.913 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -78.5 110.23 13.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.292 0.568 . . . . 2.2000000000000002 110.252 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 125' ' ' PHE . 11.1 m -117.88 159.29 18.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.587 -0.733 . . . . 0.67000000000000004 109.819 175.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' HD3' ' A' ' 66' ' ' LYS . 23.7 m -125.55 105.61 9.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.383 -0.599 . . . . 0.65000000000000002 109.383 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 122' ' ' LEU . 12.7 m -128.01 140.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.864 -0.607 . . . . 0.87 110.185 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.411 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 32.8 m170 -100.43 147.64 25.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.06 -0.718 . . . . 2.75 109.06 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -126.39 127.84 46.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.371 0.605 . . . . 0.76000000000000001 110.326 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.22 157.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.355 -0.98 . . . . 0.48999999999999999 108.355 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.61 -128.49 1.71 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.258 -0.972 . . . . 0.35999999999999999 111.454 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.679 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 59.2 pttt -157.81 170.92 21.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.993 0.425 . . . . 1.4299999999999999 111.058 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD13 ' HG ' ' A' ' 116' ' ' LEU . 46.2 tp -89.52 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.38 109.627 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 78.2 tt0 -64.36 -28.55 69.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 1.96 111.233 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.44 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 8.7 t -54.84 -29.78 55.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.532 . . . . 0.67000000000000004 111.543 -175.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -130.46 -2.45 4.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.656 0.265 . . . . 0.72999999999999998 111.086 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 45.34 50.31 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.347 -0.454 . . . . 0.78000000000000003 113.032 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 68.8 mmtt -113.51 127.1 55.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 2.8900000000000001 110.584 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.679 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 14.4 p -72.76 152.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.622 -0.717 . . . . 0.58999999999999997 111.168 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 3.5 m-30 -74.48 115.45 14.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.998 0.428 . . . . 0.78000000000000003 110.749 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -146.21 85.7 1.67 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.655 -0.702 . . . . 2.1800000000000002 109.425 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 15.0 m -116.13 -177.5 3.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.544 -0.753 . . . . 1.24 109.734 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -71.17 -37.98 72.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.947 0.404 . . . . 1.49 111.212 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.42 -48.09 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.382 0.512 . . . . 1.8 112.382 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -62.34 -45.57 92.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.926 0.713 . . . . 2.1899999999999999 112.926 -167.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 57' ' ' SER . 3.4 ptm180 -67.35 -23.25 65.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.776 0.322 . . . . 2.7799999999999998 111.326 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -87.71 -62.32 1.52 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 1.1000000000000001 110.565 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.3 107.09 30.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.631 0.729 . . . . 2.0299999999999998 110.787 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.14 138.74 37.3 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.114 2.542 . . . . 1.76 111.795 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.25 153.85 18.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.902 -0.407 . . . . 1.3100000000000001 109.902 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD3' HG23 ' A' ' 41' ' ' THR . 3.7 pptp? -130.02 146.76 51.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.303 -0.408 . . . . 1.3600000000000001 110.506 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.454 ' HB2' HE22 ' A' ' 71' ' ' GLN . 48.7 p90 -127.86 174.43 9.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.82 0.343 . . . . 0.56999999999999995 111.447 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -110.69 151.36 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 1.98 110.664 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.488 HD23 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -65.18 117.67 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.94999999999999996 110.535 -176.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.76 90.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.203 1.001 . . . . 2.0800000000000001 110.228 -171.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.454 HE22 ' HB2' ' A' ' 67' ' ' PHE . 8.2 tt0 -127.73 8.24 6.32 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.399 -1.273 . . . . 1.98 109.585 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.1 -17.67 31.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.71999999999999997 112.472 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 9.0 mm-40 -90.4 -15.53 30.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.374 0.606 . . . . 0.96999999999999997 110.329 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.56 124.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.952 -0.567 . . . . 0.57999999999999996 110.747 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -99.43 -57.07 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.74 0.644 . . . . 0.62 112.74 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.0 mtpt -137.41 -61.18 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 2.04 111.665 -171.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.46 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -52.99 -52.74 37.66 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.05 -0.595 . . . . 0.32000000000000001 112.78 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.571 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -74.87 -51.53 13.67 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.74 -0.384 . . . . 0.48999999999999999 110.431 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.41 -51.98 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.545 0.528 . . . . 1.1399999999999999 112.123 -171.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 76' ' ' LYS . 1.8 mp -65.42 -38.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.809 0.338 . . . . 0.78000000000000003 110.453 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.0 t -68.6 -46.1 70.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.284 . . . . 0.55000000000000004 110.765 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.6 m -67.98 -33.06 59.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 O-C-N 123.153 0.283 . . . . 0.83999999999999997 110.856 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -61.1 -39.24 89.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 1.4299999999999999 110.58 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.527 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 22.4 m -92.67 31.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.474 . . . . 1.23 111.15 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 85.6 mmm -104.52 175.13 5.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.615 -0.266 . . . . 2.27 110.385 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 70.4 mtt85 -144.89 165.71 27.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.465 -0.334 . . . . 4.1900000000000004 110.359 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -53.73 -35.14 60.87 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.618 0.573 . . . . 1.9399999999999999 112.316 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -125.19 41.4 3.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 1.23 110.561 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 20.2 tt0 -117.34 154.25 31.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.392 -0.367 . . . . 1.6000000000000001 110.193 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.94 117.49 7.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.376 . . . . 1.1699999999999999 109.986 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 74.5 m -124.52 162.21 24.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.092 0.472 . . . . 1.2 112.018 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.44 114.67 27.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.369 -0.832 . . . . 1.73 109.646 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.603 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.1 p -103.77 147.57 9.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.409 -0.359 . . . . 0.73999999999999999 110.983 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 94' ' ' ARG . 9.5 mmt85 -105.51 112.38 25.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.587 -0.523 . . . . 1.71 109.587 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.521 HD13 ' HD2' ' A' ' 118' ' ' PHE . 2.1 mp -94.1 105.58 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.149 0.499 . . . . 0.52000000000000002 109.67 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 97' ' ' SER . 23.0 tt0 -93.78 174.85 6.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -49.0 -45.87 43.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.76 0.424 . . . . 1.0 111.516 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.08 -8.29 58.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.948 -0.569 . . . . 1.79 112.027 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.412 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 21.6 m-85 -102.28 -18.58 15.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.75 110.578 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' C ' HD11 ' A' ' 75' ' ' ILE . . . -112.99 -174.41 19.13 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.304 -0.718 . . . . 0.70999999999999996 111.304 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 1.52 110.889 179.282 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.552 ' HB2' HD13 ' A' ' 110' ' ' ILE . 4.7 p . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 111.961 0.356 . . . . 1.52 111.961 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -160.25 87.67 1.87 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 122.892 0.477 . . . . 0.75 110.848 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.83 170.35 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.345 2.03 . . . . 1.5800000000000001 111.597 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.06 36.54 0.02 OUTLIER Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.39 -0.91 . . . . 2.0499999999999998 112.473 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.53 19.01 11.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.274 0.559 . . . . 2.0299999999999998 110.402 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 2.0 m -95.8 160.93 14.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.493 -0.776 . . . . 1.1399999999999999 110.33 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.22 122.21 45.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.375 0.607 . . . . 0.47999999999999998 110.452 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.0 mp -116.29 142.7 46.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.837 -0.62 . . . . 0.51000000000000001 109.615 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.44 121.59 45.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.142 0.496 . . . . 0.69999999999999996 110.539 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.521 ' HD2' HD13 ' A' ' 95' ' ' ILE . 44.4 m-85 -112.88 137.95 50.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.747 . . . . 0.42999999999999999 111.219 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.512 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 38.7 mt-10 -78.2 122.37 25.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.81 -0.811 . . . . 1.46 108.81 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.479 HG21 HG12 ' A' ' 82' ' ' VAL . 49.9 mt -107.16 121.16 59.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.512 -0.551 . . . . 0.47999999999999998 109.512 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -127.68 112.88 15.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.514 -0.766 . . . . 1.8799999999999999 110.639 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 42' ' ' VAL . 24.6 tp -88.93 99.59 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 1.1200000000000001 109.9 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -90.8 -31.42 16.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.872 -0.331 . . . . 1.0 111.308 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.3 m -151.21 146.21 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.713 -0.221 . . . . 1.1899999999999999 110.571 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.593 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -168.39 -179.21 3.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.523 -0.308 . . . . 0.71999999999999997 110.294 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 6.0 ptp180 -155.74 142.22 18.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.055 -0.521 . . . . 2.98 109.948 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.756 0.312 . . . . 3.3799999999999999 110.482 174.689 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 112.834 0.679 . . . . 3.6000000000000001 112.834 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.72 154.26 19.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.9 -1.046 . . . . 2.71 110.025 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 3.2 mppt? -99.41 127.83 45.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.337 -0.616 . . . . 1.8799999999999999 109.337 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -102.53 105.42 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.421 -0.585 . . . . 0.58999999999999997 109.421 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.16 140.98 29.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.253 -0.43 . . . . 2.1600000000000001 110.993 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.2 mt 54.04 44.0 29.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 1.45 111.677 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.587 HG21 ' HD3' ' A' ' 20' ' ' LYS . 9.1 t -55.92 157.3 4.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.78000000000000003 110.817 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 1.16 5.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.81000000000000005 111.19 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -80.11 3.51 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 2.3999999999999999 110.592 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.86 25.41 1.9 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.839 -0.696 . . . . 0.68000000000000005 113.539 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 66.02 68.75 1.55 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.231 -0.509 . . . . 0.60999999999999999 113.941 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.532 HG21 ' HB ' ' A' ' 80' ' ' ILE . 12.8 t -135.87 145.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.898 -0.408 . . . . 0.48999999999999999 109.898 176.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.783 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 8.8 mm -85.49 109.67 18.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.453 -0.573 . . . . 0.46999999999999997 109.453 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.587 ' HD3' HG21 ' A' ' 13' ' ' THR . 4.1 ptmt -125.0 129.13 49.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.232 0.539 . . . . 1.3400000000000001 111.158 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -101.07 114.62 28.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.644 -0.707 . . . . 0.5 109.801 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.505 HD11 ' CG ' ' A' ' 25' ' ' LYS . 10.5 tp -66.16 128.74 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.992 -0.549 . . . . 0.67000000000000004 109.792 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 0.5 OUTLIER -122.57 -78.3 0.6 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.993 0.425 . . . . 0.82999999999999996 110.776 -177.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -124.55 119.03 27.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.753 -0.658 . . . . 1.5600000000000001 109.983 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.591 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 43.7 mtpt -107.09 163.73 12.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.024 0.44 . . . . 2.9500000000000002 110.692 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.3 -124.67 5.24 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.428 -0.806 . . . . 1.3200000000000001 111.3 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -150.99 -86.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.129 0.49 . . . . 2.77 110.439 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -95.65 158.74 15.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.978 -0.556 . . . . 2.6400000000000001 110.526 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.37 53.79 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 111.218 -0.753 . . . . 1.04 111.218 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.43 -40.19 89.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.109 0.48 . . . . 2.29 110.2 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -106.51 27.18 9.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.493 0.663 . . . . 2.6400000000000001 109.802 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.504 ' OD1' ' HE3' ' A' ' 87' ' ' LYS . 36.1 m-80 -130.51 76.47 1.72 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.521 -0.763 . . . . 1.45 109.857 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.6 mm -130.48 120.53 18.89 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.066 -0.516 . . . . 0.81000000000000005 111.131 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.16 131.74 15.73 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.571 2.181 . . . . 0.75 111.52 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HB2' HD22 ' A' ' 38' ' ' ASN . 30.4 mmmt -126.05 142.22 51.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.623 -0.262 . . . . 2.6600000000000001 110.5 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 7.4 ttmm -71.22 138.64 49.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 2.5099999999999998 109.471 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.7 -27.15 13.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.809 -0.71 . . . . 1.1200000000000001 111.408 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.404 HD22 ' HB2' ' A' ' 35' ' ' LYS . 72.9 m-20 -88.88 145.37 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.82 -0.437 . . . . 1.3799999999999999 109.82 174.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 42.8 mt-10 -69.53 98.75 1.17 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.846 -0.615 . . . . 2.2000000000000002 112.126 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 125' ' ' PHE . 22.6 m -116.13 152.23 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 0.67000000000000004 109.828 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.4 m -127.36 131.05 50.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.683 -0.488 . . . . 0.65000000000000002 109.683 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 122' ' ' LEU . 10.7 m -137.12 152.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.276 0.56 . . . . 0.87 112.436 -173.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -105.38 129.44 53.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 2.75 109.58 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 8.7 p90 -134.27 140.13 46.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.854 0.359 . . . . 0.76000000000000001 111.474 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.14 158.6 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.54 -0.911 . . . . 0.48999999999999999 108.54 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -177.39 -126.63 0.99 Allowed Glycine 0 C--O 1.228 -0.227 0 C-N-CA 119.847 -1.168 . . . . 0.35999999999999999 113.019 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.573 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 20.6 pttp -155.45 170.68 21.38 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.575 -0.367 . . . . 1.4299999999999999 111.478 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HG ' ' A' ' 116' ' ' LEU . 66.0 tp -94.1 98.32 10.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.38 109.683 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 117' ' ' LEU . 2.4 tp10 -69.19 -20.65 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.309 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.543 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 5.5 t -55.31 -27.37 46.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.67000000000000004 111.504 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 t -138.18 9.22 2.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 0.72999999999999998 110.452 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.73 55.61 27.6 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.847 -0.615 . . . . 0.78000000000000003 112.636 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 27.1 mmmt -121.14 118.55 29.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.529 -0.175 . . . . 2.8900000000000001 110.529 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.573 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.5 p -69.6 153.99 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.864 0.364 . . . . 0.58999999999999997 110.973 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 7.7 m-30 -76.73 105.53 7.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.78000000000000003 110.624 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -130.82 85.58 2.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.549 0.69 . . . . 2.1800000000000002 109.81 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.32 156.17 28.29 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.587 -0.894 . . . . 1.24 108.587 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -68.33 -21.32 64.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.177 0.513 . . . . 1.49 110.77 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -94.62 -48.8 5.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 1.8 112.21 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -42.92 82.75 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.984 0.364 . . . . 2.1899999999999999 111.984 -169.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -77.49 -3.52 40.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.016 0.436 . . . . 2.7799999999999998 111.063 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.437 HD22 HG12 ' A' ' 63' ' ' VAL . 7.4 t30 -90.7 -45.73 8.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 1.1000000000000001 109.989 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.437 HG12 HD22 ' A' ' 62' ' ' ASN . 7.2 p -154.87 113.51 2.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 2.0299999999999998 110.52 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.22 171.4 17.85 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.798 2.332 . . . . 1.76 112.197 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -102.4 142.44 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.176 -0.466 . . . . 1.3100000000000001 110.175 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HD3' ' CG2' ' A' ' 41' ' ' THR . 0.0 OUTLIER -119.14 143.65 47.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 1.3600000000000001 108.996 175.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 55.8 p90 -133.44 169.89 16.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.56999999999999995 112.054 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.524 ' HE1' ' HB3' ' A' ' 39' ' ' GLU . 1.5 m-70 -104.96 148.97 26.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.676 -1.147 . . . . 1.98 109.768 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 ' HB ' ' A' ' 82' ' ' VAL . 25.3 tp -73.15 129.99 39.28 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.747 -0.381 . . . . 0.94999999999999996 110.144 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 65.72 31.77 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.929 0.768 . . . . 2.0800000000000001 111.165 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 12.2 pt20 -80.9 12.57 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 1.98 111.114 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.57 48.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.035 -0.602 . . . . 0.71999999999999997 112.828 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HB2' HE21 ' A' ' 71' ' ' GLN . 17.1 mm-40 -87.5 -32.32 19.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.449 . . . . 0.96999999999999997 110.818 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.452 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.0 m -98.52 127.05 51.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.376 0.607 . . . . 0.57999999999999996 110.62 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.645 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.65 -76.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.62 112.27 -175.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.645 ' H ' HG12 ' A' ' 75' ' ' ILE . 4.2 mmpt? -121.15 -57.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.455 . . . . 2.04 112.23 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.16 -52.31 36.66 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.292 0.37 . . . . 0.32000000000000001 113.693 -171.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.63 -43.13 49.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.94 -0.153 . . . . 0.48999999999999999 111.373 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.491 ' HA ' ' CD1' ' A' ' 69' ' ' LEU . 23.2 t70 -51.87 -52.32 50.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.526 0.565 . . . . 1.1399999999999999 112.526 -171.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.532 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.7 mp -61.62 -50.97 78.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.451 . . . . 0.78000000000000003 111.296 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 120' ' ' ILE . 47.6 t -71.21 -27.41 63.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.55000000000000004 111.734 -171.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' HD13 ' A' ' 69' ' ' LEU . 53.7 t -66.24 -40.12 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.281 . . . . 0.83999999999999997 110.873 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 t -78.39 -7.84 57.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 1.4299999999999999 110.05 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.5 m -98.09 19.0 14.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 1.23 110.76 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 6.0 mmt -98.26 -173.53 2.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 2.27 111.726 -176.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 38.1 ttm180 -157.43 163.49 38.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.957 -1.127 . . . . 4.1900000000000004 107.957 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.504 ' HE3' ' OD1' ' A' ' 32' ' ' ASN . 5.3 tppp? -50.85 -40.51 56.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.032 0.382 . . . . 1.9399999999999999 112.032 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -118.96 34.17 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.237 . . . . 1.23 110.563 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 4.3 tt0 -122.7 140.09 53.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.722 -0.391 . . . . 1.6000000000000001 110.781 -175.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.9 tmtp? -145.57 129.18 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 1.1699999999999999 109.977 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 74.4 m -137.58 171.09 14.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.074 0.464 . . . . 1.2 111.687 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 119' ' ' GLU . 58.0 mt -105.83 131.68 52.87 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.502 -0.772 . . . . 1.73 109.983 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 95' ' ' ILE . 7.3 p -112.45 140.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.044 0.449 . . . . 0.73999999999999999 110.994 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.783 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 8.3 mmm180 -99.13 112.81 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.577 . . . . 1.71 110.028 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CD1' HG13 ' A' ' 93' ' ' VAL . 3.2 mp -101.45 107.51 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.52000000000000002 110.137 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 31.4 tt0 -84.51 171.81 12.21 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.856 -0.794 . . . . 1.3700000000000001 108.856 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.6 p -56.4 -38.21 71.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.645 0.259 . . . . 1.0 111.612 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -77.21 -7.85 56.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 1.79 111.434 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.502 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.8 m-30 -97.29 1.96 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.34 -0.225 . . . . 0.75 110.508 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.57 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -134.35 -152.59 6.69 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.94 -0.573 . . . . 0.70999999999999996 111.729 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 1.52 110.746 179.451 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 110.277 -0.268 . . . . 1.52 110.277 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -154.59 66.13 5.06 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 121.025 0.441 . . . . 0.75 110.594 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.71 53.79 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.203 2.602 . . . . 1.5800000000000001 112.972 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.33 63.8 4.09 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.732 -0.746 . . . . 2.0499999999999998 112.045 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 51.73 66.25 1.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.602 0.715 . . . . 2.0299999999999998 110.407 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 49.6 m -144.93 168.45 20.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.328 -0.851 . . . . 1.1399999999999999 110.097 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.86 128.42 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.182 -0.463 . . . . 0.47999999999999998 110.415 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.1 mp -123.07 169.18 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.51000000000000001 110.293 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.16 131.64 37.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.448 -0.575 . . . . 0.69999999999999996 109.448 175.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 95' ' ' ILE . 37.9 m-85 -128.96 144.04 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.381 . . . . 0.42999999999999999 110.95 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.705 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 26.9 mt-10 -74.81 128.03 34.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.727 -0.842 . . . . 1.46 108.727 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 81' ' ' CYS . 25.8 mt -107.17 120.32 58.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.178 -0.675 . . . . 0.47999999999999998 109.178 172.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -127.07 118.07 23.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.482 -0.781 . . . . 1.8799999999999999 110.51 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HA ' HG12 ' A' ' 42' ' ' VAL . 35.8 tp -80.69 113.89 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 1.1200000000000001 109.902 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.94 -13.41 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.716 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.4 m -155.63 137.84 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.985 -0.376 . . . . 1.1899999999999999 109.985 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG12 ' A' ' 40' ' ' VAL . 9.0 p90 -160.81 175.0 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.71999999999999997 110.368 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.6 ptp180 -162.26 147.27 12.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 2.98 110.38 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 120.779 0.323 . . . . 3.3799999999999999 110.279 176.828 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.759 0.314 . . . . 3.6000000000000001 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -121.16 170.81 9.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.013 -0.54 . . . . 2.71 109.897 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 0.0 OUTLIER -90.86 157.24 17.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 1.8799999999999999 110.814 -175.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.44 HG11 ' HB ' ' A' ' 13' ' ' THR . 58.9 t -103.93 115.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.328 -0.619 . . . . 0.58999999999999997 109.328 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -87.92 99.82 12.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.474 -0.33 . . . . 2.1600000000000001 111.259 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' H ' HD13 ' A' ' 19' ' ' ILE . 66.1 mt 52.88 75.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 1.45 111.19 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.44 ' HB ' HG11 ' A' ' 10' ' ' VAL . 4.9 t -59.29 147.2 36.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 0.78000000000000003 110.32 175.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.38 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 0.81000000000000005 111.084 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.15 29.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 2.3999999999999999 111.084 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.35 -5.39 10.15 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.631 -0.795 . . . . 0.68000000000000005 113.933 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.19 71.02 1.09 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.94 -0.648 . . . . 0.60999999999999999 114.043 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.2 t -138.11 145.64 28.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.693 -0.484 . . . . 0.48999999999999999 109.693 173.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.0 mm -85.61 110.72 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.294 -0.412 . . . . 0.46999999999999997 110.802 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.51 147.24 40.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.286 -0.415 . . . . 1.3400000000000001 110.697 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 9' ' ' LYS . 26.4 m -112.98 139.46 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 0.5 110.392 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -80.03 134.97 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.147 -0.479 . . . . 0.67000000000000004 110.355 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.43 -71.16 0.72 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.086 0.47 . . . . 0.82999999999999996 110.503 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -105.47 97.54 7.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.291 -0.633 . . . . 1.5600000000000001 109.291 -177.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -75.21 138.82 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.884 0.373 . . . . 2.9500000000000002 110.855 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.69 135.59 14.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.97 -0.633 . . . . 1.3200000000000001 111.681 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.71 -55.21 37.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 2.77 110.174 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.59 170.27 19.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.39 -0.823 . . . . 2.6400000000000001 109.579 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.83 43.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 1.04 111.369 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.52 -38.0 85.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.949 0.404 . . . . 2.29 111.143 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -94.57 -20.55 19.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.809 -0.632 . . . . 2.6400000000000001 110.509 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 38.8 m-80 -95.3 81.81 3.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.129 -0.487 . . . . 1.45 110.927 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.36 120.56 26.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.81000000000000005 111.377 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.4 Cg_endo -76.49 132.75 13.76 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.204 2.603 . . . . 0.75 111.4 174.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HD3' ' OG ' ' A' ' 83' ' ' SER . 34.3 mmtm -148.78 158.94 44.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.667 0.27 . . . . 2.6600000000000001 111.109 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -55.75 128.47 35.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.961 -0.563 . . . . 2.5099999999999998 110.465 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.75 -26.59 20.65 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.9 -0.591 . . . . 1.1200000000000001 111.793 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -83.63 140.22 32.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.652 -0.499 . . . . 1.3799999999999999 109.652 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -76.91 101.59 6.01 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.325 -0.62 . . . . 2.2000000000000002 109.325 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 125' ' ' PHE . 26.3 m -115.49 133.83 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.781 -0.645 . . . . 0.67000000000000004 111.309 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' HD3' ' A' ' 66' ' ' LYS . 17.4 m -103.26 106.93 17.57 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.5 -0.555 . . . . 0.65000000000000002 109.5 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 m -119.34 141.66 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.551 0.691 . . . . 0.87 112.582 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.42 148.67 25.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.944 -1.025 . . . . 2.75 109.601 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 2.5 p90 -144.24 140.88 29.51 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.226 0.329 . . . . 0.76000000000000001 110.596 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -168.04 160.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.377 -0.601 . . . . 0.48999999999999999 109.377 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 171.32 -137.87 4.6 Favored Glycine 0 C--N 1.329 0.15 0 C-N-CA 119.59 -1.29 . . . . 0.35999999999999999 113.249 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.9 pttp -143.49 171.71 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 1.4299999999999999 110.497 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD22 HG13 ' A' ' 110' ' ' ILE . 42.7 tp -95.0 101.93 13.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.155 -0.475 . . . . 0.38 110.131 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.1 tp10 -61.68 -35.28 77.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 1.96 110.575 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 t -55.21 -32.08 61.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 0.67000000000000004 112.55 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 53' ' ' LYS . 8.8 t -123.35 -4.05 8.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.885 0.374 . . . . 0.72999999999999998 110.96 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.03 26.06 74.59 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.183 -0.532 . . . . 0.78000000000000003 113.189 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HG2' HG23 ' A' ' 51' ' ' THR . 75.4 mmtt -109.18 140.01 43.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.168 0.509 . . . . 2.8900000000000001 110.616 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 p -84.59 159.99 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.883 -0.599 . . . . 0.58999999999999997 110.035 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -74.35 131.5 41.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.116 -0.327 . . . . 0.78000000000000003 110.116 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.57 89.9 1.6 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.313 0.577 . . . . 2.1800000000000002 109.535 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -136.95 168.08 20.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.879 -0.6 . . . . 1.24 111.099 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -62.58 -29.14 70.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.49 111.403 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -92.65 -44.54 8.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.147 0.425 . . . . 1.8 112.147 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -32.45 72.79 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 2.1899999999999999 111.978 -169.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -94.2 -14.07 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.838 -0.345 . . . . 2.7799999999999998 111.21 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.516 HD22 HG13 ' A' ' 63' ' ' VAL . 11.3 t30 -100.32 -44.82 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.358 . . . . 1.1000000000000001 111.467 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG13 HD22 ' A' ' 62' ' ' ASN . 3.5 m -129.31 98.82 22.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.669 0.747 . . . . 2.0299999999999998 111.794 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 63' ' ' VAL . 46.5 Cg_endo -70.98 128.48 14.96 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.206 1.938 . . . . 1.76 111.52 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -95.86 148.29 22.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 1.3100000000000001 110.521 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD3' HG23 ' A' ' 41' ' ' THR . 2.4 pptp? -133.07 143.66 49.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 1.3600000000000001 109.658 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -128.87 -178.72 4.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.56999999999999995 111.548 -173.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.535 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 18.5 m170 -114.04 149.68 35.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.659 . . . . 1.98 110.437 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.75 HD11 ' HA ' ' A' ' 79' ' ' ASP . 22.9 tp -67.37 122.81 18.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.94999999999999996 111.787 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 42.39 72.5 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.222 1.009 . . . . 2.0800000000000001 112.259 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -119.71 19.09 12.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.709 0.766 . . . . 1.98 110.587 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.5 -18.85 46.87 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.276 -0.874 . . . . 0.71999999999999997 112.835 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.83 -50.96 6.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.407 0.622 . . . . 0.96999999999999997 109.617 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -100.16 132.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.604 -0.726 . . . . 0.57999999999999996 110.381 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.501 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.04 -74.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.799 0.666 . . . . 0.62 112.799 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 75' ' ' ILE . 19.8 mtpp -128.82 -40.81 1.51 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.876 -0.515 . . . . 2.04 112.174 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -49.51 52.58 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.824 -0.703 . . . . 0.32000000000000001 112.462 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 82' ' ' VAL . 14.7 m-90 -76.02 -41.09 52.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.626 0.25 . . . . 0.48999999999999999 110.858 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.75 ' HA ' HD11 ' A' ' 69' ' ' LEU . 35.0 t70 -56.02 -53.41 57.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.964 -0.562 . . . . 1.1399999999999999 112.329 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.75 -33.35 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.78000000000000003 110.873 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -69.25 -50.0 51.08 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.805 -0.358 . . . . 0.55000000000000004 110.243 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 69' ' ' LEU . 89.4 t -63.29 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.496 -0.32 . . . . 0.83999999999999997 111.338 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.442 ' OG ' ' HD3' ' A' ' 35' ' ' LYS . 23.3 t -71.69 -8.47 54.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.813 0.34 . . . . 1.4299999999999999 111.456 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 t -114.0 23.05 13.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.112 0.482 . . . . 1.23 110.389 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.576 ' HE1' ' HA ' ' A' ' 90' ' ' LYS . 82.8 mmm -99.45 177.33 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 2.27 111.332 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.58 ' HB2' ' CB ' ' A' ' 89' ' ' GLU . 97.1 mtt180 -141.08 159.4 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 4.1900000000000004 108.417 173.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 63.9 tttm -66.45 -21.68 66.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.093 0.473 . . . . 1.9399999999999999 111.087 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.77 12.13 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 1.23 110.703 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.58 ' CB ' ' HB2' ' A' ' 86' ' ' ARG . 18.2 tt0 -122.64 156.26 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.443 -0.344 . . . . 1.6000000000000001 110.444 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.576 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 75.3 tttt -156.51 134.93 11.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.367 -0.379 . . . . 1.1699999999999999 110.704 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 64.3 m -139.07 171.66 13.99 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.89 0.7 . . . . 1.2 112.89 -173.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.33 125.75 53.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.23 -0.895 . . . . 1.73 110.062 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.492 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 13.9 p -117.73 150.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.896 0.379 . . . . 0.73999999999999999 111.101 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -108.27 115.54 30.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 1.71 110.226 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 118' ' ' PHE . 1.9 mp -87.86 103.8 13.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.163 -0.681 . . . . 0.52000000000000002 109.163 176.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.616 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 22.1 tt0 -86.58 176.12 7.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.047 -0.979 . . . . 1.3700000000000001 109.293 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 20.6 p -49.93 -48.94 51.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.268 0.47 . . . . 1.0 112.268 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.04 -7.83 56.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.307 . . . . 1.79 111.72 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.616 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.4 m-30 -94.68 -9.52 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.57 0.224 . . . . 0.75 110.724 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 -171.74 14.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.044 -0.598 . . . . 0.70999999999999996 111.797 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 1.52 110.835 176.86 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.414 ' CB ' HD13 ' A' ' 110' ' ' ILE . 14.4 m . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.371 0.129 . . . . 1.52 111.013 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.766 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.0 57.07 3.28 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-O 120.646 0.26 . . . . 0.75 111.537 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 55.5 Cg_endo -97.7 59.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.115 2.543 . . . . 1.5800000000000001 112.538 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.6 56.14 4.16 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.729 -0.748 . . . . 2.0499999999999998 112.043 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 67.01 14.14 9.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.322 0.649 . . . . 2.0299999999999998 109.82 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -86.55 159.56 19.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.343 -0.844 . . . . 1.1399999999999999 110.406 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.87 128.07 43.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.017 0.437 . . . . 0.47999999999999998 110.694 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.6 mp -122.36 165.86 15.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.456 . . . . 0.51000000000000001 110.544 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -116.56 113.1 22.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.409 -0.589 . . . . 0.69999999999999996 109.409 176.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 95' ' ' ILE . 13.4 m-85 -111.86 124.69 52.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.374 0.607 . . . . 0.42999999999999999 110.89 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.699 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.0 tm-20 -83.0 120.54 25.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.886 -1.052 . . . . 1.46 109.172 174.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.452 HG21 HG22 ' A' ' 82' ' ' VAL . 48.4 mt -109.34 130.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.223 0.535 . . . . 0.47999999999999998 111.098 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -126.01 121.66 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.347 -0.842 . . . . 1.8799999999999999 110.329 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' A' ' 34' ' ' PRO . 27.7 tp -87.03 89.7 8.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.948 -0.76 . . . . 1.1200000000000001 108.948 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 3.3 pp -91.71 -25.77 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.762 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 m -154.13 142.26 20.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.758 0.313 . . . . 1.1899999999999999 110.546 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.645 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -167.43 179.6 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.245 -0.65 . . . . 0.71999999999999997 109.245 175.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -159.64 158.99 32.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.983 0.421 . . . . 2.98 110.682 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 3.3799999999999999 110.492 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.037 0.446 . . . . 3.6000000000000001 110.807 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.91 142.51 33.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.549 -0.751 . . . . 2.71 109.417 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -82.88 148.63 27.59 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 1.8799999999999999 109.475 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.2 t -101.87 104.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.759 . . . . 0.58999999999999997 108.952 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -91.25 110.37 21.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 2.1600000000000001 110.957 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' H ' HD13 ' A' ' 19' ' ' ILE . 87.0 mt 64.38 67.63 0.57 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.082 -0.963 . . . . 1.45 110.574 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 15' ' ' ASP . 14.7 t -74.45 167.66 21.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.03 -0.532 . . . . 0.78000000000000003 110.696 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -0.82 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.81000000000000005 112.004 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.703 ' OD2' ' HA ' ' A' ' 80' ' ' ILE . 8.4 t70 -79.09 -0.61 32.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.248 0.546 . . . . 2.3999999999999999 110.423 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.16 22.94 2.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.598 -0.811 . . . . 0.68000000000000005 113.69 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 75.68 72.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.091 -0.576 . . . . 0.60999999999999999 114.524 171.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 80' ' ' ILE . 38.8 t -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.937 -0.394 . . . . 0.48999999999999999 109.937 172.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 12' ' ' LEU . 7.7 mm -89.75 112.64 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.46999999999999997 110.845 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' HG22 ' A' ' 93' ' ' VAL . 64.3 pttt -136.96 145.97 44.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 1.3400000000000001 111.382 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -107.95 123.62 48.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.5 110.232 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 91' ' ' CYS . 8.2 tp -83.98 130.95 35.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.67000000000000004 110.997 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD21 ' HG ' ' A' ' 92' ' ' LEU . 2.5 mm? -100.14 -60.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.339 0.59 . . . . 0.82999999999999996 109.733 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -122.26 122.71 39.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 1.5600000000000001 109.659 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -82.28 147.48 28.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.295 -0.412 . . . . 2.9500000000000002 111.38 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.94 144.12 33.19 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.509 -1.036 . . . . 1.3200000000000001 110.509 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.13 -78.14 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.275 0.538 . . . . 2.77 109.62 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.58 164.83 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.218 -0.66 . . . . 2.6400000000000001 109.218 171.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 86' ' ' ARG . . . 157.24 70.35 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.957 -1.115 . . . . 1.04 113.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -75.36 -30.89 60.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.42 0.629 . . . . 2.29 110.14 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -86.39 -39.0 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.389 -0.823 . . . . 2.6400000000000001 111.419 -174.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.772 ' HB2' HH21 ' A' ' 86' ' ' ARG . 10.6 m120 -93.66 79.54 4.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.186 0.517 . . . . 1.45 111.096 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.09 125.63 21.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.073 -0.967 . . . . 0.81000000000000005 110.338 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.5 ' HG3' HD22 ' A' ' 122' ' ' LEU . 67.5 Cg_endo -73.57 140.39 29.7 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.908 2.405 . . . . 0.75 111.542 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 14.2 mmmm -127.41 147.68 50.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.426 -0.583 . . . . 2.6600000000000001 109.426 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.628 ' HA ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.31 149.14 48.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.774 -0.371 . . . . 2.5099999999999998 111.242 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.89 -17.29 53.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.836 -0.697 . . . . 1.1200000000000001 111.966 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.535 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 81.5 m-20 -85.68 175.89 8.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 1.3799999999999999 111.083 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -97.48 121.57 39.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.534 -0.757 . . . . 2.2000000000000002 109.747 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG11 HD23 ' A' ' 69' ' ' LEU . 6.9 m -140.99 166.64 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.767 0.318 . . . . 0.67000000000000004 110.446 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.547 HG23 ' HD3' ' A' ' 66' ' ' LYS . 21.0 m -133.97 116.94 16.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.65000000000000002 110.408 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 122' ' ' LEU . 34.9 m -134.87 145.25 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.437 -0.347 . . . . 0.87 110.687 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -100.84 140.52 35.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.415 -0.587 . . . . 2.75 109.415 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 42.6 p90 -125.75 135.47 52.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 111.397 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.87 155.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.391 -0.966 . . . . 0.48999999999999999 108.391 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 178.61 -130.03 1.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.744 -1.217 . . . . 0.35999999999999999 113.27 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 57.2 pttt -147.06 171.32 15.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 1.4299999999999999 110.313 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 110' ' ' ILE . 61.7 tp -96.73 98.39 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.38 109.914 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.736 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.3 tp10 -68.65 -22.41 64.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.248 0.546 . . . . 1.96 110.547 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -25.43 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.389 -0.823 . . . . 0.67000000000000004 111.407 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.616 HG23 ' HD3' ' A' ' 53' ' ' LYS . 7.9 t -132.97 -19.31 2.27 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.986 0.422 . . . . 0.72999999999999998 111.072 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 53' ' ' LYS . . . 91.6 34.82 7.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.28 -0.486 . . . . 0.78000000000000003 112.853 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HD3' HG23 ' A' ' 51' ' ' THR . 13.7 mptt -116.97 134.93 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.75 0.309 . . . . 2.8900000000000001 110.989 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.564 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.1 p -79.31 156.39 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.935 -0.575 . . . . 0.58999999999999997 110.838 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -74.25 131.15 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.78000000000000003 111.04 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.01 89.13 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.833 -0.621 . . . . 2.1800000000000002 109.882 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.2 m -124.99 147.03 49.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.533 -0.758 . . . . 1.24 110.094 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 m -59.24 -20.4 53.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.987 -0.551 . . . . 1.49 111.127 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -92.3 -50.85 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.171 -0.468 . . . . 1.8 111.901 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -32.4 72.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.936 0.347 . . . . 2.1899999999999999 111.936 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -83.4 1.83 39.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.346 0.593 . . . . 2.7799999999999998 110.26 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.463 HD22 HG12 ' A' ' 63' ' ' VAL . 10.3 t30 -109.23 -48.64 3.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.37 -0.832 . . . . 1.1000000000000001 110.448 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 HD22 ' A' ' 62' ' ' ASN . 7.6 p -152.13 126.15 4.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.036 0.446 . . . . 2.0299999999999998 111.085 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.53 162.06 19.4 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.78 2.32 . . . . 1.76 112.327 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -104.09 154.83 19.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.752 -0.462 . . . . 1.3100000000000001 109.752 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.15 136.12 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 1.3600000000000001 110.692 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -114.44 -174.23 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.553 -0.294 . . . . 0.56999999999999995 110.518 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.55 ' HB2' HE21 ' A' ' 71' ' ' GLN . 80.4 m-70 -126.45 153.05 45.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.269 -0.271 . . . . 1.98 110.269 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -51.34 151.93 2.74 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.457 0.473 . . . . 0.94999999999999996 111.659 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -22.2 98.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 113.318 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.55 HE21 ' HB2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -129.8 8.07 5.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.508 -1.224 . . . . 1.98 108.98 176.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.13 -10.45 43.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.71999999999999997 113.409 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -85.23 -46.56 10.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.804 0.802 . . . . 0.96999999999999997 109.248 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.55 134.06 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.031 -0.531 . . . . 0.57999999999999996 110.575 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.662 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.6 -69.83 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.461 0.541 . . . . 0.62 112.461 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.58 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -140.96 -45.66 0.39 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.563 0.579 . . . . 2.04 112.563 -173.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 99' ' ' TYR . . . -52.83 -53.12 34.79 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.944 -0.646 . . . . 0.32000000000000001 113.005 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.514 ' O ' HG22 ' A' ' 82' ' ' VAL . 18.3 m-90 -76.69 -31.01 56.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 0.48999999999999999 110.75 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -57.92 -49.14 77.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.46 -0.791 . . . . 1.1399999999999999 111.759 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.703 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . 1.6 mp -59.69 -31.32 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.124 0.487 . . . . 0.78000000000000003 111.051 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.767 ' HB2' HG21 ' A' ' 93' ' ' VAL . 14.9 t -77.05 -58.05 3.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.334 -0.546 . . . . 0.55000000000000004 110.713 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.67 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 15.5 m -62.13 -33.54 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.791 0.664 . . . . 0.83999999999999997 112.791 -170.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t -92.12 5.66 49.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.079 0.466 . . . . 1.4299999999999999 110.974 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 32.0 t -137.73 30.09 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.228 0.537 . . . . 1.23 110.083 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.67 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 45.3 mtm -106.59 -172.12 2.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 2.27 110.373 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.772 HH21 ' HB2' ' A' ' 32' ' ' ASN . 14.5 mtp-105 -138.73 170.74 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.515 . . . . 4.1900000000000004 110.212 171.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -64.12 -20.57 66.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.282 -0.417 . . . . 1.9399999999999999 111.621 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -127.05 16.57 7.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.36 -0.382 . . . . 1.23 111.106 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 2.1 tm-20 -110.38 153.72 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -158.86 123.33 4.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.691 -0.231 . . . . 1.1699999999999999 110.551 -173.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 1.6 p -136.53 159.05 42.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.437 -0.347 . . . . 1.2 111.421 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 23' ' ' LEU . 97.9 mt -105.2 127.17 52.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.12 -0.491 . . . . 1.73 110.852 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 81' ' ' CYS . 39.1 t -105.74 151.08 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.968 -0.56 . . . . 0.73999999999999999 111.015 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.36 112.17 25.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.445 -0.576 . . . . 1.71 109.445 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.4 mp -90.3 105.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.52000000000000002 110.43 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 97' ' ' SER . 34.0 tt0 -82.29 166.09 19.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 1.3700000000000001 109.12 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 3.6 p -52.99 -42.94 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.565 0.58 . . . . 1.0 112.565 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -76.99 -7.91 56.46 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.882 -0.327 . . . . 1.79 111.5 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.402 ' HB3' ' CA ' ' A' ' 77' ' ' GLY . 22.0 m-30 -89.03 -1.48 58.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.017 0.437 . . . . 0.75 110.196 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.662 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -146.3 -165.42 11.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.681 -0.69 . . . . 0.70999999999999996 111.411 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 117.304 0.552 . . . . 1.52 110.336 179.009 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.403 ' CB ' HD13 ' A' ' 110' ' ' ILE . 13.6 m . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.405 0.145 . . . . 1.52 111.241 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.556 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.04 81.82 10.33 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 121.15 0.5 . . . . 0.75 111.432 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -102.7 -149.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.303 3.335 . . . . 1.5800000000000001 111.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.31 73.31 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.838 -0.696 . . . . 2.0499999999999998 112.288 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 15.6 m120 56.73 23.61 8.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.118 0.485 . . . . 2.0299999999999998 111.188 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 m -114.0 151.59 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.96 -0.564 . . . . 1.1399999999999999 109.594 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.13 132.63 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.599 . . . . 0.47999999999999998 111.295 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -125.02 165.29 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.51000000000000001 109.999 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -124.83 124.74 42.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.178 -0.675 . . . . 0.69999999999999996 109.178 173.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.67 143.24 47.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.74 -0.209 . . . . 0.42999999999999999 110.553 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 38.5 mt-10 -62.63 136.49 57.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.738 -0.467 . . . . 1.46 109.738 168.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 ' SD ' ' A' ' 85' ' ' MET . 22.3 mt -128.09 116.85 44.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.229 -1.026 . . . . 0.47999999999999998 108.229 169.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -135.17 111.47 9.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.692 -0.685 . . . . 1.8799999999999999 110.535 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.688 ' HA ' HG12 ' A' ' 42' ' ' VAL . 23.0 tp -81.47 100.09 9.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.361 -0.381 . . . . 1.1200000000000001 110.788 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -104.81 -9.45 18.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.868 0.366 . . . . 1.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 67.5 m -155.28 139.52 16.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 1.1899999999999999 110.524 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.504 ' HB3' HD11 ' A' ' 122' ' ' LEU . 7.8 p90 -165.74 150.29 8.44 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.29 0.369 . . . . 0.71999999999999997 110.222 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.489 ' HE ' ' HB3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -146.24 127.33 14.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.943 0.401 . . . . 2.98 110.922 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.511 -0.768 . . . . 3.3799999999999999 111.178 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.03 0.443 . . . . 3.6000000000000001 111.158 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -81.63 151.61 27.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.675 -0.693 . . . . 2.71 109.145 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.58 145.84 25.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.79 0.329 . . . . 1.8799999999999999 110.274 -177.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 13' ' ' THR . 21.8 t -101.97 103.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.965 -1.124 . . . . 0.58999999999999997 107.965 170.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.558 ' HG2' HG23 ' A' ' 19' ' ' ILE . 45.9 mt-10 -102.47 120.84 41.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.714 . . . . 2.1600000000000001 110.622 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.9 tp 65.54 50.93 1.58 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.241 -0.89 . . . . 1.45 109.436 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.498 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.9 t -62.97 159.46 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.78000000000000003 111.617 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 2.11 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 0.81000000000000005 111.436 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.6 ' O ' HG13 ' A' ' 80' ' ' ILE . 40.3 m-20 -83.61 7.79 16.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.172 -0.467 . . . . 2.3999999999999999 111.367 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.36 22.6 2.29 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.394 -0.908 . . . . 0.68000000000000005 113.555 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.89 62.7 4.32 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.293 -0.48 . . . . 0.60999999999999999 114.083 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.475 ' HB ' HG21 ' A' ' 80' ' ' ILE . 39.4 t -137.62 152.77 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.081 0.44 . . . . 0.48999999999999999 110.224 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.558 HG23 ' HG2' ' A' ' 11' ' ' GLU . 18.1 mm -85.36 109.7 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.474 -0.565 . . . . 0.46999999999999997 109.474 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -118.99 130.45 55.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 110.65 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 m -109.94 117.69 34.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.097 -0.502 . . . . 0.5 110.703 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.509 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.2 tp -74.77 131.71 34.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.67000000000000004 111.356 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 2.6 mm? -120.76 -81.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.82999999999999996 111.362 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -89.44 134.3 34.15 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.928 0.394 . . . . 1.5600000000000001 110.309 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 41.3 mtmt -111.34 113.18 25.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.779 -0.646 . . . . 2.9500000000000002 110.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.526 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -73.71 -151.74 2.08 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.219 -0.515 . . . . 1.3200000000000001 111.89 174.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.47 -97.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.104 -0.645 . . . . 2.77 111.725 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.72 126.45 36.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.46 0.647 . . . . 2.6400000000000001 110.934 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -140.51 47.79 0.86 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.582 -0.818 . . . . 1.04 112.611 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.15 -42.11 99.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 2.29 109.945 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.25 28.2 8.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.977 -1.01 . . . . 2.6400000000000001 109.4 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.403 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -135.79 76.87 1.63 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.45 110.89 -179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG22 ' HD3' ' A' ' 35' ' ' LYS . 30.8 mm -141.94 116.28 6.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 123.265 0.353 . . . . 0.81000000000000005 111.274 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 28.1 Cg_endo -63.41 138.69 67.03 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.058 2.505 . . . . 0.75 111.065 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HD3' HG22 ' A' ' 33' ' ' ILE . 6.0 mmmm -126.54 155.07 42.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.106 0.479 . . . . 2.6600000000000001 111.713 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -70.38 117.54 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.17 -0.923 . . . . 2.5099999999999998 110.291 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.81 -26.88 22.82 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.99 -0.624 . . . . 1.1200000000000001 111.923 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.69 154.19 42.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 1.3799999999999999 110.179 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 40.8 mt-10 -76.99 99.9 5.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.113 0.482 . . . . 2.2000000000000002 110.822 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.659 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.3 m -118.64 143.61 29.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.335 -0.617 . . . . 0.67000000000000004 109.335 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.7 m -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.267 -0.642 . . . . 0.65000000000000002 109.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.38 139.35 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.334 0.587 . . . . 0.87 111.839 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -104.39 134.88 46.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 2.75 110.39 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -123.87 136.82 54.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.76000000000000001 110.464 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.45 153.23 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.488 -0.93 . . . . 0.48999999999999999 108.488 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.93 -124.44 0.91 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.775 -1.202 . . . . 0.35999999999999999 113.231 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.7 pttp -157.61 170.12 23.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 1.4299999999999999 111.0 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 69.8 tp -97.26 103.18 15.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.506 -0.77 . . . . 0.38 110.145 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.854 ' HB2' HD11 ' A' ' 117' ' ' LEU . 6.5 tp10 -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.873 0.368 . . . . 1.96 110.151 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 115' ' ' VAL . 8.3 t -55.4 -28.92 57.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 0.67000000000000004 112.089 -174.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 t -140.26 14.55 2.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.285 0.564 . . . . 0.72999999999999998 110.486 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.9 44.33 96.13 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.336 -0.847 . . . . 0.78000000000000003 113.065 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 12.2 mmmt -105.98 126.03 51.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.278 -0.267 . . . . 2.8900000000000001 110.278 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.1 p -83.99 159.48 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.509 -0.552 . . . . 0.58999999999999997 109.509 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -75.04 102.94 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 0.78000000000000003 110.984 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -125.58 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.604 0.716 . . . . 2.1800000000000002 109.835 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.8 m -126.11 169.22 13.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.959 -0.564 . . . . 1.24 110.536 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -71.44 -26.31 62.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.088 0.47 . . . . 1.49 110.818 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.2 -44.77 7.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.923 -0.58 . . . . 1.8 112.371 -170.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -44.82 80.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.989 0.366 . . . . 2.1899999999999999 111.989 -169.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -77.1 -9.17 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.423 . . . . 2.7799999999999998 110.938 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -96.13 -61.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.018 -0.537 . . . . 1.1000000000000001 109.978 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.23 109.77 7.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.446 0.641 . . . . 2.0299999999999998 110.474 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.07 158.18 38.08 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.58 2.187 . . . . 1.76 112.543 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.56 154.07 19.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 1.3100000000000001 109.775 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -129.91 159.54 36.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 1.3600000000000001 109.999 178.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.69 173.35 11.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.56999999999999995 111.066 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -116.01 140.17 49.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.408 -0.815 . . . . 1.98 109.609 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 82' ' ' VAL . 26.4 tp -69.1 131.91 45.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.232 -0.284 . . . . 0.94999999999999996 110.232 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.56 79.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.92 0.867 . . . . 2.0800000000000001 109.232 -169.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.531 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 28.4 tt0 -131.64 -3.6 3.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.341 -1.3 . . . . 1.98 110.211 -174.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.6 -18.53 24.48 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.998 -0.62 . . . . 0.71999999999999997 112.353 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 2.1 mm-40 -93.64 -11.39 31.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.96999999999999997 109.954 -177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.17 124.48 64.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.57999999999999996 109.702 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.1 -61.45 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.62 112.925 -176.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 mmpt? -138.11 -48.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 2.04 111.881 -173.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.08 -50.72 44.29 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.037 -0.601 . . . . 0.32000000000000001 113.12 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.12 -41.16 59.06 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.807 -0.231 . . . . 0.48999999999999999 110.433 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.63 -51.57 54.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.607 -0.724 . . . . 1.1399999999999999 112.041 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.7 mp -63.04 -42.97 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.78000000000000003 111.52 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.558 ' HB3' HD12 ' A' ' 120' ' ' ILE . 49.3 t -75.32 -42.34 54.75 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.848 0.314 . . . . 0.55000000000000004 111.848 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 69' ' ' LEU . 35.4 m -69.15 -34.41 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.779 0.288 . . . . 0.83999999999999997 111.779 -175.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 p -72.03 -16.44 62.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 110.814 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.7 m -97.57 8.26 44.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.981 -0.554 . . . . 1.23 110.928 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 20.1 mmt -93.94 -173.65 3.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 2.27 111.495 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 33.6 mtp-105 -143.2 -171.27 3.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.349 -0.841 . . . . 4.1900000000000004 109.002 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.42 -24.63 67.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.299 0.374 . . . . 1.9399999999999999 111.992 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -135.39 15.28 3.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 1.23 111.309 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -79.87 159.94 26.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.889 0.376 . . . . 1.6000000000000001 110.683 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -158.36 132.45 7.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.089 -0.505 . . . . 1.1699999999999999 110.354 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 99.9 m -150.7 170.93 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 1.2 110.816 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.34 124.95 52.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.54 . . . . 1.73 110.237 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 95' ' ' ILE . 6.3 p -100.76 146.22 9.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.15 -0.477 . . . . 0.73999999999999999 110.264 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.541 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 12.3 mmt180 -98.63 112.06 24.23 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.177 -0.675 . . . . 1.71 109.177 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.628 HD11 HG13 ' A' ' 93' ' ' VAL . 4.1 mp -98.04 103.87 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.52000000000000002 110.447 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.557 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 27.6 tt0 -86.49 170.73 11.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.336 -0.987 . . . . 1.3700000000000001 108.336 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.9 p -51.69 -38.32 54.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.826 0.306 . . . . 1.0 111.826 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -77.71 -8.72 58.35 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.042 0.386 . . . . 1.79 112.042 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.557 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 20.6 m-85 -102.62 -16.36 16.09 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.752 0.31 . . . . 0.75 110.607 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.36 -163.01 12.45 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.252 -0.739 . . . . 0.70999999999999996 111.252 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.52 110.992 177.285 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.405 ' CB ' HD13 ' A' ' 110' ' ' ILE . 5.9 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 111.426 0.158 . . . . 1.52 111.426 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.405 HD13 ' CB ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -147.45 96.75 4.13 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.059 0.457 . . . . 0.75 111.45 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -91.5 -164.1 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.833 2.355 . . . . 1.5800000000000001 111.888 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 121.7 50.26 0.25 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.382 -0.913 . . . . 2.0499999999999998 113.285 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.7 m120 62.8 17.21 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.068 0.461 . . . . 2.0299999999999998 111.336 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.3 p -94.83 175.68 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.833 -0.621 . . . . 1.1399999999999999 111.339 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.484 ' H ' ' HB2' ' A' ' 50' ' ' SER . 6.3 p -114.7 127.49 72.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 116.136 -0.483 . . . . 0.47999999999999998 110.203 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.9 mp -120.97 169.7 10.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.007 -0.542 . . . . 0.51000000000000001 111.054 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.854 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -128.95 126.28 39.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.084 -0.71 . . . . 0.69999999999999996 109.084 175.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -118.8 123.96 46.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.075 0.464 . . . . 0.42999999999999999 111.151 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.86 119.44 16.04 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.186 -1.042 . . . . 1.46 108.186 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 81' ' ' CYS . 42.2 mt -106.41 116.14 49.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 0.47999999999999998 109.5 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -126.94 119.3 26.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.779 -1.1 . . . . 1.8799999999999999 109.466 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 tt -90.88 117.14 29.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.804 -0.635 . . . . 1.1200000000000001 109.731 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.39 -23.81 15.02 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.668 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -164.05 153.45 14.11 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.004 0.431 . . . . 1.1899999999999999 110.564 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.659 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -161.83 178.72 8.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.652 -0.704 . . . . 0.71999999999999997 109.618 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 39' ' ' GLU . 14.0 ptm180 -150.93 137.9 19.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 2.98 110.053 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 3.3799999999999999 110.556 179.189 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.056 0.455 . . . . 3.6000000000000001 111.3 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.86 144.12 32.23 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.876 -0.787 . . . . 2.71 108.876 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.15 139.07 35.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.219 -0.66 . . . . 1.8799999999999999 109.219 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.625 HG12 ' HB ' ' A' ' 13' ' ' THR . 32.9 t -100.99 104.43 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.528 -0.545 . . . . 0.58999999999999997 109.528 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -102.64 134.91 45.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.939 -0.573 . . . . 2.1600000000000001 111.566 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.856 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 81.8 mt 52.25 51.89 15.38 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.511 -0.768 . . . . 1.45 111.332 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.625 ' HB ' HG12 ' A' ' 10' ' ' VAL . 15.4 t -70.68 168.36 16.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.78000000000000003 110.521 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.35 -12.56 61.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.837 0.68 . . . . 0.81000000000000005 112.837 -170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 80' ' ' ILE . 3.3 t70 -89.57 14.02 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.717 -0.393 . . . . 2.3999999999999999 111.638 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.44 29.93 1.04 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.589 -0.815 . . . . 0.68000000000000005 114.119 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.856 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 60.01 33.29 78.46 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.881 1.112 . . . . 0.60999999999999999 115.881 166.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 30.6 t -104.06 142.48 17.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 117.886 0.843 . . . . 0.48999999999999999 110.727 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 2.3 mm -88.57 116.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.46999999999999997 110.013 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HE2' ' HB3' ' A' ' 84' ' ' SER . 21.4 pttp -138.75 136.02 35.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 1.3400000000000001 111.021 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 m -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.163 -0.926 . . . . 0.5 109.923 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tp -88.7 127.62 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.087 0.47 . . . . 0.67000000000000004 110.811 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -116.26 -52.13 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.427 0.632 . . . . 0.82999999999999996 110.499 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' CB ' ' A' ' 90' ' ' LYS . 29.6 ttpt -119.07 121.91 40.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.63 -0.714 . . . . 1.5600000000000001 110.047 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -99.98 126.19 46.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.392 -0.367 . . . . 2.9500000000000002 111.14 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 155.64 32.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.972 -0.633 . . . . 1.3200000000000001 111.743 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.4 -81.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.646 0.26 . . . . 2.77 111.171 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.11 150.08 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 2.6400000000000001 110.426 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -156.68 51.05 0.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.308 -0.948 . . . . 1.04 112.854 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.3 -42.23 55.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.584 0.707 . . . . 2.29 109.299 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 -16.59 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 2.6400000000000001 110.562 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 19.3 m-80 -85.48 76.04 10.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.232 -0.44 . . . . 1.45 110.537 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 33.3 mm -140.87 119.7 8.27 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.857 -0.61 . . . . 0.81000000000000005 109.863 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 1.5 Cg_endo -82.15 111.05 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.75 111.638 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -118.06 152.24 35.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.472 -0.566 . . . . 2.6600000000000001 109.472 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 148.97 46.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.977 0.418 . . . . 2.5099999999999998 110.278 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.91 -9.78 65.94 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.887 -0.885 . . . . 1.1200000000000001 110.887 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 95.5 m-20 -107.49 159.42 16.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.856 -0.672 . . . . 1.3799999999999999 109.511 174.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 102.32 14.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.497 -0.557 . . . . 2.2000000000000002 109.497 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -116.19 145.03 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.693 -0.685 . . . . 0.67000000000000004 109.579 175.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 108.63 13.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.047 -0.524 . . . . 0.65000000000000002 110.263 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 122' ' ' LEU . 18.5 m -131.36 153.3 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.527 -0.306 . . . . 0.87 111.544 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 36.7 m170 -105.24 162.51 13.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 2.75 110.337 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 12.7 p90 -145.58 129.44 17.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.76000000000000001 110.028 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -167.02 153.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.85 -0.426 . . . . 0.48999999999999999 109.85 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 55' ' ' PHE . . . 176.3 -111.57 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.717 -1.23 . . . . 0.35999999999999999 112.968 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG3' HD12 ' A' ' 117' ' ' LEU . 51.7 pttt -157.23 166.95 31.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.987 0.423 . . . . 1.4299999999999999 110.882 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.2 tp -92.56 102.07 14.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.963 -0.562 . . . . 0.38 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 3.6 tp10 -58.71 -30.47 67.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.616 -0.72 . . . . 1.96 111.039 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -55.88 -32.43 63.69 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.563 -0.744 . . . . 0.67000000000000004 112.264 -173.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 53' ' ' LYS . 13.6 t -140.21 5.52 2.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.445 -0.502 . . . . 0.72999999999999998 111.983 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.83 46.63 59.62 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 121.098 -0.572 . . . . 0.78000000000000003 112.394 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HB2' HG23 ' A' ' 51' ' ' THR . 2.0 tmtp? -115.14 126.36 54.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.652 -0.499 . . . . 2.8900000000000001 109.652 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.07 153.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.454 -0.339 . . . . 0.58999999999999997 110.196 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 0.8 OUTLIER -74.45 106.4 6.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.403 . . . . 0.78000000000000003 110.722 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -121.7 103.57 8.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.87 0.843 . . . . 2.1800000000000002 110.324 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 34.8 m -136.81 150.53 48.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.119 -0.491 . . . . 1.24 110.004 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.4 m -62.6 -36.09 81.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 1.49 111.174 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.21 -33.9 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.348 -0.387 . . . . 1.8 110.887 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 6.9 t70 -56.99 -52.48 65.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.934 0.397 . . . . 2.1899999999999999 111.993 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -77.25 2.6 15.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.368 -0.378 . . . . 2.7799999999999998 111.44 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -111.5 -52.85 2.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.42 -0.355 . . . . 1.1000000000000001 110.845 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.7 p -133.04 117.18 14.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.197 0.522 . . . . 2.0299999999999998 111.167 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.4 Cg_exo -77.03 146.08 25.37 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.041 2.494 . . . . 1.76 111.459 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -103.82 151.09 23.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.464 -0.335 . . . . 1.3100000000000001 110.251 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.525 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 1.7 pptp? -128.93 154.19 46.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.529 -0.305 . . . . 1.3600000000000001 110.911 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -137.21 174.49 10.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.524 -0.307 . . . . 0.56999999999999995 111.156 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.84 150.21 33.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.076 -0.712 . . . . 1.98 109.076 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.757 HD13 HG23 ' A' ' 82' ' ' VAL . 16.8 tp -70.6 124.66 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.475 0.546 . . . . 0.94999999999999996 112.475 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER 42.4 63.29 1.44 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.388 -1.278 . . . . 2.0800000000000001 112.335 173.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -108.55 9.28 27.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.71 -1.132 . . . . 1.98 108.751 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.6 -16.38 48.06 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.971 -1.013 . . . . 0.71999999999999997 113.084 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -85.48 -39.43 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.457 0.629 . . . . 0.96999999999999997 110.501 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 m -97.9 135.41 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.389 -0.597 . . . . 0.57999999999999996 109.389 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.764 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -94.55 -76.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.382 0.512 . . . . 0.62 112.382 -172.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.764 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.25 -37.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.873 -0.517 . . . . 2.04 112.315 -175.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.61 -54.29 31.17 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.449 -0.881 . . . . 0.32000000000000001 113.153 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.626 ' O ' HG22 ' A' ' 82' ' ' VAL . 23.3 m-90 -76.67 -31.52 57.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.736 -0.273 . . . . 0.48999999999999999 110.708 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -51.49 -53.35 38.32 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.019 0.824 . . . . 1.1399999999999999 111.843 -170.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 2.0 mp -68.77 -29.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 111.275 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.627 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 19.9 t -72.55 -38.23 68.05 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.603 -0.439 . . . . 0.55000000000000004 110.514 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 HD13 ' A' ' 69' ' ' LEU . 2.1 m -83.86 -33.95 9.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.791 -0.364 . . . . 0.83999999999999997 111.498 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -65.66 -25.57 67.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.157 0.503 . . . . 1.4299999999999999 110.63 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.558 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 22.0 t -121.92 44.97 2.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.777 -0.647 . . . . 1.23 110.489 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 82' ' ' VAL . 19.8 ptm -124.68 -175.89 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.989 -0.551 . . . . 2.27 109.688 173.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 64.3 mtt85 -142.95 162.86 34.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.123 -0.695 . . . . 4.1900000000000004 109.123 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HG3' HD22 ' A' ' 122' ' ' LEU . 85.6 tttt -61.31 -43.06 99.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 1.9399999999999999 111.364 -175.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -97.29 24.7 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 1.23 110.709 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 37.5 tt0 -114.87 163.68 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.037 -0.727 . . . . 1.6000000000000001 109.037 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 76.1 tttt -157.54 127.56 6.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.926 0.393 . . . . 1.1699999999999999 110.439 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.1 p -134.7 148.11 50.24 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.785 -0.643 . . . . 1.2 111.01 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.73 122.02 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 1.73 109.357 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.627 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.4 p -100.65 143.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.159 0.504 . . . . 0.73999999999999999 111.427 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 18.3 mmt180 -106.2 112.15 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.438 -0.801 . . . . 1.71 109.441 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 3.9 mp -93.96 100.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.828 -0.349 . . . . 0.52000000000000002 110.111 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.493 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 9.6 tp10 -70.07 156.72 38.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 1.3700000000000001 109.183 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 p -50.12 -44.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.06 0.544 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.42 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 24.1 ptp -74.76 -8.09 55.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 1.79 111.721 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 96' ' ' GLU . 21.8 m-30 -100.05 8.62 43.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.626 0.25 . . . . 0.75 110.426 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.613 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -139.09 -176.28 14.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.21 -0.519 . . . . 0.70999999999999996 112.201 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 121.14 0.495 . . . . 1.52 111.077 179.02 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.76 0.281 . . . . 1.52 111.76 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 89.99 3.36 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-O 121.146 0.498 . . . . 0.75 110.296 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -96.84 -155.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.488 2.792 . . . . 1.5800000000000001 111.663 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.83 31.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.461 -0.876 . . . . 2.0499999999999998 112.85 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.01 41.81 27.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.314 0.578 . . . . 2.0299999999999998 110.553 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 p -122.13 177.05 5.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.5 -0.773 . . . . 1.1399999999999999 110.38 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 5.3 p -93.94 125.47 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.256 0.55 . . . . 0.47999999999999998 110.889 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.83 162.1 15.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.51000000000000001 110.103 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.608 HD12 ' HG3' ' A' ' 47' ' ' LYS . 36.8 mt -119.04 117.47 28.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.69999999999999996 110.228 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -125.81 138.0 53.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.259 0.552 . . . . 0.42999999999999999 112.321 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 50.5 mt-10 -79.16 132.77 36.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.226 -0.897 . . . . 1.46 108.981 167.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 82' ' ' VAL . 19.5 mt -113.17 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.516 0.674 . . . . 0.47999999999999998 110.252 171.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.43 ' OE1' ' HD2' ' A' ' 90' ' ' LYS . 5.1 tp10 -118.75 120.1 36.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 1.8799999999999999 109.597 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.745 ' HA ' HG12 ' A' ' 42' ' ' VAL . 4.9 tt -89.87 102.4 15.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.526 -0.546 . . . . 1.1200000000000001 109.526 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -88.89 -35.63 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.486 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 t -152.26 144.79 24.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.598 -0.274 . . . . 1.1899999999999999 110.755 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.606 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -164.97 171.75 13.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.71999999999999997 109.799 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 14.0 ptp180 -150.07 124.6 9.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.579 -0.282 . . . . 2.98 110.325 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--N 1.326 -0.451 0 N-CA-C 109.871 -0.418 . . . . 3.3799999999999999 109.871 176.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.457 0.646 . . . . 3.6000000000000001 112.504 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.95 153.28 21.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.445 -0.798 . . . . 2.71 109.057 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 6.2 mptt -98.79 144.3 28.17 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.208 -0.664 . . . . 1.8799999999999999 109.208 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.11 112.83 38.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.886 -0.326 . . . . 0.58999999999999997 110.704 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 4.2 pt-20 -86.59 131.05 34.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.224 -0.287 . . . . 2.1600000000000001 110.224 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.9 mt 45.58 59.84 3.41 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.897 0.748 . . . . 1.45 111.869 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 18' ' ' VAL . 7.5 t -59.01 153.75 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.78000000000000003 110.757 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.82 43.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.48 0.548 . . . . 0.81000000000000005 112.48 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.6 t0 -85.39 18.27 2.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.706 0.289 . . . . 2.3999999999999999 111.406 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 2.7 9.22 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.422 -0.894 . . . . 0.68000000000000005 114.41 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 77.59 80.31 0.68 Allowed Glycine 0 C--O 1.224 -0.485 0 C-N-CA 121.021 -0.609 . . . . 0.60999999999999999 114.172 170.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 13' ' ' THR . 11.8 t -142.7 145.04 23.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.696 -0.483 . . . . 0.48999999999999999 109.696 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.68 110.99 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.46999999999999997 110.244 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -136.09 147.12 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 1.3400000000000001 111.281 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.6 m -117.95 144.25 45.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 0.5 110.469 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 25' ' ' LYS . 9.7 tp -93.39 135.3 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.9 0.381 . . . . 0.67000000000000004 111.931 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.51 HD21 ' HG ' ' A' ' 92' ' ' LEU . 3.0 mm? -123.34 -71.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.383 0.611 . . . . 0.82999999999999996 109.369 174.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 2.2 mmmt -104.86 116.19 31.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.331 -0.85 . . . . 1.5600000000000001 109.378 176.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -112.9 150.86 31.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.844 -0.342 . . . . 2.9500000000000002 110.294 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.85 163.25 47.55 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.923 -0.656 . . . . 1.3200000000000001 111.991 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.38 -57.59 2.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.252 0.548 . . . . 2.77 109.752 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -121.12 174.12 6.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.815 . . . . 2.6400000000000001 108.817 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.568 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 126.55 51.88 0.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.546 -0.835 . . . . 1.04 112.296 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.63 -41.29 98.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.809 0.358 . . . . 2.29 111.408 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' C ' HD22 ' A' ' 32' ' ' ASN . 32.5 tt0 -89.07 4.27 48.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.427 0.632 . . . . 2.6400000000000001 110.398 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.631 ' HB2' HH21 ' A' ' 86' ' ' ARG . 0.9 OUTLIER -116.59 78.64 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 1.45 109.617 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.6 mm -134.41 123.85 16.76 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.637 . . . . 0.81000000000000005 110.775 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HG3' HD22 ' A' ' 122' ' ' LEU . 57.2 Cg_endo -70.18 138.45 36.51 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.876 2.384 . . . . 0.75 111.457 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -145.66 156.71 43.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.007 0.432 . . . . 2.6600000000000001 111.871 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 70' ' ' GLU . 1.9 ttmp? -68.56 147.59 51.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.127 -0.942 . . . . 2.5099999999999998 111.111 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 36' ' ' LYS . . . 93.23 -18.48 56.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.56 -1.016 . . . . 1.1200000000000001 110.56 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 3.6 m-20 -99.18 163.38 12.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.778 -0.711 . . . . 1.3799999999999999 109.834 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.58 126.16 35.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 2.2000000000000002 110.529 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 125' ' ' PHE . 21.1 m -131.05 153.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.67000000000000004 109.691 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 29.7 m -113.61 106.07 14.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.374 -0.602 . . . . 0.65000000000000002 109.374 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.48 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.195 0.522 . . . . 0.87 111.341 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -100.34 136.03 40.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.622 -0.717 . . . . 2.75 109.079 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.693 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 47.6 p90 -122.87 144.35 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.76000000000000001 110.364 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -169.08 157.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.416 -0.957 . . . . 0.48999999999999999 108.416 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.91 -126.66 1.13 Allowed Glycine 0 CA--C 1.51 -0.244 0 C-N-CA 119.739 -1.22 . . . . 0.35999999999999999 113.262 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 64.7 pttt -150.98 165.76 32.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.218 0.532 . . . . 1.4299999999999999 111.033 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD12 ' HG ' ' A' ' 116' ' ' LEU . 63.5 tp -83.64 97.42 9.08 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.06 -0.719 . . . . 0.38 109.06 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.594 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 48.4 tp10 -60.93 -25.76 67.0 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.017 -0.538 . . . . 1.96 111.856 -174.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 t -56.19 -27.17 53.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.426 -0.352 . . . . 0.67000000000000004 111.38 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.661 HG23 ' HD3' ' A' ' 53' ' ' LYS . 10.1 t -134.9 -13.93 2.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.835 0.35 . . . . 0.72999999999999998 111.571 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.54 28.7 34.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.159 -0.543 . . . . 0.78000000000000003 112.957 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.661 ' HD3' HG23 ' A' ' 51' ' ' THR . 13.9 mptt -100.42 122.57 43.37 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.604 -0.351 . . . . 2.8900000000000001 110.577 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 8.6 p -73.98 160.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 110.407 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.403 ' CE1' HD11 ' A' ' 110' ' ' ILE . 22.6 m-30 -74.77 147.86 40.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 0.78000000000000003 111.392 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -159.1 89.91 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.254 -0.885 . . . . 2.1800000000000002 108.939 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -136.72 -177.14 4.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 1.24 110.815 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -71.56 -38.63 70.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.973 -0.558 . . . . 1.49 111.425 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.86 -36.96 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.211 0.819 . . . . 1.8 113.211 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -59.97 -33.01 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.878 0.325 . . . . 2.1899999999999999 111.878 -169.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -104.4 -0.94 27.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.282 0.475 . . . . 2.7799999999999998 112.282 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.555 HD22 HG23 ' A' ' 63' ' ' VAL . 20.4 t30 -114.19 -45.79 3.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.302 -0.559 . . . . 1.1000000000000001 111.576 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.555 HG23 HD22 ' A' ' 62' ' ' ASN . 95.2 t -132.08 97.81 17.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.918 0.39 . . . . 2.0299999999999998 110.05 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.29 141.73 43.81 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.988 2.459 . . . . 1.76 112.599 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.58 146.55 25.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 1.3100000000000001 110.008 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -144.21 153.71 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.981 -0.377 . . . . 1.3600000000000001 109.981 177.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -133.99 175.07 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.56999999999999995 111.152 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -104.58 148.28 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.942 -0.762 . . . . 1.98 108.942 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.605 HD22 HG23 ' A' ' 82' ' ' VAL . 11.3 tp -69.4 119.47 13.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.034 0.445 . . . . 0.94999999999999996 110.584 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 57.55 66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.654 -1.157 . . . . 2.0800000000000001 110.646 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.01 17.78 23.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.947 -1.024 . . . . 1.98 109.063 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.04 -18.03 38.37 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.71999999999999997 112.479 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.86 -23.31 22.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.96999999999999997 110.984 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.8 126.24 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.57999999999999996 110.353 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.641 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -95.75 -58.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.62 113.437 -172.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.66 -48.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 2.04 112.644 -170.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -52.4 38.13 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.917 -0.659 . . . . 0.32000000000000001 113.131 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.5 ' O ' HG22 ' A' ' 82' ' ' VAL . 9.0 m-90 -76.01 -32.22 59.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.672 0.273 . . . . 0.48999999999999999 110.702 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -53.86 -51.93 62.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.45 -0.795 . . . . 1.1399999999999999 112.179 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -69.29 -43.84 80.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 0.78000000000000003 110.82 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.8 t -62.21 -50.06 73.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.53 -0.304 . . . . 0.55000000000000004 111.009 -175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG23 HD22 ' A' ' 69' ' ' LEU . 33.9 m -66.09 -32.81 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.652 0.263 . . . . 0.83999999999999997 110.911 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 t -66.05 -40.12 90.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.931 0.396 . . . . 1.4299999999999999 110.131 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 m -89.69 36.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.579 . . . . 1.23 111.08 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.967 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 4.4 mmt -112.81 -175.25 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 2.27 110.468 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.631 HH21 ' HB2' ' A' ' 32' ' ' ASN . 8.3 mtp-105 -149.87 175.4 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 4.1900000000000004 110.116 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.63 -22.24 66.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.654 -0.703 . . . . 1.9399999999999999 112.436 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -136.32 34.88 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 1.23 110.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 30.8 tt0 -120.51 154.06 35.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 1.6000000000000001 109.787 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.6 tttt -156.94 132.22 9.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.663 0.268 . . . . 1.1699999999999999 111.359 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.454 ' SG ' HD12 ' A' ' 22' ' ' ILE . 93.8 m -135.2 165.35 25.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.111 0.481 . . . . 1.2 111.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.51 ' HG ' HD21 ' A' ' 23' ' ' LEU . 78.5 mt -106.34 114.95 29.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.461 -0.79 . . . . 1.73 109.676 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.404 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.3 p -108.3 141.93 22.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.297 -0.41 . . . . 0.73999999999999999 111.232 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.477 ' NE ' HD23 ' A' ' 117' ' ' LEU . 7.2 mpt_? -90.91 117.13 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.414 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.621 HD13 ' HD2' ' A' ' 118' ' ' PHE . 2.7 mp -96.64 101.08 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.28 -1.007 . . . . 0.52000000000000002 108.28 172.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.572 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 8.1 tt0 -98.41 177.04 5.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.268 -0.878 . . . . 1.3700000000000001 109.434 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -55.36 -36.37 66.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 1.0 110.962 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.426 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 24.2 ptp -76.86 -7.64 55.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.036 -0.529 . . . . 1.79 111.296 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.572 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.0 m-85 -112.65 4.85 17.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.606 0.241 . . . . 0.75 110.952 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.641 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -138.7 -173.1 12.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.929 -0.653 . . . . 0.70999999999999996 112.285 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 1.52 111.356 179.635 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 110.085 -0.339 . . . . 1.52 110.085 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.483 HG12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -158.47 97.62 1.78 Allowed Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.124 -0.489 . . . . 0.75 110.553 176.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.16 177.95 4.94 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.509 2.139 . . . . 1.5800000000000001 111.384 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.67 -162.73 27.35 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.11 -1.043 . . . . 2.0499999999999998 113.038 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -98.08 39.88 1.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 2.0299999999999998 109.086 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.9 m -125.2 158.31 34.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.797 -0.638 . . . . 1.1399999999999999 110.37 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.37 127.42 42.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.51 0.671 . . . . 0.47999999999999998 111.653 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.483 HD21 HG12 ' A' ' 110' ' ' ILE . 6.7 mp -123.55 167.63 13.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.681 -0.691 . . . . 0.51000000000000001 109.873 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -138.3 131.89 30.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.006 0.431 . . . . 0.69999999999999996 110.518 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.621 ' HD2' HD13 ' A' ' 95' ' ' ILE . 59.3 m-85 -121.6 145.76 47.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.961 -0.563 . . . . 0.42999999999999999 110.669 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.5 mt-10 -68.65 123.62 21.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.816 -0.809 . . . . 1.46 108.816 170.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 81' ' ' CYS . 10.2 mt -107.74 115.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.298 0.57 . . . . 0.47999999999999998 109.622 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -125.62 114.07 18.22 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.002 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.52 HD22 ' HG3' ' A' ' 34' ' ' PRO . 14.9 tp -86.84 99.92 12.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 1.1200000000000001 109.896 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.1 pt? -98.63 -19.96 17.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.305 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.532 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 20.5 m -151.7 145.66 25.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.46 0.171 . . . . 1.1899999999999999 110.802 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.445 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -166.92 156.98 11.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.448 -0.342 . . . . 0.71999999999999997 110.255 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.81 49.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.202 -0.454 . . . . 2.98 110.704 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mp0 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.137 -0.483 . . . . 3.3799999999999999 110.591 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.075 0.464 . . . . 3.6000000000000001 110.852 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -116.14 158.42 23.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.783 -0.644 . . . . 2.71 110.013 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 6.4 mptt -102.37 148.16 25.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.048 -0.723 . . . . 1.8799999999999999 109.048 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.65 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 15.6 t -101.03 109.24 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.383 0.611 . . . . 0.58999999999999997 110.168 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -79.82 99.74 7.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.031 -0.986 . . . . 2.1600000000000001 111.475 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt 51.32 79.17 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.691 0.619 . . . . 1.45 111.328 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.65 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 11.6 t -89.93 177.17 6.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.78000000000000003 110.903 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.93 -3.63 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.81000000000000005 111.828 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.516 ' HB2' HG23 ' A' ' 80' ' ' ILE . 27.0 m-20 -75.93 2.33 12.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.533 0.206 . . . . 2.3999999999999999 110.652 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.3 8.92 6.86 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.612 -0.804 . . . . 0.68000000000000005 113.326 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.22 63.48 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.019 -0.61 . . . . 0.60999999999999999 114.42 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.537 ' HB ' ' CB ' ' A' ' 80' ' ' ILE . 23.5 t -134.42 148.39 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.929 -0.397 . . . . 0.48999999999999999 109.929 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.92 109.73 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.18 0.514 . . . . 0.46999999999999997 110.44 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.526 ' HE2' HG21 ' A' ' 13' ' ' THR . 47.7 pttt -123.32 148.28 46.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.99 -0.55 . . . . 1.3400000000000001 110.368 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -109.43 124.33 50.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.828 -0.624 . . . . 0.5 110.332 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.482 HD12 ' SG ' ' A' ' 91' ' ' CYS . 5.1 tp -75.65 113.9 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.67000000000000004 110.924 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 3.5 mm? -99.24 -60.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 0.82999999999999996 110.481 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -120.33 133.96 55.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.5600000000000001 110.076 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 37.7 pttt -106.46 124.17 49.18 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.491 . . . . 2.9500000000000002 110.212 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 161.85 37.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.66 -0.781 . . . . 1.3200000000000001 111.788 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -68.07 -67.1 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 2.77 110.692 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.17 -177.81 4.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 2.6400000000000001 110.806 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.96 45.85 0.17 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.49 -0.777 . . . . 1.04 111.27 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.32 -41.5 89.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 2.29 110.552 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -113.83 26.03 10.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.309 0.576 . . . . 2.6400000000000001 109.817 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 79.81 1.79 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 1.45 110.07 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.5 HG21 ' HE3' ' A' ' 35' ' ' LYS . 36.1 mm -129.48 128.46 23.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.81000000000000005 111.084 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 1.1 Cg_endo -81.55 114.65 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.896 2.397 . . . . 0.75 111.256 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 33' ' ' ILE . 28.3 mmtp -120.46 146.45 46.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.21 -0.45 . . . . 2.6600000000000001 111.065 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 5.3 tmmm? -57.02 124.58 19.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.701 -0.681 . . . . 2.5099999999999998 109.783 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.58 37.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.752 -0.737 . . . . 1.1200000000000001 112.277 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 82.3 m-20 -79.39 142.57 35.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.964 0.412 . . . . 1.3799999999999999 110.122 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.524 ' HB3' ' CG ' ' A' ' 126' ' ' ARG . 37.6 tp10 -76.46 102.32 5.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.797 -0.638 . . . . 2.2000000000000002 109.797 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 125' ' ' PHE . 28.0 m -112.94 156.02 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.088 -0.505 . . . . 0.67000000000000004 110.868 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.8 m -132.6 110.87 10.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.65000000000000002 109.709 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.685 HG12 ' HA ' ' A' ' 122' ' ' LEU . 27.4 m -125.15 151.03 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.87 111.405 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -101.17 149.28 24.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.75 109.709 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 39.9 p90 -133.32 136.92 45.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.708 0.29 . . . . 0.76000000000000001 110.233 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -164.89 146.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.58 -0.526 . . . . 0.48999999999999999 109.58 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -176.18 -127.86 1.07 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.325 -0.94 . . . . 0.35999999999999999 112.513 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.54 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 63.6 pttt -157.77 171.94 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 1.4299999999999999 110.831 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.754 HD22 HG13 ' A' ' 110' ' ' ILE . 58.2 tp -87.04 108.89 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.38 110.794 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.555 ' HB3' HG13 ' A' ' 115' ' ' VAL . 2.1 tp10 -61.46 -35.33 77.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.51 0.672 . . . . 1.96 110.615 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -55.71 -27.82 52.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.67000000000000004 112.792 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.497 HG22 HD23 ' A' ' 48' ' ' LEU . 15.2 t -140.55 -23.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.178 -0.609 . . . . 0.72999999999999998 112.35 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.69 34.65 4.89 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.502 -0.856 . . . . 0.78000000000000003 113.014 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HG2' HG23 ' A' ' 51' ' ' THR . 73.8 mmtt -102.84 125.51 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.132 -0.321 . . . . 2.8900000000000001 110.132 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.7 p -82.44 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.108 -0.33 . . . . 0.58999999999999997 110.108 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -78.69 127.23 31.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.387 0.514 . . . . 0.78000000000000003 112.387 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -161.24 85.74 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.025 -0.989 . . . . 2.1800000000000002 108.549 167.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 23.5 t -122.54 158.11 30.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.747 -0.66 . . . . 1.24 109.986 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -50.0 -44.0 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.245 0.618 . . . . 1.49 112.437 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -87.76 -33.67 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 1.8 110.532 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -64.71 -52.0 59.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 2.1899999999999999 111.738 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.1 ptp180 -67.49 -20.49 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.352 . . . . 2.7799999999999998 111.309 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' ND2' HG23 ' A' ' 63' ' ' VAL . 8.3 t30 -75.58 -64.12 1.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.297 -0.411 . . . . 1.1000000000000001 110.108 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.521 HG23 ' ND2' ' A' ' 62' ' ' ASN . 73.1 t -142.55 106.43 5.49 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.382 -0.372 . . . . 2.0299999999999998 111.007 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.37 140.16 92.24 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.287 1.991 . . . . 1.76 110.818 171.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -93.3 151.0 20.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.917 0.389 . . . . 1.3100000000000001 110.582 -171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 143.14 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.117 -0.697 . . . . 1.3600000000000001 109.117 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 82' ' ' VAL . 30.0 p90 -124.39 153.85 41.27 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.968 -0.693 . . . . 0.56999999999999995 111.212 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . 41.7 t-80 -94.5 145.02 25.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.149 -0.932 . . . . 1.98 109.788 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 HD13 ' CG2' ' A' ' 82' ' ' VAL . 38.3 tp -69.13 128.84 38.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.991 -0.744 . . . . 0.94999999999999996 108.991 173.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG2' ' CG ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.49 78.75 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.146 0.974 . . . . 2.0800000000000001 110.403 -168.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 68' ' ' HIS . 26.2 tt0 -126.42 -5.66 6.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.13 -1.395 . . . . 1.98 109.994 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 -19.24 33.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.701 -0.681 . . . . 0.71999999999999997 112.681 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 42.3 mm-40 -87.73 -21.76 25.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.531 0.682 . . . . 0.96999999999999997 109.504 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.9 m -108.87 124.18 65.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.65 -0.705 . . . . 0.57999999999999996 109.979 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.73 -59.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.179 0.437 . . . . 0.62 112.179 -178.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -149.19 -38.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.307 -0.246 . . . . 2.04 111.468 -174.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.7 -52.62 44.45 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.561 -0.828 . . . . 0.32000000000000001 112.857 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 82' ' ' VAL . 15.2 m-90 -76.18 -27.72 57.03 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.8 -0.235 . . . . 0.48999999999999999 110.895 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.12 -54.02 35.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.603 -0.726 . . . . 1.1399999999999999 111.37 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.537 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -68.16 -30.99 49.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.636 -0.711 . . . . 0.78000000000000003 111.586 -173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 85' ' ' MET . 34.8 t -76.08 -55.92 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.748 0.309 . . . . 0.55000000000000004 111.038 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.677 HG12 HG21 ' A' ' 120' ' ' ILE . 32.0 m -67.34 -33.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.324 0.861 . . . . 0.83999999999999997 113.324 -169.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 62.2 p -79.64 -0.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.987 0.422 . . . . 1.4299999999999999 111.167 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -125.77 25.5 6.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 1.23 110.384 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.789 ' HE3' ' HB2' ' A' ' 122' ' ' LEU . 31.4 mtm -114.78 142.37 46.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.95 0.405 . . . . 2.27 111.664 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.482 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 51.2 mtt180 -90.88 164.62 13.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.538 -0.542 . . . . 4.1900000000000004 109.538 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HA ' HD22 ' A' ' 122' ' ' LEU . 61.3 tttm -65.16 -21.66 66.81 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.641 0.608 . . . . 1.9399999999999999 112.641 -171.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -117.54 24.65 10.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.537 0.684 . . . . 1.23 109.805 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.482 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 35.8 tt0 -117.85 132.71 56.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.995 -1.002 . . . . 1.6000000000000001 109.898 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 11.9 tmtt? -137.44 129.68 29.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.94 -0.573 . . . . 1.1699999999999999 110.226 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 78.9 m -138.51 171.74 13.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.372 -0.377 . . . . 1.2 111.269 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.957 HD21 ' HB3' ' A' ' 117' ' ' LEU . 6.1 tt -112.54 145.63 39.96 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.608 -0.886 . . . . 1.73 108.608 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.561 ' N ' HD23 ' A' ' 92' ' ' LEU . 13.9 p -121.07 146.34 26.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 116.443 -0.344 . . . . 0.73999999999999999 110.303 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -107.07 111.13 23.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.643 -1.243 . . . . 1.71 107.643 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.555 HD11 HG13 ' A' ' 93' ' ' VAL . 4.9 mp -93.36 99.8 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.08 -0.648 . . . . 0.52000000000000002 110.459 -172.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 98' ' ' MET . 10.3 tp10 -63.55 155.55 29.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.926 -1.033 . . . . 1.3700000000000001 109.82 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.438 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 6.4 p -53.34 -38.59 63.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.495 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.426 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.1 ptp -78.08 -11.18 59.89 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.562 -0.29 . . . . 1.79 111.428 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -101.7 -2.66 29.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.877 0.37 . . . . 0.75 110.145 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 -178.01 44.91 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.70999999999999996 111.795 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.886 0.374 . . . . 1.52 110.733 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.468 ' CB ' HD13 ' A' ' 110' ' ' ILE . 16.6 m . . . . . 0 C--O 1.235 0.324 0 CA-C-O 120.42 0.152 . . . . 1.52 111.368 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.754 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -141.48 77.68 19.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.211 0.529 . . . . 0.75 111.421 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -93.74 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.25 2.633 . . . . 1.5800000000000001 111.649 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.37 -125.32 7.25 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.517 -0.849 . . . . 2.0499999999999998 111.958 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 97' ' ' SER . 3.3 t-20 -105.41 1.16 27.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.61 0.719 . . . . 2.0299999999999998 109.352 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.9 m -79.56 152.15 30.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.323 -0.853 . . . . 1.1399999999999999 110.632 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.555 HG13 ' HB3' ' A' ' 49' ' ' GLU . 6.5 p -90.14 135.03 27.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.197 -0.456 . . . . 0.47999999999999998 110.686 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 49' ' ' GLU . 6.2 mp -126.67 167.01 16.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.75 0.31 . . . . 0.51000000000000001 110.991 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.957 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -117.26 114.53 23.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.184 -0.673 . . . . 0.69999999999999996 109.184 174.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -113.13 122.04 46.33 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.944 -0.303 . . . . 0.42999999999999999 110.721 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.57 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 33.6 mt-10 -86.12 130.05 34.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.003 -0.74 . . . . 1.46 109.003 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 82' ' ' VAL . 70.7 mt -113.5 127.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.997 -0.547 . . . . 0.47999999999999998 111.504 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -115.91 115.34 26.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.462 -0.79 . . . . 1.8799999999999999 110.815 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.789 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 6.0 tt -91.35 102.24 14.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.871 -0.789 . . . . 1.1200000000000001 108.871 173.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.2 pt? -97.85 -34.43 10.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.184 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.0 t -146.57 144.01 29.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.72 0.295 . . . . 1.1899999999999999 110.759 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.566 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -165.39 148.41 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.71999999999999997 109.873 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.524 ' CG ' ' HB3' ' A' ' 39' ' ' GLU . 7.8 ptp85 -127.49 129.48 47.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 2.98 109.988 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 110.951 -174.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 121.145 0.498 . . . . 3.6000000000000001 110.497 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.93 150.26 21.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 2.71 110.63 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -101.67 141.72 34.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 1.8799999999999999 109.129 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.67 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 16.9 t -102.47 109.57 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.092 0.472 . . . . 0.58999999999999997 111.217 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.13 108.79 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.73 -0.668 . . . . 2.1600000000000001 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.487 ' H ' HD13 ' A' ' 19' ' ' ILE . 23.0 tp 53.05 72.54 0.42 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.638 0.586 . . . . 1.45 111.201 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.67 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 6.8 t -80.43 156.6 26.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.78000000000000003 111.349 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 1.67 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.81000000000000005 111.972 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.6 3.38 3.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.577 0.227 . . . . 2.3999999999999999 110.835 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.26 6.82 8.02 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.091 -0.576 . . . . 0.68000000000000005 112.974 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.01 70.32 1.33 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.708 -0.758 . . . . 0.60999999999999999 113.928 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.89 145.17 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.786 -0.45 . . . . 0.48999999999999999 109.786 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.1 mm -85.53 109.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.46999999999999997 110.323 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 13' ' ' THR . 18.2 pttp -131.05 143.67 50.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.13 0.491 . . . . 1.3400000000000001 111.011 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -110.73 121.73 46.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.609 -0.723 . . . . 0.5 110.237 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.83 134.87 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 0.67000000000000004 110.15 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.4 -74.02 0.62 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.019 -0.363 . . . . 0.82999999999999996 110.019 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -88.26 153.17 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.833 -0.803 . . . . 1.5600000000000001 108.833 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -126.28 120.08 29.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.212 0.53 . . . . 2.9500000000000002 111.001 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.45 27.31 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.124 -0.944 . . . . 1.3200000000000001 112.13 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.92 -65.81 0.97 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.766 0.317 . . . . 2.77 110.877 -176.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 2.7 pp20? -99.69 139.07 35.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.848 0.356 . . . . 2.6400000000000001 110.493 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.679 ' HA3' ' HD3' ' A' ' 86' ' ' ARG . . . -157.17 36.77 0.56 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.567 -0.613 . . . . 1.04 111.567 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.519 0.676 . . . . 2.29 109.188 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -112.09 4.33 17.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.215 -0.902 . . . . 2.6400000000000001 110.353 176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.531 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 11.7 m120 -114.55 78.82 1.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.608 -0.437 . . . . 1.45 111.254 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.1 mm -128.33 114.99 19.89 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.61 -0.723 . . . . 0.81000000000000005 109.559 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.08 106.21 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.132 2.555 . . . . 0.75 111.84 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 31.5 mmtp -118.7 158.21 25.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.749 0.309 . . . . 2.6600000000000001 110.671 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 1.018 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -80.56 150.65 29.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 2.5099999999999998 111.384 -175.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.64 -26.06 25.41 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.808 -0.633 . . . . 1.1200000000000001 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -93.46 157.7 16.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 1.3799999999999999 110.186 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -71.67 95.71 1.49 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 2.2000000000000002 110.805 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 125' ' ' PHE . 10.4 m -114.49 153.03 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.459 -0.337 . . . . 0.67000000000000004 110.351 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 ' HD2' ' A' ' 66' ' ' LYS . 9.1 m -128.27 107.09 9.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.447 -0.342 . . . . 0.65000000000000002 110.406 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -123.75 143.37 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.87 111.534 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -112.99 145.44 40.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.561 -0.745 . . . . 2.75 110.236 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.688 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.2 p90 -132.94 141.42 48.34 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.18 0.3 . . . . 0.76000000000000001 110.831 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p -168.24 154.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.271 -0.641 . . . . 0.48999999999999999 109.271 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 177.92 -120.31 0.71 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.83 -1.176 . . . . 0.35999999999999999 113.225 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.826 ' HG3' HD13 ' A' ' 117' ' ' LEU . 21.0 pttp -157.53 173.28 17.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.545 0.212 . . . . 1.4299999999999999 111.06 -178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.835 HD22 HG13 ' A' ' 110' ' ' ILE . 59.3 tp -90.9 106.66 18.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.688 -0.486 . . . . 0.38 109.688 176.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.0 tp10 -68.73 -25.61 64.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 1.96 110.793 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 17.1 t -55.0 -35.1 64.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.118 -0.946 . . . . 0.67000000000000004 111.461 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 53' ' ' LYS . 2.8 t -125.21 -20.64 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.346 -0.388 . . . . 0.72999999999999998 111.083 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.25 11.58 51.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.78000000000000003 112.771 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 51' ' ' THR . 29.0 mmmt -85.02 131.03 34.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.955 -0.387 . . . . 2.8900000000000001 109.955 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.671 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.5 p -79.1 164.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.315 -0.402 . . . . 0.58999999999999997 110.097 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.449 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 7.3 m-30 -73.61 98.47 2.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.367 0.603 . . . . 0.78000000000000003 110.791 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.32 85.7 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.454 -0.793 . . . . 2.1800000000000002 109.706 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.693 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 19.0 m -135.89 169.24 17.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.376 -0.829 . . . . 1.24 109.54 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 m -57.91 -44.57 86.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.818 0.673 . . . . 1.49 112.818 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -91.01 -48.26 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 1.8 111.456 -171.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.693 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 1.6 m-20 -54.4 -44.74 72.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.985 -1.007 . . . . 2.1899999999999999 112.73 -169.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -83.83 0.7 46.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.851 -0.34 . . . . 2.7799999999999998 111.657 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.594 HD22 HG13 ' A' ' 63' ' ' VAL . 10.7 t30 -104.09 -42.25 5.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.447 -0.342 . . . . 1.1000000000000001 110.807 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.594 HG13 HD22 ' A' ' 62' ' ' ASN . 8.4 m -124.24 125.82 25.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.843 0.354 . . . . 2.0299999999999998 111.521 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 1.7 Cg_endo -85.57 139.57 6.81 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.256 2.637 . . . . 1.76 112.451 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.79 148.95 32.44 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.891 0.377 . . . . 1.3100000000000001 111.179 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HD2' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -136.51 157.62 46.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.998 -0.546 . . . . 1.3600000000000001 110.198 177.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -140.34 176.95 8.35 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.034 0.445 . . . . 0.56999999999999995 111.982 -175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 55.4 m80 -107.75 148.46 29.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.98 110.659 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 36' ' ' LYS . 24.0 tp -78.72 124.45 28.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.103 -0.703 . . . . 0.94999999999999996 109.103 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 1.018 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 1.4 mm-40 63.51 79.57 0.25 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.457 1.122 . . . . 2.0800000000000001 110.255 -168.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 27.6 tt0 -130.61 -3.73 4.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.653 -1.612 . . . . 1.98 109.836 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.22 -11.06 61.64 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.557 -0.747 . . . . 0.71999999999999997 111.847 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.02 -18.77 16.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.96999999999999997 110.836 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -111.74 127.95 68.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 0.57999999999999996 110.282 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.68 -76.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.299 0.481 . . . . 0.62 112.299 -176.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' H ' HG12 ' A' ' 75' ' ' ILE . 37.2 mtpt -127.59 -49.87 1.38 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.472 0.545 . . . . 2.04 112.472 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.4 -53.06 33.53 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.955 -0.64 . . . . 0.32000000000000001 113.342 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.6 m-90 -76.03 -44.27 40.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.639 0.257 . . . . 0.48999999999999999 110.571 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.14 -49.32 69.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.587 -0.733 . . . . 1.1399999999999999 112.026 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -73.37 -36.42 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.165 -0.47 . . . . 0.78000000000000003 111.413 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.703 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 46.3 t -72.46 -42.84 64.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.687 -0.233 . . . . 0.55000000000000004 111.426 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.885 HG12 HG21 ' A' ' 120' ' ' ILE . 27.4 m -64.06 -32.53 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.895 0.379 . . . . 0.83999999999999997 111.121 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -79.11 5.1 12.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.062 0.458 . . . . 1.4299999999999999 110.863 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -113.38 5.73 16.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 1.23 110.824 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.751 ' HE1' ' HB2' ' A' ' 122' ' ' LEU . 55.9 mtm -93.75 -172.73 2.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.519 0.676 . . . . 2.27 112.288 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.679 ' HD3' ' HA3' ' A' ' 29' ' ' GLY . 1.6 ttm180 -145.55 165.51 28.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.153 -1.054 . . . . 4.1900000000000004 108.153 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -63.2 -23.81 67.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.924 0.392 . . . . 1.9399999999999999 111.715 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -117.49 24.91 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.072 0.463 . . . . 1.23 110.065 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.603 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 5.3 tm-20 -123.07 152.85 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 1.6000000000000001 109.629 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -155.23 124.67 6.37 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.146 -0.316 . . . . 1.1699999999999999 110.146 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.69 171.17 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 1.2 111.383 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.85 137.41 52.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.73 110.32 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.703 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 6.2 p -111.73 149.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.89 -0.595 . . . . 0.73999999999999999 111.075 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -104.14 112.56 25.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.566 -0.531 . . . . 1.71 109.566 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.515 HD11 HG13 ' A' ' 93' ' ' VAL . 2.6 mp -92.2 106.57 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.52000000000000002 110.504 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.526 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 28.5 tt0 -90.48 168.29 11.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.393 -0.822 . . . . 1.3700000000000001 108.932 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.419 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 8.8 m -51.03 -39.32 55.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.5 ptp -77.39 -7.91 56.85 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.61 0.243 . . . . 1.79 111.487 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.526 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -99.05 -3.35 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.549 0.214 . . . . 0.75 110.772 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.504 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -135.01 -177.51 15.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.253 -0.499 . . . . 0.70999999999999996 112.015 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.697 0.248 . . . . 1.52 111.175 -179.225 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.552 ' HB2' HD13 ' A' ' 110' ' ' ILE . 3.4 m . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.17 0.51 . . . . 1.52 110.803 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.835 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.63 85.95 50.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.75 110.818 178.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.55 -175.59 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.292 1.995 . . . . 1.5800000000000001 111.905 175.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.53 -132.44 5.12 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.456 -0.878 . . . . 2.0499999999999998 112.117 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -122.77 36.53 4.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 2.0299999999999998 109.965 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 21.3 p -114.84 179.31 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.1399999999999999 110.819 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.1 p -104.98 129.17 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.146 0.498 . . . . 0.47999999999999998 111.016 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -119.94 172.73 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.51000000000000001 110.382 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.826 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -128.08 130.83 48.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.695 -0.483 . . . . 0.69999999999999996 109.695 177.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.678 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 34.7 m-85 -130.4 128.34 41.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.672 0.272 . . . . 0.42999999999999999 110.672 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 62.5 mt-10 -71.28 126.44 29.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.265 -1.013 . . . . 1.46 108.265 169.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.885 HG21 HG12 ' A' ' 82' ' ' VAL . 34.8 mt -107.67 123.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.212 -0.595 . . . . 0.47999999999999998 109.677 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.96 114.7 20.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.682 -0.69 . . . . 1.8799999999999999 110.678 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.751 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 35.9 tp -87.29 90.62 8.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.51 . . . . 1.1200000000000001 109.753 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 124' ' ' SER . 3.5 pp -86.48 -25.26 25.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.741 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.425 ' N ' HD12 ' A' ' 123' ' ' LEU . 75.7 m -159.46 148.23 17.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.361 -0.381 . . . . 1.1899999999999999 110.292 177.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.596 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -167.02 -176.22 3.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.71999999999999997 109.877 -178.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.88 170.54 22.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.524 -0.307 . . . . 2.98 110.178 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 107.908 -1.145 . . . . 3.3799999999999999 107.908 171.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 121.04 0.448 . . . . 3.6000000000000001 110.896 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.42 139.01 36.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 2.71 109.899 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -113.51 151.4 31.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 1.8799999999999999 110.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.518 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 21.6 t -114.0 120.55 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.58999999999999997 111.352 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.93 112.56 25.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 2.1600000000000001 111.138 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.419 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.2 mt 49.74 74.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.752 0.657 . . . . 1.45 112.022 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.518 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 3.5 t -86.34 163.01 17.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.78000000000000003 110.739 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.03 -5.45 13.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.363 0.601 . . . . 0.81000000000000005 110.685 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB3' HG23 ' A' ' 13' ' ' THR . 38.4 t70 -74.52 6.87 3.36 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.629 -0.714 . . . . 2.3999999999999999 111.084 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.28 16.52 3.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.67 -0.776 . . . . 0.68000000000000005 113.851 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.41 62.38 6.07 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.293 -0.479 . . . . 0.60999999999999999 113.82 173.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 80' ' ' ILE . 47.3 t -136.57 145.47 30.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.04 -0.356 . . . . 0.48999999999999999 110.04 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.6 mm -85.78 109.95 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.46999999999999997 110.372 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -138.38 146.78 42.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 110.835 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -119.63 137.56 53.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.5 110.524 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -80.27 126.9 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.051 0.453 . . . . 0.67000000000000004 110.844 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' HD23 ' A' ' 92' ' ' LEU . 4.5 mm? -118.03 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.82999999999999996 110.423 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 39.5 ttpt -116.63 106.44 13.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.56 -0.533 . . . . 1.5600000000000001 109.56 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -88.02 148.94 24.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.245 -0.434 . . . . 2.9500000000000002 110.944 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.93 124.37 8.1 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.635 -0.986 . . . . 1.3200000000000001 110.635 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -61.99 -54.81 36.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.642 0.221 . . . . 2.77 111.493 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.9 151.71 40.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.107 0.48 . . . . 2.6400000000000001 110.719 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.3 34.12 0.11 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.274 -0.875 . . . . 1.04 110.937 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.11 -41.33 78.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 2.29 111.541 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -110.62 26.55 10.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.761 0.791 . . . . 2.6400000000000001 109.274 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.38 77.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.446 -0.797 . . . . 1.45 110.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -123.95 119.48 26.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.956 0.407 . . . . 0.81000000000000005 111.155 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.93 128.68 20.26 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.74 2.293 . . . . 0.75 111.525 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB2' ' CG ' ' A' ' 38' ' ' ASN . 7.9 mmmm -121.24 147.74 45.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.172 -0.467 . . . . 2.6600000000000001 111.442 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.583 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 7.5 ttmm -76.61 129.72 36.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.617 -0.72 . . . . 2.5099999999999998 109.111 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.9 -21.67 44.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.784 -0.722 . . . . 1.1200000000000001 111.904 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.406 ' CG ' ' HB2' ' A' ' 35' ' ' LYS . 3.2 m-20 -83.0 156.61 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.65 95.49 3.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.559 -0.534 . . . . 2.2000000000000002 109.559 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.603 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -125.06 147.69 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.67000000000000004 110.615 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.497 HG23 ' HD3' ' A' ' 66' ' ' LYS . 82.3 m -124.66 119.69 29.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.182 -0.463 . . . . 0.65000000000000002 109.998 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 122' ' ' LEU . 15.5 m -126.95 157.62 38.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.87 111.576 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.459 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 9.8 t60 -110.17 131.04 55.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.347 -0.842 . . . . 2.75 109.898 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 14.4 p90 -133.7 135.75 44.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.076 0.465 . . . . 0.76000000000000001 111.221 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -168.32 151.73 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.295 -1.002 . . . . 0.48999999999999999 108.295 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.78 -126.83 0.98 Allowed Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.504 -1.331 . . . . 0.35999999999999999 112.714 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.666 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 65.8 pttt -155.87 170.5 21.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 111.441 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 114' ' ' SER . 54.4 tp -92.52 109.71 21.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.774 -0.648 . . . . 0.38 110.392 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB3' HG13 ' A' ' 115' ' ' VAL . 7.8 tm-20 -66.44 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 1.96 109.942 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -55.29 -20.11 10.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.67000000000000004 112.444 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -136.52 -26.57 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.274 -0.266 . . . . 0.72999999999999998 111.584 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.73 20.03 18.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 0.78000000000000003 112.004 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.9 mmtt -91.99 126.37 37.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.625 0.25 . . . . 2.8900000000000001 111.441 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.666 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.4 p -76.0 159.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.58999999999999997 109.956 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.555 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 4.8 m-30 -73.97 110.69 8.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.454 0.645 . . . . 0.78000000000000003 111.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -139.34 89.08 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.09 . . . . 2.1800000000000002 109.02 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.552 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 47.5 m -126.99 -171.01 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.801 -0.636 . . . . 1.24 109.947 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -72.84 -48.0 41.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.478 0.547 . . . . 1.49 112.478 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -95.64 -47.52 6.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.283 0.475 . . . . 1.8 112.283 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 6.3 p-10 -57.51 -29.86 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.859 -0.61 . . . . 2.1899999999999999 111.878 -172.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -70.83 -14.35 62.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 2.7799999999999998 111.329 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -125.51 -56.4 1.5 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.788 0.328 . . . . 1.1000000000000001 111.656 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -99.01 113.37 64.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 2.0299999999999998 110.538 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HB3' ' CE1' ' A' ' 43' ' ' HIS . 22.4 Cg_exo -65.29 137.66 52.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.966 2.444 . . . . 1.76 112.515 -177.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.99 127.28 39.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 1.3100000000000001 109.836 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HD3' HG23 ' A' ' 41' ' ' THR . 3.0 pptp? -125.22 158.2 34.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.947 -0.57 . . . . 1.3600000000000001 109.922 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -148.14 171.75 15.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.652 0.263 . . . . 0.56999999999999995 110.357 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 12.0 m170 -112.82 148.47 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 1.98 108.888 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.62 HD13 ' CG2' ' A' ' 82' ' ' VAL . 10.5 tp -66.63 114.25 5.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.546 0.689 . . . . 0.94999999999999996 111.834 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.22 75.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 113.986 -1.461 . . . . 2.0800000000000001 111.081 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 68' ' ' HIS . 6.3 pt20 -113.16 20.98 15.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 1.98 109.748 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 -10.02 64.8 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.841 -0.618 . . . . 0.71999999999999997 111.908 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.41 -24.91 17.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.998 0.428 . . . . 0.96999999999999997 110.921 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.23 128.14 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.682 -0.488 . . . . 0.57999999999999996 109.682 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.593 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -95.75 -64.49 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.536 0.939 . . . . 0.62 113.536 -174.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.461 ' H ' HG12 ' A' ' 75' ' ' ILE . 27.5 mtpt -133.07 -48.58 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.214 0.82 . . . . 2.04 113.214 -172.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.452 ' HA3' HG13 ' A' ' 95' ' ' ILE . . . -52.41 -53.03 33.73 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.815 -0.707 . . . . 0.32000000000000001 113.225 -171.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.513 ' O ' HG22 ' A' ' 82' ' ' VAL . 6.3 m-90 -76.76 -38.29 54.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.888 0.375 . . . . 0.48999999999999999 110.285 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' HD11 ' A' ' 69' ' ' LEU . 11.6 t70 -54.28 -53.59 51.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.103 -0.953 . . . . 1.1399999999999999 112.74 -172.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.461 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -66.34 -40.22 86.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 0.78000000000000003 110.629 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.9 t -62.66 -50.02 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.55000000000000004 111.117 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.62 ' CG2' HD13 ' A' ' 69' ' ' LEU . 30.6 m -71.59 -32.84 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.338 0.496 . . . . 0.83999999999999997 112.338 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.509 ' HB3' HD21 ' A' ' 69' ' ' LEU . 32.8 p -74.61 -9.61 58.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.837 0.31 . . . . 1.4299999999999999 111.837 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 t -118.67 38.87 3.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.404 0.621 . . . . 1.23 109.39 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.902 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 5.7 mmt -111.9 -173.93 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.83 . . . . 2.27 111.083 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.514 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -134.63 171.0 14.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.148 -1.056 . . . . 4.1900000000000004 108.148 171.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HA ' HD22 ' A' ' 122' ' ' LEU . 58.8 tttm -62.7 -31.54 72.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.204 0.446 . . . . 1.9399999999999999 112.204 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.42 25.63 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 1.23 110.741 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 26.4 tt0 -104.23 148.58 26.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 1.6000000000000001 110.525 -176.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.671 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 79.9 tttt -145.49 129.93 17.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.946 -0.57 . . . . 1.1699999999999999 110.711 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 98.1 m -136.23 162.87 31.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.053 0.454 . . . . 1.2 111.267 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.537 HD23 ' HG ' ' A' ' 23' ' ' LEU . 3.8 mm? -102.22 119.79 39.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.73 109.791 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.0 140.53 28.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.966 -0.561 . . . . 0.73999999999999999 110.927 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.836 ' HE ' HD23 ' A' ' 117' ' ' LEU . 1.3 mpt_? -99.43 112.4 24.59 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.756 -0.461 . . . . 1.71 109.756 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.616 HD13 ' HD2' ' A' ' 118' ' ' PHE . 1.8 mp -88.38 105.66 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.237 0.541 . . . . 0.52000000000000002 110.145 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 1.1 tm-20 -79.37 163.79 24.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.645 -1.162 . . . . 1.3700000000000001 107.933 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.9 p -58.74 -29.81 67.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.504 0.192 . . . . 1.0 110.778 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 17.4 ptm -75.93 -9.67 58.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.883 0.373 . . . . 1.79 111.249 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.3 m-30 -100.93 -4.48 27.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.676 -0.238 . . . . 0.75 111.422 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.593 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -141.55 171.36 24.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.638 . . . . 0.70999999999999996 112.371 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.735 0.303 . . . . 1.52 110.614 179.9 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' HD13 ' A' ' 110' ' ' ILE . 37.4 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 111.788 0.292 . . . . 1.52 111.788 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.641 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.21 60.64 9.21 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.137 0.421 . . . . 0.75 112.137 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 31.7 Cg_endo -96.04 93.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.963 2.442 . . . . 1.5800000000000001 111.992 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.36 82.47 0.19 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.273 -0.731 . . . . 2.0499999999999998 111.273 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.1 m120 63.11 21.84 13.09 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.919 0.866 . . . . 2.0299999999999998 109.468 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.817 ' HB2' HD11 ' A' ' 48' ' ' LEU . 8.0 p -118.7 131.75 56.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.726 -1.125 . . . . 1.1399999999999999 110.389 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.4 p -86.89 135.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 0.47999999999999998 110.419 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.488 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -123.03 168.3 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.51000000000000001 110.763 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.836 HD23 ' HE ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -122.33 112.01 17.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.052 -0.722 . . . . 0.69999999999999996 109.052 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.616 ' HD2' HD13 ' A' ' 95' ' ' ILE . 45.3 m-85 -104.07 128.29 51.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.076 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.671 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 44.2 mt-10 -75.65 112.14 11.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 171.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.581 HG21 HG12 ' A' ' 82' ' ' VAL . 25.4 mt -105.88 120.85 57.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.062 0.458 . . . . 0.47999999999999998 110.254 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.33 -0.85 . . . . 1.8799999999999999 109.287 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 87' ' ' LYS . 7.9 tt -91.9 135.52 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.439 . . . . 1.1200000000000001 109.813 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.97 -31.27 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.663 -0.415 . . . . 1.0 112.025 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m -149.99 139.38 21.42 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.124 -0.36 . . . . 1.1899999999999999 111.399 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.603 ' HB2' HG12 ' A' ' 40' ' ' VAL . 3.4 p90 -167.62 171.34 10.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.905 -0.776 . . . . 0.71999999999999997 108.905 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.1 153.47 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.697 0.284 . . . . 2.98 110.99 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 3.3799999999999999 110.36 176.563 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.105 0.479 . . . . 3.6000000000000001 110.959 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -96.62 156.98 16.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.888 -0.596 . . . . 2.71 109.605 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 7.0 mptt -101.64 142.63 32.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.344 -0.243 . . . . 1.8799999999999999 110.344 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.7 t -103.89 118.73 51.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.73 -0.47 . . . . 0.58999999999999997 109.73 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.88 126.99 46.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.419 -0.355 . . . . 2.1600000000000001 110.842 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt 50.1 51.15 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.589 -0.732 . . . . 1.45 112.12 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -55.51 151.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.78000000000000003 110.967 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -8.54 13.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.363 0.505 . . . . 0.81000000000000005 112.363 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 80' ' ' ILE . 7.1 t70 -82.31 24.33 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.022 0.439 . . . . 2.3999999999999999 111.066 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.07 -7.42 9.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.026 -0.607 . . . . 0.68000000000000005 114.163 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.43 76.07 1.08 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.415 -0.898 . . . . 0.60999999999999999 113.942 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 t -143.76 150.21 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.611 -0.514 . . . . 0.48999999999999999 109.611 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mm -85.27 109.89 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 123.237 0.335 . . . . 0.46999999999999997 110.162 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -123.64 147.08 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.272 0.558 . . . . 1.3400000000000001 111.349 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.1 m -119.08 122.26 41.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.502 -0.772 . . . . 0.5 110.365 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.599 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.7 tp -71.7 131.95 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 0.67000000000000004 111.315 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 1.6 mm? -121.94 -59.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.82999999999999996 110.916 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 88' ' ' ASN . 37.1 ttpt -128.65 154.82 45.88 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.217 -0.66 . . . . 1.5600000000000001 109.217 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -125.23 156.39 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.894 0.378 . . . . 2.9500000000000002 111.106 -173.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.39 163.2 14.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.815 -0.914 . . . . 1.3200000000000001 110.815 170.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -87.51 -97.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.336 0.568 . . . . 2.77 110.648 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.94 155.99 18.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.515 -0.55 . . . . 2.6400000000000001 109.515 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 171.68 62.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.092 -1.051 . . . . 1.04 112.299 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.83 -41.65 99.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.009 0.433 . . . . 2.29 110.318 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.79 20.81 13.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.728 0.775 . . . . 2.6400000000000001 110.466 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.456 ' HB3' HH21 ' A' ' 86' ' ' ARG . 0.2 OUTLIER -135.9 78.3 1.71 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 1.45 109.929 175.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 35' ' ' LYS . 36.0 mm -136.58 123.87 14.34 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.81000000000000005 110.811 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 121.49 7.86 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.69 2.26 . . . . 0.75 110.911 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -135.73 150.47 49.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.013 -0.429 . . . . 2.6600000000000001 111.263 -178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.596 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -60.4 132.03 52.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.774 -0.648 . . . . 2.5099999999999998 109.857 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -22.36 31.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.475 -0.65 . . . . 1.1200000000000001 111.475 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -104.05 130.97 51.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.851 -0.425 . . . . 1.3799999999999999 109.851 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -69.07 109.21 3.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.051 -0.522 . . . . 2.2000000000000002 111.765 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 69' ' ' LEU . 22.3 m -99.56 154.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.693 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -122.43 113.01 18.76 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.407 -0.59 . . . . 0.65000000000000002 109.407 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.84 159.85 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.019 0.748 . . . . 0.87 113.019 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -111.85 128.21 56.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 2.75 108.901 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 55.0 p90 -131.25 139.34 49.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.205 0.526 . . . . 0.76000000000000001 111.54 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -168.63 158.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.401 -0.962 . . . . 0.48999999999999999 108.401 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.53 -130.87 1.74 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.926 -1.13 . . . . 0.35999999999999999 112.434 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.717 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 62.4 pttt -156.19 170.05 23.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.13 0.49 . . . . 1.4299999999999999 111.028 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -82.76 101.64 11.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.811 -0.632 . . . . 0.38 110.079 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.65 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 44.5 tt0 -57.54 -33.1 67.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.88 0.371 . . . . 1.96 110.942 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -57.27 -19.62 22.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.67000000000000004 112.106 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 53' ' ' LYS . 7.5 t -138.22 -8.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.792 -0.363 . . . . 0.72999999999999998 111.709 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.07 83.14 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.217 -0.516 . . . . 0.78000000000000003 112.981 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 12.8 mmmm -87.99 120.96 29.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.707 0.289 . . . . 2.8900000000000001 110.99 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.717 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 13.6 p -75.56 151.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.591 . . . . 0.58999999999999997 110.195 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.48 ' CE1' HD11 ' A' ' 110' ' ' ILE . 17.7 m-30 -73.85 127.39 32.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.78000000000000003 111.015 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -141.39 85.76 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.868 0.842 . . . . 2.1800000000000002 110.2 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 m -122.57 -175.93 3.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.234 -0.654 . . . . 1.24 109.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.4 m -72.31 -47.03 53.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.752 0.31 . . . . 1.49 111.604 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -96.42 -36.76 10.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.964 0.727 . . . . 1.8 112.964 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 47.7 p-10 -60.62 -45.38 94.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.586 0.587 . . . . 2.1899999999999999 112.586 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.4 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -86.89 15.38 5.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.214 0.531 . . . . 2.7799999999999998 110.775 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.05 -47.09 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 1.1000000000000001 111.793 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 7.1 p -114.38 124.89 29.96 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 2.0299999999999998 110.947 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 2.8 Cg_exo -75.83 120.67 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.046 2.497 . . . . 1.76 111.788 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.44 146.72 23.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.436 -0.579 . . . . 1.3100000000000001 109.436 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 162.08 37.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.331 -0.395 . . . . 1.3600000000000001 110.755 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CE1' HG11 ' A' ' 74' ' ' VAL . 41.0 p90 -144.74 175.63 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.56999999999999995 110.302 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.8 m-70 -111.4 147.79 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.296 -0.631 . . . . 1.98 109.296 173.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HB2' HG22 ' A' ' 40' ' ' VAL . 16.9 tp -72.02 127.02 31.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.403 . . . . 0.94999999999999996 109.911 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.596 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 64.44 72.78 0.44 Allowed 'General case' 0 C--N 1.331 -0.206 0 O-C-N 124.15 0.906 . . . . 2.0800000000000001 111.453 -175.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 73' ' ' GLU . 11.9 pt20 -130.35 14.71 5.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.326 -0.852 . . . . 1.98 109.597 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.92 -17.44 31.73 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.71999999999999997 113.11 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HB2' HE21 ' A' ' 71' ' ' GLN . 14.2 mm-40 -84.36 -39.41 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.058 0.456 . . . . 0.96999999999999997 111.465 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 67' ' ' PHE . 18.1 m -97.97 127.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.108 -0.496 . . . . 0.57999999999999996 110.456 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.689 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.61 -68.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.537 0.569 . . . . 0.62 112.537 -175.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.689 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -139.95 -45.97 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.231 0.456 . . . . 2.04 112.231 -175.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.75 -53.16 34.31 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.12 -0.562 . . . . 0.32000000000000001 113.275 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.463 ' O ' HG22 ' A' ' 82' ' ' VAL . 20.2 m-90 -75.8 -31.87 59.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.9 0.381 . . . . 0.48999999999999999 110.628 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.487 ' OD1' HD11 ' A' ' 69' ' ' LEU . 22.1 t0 -53.98 -52.88 59.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.201 -0.909 . . . . 1.1399999999999999 112.068 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.87 -41.07 81.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.903 0.383 . . . . 0.78000000000000003 111.191 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.664 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 25.4 t -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.712 -0.395 . . . . 0.55000000000000004 111.385 -176.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 69' ' ' LEU . 34.9 m -67.96 -32.03 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.97 0.414 . . . . 0.83999999999999997 110.173 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -64.76 -27.17 68.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 1.4299999999999999 110.802 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 t -101.43 24.66 9.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.815 -0.629 . . . . 1.23 110.812 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.046 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 5.1 mmt -104.98 -173.32 2.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.561 -0.29 . . . . 2.27 110.921 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 24.1 mtp-105 -151.99 175.01 12.95 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.937 -0.764 . . . . 4.1900000000000004 108.937 170.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -61.27 -24.32 66.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.061 0.458 . . . . 1.9399999999999999 111.254 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.465 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 35.3 m-80 -130.37 28.62 4.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.444 -0.344 . . . . 1.23 110.966 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 28.4 tt0 -121.19 142.85 49.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.58 -0.526 . . . . 1.6000000000000001 109.58 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.556 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.32 130.24 16.23 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.713 -0.477 . . . . 1.1699999999999999 109.713 -171.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.599 ' SG ' HD12 ' A' ' 22' ' ' ILE . 96.9 m -141.96 171.68 13.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 1.2 111.996 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.7 134.76 46.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.36 -0.836 . . . . 1.73 110.015 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.664 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.1 p -112.93 140.96 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.901 0.382 . . . . 0.73999999999999999 111.165 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.625 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.09 112.48 25.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.919 -0.582 . . . . 1.71 110.263 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.8 mp -95.84 102.1 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.52000000000000002 110.03 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.425 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 24.7 tt0 -83.89 168.74 15.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.43 -0.952 . . . . 1.3700000000000001 108.43 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.4 p -53.22 -36.05 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.52 -7.47 54.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.366 -0.379 . . . . 1.79 111.801 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.425 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -100.44 0.03 38.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.576 0.227 . . . . 0.75 111.265 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -127.07 -165.15 11.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.891 -0.671 . . . . 0.70999999999999996 111.928 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.876 0.338 . . . . 1.52 111.102 179.144 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 N-CA-C 111.985 0.365 . . . . 1.52 111.985 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.48 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -152.69 87.34 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.139 -0.689 . . . . 0.75 109.139 175.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.73 -171.7 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.489 2.793 . . . . 1.5800000000000001 113.196 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.87 -143.51 13.85 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.61 -0.596 . . . . 2.0499999999999998 111.61 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -101.14 1.52 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.907 0.384 . . . . 2.0299999999999998 110.599 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 p -82.43 158.27 23.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.928 -0.578 . . . . 1.1399999999999999 110.939 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.83 132.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.47999999999999998 111.095 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -119.18 155.13 32.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.51000000000000001 109.695 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.65 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -124.67 127.64 47.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 0.69999999999999996 110.48 172.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -122.74 141.31 51.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.814 -0.63 . . . . 0.42999999999999999 110.589 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.7 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 40.3 mt-10 -76.54 121.5 23.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.846 -0.798 . . . . 1.46 108.846 169.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.535 HD12 ' HB3' ' A' ' 81' ' ' CYS . 13.1 mt -106.8 127.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.524 -0.547 . . . . 0.47999999999999998 109.524 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -134.16 111.02 9.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.051 -0.977 . . . . 1.8799999999999999 110.354 -169.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.459 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 24.9 tp -84.8 96.92 9.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 1.1200000000000001 109.991 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.14 -21.9 24.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.349 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -173.17 163.54 4.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.503 -0.317 . . . . 1.1899999999999999 110.203 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.24 174.12 8.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.71999999999999997 110.201 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -137.21 138.79 40.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.431 . . . . 2.98 110.904 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.555 -0.748 . . . . 3.3799999999999999 110.207 -177.636 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.831 0.348 . . . . 7.4800000000000004 110.52 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.34 122.74 24.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.322 -0.399 . . . . 5.9000000000000004 110.767 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 4' ' ' GLU . 13.0 t -91.93 -33.79 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.27 -0.641 . . . . 4.4400000000000004 109.27 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.565 ' HG2' HG23 ' A' ' 3' ' ' THR . 23.4 mm-40 -109.13 95.94 5.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.509 -0.769 . . . . 4.4400000000000004 108.94 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -67.41 131.65 46.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 4.1500000000000004 111.249 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.78 79.16 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.816 -0.629 . . . . 3.6099999999999999 109.77 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.34 150.47 21.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.212 0.53 . . . . 3.6000000000000001 111.328 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.06 150.84 21.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.393 -0.821 . . . . 2.71 109.156 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -98.9 151.58 20.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.898 -0.408 . . . . 1.8799999999999999 109.898 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -101.42 104.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.545 -0.909 . . . . 0.58999999999999997 108.545 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.54 108.49 20.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.222 -0.899 . . . . 2.1600000000000001 110.825 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 84.1 mt 65.01 69.5 0.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 1.45 110.406 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -65.21 163.7 14.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.838 -0.619 . . . . 0.78000000000000003 110.571 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.37 -3.74 29.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.672 0.619 . . . . 0.81000000000000005 112.672 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.534 ' HB3' HG13 ' A' ' 80' ' ' ILE . 29.1 t70 -90.55 14.76 12.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.361 0.601 . . . . 2.3999999999999999 110.946 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.03 19.46 2.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.323 -0.942 . . . . 0.68000000000000005 114.241 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 69.03 76.64 0.45 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.639 0.615 . . . . 0.60999999999999999 114.639 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.534 ' HB ' HG21 ' A' ' 80' ' ' ILE . 96.9 t -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.85 -0.426 . . . . 0.48999999999999999 109.85 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 13.7 mm -91.86 116.02 32.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 O-C-N 123.385 0.428 . . . . 0.46999999999999997 110.594 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -135.12 146.46 48.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 1.3400000000000001 111.263 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 m -108.56 131.91 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.691 . . . . 0.5 110.356 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -80.44 120.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.109 0.48 . . . . 0.67000000000000004 111.188 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.38 -52.57 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.82999999999999996 110.632 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 39.5 ttmt -127.44 149.19 50.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.351 -0.611 . . . . 1.5600000000000001 109.351 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -115.15 140.83 48.75 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.134 0.271 . . . . 2.9500000000000002 110.325 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.03 121.7 25.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.956 -0.64 . . . . 1.3200000000000001 112.009 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.05 -60.29 4.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.342 . . . . 2.77 111.511 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -160.96 141.01 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 2.6400000000000001 110.407 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 32' ' ' ASN . . . 167.86 103.31 0.17 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.551 -0.833 . . . . 1.04 112.026 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -74.65 -41.62 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.598 0.714 . . . . 2.29 109.246 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -88.48 -10.4 49.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.521 -1.218 . . . . 2.6400000000000001 110.607 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.655 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.5 m-80 -84.86 75.52 10.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.989 -0.551 . . . . 1.45 111.036 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 31.8 mm -144.58 102.22 4.63 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.757 -0.656 . . . . 0.81000000000000005 110.262 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HG3' HD22 ' A' ' 122' ' ' LEU . 65.2 Cg_endo -71.81 111.33 3.12 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 123.329 2.686 . . . . 0.75 112.181 175.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -116.87 166.47 12.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.624 0.726 . . . . 2.6600000000000001 112.189 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 1.024 ' HE3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -70.11 153.88 42.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.891 -1.05 . . . . 2.5099999999999998 111.736 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' H ' ' HB2' ' A' ' 70' ' ' GLU . . . 86.68 -5.11 85.53 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.365 -0.834 . . . . 1.1200000000000001 111.49 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -119.85 163.8 16.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.163 0.506 . . . . 1.3799999999999999 111.119 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -87.54 121.79 30.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 2.2000000000000002 110.769 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 125' ' ' PHE . 17.8 m -132.73 156.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.217 -0.447 . . . . 0.67000000000000004 109.974 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 124' ' ' SER . 39.0 m -127.75 116.58 20.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.229 -0.442 . . . . 0.65000000000000002 109.916 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 122' ' ' LEU . 33.7 m -137.46 156.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.614 -0.266 . . . . 0.87 111.088 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.73 142.71 45.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.956 -0.757 . . . . 2.75 108.956 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -124.16 141.23 52.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.76000000000000001 110.71 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -168.77 161.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 109.251 -0.648 . . . . 0.48999999999999999 109.251 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.22 -128.61 1.79 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.312 -0.947 . . . . 0.35999999999999999 112.341 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.665 ' O ' HD12 ' A' ' 117' ' ' LEU . 18.6 pttm -156.69 173.16 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.929 0.395 . . . . 1.4299999999999999 110.805 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.627 HD22 HG13 ' A' ' 110' ' ' ILE . 65.9 tp -91.15 98.29 11.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.38 110.184 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.71 ' HB2' HD11 ' A' ' 117' ' ' LEU . 35.7 tt0 -66.58 -21.15 66.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.846 0.355 . . . . 1.96 110.704 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.518 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 23.2 t -55.89 -29.97 60.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.67000000000000004 111.48 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 53' ' ' LYS . 9.6 t -138.04 1.31 2.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.868 0.366 . . . . 0.72999999999999998 111.406 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.91 20.42 73.41 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.215 -0.517 . . . . 0.78000000000000003 112.869 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HB2' HG23 ' A' ' 51' ' ' THR . 0.2 OUTLIER -84.19 116.42 22.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.629 0.252 . . . . 2.8900000000000001 110.784 -178.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.2 p -70.57 150.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.58999999999999997 110.054 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 8.4 m-30 -74.92 124.52 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.971 0.415 . . . . 0.78000000000000003 111.425 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.63 85.25 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.504 0.669 . . . . 2.1800000000000002 110.674 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.409 ' HB3' ' OD1' ' A' ' 60' ' ' ASP . 46.8 t -126.53 166.59 17.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.656 -0.702 . . . . 1.24 109.227 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -71.18 -22.05 62.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.897 0.38 . . . . 1.49 111.082 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.566 ' O ' HG12 ' A' ' 63' ' ' VAL . 43.3 m-85 -95.02 -55.65 3.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.793 0.664 . . . . 1.8 112.793 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 5.5 p-10 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.548 0.573 . . . . 2.1899999999999999 112.548 -167.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -1.94 55.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.842 0.353 . . . . 2.7799999999999998 111.278 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -116.29 -53.99 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 1.1000000000000001 111.765 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 59' ' ' PHE . 13.0 p -87.09 127.27 59.99 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.441 0.638 . . . . 2.0299999999999998 111.858 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.6 Cg_exo -78.18 90.48 1.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.586 2.191 . . . . 1.76 111.027 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -94.39 132.61 38.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.148 -0.686 . . . . 1.3100000000000001 109.148 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -138.55 147.31 42.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.106 -0.497 . . . . 1.3600000000000001 110.206 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -115.47 178.35 4.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.56999999999999995 109.722 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -115.72 148.9 39.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.237 -1.023 . . . . 1.98 108.237 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.621 HD13 ' CG2' ' A' ' 82' ' ' VAL . 18.3 tp -74.36 128.91 36.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.995 0.426 . . . . 0.94999999999999996 111.226 -175.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 1.024 ' HG3' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 58.93 64.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.879 -1.055 . . . . 2.0800000000000001 112.229 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 73' ' ' GLU . 10.0 pt20 -115.84 10.13 15.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.3 -1.318 . . . . 1.98 108.967 172.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.8 -18.7 41.89 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.71999999999999997 112.772 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' HB2' HE21 ' A' ' 71' ' ' GLN . 19.9 mm-40 -76.63 -32.92 58.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.178 0.513 . . . . 0.96999999999999997 110.791 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.78 129.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.813 -0.631 . . . . 0.57999999999999996 109.725 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.657 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.93 -73.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.261 -0.427 . . . . 0.62 111.592 -175.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.657 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -138.16 -44.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.022 -0.424 . . . . 2.04 112.018 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -54.5 -53.87 35.93 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.792 -0.718 . . . . 0.32000000000000001 113.101 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.604 ' O ' HG22 ' A' ' 82' ' ' VAL . 11.4 m-90 -75.78 -36.59 59.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.439 -0.448 . . . . 0.48999999999999999 110.266 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -51.41 -53.79 33.2 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.063 0.852 . . . . 1.1399999999999999 111.951 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 15' ' ' ASP . 1.6 mp -65.23 -38.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.829 0.347 . . . . 0.78000000000000003 111.164 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.593 ' O ' ' HG2' ' A' ' 85' ' ' MET . 23.6 t -66.86 -55.85 12.94 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.888 -0.325 . . . . 0.55000000000000004 110.616 -176.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.621 ' CG2' HD13 ' A' ' 69' ' ' LEU . 29.9 m -71.76 -33.23 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.038 0.385 . . . . 0.83999999999999997 112.038 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 t -78.05 0.83 23.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.264 0.555 . . . . 1.4299999999999999 110.734 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 t -131.69 20.48 4.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.687 . . . . 1.23 109.843 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.661 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.1 mmt -90.81 -174.66 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 2.27 110.699 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 50.8 mtt85 -149.42 154.97 39.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.03 -1.1 . . . . 4.1900000000000004 108.03 172.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 125' ' ' PHE . 62.2 tttm -65.27 -14.33 60.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.128 0.489 . . . . 1.9399999999999999 111.911 -173.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -124.06 25.08 8.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.96 0.41 . . . . 1.23 110.185 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 32.3 tt0 -123.61 166.66 15.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.862 -0.608 . . . . 1.6000000000000001 110.363 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -158.8 133.72 8.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.715 0.293 . . . . 1.1699999999999999 111.301 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.3 m -136.79 153.94 50.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.342 -0.39 . . . . 1.2 110.738 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -101.21 121.46 41.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.35 -0.611 . . . . 1.73 109.35 175.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 77' ' ' GLY . 12.6 p -106.44 145.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.453 -0.34 . . . . 0.73999999999999999 110.896 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.534 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 41.5 mmt-85 -96.5 118.14 32.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.976 -0.557 . . . . 1.71 110.497 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.2 mp -96.43 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.227 -0.657 . . . . 0.52000000000000002 109.227 175.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 99' ' ' TYR . 42.1 tt0 -92.63 173.29 7.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.975 -1.012 . . . . 1.3700000000000001 108.898 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 17.1 p -51.42 -50.05 60.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.765 0.283 . . . . 1.0 111.765 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.6 ptm -77.55 -16.82 58.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.074 0.398 . . . . 1.79 112.074 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.489 ' HB2' ' H ' ' A' ' 96' ' ' GLU . 21.7 m-30 -85.59 -17.17 37.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.177 -0.305 . . . . 0.75 110.177 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.85 -154.22 9.25 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.488 -0.778 . . . . 0.70999999999999996 111.463 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -93.36 47.31 1.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 1.52 111.847 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.53 -10.39 79.34 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.577 -0.821 . . . . 2.2999999999999998 111.344 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.34 -59.15 2.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.91 0.386 . . . . 5.8600000000000003 110.837 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.29 -33.5 43.29 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.877 -0.601 . . . . 4.2699999999999996 110.878 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 99.62 -5.21 58.37 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.617 -0.801 . . . . 2.1600000000000001 113.169 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.0 t -82.64 97.45 8.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.178 0.513 . . . . 3.3399999999999999 110.846 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -122.89 -168.14 13.06 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.857 -0.687 . . . . 1.2 111.594 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.47 -68.82 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.248 0.524 . . . . 3.0800000000000001 111.837 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.507 ' HB2' HD13 ' A' ' 110' ' ' ILE . 11.4 p -79.65 -74.99 0.27 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.959 -0.296 . . . . 1.52 111.753 -174.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.627 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -144.43 84.27 9.36 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.617 0.722 . . . . 0.75 110.861 177.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.566 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 68.5 Cg_endo -95.15 90.9 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.029 2.486 . . . . 1.5800000000000001 112.272 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.95 47.66 1.0 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.079 -1.058 . . . . 2.0499999999999998 112.302 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 3.6 m-20 60.34 21.68 11.2 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.534 0.683 . . . . 2.0299999999999998 110.76 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.518 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 7.4 m -96.46 156.55 16.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 1.1399999999999999 109.852 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -87.03 121.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.404 0.621 . . . . 0.47999999999999998 110.766 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -114.57 157.27 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.601 -0.727 . . . . 0.51000000000000001 110.159 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -116.77 129.19 55.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 110.0 -0.37 . . . . 0.69999999999999996 110.0 175.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.461 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 21.1 m-85 -122.33 122.0 38.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.598 -0.274 . . . . 0.42999999999999999 110.351 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.471 ' HG2' ' HG ' ' A' ' 92' ' ' LEU . 42.7 mt-10 -75.25 114.52 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.191 -0.67 . . . . 1.46 109.191 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.436 HD11 ' HD1' ' A' ' 78' ' ' TRP . 65.4 mt -106.76 122.29 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.913 0.387 . . . . 0.47999999999999998 110.005 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.29 115.66 22.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 109.5 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.86 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -86.0 94.43 9.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 1.1200000000000001 110.362 -176.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.678 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.2 pt? -86.08 -28.65 23.94 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.16 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.54 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 t -141.05 144.82 35.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.044 0.45 . . . . 1.1899999999999999 110.555 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 87' ' ' LYS . 6.1 p90 -164.47 168.16 18.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.931 -0.766 . . . . 0.71999999999999997 108.931 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -161.97 109.16 1.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 2.98 111.339 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -71.33 115.44 10.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.541 -0.754 . . . . 3.3799999999999999 110.365 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.7 tp -108.87 122.55 47.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.278 -0.638 . . . . 3.3500000000000001 109.278 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -80.62 91.33 5.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.252 0.548 . . . . 5.3899999999999997 110.874 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -108.78 73.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.862 0.839 . . . . 7.04 110.628 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -156.9 155.69 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.446 -1.252 . . . . 7.21 108.0 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -67.77 139.7 56.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.59 -0.444 . . . . 9.0199999999999996 110.842 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.18 110.71 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 9.75 110.398 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -61.37 -39.76 91.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.136 0.493 . . . . 12.26 110.291 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.915 -0.772 . . . . 13.35 108.915 170.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.652 0.263 . . . . 7.4800000000000004 110.809 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -70.9 159.69 34.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.139 -0.319 . . . . 5.9000000000000004 110.139 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.0 m -150.68 -66.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 4.4400000000000004 110.836 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -117.19 176.55 5.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.893 0.378 . . . . 4.4400000000000004 110.377 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -76.14 101.28 5.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 4.1500000000000004 110.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.88 34.8 0.98 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.698 0.761 . . . . 3.6099999999999999 109.355 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.13 -170.86 1.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.303 -0.862 . . . . 3.6000000000000001 110.466 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.28 150.07 49.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.038 0.447 . . . . 2.71 110.826 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.475 ' HG3' HG23 ' A' ' 21' ' ' THR . 3.6 mppt? -91.6 144.4 25.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 1.8799999999999999 109.605 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 41.4 t -101.34 103.85 15.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 0.58999999999999997 108.427 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -103.45 113.75 27.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.129 -0.941 . . . . 2.1600000000000001 110.66 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 19' ' ' ILE . 52.2 mt 60.67 54.65 3.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.962 0.789 . . . . 1.45 111.206 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.49 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -57.29 148.63 22.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.92 . . . . 0.78000000000000003 110.607 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.43 1.3 4.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.81000000000000005 110.502 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.1 16.64 4.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 2.3999999999999999 110.908 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.18 5.04 8.98 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.396 -0.907 . . . . 0.68000000000000005 114.114 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.34 72.26 0.9 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.226 -0.512 . . . . 0.60999999999999999 113.652 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' A' ' 80' ' ' ILE . 62.4 t -135.68 142.72 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.782 -0.451 . . . . 0.48999999999999999 109.782 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 12' ' ' LEU . 18.5 mm -88.11 114.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.721 -0.474 . . . . 0.46999999999999997 109.721 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HD2' ' SG ' ' A' ' 81' ' ' CYS . 12.1 pttp -142.4 138.51 31.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.314 0.578 . . . . 1.3400000000000001 111.418 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 24.6 m -100.02 123.81 44.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.5 110.126 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.557 HG12 ' HE2' ' A' ' 25' ' ' LYS . 8.9 tp -80.42 132.76 31.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.997 0.427 . . . . 0.67000000000000004 110.1 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' LEU . 3.9 mm? -113.68 -51.06 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.049 -0.523 . . . . 0.82999999999999996 110.983 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 117.19 19.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.454 -0.339 . . . . 1.5600000000000001 110.392 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 58.0 mttm -101.91 160.63 14.32 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.148 -0.478 . . . . 2.9500000000000002 110.312 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.42 -142.23 12.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.789 -0.719 . . . . 1.3200000000000001 111.919 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -76.0 0.56 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.961 0.41 . . . . 2.77 110.293 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.79 -178.58 3.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.136 -0.483 . . . . 2.6400000000000001 110.116 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 52.31 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.081 -0.807 . . . . 1.04 111.081 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.78 -40.64 93.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.983 0.42 . . . . 2.29 110.948 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -108.79 9.28 26.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.536 . . . . 2.6400000000000001 110.474 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -111.79 77.37 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 1.45 110.296 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.452 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 36.4 mm -132.87 120.69 16.57 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.398 -0.819 . . . . 0.81000000000000005 110.101 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.452 ' HG3' HD22 ' A' ' 122' ' ' LEU . 85.7 Cg_endo -87.04 115.9 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.815 2.343 . . . . 0.75 112.576 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HE2' ' CG2' ' A' ' 33' ' ' ILE . 71.3 mmtt -129.9 158.29 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 2.6600000000000001 111.444 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 12.1 ttmm -65.43 150.27 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.158 -0.928 . . . . 2.5099999999999998 111.365 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.2 -11.66 68.92 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.934 -0.867 . . . . 1.1200000000000001 110.934 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -105.05 155.71 18.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.517 . . . . 1.3799999999999999 110.878 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -85.25 104.25 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 2.2000000000000002 110.682 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 m -118.08 162.12 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 0.67000000000000004 110.655 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 31.5 m -133.45 120.91 21.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.797 -0.638 . . . . 0.65000000000000002 109.611 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.68 148.79 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.87 111.577 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.22 143.84 30.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.297 -0.631 . . . . 2.75 109.297 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 30.6 p90 -141.97 137.02 30.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.76000000000000001 110.505 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.55 160.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.125 -0.694 . . . . 0.48999999999999999 109.125 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.11 -118.88 0.68 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.539 -0.839 . . . . 0.35999999999999999 112.597 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HG3' HD11 ' A' ' 117' ' ' LEU . 55.5 pttt -149.94 171.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 1.4299999999999999 110.111 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.506 HD12 ' HG ' ' A' ' 116' ' ' LEU . 57.0 tp -87.23 98.01 11.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.879 -0.6 . . . . 0.38 109.533 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.577 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 4.9 tp10 -57.59 -35.09 69.94 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.46 0.541 . . . . 1.96 112.46 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -58.26 -20.06 39.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.372 0.508 . . . . 0.67000000000000004 112.372 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 53' ' ' LYS . 11.4 t -134.05 -30.81 1.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.971 0.415 . . . . 0.72999999999999998 110.773 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.26 15.84 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.254 -0.498 . . . . 0.78000000000000003 113.151 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' H ' HG23 ' A' ' 51' ' ' THR . 11.2 mmmm -81.49 125.33 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.932 0.366 . . . . 2.8900000000000001 110.67 177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.24 154.98 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.58999999999999997 110.03 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 22.0 m-30 -75.2 99.96 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.167 0.508 . . . . 0.78000000000000003 111.918 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -116.87 85.89 2.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.371 -0.974 . . . . 2.1800000000000002 108.371 168.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -135.33 158.06 45.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.62 -0.718 . . . . 1.24 110.248 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -48.67 -42.08 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.769 0.668 . . . . 1.49 112.496 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -93.88 -50.64 5.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.771 0.32 . . . . 1.8 110.609 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.66 -37.87 59.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 2.1899999999999999 112.626 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -84.53 -4.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 2.7799999999999998 111.267 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -115.49 -61.44 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.939 -0.305 . . . . 1.1000000000000001 110.569 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.19 109.61 6.96 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.32 -0.4 . . . . 2.0299999999999998 110.225 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.49 161.17 42.32 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.709 2.273 . . . . 1.76 112.137 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -94.03 154.12 17.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.079 -0.509 . . . . 1.3100000000000001 110.279 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.8 pptp? -134.47 151.1 50.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 1.3600000000000001 110.263 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -129.68 -171.85 2.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.37 -0.377 . . . . 0.56999999999999995 110.989 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -116.72 149.2 40.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.289 -0.634 . . . . 1.98 109.289 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 HG21 ' A' ' 82' ' ' VAL . 9.8 tp -67.81 112.86 5.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.94999999999999996 111.89 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.97 73.11 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.334 -1.303 . . . . 2.0800000000000001 111.63 176.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -113.44 17.43 18.43 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.187 -1.042 . . . . 1.98 108.187 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.99 -18.28 55.99 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.585 -1.189 . . . . 0.71999999999999997 113.062 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.25 -14.54 28.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.956 0.378 . . . . 0.96999999999999997 111.446 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.15 121.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.643 0.735 . . . . 0.57999999999999996 109.751 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.431 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -99.37 -62.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.08 -0.964 . . . . 0.62 112.774 -172.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -125.92 -66.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.278 0.473 . . . . 2.04 112.278 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.33 -52.6 35.82 Favored Glycine 0 C--N 1.333 0.384 0 O-C-N 123.56 0.538 . . . . 0.32000000000000001 113.59 -169.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.45 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.9 m-90 -75.39 -46.44 32.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.769 0.318 . . . . 0.48999999999999999 110.393 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.36 -48.26 65.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.026 -0.988 . . . . 1.1399999999999999 112.251 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.593 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -73.89 -45.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.488 -0.324 . . . . 0.78000000000000003 110.894 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.489 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 53.1 t -63.56 -41.8 98.4 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.591 0.219 . . . . 0.55000000000000004 111.591 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.607 HG21 HD13 ' A' ' 69' ' ' LEU . 34.4 m -67.66 -32.34 56.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.768 -0.373 . . . . 0.83999999999999997 110.805 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.1 m -79.48 -4.0 49.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.946 0.403 . . . . 1.4299999999999999 111.169 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.425 ' OG ' ' HE2' ' A' ' 20' ' ' LYS . 9.7 p -124.01 39.32 3.99 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.227 0.537 . . . . 1.23 111.096 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.497 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 0.1 OUTLIER -116.13 174.57 5.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 2.27 110.488 176.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 86' ' ' ARG . 6.1 ttm180 -127.51 163.36 24.31 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.36 -1.348 . . . . 4.1900000000000004 107.36 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -64.42 -17.55 63.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.238 0.542 . . . . 1.9399999999999999 110.846 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -122.81 16.73 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.069 -0.514 . . . . 1.23 110.703 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 25' ' ' LYS . 33.6 tt0 -123.7 129.38 51.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 1.6000000000000001 110.642 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 85.4 tttt -136.58 143.75 43.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 1.1699999999999999 109.894 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 21' ' ' THR . 28.8 p -149.79 165.26 33.0 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.001 0.429 . . . . 1.2 111.733 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.8 mt -91.97 120.65 32.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.291 -0.868 . . . . 1.73 110.007 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.489 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.5 p -99.89 134.59 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.286 -0.415 . . . . 0.73999999999999999 110.096 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 26.2 mmm-85 -96.1 111.38 23.43 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.463 -0.569 . . . . 1.71 109.463 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.426 HD13 ' CD2' ' A' ' 118' ' ' PHE . 2.1 mp -91.44 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.019 -0.734 . . . . 0.52000000000000002 109.019 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 97' ' ' SER . 43.7 tt0 -79.7 168.52 19.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.313 -0.858 . . . . 1.3700000000000001 109.449 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -48.16 -48.48 34.32 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.323 0.649 . . . . 1.0 111.463 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -78.56 -8.07 58.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.362 0.504 . . . . 1.79 112.362 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -96.25 -12.86 23.95 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.237 -0.289 . . . . 0.75 110.848 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 176.06 19.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.847 -0.692 . . . . 0.70999999999999996 112.36 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -41.49 97.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.916 0.388 . . . . 1.52 110.996 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.51 165.56 18.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.562 -0.827 . . . . 2.2999999999999998 112.447 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -72.51 -23.37 61.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.327 0.584 . . . . 5.8600000000000003 111.015 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -87.32 10.9 15.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.724 -0.671 . . . . 4.2699999999999996 110.742 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.43 -161.86 10.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.532 -0.842 . . . . 2.1600000000000001 112.227 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.1 m -72.31 126.31 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.788 0.328 . . . . 3.3399999999999999 110.326 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.6 142.58 16.05 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.874 -0.679 . . . . 1.2 111.914 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.18 -71.57 0.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.608 -0.516 . . . . 3.0800000000000001 109.608 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -104.86 -72.08 0.72 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.147 -0.686 . . . . 1.52 109.147 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.449 HG13 HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -143.62 112.38 5.43 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.35 -0.387 . . . . 0.75 110.095 175.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -83.06 -83.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.516 2.144 . . . . 1.5800000000000001 112.831 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.89 18.16 59.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.952 -0.36 . . . . 2.0499999999999998 113.694 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 52.65 35.39 18.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.006 0.431 . . . . 2.0299999999999998 111.181 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.3 m -107.77 179.49 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 1.1399999999999999 110.67 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.33 129.57 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.174 0.512 . . . . 0.47999999999999998 111.008 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.506 ' HG ' HD12 ' A' ' 48' ' ' LEU . 6.3 mp -127.21 174.82 8.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.297 -0.631 . . . . 0.51000000000000001 109.297 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.631 ' HB3' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -147.01 133.04 19.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.29 0.567 . . . . 0.69999999999999996 110.578 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.485 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 43.6 m-85 -127.98 141.76 51.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.42999999999999999 110.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.3 mt-10 -76.26 127.15 32.32 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.062 -0.718 . . . . 1.46 109.062 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.7 mt -105.89 118.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.601 0.715 . . . . 0.47999999999999998 110.216 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -110.68 116.0 30.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.687 -1.142 . . . . 1.8799999999999999 110.458 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 34' ' ' PRO . 30.3 tp -91.89 89.6 7.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 1.1200000000000001 109.977 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.7 pt? -95.17 -33.32 12.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.042 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 13.8 m -135.12 128.18 31.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.024 -0.362 . . . . 1.1899999999999999 110.024 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.25 171.16 11.01 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.559 -0.534 . . . . 0.71999999999999997 109.559 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -162.11 168.49 22.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.007 -0.368 . . . . 2.98 110.007 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.78 152.15 40.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.139 -1.06 . . . . 3.3799999999999999 108.139 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.87 -37.67 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.407 0.521 . . . . 3.3500000000000001 112.407 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -108.5 98.33 7.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.05 -0.66 . . . . 5.3899999999999997 111.964 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -89.28 55.37 3.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.143 -0.935 . . . . 7.04 108.926 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -135.54 137.0 41.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.309 -0.859 . . . . 7.21 110.098 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.96 119.26 32.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.901 0.381 . . . . 9.0199999999999996 110.729 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -75.66 127.47 33.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.8 -0.636 . . . . 9.75 109.33 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 21.4 p80 -65.3 -58.63 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.825 -0.35 . . . . 12.26 111.099 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 69.0 t60 . . . . . 0 C--O 1.243 0.72 0 CA-C-O 118.493 -0.765 . . . . 13.35 109.452 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.707 -0.479 . . . . 7.4800000000000004 109.707 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m 75.02 14.97 3.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.715 0.769 . . . . 5.9000000000000004 110.251 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.59 113.17 20.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 4.4400000000000004 110.612 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.82 125.99 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.042 0.839 . . . . 4.4400000000000004 110.739 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -144.63 153.12 41.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.676 -0.693 . . . . 4.1500000000000004 111.144 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -85.45 44.05 1.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.627 -0.715 . . . . 3.6099999999999999 109.823 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -81.98 165.18 20.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 3.6000000000000001 111.57 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -94.14 153.99 17.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.013 -0.994 . . . . 2.71 110.053 -175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 11.5 mptt -114.73 147.51 39.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.765 0.317 . . . . 1.8799999999999999 110.697 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.98 108.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.536 -0.542 . . . . 0.58999999999999997 109.536 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -89.45 125.06 35.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.237 0.542 . . . . 2.1600000000000001 111.421 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' H ' HD13 ' A' ' 19' ' ' ILE . 11.1 tp 54.76 64.38 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.953 -1.021 . . . . 1.45 111.027 174.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 80' ' ' ILE . 9.0 t -59.16 156.03 12.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.636 -0.711 . . . . 0.78000000000000003 111.61 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -19.86 64.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.743 -0.662 . . . . 0.81000000000000005 112.588 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.62 19.93 1.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.324 0.49 . . . . 2.3999999999999999 112.324 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.64 30.64 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.68000000000000005 114.429 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.85 83.6 0.06 OUTLIER Glycine 0 C--O 1.227 -0.334 0 N-CA-C 114.648 0.619 . . . . 0.60999999999999999 114.648 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' THR . 55.0 t -141.21 140.1 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.38 -0.6 . . . . 0.48999999999999999 109.38 174.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 12' ' ' LEU . 10.0 mm -93.07 113.58 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.228 0.33 . . . . 0.46999999999999997 110.113 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -141.27 146.9 37.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.338 0.59 . . . . 1.3400000000000001 111.616 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -109.68 138.65 45.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.106 -0.952 . . . . 0.5 110.113 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.84 132.3 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.234 -0.284 . . . . 0.67000000000000004 110.234 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 92' ' ' LEU . 3.5 mm? -115.57 -51.58 2.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.456 -0.338 . . . . 0.82999999999999996 110.64 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 29.1 ttmt -122.9 135.07 54.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.726 -0.472 . . . . 1.5600000000000001 109.726 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -99.63 147.12 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 123.46 0.475 . . . . 2.9500000000000002 110.785 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 171.4 52.15 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 116.028 -0.533 . . . . 1.3200000000000001 111.939 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.55 -65.92 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 2.77 110.768 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -151.7 153.05 33.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 2.6400000000000001 110.074 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.43 100.8 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.181 -1.009 . . . . 1.04 112.98 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -74.63 -42.33 58.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.574 . . . . 2.29 109.793 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -81.4 -23.31 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.377 -0.829 . . . . 2.6400000000000001 110.663 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.69 75.78 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.421 0.629 . . . . 1.45 109.611 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mm -146.4 118.78 4.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.735 -1.12 . . . . 0.81000000000000005 109.209 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HG3' HD22 ' A' ' 122' ' ' LEU . 20.3 Cg_endo -60.78 124.73 15.57 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.799 2.333 . . . . 0.75 111.716 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -116.37 149.54 39.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.601 -0.518 . . . . 2.6600000000000001 109.601 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -77.19 144.54 38.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.416 -0.514 . . . . 2.5099999999999998 110.633 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.34 -22.31 41.32 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.162 -0.775 . . . . 1.1200000000000001 111.162 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -99.33 169.96 8.98 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.079 -0.341 . . . . 1.3799999999999999 110.079 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.05 125.63 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.286 0.565 . . . . 2.2000000000000002 111.324 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG12 ' HB2' ' A' ' 125' ' ' PHE . 19.0 m -135.12 160.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.598 -0.728 . . . . 0.67000000000000004 109.235 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 28.6 m -130.51 111.85 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.407 -0.59 . . . . 0.65000000000000002 109.407 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.26 153.34 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.87 111.751 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -116.18 130.25 56.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 2.75 109.022 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 21.8 p90 -127.23 144.3 51.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.788 0.327 . . . . 0.76000000000000001 110.143 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -167.82 158.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.892 -0.781 . . . . 0.48999999999999999 108.892 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.67 -130.35 1.98 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.841 -1.171 . . . . 0.35999999999999999 113.05 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.744 ' HG3' HD13 ' A' ' 117' ' ' LEU . 57.2 pttt -157.38 173.07 17.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.377 . . . . 1.4299999999999999 110.682 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 66.7 tp -94.53 109.34 21.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 0.38 110.28 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' HD11 ' A' ' 117' ' ' LEU . 24.2 tt0 -68.43 -20.69 64.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.204 0.526 . . . . 1.96 110.091 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.445 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . 39.7 t -55.1 -43.27 73.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.154 -0.93 . . . . 0.67000000000000004 111.328 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.459 HG22 HD23 ' A' ' 48' ' ' LEU . 8.8 t -124.38 3.31 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.72999999999999998 111.41 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.35 78.51 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 120.902 -0.666 . . . . 0.78000000000000003 113.039 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 67.0 mmtt -91.82 132.92 36.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 2.8900000000000001 110.917 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.661 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.8 p -75.84 166.84 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 0.58999999999999997 109.95 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.96 117.99 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.431 0.634 . . . . 0.78000000000000003 110.582 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.72 95.01 2.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.113 -0.949 . . . . 2.1800000000000002 109.42 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 m -137.4 171.2 14.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.933 0.397 . . . . 1.24 110.337 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -70.41 -33.7 71.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.15 -0.477 . . . . 1.49 110.9 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -92.33 -35.93 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.541 0.571 . . . . 1.8 112.541 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -33.77 74.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.819 0.342 . . . . 2.1899999999999999 111.544 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.71 -12.15 51.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.051 0.453 . . . . 2.7799999999999998 110.941 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.864 HD22 HG23 ' A' ' 63' ' ' VAL . 6.9 t30 -112.24 -61.04 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.129 -0.487 . . . . 1.1000000000000001 111.815 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.864 HG23 HD22 ' A' ' 62' ' ' ASN . 96.9 t -119.25 104.09 46.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.598 -0.274 . . . . 2.0299999999999998 110.289 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.42 147.83 47.44 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.086 2.524 . . . . 1.76 112.035 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -101.99 150.39 23.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.295 -0.411 . . . . 1.3100000000000001 109.929 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.09 146.35 31.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 1.3600000000000001 109.792 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -127.59 -177.32 4.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.895 0.379 . . . . 0.56999999999999995 111.278 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -118.51 149.81 40.67 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.363 -0.606 . . . . 1.98 109.363 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 82' ' ' VAL . 15.9 tp -75.87 117.08 17.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.026 0.38 . . . . 0.94999999999999996 112.026 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 68.26 48.79 0.87 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.187 -0.915 . . . . 2.0800000000000001 112.395 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 1.3 pm0 -92.33 0.67 57.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.096 -0.705 . . . . 1.98 109.096 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.37 1.38 44.09 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.71999999999999997 113.091 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 7.9 mm-40 -99.04 -24.27 14.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.412 0.606 . . . . 0.96999999999999997 111.255 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.8 123.64 57.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.923 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.539 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -97.17 -62.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 0.62 112.293 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.626 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 8.7 mmpt? -129.2 -61.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 2.04 112.494 -172.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 -53.21 34.38 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.065 -0.588 . . . . 0.32000000000000001 113.459 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.572 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.0 m-90 -75.24 -37.12 61.17 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.841 -0.211 . . . . 0.48999999999999999 110.644 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.75 -52.09 57.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.826 0.703 . . . . 1.1399999999999999 111.685 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.576 HG21 HG21 ' A' ' 13' ' ' THR . 2.4 mp -74.26 -41.89 50.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 0.78000000000000003 110.995 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.51 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 44.6 t -60.33 -51.03 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.55000000000000004 111.589 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 69' ' ' LEU . 28.6 m -67.69 -43.1 86.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 111.975 0.361 . . . . 0.83999999999999997 111.975 -174.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.429 ' OG ' HD21 ' A' ' 69' ' ' LEU . 21.6 m -70.16 -14.92 62.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.028 0.442 . . . . 1.4299999999999999 111.463 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -99.46 24.95 7.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.367 -0.379 . . . . 1.23 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.592 ' HE1' ' HA ' ' A' ' 82' ' ' VAL . 37.2 mtm -118.83 -173.58 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.215 0.531 . . . . 2.27 111.214 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.498 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 53.5 mtm180 -142.2 175.46 9.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.155 -0.93 . . . . 4.1900000000000004 109.271 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -62.31 -16.88 56.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.563 0.579 . . . . 1.9399999999999999 112.563 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -135.32 29.4 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 1.23 110.747 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 4.5 tt0 -113.91 153.95 28.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.527 -0.546 . . . . 1.6000000000000001 109.527 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.545 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 1.5 tmtp? -143.58 127.49 17.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.972 -0.291 . . . . 1.1699999999999999 110.955 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 71.2 m -127.61 151.45 48.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.222 -0.445 . . . . 1.2 111.425 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.457 ' HB2' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -107.29 118.96 38.1 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.151 -0.685 . . . . 1.73 109.151 173.01 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.2 p -109.7 141.89 23.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.243 0.544 . . . . 0.73999999999999999 111.43 -173.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -99.29 117.44 33.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 1.71 109.88 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.9 mp -96.92 104.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.462 . . . . 0.52000000000000002 109.751 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 97' ' ' SER . 28.9 tt0 -83.76 170.87 13.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.787 -0.82 . . . . 1.3700000000000001 108.787 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 9.5 p -49.6 -49.9 44.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.526 0.33 . . . . 1.0 111.85 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.9 ptp -76.61 -13.5 60.06 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.236 -0.438 . . . . 1.79 111.635 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 16.1 m-30 -84.54 -5.84 59.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.871 0.367 . . . . 0.75 110.149 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -138.39 -161.2 8.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.55 -0.75 . . . . 0.70999999999999996 111.52 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -92.89 30.43 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 1.52 110.975 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.8 -31.94 82.58 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.045 -0.525 . . . . 2.2999999999999998 112.313 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.16 -35.53 75.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.151 0.5 . . . . 5.8600000000000003 110.738 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.51 -40.5 12.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.569 -0.741 . . . . 4.2699999999999996 110.533 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.99 15.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.781 -0.723 . . . . 2.1600000000000001 112.494 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -74.09 108.71 7.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.099 0.476 . . . . 3.3399999999999999 110.865 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -137.95 137.02 8.53 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.773 -0.649 . . . . 1.2 111.768 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -71.44 -46.35 60.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.925 0.393 . . . . 3.0800000000000001 110.988 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 t -110.99 -73.75 0.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.673 -0.491 . . . . 1.52 109.673 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -143.21 117.0 6.13 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.75 110.452 176.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 7.0 Cg_endo -80.56 -68.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.015 1.81 . . . . 1.5800000000000001 111.717 170.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.87 1.25 17.2 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.176 -0.466 . . . . 2.0499999999999998 113.409 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 m120 60.88 27.71 17.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.192 0.52 . . . . 2.0299999999999998 110.917 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -119.7 -163.69 1.01 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.896 -0.593 . . . . 1.1399999999999999 110.307 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 7.6 p -108.17 130.05 61.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.309 0.576 . . . . 0.47999999999999998 111.775 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -112.94 161.89 16.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 109.79 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.744 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.28 116.82 28.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.494 -0.558 . . . . 0.69999999999999996 109.494 175.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.425 ' HD2' HD13 ' A' ' 95' ' ' ILE . 29.4 m-85 -113.87 125.0 53.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.108 0.48 . . . . 0.42999999999999999 111.045 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 47.9 mt-10 -80.13 113.96 18.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.463 -0.789 . . . . 1.46 109.081 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.599 HG21 HG12 ' A' ' 82' ' ' VAL . 40.0 mt -107.93 123.94 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.028 0.442 . . . . 0.47999999999999998 110.352 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 18.3 mt-10 -127.87 130.33 48.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.646 -0.706 . . . . 1.8799999999999999 109.875 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 34' ' ' PRO . 25.6 tp -91.82 100.4 13.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 1.1200000000000001 110.341 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.5 OUTLIER -89.74 -30.2 18.19 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.082 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.454 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 58.0 m -150.41 147.76 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.436 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' HB2' HG12 ' A' ' 40' ' ' VAL . 2.0 p90 -165.05 159.62 18.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.714 . . . . 0.71999999999999997 109.352 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 126' ' ' ARG . 2.3 ptm180 -158.63 113.72 2.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.95 0.405 . . . . 2.98 111.352 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.16 139.92 30.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.363 -0.38 . . . . 3.3799999999999999 110.758 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.3 mt -140.3 52.88 1.65 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.572 -0.74 . . . . 3.3500000000000001 109.761 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.814 ' HB3' ' HE1' ' A' ' 132' ' ' HIS . 1.0 OUTLIER 76.27 -176.13 0.12 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.919 0.762 . . . . 5.3899999999999997 110.02 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -123.76 -49.28 1.88 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.842 0.682 . . . . 7.04 112.842 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -126.93 100.91 6.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.943 0.401 . . . . 7.21 111.72 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.814 ' HE1' ' HB3' ' A' ' 129' ' ' GLU . 15.1 m-70 -91.14 67.24 5.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.2 -0.454 . . . . 9.0199999999999996 110.157 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 24.6 m80 52.74 67.42 0.99 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.552 0.532 . . . . 9.75 111.636 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.7 134.09 20.74 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.689 -0.486 . . . . 12.26 109.689 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.369 -0.824 . . . . 13.35 110.438 -175.106 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.402 -0.221 . . . . 7.4800000000000004 110.402 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.1 p -72.22 99.09 2.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.998 0.427 . . . . 5.9000000000000004 110.256 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -112.36 113.27 25.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.104 0.478 . . . . 4.4400000000000004 111.98 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.72 150.68 22.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.817 -0.629 . . . . 4.4400000000000004 109.512 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -75.61 125.38 28.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.918 0.39 . . . . 4.1500000000000004 111.603 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -84.38 104.47 14.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 3.6099999999999999 109.999 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.15 136.68 54.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.267 0.556 . . . . 3.6000000000000001 111.036 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.85 143.07 42.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 2.71 110.447 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.18 136.27 47.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 1.8799999999999999 109.84 -174.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.6 107.65 23.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.601 -0.518 . . . . 0.58999999999999997 109.601 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HB2' HD12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -102.58 134.95 45.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.138 -0.483 . . . . 2.1600000000000001 111.462 -176.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt 56.64 51.74 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.248 -0.887 . . . . 1.45 112.493 171.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -61.29 153.65 25.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.275 -0.42 . . . . 0.78000000000000003 110.117 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.9 1.07 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.688 0.625 . . . . 0.81000000000000005 112.688 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.64 24.81 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 2.3999999999999999 111.264 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.47 10.42 5.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.378 -0.915 . . . . 0.68000000000000005 114.011 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 57.75 67.14 2.36 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.892 0.717 . . . . 0.60999999999999999 114.892 170.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG21 ' HB ' ' A' ' 80' ' ' ILE . 25.6 t -116.83 139.21 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 122.285 -0.538 . . . . 0.48999999999999999 110.58 173.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 94' ' ' ARG . 5.6 mm -88.18 109.34 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.214 -0.661 . . . . 0.46999999999999997 109.214 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -125.66 146.23 49.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.393 0.616 . . . . 1.3400000000000001 111.222 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 m -114.07 121.43 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.419 -0.81 . . . . 0.5 109.603 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.522 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 tp -72.43 125.96 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.883 0.373 . . . . 0.67000000000000004 111.565 -174.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.03 -63.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.17 0.509 . . . . 0.82999999999999996 109.954 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 50.7 mtmt -117.6 134.9 54.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 1.5600000000000001 108.981 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -102.99 139.46 38.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.754 0.311 . . . . 2.9500000000000002 110.985 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 134.26 12.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.77 -0.729 . . . . 1.3200000000000001 111.718 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.9 -65.32 1.02 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.827 -0.435 . . . . 2.77 109.827 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -96.0 144.17 26.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.0 -0.545 . . . . 2.6400000000000001 109.548 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.556 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -154.34 14.54 0.55 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.547 -0.835 . . . . 1.04 111.852 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.21 -21.05 62.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 2.29 110.406 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' C ' HD22 ' A' ' 32' ' ' ASN . 47.4 mt-10 -115.18 14.49 16.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.773 -0.649 . . . . 2.6400000000000001 109.927 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.556 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -138.78 80.86 1.81 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.083 -0.508 . . . . 1.45 111.4 -172.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.82 113.03 27.0 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.223 0.535 . . . . 0.81000000000000005 111.923 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.2 Cg_endo -91.04 111.08 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.963 2.442 . . . . 0.75 112.384 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 27.9 mmtp -136.64 -173.68 3.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.6600000000000001 110.951 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.36 152.94 20.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 2.5099999999999998 110.726 -176.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.27 -5.19 38.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.744 . . . . 1.1200000000000001 111.904 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' HG13 ' A' ' 40' ' ' VAL . 31.4 p30 -135.24 -175.77 4.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.74 0.305 . . . . 1.3799999999999999 110.513 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -96.99 94.21 7.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 2.2000000000000002 110.743 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 ' OD1' ' A' ' 38' ' ' ASN . 9.6 m -97.85 122.22 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.903 -0.777 . . . . 0.67000000000000004 108.903 168.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.542 HG23 ' HD3' ' A' ' 66' ' ' LYS . 27.0 m -96.72 111.42 23.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.198 0.523 . . . . 0.65000000000000002 109.96 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 120' ' ' ILE . 54.1 t -117.24 130.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.499 -0.773 . . . . 0.87 110.329 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -101.79 127.96 48.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.204 -0.665 . . . . 2.75 109.204 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 6.6 p90 -128.23 144.5 51.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 0.76000000000000001 111.105 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -166.38 144.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.557 -0.747 . . . . 0.48999999999999999 109.841 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 118' ' ' PHE . . . -171.02 -139.91 2.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.613 -0.803 . . . . 0.35999999999999999 112.135 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 64.7 pttt -157.69 172.3 18.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 1.4299999999999999 110.886 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 114' ' ' SER . 60.7 tp -85.55 101.15 12.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.046 -0.525 . . . . 0.38 110.539 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 40.8 tt0 -68.42 -25.87 65.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.771 0.319 . . . . 1.96 110.935 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -54.38 -27.1 34.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 0.67000000000000004 111.543 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.576 HG23 ' HB2' ' A' ' 53' ' ' LYS . 14.8 t -139.18 9.05 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.051 0.453 . . . . 0.72999999999999998 110.482 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.13 41.59 98.18 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.635 -0.711 . . . . 0.78000000000000003 112.755 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.576 ' HB2' HG23 ' A' ' 51' ' ' THR . 4.3 tmtt? -102.83 118.34 36.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 2.8900000000000001 110.29 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.7 p -74.1 160.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.58999999999999997 109.856 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 13.0 m-30 -78.0 124.58 28.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 111.083 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.95 88.27 2.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.854 0.835 . . . . 2.1800000000000002 109.306 171.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.8 m -136.48 172.97 12.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.596 -0.729 . . . . 1.24 111.19 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -71.6 -23.83 61.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.79 -0.641 . . . . 1.49 110.865 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -93.83 -51.1 5.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.147 0.795 . . . . 1.8 113.147 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.8 -43.23 85.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.335 0.397 . . . . 2.1899999999999999 111.996 -168.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -92.22 9.34 34.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.928 0.394 . . . . 2.7799999999999998 111.602 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -115.7 -64.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.283 -0.417 . . . . 1.1000000000000001 111.597 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.8 m -105.01 127.56 28.48 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.384 0.611 . . . . 2.0299999999999998 111.997 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.5 Cg_endo -83.44 111.29 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.956 2.437 . . . . 1.76 111.511 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -94.72 154.57 17.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 1.3100000000000001 110.888 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.542 ' HD3' HG23 ' A' ' 41' ' ' THR . 1.7 pptp? -142.44 157.48 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.942 -0.572 . . . . 1.3600000000000001 110.01 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.09 172.65 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.56999999999999995 110.912 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -122.47 150.3 42.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.813 -0.63 . . . . 1.98 109.641 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.505 HD22 HG23 ' A' ' 82' ' ' VAL . 35.2 tp -71.38 136.29 47.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.792 0.33 . . . . 0.94999999999999996 111.528 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 36.1 mt-10 51.69 37.72 20.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.57 -0.741 . . . . 2.0800000000000001 112.205 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.463 HE21 ' HB2' ' A' ' 73' ' ' GLU . 13.8 pt20 -77.49 -8.28 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.359 0.599 . . . . 1.98 109.597 169.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.24 -19.21 46.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.71999999999999997 112.845 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' HE21 ' A' ' 71' ' ' GLN . 10.1 mm-40 -84.0 -21.92 31.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.883 0.342 . . . . 0.96999999999999997 110.754 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 m -113.61 135.11 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.57999999999999996 110.379 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.02 -61.29 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.083 0.772 . . . . 0.62 113.083 -172.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.3 mmpt? -143.18 -44.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.957 0.725 . . . . 2.04 112.957 -171.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.03 -53.0 36.14 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.651 -0.785 . . . . 0.32000000000000001 112.684 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.448 ' O ' HG22 ' A' ' 82' ' ' VAL . 4.2 m-90 -75.94 -30.94 58.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.853 0.359 . . . . 0.48999999999999999 110.501 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 21.7 t70 -52.24 -54.3 32.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.169 -0.923 . . . . 1.1399999999999999 112.148 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.544 ' HB ' HG21 ' A' ' 18' ' ' VAL . 2.8 mp -75.38 -42.31 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.78000000000000003 110.985 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.577 ' O ' ' HG2' ' A' ' 85' ' ' MET . 20.7 t -56.99 -47.34 81.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.958 -0.565 . . . . 0.55000000000000004 111.182 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.505 HG23 HD22 ' A' ' 69' ' ' LEU . 27.1 m -72.91 -32.21 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 123.0 0.188 . . . . 0.83999999999999997 110.979 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 66.2 m -65.79 -23.3 66.68 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.436 0.636 . . . . 1.4299999999999999 110.869 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -112.25 46.4 1.17 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 1.23 110.455 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.928 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 2.6 mmt -125.41 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.281 0.562 . . . . 2.27 111.226 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.966 ' HD3' ' H ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -155.25 160.69 41.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.056 -1.09 . . . . 4.1900000000000004 108.056 174.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -46.97 -38.27 10.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.461 0.541 . . . . 1.9399999999999999 112.461 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.966 ' H ' ' HD3' ' A' ' 86' ' ' ARG . 16.5 m120 -109.54 6.24 23.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 1.23 111.122 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 30.6 tt0 -105.38 140.85 37.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.161 -0.681 . . . . 1.6000000000000001 109.161 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.5 tttt -146.93 135.92 22.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.266 -0.424 . . . . 1.1699999999999999 110.728 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 22' ' ' ILE . 83.9 m -136.06 159.19 42.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.234 0.54 . . . . 1.2 110.825 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 117' ' ' LEU . 1.8 tp -91.34 142.18 27.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.25 -1.018 . . . . 1.73 108.25 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.97 135.48 52.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 O-C-N 123.366 0.416 . . . . 0.73999999999999999 110.36 -176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -107.28 111.86 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.638 -0.505 . . . . 1.71 109.638 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -96.4 107.1 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.898 -0.408 . . . . 0.52000000000000002 109.898 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.651 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 9.7 tt0 -85.43 177.41 7.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.107 -0.701 . . . . 1.3700000000000001 109.107 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -57.32 -37.29 72.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.4 ptp -77.62 -9.73 59.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.182 0.438 . . . . 1.79 112.182 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.7 m-85 -103.62 6.33 37.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.017 -0.273 . . . . 0.75 111.037 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.71 174.92 16.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.952 -0.642 . . . . 0.70999999999999996 112.468 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.438 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 50.4 m-85 -81.05 -6.9 59.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.941 0.401 . . . . 1.52 111.183 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.51 -149.68 51.51 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.577 -0.82 . . . . 2.2999999999999998 111.655 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.35 -6.52 57.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 5.8600000000000003 111.265 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -84.48 -46.14 11.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.309 -0.405 . . . . 4.2699999999999996 111.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -84.47 170.41 46.47 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.634 -0.793 . . . . 2.1600000000000001 112.323 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -82.08 95.06 7.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.108 0.48 . . . . 3.3399999999999999 110.484 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.538 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -68.34 152.79 52.67 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.68 -0.691 . . . . 1.2 112.347 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -71.71 -58.71 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.377 0.14 . . . . 3.0800000000000001 111.377 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -108.22 -75.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.631 -0.428 . . . . 1.52 111.33 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.407 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -148.23 104.16 3.56 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.75 111.225 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.538 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 50.4 Cg_endo -97.42 179.89 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.076 2.517 . . . . 1.5800000000000001 112.274 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.61 66.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.267 -0.968 . . . . 2.0499999999999998 113.187 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 m120 55.48 23.84 6.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.954 0.406 . . . . 2.0299999999999998 111.835 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.579 ' HB3' HD11 ' A' ' 48' ' ' LEU . 30.1 m -110.03 150.71 28.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.942 -0.572 . . . . 1.1399999999999999 110.003 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.17 130.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.47999999999999998 110.206 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.433 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.6 mp -123.34 151.45 42.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.063 -0.517 . . . . 0.51000000000000001 110.411 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -128.22 125.54 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.497 . . . . 0.69999999999999996 110.926 177.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.444 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 46.1 m-85 -126.14 153.22 44.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.745 -0.661 . . . . 0.42999999999999999 110.221 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.578 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 42.7 mt-10 -85.46 126.88 34.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.279 -0.638 . . . . 1.46 109.279 170.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.481 HG23 HG11 ' A' ' 42' ' ' VAL . 10.6 mt -108.58 118.18 55.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 0.47999999999999998 109.865 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 45.2 tt0 -132.96 132.29 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 1.8799999999999999 110.24 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.21 115.7 28.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 1.1200000000000001 110.678 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.31 -21.4 13.84 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.757 -0.377 . . . . 1.0 112.016 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.507 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 29.3 t -155.63 149.61 25.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.003 -0.279 . . . . 1.1899999999999999 110.393 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -168.19 172.66 8.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 0.71999999999999997 110.036 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -161.04 126.38 3.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 2.98 110.177 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -89.4 139.09 30.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 3.3799999999999999 111.536 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 39.8 tp -99.92 -6.39 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.488 -0.778 . . . . 3.3500000000000001 110.786 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.67 158.87 0.21 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.524 -0.762 . . . . 5.3899999999999997 111.967 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -62.56 126.27 26.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.333 -0.848 . . . . 7.04 110.969 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -101.67 -21.6 14.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.414 -0.812 . . . . 7.21 111.305 -171.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -84.58 135.12 34.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.838 -0.43 . . . . 9.0199999999999996 109.838 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -100.74 129.23 46.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.967 0.413 . . . . 9.75 111.212 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -93.32 -28.24 16.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.649 -0.871 . . . . 12.26 108.649 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 . . . . . 0 C--O 1.242 0.692 0 CA-C-N 114.79 -1.095 . . . . 13.35 108.987 177.701 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.81 0.338 . . . . 7.4800000000000004 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 p -129.81 -49.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.78 0.324 . . . . 5.9000000000000004 110.158 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m 57.94 78.34 0.24 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.761 0.791 . . . . 4.4400000000000004 110.475 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -107.68 175.5 5.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.982 -1.008 . . . . 4.4400000000000004 110.061 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -68.14 101.83 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.523 . . . . 4.1500000000000004 110.438 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.56 46.08 1.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.61 -0.723 . . . . 3.6099999999999999 110.063 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -113.03 144.74 42.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.474 . . . . 3.6000000000000001 110.887 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.39 157.07 17.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.51 0.672 . . . . 2.71 110.609 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -103.0 148.26 25.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.789 -1.096 . . . . 1.8799999999999999 111.052 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.41 106.92 20.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.58999999999999997 109.495 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 7.4 pt-20 -78.85 113.35 16.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.803 -0.635 . . . . 2.1600000000000001 111.542 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.47 ' H ' HD13 ' A' ' 19' ' ' ILE . 17.2 tp 58.25 65.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 1.45 111.215 169.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 t -61.73 144.9 53.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 0.78000000000000003 110.076 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 0.72 7.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.95 0.352 . . . . 0.81000000000000005 111.95 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.48 25.73 1.01 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.532 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.09 2.64 9.16 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.68000000000000005 113.92 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.47 78.28 0.61 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.072 -0.585 . . . . 0.60999999999999999 114.169 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 80' ' ' ILE . 53.7 t -140.78 143.82 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.935 -0.394 . . . . 0.48999999999999999 109.935 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 17.9 mm -86.27 116.31 28.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.595 -0.52 . . . . 0.46999999999999997 109.595 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -138.19 144.34 40.64 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.507 -0.477 . . . . 1.3400000000000001 111.464 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 6.8 m -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.916 -0.583 . . . . 0.5 109.864 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.5 tp -84.82 118.91 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.67000000000000004 110.585 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.18 -70.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.82999999999999996 110.605 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 36.9 ttpt -109.7 116.33 31.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.519 -0.31 . . . . 1.5600000000000001 110.531 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.55 137.62 42.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.033 -0.531 . . . . 2.9500000000000002 110.171 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.44 162.35 54.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.735 -0.745 . . . . 1.3200000000000001 112.309 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.76 -68.26 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 2.77 110.74 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -150.37 132.61 15.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.095 0.474 . . . . 2.6400000000000001 109.781 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.08 33.33 0.94 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.498 -0.858 . . . . 1.04 111.492 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.26 -28.93 70.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.24 0.543 . . . . 2.29 110.402 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -94.88 -4.75 46.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.332 -0.849 . . . . 2.6400000000000001 110.381 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -138.81 91.46 2.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.051 0.453 . . . . 1.45 111.259 -173.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.09 123.98 28.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.81000000000000005 110.776 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 43.0 Cg_endo -69.96 92.54 0.53 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.644 2.229 . . . . 0.75 111.807 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 53.5 mmtt -94.7 146.53 24.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.365 0.602 . . . . 2.6600000000000001 112.261 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -71.99 124.54 25.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.933 -1.031 . . . . 2.5099999999999998 110.0 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.89 -9.24 43.49 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.422 -0.671 . . . . 1.1200000000000001 111.422 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -101.09 154.65 18.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.343 . . . . 1.3799999999999999 110.219 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -79.3 106.21 11.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.329 0.585 . . . . 2.2000000000000002 111.123 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' HIS . 3.1 m -121.68 152.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.843 -0.799 . . . . 0.67000000000000004 108.843 174.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.2 m -117.75 119.42 34.86 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.651 -0.5 . . . . 0.65000000000000002 109.651 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.549 HG11 HG23 ' A' ' 120' ' ' ILE . 90.3 t -131.82 144.06 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.999 -0.546 . . . . 0.87 110.764 -174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.468 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 24.5 m80 -99.96 145.29 28.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.044 -0.354 . . . . 2.75 110.044 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 29.2 p90 -143.06 130.63 21.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.055 0.455 . . . . 0.76000000000000001 110.934 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.57 159.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.224 -0.658 . . . . 0.48999999999999999 109.224 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.41 -121.0 0.7 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.041 -1.076 . . . . 0.35999999999999999 112.751 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 50.1 pttt -150.9 168.06 25.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.666 0.27 . . . . 1.4299999999999999 110.505 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' HG ' ' A' ' 116' ' ' LEU . 57.3 tp -85.02 98.37 10.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.031 -0.729 . . . . 0.38 109.031 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 50.0 tp10 -62.55 -26.94 68.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 1.96 112.381 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 4.4 t -63.17 -18.56 63.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 0.67000000000000004 111.279 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -129.63 -26.12 2.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.034 0.445 . . . . 0.72999999999999998 110.767 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.44 35.64 10.4 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.369 -0.443 . . . . 0.78000000000000003 112.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.38 128.86 56.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.715 0.293 . . . . 2.8900000000000001 110.362 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.8 p -71.77 158.35 6.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.58999999999999997 109.78 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 21.7 m-85 -73.93 98.49 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.315 0.579 . . . . 0.78000000000000003 111.784 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.72 86.15 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.13 -1.063 . . . . 2.1800000000000002 108.13 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -136.54 164.47 28.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.811 -0.631 . . . . 1.24 110.571 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -57.97 -45.76 86.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 1.49 112.046 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -93.32 -45.45 7.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.012 0.434 . . . . 1.8 110.943 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -34.49 58.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.122 -0.944 . . . . 2.1899999999999999 111.655 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 61' ' ' ARG . 6.1 ptm85 -77.52 -22.88 50.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 2.7799999999999998 111.801 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -100.66 -52.79 3.24 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.818 -0.353 . . . . 1.1000000000000001 110.942 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.26 108.77 6.25 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.996 0.427 . . . . 2.0299999999999998 111.698 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.7 153.34 56.61 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.553 2.169 . . . . 1.76 110.547 173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -93.47 149.14 21.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.007 0.432 . . . . 1.3100000000000001 110.515 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 3.0 pptp? -123.12 142.67 50.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.794 -0.639 . . . . 1.3600000000000001 109.587 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -128.86 171.42 12.3 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.985 0.421 . . . . 0.56999999999999995 110.999 -176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 98.0 m-70 -112.22 145.94 39.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.464 -0.789 . . . . 1.98 109.113 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 36' ' ' LYS . 16.6 tp -72.62 120.42 18.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.315 0.579 . . . . 0.94999999999999996 110.371 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 66.56 54.59 0.86 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.447 -1.251 . . . . 2.0800000000000001 111.077 -176.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.444 HE21 ' HB2' ' A' ' 73' ' ' GLU . 12.2 pt20 -96.07 10.01 38.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 1.98 109.414 169.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.07 -12.18 62.93 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.422 -0.808 . . . . 0.71999999999999997 112.801 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HB2' HE21 ' A' ' 71' ' ' GLN . 13.3 mm-40 -96.18 -10.16 28.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.712 0.291 . . . . 0.96999999999999997 111.279 -174.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.3 m -110.07 125.11 67.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.006 0.431 . . . . 0.57999999999999996 110.713 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.762 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -95.78 -59.13 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.921 0.711 . . . . 0.62 112.921 -173.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 75' ' ' ILE . 6.6 mmpt? -140.0 -61.06 0.53 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.094 -0.378 . . . . 2.04 111.401 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.42 -52.79 35.12 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.953 -0.567 . . . . 0.32000000000000001 113.656 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.6 m-90 -74.98 -44.78 46.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.975 0.387 . . . . 0.48999999999999999 110.738 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -51.61 -51.83 52.48 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.039 0.837 . . . . 1.1399999999999999 111.933 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.513 ' HB ' HG21 ' A' ' 18' ' ' VAL . 2.1 mp -75.05 -38.64 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 0.78000000000000003 110.972 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.701 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 34.3 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.55000000000000004 110.68 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 78' ' ' TRP . 34.7 m -67.74 -32.64 57.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.738 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.0 t -62.38 -32.73 73.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.4299999999999999 110.886 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.7 t -96.09 31.18 2.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.141 -0.481 . . . . 1.23 110.627 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.579 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mmt -110.42 -173.33 2.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.386 0.613 . . . . 2.27 111.609 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 6.4 ttm180 -139.76 168.46 19.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.878 -1.156 . . . . 4.1900000000000004 107.878 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.0 -35.18 70.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.338 . . . . 1.9399999999999999 111.392 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -122.2 31.98 5.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 1.23 110.862 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 23.6 tt0 -122.36 143.98 49.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.308 -0.405 . . . . 1.6000000000000001 110.452 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.87 137.9 35.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.716 0.293 . . . . 1.1699999999999999 110.529 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' THR . 27.5 p -141.22 171.37 14.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 1.2 111.194 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.09 123.05 49.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.68 . . . . 1.73 109.533 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.701 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.0 p -99.92 137.48 27.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.255 0.55 . . . . 0.73999999999999999 110.8 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 55.2 mmt-85 -91.11 112.38 24.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.633 -0.712 . . . . 1.71 110.086 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.491 HD11 HG13 ' A' ' 93' ' ' VAL . 2.9 mp -93.7 100.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.368 -0.604 . . . . 0.52000000000000002 109.368 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 97' ' ' SER . 29.6 tt0 -81.05 170.25 16.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.484 -0.932 . . . . 1.3700000000000001 108.484 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.517 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 8.7 p -51.4 -44.13 62.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.767 0.284 . . . . 1.0 111.767 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.6 ptp -77.56 -8.43 57.81 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.128 0.418 . . . . 1.79 112.128 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -103.88 -11.86 17.24 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 122.267 -0.271 . . . . 0.75 110.941 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.06 164.61 17.12 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.734 -0.746 . . . . 0.70999999999999996 113.24 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.49 94.08 8.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.995 -0.372 . . . . 1.52 109.995 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.33 62.16 0.37 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.506 -0.854 . . . . 2.2999999999999998 112.695 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 97' ' ' SER . 17.8 t70 -69.71 -30.21 67.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 5.8600000000000003 110.438 174.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.55 -46.43 86.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.346 -0.843 . . . . 4.2699999999999996 111.477 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -168.14 -128.04 0.96 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.391 -0.909 . . . . 2.1600000000000001 112.538 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.706 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 81.4 m -87.69 149.05 24.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.956 0.408 . . . . 3.3399999999999999 111.073 -175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.14 -101.74 0.33 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.297 -0.721 . . . . 1.2 111.297 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.63 -71.93 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.687 0.28 . . . . 3.0800000000000001 110.77 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -111.55 -75.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.52 110.666 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.03 83.66 4.22 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-O 120.814 0.34 . . . . 0.75 111.844 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.706 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 52.1 Cg_endo -98.54 -160.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.228 2.618 . . . . 1.5800000000000001 111.457 171.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.38 91.48 2.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 2.0499999999999998 113.189 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.4 m120 56.66 27.13 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 2.0299999999999998 111.738 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 9.7 p -133.93 171.04 14.72 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.633 -0.258 . . . . 1.1399999999999999 110.875 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.24 133.43 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.198 0.523 . . . . 0.47999999999999998 110.348 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.6 mp -122.38 169.6 10.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.51000000000000001 109.699 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -147.42 133.8 19.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.061 0.457 . . . . 0.69999999999999996 110.596 172.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' A' ' 55' ' ' PHE . 39.9 m-85 -122.41 142.29 50.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.89 -0.595 . . . . 0.42999999999999999 109.616 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 32.5 mt-10 -74.18 122.97 23.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.724 -0.843 . . . . 1.46 108.724 171.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.549 HG23 HG11 ' A' ' 42' ' ' VAL . 8.1 mt -105.95 115.42 47.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.422 0.63 . . . . 0.47999999999999998 109.739 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -132.08 116.59 17.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.098 -0.955 . . . . 1.8799999999999999 110.284 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 123' ' ' LEU . 6.8 tt -87.12 133.71 33.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 1.1200000000000001 109.219 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 122' ' ' LEU . 1.1 pt? -117.1 -43.96 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.786 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.9 t -140.78 140.87 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.783 -0.451 . . . . 1.1899999999999999 109.783 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.584 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -167.04 177.57 6.21 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.174 0.297 . . . . 0.71999999999999997 110.6 -179.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -157.49 150.72 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 2.98 111.051 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.21 116.84 31.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.582 -0.525 . . . . 3.3799999999999999 109.582 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 31.9 tp -150.62 157.69 43.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 3.3500000000000001 110.581 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.57 137.02 32.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.241 -0.436 . . . . 5.3899999999999997 110.953 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -83.91 53.28 2.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.126 -1.064 . . . . 7.04 108.126 165.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -79.53 53.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.348 -1.297 . . . . 7.21 110.286 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 63.63 -168.71 0.2 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.007 -0.542 . . . . 9.0199999999999996 110.924 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.01 158.78 19.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.138 -0.689 . . . . 9.75 109.138 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -169.36 169.66 8.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.503 -0.317 . . . . 12.26 110.188 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 . . . . . 0 C--O 1.245 0.864 0 N-CA-C 109.244 -0.651 . . . . 13.35 109.244 176.603 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.421 0.153 . . . . 7.4800000000000004 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 t -71.9 111.85 7.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.585 . . . . 5.9000000000000004 109.422 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.28 10.37 15.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.141 0.496 . . . . 4.4400000000000004 111.181 -172.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -105.25 124.12 49.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.879 -0.6 . . . . 4.4400000000000004 110.367 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -59.62 130.08 45.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 4.1500000000000004 109.834 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.67 84.76 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.157 0.503 . . . . 3.6099999999999999 111.24 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -141.57 163.13 33.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.621 -0.718 . . . . 3.6000000000000001 109.607 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.34 148.83 29.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.11 0.481 . . . . 2.71 110.878 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.7 mppt? -91.96 143.17 26.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 110.283 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' A' ' 13' ' ' THR . 5.1 t -108.94 108.55 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 110.054 -0.35 . . . . 0.58999999999999997 110.054 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.81 128.92 43.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.1600000000000001 110.974 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 19' ' ' ILE . 13.5 tp 55.76 46.26 22.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.689 0.757 . . . . 1.45 110.113 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.5 t -63.84 164.04 10.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.868 -1.06 . . . . 0.78000000000000003 111.532 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.66 1.37 8.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.81000000000000005 111.253 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' O ' HG13 ' A' ' 80' ' ' ILE . 25.9 m-20 -80.65 14.19 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 2.3999999999999999 111.054 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.27 9.39 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.52 -0.847 . . . . 0.68000000000000005 113.598 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.25 64.07 1.81 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.803 -0.713 . . . . 0.60999999999999999 114.045 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.555 ' HB ' HG21 ' A' ' 80' ' ' ILE . 3.3 t -145.35 154.23 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.894 -0.41 . . . . 0.48999999999999999 109.894 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 12' ' ' LEU . 4.7 mm -85.24 109.65 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.243 -0.28 . . . . 0.46999999999999997 110.243 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HE3' HG21 ' A' ' 13' ' ' THR . 21.6 pttp -132.61 142.65 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.3400000000000001 111.181 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -110.8 140.87 44.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.476 -0.784 . . . . 0.5 110.246 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' C ' HD22 ' A' ' 23' ' ' LEU . 7.6 tp -86.44 130.3 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.422 -0.354 . . . . 0.67000000000000004 110.369 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 22' ' ' ILE . 3.5 mm? -132.72 -69.32 0.57 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.455 0.645 . . . . 0.82999999999999996 110.515 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 80.7 tttt -91.5 97.66 11.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.41 -0.814 . . . . 1.5600000000000001 109.53 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -73.74 127.29 32.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.068 -0.969 . . . . 2.9500000000000002 110.21 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.7 -148.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.09 -0.505 . . . . 1.3200000000000001 113.33 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.5 -167.84 2.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.463 -0.94 . . . . 2.77 108.463 -172.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -85.46 127.3 34.35 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.739 -0.467 . . . . 2.6400000000000001 109.739 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -168.39 75.37 0.12 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.108 -0.797 . . . . 1.04 111.108 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.44 -32.99 69.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.749 0.278 . . . . 2.29 111.749 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.72 0.38 56.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.272 0.558 . . . . 2.6400000000000001 110.579 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.406 ' HA ' ' HZ ' ' A' ' 125' ' ' PHE . 0.9 OUTLIER -105.5 79.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 1.45 110.877 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.8 mm -131.37 122.04 18.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.81000000000000005 110.909 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 122' ' ' LEU . 69.6 Cg_endo -77.55 126.56 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.689 2.259 . . . . 0.75 112.023 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 27.1 mmtp -132.92 161.92 32.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.905 0.383 . . . . 2.6600000000000001 110.77 177.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -71.77 150.21 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.969 -0.559 . . . . 2.5099999999999998 111.882 -172.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.43 -23.03 29.69 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.722 -0.672 . . . . 1.1200000000000001 111.799 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.447 ' OD1' ' HG ' ' A' ' 128' ' ' LEU . 85.1 m-20 -86.66 153.41 21.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.003 0.43 . . . . 1.3799999999999999 110.968 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 51.0 mt-10 -79.0 95.39 5.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.016 -0.538 . . . . 2.2000000000000002 110.481 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG21 HD23 ' A' ' 69' ' ' LEU . 19.9 m -102.87 151.08 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.6 -0.519 . . . . 0.67000000000000004 109.6 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -111.95 106.51 15.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.167 -0.679 . . . . 0.65000000000000002 109.167 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -126.33 138.99 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.87 110.863 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 22.3 m-70 -104.16 142.91 33.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.521 -0.548 . . . . 2.75 109.521 172.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.5 p90 -137.15 139.52 41.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 0.76000000000000001 110.021 175.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.11 154.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 0.48999999999999999 109.146 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 179.77 -134.6 2.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.878 -1.153 . . . . 0.35999999999999999 112.98 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 117' ' ' LEU . 22.8 pttp -151.68 171.33 17.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.032 0.444 . . . . 1.4299999999999999 110.671 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 114' ' ' SER . 61.3 tp -85.58 107.38 17.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.621 . . . . 0.38 109.758 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.6 tp10 -68.05 -31.19 70.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.031 0.443 . . . . 1.96 110.81 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 t -54.3 -43.04 70.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.342 -0.844 . . . . 0.67000000000000004 112.05 -173.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.498 HG22 HD23 ' A' ' 48' ' ' LEU . 15.4 t -119.96 -10.97 9.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.72999999999999998 110.604 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 56.12 3.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.892 -0.671 . . . . 0.78000000000000003 111.648 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -125.03 130.02 51.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.175 -0.305 . . . . 2.8900000000000001 110.175 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.2 156.87 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.114 -0.328 . . . . 0.58999999999999997 110.114 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -74.6 99.33 3.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.386 . . . . 0.78000000000000003 111.763 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.83 91.84 3.82 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.485 -0.932 . . . . 2.1800000000000002 108.485 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 28.7 t -137.59 148.3 45.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.46 -0.791 . . . . 1.24 109.985 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -53.8 -42.49 68.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.312 0.486 . . . . 1.49 112.312 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -84.84 -46.15 11.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 1.8 110.692 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -36.82 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 2.1899999999999999 111.629 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' SER . 14.8 ptm180 -81.56 4.11 22.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.697 0.284 . . . . 2.7799999999999998 111.542 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' A' ' 63' ' ' VAL . 14.3 t30 -121.29 -60.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.645 -0.252 . . . . 1.1000000000000001 110.702 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG13 ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -133.32 133.7 23.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.692 0.282 . . . . 2.0299999999999998 111.598 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.0 Cg_exo -77.3 163.35 30.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.838 2.359 . . . . 1.76 111.869 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -103.87 154.74 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.427 -0.351 . . . . 1.3100000000000001 110.302 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -137.49 151.36 48.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 1.3600000000000001 109.649 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -136.42 -175.55 4.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.756 0.313 . . . . 0.56999999999999995 110.819 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -121.03 150.05 41.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 1.98 109.991 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -58.14 121.67 11.25 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.752 0.657 . . . . 0.94999999999999996 111.348 -174.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER 55.29 45.95 24.58 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.589 0.556 . . . . 2.0800000000000001 111.806 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.554 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 6.7 pm0 -78.96 -4.3 49.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.094 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.15 -9.13 50.02 Favored Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.71999999999999997 113.161 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 15.9 mm-40 -95.57 -17.08 21.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.96999999999999997 110.724 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.14 132.74 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.74 0.305 . . . . 0.57999999999999996 110.695 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.484 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.5 -68.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.373 0.508 . . . . 0.62 112.373 -178.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.618 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 5.6 mtpp -140.94 -41.26 0.4 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.449 0.537 . . . . 2.04 112.449 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.02 -46.73 61.08 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.32000000000000001 112.56 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.499 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.9 m-90 -76.13 -36.89 58.61 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.922 -0.163 . . . . 0.48999999999999999 111.127 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -63.42 -40.43 97.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.033 0.383 . . . . 1.1399999999999999 112.033 -169.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.555 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -64.35 -39.45 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.013 0.435 . . . . 0.78000000000000003 110.631 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -72.3 -51.28 21.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.406 -0.361 . . . . 0.55000000000000004 110.891 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.0 m -64.63 -33.89 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.254 0.465 . . . . 0.83999999999999997 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 t -80.19 -0.84 37.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.018 0.437 . . . . 1.4299999999999999 110.769 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 t -119.88 14.41 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.18 -0.464 . . . . 1.23 110.387 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.041 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 4.0 mmt -98.95 179.18 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 2.27 110.809 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.469 ' NH1' ' HA3' ' A' ' 29' ' ' GLY . 22.3 ttp85 -143.6 174.05 11.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.133 -1.062 . . . . 4.1900000000000004 108.133 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 60.3 tttm -67.7 -6.09 19.1 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.8 0.334 . . . . 1.9399999999999999 111.832 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -141.56 21.2 2.19 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.581 0.229 . . . . 1.23 110.594 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.5 tt0 -118.76 148.64 42.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.512 -0.313 . . . . 1.6000000000000001 110.66 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 24' ' ' LYS . 75.2 tttt -149.06 138.66 21.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 1.1699999999999999 110.794 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 87.5 m -134.02 164.33 27.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.44 -0.345 . . . . 1.2 111.142 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.508 ' CD2' ' HG2' ' A' ' 119' ' ' GLU . 63.6 mt -100.53 111.62 23.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.037 -0.529 . . . . 1.73 109.605 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 77' ' ' GLY . 7.1 p -100.98 135.95 34.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.73999999999999999 109.994 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mmm-85 -100.45 111.43 23.69 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.115 -0.698 . . . . 1.71 109.115 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 93' ' ' VAL . 3.2 mp -92.21 103.62 14.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.127 0.489 . . . . 0.52000000000000002 109.833 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.54 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 32.5 tt0 -82.41 173.44 12.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.321 -0.854 . . . . 1.3700000000000001 109.02 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.6 p -51.54 -41.31 60.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.631 0.372 . . . . 1.0 111.898 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.0 ptm -77.21 -15.7 59.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 1.79 111.771 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.7 m-30 -91.2 -13.96 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.75 110.885 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.55 -172.54 15.54 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.348 -0.701 . . . . 0.70999999999999996 111.348 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -84.09 41.77 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 1.52 111.209 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.4 -21.98 76.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.804 -0.713 . . . . 2.2999999999999998 112.202 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -76.23 -46.29 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 5.8600000000000003 110.569 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -74.71 -43.04 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 4.2699999999999996 110.998 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.2 22.93 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.517 -0.849 . . . . 2.1600000000000001 112.425 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.3 m -75.07 139.36 42.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.22 -0.289 . . . . 3.3399999999999999 110.22 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.523 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -168.48 165.36 38.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.69 -0.767 . . . . 1.2 111.545 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -76.46 -70.93 0.42 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.823 0.311 . . . . 3.0800000000000001 110.881 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -93.35 -73.24 0.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.588 -0.278 . . . . 1.52 111.066 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.445 HG12 HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -146.13 100.2 4.22 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 121.143 0.496 . . . . 0.75 111.285 177.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.523 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 61.0 Cg_endo -90.29 -166.33 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.874 2.383 . . . . 1.5800000000000001 111.856 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.82 -139.5 13.49 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.553 -0.832 . . . . 2.0499999999999998 112.748 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.4 m120 -93.42 6.11 49.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.124 0.488 . . . . 2.0299999999999998 110.349 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 48' ' ' LEU . 47.1 m -94.44 146.95 23.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.74 -0.664 . . . . 1.1399999999999999 111.349 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.2 p -95.02 138.82 19.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.2 -0.455 . . . . 0.47999999999999998 110.286 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.4 mp -126.36 174.27 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 0.51000000000000001 110.622 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -132.78 124.4 28.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.157 -0.683 . . . . 0.69999999999999996 109.157 176.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 22.2 m-85 -116.13 126.6 53.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.934 0.397 . . . . 0.42999999999999999 110.546 178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.609 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 37.8 mt-10 -81.18 107.66 14.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 1.46 109.504 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' HIS . 58.4 mt -107.85 124.46 64.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.061 -0.256 . . . . 0.47999999999999998 110.9 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 90' ' ' LYS . 34.3 mt-10 -121.5 131.02 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 1.8799999999999999 110.308 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 42' ' ' VAL . 6.9 tt -100.26 101.85 12.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 1.1200000000000001 109.576 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -96.69 -16.23 21.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -175.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.5 m -153.19 150.76 29.37 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.454 -0.202 . . . . 1.1899999999999999 110.454 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.498 ' HB3' HD21 ' A' ' 122' ' ' LEU . 1.5 p90 -164.85 178.74 6.96 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.963 -0.384 . . . . 0.71999999999999997 109.963 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.635 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.9 ptp180 -162.17 167.84 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.617 0.573 . . . . 2.98 109.547 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.69 151.54 37.79 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.201 0.313 . . . . 3.3799999999999999 110.265 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.447 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 95.6 mt -101.76 138.22 39.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.46 -0.336 . . . . 3.3500000000000001 110.924 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.42 154.83 26.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 5.3899999999999997 108.88 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -83.64 -92.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.433 -0.349 . . . . 7.04 110.867 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.96 92.22 2.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.569 . . . . 7.21 109.465 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -82.52 114.66 21.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 9.0199999999999996 109.433 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -59.33 140.21 56.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.041 0.448 . . . . 9.75 111.01 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -160.73 142.4 12.25 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.906 -0.776 . . . . 12.26 108.906 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.543 -0.741 . . . . 13.35 110.19 -177.215 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mmm . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.515 0.197 . . . . 7.4800000000000004 110.634 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.9 p -79.81 155.73 27.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.251 -0.431 . . . . 5.9000000000000004 110.142 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p -73.35 162.33 29.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.495 -0.32 . . . . 4.4400000000000004 111.335 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 60.43 -149.15 0.43 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.59 0.556 . . . . 4.4400000000000004 110.636 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.52 139.23 36.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.306 -0.406 . . . . 4.1500000000000004 110.13 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.78 38.0 1.62 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.036 -0.529 . . . . 3.6099999999999999 110.481 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -101.28 113.89 27.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 110.224 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -89.44 156.08 18.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.444 -0.576 . . . . 2.71 109.444 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.28 153.85 24.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.405 -0.361 . . . . 1.8799999999999999 110.8 -171.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.38 104.83 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.58999999999999997 109.029 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.87 120.29 30.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 2.1600000000000001 110.612 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' H ' HD13 ' A' ' 19' ' ' ILE . 96.2 mt 58.67 64.72 1.38 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.569 0.7 . . . . 1.45 110.727 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.5 HG21 ' HE2' ' A' ' 20' ' ' LYS . 9.2 t -65.79 160.84 22.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.936 -1.029 . . . . 0.78000000000000003 111.115 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.33 -5.22 21.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.093 0.405 . . . . 0.81000000000000005 112.093 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -71.05 -0.36 9.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.407 -0.36 . . . . 2.3999999999999999 111.268 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.98 24.79 2.2 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.79 -0.719 . . . . 0.68000000000000005 113.321 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.14 72.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.011 -0.614 . . . . 0.60999999999999999 113.576 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.539 ' HB ' HG21 ' A' ' 80' ' ' ILE . 12.2 t -138.84 146.11 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.856 -0.424 . . . . 0.48999999999999999 109.856 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 12' ' ' LEU . 22.0 mm -87.08 110.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.013 -0.365 . . . . 0.46999999999999997 110.013 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.5 ' HE2' HG21 ' A' ' 13' ' ' THR . 58.3 pttt -125.27 145.53 49.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 1.3400000000000001 111.096 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -126.01 120.49 30.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 0.5 109.8 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.542 HG12 ' HG3' ' A' ' 25' ' ' LYS . 10.0 tp -76.01 145.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.386 . . . . 0.67000000000000004 110.734 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.39 -34.85 2.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.431 -0.35 . . . . 0.82999999999999996 111.173 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 38.8 ttpt -150.78 118.32 6.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.637 -0.505 . . . . 1.5600000000000001 109.637 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HG3' HG12 ' A' ' 22' ' ' ILE . 88.8 mttt -101.0 154.28 18.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.188 0.518 . . . . 2.9500000000000002 112.021 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.89 164.75 16.07 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 111.683 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.65 -95.12 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.045 0.422 . . . . 2.77 111.133 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -91.48 145.38 24.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.944 0.402 . . . . 2.6400000000000001 110.845 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 162.51 64.57 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.787 -0.642 . . . . 1.04 111.615 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.23 -35.0 72.86 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.072 0.463 . . . . 2.29 111.011 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -104.25 26.34 8.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 2.6400000000000001 111.539 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.48 74.9 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.753 -0.462 . . . . 1.45 109.753 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.528 HG22 ' HG2' ' A' ' 35' ' ' LYS . 27.6 mm -136.68 108.92 9.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 0.81000000000000005 110.829 -177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 83' ' ' SER . 58.6 Cg_endo -71.46 88.24 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.643 2.229 . . . . 0.75 112.067 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HG2' HG22 ' A' ' 33' ' ' ILE . 29.7 mmtp -97.7 159.41 14.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.533 0.682 . . . . 2.6600000000000001 111.876 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HA ' HD23 ' A' ' 69' ' ' LEU . 8.8 ttmm -67.88 150.29 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.683 -1.144 . . . . 2.5099999999999998 111.531 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.68 -26.13 22.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.192 -0.528 . . . . 1.1200000000000001 112.119 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 128' ' ' LEU . 92.4 m-20 -111.13 158.45 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.698 0.285 . . . . 1.3799999999999999 110.726 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.76 97.75 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.19 0.519 . . . . 2.2000000000000002 111.721 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.9 m -96.86 143.81 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.065 -0.717 . . . . 0.67000000000000004 109.065 170.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 20.1 m -111.62 113.63 26.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.877 0.37 . . . . 0.65000000000000002 110.755 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 122' ' ' LEU . 22.9 m -131.6 160.8 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.073 -0.512 . . . . 0.87 111.599 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -117.18 153.99 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 2.75 109.254 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -137.69 143.56 41.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.44 -0.345 . . . . 0.76000000000000001 110.233 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.89 160.79 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.878 -0.786 . . . . 0.48999999999999999 108.878 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 167.08 -136.55 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.351 -0.928 . . . . 0.35999999999999999 112.38 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.626 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 60.6 pttt -158.45 171.97 19.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.653 0.263 . . . . 1.4299999999999999 110.995 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.494 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -88.86 105.25 17.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.38 110.403 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 32.7 tt0 -64.04 -27.39 69.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.36 -0.382 . . . . 1.96 111.249 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.7 t -54.76 -40.59 69.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.894 -0.594 . . . . 0.67000000000000004 111.545 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.452 HG22 HD23 ' A' ' 48' ' ' LEU . 10.1 t -120.01 -12.47 9.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.583 0.23 . . . . 0.72999999999999998 111.597 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.42 10.75 73.26 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.75 -0.738 . . . . 0.78000000000000003 112.896 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 33.7 mmtp -88.39 132.03 34.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.871 0.367 . . . . 2.8900000000000001 111.163 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.626 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 11.3 p -81.65 160.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.472 -0.786 . . . . 0.58999999999999997 109.963 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -74.53 114.56 13.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.021 0.439 . . . . 0.78000000000000003 111.249 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -129.03 91.23 3.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.145 -0.687 . . . . 2.1800000000000002 109.145 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -123.95 -173.55 2.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 1.24 109.87 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.1 m -72.9 -47.3 47.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.772 0.32 . . . . 1.49 111.49 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -95.15 -39.11 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.739 1.015 . . . . 1.8 113.739 -171.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.28 -42.84 87.41 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.977 0.362 . . . . 2.1899999999999999 111.977 -168.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -90.75 11.28 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.39 0.614 . . . . 2.7799999999999998 111.277 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -106.08 -50.15 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 1.1000000000000001 109.047 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.4 p -149.4 121.82 4.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 2.0299999999999998 110.223 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 10.5 Cg_exo -70.82 154.65 63.42 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.819 2.346 . . . . 1.76 112.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -93.94 153.88 17.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.998 -0.546 . . . . 1.3100000000000001 109.717 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -125.99 161.39 27.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.352 -0.61 . . . . 1.3600000000000001 109.352 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.65 175.35 13.35 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.518 -0.473 . . . . 0.56999999999999995 111.489 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 75.1 m-70 -118.37 150.55 39.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.836 . . . . 1.98 109.769 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.603 HD11 ' OD1' ' A' ' 79' ' ' ASP . 14.5 tp -66.13 127.43 32.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.366 -0.379 . . . . 0.94999999999999996 111.871 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 50.56 37.58 16.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.193 0.997 . . . . 2.0800000000000001 111.467 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 13.9 tt0 -72.11 -6.07 39.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.865 -1.516 . . . . 1.98 111.192 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.98 56.19 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 111.661 -0.576 . . . . 0.71999999999999997 111.661 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.19 -18.35 25.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.449 0.642 . . . . 0.96999999999999997 109.759 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.6 125.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.372 -0.831 . . . . 0.57999999999999996 109.578 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -95.94 -58.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.7 1.0 . . . . 0.62 113.7 -172.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.95 -50.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.79 -0.568 . . . . 2.04 112.295 -169.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.13 -52.43 40.17 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.791 -0.719 . . . . 0.32000000000000001 112.707 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.46 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -75.94 -33.94 59.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.618 0.247 . . . . 0.48999999999999999 110.698 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.603 ' OD1' HD11 ' A' ' 69' ' ' LEU . 10.4 t70 -53.04 -51.69 60.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.703 -0.681 . . . . 1.1399999999999999 111.428 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.539 HG21 ' HB ' ' A' ' 18' ' ' VAL . 1.8 mp -65.83 -48.37 82.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.09 -0.505 . . . . 0.78000000000000003 110.75 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 120' ' ' ILE . 28.7 t -60.55 -48.24 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.55000000000000004 111.625 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.833 HG12 HG21 ' A' ' 120' ' ' ILE . 32.0 m -70.12 -33.23 54.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.962 -0.295 . . . . 0.83999999999999997 111.295 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 32.6 t -79.17 0.25 29.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 1.4299999999999999 110.882 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -110.38 10.6 23.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.285 -0.416 . . . . 1.23 111.19 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.59 ' SD ' HG22 ' A' ' 120' ' ' ILE . 47.9 mtm -102.3 -173.42 2.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.797 0.808 . . . . 2.27 112.054 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.452 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 14.2 mtp180 -140.9 -177.44 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.439 -1.255 . . . . 4.1900000000000004 108.5 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -67.06 -23.44 65.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 1.9399999999999999 111.273 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -126.68 17.93 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 1.23 111.219 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 25.8 tt0 -112.2 131.85 55.24 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.695 -0.483 . . . . 1.6000000000000001 109.695 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 12.8 tmtt? -134.93 134.97 41.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.518 -0.765 . . . . 1.1699999999999999 109.868 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.457 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.7 p -137.57 172.82 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.258 -0.428 . . . . 1.2 110.683 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 93' ' ' VAL . 3.2 tt -119.43 140.27 50.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.281 -1.007 . . . . 1.73 108.281 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 95' ' ' ILE . 6.1 p -121.39 141.57 41.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 120.958 0.409 . . . . 0.73999999999999999 110.903 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -98.89 111.65 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.156 -0.683 . . . . 1.71 109.156 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.524 HD11 HG13 ' A' ' 93' ' ' VAL . 3.2 mp -93.4 109.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.378 . . . . 0.52000000000000002 110.187 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -84.81 166.04 17.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.579 -0.897 . . . . 1.3700000000000001 108.579 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.4 p -51.01 -40.68 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.29 0.369 . . . . 1.0 111.956 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.5 ptp -77.19 -16.27 59.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.33 -0.395 . . . . 1.79 111.993 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -92.67 -16.27 25.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.945 0.402 . . . . 0.75 110.432 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.437 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -115.24 -160.15 12.56 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.103 -0.799 . . . . 0.70999999999999996 111.103 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -94.54 29.55 2.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.722 0.296 . . . . 1.52 111.012 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.02 -28.81 73.35 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.931 -0.577 . . . . 2.2999999999999998 112.333 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -70.82 -31.79 68.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 5.8600000000000003 110.683 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.22 -32.1 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 4.2699999999999996 110.322 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.33 -7.26 39.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.829 -0.7 . . . . 2.1600000000000001 112.322 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 55.5 m -86.68 147.58 25.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.005 0.431 . . . . 3.3399999999999999 110.959 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.71 169.23 42.22 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.898 -0.668 . . . . 1.2 111.518 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -84.44 -69.84 0.62 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.682 0.277 . . . . 3.0800000000000001 111.171 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 m -90.85 -73.45 0.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.861 -0.336 . . . . 1.52 110.581 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.469 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.02 103.45 4.43 Favored Pre-proline 0 N--CA 1.465 0.277 0 N-CA-C 109.879 -0.415 . . . . 0.75 109.879 176.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.21 -74.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.346 2.031 . . . . 1.5800000000000001 112.846 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.78 -134.78 44.0 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.805 -0.712 . . . . 2.0499999999999998 112.224 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -133.67 21.39 3.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.466 -0.568 . . . . 2.0299999999999998 109.466 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 22.4 m -105.77 179.19 4.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.76 -0.655 . . . . 1.1399999999999999 111.196 -173.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -97.53 138.57 22.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.128 0.489 . . . . 0.47999999999999998 111.006 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.4 mp -120.41 166.78 13.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.371 -0.377 . . . . 0.51000000000000001 110.907 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 5.4 mt -116.14 110.21 18.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.69999999999999996 109.662 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.64 124.51 48.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.793 0.33 . . . . 0.42999999999999999 110.625 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -92.1 126.25 37.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.304 -0.628 . . . . 1.46 109.304 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.833 HG21 HG12 ' A' ' 82' ' ' VAL . 76.0 mt -120.06 131.62 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.471 -0.331 . . . . 0.47999999999999998 110.979 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -136.25 143.66 44.4 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.103 -0.499 . . . . 1.8799999999999999 110.447 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.545 ' HA ' HG12 ' A' ' 42' ' ' VAL . 24.7 tp -90.94 118.77 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 1.1200000000000001 110.72 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.36 -27.89 10.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 1.0 111.239 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.5 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 39.9 m -151.69 149.8 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.374 . . . . 1.1899999999999999 109.989 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.56 ' HB2' HG12 ' A' ' 40' ' ' VAL . 4.0 p90 -165.5 158.5 15.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.808 0.337 . . . . 0.71999999999999997 111.123 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -125.39 123.44 39.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.103 -0.498 . . . . 2.98 110.052 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -103.05 114.39 28.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 3.3799999999999999 109.927 171.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.416 ' H ' ' ND2' ' A' ' 38' ' ' ASN . 44.0 tp -134.38 150.22 50.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.385 -0.825 . . . . 3.3500000000000001 109.372 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.71 130.53 49.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.875 0.369 . . . . 5.3899999999999997 110.544 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -84.47 113.28 21.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 7.04 110.037 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.91 156.52 21.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.103 0.779 . . . . 7.21 113.103 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -111.92 168.3 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.873 -1.058 . . . . 9.0199999999999996 109.52 168.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -143.84 123.84 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.55 0.214 . . . . 9.75 110.65 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -138.14 -178.16 5.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.148 -0.478 . . . . 12.26 109.836 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.6 -1.19 . . . . 13.35 109.26 174.856 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.238 -0.282 . . . . 7.4800000000000004 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -102.83 99.21 9.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.736 0.303 . . . . 5.9000000000000004 110.459 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.0 m -101.87 -43.6 5.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 4.4400000000000004 110.264 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.92 137.07 34.5 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.946 -0.761 . . . . 4.4400000000000004 108.946 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -87.22 141.91 28.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.038 0.447 . . . . 4.1500000000000004 111.003 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.9 93.34 9.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.428 -0.582 . . . . 3.6099999999999999 109.428 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -119.41 141.53 49.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.035 -0.529 . . . . 3.6000000000000001 110.099 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.1 137.77 45.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.529 -0.759 . . . . 2.71 111.262 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -100.39 128.78 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.307 -0.627 . . . . 1.8799999999999999 109.307 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 23.2 t -102.29 105.1 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.11 0.481 . . . . 0.58999999999999997 110.372 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.1 103.9 16.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.607 -0.724 . . . . 2.1600000000000001 110.663 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 19' ' ' ILE . 21.6 tp 62.24 76.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.255 -0.884 . . . . 1.45 110.863 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 2.8 t -80.92 159.82 24.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.731 -0.668 . . . . 0.78000000000000003 110.928 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.87 -5.09 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.29 0.567 . . . . 0.81000000000000005 111.023 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.9 t70 -78.17 30.3 0.18 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 2.3999999999999999 111.645 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' HA3' HG13 ' A' ' 80' ' ' ILE . . . 121.91 -26.17 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.754 -0.736 . . . . 0.68000000000000005 112.735 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.05 60.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.394 -0.908 . . . . 0.60999999999999999 113.372 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.09 152.17 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.965 -0.383 . . . . 0.48999999999999999 109.965 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 12' ' ' LEU . 7.4 mm -85.75 120.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.505 0.322 . . . . 0.46999999999999997 110.257 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 84' ' ' SER . 51.7 pttt -142.73 147.09 35.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.177 0.513 . . . . 1.3400000000000001 111.461 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.38 135.29 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.509 -0.769 . . . . 0.5 109.891 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.4 112.97 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.102 0.477 . . . . 0.67000000000000004 110.624 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 -52.83 3.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.82999999999999996 110.813 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -115.93 151.97 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.331 -0.618 . . . . 1.5600000000000001 109.331 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.89 110.97 19.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.823 -0.436 . . . . 2.9500000000000002 109.823 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.87 163.18 10.46 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.535 -0.757 . . . . 1.3200000000000001 112.821 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 28' ' ' GLU . 12.5 t70 -104.96 -149.22 0.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.554 -0.536 . . . . 2.77 109.554 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 42.4 tt0 -59.27 125.1 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.15 0.5 . . . . 2.6400000000000001 110.793 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.85 52.37 0.24 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 111.215 -0.754 . . . . 1.04 111.215 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.91 -33.87 73.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.5 . . . . 2.29 110.619 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -98.46 18.3 16.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.583 -0.735 . . . . 2.6400000000000001 110.091 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -126.41 76.74 1.64 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.911 -0.586 . . . . 1.45 109.94 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 38.4 mm -129.14 119.98 19.95 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.398 0.618 . . . . 0.81000000000000005 111.886 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -87.05 100.75 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.148 3.232 . . . . 0.75 112.186 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.585 ' HE2' ' HB3' ' A' ' 83' ' ' SER . 28.1 mmtp -135.95 178.44 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.15 0.5 . . . . 2.6600000000000001 112.264 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.53 139.51 57.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.145 -0.934 . . . . 2.5099999999999998 111.511 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.51 56.42 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.265 -0.734 . . . . 1.1200000000000001 111.265 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 45.6 m-20 -113.87 161.92 17.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.388 . . . . 1.3799999999999999 110.154 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 25.7 mt-10 -94.57 103.92 15.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.176 -0.465 . . . . 2.2000000000000002 110.613 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.86 132.2 49.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.63 -0.507 . . . . 0.67000000000000004 109.63 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -108.39 109.83 21.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.581 -0.526 . . . . 0.65000000000000002 109.581 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' CG1' HD12 ' A' ' 122' ' ' LEU . 15.8 m -124.04 140.49 47.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.692 -0.685 . . . . 0.87 111.009 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -105.6 140.7 38.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.676 -0.693 . . . . 2.75 109.482 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -123.73 142.67 50.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.107 -0.331 . . . . 0.76000000000000001 110.107 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 p -167.08 148.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.237 -0.653 . . . . 0.48999999999999999 109.237 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.6 1.77 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.127 -0.789 . . . . 0.35999999999999999 111.127 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 63.7 pttt -157.8 171.39 20.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 111.499 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.858 ' HA ' HD23 ' A' ' 116' ' ' LEU . 63.8 tp -81.75 98.17 8.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.814 -0.63 . . . . 0.38 110.253 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.616 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 33.6 tt0 -60.17 -27.75 67.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.756 0.312 . . . . 1.96 111.142 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 t -55.36 -27.2 45.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.955 -0.566 . . . . 0.67000000000000004 111.783 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 53' ' ' LYS . 11.8 t -139.96 4.61 2.09 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.286 0.565 . . . . 0.72999999999999998 110.926 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.89 13.48 75.57 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.94 -0.573 . . . . 0.78000000000000003 113.077 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -77.8 118.34 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.606 0.241 . . . . 2.8900000000000001 111.141 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.724 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 9.9 p -76.84 159.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.58999999999999997 110.039 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.55 ' CE1' HD11 ' A' ' 110' ' ' ILE . 18.3 m-30 -80.26 99.44 7.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.518 -0.31 . . . . 0.78000000000000003 110.675 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -124.51 84.72 2.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.889 0.852 . . . . 2.1800000000000002 111.28 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.513 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.9 m -136.92 -178.16 5.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.133 -0.94 . . . . 1.24 108.81 175.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.9 p -67.36 -44.15 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 1.49 111.104 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.35 -51.59 23.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.039 -0.528 . . . . 1.8 110.141 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.7 OUTLIER -45.89 -43.81 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.745 -1.116 . . . . 2.1899999999999999 112.191 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.39 -11.9 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.501 . . . . 2.7799999999999998 112.351 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -103.9 -61.91 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.699 -0.401 . . . . 1.1000000000000001 111.588 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 29.0 m -86.0 124.11 71.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.488 . . . . 2.0299999999999998 112.03 -169.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 5.7 Cg_endo -87.22 103.98 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.147 2.565 . . . . 1.76 111.21 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -94.8 149.16 21.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.454 -0.339 . . . . 1.3100000000000001 110.519 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -141.41 165.88 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 1.3600000000000001 109.939 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 74' ' ' VAL . 54.4 p90 -149.86 -176.88 5.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.088 0.47 . . . . 0.56999999999999995 111.516 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 3.9 m-70 -120.03 150.93 39.77 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.477 -0.783 . . . . 1.98 110.075 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 82' ' ' VAL . 45.6 tp -68.76 134.98 50.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.552 0.215 . . . . 0.94999999999999996 110.46 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 53.21 31.22 11.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.504 0.669 . . . . 2.0800000000000001 111.518 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 16.5 tt0 -69.62 -12.04 61.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.076 -0.965 . . . . 1.98 111.033 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.52 -14.31 54.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.741 -0.743 . . . . 0.71999999999999997 111.744 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB2' HE21 ' A' ' 71' ' ' GLN . 18.3 mm-40 -104.07 0.02 29.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.96999999999999997 110.737 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.9 m -132.3 124.65 52.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.57999999999999996 110.266 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.793 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -96.36 -60.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.03 0.752 . . . . 0.62 113.03 -176.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 75' ' ' ILE . 35.6 mmtt -145.03 -41.49 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.285 0.846 . . . . 2.04 113.285 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.36 -52.33 37.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.307 -0.949 . . . . 0.32000000000000001 112.212 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.417 ' O ' HG22 ' A' ' 82' ' ' VAL . 14.2 m-90 -76.48 -33.13 58.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.543 0.211 . . . . 0.48999999999999999 110.992 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 10.4 t70 -52.33 -53.33 45.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.77 -0.65 . . . . 1.1399999999999999 112.102 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.11 -33.13 59.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.441 0.638 . . . . 0.78000000000000003 111.22 -176.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.8 t -76.19 -39.52 54.56 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.896 -0.502 . . . . 0.55000000000000004 111.661 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 69' ' ' LEU . 33.8 m -81.02 -32.82 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.452 0.167 . . . . 0.83999999999999997 111.131 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.585 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 62.6 m -61.27 -40.71 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 1.4299999999999999 110.7 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 21.4 m -101.42 64.38 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 1.23 111.038 174.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 11.4 mmt -120.9 172.47 7.89 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.149 -0.932 . . . . 2.27 110.074 171.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -142.96 162.83 34.41 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.69 -0.856 . . . . 4.1900000000000004 108.69 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HA ' HD23 ' A' ' 122' ' ' LEU . 3.4 tmtm? -56.11 -29.56 60.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.981 0.363 . . . . 1.9399999999999999 111.981 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -118.96 18.12 13.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.68 0.276 . . . . 1.23 111.13 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.37 158.03 16.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.395 -0.366 . . . . 1.6000000000000001 110.578 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -152.29 124.06 7.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.283 -0.636 . . . . 1.1699999999999999 109.283 -175.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.8 m -129.63 160.7 32.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.324 -0.398 . . . . 1.2 110.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' CD2' ' HE2' ' A' ' 90' ' ' LYS . 2.6 mm? -103.17 118.21 36.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.73 109.655 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.737 HG13 HD11 ' A' ' 95' ' ' ILE . 7.5 p -100.63 138.17 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.822 0.344 . . . . 0.73999999999999999 110.224 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 mmm-85 -107.42 111.44 23.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.571 -0.899 . . . . 1.71 108.571 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.737 HD11 HG13 ' A' ' 93' ' ' VAL . 5.1 mp -104.28 107.17 21.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.155 -0.475 . . . . 0.52000000000000002 110.181 -173.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.595 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 2.2 tt0 -83.46 176.01 9.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.153 -0.684 . . . . 1.3700000000000001 109.153 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -30.99 67.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.14 -9.29 59.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.294 -0.412 . . . . 1.79 111.983 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.595 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 17.7 m-85 -109.42 -0.69 18.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 0.75 110.29 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.58 176.09 22.95 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.70999999999999996 112.134 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.716 ' HD1' ' HB3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -86.54 32.18 0.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.704 0.261 . . . . 1.52 111.704 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.92 -27.06 71.25 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.08 -0.581 . . . . 2.2999999999999998 111.767 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.42 -54.83 42.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.055 0.455 . . . . 5.8600000000000003 110.244 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.716 ' HB3' ' HD1' ' A' ' 101' ' ' TYR . 15.3 tp10 -64.99 -42.65 94.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.627 -0.715 . . . . 4.2699999999999996 110.544 175.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.21 22.03 7.72 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.915 -0.66 . . . . 2.1600000000000001 112.241 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 48.9 t -91.82 121.88 33.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.282 . . . . 3.3399999999999999 110.537 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -107.7 119.48 5.79 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.053 -0.594 . . . . 1.2 111.667 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -99.09 -71.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.05 -0.352 . . . . 3.0800000000000001 110.05 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -75.6 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.072 -0.251 . . . . 1.52 111.09 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.55 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -156.15 72.83 5.1 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 0.75 110.95 175.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.566 ' HG2' ' HA2' ' A' ' 107' ' ' GLY . 19.4 Cg_endo -94.82 102.81 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.161 2.574 . . . . 1.5800000000000001 112.342 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.3 73.3 0.46 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.969 -0.853 . . . . 2.0499999999999998 110.969 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.02 31.33 0.33 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.92 0.888 . . . . 2.0299999999999998 111.26 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 48' ' ' LEU . 6.8 p -104.27 -177.33 3.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.1399999999999999 111.018 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.82 137.64 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.07 -0.514 . . . . 0.47999999999999998 110.035 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.858 HD23 ' HA ' ' A' ' 48' ' ' LEU . 10.1 mt -124.55 156.4 37.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 0.51000000000000001 110.72 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.616 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -125.56 119.67 28.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.829 -0.434 . . . . 0.69999999999999996 109.829 171.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 95' ' ' ILE . 21.2 m-85 -114.52 137.93 51.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.962 -0.563 . . . . 0.42999999999999999 111.006 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.43 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 36.2 mt-10 -89.12 116.09 27.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.295 -0.866 . . . . 1.46 108.869 172.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.465 HG21 HG12 ' A' ' 82' ' ' VAL . 44.6 mt -106.78 127.82 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.705 0.288 . . . . 0.47999999999999998 110.258 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.26 125.82 50.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.806 -0.634 . . . . 1.8799999999999999 110.601 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 87' ' ' LYS . 4.4 tp -91.88 89.86 7.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.518 -0.549 . . . . 1.1200000000000001 109.518 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -78.78 -37.07 41.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.43 -176.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.3 m -146.77 151.36 37.03 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.128 -0.229 . . . . 1.1899999999999999 110.794 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -165.86 -177.71 4.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.507 -0.553 . . . . 0.71999999999999997 109.507 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.549 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -162.33 172.38 15.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 2.98 109.786 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.435 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 26.8 mt-10 -135.18 121.71 20.62 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.366 0.416 . . . . 3.3799999999999999 110.94 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.4 mt -128.52 166.37 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.971 -0.559 . . . . 3.3500000000000001 110.006 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.79 137.01 36.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 5.3899999999999997 110.728 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -111.11 121.5 45.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.115 -0.493 . . . . 7.04 110.614 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -107.05 124.37 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.685 -0.487 . . . . 7.21 109.685 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -140.77 118.66 11.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 9.0199999999999996 110.146 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -129.29 121.78 28.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.18 -0.464 . . . . 9.75 110.327 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -94.4 -62.72 1.28 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.905 0.383 . . . . 12.26 110.235 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 t60 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.333 -0.841 . . . . 13.35 109.682 178.821 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.824 0.345 . . . . 7.4800000000000004 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.4 m -85.12 153.71 22.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.576 -0.528 . . . . 5.9000000000000004 109.576 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p -61.96 153.64 28.77 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.985 0.178 . . . . 4.4400000000000004 111.247 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 67.81 -162.73 0.21 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.063 -0.517 . . . . 4.4400000000000004 109.644 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.57 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 35.7 tt0 -155.98 170.83 21.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 4.1500000000000004 110.608 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 6.4 pt-20 -94.52 80.52 3.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 3.6099999999999999 111.454 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 68.7 m-85 -106.04 164.84 11.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.877 -0.601 . . . . 3.6000000000000001 110.354 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -112.35 136.53 51.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.018 -0.537 . . . . 2.71 110.178 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HG3' HG23 ' A' ' 21' ' ' THR . 7.1 mptt -111.34 125.82 54.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.722 -0.474 . . . . 1.8799999999999999 109.722 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.42 115.54 45.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.537 -0.301 . . . . 0.58999999999999997 110.349 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.04 126.67 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.095 -0.502 . . . . 2.1600000000000001 111.09 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.3 mt 57.26 53.31 7.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 1.45 110.04 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.532 HG21 ' HE2' ' A' ' 20' ' ' LYS . 11.7 t -59.23 157.72 10.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.78000000000000003 111.169 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -2.76 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.81000000000000005 112.115 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.53 -4.41 36.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 2.3999999999999999 110.658 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.27 37.41 0.69 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.574 -0.822 . . . . 0.68000000000000005 113.107 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.29 0.85 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.906 -0.664 . . . . 0.60999999999999999 113.489 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG21 ' HB ' ' A' ' 80' ' ' ILE . 38.6 t -141.13 141.36 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.272 -0.27 . . . . 0.48999999999999999 110.272 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 12' ' ' LEU . 14.3 mm -90.83 110.82 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.46999999999999997 109.753 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.532 ' HE2' HG21 ' A' ' 13' ' ' THR . 61.3 pttt -137.09 144.83 43.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.192 0.52 . . . . 1.3400000000000001 111.076 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 9' ' ' LYS . 25.2 m -116.77 131.37 56.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.5 110.239 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.478 HD11 ' HA ' ' A' ' 25' ' ' LYS . 4.9 tp -91.17 126.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.67000000000000004 110.267 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.578 ' CD2' ' HG ' ' A' ' 92' ' ' LEU . 3.3 mm? -108.04 -72.85 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.38 0.609 . . . . 0.82999999999999996 110.135 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -108.07 103.28 12.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.146 -0.687 . . . . 1.5600000000000001 109.146 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HA ' HD11 ' A' ' 22' ' ' ILE . 73.4 tttt -72.26 157.38 37.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.851 -0.425 . . . . 2.9500000000000002 109.851 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.27 -136.83 0.12 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 114.559 0.583 . . . . 1.3200000000000001 114.559 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 14.0 t70 -167.3 -162.98 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.556 -1.275 . . . . 2.77 107.556 -170.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 39.2 tt0 -77.81 125.38 29.25 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 2.6400000000000001 110.716 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.93 70.0 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.559 -1.016 . . . . 1.04 110.559 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.46 -22.43 59.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.043 0.449 . . . . 2.29 111.03 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.47 1.1 55.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.645 0.736 . . . . 2.6400000000000001 109.328 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -105.71 76.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.647 -0.706 . . . . 1.45 109.243 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.1 mm -137.07 130.42 17.44 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.81000000000000005 111.138 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.501 ' HG3' ' O ' ' A' ' 85' ' ' MET . 74.0 Cg_endo -74.74 133.86 17.55 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.031 2.488 . . . . 0.75 111.424 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 29.9 mmmt -134.12 142.06 47.36 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.283 -0.261 . . . . 2.6600000000000001 110.539 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.635 ' HE3' ' HB3' ' A' ' 70' ' ' GLU . 17.3 tptm -56.14 127.51 31.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 2.5099999999999998 110.47 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.53 -25.25 23.61 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.474 -0.785 . . . . 1.1200000000000001 111.825 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 128' ' ' LEU . 78.9 m-20 -94.28 165.73 12.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 1.3799999999999999 110.305 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.27 132.26 34.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.142 0.496 . . . . 2.2000000000000002 111.857 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.8 150.8 35.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.765 -0.828 . . . . 0.67000000000000004 108.765 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 25.6 m -125.55 106.41 9.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.861 -0.422 . . . . 0.65000000000000002 109.861 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 122' ' ' LEU . 34.0 m -131.22 160.48 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.573 . . . . 0.87 111.385 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -113.92 152.73 30.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.647 -0.872 . . . . 2.75 108.647 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -128.06 132.64 49.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.76000000000000001 110.253 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -165.14 158.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.807 -0.812 . . . . 0.48999999999999999 108.807 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.84 -127.35 1.51 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.038 -1.077 . . . . 0.35999999999999999 112.372 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 58.5 pttt -150.42 166.63 29.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 1.4299999999999999 110.471 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.579 HD22 HG13 ' A' ' 110' ' ' ILE . 66.3 tp -86.23 101.97 13.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 0.38 109.694 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 18.9 tt0 -59.78 -24.54 64.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.807 0.337 . . . . 1.96 111.817 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 t -55.86 -25.35 41.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.188 -0.46 . . . . 0.67000000000000004 111.468 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 53' ' ' LYS . 3.0 t -137.84 -31.62 0.77 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.933 0.396 . . . . 0.72999999999999998 111.567 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.72 14.75 26.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.84 -0.695 . . . . 0.78000000000000003 112.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' A' ' 51' ' ' THR . 70.2 mmtt -86.59 133.7 33.69 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.652 -0.499 . . . . 2.8900000000000001 109.652 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.3 p -83.06 155.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.211 -0.45 . . . . 0.58999999999999997 111.46 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 3.2 m-85 -74.33 102.11 4.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.78000000000000003 110.77 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.52 85.3 2.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.375 0.607 . . . . 2.1800000000000002 110.004 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.531 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 67.3 m -138.58 -177.61 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 1.24 110.323 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -48.47 -47.0 38.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.887 0.699 . . . . 1.49 112.887 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.89 -43.29 8.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 1.8 110.339 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.8 OUTLIER -57.29 -30.5 64.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 2.1899999999999999 112.185 -174.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -19.91 21.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 2.7799999999999998 110.973 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.673 HD22 HG12 ' A' ' 63' ' ' VAL . 8.5 t30 -86.81 -61.02 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 1.1000000000000001 110.94 -171.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.673 HG12 HD22 ' A' ' 62' ' ' ASN . 7.1 p -156.13 126.36 3.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 2.0299999999999998 111.121 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 8.9 Cg_exo -72.02 152.74 57.44 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.694 2.262 . . . . 1.76 111.326 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.71 146.41 23.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.676 0.274 . . . . 1.3100000000000001 110.328 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 2.7 pptp? -105.89 143.35 34.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.979 -0.378 . . . . 1.3600000000000001 109.979 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 47.7 p90 -134.31 170.44 15.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.01 0.433 . . . . 0.56999999999999995 111.131 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -103.96 149.58 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.759 -0.655 . . . . 1.98 109.966 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.614 HD13 ' CG2' ' A' ' 82' ' ' VAL . 16.5 tp -64.19 119.46 10.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.94 0.4 . . . . 0.94999999999999996 110.928 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.635 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER 42.31 74.94 0.1 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 114.405 -1.271 . . . . 2.0800000000000001 111.767 -174.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 6.1 pt20 -100.85 17.39 22.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.548 -1.206 . . . . 1.98 109.536 174.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.5 -16.6 59.62 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.604 -0.726 . . . . 0.71999999999999997 111.787 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.53 -41.56 11.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.466 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.87 135.36 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.651 0.262 . . . . 0.57999999999999996 110.301 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.562 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.61 -68.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.455 0.539 . . . . 0.62 112.455 -175.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 75' ' ' ILE . 41.7 mtpt -133.52 -51.09 0.86 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 122.026 -0.421 . . . . 2.04 111.892 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -53.07 -53.41 34.22 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.049 -0.596 . . . . 0.32000000000000001 113.513 -172.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.427 ' O ' HG22 ' A' ' 82' ' ' VAL . 17.7 m-90 -75.86 -37.72 58.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.652 0.263 . . . . 0.48999999999999999 110.632 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.01 -54.06 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 1.1399999999999999 111.791 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.462 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -68.59 -35.31 69.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 110.559 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 120' ' ' ILE . 44.2 t -69.43 -48.19 61.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.096 -0.502 . . . . 0.55000000000000004 111.083 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.614 ' CG2' HD13 ' A' ' 69' ' ' LEU . 34.0 m -66.7 -32.37 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 121.169 -0.212 . . . . 0.83999999999999997 111.125 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -80.92 3.38 22.99 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.275 0.56 . . . . 1.4299999999999999 110.237 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 t -123.93 27.48 7.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.558 -0.746 . . . . 1.23 109.001 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.63 ' HE1' ' HA ' ' A' ' 90' ' ' LYS . 40.7 mmm -123.79 116.45 23.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 2.27 111.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.534 HH21 ' HB2' ' A' ' 88' ' ' ASN . 18.0 ttp85 -82.41 162.06 22.27 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 4.1900000000000004 109.753 175.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -66.12 -13.68 60.53 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.108 0.41 . . . . 1.9399999999999999 112.108 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.534 ' HB2' HH21 ' A' ' 86' ' ' ARG . 37.0 m-80 -121.42 25.51 9.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.004 0.43 . . . . 1.23 109.976 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -123.16 166.4 15.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.634 -0.712 . . . . 1.6000000000000001 109.737 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.63 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 79.2 tttt -157.28 121.03 4.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 1.1699999999999999 111.405 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.27 160.96 25.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.522 -0.763 . . . . 1.2 110.646 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 75.2 mt -115.13 126.22 54.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.544 -0.539 . . . . 1.73 109.544 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 77' ' ' GLY . 10.0 p -101.22 142.45 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 110.024 -0.362 . . . . 0.73999999999999999 110.024 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 15.3 mmm-85 -100.98 112.84 25.38 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.84 -0.8 . . . . 1.71 108.84 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.3 mp -87.23 101.18 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.52000000000000002 110.928 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 98' ' ' MET . 10.2 tp10 -79.75 159.22 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.433 -0.951 . . . . 1.3700000000000001 108.433 170.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.411 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 8.5 p -55.37 -36.1 65.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.889 0.376 . . . . 1.0 111.499 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 96' ' ' GLU . 22.2 ptp -76.95 -8.27 57.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.166 -0.47 . . . . 1.79 111.021 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -96.08 -2.4 46.72 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.154 -0.313 . . . . 0.75 110.154 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.562 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -133.72 -152.45 6.78 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.684 -0.689 . . . . 0.70999999999999996 112.335 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.609 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 36.0 m-85 -96.8 -0.12 48.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.926 0.343 . . . . 1.52 111.926 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.32 -137.28 45.25 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 2.2999999999999998 113.145 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.03 -32.45 17.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.156 0.503 . . . . 5.8600000000000003 110.588 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.09 -53.08 55.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 4.2699999999999996 112.193 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.609 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -76.68 161.11 51.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.091 -0.575 . . . . 2.1600000000000001 113.214 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 23.1 p -71.63 128.31 35.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 3.3399999999999999 110.347 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.62 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -102.89 173.88 22.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 1.2 112.862 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -96.32 -71.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.799 0.296 . . . . 3.0800000000000001 111.799 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.568 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 3.0 t -106.65 -73.25 0.69 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.305 -0.247 . . . . 1.52 110.751 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.579 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.59 71.36 17.49 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.922 0.392 . . . . 0.75 111.77 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.62 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 83.4 Cg_endo -92.23 -158.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.766 2.311 . . . . 1.5800000000000001 112.558 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.14 -133.0 9.65 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.336 -0.706 . . . . 2.0499999999999998 111.336 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 2.3 t-20 -96.64 24.07 6.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.753 0.787 . . . . 2.0299999999999998 109.732 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -104.93 146.5 28.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.397 -0.82 . . . . 1.1399999999999999 109.737 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.19 132.06 34.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.158 0.504 . . . . 0.47999999999999998 110.66 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.7 mp -121.07 168.95 10.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.545 . . . . 0.51000000000000001 109.624 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -138.97 122.83 17.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.69999999999999996 110.333 172.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -110.94 140.6 45.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.42999999999999999 111.453 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.434 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 34.3 mt-10 -80.45 119.58 23.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.274 -0.875 . . . . 1.46 108.903 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.587 HD12 ' SG ' ' A' ' 81' ' ' CYS . 47.8 mt -108.12 134.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.248 -0.649 . . . . 0.47999999999999998 109.248 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -134.93 114.38 12.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.529 . . . . 1.8799999999999999 110.7 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.71 ' HA ' HG12 ' A' ' 42' ' ' VAL . 4.9 tp -84.0 91.72 7.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.852 -0.425 . . . . 1.1200000000000001 109.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 41' ' ' THR . 2.8 pp -84.27 -36.81 22.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.279 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.4 m -143.14 150.66 39.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.047 -0.353 . . . . 1.1899999999999999 110.047 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -165.91 -178.89 4.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.494 -0.558 . . . . 0.71999999999999997 109.494 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.86 138.92 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 2.98 110.554 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -93.51 151.71 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.318 -0.623 . . . . 3.3799999999999999 109.318 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.499 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 19.8 tp -75.3 138.78 42.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.611 0.243 . . . . 3.3500000000000001 111.211 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -81.69 168.16 18.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.933 0.397 . . . . 5.3899999999999997 111.344 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.0 m80 59.36 -163.45 0.23 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.257 -0.883 . . . . 7.04 111.084 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -135.54 121.84 20.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.114 0.483 . . . . 7.21 109.715 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -125.29 95.31 4.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 9.0199999999999996 110.689 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -169.59 127.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.82 -0.627 . . . . 9.75 109.481 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -91.94 126.58 37.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.245 -0.582 . . . . 12.26 109.845 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-N 115.311 -0.859 . . . . 13.35 110.689 -176.774 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.702 0.287 . . . . 7.4800000000000004 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -85.72 81.69 8.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.375 0.607 . . . . 5.9000000000000004 111.526 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.8 p -100.12 -25.82 14.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.675 0.75 . . . . 4.4400000000000004 109.325 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.72 130.17 34.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.795 -1.093 . . . . 4.4400000000000004 108.867 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -151.31 162.85 40.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.685 0.278 . . . . 4.1500000000000004 110.333 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.31 86.73 2.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.012 0.434 . . . . 3.6099999999999999 110.403 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.62 122.64 22.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.818 -0.628 . . . . 3.6000000000000001 109.754 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.35 154.13 39.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.263 0.554 . . . . 2.71 110.77 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 2.4 mppt? -94.42 152.04 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.039 -0.726 . . . . 1.8799999999999999 109.039 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.31 105.19 17.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.562 -0.533 . . . . 0.58999999999999997 109.562 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.8 99.75 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 2.1600000000000001 110.247 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt 66.75 78.63 0.25 Allowed 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.027 0.829 . . . . 1.45 110.858 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -68.3 156.07 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.78000000000000003 110.366 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.27 -20.27 65.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.247 -0.433 . . . . 0.81000000000000005 111.902 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.51 30.69 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.87 0.367 . . . . 2.3999999999999999 111.83 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 11.38 5.32 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.043 -1.075 . . . . 0.68000000000000005 114.548 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.92 64.33 4.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.545 0.578 . . . . 0.60999999999999999 114.545 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.14 147.55 32.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 0.48999999999999999 109.984 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -85.5 111.17 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.789 -0.449 . . . . 0.46999999999999997 109.789 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 18.5 pttp -141.68 146.92 36.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.945 0.402 . . . . 1.3400000000000001 110.769 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -102.79 132.02 49.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.5 110.034 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 tp -93.63 121.93 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.878 0.371 . . . . 0.67000000000000004 110.194 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.88 -78.83 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.82999999999999996 110.419 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 108.69 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.579 -0.737 . . . . 1.5600000000000001 109.675 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -72.88 147.39 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.885 -0.598 . . . . 2.9500000000000002 111.901 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.73 88.75 1.38 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.072 -1.211 . . . . 1.3200000000000001 110.072 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -49.33 -43.21 43.5 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.767 0.654 . . . . 2.77 112.767 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.32 144.38 34.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.924 0.392 . . . . 2.6400000000000001 110.709 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.81 51.8 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.977 -0.63 . . . . 1.04 111.643 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.95 -45.98 64.58 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.583 0.586 . . . . 2.29 112.583 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.47 27.65 8.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.962 0.411 . . . . 2.6400000000000001 111.035 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 30.9 m-80 -129.26 78.62 1.86 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 1.45 110.609 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.25 124.31 21.18 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.134 -0.485 . . . . 0.81000000000000005 111.066 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HG3' HD22 ' A' ' 122' ' ' LEU . 42.8 Cg_endo -67.65 112.83 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.713 2.275 . . . . 0.75 111.504 176.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.7 mmtp -133.39 172.78 12.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.364 0.875 . . . . 2.6600000000000001 113.364 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -43.42 126.48 4.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.02 -1.445 . . . . 2.5099999999999998 113.211 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 -16.01 45.1 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.935 -0.575 . . . . 1.1200000000000001 113.301 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 92.7 m-20 -83.58 146.99 28.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.057 0.456 . . . . 1.3799999999999999 110.913 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -78.5 110.23 13.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.292 0.568 . . . . 2.2000000000000002 110.252 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 125' ' ' PHE . 11.1 m -117.88 159.29 18.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.587 -0.733 . . . . 0.67000000000000004 109.819 175.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' HD3' ' A' ' 66' ' ' LYS . 23.7 m -125.55 105.61 9.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.383 -0.599 . . . . 0.65000000000000002 109.383 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 122' ' ' LEU . 12.7 m -128.01 140.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.864 -0.607 . . . . 0.87 110.185 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.411 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 32.8 m170 -100.43 147.64 25.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.06 -0.718 . . . . 2.75 109.06 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -126.39 127.84 46.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.371 0.605 . . . . 0.76000000000000001 110.326 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.22 157.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.355 -0.98 . . . . 0.48999999999999999 108.355 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.61 -128.49 1.71 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.258 -0.972 . . . . 0.35999999999999999 111.454 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.679 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 59.2 pttt -157.81 170.92 21.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.993 0.425 . . . . 1.4299999999999999 111.058 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD13 ' HG ' ' A' ' 116' ' ' LEU . 46.2 tp -89.52 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.38 109.627 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 78.2 tt0 -64.36 -28.55 69.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 1.96 111.233 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.44 ' CB ' ' HB3' ' A' ' 114' ' ' SER . 8.7 t -54.84 -29.78 55.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.532 . . . . 0.67000000000000004 111.543 -175.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -130.46 -2.45 4.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.656 0.265 . . . . 0.72999999999999998 111.086 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 45.34 50.31 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.347 -0.454 . . . . 0.78000000000000003 113.032 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 68.8 mmtt -113.51 127.1 55.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 2.8900000000000001 110.584 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.679 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 14.4 p -72.76 152.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.622 -0.717 . . . . 0.58999999999999997 111.168 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 3.5 m-30 -74.48 115.45 14.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.998 0.428 . . . . 0.78000000000000003 110.749 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -146.21 85.7 1.67 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.655 -0.702 . . . . 2.1800000000000002 109.425 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 15.0 m -116.13 -177.5 3.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.544 -0.753 . . . . 1.24 109.734 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -71.17 -37.98 72.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.947 0.404 . . . . 1.49 111.212 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.42 -48.09 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.382 0.512 . . . . 1.8 112.382 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -62.34 -45.57 92.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.926 0.713 . . . . 2.1899999999999999 112.926 -167.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 57' ' ' SER . 3.4 ptm180 -67.35 -23.25 65.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.776 0.322 . . . . 2.7799999999999998 111.326 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -87.71 -62.32 1.52 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 1.1000000000000001 110.565 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.3 107.09 30.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.631 0.729 . . . . 2.0299999999999998 110.787 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.14 138.74 37.3 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.114 2.542 . . . . 1.76 111.795 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.25 153.85 18.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.902 -0.407 . . . . 1.3100000000000001 109.902 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD3' HG23 ' A' ' 41' ' ' THR . 3.7 pptp? -130.02 146.76 51.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.303 -0.408 . . . . 1.3600000000000001 110.506 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.454 ' HB2' HE22 ' A' ' 71' ' ' GLN . 48.7 p90 -127.86 174.43 9.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.82 0.343 . . . . 0.56999999999999995 111.447 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -110.69 151.36 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 1.98 110.664 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.488 HD23 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -65.18 117.67 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.94999999999999996 110.535 -176.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.76 90.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.203 1.001 . . . . 2.0800000000000001 110.228 -171.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.454 HE22 ' HB2' ' A' ' 67' ' ' PHE . 8.2 tt0 -127.73 8.24 6.32 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.399 -1.273 . . . . 1.98 109.585 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.1 -17.67 31.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.71999999999999997 112.472 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 9.0 mm-40 -90.4 -15.53 30.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.374 0.606 . . . . 0.96999999999999997 110.329 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.56 124.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.952 -0.567 . . . . 0.57999999999999996 110.747 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -99.43 -57.07 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.74 0.644 . . . . 0.62 112.74 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.0 mtpt -137.41 -61.18 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 2.04 111.665 -171.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.46 ' O ' HG21 ' A' ' 93' ' ' VAL . . . -52.99 -52.74 37.66 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.05 -0.595 . . . . 0.32000000000000001 112.78 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.571 ' O ' HG22 ' A' ' 82' ' ' VAL . 12.0 m-90 -74.87 -51.53 13.67 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.74 -0.384 . . . . 0.48999999999999999 110.431 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.41 -51.98 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.545 0.528 . . . . 1.1399999999999999 112.123 -171.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 76' ' ' LYS . 1.8 mp -65.42 -38.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.809 0.338 . . . . 0.78000000000000003 110.453 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.0 t -68.6 -46.1 70.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.284 . . . . 0.55000000000000004 110.765 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 78' ' ' TRP . 27.6 m -67.98 -33.06 59.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 O-C-N 123.153 0.283 . . . . 0.83999999999999997 110.856 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -61.1 -39.24 89.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 1.4299999999999999 110.58 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.527 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 22.4 m -92.67 31.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.474 . . . . 1.23 111.15 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 85.6 mmm -104.52 175.13 5.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.615 -0.266 . . . . 2.27 110.385 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 70.4 mtt85 -144.89 165.71 27.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.465 -0.334 . . . . 4.1900000000000004 110.359 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -53.73 -35.14 60.87 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.618 0.573 . . . . 1.9399999999999999 112.316 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -125.19 41.4 3.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 1.23 110.561 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 20.2 tt0 -117.34 154.25 31.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.392 -0.367 . . . . 1.6000000000000001 110.193 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.94 117.49 7.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.376 . . . . 1.1699999999999999 109.986 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 74.5 m -124.52 162.21 24.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.092 0.472 . . . . 1.2 112.018 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.44 114.67 27.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.369 -0.832 . . . . 1.73 109.646 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.603 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.1 p -103.77 147.57 9.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.409 -0.359 . . . . 0.73999999999999999 110.983 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 94' ' ' ARG . 9.5 mmt85 -105.51 112.38 25.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.587 -0.523 . . . . 1.71 109.587 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.521 HD13 ' HD2' ' A' ' 118' ' ' PHE . 2.1 mp -94.1 105.58 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.149 0.499 . . . . 0.52000000000000002 109.67 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 97' ' ' SER . 23.0 tt0 -93.78 174.85 6.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -49.0 -45.87 43.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.76 0.424 . . . . 1.0 111.516 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.0 ptp -78.08 -8.29 58.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.948 -0.569 . . . . 1.79 112.027 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.412 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 21.6 m-85 -102.28 -18.58 15.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.75 110.578 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' C ' HD11 ' A' ' 75' ' ' ILE . . . -112.99 -174.41 19.13 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.304 -0.718 . . . . 0.70999999999999996 111.304 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.47 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . 5.7 m-85 -82.38 59.96 4.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 1.52 110.889 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -89.34 -0.32 80.04 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.397 -0.681 . . . . 2.2999999999999998 111.397 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.39 -55.22 4.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 5.8600000000000003 109.985 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -81.64 -54.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.571 -0.74 . . . . 4.2699999999999996 110.365 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.75 67.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.779 . . . . 2.1600000000000001 112.828 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . 43.9 t -123.32 136.71 54.81 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.653 -0.322 . . . . 3.3399999999999999 110.379 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.555 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -176.34 99.88 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.587 -0.605 . . . . 1.2 111.587 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 1.7 mp0 -66.11 -34.35 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.274 . . . . 3.0800000000000001 111.604 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.552 ' HB2' HD13 ' A' ' 110' ' ' ILE . 4.7 p -93.94 -76.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.961 0.356 . . . . 1.52 111.961 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -160.25 87.67 1.87 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 122.892 0.477 . . . . 0.75 110.848 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.555 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 87.1 Cg_endo -84.83 170.35 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.345 2.03 . . . . 1.5800000000000001 111.597 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.06 36.54 0.02 OUTLIER Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.39 -0.91 . . . . 2.0499999999999998 112.473 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.53 19.01 11.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.274 0.559 . . . . 2.0299999999999998 110.402 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' A' ' 50' ' ' SER . 2.0 m -95.8 160.93 14.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.493 -0.776 . . . . 1.1399999999999999 110.33 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.22 122.21 45.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.375 0.607 . . . . 0.47999999999999998 110.452 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.0 mp -116.29 142.7 46.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.837 -0.62 . . . . 0.51000000000000001 109.615 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.44 121.59 45.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.142 0.496 . . . . 0.69999999999999996 110.539 175.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.521 ' HD2' HD13 ' A' ' 95' ' ' ILE . 44.4 m-85 -112.88 137.95 50.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.747 . . . . 0.42999999999999999 111.219 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.512 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 38.7 mt-10 -78.2 122.37 25.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.81 -0.811 . . . . 1.46 108.81 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.479 HG21 HG12 ' A' ' 82' ' ' VAL . 49.9 mt -107.16 121.16 59.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.512 -0.551 . . . . 0.47999999999999998 109.512 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -127.68 112.88 15.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.514 -0.766 . . . . 1.8799999999999999 110.639 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 42' ' ' VAL . 24.6 tp -88.93 99.59 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 1.1200000000000001 109.9 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -90.8 -31.42 16.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.872 -0.331 . . . . 1.0 111.308 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.3 m -151.21 146.21 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.713 -0.221 . . . . 1.1899999999999999 110.571 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.593 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -168.39 -179.21 3.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.523 -0.308 . . . . 0.71999999999999997 110.294 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 6.0 ptp180 -155.74 142.22 18.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.055 -0.521 . . . . 2.98 109.948 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.92 150.99 25.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.756 0.312 . . . . 3.3799999999999999 110.482 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.2 mt -101.27 127.77 47.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.032 0.444 . . . . 3.3500000000000001 110.454 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.34 168.86 13.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.694 -0.685 . . . . 5.3899999999999997 109.308 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -63.15 122.0 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.293 -0.262 . . . . 7.04 110.293 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -135.89 98.99 4.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.331 0.586 . . . . 7.21 111.722 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -126.19 -76.63 0.58 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.386 -0.968 . . . . 9.0199999999999996 108.386 172.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 62.73 -6.96 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.38 1.622 . . . . 9.75 115.38 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -81.17 -20.69 40.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.932 -1.136 . . . . 12.26 107.932 167.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 70.3 t60 . . . . . 0 C--O 1.244 0.765 0 CA-C-N 114.101 -1.408 . . . . 13.35 107.977 173.921 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.721 0.296 . . . . 7.4800000000000004 111.082 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.4 t -82.41 -19.35 39.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.624 -0.262 . . . . 5.9000000000000004 110.95 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.791 HG22 ' H ' ' A' ' 4' ' ' GLU . 3.6 m 66.09 -174.2 0.18 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.344 -0.389 . . . . 4.4400000000000004 110.577 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.791 ' H ' HG22 ' A' ' 3' ' ' THR . 18.6 tt0 -130.58 178.16 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.956 -0.465 . . . . 4.4400000000000004 109.82 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 49.8 mt-30 -76.8 149.99 36.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.996 0.427 . . . . 4.1500000000000004 111.457 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.67 79.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.649 -0.871 . . . . 3.6099999999999999 108.649 172.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.46 160.44 25.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.561 -0.745 . . . . 3.6000000000000001 112.834 -171.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.72 154.26 19.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.9 -1.046 . . . . 2.71 110.025 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 3.2 mppt? -99.41 127.83 45.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.337 -0.616 . . . . 1.8799999999999999 109.337 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -102.53 105.42 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.421 -0.585 . . . . 0.58999999999999997 109.421 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.16 140.98 29.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.253 -0.43 . . . . 2.1600000000000001 110.993 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.2 mt 54.04 44.0 29.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 1.45 111.677 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.587 HG21 ' HD3' ' A' ' 20' ' ' LYS . 9.1 t -55.92 157.3 4.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.78000000000000003 110.817 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 1.16 5.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.81000000000000005 111.19 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -80.11 3.51 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 2.3999999999999999 110.592 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.86 25.41 1.9 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.839 -0.696 . . . . 0.68000000000000005 113.539 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 66.02 68.75 1.55 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.231 -0.509 . . . . 0.60999999999999999 113.941 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.532 HG21 ' HB ' ' A' ' 80' ' ' ILE . 12.8 t -135.87 145.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.898 -0.408 . . . . 0.48999999999999999 109.898 176.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.783 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 8.8 mm -85.49 109.67 18.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.453 -0.573 . . . . 0.46999999999999997 109.453 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.587 ' HD3' HG21 ' A' ' 13' ' ' THR . 4.1 ptmt -125.0 129.13 49.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.232 0.539 . . . . 1.3400000000000001 111.158 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -101.07 114.62 28.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.644 -0.707 . . . . 0.5 109.801 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.505 HD11 ' CG ' ' A' ' 25' ' ' LYS . 10.5 tp -66.16 128.74 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.992 -0.549 . . . . 0.67000000000000004 109.792 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 0.5 OUTLIER -122.57 -78.3 0.6 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.993 0.425 . . . . 0.82999999999999996 110.776 -177.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -124.55 119.03 27.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.753 -0.658 . . . . 1.5600000000000001 109.983 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.591 ' HA ' ' HG3' ' A' ' 89' ' ' GLU . 43.7 mtpt -107.09 163.73 12.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.024 0.44 . . . . 2.9500000000000002 110.692 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.3 -124.67 5.24 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.428 -0.806 . . . . 1.3200000000000001 111.3 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -150.99 -86.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.129 0.49 . . . . 2.77 110.439 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -95.65 158.74 15.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.978 -0.556 . . . . 2.6400000000000001 110.526 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.37 53.79 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 111.218 -0.753 . . . . 1.04 111.218 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.43 -40.19 89.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.109 0.48 . . . . 2.29 110.2 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -106.51 27.18 9.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.493 0.663 . . . . 2.6400000000000001 109.802 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' OD1' ' HE3' ' A' ' 87' ' ' LYS . 36.1 m-80 -130.51 76.47 1.72 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.521 -0.763 . . . . 1.45 109.857 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.6 mm -130.48 120.53 18.89 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.066 -0.516 . . . . 0.81000000000000005 111.131 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.16 131.74 15.73 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.571 2.181 . . . . 0.75 111.52 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HB2' HD22 ' A' ' 38' ' ' ASN . 30.4 mmmt -126.05 142.22 51.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.623 -0.262 . . . . 2.6600000000000001 110.5 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 7.4 ttmm -71.22 138.64 49.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 2.5099999999999998 109.471 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.7 -27.15 13.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.809 -0.71 . . . . 1.1200000000000001 111.408 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.404 HD22 ' HB2' ' A' ' 35' ' ' LYS . 72.9 m-20 -88.88 145.37 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.82 -0.437 . . . . 1.3799999999999999 109.82 174.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 42.8 mt-10 -69.53 98.75 1.17 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.846 -0.615 . . . . 2.2000000000000002 112.126 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 125' ' ' PHE . 22.6 m -116.13 152.23 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 0.67000000000000004 109.828 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.4 m -127.36 131.05 50.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.683 -0.488 . . . . 0.65000000000000002 109.683 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 122' ' ' LEU . 10.7 m -137.12 152.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.276 0.56 . . . . 0.87 112.436 -173.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -105.38 129.44 53.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 2.75 109.58 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 8.7 p90 -134.27 140.13 46.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.854 0.359 . . . . 0.76000000000000001 111.474 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.14 158.6 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.54 -0.911 . . . . 0.48999999999999999 108.54 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -177.39 -126.63 0.99 Allowed Glycine 0 C--O 1.228 -0.227 0 C-N-CA 119.847 -1.168 . . . . 0.35999999999999999 113.019 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.573 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 20.6 pttp -155.45 170.68 21.38 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.575 -0.367 . . . . 1.4299999999999999 111.478 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HG ' ' A' ' 116' ' ' LEU . 66.0 tp -94.1 98.32 10.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.38 109.683 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 117' ' ' LEU . 2.4 tp10 -69.19 -20.65 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.96 111.309 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.543 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 5.5 t -55.31 -27.37 46.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.67000000000000004 111.504 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 t -138.18 9.22 2.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 0.72999999999999998 110.452 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.73 55.61 27.6 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.847 -0.615 . . . . 0.78000000000000003 112.636 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 27.1 mmmt -121.14 118.55 29.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.529 -0.175 . . . . 2.8900000000000001 110.529 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.573 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.5 p -69.6 153.99 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.864 0.364 . . . . 0.58999999999999997 110.973 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 7.7 m-30 -76.73 105.53 7.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.78000000000000003 110.624 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -130.82 85.58 2.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.549 0.69 . . . . 2.1800000000000002 109.81 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.32 156.17 28.29 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.587 -0.894 . . . . 1.24 108.587 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -68.33 -21.32 64.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.177 0.513 . . . . 1.49 110.77 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -94.62 -48.8 5.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 1.8 112.21 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -42.92 82.75 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.984 0.364 . . . . 2.1899999999999999 111.984 -169.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -77.49 -3.52 40.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.016 0.436 . . . . 2.7799999999999998 111.063 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.437 HD22 HG12 ' A' ' 63' ' ' VAL . 7.4 t30 -90.7 -45.73 8.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 1.1000000000000001 109.989 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.437 HG12 HD22 ' A' ' 62' ' ' ASN . 7.2 p -154.87 113.51 2.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 2.0299999999999998 110.52 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.22 171.4 17.85 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.798 2.332 . . . . 1.76 112.197 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -102.4 142.44 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.176 -0.466 . . . . 1.3100000000000001 110.175 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HD3' ' CG2' ' A' ' 41' ' ' THR . 0.0 OUTLIER -119.14 143.65 47.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 1.3600000000000001 108.996 175.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . 55.8 p90 -133.44 169.89 16.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.56999999999999995 112.054 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.524 ' HE1' ' HB3' ' A' ' 39' ' ' GLU . 1.5 m-70 -104.96 148.97 26.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.676 -1.147 . . . . 1.98 109.768 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 ' HB ' ' A' ' 82' ' ' VAL . 25.3 tp -73.15 129.99 39.28 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.747 -0.381 . . . . 0.94999999999999996 110.144 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 65.72 31.77 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.929 0.768 . . . . 2.0800000000000001 111.165 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 67' ' ' PHE . 12.2 pt20 -80.9 12.57 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 1.98 111.114 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.57 48.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.035 -0.602 . . . . 0.71999999999999997 112.828 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HB2' HE21 ' A' ' 71' ' ' GLN . 17.1 mm-40 -87.5 -32.32 19.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.044 0.449 . . . . 0.96999999999999997 110.818 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.452 HG11 ' CE2' ' A' ' 67' ' ' PHE . 28.0 m -98.52 127.05 51.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.376 0.607 . . . . 0.57999999999999996 110.62 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.645 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.65 -76.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.62 112.27 -175.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.645 ' H ' HG12 ' A' ' 75' ' ' ILE . 4.2 mmpt? -121.15 -57.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.455 . . . . 2.04 112.23 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.16 -52.31 36.66 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.292 0.37 . . . . 0.32000000000000001 113.693 -171.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.63 -43.13 49.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.94 -0.153 . . . . 0.48999999999999999 111.373 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.491 ' HA ' ' CD1' ' A' ' 69' ' ' LEU . 23.2 t70 -51.87 -52.32 50.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.526 0.565 . . . . 1.1399999999999999 112.526 -171.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.532 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.7 mp -61.62 -50.97 78.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.451 . . . . 0.78000000000000003 111.296 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 120' ' ' ILE . 47.6 t -71.21 -27.41 63.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.55000000000000004 111.734 -171.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' HD13 ' A' ' 69' ' ' LEU . 53.7 t -66.24 -40.12 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.281 . . . . 0.83999999999999997 110.873 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 t -78.39 -7.84 57.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 1.4299999999999999 110.05 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.5 m -98.09 19.0 14.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 1.23 110.76 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 6.0 mmt -98.26 -173.53 2.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 2.27 111.726 -176.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 38.1 ttm180 -157.43 163.49 38.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.957 -1.127 . . . . 4.1900000000000004 107.957 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.504 ' HE3' ' OD1' ' A' ' 32' ' ' ASN . 5.3 tppp? -50.85 -40.51 56.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.032 0.382 . . . . 1.9399999999999999 112.032 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -118.96 34.17 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.237 . . . . 1.23 110.563 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 4.3 tt0 -122.7 140.09 53.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.722 -0.391 . . . . 1.6000000000000001 110.781 -175.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 1.9 tmtp? -145.57 129.18 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 1.1699999999999999 109.977 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 74.4 m -137.58 171.09 14.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.074 0.464 . . . . 1.2 111.687 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 119' ' ' GLU . 58.0 mt -105.83 131.68 52.87 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.502 -0.772 . . . . 1.73 109.983 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 95' ' ' ILE . 7.3 p -112.45 140.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.044 0.449 . . . . 0.73999999999999999 110.994 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.783 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 8.3 mmm180 -99.13 112.81 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.577 . . . . 1.71 110.028 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CD1' HG13 ' A' ' 93' ' ' VAL . 3.2 mp -101.45 107.51 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.52000000000000002 110.137 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 31.4 tt0 -84.51 171.81 12.21 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.856 -0.794 . . . . 1.3700000000000001 108.856 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.6 p -56.4 -38.21 71.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.645 0.259 . . . . 1.0 111.612 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.0 ptp -77.21 -7.85 56.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 1.79 111.434 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.502 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.8 m-30 -97.29 1.96 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.34 -0.225 . . . . 0.75 110.508 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.57 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -134.35 -152.59 6.69 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.94 -0.573 . . . . 0.70999999999999996 111.729 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.07 -70.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 1.52 110.746 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 111' ' ' PRO . . . 121.98 -175.42 16.3 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.2999999999999998 112.012 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -74.6 -6.92 51.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.913 0.387 . . . . 5.8600000000000003 110.41 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -61.96 -36.86 82.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 4.2699999999999996 111.155 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.48 -82.98 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.286 -0.959 . . . . 2.1600000000000001 112.539 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 86.1 m -81.8 113.48 19.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.272 0.558 . . . . 3.3399999999999999 111.168 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -117.08 83.8 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.411 -0.813 . . . . 1.2 111.228 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 108' ' ' GLU . 21.9 mp0 -53.77 -64.85 0.69 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.722 0.409 . . . . 3.0800000000000001 110.866 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m -112.21 -74.91 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.264 -0.426 . . . . 1.52 110.277 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -154.59 66.13 5.06 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 121.025 0.441 . . . . 0.75 110.594 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.513 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 11.0 Cg_endo -91.71 53.79 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.203 2.602 . . . . 1.5800000000000001 112.972 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.33 63.8 4.09 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.732 -0.746 . . . . 2.0499999999999998 112.045 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 51.73 66.25 1.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.602 0.715 . . . . 2.0299999999999998 110.407 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 49.6 m -144.93 168.45 20.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.328 -0.851 . . . . 1.1399999999999999 110.097 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.86 128.42 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.182 -0.463 . . . . 0.47999999999999998 110.415 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 48' ' ' LEU . 5.1 mp -123.07 169.18 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.51000000000000001 110.293 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.16 131.64 37.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.448 -0.575 . . . . 0.69999999999999996 109.448 175.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 95' ' ' ILE . 37.9 m-85 -128.96 144.04 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.381 . . . . 0.42999999999999999 110.95 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.705 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 26.9 mt-10 -74.81 128.03 34.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.727 -0.842 . . . . 1.46 108.727 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 81' ' ' CYS . 25.8 mt -107.17 120.32 58.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.178 -0.675 . . . . 0.47999999999999998 109.178 172.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -127.07 118.07 23.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.482 -0.781 . . . . 1.8799999999999999 110.51 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HA ' HG12 ' A' ' 42' ' ' VAL . 35.8 tp -80.69 113.89 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 1.1200000000000001 109.902 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.94 -13.41 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.716 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.4 m -155.63 137.84 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.985 -0.376 . . . . 1.1899999999999999 109.985 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG12 ' A' ' 40' ' ' VAL . 9.0 p90 -160.81 175.0 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.71999999999999997 110.368 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 39' ' ' GLU . 2.6 ptp180 -162.26 147.27 12.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 2.98 110.38 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.54 152.14 33.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.779 0.323 . . . . 3.3799999999999999 110.279 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 tt -151.76 127.05 9.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.06 -1.089 . . . . 3.3500000000000001 108.06 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.42 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 2.1 pp20? -96.79 167.2 11.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.02 0.438 . . . . 5.3899999999999997 112.022 -173.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -69.07 -43.3 74.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.774 -0.648 . . . . 7.04 111.86 -172.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 56.14 89.8 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.948 0.78 . . . . 7.21 111.975 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -108.4 127.81 54.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.653 -0.419 . . . . 9.0199999999999996 109.96 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -78.53 93.0 4.72 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.958 -0.564 . . . . 9.75 110.585 -176.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 7.1 p80 -82.38 124.21 29.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 12.26 109.372 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 29.6 m-70 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.687 -1.149 . . . . 13.35 111.211 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.866 0.365 . . . . 7.4800000000000004 110.573 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.57 120.57 15.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 5.9000000000000004 112.11 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.2 p -95.28 12.04 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.286 0.565 . . . . 4.4400000000000004 110.485 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -120.19 138.36 53.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.665 . . . . 4.4400000000000004 110.27 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -89.96 163.32 15.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.451 -0.341 . . . . 4.1500000000000004 110.512 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.34 2.68 34.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 3.6099999999999999 111.036 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.46 158.16 15.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.377 -0.374 . . . . 3.6000000000000001 110.99 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -121.16 170.81 9.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.013 -0.54 . . . . 2.71 109.897 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 0.0 OUTLIER -90.86 157.24 17.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 1.8799999999999999 110.814 -175.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.44 HG11 ' HB ' ' A' ' 13' ' ' THR . 58.9 t -103.93 115.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.328 -0.619 . . . . 0.58999999999999997 109.328 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -87.92 99.82 12.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.474 -0.33 . . . . 2.1600000000000001 111.259 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' H ' HD13 ' A' ' 19' ' ' ILE . 66.1 mt 52.88 75.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 1.45 111.19 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.44 ' HB ' HG11 ' A' ' 10' ' ' VAL . 4.9 t -59.29 147.2 36.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 0.78000000000000003 110.32 175.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.38 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 0.81000000000000005 111.084 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.15 29.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 2.3999999999999999 111.084 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.35 -5.39 10.15 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.631 -0.795 . . . . 0.68000000000000005 113.933 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.19 71.02 1.09 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.94 -0.648 . . . . 0.60999999999999999 114.043 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.2 t -138.11 145.64 28.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.693 -0.484 . . . . 0.48999999999999999 109.693 173.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.0 mm -85.61 110.72 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.294 -0.412 . . . . 0.46999999999999997 110.802 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.51 147.24 40.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.286 -0.415 . . . . 1.3400000000000001 110.697 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 9' ' ' LYS . 26.4 m -112.98 139.46 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 0.5 110.392 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 tp -80.03 134.97 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.147 -0.479 . . . . 0.67000000000000004 110.355 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.43 -71.16 0.72 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.086 0.47 . . . . 0.82999999999999996 110.503 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -105.47 97.54 7.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.291 -0.633 . . . . 1.5600000000000001 109.291 -177.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -75.21 138.82 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.884 0.373 . . . . 2.9500000000000002 110.855 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.69 135.59 14.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.97 -0.633 . . . . 1.3200000000000001 111.681 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.71 -55.21 37.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 2.77 110.174 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.59 170.27 19.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.39 -0.823 . . . . 2.6400000000000001 109.579 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.83 43.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 1.04 111.369 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.52 -38.0 85.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.949 0.404 . . . . 2.29 111.143 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -94.57 -20.55 19.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.809 -0.632 . . . . 2.6400000000000001 110.509 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 38.8 m-80 -95.3 81.81 3.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.129 -0.487 . . . . 1.45 110.927 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.36 120.56 26.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.81000000000000005 111.377 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.4 Cg_endo -76.49 132.75 13.76 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.204 2.603 . . . . 0.75 111.4 174.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HD3' ' OG ' ' A' ' 83' ' ' SER . 34.3 mmtm -148.78 158.94 44.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.667 0.27 . . . . 2.6600000000000001 111.109 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -55.75 128.47 35.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.961 -0.563 . . . . 2.5099999999999998 110.465 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.75 -26.59 20.65 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.9 -0.591 . . . . 1.1200000000000001 111.793 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -83.63 140.22 32.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.652 -0.499 . . . . 1.3799999999999999 109.652 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -76.91 101.59 6.01 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.325 -0.62 . . . . 2.2000000000000002 109.325 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 125' ' ' PHE . 26.3 m -115.49 133.83 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.781 -0.645 . . . . 0.67000000000000004 111.309 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' HD3' ' A' ' 66' ' ' LYS . 17.4 m -103.26 106.93 17.57 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.5 -0.555 . . . . 0.65000000000000002 109.5 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 m -119.34 141.66 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.551 0.691 . . . . 0.87 112.582 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.42 148.67 25.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.944 -1.025 . . . . 2.75 109.601 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 2.5 p90 -144.24 140.88 29.51 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.226 0.329 . . . . 0.76000000000000001 110.596 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -168.04 160.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.377 -0.601 . . . . 0.48999999999999999 109.377 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 171.32 -137.87 4.6 Favored Glycine 0 C--N 1.329 0.15 0 C-N-CA 119.59 -1.29 . . . . 0.35999999999999999 113.249 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.9 pttp -143.49 171.71 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 1.4299999999999999 110.497 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD22 HG13 ' A' ' 110' ' ' ILE . 42.7 tp -95.0 101.93 13.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.155 -0.475 . . . . 0.38 110.131 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.1 tp10 -61.68 -35.28 77.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 1.96 110.575 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 t -55.21 -32.08 61.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 0.67000000000000004 112.55 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 53' ' ' LYS . 8.8 t -123.35 -4.05 8.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.885 0.374 . . . . 0.72999999999999998 110.96 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.03 26.06 74.59 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.183 -0.532 . . . . 0.78000000000000003 113.189 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HG2' HG23 ' A' ' 51' ' ' THR . 75.4 mmtt -109.18 140.01 43.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.168 0.509 . . . . 2.8900000000000001 110.616 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 p -84.59 159.99 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.883 -0.599 . . . . 0.58999999999999997 110.035 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -74.35 131.5 41.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.116 -0.327 . . . . 0.78000000000000003 110.116 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.57 89.9 1.6 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.313 0.577 . . . . 2.1800000000000002 109.535 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -136.95 168.08 20.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.879 -0.6 . . . . 1.24 111.099 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -62.58 -29.14 70.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.49 111.403 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -92.65 -44.54 8.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.147 0.425 . . . . 1.8 112.147 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -32.45 72.79 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 2.1899999999999999 111.978 -169.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -94.2 -14.07 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.838 -0.345 . . . . 2.7799999999999998 111.21 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.516 HD22 HG13 ' A' ' 63' ' ' VAL . 11.3 t30 -100.32 -44.82 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.358 . . . . 1.1000000000000001 111.467 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG13 HD22 ' A' ' 62' ' ' ASN . 3.5 m -129.31 98.82 22.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.669 0.747 . . . . 2.0299999999999998 111.794 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 63' ' ' VAL . 46.5 Cg_endo -70.98 128.48 14.96 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.206 1.938 . . . . 1.76 111.52 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -95.86 148.29 22.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 1.3100000000000001 110.521 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD3' HG23 ' A' ' 41' ' ' THR . 2.4 pptp? -133.07 143.66 49.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 1.3600000000000001 109.658 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -128.87 -178.72 4.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.56999999999999995 111.548 -173.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.535 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 18.5 m170 -114.04 149.68 35.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.659 . . . . 1.98 110.437 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.75 HD11 ' HA ' ' A' ' 79' ' ' ASP . 22.9 tp -67.37 122.81 18.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.94999999999999996 111.787 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 42.39 72.5 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.222 1.009 . . . . 2.0800000000000001 112.259 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -119.71 19.09 12.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.709 0.766 . . . . 1.98 110.587 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.5 -18.85 46.87 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.276 -0.874 . . . . 0.71999999999999997 112.835 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.83 -50.96 6.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.407 0.622 . . . . 0.96999999999999997 109.617 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -100.16 132.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.604 -0.726 . . . . 0.57999999999999996 110.381 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.501 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.04 -74.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.799 0.666 . . . . 0.62 112.799 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 75' ' ' ILE . 19.8 mtpp -128.82 -40.81 1.51 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.876 -0.515 . . . . 2.04 112.174 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -49.51 52.58 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.824 -0.703 . . . . 0.32000000000000001 112.462 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 82' ' ' VAL . 14.7 m-90 -76.02 -41.09 52.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.626 0.25 . . . . 0.48999999999999999 110.858 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.75 ' HA ' HD11 ' A' ' 69' ' ' LEU . 35.0 t70 -56.02 -53.41 57.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.964 -0.562 . . . . 1.1399999999999999 112.329 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.75 -33.35 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.78000000000000003 110.873 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 85' ' ' MET . 48.7 t -69.25 -50.0 51.08 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.805 -0.358 . . . . 0.55000000000000004 110.243 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 69' ' ' LEU . 89.4 t -63.29 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.496 -0.32 . . . . 0.83999999999999997 111.338 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.442 ' OG ' ' HD3' ' A' ' 35' ' ' LYS . 23.3 t -71.69 -8.47 54.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.813 0.34 . . . . 1.4299999999999999 111.456 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 t -114.0 23.05 13.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.112 0.482 . . . . 1.23 110.389 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.576 ' HE1' ' HA ' ' A' ' 90' ' ' LYS . 82.8 mmm -99.45 177.33 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 2.27 111.332 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.58 ' HB2' ' CB ' ' A' ' 89' ' ' GLU . 97.1 mtt180 -141.08 159.4 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 4.1900000000000004 108.417 173.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HD2' ' HE1' ' A' ' 125' ' ' PHE . 63.9 tttm -66.45 -21.68 66.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.093 0.473 . . . . 1.9399999999999999 111.087 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.77 12.13 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 1.23 110.703 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.58 ' CB ' ' HB2' ' A' ' 86' ' ' ARG . 18.2 tt0 -122.64 156.26 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.443 -0.344 . . . . 1.6000000000000001 110.444 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.576 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 75.3 tttt -156.51 134.93 11.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.367 -0.379 . . . . 1.1699999999999999 110.704 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 64.3 m -139.07 171.66 13.99 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.89 0.7 . . . . 1.2 112.89 -173.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.33 125.75 53.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.23 -0.895 . . . . 1.73 110.062 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.492 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 13.9 p -117.73 150.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.896 0.379 . . . . 0.73999999999999999 111.101 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -108.27 115.54 30.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 1.71 110.226 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 118' ' ' PHE . 1.9 mp -87.86 103.8 13.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.163 -0.681 . . . . 0.52000000000000002 109.163 176.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.616 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 22.1 tt0 -86.58 176.12 7.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.047 -0.979 . . . . 1.3700000000000001 109.293 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 20.6 p -49.93 -48.94 51.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.268 0.47 . . . . 1.0 112.268 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.04 -7.83 56.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.307 . . . . 1.79 111.72 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.616 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 22.4 m-30 -94.68 -9.52 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.57 0.224 . . . . 0.75 110.724 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 -171.74 14.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.044 -0.598 . . . . 0.70999999999999996 111.797 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.446 ' HB3' ' HA3' ' A' ' 105' ' ' GLY . 22.3 m-85 -88.45 -33.69 17.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 1.52 110.835 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.31 -154.42 33.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.643 -0.789 . . . . 2.2999999999999998 112.642 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.1 -30.28 34.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.984 0.421 . . . . 5.8600000000000003 111.224 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -87.38 11.25 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.45 0.643 . . . . 4.2699999999999996 110.533 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 101' ' ' TYR . . . -133.96 -135.07 3.51 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.751 -0.659 . . . . 2.1600000000000001 111.645 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 68.9 m -104.54 120.6 41.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 3.3399999999999999 110.436 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 111' ' ' PRO . . . -110.98 120.8 5.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.768 -0.73 . . . . 1.2 112.093 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.24 -70.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.782 0.325 . . . . 3.0800000000000001 111.257 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.414 ' CB ' HD13 ' A' ' 110' ' ' ILE . 14.4 m -105.41 -74.73 0.64 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.861 -0.336 . . . . 1.52 111.013 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.766 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.0 57.07 3.28 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-O 120.646 0.26 . . . . 0.75 111.537 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 55.5 Cg_endo -97.7 59.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.115 2.543 . . . . 1.5800000000000001 112.538 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.6 56.14 4.16 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.729 -0.748 . . . . 2.0499999999999998 112.043 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 67.01 14.14 9.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.322 0.649 . . . . 2.0299999999999998 109.82 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -86.55 159.56 19.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.343 -0.844 . . . . 1.1399999999999999 110.406 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.87 128.07 43.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.017 0.437 . . . . 0.47999999999999998 110.694 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.6 mp -122.36 165.86 15.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.456 . . . . 0.51000000000000001 110.544 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -116.56 113.1 22.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.409 -0.589 . . . . 0.69999999999999996 109.409 176.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 95' ' ' ILE . 13.4 m-85 -111.86 124.69 52.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.374 0.607 . . . . 0.42999999999999999 110.89 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.699 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.0 tm-20 -83.0 120.54 25.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.886 -1.052 . . . . 1.46 109.172 174.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.452 HG21 HG22 ' A' ' 82' ' ' VAL . 48.4 mt -109.34 130.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.223 0.535 . . . . 0.47999999999999998 111.098 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -126.01 121.66 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.347 -0.842 . . . . 1.8799999999999999 110.329 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' A' ' 34' ' ' PRO . 27.7 tp -87.03 89.7 8.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.948 -0.76 . . . . 1.1200000000000001 108.948 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 3.3 pp -91.71 -25.77 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.762 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 m -154.13 142.26 20.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.758 0.313 . . . . 1.1899999999999999 110.546 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.645 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -167.43 179.6 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.245 -0.65 . . . . 0.71999999999999997 109.245 175.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -159.64 158.99 32.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.983 0.421 . . . . 2.98 110.682 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.21 115.54 28.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 3.3799999999999999 110.492 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -108.59 113.54 26.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.387 -0.37 . . . . 3.3500000000000001 110.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -96.28 145.09 25.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.199 -0.455 . . . . 5.3899999999999997 111.197 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -128.86 -58.23 1.16 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.377 -0.601 . . . . 7.04 109.377 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 69.26 152.73 0.1 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.754 0.659 . . . . 7.21 110.802 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -116.07 -26.58 7.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.262 0.553 . . . . 9.0199999999999996 109.772 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -66.49 127.56 32.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.445 -0.798 . . . . 9.75 109.495 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -67.35 93.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.199 0.523 . . . . 12.26 110.524 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.252 1.218 0 CA-C-N 115.304 -0.862 . . . . 13.35 110.381 -177.29 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.275 -0.269 . . . . 7.4800000000000004 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.83 115.16 3.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.485 0.659 . . . . 5.9000000000000004 111.014 174.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.8 p -86.89 -68.04 0.77 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.185 -0.916 . . . . 4.4400000000000004 109.114 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 47.12 92.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 O-C-N 124.097 0.873 . . . . 4.4400000000000004 112.202 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -52.13 151.31 3.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.26 -0.882 . . . . 4.1500000000000004 111.771 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -81.64 90.98 6.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 3.6099999999999999 111.109 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.94 144.93 26.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.037 0.446 . . . . 3.6000000000000001 110.807 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.91 142.51 33.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.549 -0.751 . . . . 2.71 109.417 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -82.88 148.63 27.59 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 1.8799999999999999 109.475 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.2 t -101.87 104.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.759 . . . . 0.58999999999999997 108.952 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -91.25 110.37 21.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 2.1600000000000001 110.957 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' H ' HD13 ' A' ' 19' ' ' ILE . 87.0 mt 64.38 67.63 0.57 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.082 -0.963 . . . . 1.45 110.574 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 15' ' ' ASP . 14.7 t -74.45 167.66 21.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.03 -0.532 . . . . 0.78000000000000003 110.696 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -0.82 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.81000000000000005 112.004 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.703 ' OD2' ' HA ' ' A' ' 80' ' ' ILE . 8.4 t70 -79.09 -0.61 32.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.248 0.546 . . . . 2.3999999999999999 110.423 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.16 22.94 2.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.598 -0.811 . . . . 0.68000000000000005 113.69 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 75.68 72.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.091 -0.576 . . . . 0.60999999999999999 114.524 171.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 80' ' ' ILE . 38.8 t -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.937 -0.394 . . . . 0.48999999999999999 109.937 172.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 12' ' ' LEU . 7.7 mm -89.75 112.64 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.46999999999999997 110.845 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' HG22 ' A' ' 93' ' ' VAL . 64.3 pttt -136.96 145.97 44.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 1.3400000000000001 111.382 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -107.95 123.62 48.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.5 110.232 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 91' ' ' CYS . 8.2 tp -83.98 130.95 35.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.67000000000000004 110.997 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD21 ' HG ' ' A' ' 92' ' ' LEU . 2.5 mm? -100.14 -60.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.339 0.59 . . . . 0.82999999999999996 109.733 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -122.26 122.71 39.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 1.5600000000000001 109.659 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -82.28 147.48 28.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.295 -0.412 . . . . 2.9500000000000002 111.38 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.94 144.12 33.19 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.509 -1.036 . . . . 1.3200000000000001 110.509 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.13 -78.14 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.275 0.538 . . . . 2.77 109.62 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.58 164.83 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.218 -0.66 . . . . 2.6400000000000001 109.218 171.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 86' ' ' ARG . . . 157.24 70.35 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.957 -1.115 . . . . 1.04 113.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -75.36 -30.89 60.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.42 0.629 . . . . 2.29 110.14 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -86.39 -39.0 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.389 -0.823 . . . . 2.6400000000000001 111.419 -174.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.772 ' HB2' HH21 ' A' ' 86' ' ' ARG . 10.6 m120 -93.66 79.54 4.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.186 0.517 . . . . 1.45 111.096 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.09 125.63 21.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.073 -0.967 . . . . 0.81000000000000005 110.338 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.5 ' HG3' HD22 ' A' ' 122' ' ' LEU . 67.5 Cg_endo -73.57 140.39 29.7 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.908 2.405 . . . . 0.75 111.542 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 14.2 mmmm -127.41 147.68 50.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.426 -0.583 . . . . 2.6600000000000001 109.426 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.628 ' HA ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.31 149.14 48.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.774 -0.371 . . . . 2.5099999999999998 111.242 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.89 -17.29 53.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.836 -0.697 . . . . 1.1200000000000001 111.966 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.535 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 81.5 m-20 -85.68 175.89 8.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.301 0.572 . . . . 1.3799999999999999 111.083 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -97.48 121.57 39.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.534 -0.757 . . . . 2.2000000000000002 109.747 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG11 HD23 ' A' ' 69' ' ' LEU . 6.9 m -140.99 166.64 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.767 0.318 . . . . 0.67000000000000004 110.446 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.547 HG23 ' HD3' ' A' ' 66' ' ' LYS . 21.0 m -133.97 116.94 16.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.65000000000000002 110.408 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 122' ' ' LEU . 34.9 m -134.87 145.25 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.437 -0.347 . . . . 0.87 110.687 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -100.84 140.52 35.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.415 -0.587 . . . . 2.75 109.415 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 42.6 p90 -125.75 135.47 52.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 111.397 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -168.87 155.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.391 -0.966 . . . . 0.48999999999999999 108.391 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 178.61 -130.03 1.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.744 -1.217 . . . . 0.35999999999999999 113.27 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 57.2 pttt -147.06 171.32 15.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 1.4299999999999999 110.313 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 110' ' ' ILE . 61.7 tp -96.73 98.39 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.38 109.914 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.736 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.3 tp10 -68.65 -22.41 64.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.248 0.546 . . . . 1.96 110.547 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -25.43 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.389 -0.823 . . . . 0.67000000000000004 111.407 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.616 HG23 ' HD3' ' A' ' 53' ' ' LYS . 7.9 t -132.97 -19.31 2.27 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.986 0.422 . . . . 0.72999999999999998 111.072 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 53' ' ' LYS . . . 91.6 34.82 7.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.28 -0.486 . . . . 0.78000000000000003 112.853 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HD3' HG23 ' A' ' 51' ' ' THR . 13.7 mptt -116.97 134.93 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.75 0.309 . . . . 2.8900000000000001 110.989 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.564 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 10.1 p -79.31 156.39 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.935 -0.575 . . . . 0.58999999999999997 110.838 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -74.25 131.15 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.78000000000000003 111.04 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.01 89.13 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.833 -0.621 . . . . 2.1800000000000002 109.882 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.2 m -124.99 147.03 49.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.533 -0.758 . . . . 1.24 110.094 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 m -59.24 -20.4 53.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.987 -0.551 . . . . 1.49 111.127 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -92.3 -50.85 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.171 -0.468 . . . . 1.8 111.901 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -32.4 72.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.936 0.347 . . . . 2.1899999999999999 111.936 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -83.4 1.83 39.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.346 0.593 . . . . 2.7799999999999998 110.26 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.463 HD22 HG12 ' A' ' 63' ' ' VAL . 10.3 t30 -109.23 -48.64 3.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.37 -0.832 . . . . 1.1000000000000001 110.448 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 HD22 ' A' ' 62' ' ' ASN . 7.6 p -152.13 126.15 4.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.036 0.446 . . . . 2.0299999999999998 111.085 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.53 162.06 19.4 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.78 2.32 . . . . 1.76 112.327 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -104.09 154.83 19.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.752 -0.462 . . . . 1.3100000000000001 109.752 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.15 136.12 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 1.3600000000000001 110.692 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -114.44 -174.23 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.553 -0.294 . . . . 0.56999999999999995 110.518 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.55 ' HB2' HE21 ' A' ' 71' ' ' GLN . 80.4 m-70 -126.45 153.05 45.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.269 -0.271 . . . . 1.98 110.269 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -51.34 151.93 2.74 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.457 0.473 . . . . 0.94999999999999996 111.659 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -22.2 98.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 113.318 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.55 HE21 ' HB2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -129.8 8.07 5.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.508 -1.224 . . . . 1.98 108.98 176.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.13 -10.45 43.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.71999999999999997 113.409 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -85.23 -46.56 10.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.804 0.802 . . . . 0.96999999999999997 109.248 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.55 134.06 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.031 -0.531 . . . . 0.57999999999999996 110.575 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.662 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -96.6 -69.83 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.461 0.541 . . . . 0.62 112.461 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.58 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -140.96 -45.66 0.39 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.563 0.579 . . . . 2.04 112.563 -173.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 99' ' ' TYR . . . -52.83 -53.12 34.79 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.944 -0.646 . . . . 0.32000000000000001 113.005 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.514 ' O ' HG22 ' A' ' 82' ' ' VAL . 18.3 m-90 -76.69 -31.01 56.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 0.48999999999999999 110.75 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -57.92 -49.14 77.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.46 -0.791 . . . . 1.1399999999999999 111.759 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.703 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . 1.6 mp -59.69 -31.32 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.124 0.487 . . . . 0.78000000000000003 111.051 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.767 ' HB2' HG21 ' A' ' 93' ' ' VAL . 14.9 t -77.05 -58.05 3.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.334 -0.546 . . . . 0.55000000000000004 110.713 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.67 ' HA ' ' HE2' ' A' ' 85' ' ' MET . 15.5 m -62.13 -33.54 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.791 0.664 . . . . 0.83999999999999997 112.791 -170.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t -92.12 5.66 49.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.079 0.466 . . . . 1.4299999999999999 110.974 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 32.0 t -137.73 30.09 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.228 0.537 . . . . 1.23 110.083 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.67 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 45.3 mtm -106.59 -172.12 2.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 2.27 110.373 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.772 HH21 ' HB2' ' A' ' 32' ' ' ASN . 14.5 mtp-105 -138.73 170.74 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.515 . . . . 4.1900000000000004 110.212 171.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -64.12 -20.57 66.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.282 -0.417 . . . . 1.9399999999999999 111.621 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -127.05 16.57 7.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.36 -0.382 . . . . 1.23 111.106 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 2.1 tm-20 -110.38 153.72 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -158.86 123.33 4.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.691 -0.231 . . . . 1.1699999999999999 110.551 -173.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 1.6 p -136.53 159.05 42.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.437 -0.347 . . . . 1.2 111.421 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 23' ' ' LEU . 97.9 mt -105.2 127.17 52.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.12 -0.491 . . . . 1.73 110.852 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 81' ' ' CYS . 39.1 t -105.74 151.08 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.968 -0.56 . . . . 0.73999999999999999 111.015 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.36 112.17 25.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.445 -0.576 . . . . 1.71 109.445 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.4 mp -90.3 105.71 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.52000000000000002 110.43 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 97' ' ' SER . 34.0 tt0 -82.29 166.09 19.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 1.3700000000000001 109.12 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 3.6 p -52.99 -42.94 66.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.565 0.58 . . . . 1.0 112.565 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -76.99 -7.91 56.46 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.882 -0.327 . . . . 1.79 111.5 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.402 ' HB3' ' CA ' ' A' ' 77' ' ' GLY . 22.0 m-30 -89.03 -1.48 58.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.017 0.437 . . . . 0.75 110.196 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.662 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -146.3 -165.42 11.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.681 -0.69 . . . . 0.70999999999999996 111.411 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -87.77 80.51 7.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.304 0.552 . . . . 1.52 110.336 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -91.53 -29.46 12.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 2.2999999999999998 112.427 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.64 -56.9 5.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.032 0.444 . . . . 5.8600000000000003 110.044 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.92 -40.36 79.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.69 -0.686 . . . . 4.2699999999999996 110.149 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 82.3 1.65 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.876 -0.678 . . . . 2.1600000000000001 112.786 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.2 t -93.66 118.81 31.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.406 -0.59 . . . . 3.3399999999999999 109.406 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.594 ' HA2' ' HG3' ' A' ' 111' ' ' PRO . . . -120.62 121.87 5.02 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.35 -0.928 . . . . 1.2 113.506 -175.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -111.51 -67.68 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.786 0.327 . . . . 3.0800000000000001 110.182 171.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.403 ' CB ' HD13 ' A' ' 110' ' ' ILE . 13.6 m -108.41 -74.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.921 -0.312 . . . . 1.52 111.241 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.556 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.04 81.82 10.33 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 121.15 0.5 . . . . 0.75 111.432 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.594 ' HG3' ' HA2' ' A' ' 107' ' ' GLY . 64.2 Cg_endo -102.7 -149.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.303 3.335 . . . . 1.5800000000000001 111.891 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.31 73.31 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.838 -0.696 . . . . 2.0499999999999998 112.288 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 15.6 m120 56.73 23.61 8.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.118 0.485 . . . . 2.0299999999999998 111.188 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 m -114.0 151.59 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.96 -0.564 . . . . 1.1399999999999999 109.594 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.13 132.63 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.599 . . . . 0.47999999999999998 111.295 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -125.02 165.29 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.51000000000000001 109.999 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -124.83 124.74 42.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.178 -0.675 . . . . 0.69999999999999996 109.178 173.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.67 143.24 47.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.74 -0.209 . . . . 0.42999999999999999 110.553 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 38.5 mt-10 -62.63 136.49 57.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.738 -0.467 . . . . 1.46 109.738 168.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 ' SD ' ' A' ' 85' ' ' MET . 22.3 mt -128.09 116.85 44.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.229 -1.026 . . . . 0.47999999999999998 108.229 169.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -135.17 111.47 9.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.692 -0.685 . . . . 1.8799999999999999 110.535 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.688 ' HA ' HG12 ' A' ' 42' ' ' VAL . 23.0 tp -81.47 100.09 9.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.361 -0.381 . . . . 1.1200000000000001 110.788 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -104.81 -9.45 18.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.868 0.366 . . . . 1.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 67.5 m -155.28 139.52 16.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 1.1899999999999999 110.524 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.504 ' HB3' HD11 ' A' ' 122' ' ' LEU . 7.8 p90 -165.74 150.29 8.44 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.29 0.369 . . . . 0.71999999999999997 110.222 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.489 ' HE ' ' HB3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -146.24 127.33 14.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.943 0.401 . . . . 2.98 110.922 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.24 122.91 29.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.511 -0.768 . . . . 3.3799999999999999 111.178 -176.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.541 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 50.7 tp -143.17 -103.2 0.13 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.691 -0.231 . . . . 3.3500000000000001 111.414 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 7.6 mt-10 171.57 -178.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.484 1.114 . . . . 5.3899999999999997 108.3 -172.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -95.38 -54.81 3.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.91 -0.404 . . . . 7.04 109.91 171.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -177.93 -29.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.248 -0.433 . . . . 7.21 110.956 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.2 t60 46.18 79.56 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.908 0.755 . . . . 9.0199999999999996 111.685 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -176.76 94.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.752 -1.203 . . . . 9.75 107.752 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.53 -31.97 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 12.26 111.902 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.4 t60 . . . . . 0 C--O 1.243 0.719 0 CA-C-O 118.284 -0.865 . . . . 13.35 109.226 175.315 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttm . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.803 0.335 . . . . 7.4800000000000004 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -145.88 -30.67 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.426 -0.352 . . . . 5.9000000000000004 110.992 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.2 m 64.28 97.66 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.914 0.388 . . . . 4.4400000000000004 111.051 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.47 103.57 2.07 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.772 -0.455 . . . . 4.4400000000000004 109.772 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.27 131.34 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.492 -0.777 . . . . 4.1500000000000004 111.087 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -81.39 99.83 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.422 -0.584 . . . . 3.6099999999999999 109.422 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.87 137.01 34.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.659 -0.7 . . . . 3.6000000000000001 111.158 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -81.63 151.61 27.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.675 -0.693 . . . . 2.71 109.145 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.58 145.84 25.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.79 0.329 . . . . 1.8799999999999999 110.274 -177.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 13' ' ' THR . 21.8 t -101.97 103.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.965 -1.124 . . . . 0.58999999999999997 107.965 170.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.558 ' HG2' HG23 ' A' ' 19' ' ' ILE . 45.9 mt-10 -102.47 120.84 41.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.714 . . . . 2.1600000000000001 110.622 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.9 tp 65.54 50.93 1.58 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.241 -0.89 . . . . 1.45 109.436 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.498 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.9 t -62.97 159.46 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.78000000000000003 111.617 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 2.11 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 0.81000000000000005 111.436 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.6 ' O ' HG13 ' A' ' 80' ' ' ILE . 40.3 m-20 -83.61 7.79 16.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.172 -0.467 . . . . 2.3999999999999999 111.367 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.36 22.6 2.29 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.394 -0.908 . . . . 0.68000000000000005 113.555 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.89 62.7 4.32 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.293 -0.48 . . . . 0.60999999999999999 114.083 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.475 ' HB ' HG21 ' A' ' 80' ' ' ILE . 39.4 t -137.62 152.77 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.081 0.44 . . . . 0.48999999999999999 110.224 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.558 HG23 ' HG2' ' A' ' 11' ' ' GLU . 18.1 mm -85.36 109.7 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.474 -0.565 . . . . 0.46999999999999997 109.474 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -118.99 130.45 55.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 110.65 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 m -109.94 117.69 34.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.097 -0.502 . . . . 0.5 110.703 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.509 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.2 tp -74.77 131.71 34.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.67000000000000004 111.356 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 2.6 mm? -120.76 -81.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.82999999999999996 111.362 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -89.44 134.3 34.15 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.928 0.394 . . . . 1.5600000000000001 110.309 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 41.3 mtmt -111.34 113.18 25.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.779 -0.646 . . . . 2.9500000000000002 110.383 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.526 ' HA3' ' NH1' ' A' ' 86' ' ' ARG . . . -73.71 -151.74 2.08 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.219 -0.515 . . . . 1.3200000000000001 111.89 174.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.47 -97.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.104 -0.645 . . . . 2.77 111.725 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.72 126.45 36.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.46 0.647 . . . . 2.6400000000000001 110.934 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -140.51 47.79 0.86 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.582 -0.818 . . . . 1.04 112.611 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.15 -42.11 99.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 2.29 109.945 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.25 28.2 8.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.977 -1.01 . . . . 2.6400000000000001 109.4 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.403 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -135.79 76.87 1.63 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.45 110.89 -179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.54 HG22 ' HD3' ' A' ' 35' ' ' LYS . 30.8 mm -141.94 116.28 6.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 123.265 0.353 . . . . 0.81000000000000005 111.274 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 28.1 Cg_endo -63.41 138.69 67.03 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.058 2.505 . . . . 0.75 111.065 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HD3' HG22 ' A' ' 33' ' ' ILE . 6.0 mmmm -126.54 155.07 42.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.106 0.479 . . . . 2.6600000000000001 111.713 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -70.38 117.54 12.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.17 -0.923 . . . . 2.5099999999999998 110.291 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.81 -26.88 22.82 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.99 -0.624 . . . . 1.1200000000000001 111.923 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.69 154.19 42.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 1.3799999999999999 110.179 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 40.8 mt-10 -76.99 99.9 5.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.113 0.482 . . . . 2.2000000000000002 110.822 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.659 HG12 ' HB2' ' A' ' 125' ' ' PHE . 29.3 m -118.64 143.61 29.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.335 -0.617 . . . . 0.67000000000000004 109.335 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.7 m -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.267 -0.642 . . . . 0.65000000000000002 109.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.38 139.35 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.334 0.587 . . . . 0.87 111.839 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -104.39 134.88 46.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 2.75 110.39 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -123.87 136.82 54.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.76000000000000001 110.464 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.45 153.23 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.488 -0.93 . . . . 0.48999999999999999 108.488 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.93 -124.44 0.91 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.775 -1.202 . . . . 0.35999999999999999 113.231 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 21.7 pttp -157.61 170.12 23.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 1.4299999999999999 111.0 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 69.8 tp -97.26 103.18 15.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.506 -0.77 . . . . 0.38 110.145 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.854 ' HB2' HD11 ' A' ' 117' ' ' LEU . 6.5 tp10 -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.873 0.368 . . . . 1.96 110.151 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 115' ' ' VAL . 8.3 t -55.4 -28.92 57.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 0.67000000000000004 112.089 -174.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 t -140.26 14.55 2.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.285 0.564 . . . . 0.72999999999999998 110.486 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.9 44.33 96.13 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.336 -0.847 . . . . 0.78000000000000003 113.065 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 12.2 mmmt -105.98 126.03 51.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.278 -0.267 . . . . 2.8900000000000001 110.278 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 8.1 p -83.99 159.48 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.509 -0.552 . . . . 0.58999999999999997 109.509 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -75.04 102.94 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.351 . . . . 0.78000000000000003 110.984 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -125.58 85.81 2.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.604 0.716 . . . . 2.1800000000000002 109.835 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.8 m -126.11 169.22 13.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.959 -0.564 . . . . 1.24 110.536 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -71.44 -26.31 62.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.088 0.47 . . . . 1.49 110.818 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.2 -44.77 7.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.923 -0.58 . . . . 1.8 112.371 -170.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -44.82 80.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.989 0.366 . . . . 2.1899999999999999 111.989 -169.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -77.1 -9.17 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.423 . . . . 2.7799999999999998 110.938 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -96.13 -61.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.018 -0.537 . . . . 1.1000000000000001 109.978 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.23 109.77 7.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.446 0.641 . . . . 2.0299999999999998 110.474 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.07 158.18 38.08 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.58 2.187 . . . . 1.76 112.543 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.56 154.07 19.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 1.3100000000000001 109.775 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -129.91 159.54 36.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 1.3600000000000001 109.999 178.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.69 173.35 11.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.56999999999999995 111.066 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -116.01 140.17 49.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.408 -0.815 . . . . 1.98 109.609 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 82' ' ' VAL . 26.4 tp -69.1 131.91 45.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.232 -0.284 . . . . 0.94999999999999996 110.232 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.56 79.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.92 0.867 . . . . 2.0800000000000001 109.232 -169.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.531 ' HG2' ' HG2' ' A' ' 73' ' ' GLU . 28.4 tt0 -131.64 -3.6 3.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.341 -1.3 . . . . 1.98 110.211 -174.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.6 -18.53 24.48 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.998 -0.62 . . . . 0.71999999999999997 112.353 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 2.1 mm-40 -93.64 -11.39 31.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.96999999999999997 109.954 -177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.17 124.48 64.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.57999999999999996 109.702 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.1 -61.45 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.62 112.925 -176.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 mmpt? -138.11 -48.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 2.04 111.881 -173.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.08 -50.72 44.29 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.037 -0.601 . . . . 0.32000000000000001 113.12 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 82' ' ' VAL . 22.0 m-90 -75.12 -41.16 59.06 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.807 -0.231 . . . . 0.48999999999999999 110.433 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.63 -51.57 54.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.607 -0.724 . . . . 1.1399999999999999 112.041 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.7 mp -63.04 -42.97 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.78000000000000003 111.52 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.558 ' HB3' HD12 ' A' ' 120' ' ' ILE . 49.3 t -75.32 -42.34 54.75 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.848 0.314 . . . . 0.55000000000000004 111.848 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 69' ' ' LEU . 35.4 m -69.15 -34.41 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.779 0.288 . . . . 0.83999999999999997 111.779 -175.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 p -72.03 -16.44 62.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 110.814 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.7 m -97.57 8.26 44.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.981 -0.554 . . . . 1.23 110.928 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 81' ' ' CYS . 20.1 mmt -93.94 -173.65 3.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 2.27 111.495 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 33.6 mtp-105 -143.2 -171.27 3.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.349 -0.841 . . . . 4.1900000000000004 109.002 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.42 -24.63 67.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.299 0.374 . . . . 1.9399999999999999 111.992 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -135.39 15.28 3.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 1.23 111.309 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -79.87 159.94 26.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.889 0.376 . . . . 1.6000000000000001 110.683 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -158.36 132.45 7.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.089 -0.505 . . . . 1.1699999999999999 110.354 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 99.9 m -150.7 170.93 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 1.2 110.816 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.34 124.95 52.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.54 . . . . 1.73 110.237 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 95' ' ' ILE . 6.3 p -100.76 146.22 9.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.15 -0.477 . . . . 0.73999999999999999 110.264 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.541 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 12.3 mmt180 -98.63 112.06 24.23 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.177 -0.675 . . . . 1.71 109.177 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.628 HD11 HG13 ' A' ' 93' ' ' VAL . 4.1 mp -98.04 103.87 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.52000000000000002 110.447 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.557 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 27.6 tt0 -86.49 170.73 11.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.336 -0.987 . . . . 1.3700000000000001 108.336 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 113' ' ' ASN . 11.9 p -51.69 -38.32 54.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.826 0.306 . . . . 1.0 111.826 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -77.71 -8.72 58.35 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.042 0.386 . . . . 1.79 112.042 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.557 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 20.6 m-85 -102.62 -16.36 16.09 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.752 0.31 . . . . 0.75 110.607 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.36 -163.01 12.45 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.252 -0.739 . . . . 0.70999999999999996 111.252 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -99.07 90.86 4.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.175 0.512 . . . . 1.52 110.992 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.28 -20.24 10.59 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.65 -0.786 . . . . 2.2999999999999998 111.559 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.88 -47.46 18.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.286 0.565 . . . . 5.8600000000000003 110.901 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -87.24 -17.81 31.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 4.2699999999999996 111.355 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.15 -11.68 68.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.643 -0.789 . . . . 2.1600000000000001 113.232 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.82 97.43 1.39 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.439 0.637 . . . . 3.3399999999999999 111.145 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -130.3 149.07 18.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.917 -0.659 . . . . 1.2 111.684 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -78.69 -69.39 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.872 0.323 . . . . 3.0800000000000001 111.872 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.405 ' CB ' HD13 ' A' ' 110' ' ' ILE . 5.9 m -89.41 -74.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 1.52 111.426 -175.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.405 HD13 ' CB ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -147.45 96.75 4.13 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.059 0.457 . . . . 0.75 111.45 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.532 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 62.1 Cg_endo -91.5 -164.1 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.833 2.355 . . . . 1.5800000000000001 111.888 173.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 121.7 50.26 0.25 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.382 -0.913 . . . . 2.0499999999999998 113.285 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' ' 97' ' ' SER . 17.7 m120 62.8 17.21 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.068 0.461 . . . . 2.0299999999999998 111.336 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.3 p -94.83 175.68 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.833 -0.621 . . . . 1.1399999999999999 111.339 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.484 ' H ' ' HB2' ' A' ' 50' ' ' SER . 6.3 p -114.7 127.49 72.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-N 116.136 -0.483 . . . . 0.47999999999999998 110.203 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.9 mp -120.97 169.7 10.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.007 -0.542 . . . . 0.51000000000000001 111.054 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.854 HD11 ' HB2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -128.95 126.28 39.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.084 -0.71 . . . . 0.69999999999999996 109.084 175.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -118.8 123.96 46.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.075 0.464 . . . . 0.42999999999999999 111.151 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.86 119.44 16.04 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.186 -1.042 . . . . 1.46 108.186 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 81' ' ' CYS . 42.2 mt -106.41 116.14 49.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 0.47999999999999998 109.5 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -126.94 119.3 26.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.779 -1.1 . . . . 1.8799999999999999 109.466 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 tt -90.88 117.14 29.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.804 -0.635 . . . . 1.1200000000000001 109.731 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.39 -23.81 15.02 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.668 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -164.05 153.45 14.11 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.004 0.431 . . . . 1.1899999999999999 110.564 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.659 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -161.83 178.72 8.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.652 -0.704 . . . . 0.71999999999999997 109.618 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 39' ' ' GLU . 14.0 ptm180 -150.93 137.9 19.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 2.98 110.053 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -100.22 152.83 19.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 3.3799999999999999 110.556 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 tt -159.14 116.85 2.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.711 -0.848 . . . . 3.3500000000000001 108.711 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.01 130.84 36.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.448 . . . . 5.3899999999999997 109.855 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 63.8 t60 -114.42 166.3 11.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.848 -0.614 . . . . 7.04 110.041 -172.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' HIS . 46.3 m80 74.99 -170.96 0.1 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.072 0.549 . . . . 7.21 111.238 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -95.42 155.87 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 9.0199999999999996 109.499 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 82.45 4.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.773 -0.371 . . . . 9.75 110.899 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 72.97 118.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.26 -0.882 . . . . 12.26 112.055 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.183 -0.913 . . . . 13.35 109.811 173.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.802 0.334 . . . . 7.4800000000000004 110.772 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.5 m -81.34 -34.88 31.52 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.363 -0.606 . . . . 5.9000000000000004 109.363 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m 61.42 26.47 16.24 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.261 -0.881 . . . . 4.4400000000000004 110.212 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 56.8 -160.11 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.291 -0.868 . . . . 4.4400000000000004 110.415 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -114.81 126.51 54.91 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.763 0.316 . . . . 4.1500000000000004 111.44 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.55 79.79 9.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.155 -1.054 . . . . 3.6099999999999999 108.155 168.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.26 140.91 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.36 -0.836 . . . . 3.6000000000000001 111.3 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.86 144.12 32.23 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.876 -0.787 . . . . 2.71 108.876 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.15 139.07 35.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.219 -0.66 . . . . 1.8799999999999999 109.219 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.625 HG12 ' HB ' ' A' ' 13' ' ' THR . 32.9 t -100.99 104.43 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 109.528 -0.545 . . . . 0.58999999999999997 109.528 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -102.64 134.91 45.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.939 -0.573 . . . . 2.1600000000000001 111.566 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.856 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 81.8 mt 52.25 51.89 15.38 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.511 -0.768 . . . . 1.45 111.332 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.625 ' HB ' HG12 ' A' ' 10' ' ' VAL . 15.4 t -70.68 168.36 16.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.78000000000000003 110.521 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.35 -12.56 61.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.837 0.68 . . . . 0.81000000000000005 112.837 -170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 80' ' ' ILE . 3.3 t70 -89.57 14.02 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.717 -0.393 . . . . 2.3999999999999999 111.638 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.44 29.93 1.04 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.589 -0.815 . . . . 0.68000000000000005 114.119 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.856 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 60.01 33.29 78.46 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.881 1.112 . . . . 0.60999999999999999 115.881 166.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 80' ' ' ILE . 30.6 t -104.06 142.48 17.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 117.886 0.843 . . . . 0.48999999999999999 110.727 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 94' ' ' ARG . 2.3 mm -88.57 116.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.46999999999999997 110.013 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HE2' ' HB3' ' A' ' 84' ' ' SER . 21.4 pttp -138.75 136.02 35.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 1.3400000000000001 111.021 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 m -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.163 -0.926 . . . . 0.5 109.923 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tp -88.7 127.62 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.087 0.47 . . . . 0.67000000000000004 110.811 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -116.26 -52.13 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.427 0.632 . . . . 0.82999999999999996 110.499 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' CB ' ' A' ' 90' ' ' LYS . 29.6 ttpt -119.07 121.91 40.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.63 -0.714 . . . . 1.5600000000000001 110.047 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -99.98 126.19 46.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.392 -0.367 . . . . 2.9500000000000002 111.14 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 155.64 32.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.972 -0.633 . . . . 1.3200000000000001 111.743 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.4 -81.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.646 0.26 . . . . 2.77 111.171 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.11 150.08 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 2.6400000000000001 110.426 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 32' ' ' ASN . . . -156.68 51.05 0.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.308 -0.948 . . . . 1.04 112.854 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.3 -42.23 55.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.584 0.707 . . . . 2.29 109.299 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 -16.59 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 2.6400000000000001 110.562 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 19.3 m-80 -85.48 76.04 10.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.232 -0.44 . . . . 1.45 110.537 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 33.3 mm -140.87 119.7 8.27 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.857 -0.61 . . . . 0.81000000000000005 109.863 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 1.5 Cg_endo -82.15 111.05 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.75 111.638 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -118.06 152.24 35.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.472 -0.566 . . . . 2.6600000000000001 109.472 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 148.97 46.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.977 0.418 . . . . 2.5099999999999998 110.278 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.91 -9.78 65.94 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.887 -0.885 . . . . 1.1200000000000001 110.887 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 126' ' ' ARG . 95.5 m-20 -107.49 159.42 16.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.856 -0.672 . . . . 1.3799999999999999 109.511 174.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 102.32 14.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.497 -0.557 . . . . 2.2000000000000002 109.497 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -116.19 145.03 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.693 -0.685 . . . . 0.67000000000000004 109.579 175.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 108.63 13.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.047 -0.524 . . . . 0.65000000000000002 110.263 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 122' ' ' LEU . 18.5 m -131.36 153.3 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.527 -0.306 . . . . 0.87 111.544 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' A' ' 66' ' ' LYS . 36.7 m170 -105.24 162.51 13.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 2.75 110.337 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 12.7 p90 -145.58 129.44 17.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.76000000000000001 110.028 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -167.02 153.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.85 -0.426 . . . . 0.48999999999999999 109.85 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 55' ' ' PHE . . . 176.3 -111.57 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.717 -1.23 . . . . 0.35999999999999999 112.968 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG3' HD12 ' A' ' 117' ' ' LEU . 51.7 pttt -157.23 166.95 31.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.987 0.423 . . . . 1.4299999999999999 110.882 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.2 tp -92.56 102.07 14.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.963 -0.562 . . . . 0.38 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 3.6 tp10 -58.71 -30.47 67.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.616 -0.72 . . . . 1.96 111.039 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -55.88 -32.43 63.69 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.563 -0.744 . . . . 0.67000000000000004 112.264 -173.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 53' ' ' LYS . 13.6 t -140.21 5.52 2.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.445 -0.502 . . . . 0.72999999999999998 111.983 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.83 46.63 59.62 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 121.098 -0.572 . . . . 0.78000000000000003 112.394 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HB2' HG23 ' A' ' 51' ' ' THR . 2.0 tmtp? -115.14 126.36 54.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.652 -0.499 . . . . 2.8900000000000001 109.652 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.07 153.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.454 -0.339 . . . . 0.58999999999999997 110.196 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 0.8 OUTLIER -74.45 106.4 6.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.403 . . . . 0.78000000000000003 110.722 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -121.7 103.57 8.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.87 0.843 . . . . 2.1800000000000002 110.324 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 34.8 m -136.81 150.53 48.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.119 -0.491 . . . . 1.24 110.004 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.4 m -62.6 -36.09 81.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 1.49 111.174 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.21 -33.9 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.348 -0.387 . . . . 1.8 110.887 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 6.9 t70 -56.99 -52.48 65.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.934 0.397 . . . . 2.1899999999999999 111.993 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -77.25 2.6 15.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.368 -0.378 . . . . 2.7799999999999998 111.44 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -111.5 -52.85 2.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.42 -0.355 . . . . 1.1000000000000001 110.845 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.7 p -133.04 117.18 14.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.197 0.522 . . . . 2.0299999999999998 111.167 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 3.4 Cg_exo -77.03 146.08 25.37 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.041 2.494 . . . . 1.76 111.459 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -103.82 151.09 23.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.464 -0.335 . . . . 1.3100000000000001 110.251 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.525 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . 1.7 pptp? -128.93 154.19 46.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.529 -0.305 . . . . 1.3600000000000001 110.911 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -137.21 174.49 10.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.524 -0.307 . . . . 0.56999999999999995 111.156 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.84 150.21 33.89 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.076 -0.712 . . . . 1.98 109.076 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.757 HD13 HG23 ' A' ' 82' ' ' VAL . 16.8 tp -70.6 124.66 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.475 0.546 . . . . 0.94999999999999996 112.475 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER 42.4 63.29 1.44 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.388 -1.278 . . . . 2.0800000000000001 112.335 173.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -108.55 9.28 27.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.71 -1.132 . . . . 1.98 108.751 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.6 -16.38 48.06 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.971 -1.013 . . . . 0.71999999999999997 113.084 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -85.48 -39.43 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.457 0.629 . . . . 0.96999999999999997 110.501 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 m -97.9 135.41 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.389 -0.597 . . . . 0.57999999999999996 109.389 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.764 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -94.55 -76.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.382 0.512 . . . . 0.62 112.382 -172.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.764 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -137.25 -37.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.873 -0.517 . . . . 2.04 112.315 -175.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.61 -54.29 31.17 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.449 -0.881 . . . . 0.32000000000000001 113.153 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.626 ' O ' HG22 ' A' ' 82' ' ' VAL . 23.3 m-90 -76.67 -31.52 57.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.736 -0.273 . . . . 0.48999999999999999 110.708 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -51.49 -53.35 38.32 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.019 0.824 . . . . 1.1399999999999999 111.843 -170.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 2.0 mp -68.77 -29.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 111.275 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.627 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 19.9 t -72.55 -38.23 68.05 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.603 -0.439 . . . . 0.55000000000000004 110.514 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 HD13 ' A' ' 69' ' ' LEU . 2.1 m -83.86 -33.95 9.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.791 -0.364 . . . . 0.83999999999999997 111.498 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -65.66 -25.57 67.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.157 0.503 . . . . 1.4299999999999999 110.63 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.558 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 22.0 t -121.92 44.97 2.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.777 -0.647 . . . . 1.23 110.489 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 82' ' ' VAL . 19.8 ptm -124.68 -175.89 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.989 -0.551 . . . . 2.27 109.688 173.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 64.3 mtt85 -142.95 162.86 34.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.123 -0.695 . . . . 4.1900000000000004 109.123 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HG3' HD22 ' A' ' 122' ' ' LEU . 85.6 tttt -61.31 -43.06 99.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 1.9399999999999999 111.364 -175.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -97.29 24.7 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 1.23 110.709 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 37.5 tt0 -114.87 163.68 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.037 -0.727 . . . . 1.6000000000000001 109.037 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 76.1 tttt -157.54 127.56 6.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.926 0.393 . . . . 1.1699999999999999 110.439 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.1 p -134.7 148.11 50.24 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.785 -0.643 . . . . 1.2 111.01 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.73 122.02 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 1.73 109.357 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.627 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.4 p -100.65 143.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.159 0.504 . . . . 0.73999999999999999 111.427 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 18.3 mmt180 -106.2 112.15 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.438 -0.801 . . . . 1.71 109.441 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 3.9 mp -93.96 100.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.828 -0.349 . . . . 0.52000000000000002 110.111 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.493 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 9.6 tp10 -70.07 156.72 38.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 1.3700000000000001 109.183 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.6 p -50.12 -44.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.06 0.544 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.42 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 24.1 ptp -74.76 -8.09 55.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 1.79 111.721 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 96' ' ' GLU . 21.8 m-30 -100.05 8.62 43.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.626 0.25 . . . . 0.75 110.426 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.613 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -139.09 -176.28 14.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.21 -0.519 . . . . 0.70999999999999996 112.201 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -70.3 -70.03 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.14 0.495 . . . . 1.52 111.077 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.18 -170.1 21.93 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.731 -0.747 . . . . 2.2999999999999998 111.551 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.865 ' HB2' ' HA2' ' A' ' 112' ' ' GLY . 24.8 t70 -81.45 -25.23 36.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 5.8600000000000003 111.028 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.5 8.86 25.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.48 0.657 . . . . 4.2699999999999996 110.914 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -117.46 -116.85 2.83 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.461 -0.876 . . . . 2.1600000000000001 112.023 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.84 126.48 52.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.514 -0.55 . . . . 3.3399999999999999 109.514 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.66 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -151.21 105.41 0.29 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.511 -0.852 . . . . 1.2 112.41 -176.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -95.14 -61.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.267 0.469 . . . . 3.0800000000000001 112.267 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 m -78.5 -76.52 0.19 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.76 0.281 . . . . 1.52 111.76 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 89.99 3.36 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-O 121.146 0.498 . . . . 0.75 110.296 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.66 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 72.4 Cg_endo -96.84 -155.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.488 2.792 . . . . 1.5800000000000001 111.663 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.865 ' HA2' ' HB2' ' A' ' 103' ' ' ASP . . . 127.83 31.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.461 -0.876 . . . . 2.0499999999999998 112.85 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.01 41.81 27.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.314 0.578 . . . . 2.0299999999999998 110.553 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 p -122.13 177.05 5.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.5 -0.773 . . . . 1.1399999999999999 110.38 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 95' ' ' ILE . 5.3 p -93.94 125.47 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.256 0.55 . . . . 0.47999999999999998 110.889 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.83 162.1 15.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.51000000000000001 110.103 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.608 HD12 ' HG3' ' A' ' 47' ' ' LYS . 36.8 mt -119.04 117.47 28.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.69999999999999996 110.228 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -125.81 138.0 53.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.259 0.552 . . . . 0.42999999999999999 112.321 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 50.5 mt-10 -79.16 132.77 36.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.226 -0.897 . . . . 1.46 108.981 167.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 82' ' ' VAL . 19.5 mt -113.17 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.516 0.674 . . . . 0.47999999999999998 110.252 171.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.43 ' OE1' ' HD2' ' A' ' 90' ' ' LYS . 5.1 tp10 -118.75 120.1 36.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 1.8799999999999999 109.597 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.745 ' HA ' HG12 ' A' ' 42' ' ' VAL . 4.9 tt -89.87 102.4 15.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.526 -0.546 . . . . 1.1200000000000001 109.526 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -88.89 -35.63 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.486 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 t -152.26 144.79 24.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.598 -0.274 . . . . 1.1899999999999999 110.755 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.606 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -164.97 171.75 13.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.71999999999999997 109.799 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 14.0 ptp180 -150.07 124.6 9.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.579 -0.282 . . . . 2.98 110.325 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -95.58 139.49 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.871 -0.418 . . . . 3.3799999999999999 109.871 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.9 ' HG ' ' H ' ' A' ' 129' ' ' GLU . 15.9 tp 66.33 -162.7 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.82 0.7 . . . . 3.3500000000000001 110.947 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.9 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 15.3 tp10 62.8 79.75 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.617 0.722 . . . . 5.3899999999999997 111.47 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -116.89 116.1 26.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.133 -0.692 . . . . 7.04 109.133 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -89.39 29.43 1.11 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.486 0.55 . . . . 7.21 112.486 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -132.27 -67.54 0.65 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.58 -0.282 . . . . 9.0199999999999996 110.506 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 70.23 -72.29 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.784 0.677 . . . . 9.75 110.471 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.3 t60 52.55 79.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.327 0.651 . . . . 12.26 111.13 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.903 -1.046 . . . . 13.35 110.189 -177.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.167 0.508 . . . . 7.4800000000000004 110.577 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 p -114.36 120.22 39.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.854 -0.612 . . . . 5.9000000000000004 110.763 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.9 m -70.23 -48.3 57.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.591 -0.522 . . . . 4.4400000000000004 109.591 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.09 158.11 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 4.4400000000000004 109.423 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.11 161.04 15.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.826 0.346 . . . . 4.1500000000000004 111.193 -174.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -82.05 32.03 0.38 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.947 0.404 . . . . 3.6099999999999999 111.093 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.87 128.4 36.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.457 0.646 . . . . 3.6000000000000001 112.504 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.95 153.28 21.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.445 -0.798 . . . . 2.71 109.057 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 6.2 mptt -98.79 144.3 28.17 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.208 -0.664 . . . . 1.8799999999999999 109.208 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.11 112.83 38.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.886 -0.326 . . . . 0.58999999999999997 110.704 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 4.2 pt-20 -86.59 131.05 34.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.224 -0.287 . . . . 2.1600000000000001 110.224 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 90.9 mt 45.58 59.84 3.41 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.897 0.748 . . . . 1.45 111.869 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 18' ' ' VAL . 7.5 t -59.01 153.75 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.78000000000000003 110.757 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.82 43.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.48 0.548 . . . . 0.81000000000000005 112.48 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 80' ' ' ILE . 28.6 t0 -85.39 18.27 2.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.706 0.289 . . . . 2.3999999999999999 111.406 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.0 2.7 9.22 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.422 -0.894 . . . . 0.68000000000000005 114.41 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 12' ' ' LEU . . . 77.59 80.31 0.68 Allowed Glycine 0 C--O 1.224 -0.485 0 C-N-CA 121.021 -0.609 . . . . 0.60999999999999999 114.172 170.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 13' ' ' THR . 11.8 t -142.7 145.04 23.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.696 -0.483 . . . . 0.48999999999999999 109.696 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.68 110.99 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.46999999999999997 110.244 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -136.09 147.12 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 1.3400000000000001 111.281 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.6 m -117.95 144.25 45.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 0.5 110.469 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 25' ' ' LYS . 9.7 tp -93.39 135.3 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.9 0.381 . . . . 0.67000000000000004 111.931 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD21 ' HG ' ' A' ' 92' ' ' LEU . 3.0 mm? -123.34 -71.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.383 0.611 . . . . 0.82999999999999996 109.369 174.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 2.2 mmmt -104.86 116.19 31.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.331 -0.85 . . . . 1.5600000000000001 109.378 176.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -112.9 150.86 31.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.844 -0.342 . . . . 2.9500000000000002 110.294 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.85 163.25 47.55 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.923 -0.656 . . . . 1.3200000000000001 111.991 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.38 -57.59 2.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.252 0.548 . . . . 2.77 109.752 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -121.12 174.12 6.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.815 . . . . 2.6400000000000001 108.817 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.568 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 126.55 51.88 0.16 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.546 -0.835 . . . . 1.04 112.296 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.63 -41.29 98.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.809 0.358 . . . . 2.29 111.408 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' C ' HD22 ' A' ' 32' ' ' ASN . 32.5 tt0 -89.07 4.27 48.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.427 0.632 . . . . 2.6400000000000001 110.398 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.631 ' HB2' HH21 ' A' ' 86' ' ' ARG . 0.9 OUTLIER -116.59 78.64 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 1.45 109.617 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.6 mm -134.41 123.85 16.76 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.637 . . . . 0.81000000000000005 110.775 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HG3' HD22 ' A' ' 122' ' ' LEU . 57.2 Cg_endo -70.18 138.45 36.51 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.876 2.384 . . . . 0.75 111.457 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -145.66 156.71 43.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.007 0.432 . . . . 2.6600000000000001 111.871 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 70' ' ' GLU . 1.9 ttmp? -68.56 147.59 51.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.127 -0.942 . . . . 2.5099999999999998 111.111 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 36' ' ' LYS . . . 93.23 -18.48 56.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.56 -1.016 . . . . 1.1200000000000001 110.56 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 127' ' ' GLU . 3.6 m-20 -99.18 163.38 12.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.778 -0.711 . . . . 1.3799999999999999 109.834 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.58 126.16 35.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 2.2000000000000002 110.529 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 125' ' ' PHE . 21.1 m -131.05 153.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.67000000000000004 109.691 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 29.7 m -113.61 106.07 14.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.374 -0.602 . . . . 0.65000000000000002 109.374 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.48 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.195 0.522 . . . . 0.87 111.341 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -100.34 136.03 40.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.622 -0.717 . . . . 2.75 109.079 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.693 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 47.6 p90 -122.87 144.35 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.76000000000000001 110.364 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -169.08 157.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.416 -0.957 . . . . 0.48999999999999999 108.416 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.91 -126.66 1.13 Allowed Glycine 0 CA--C 1.51 -0.244 0 C-N-CA 119.739 -1.22 . . . . 0.35999999999999999 113.262 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 64.7 pttt -150.98 165.76 32.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.218 0.532 . . . . 1.4299999999999999 111.033 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD12 ' HG ' ' A' ' 116' ' ' LEU . 63.5 tp -83.64 97.42 9.08 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.06 -0.719 . . . . 0.38 109.06 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.594 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 48.4 tp10 -60.93 -25.76 67.0 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.017 -0.538 . . . . 1.96 111.856 -174.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 t -56.19 -27.17 53.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.426 -0.352 . . . . 0.67000000000000004 111.38 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.661 HG23 ' HD3' ' A' ' 53' ' ' LYS . 10.1 t -134.9 -13.93 2.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.835 0.35 . . . . 0.72999999999999998 111.571 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.54 28.7 34.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.159 -0.543 . . . . 0.78000000000000003 112.957 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.661 ' HD3' HG23 ' A' ' 51' ' ' THR . 13.9 mptt -100.42 122.57 43.37 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.604 -0.351 . . . . 2.8900000000000001 110.577 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 8.6 p -73.98 160.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 110.407 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.403 ' CE1' HD11 ' A' ' 110' ' ' ILE . 22.6 m-30 -74.77 147.86 40.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 0.78000000000000003 111.392 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -159.1 89.91 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.254 -0.885 . . . . 2.1800000000000002 108.939 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -136.72 -177.14 4.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 1.24 110.815 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -71.56 -38.63 70.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.973 -0.558 . . . . 1.49 111.425 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.86 -36.96 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.211 0.819 . . . . 1.8 113.211 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -59.97 -33.01 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.878 0.325 . . . . 2.1899999999999999 111.878 -169.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -104.4 -0.94 27.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.282 0.475 . . . . 2.7799999999999998 112.282 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.555 HD22 HG23 ' A' ' 63' ' ' VAL . 20.4 t30 -114.19 -45.79 3.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.302 -0.559 . . . . 1.1000000000000001 111.576 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.555 HG23 HD22 ' A' ' 62' ' ' ASN . 95.2 t -132.08 97.81 17.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.918 0.39 . . . . 2.0299999999999998 110.05 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.29 141.73 43.81 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.988 2.459 . . . . 1.76 112.599 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.58 146.55 25.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 1.3100000000000001 110.008 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HD3' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -144.21 153.71 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.981 -0.377 . . . . 1.3600000000000001 109.981 177.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -133.99 175.07 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.56999999999999995 111.152 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -104.58 148.28 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.942 -0.762 . . . . 1.98 108.942 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD22 HG23 ' A' ' 82' ' ' VAL . 11.3 tp -69.4 119.47 13.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.034 0.445 . . . . 0.94999999999999996 110.584 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 57.55 66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.654 -1.157 . . . . 2.0800000000000001 110.646 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.01 17.78 23.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.947 -1.024 . . . . 1.98 109.063 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.04 -18.03 38.37 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.71999999999999997 112.479 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.86 -23.31 22.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.96999999999999997 110.984 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.8 126.24 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.57999999999999996 110.353 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.641 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -95.75 -58.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.62 113.437 -172.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.66 -48.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 2.04 112.644 -170.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.61 -52.4 38.13 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.917 -0.659 . . . . 0.32000000000000001 113.131 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.5 ' O ' HG22 ' A' ' 82' ' ' VAL . 9.0 m-90 -76.01 -32.22 59.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.672 0.273 . . . . 0.48999999999999999 110.702 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -53.86 -51.93 62.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.45 -0.795 . . . . 1.1399999999999999 112.179 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -69.29 -43.84 80.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 0.78000000000000003 110.82 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 85' ' ' MET . 44.8 t -62.21 -50.06 73.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.53 -0.304 . . . . 0.55000000000000004 111.009 -175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG23 HD22 ' A' ' 69' ' ' LEU . 33.9 m -66.09 -32.81 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.652 0.263 . . . . 0.83999999999999997 110.911 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 t -66.05 -40.12 90.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.931 0.396 . . . . 1.4299999999999999 110.131 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.4 m -89.69 36.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.579 . . . . 1.23 111.08 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.967 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 4.4 mmt -112.81 -175.25 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 2.27 110.468 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.631 HH21 ' HB2' ' A' ' 32' ' ' ASN . 8.3 mtp-105 -149.87 175.4 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 4.1900000000000004 110.116 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -62.63 -22.24 66.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.654 -0.703 . . . . 1.9399999999999999 112.436 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -136.32 34.88 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 1.23 110.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 30.8 tt0 -120.51 154.06 35.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 1.6000000000000001 109.787 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 82.6 tttt -156.94 132.22 9.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.663 0.268 . . . . 1.1699999999999999 111.359 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.454 ' SG ' HD12 ' A' ' 22' ' ' ILE . 93.8 m -135.2 165.35 25.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.111 0.481 . . . . 1.2 111.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.51 ' HG ' HD21 ' A' ' 23' ' ' LEU . 78.5 mt -106.34 114.95 29.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.461 -0.79 . . . . 1.73 109.676 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.404 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 7.3 p -108.3 141.93 22.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.297 -0.41 . . . . 0.73999999999999999 111.232 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.477 ' NE ' HD23 ' A' ' 117' ' ' LEU . 7.2 mpt_? -90.91 117.13 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.414 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.621 HD13 ' HD2' ' A' ' 118' ' ' PHE . 2.7 mp -96.64 101.08 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.28 -1.007 . . . . 0.52000000000000002 108.28 172.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.572 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 8.1 tt0 -98.41 177.04 5.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.268 -0.878 . . . . 1.3700000000000001 109.434 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -55.36 -36.37 66.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 1.0 110.962 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.426 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 24.2 ptp -76.86 -7.64 55.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.036 -0.529 . . . . 1.79 111.296 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.572 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 19.0 m-85 -112.65 4.85 17.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.606 0.241 . . . . 0.75 110.952 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.641 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -138.7 -173.1 12.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.929 -0.653 . . . . 0.70999999999999996 112.285 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -88.73 7.69 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 1.52 111.356 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.25 -152.18 39.54 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 2.2999999999999998 112.672 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' CB ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 t70 -88.42 -17.08 31.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.18 0.514 . . . . 5.8600000000000003 110.449 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.64 -29.71 69.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.591 -0.732 . . . . 4.2699999999999996 111.267 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.68 159.84 36.88 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.783 -0.722 . . . . 2.1600000000000001 113.028 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.9 m -76.62 131.98 39.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.206 -0.294 . . . . 3.3399999999999999 110.206 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -119.44 164.81 13.3 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.448 -0.882 . . . . 1.2 112.432 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.51 -46.8 5.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 3.0800000000000001 110.741 -178.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.438 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 20.2 m -97.4 -74.7 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 1.52 110.085 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.483 HG12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -158.47 97.62 1.78 Allowed Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.124 -0.489 . . . . 0.75 110.553 176.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 74.4 Cg_endo -85.16 177.95 4.94 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.509 2.139 . . . . 1.5800000000000001 111.384 175.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 103' ' ' ASP . . . 142.67 -162.73 27.35 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.11 -1.043 . . . . 2.0499999999999998 113.038 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -98.08 39.88 1.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 2.0299999999999998 109.086 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.9 m -125.2 158.31 34.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.797 -0.638 . . . . 1.1399999999999999 110.37 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.37 127.42 42.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.51 0.671 . . . . 0.47999999999999998 111.653 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.483 HD21 HG12 ' A' ' 110' ' ' ILE . 6.7 mp -123.55 167.63 13.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.681 -0.691 . . . . 0.51000000000000001 109.873 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -138.3 131.89 30.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.006 0.431 . . . . 0.69999999999999996 110.518 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.621 ' HD2' HD13 ' A' ' 95' ' ' ILE . 59.3 m-85 -121.6 145.76 47.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.961 -0.563 . . . . 0.42999999999999999 110.669 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 43.5 mt-10 -68.65 123.62 21.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.816 -0.809 . . . . 1.46 108.816 170.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 81' ' ' CYS . 10.2 mt -107.74 115.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.298 0.57 . . . . 0.47999999999999998 109.622 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -125.62 114.07 18.22 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.002 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.52 HD22 ' HG3' ' A' ' 34' ' ' PRO . 14.9 tp -86.84 99.92 12.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 1.1200000000000001 109.896 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.1 pt? -98.63 -19.96 17.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.305 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.532 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 20.5 m -151.7 145.66 25.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.46 0.171 . . . . 1.1899999999999999 110.802 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.445 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -166.92 156.98 11.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.448 -0.342 . . . . 0.71999999999999997 110.255 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.81 49.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.202 -0.454 . . . . 2.98 110.704 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mp0 -96.71 115.05 26.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.137 -0.483 . . . . 3.3799999999999999 110.591 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 tp -150.47 110.62 4.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 3.3500000000000001 109.795 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.44 138.2 53.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.966 -0.561 . . . . 5.3899999999999997 111.966 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.426 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -86.96 115.69 24.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.479 -0.782 . . . . 7.04 110.042 176.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -131.77 163.13 28.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.313 -0.403 . . . . 7.21 110.957 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.32 133.2 38.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.869 0.366 . . . . 9.0199999999999996 111.107 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -94.72 108.4 20.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 9.75 110.114 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -90.05 140.42 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.043 -0.526 . . . . 12.26 111.129 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.755 -0.641 . . . . 13.35 109.451 175.744 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.7 -0.481 . . . . 7.4800000000000004 109.7 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.0 p -74.69 105.92 6.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 5.9000000000000004 111.336 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.0 m -88.29 117.35 27.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 4.4400000000000004 110.348 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.46 78.4 9.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.398 -0.593 . . . . 4.4400000000000004 109.398 175.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -66.16 126.91 30.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.716 . . . . 4.1500000000000004 110.156 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.54 73.11 6.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.609 0.719 . . . . 3.6099999999999999 110.219 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.4 169.8 16.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.242 -0.89 . . . . 3.6000000000000001 110.852 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -116.14 158.42 23.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.783 -0.644 . . . . 2.71 110.013 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 6.4 mptt -102.37 148.16 25.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.048 -0.723 . . . . 1.8799999999999999 109.048 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.65 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 15.6 t -101.03 109.24 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.383 0.611 . . . . 0.58999999999999997 110.168 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -79.82 99.74 7.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.031 -0.986 . . . . 2.1600000000000001 111.475 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt 51.32 79.17 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.691 0.619 . . . . 1.45 111.328 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.65 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 11.6 t -89.93 177.17 6.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.78000000000000003 110.903 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.93 -3.63 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.81000000000000005 111.828 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.516 ' HB2' HG23 ' A' ' 80' ' ' ILE . 27.0 m-20 -75.93 2.33 12.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.533 0.206 . . . . 2.3999999999999999 110.652 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.3 8.92 6.86 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.612 -0.804 . . . . 0.68000000000000005 113.326 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.22 63.48 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.019 -0.61 . . . . 0.60999999999999999 114.42 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.537 ' HB ' ' CB ' ' A' ' 80' ' ' ILE . 23.5 t -134.42 148.39 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.929 -0.397 . . . . 0.48999999999999999 109.929 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.92 109.73 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.18 0.514 . . . . 0.46999999999999997 110.44 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.526 ' HE2' HG21 ' A' ' 13' ' ' THR . 47.7 pttt -123.32 148.28 46.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.99 -0.55 . . . . 1.3400000000000001 110.368 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m -109.43 124.33 50.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.828 -0.624 . . . . 0.5 110.332 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.482 HD12 ' SG ' ' A' ' 91' ' ' CYS . 5.1 tp -75.65 113.9 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.67000000000000004 110.924 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 3.5 mm? -99.24 -60.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 0.82999999999999996 110.481 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -120.33 133.96 55.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.5600000000000001 110.076 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 37.7 pttt -106.46 124.17 49.18 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.491 . . . . 2.9500000000000002 110.212 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 161.85 37.09 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.66 -0.781 . . . . 1.3200000000000001 111.788 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -68.07 -67.1 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 2.77 110.692 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.17 -177.81 4.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 2.6400000000000001 110.806 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.96 45.85 0.17 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.49 -0.777 . . . . 1.04 111.27 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.32 -41.5 89.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 2.29 110.552 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -113.83 26.03 10.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.309 0.576 . . . . 2.6400000000000001 109.817 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.19 79.81 1.79 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.321 -0.854 . . . . 1.45 110.07 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.5 HG21 ' HE3' ' A' ' 35' ' ' LYS . 36.1 mm -129.48 128.46 23.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.81000000000000005 111.084 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 1.1 Cg_endo -81.55 114.65 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.896 2.397 . . . . 0.75 111.256 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 33' ' ' ILE . 28.3 mmtp -120.46 146.45 46.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.21 -0.45 . . . . 2.6600000000000001 111.065 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 5.3 tmmm? -57.02 124.58 19.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.701 -0.681 . . . . 2.5099999999999998 109.783 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.58 37.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.752 -0.737 . . . . 1.1200000000000001 112.277 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 35' ' ' LYS . 82.3 m-20 -79.39 142.57 35.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.964 0.412 . . . . 1.3799999999999999 110.122 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.524 ' HB3' ' CG ' ' A' ' 126' ' ' ARG . 37.6 tp10 -76.46 102.32 5.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.797 -0.638 . . . . 2.2000000000000002 109.797 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 125' ' ' PHE . 28.0 m -112.94 156.02 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.088 -0.505 . . . . 0.67000000000000004 110.868 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.8 m -132.6 110.87 10.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.65000000000000002 109.709 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.685 HG12 ' HA ' ' A' ' 122' ' ' LEU . 27.4 m -125.15 151.03 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.87 111.405 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -101.17 149.28 24.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.75 109.709 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 39.9 p90 -133.32 136.92 45.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.708 0.29 . . . . 0.76000000000000001 110.233 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -164.89 146.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.58 -0.526 . . . . 0.48999999999999999 109.58 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . -176.18 -127.86 1.07 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.325 -0.94 . . . . 0.35999999999999999 112.513 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.54 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 63.6 pttt -157.77 171.94 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 1.4299999999999999 110.831 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.754 HD22 HG13 ' A' ' 110' ' ' ILE . 58.2 tp -87.04 108.89 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.38 110.794 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.555 ' HB3' HG13 ' A' ' 115' ' ' VAL . 2.1 tp10 -61.46 -35.33 77.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.51 0.672 . . . . 1.96 110.615 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -55.71 -27.82 52.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.67000000000000004 112.792 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.497 HG22 HD23 ' A' ' 48' ' ' LEU . 15.2 t -140.55 -23.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.178 -0.609 . . . . 0.72999999999999998 112.35 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.69 34.65 4.89 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.502 -0.856 . . . . 0.78000000000000003 113.014 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HG2' HG23 ' A' ' 51' ' ' THR . 73.8 mmtt -102.84 125.51 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.132 -0.321 . . . . 2.8900000000000001 110.132 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.7 p -82.44 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.108 -0.33 . . . . 0.58999999999999997 110.108 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -78.69 127.23 31.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.387 0.514 . . . . 0.78000000000000003 112.387 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -161.24 85.74 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.025 -0.989 . . . . 2.1800000000000002 108.549 167.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 23.5 t -122.54 158.11 30.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.747 -0.66 . . . . 1.24 109.986 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -50.0 -44.0 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.245 0.618 . . . . 1.49 112.437 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -87.76 -33.67 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 1.8 110.532 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -64.71 -52.0 59.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 2.1899999999999999 111.738 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.1 ptp180 -67.49 -20.49 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.352 . . . . 2.7799999999999998 111.309 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' ND2' HG23 ' A' ' 63' ' ' VAL . 8.3 t30 -75.58 -64.12 1.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.297 -0.411 . . . . 1.1000000000000001 110.108 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.521 HG23 ' ND2' ' A' ' 62' ' ' ASN . 73.1 t -142.55 106.43 5.49 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.382 -0.372 . . . . 2.0299999999999998 111.007 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.37 140.16 92.24 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.287 1.991 . . . . 1.76 110.818 171.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -93.3 151.0 20.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.917 0.389 . . . . 1.3100000000000001 110.582 -171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 143.14 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.117 -0.697 . . . . 1.3600000000000001 109.117 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 82' ' ' VAL . 30.0 p90 -124.39 153.85 41.27 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.968 -0.693 . . . . 0.56999999999999995 111.212 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . 41.7 t-80 -94.5 145.02 25.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.149 -0.932 . . . . 1.98 109.788 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 HD13 ' CG2' ' A' ' 82' ' ' VAL . 38.3 tp -69.13 128.84 38.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.991 -0.744 . . . . 0.94999999999999996 108.991 173.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG2' ' CG ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER 56.49 78.75 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.146 0.974 . . . . 2.0800000000000001 110.403 -168.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 68' ' ' HIS . 26.2 tt0 -126.42 -5.66 6.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.13 -1.395 . . . . 1.98 109.994 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 -19.24 33.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.701 -0.681 . . . . 0.71999999999999997 112.681 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 71' ' ' GLN . 42.3 mm-40 -87.73 -21.76 25.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.531 0.682 . . . . 0.96999999999999997 109.504 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.9 m -108.87 124.18 65.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.65 -0.705 . . . . 0.57999999999999996 109.979 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -96.73 -59.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.179 0.437 . . . . 0.62 112.179 -178.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -149.19 -38.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.307 -0.246 . . . . 2.04 111.468 -174.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.7 -52.62 44.45 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.561 -0.828 . . . . 0.32000000000000001 112.857 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 82' ' ' VAL . 15.2 m-90 -76.18 -27.72 57.03 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.8 -0.235 . . . . 0.48999999999999999 110.895 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.12 -54.02 35.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.603 -0.726 . . . . 1.1399999999999999 111.37 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.537 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 1.7 mp -68.16 -30.99 49.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.636 -0.711 . . . . 0.78000000000000003 111.586 -173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 85' ' ' MET . 34.8 t -76.08 -55.92 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.748 0.309 . . . . 0.55000000000000004 111.038 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.677 HG12 HG21 ' A' ' 120' ' ' ILE . 32.0 m -67.34 -33.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.324 0.861 . . . . 0.83999999999999997 113.324 -169.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 62.2 p -79.64 -0.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.987 0.422 . . . . 1.4299999999999999 111.167 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -125.77 25.5 6.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 1.23 110.384 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.789 ' HE3' ' HB2' ' A' ' 122' ' ' LEU . 31.4 mtm -114.78 142.37 46.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.95 0.405 . . . . 2.27 111.664 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.482 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 51.2 mtt180 -90.88 164.62 13.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.538 -0.542 . . . . 4.1900000000000004 109.538 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HA ' HD22 ' A' ' 122' ' ' LEU . 61.3 tttm -65.16 -21.66 66.81 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.641 0.608 . . . . 1.9399999999999999 112.641 -171.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -117.54 24.65 10.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.537 0.684 . . . . 1.23 109.805 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.482 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 35.8 tt0 -117.85 132.71 56.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.995 -1.002 . . . . 1.6000000000000001 109.898 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 11.9 tmtt? -137.44 129.68 29.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.94 -0.573 . . . . 1.1699999999999999 110.226 -173.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 78.9 m -138.51 171.74 13.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.372 -0.377 . . . . 1.2 111.269 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.957 HD21 ' HB3' ' A' ' 117' ' ' LEU . 6.1 tt -112.54 145.63 39.96 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.608 -0.886 . . . . 1.73 108.608 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.561 ' N ' HD23 ' A' ' 92' ' ' LEU . 13.9 p -121.07 146.34 26.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 116.443 -0.344 . . . . 0.73999999999999999 110.303 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -107.07 111.13 23.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.643 -1.243 . . . . 1.71 107.643 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.555 HD11 HG13 ' A' ' 93' ' ' VAL . 4.9 mp -93.36 99.8 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.08 -0.648 . . . . 0.52000000000000002 110.459 -172.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 98' ' ' MET . 10.3 tp10 -63.55 155.55 29.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.926 -1.033 . . . . 1.3700000000000001 109.82 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.438 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 6.4 p -53.34 -38.59 63.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.495 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.426 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.1 ptp -78.08 -11.18 59.89 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.562 -0.29 . . . . 1.79 111.428 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -101.7 -2.66 29.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.877 0.37 . . . . 0.75 110.145 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 -178.01 44.91 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.70999999999999996 111.795 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -40.52 10.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.886 0.374 . . . . 1.52 110.733 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.81 174.44 14.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.811 -0.709 . . . . 2.2999999999999998 112.471 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.1 -21.46 24.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.6 0.714 . . . . 5.8600000000000003 109.786 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.58 -7.84 42.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.849 -1.069 . . . . 4.2699999999999996 111.823 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.93 18.47 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.832 -0.699 . . . . 2.1600000000000001 112.399 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.3 m -103.23 154.29 19.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.576 0.227 . . . . 3.3399999999999999 110.605 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.586 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -151.44 175.17 30.41 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.671 -0.776 . . . . 1.2 112.6 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.81 -70.49 0.7 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.942 0.349 . . . . 3.0800000000000001 111.942 -175.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.575 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 16.6 m -107.08 -73.17 0.7 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.42 0.152 . . . . 1.52 111.368 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.754 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -141.48 77.68 19.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.211 0.529 . . . . 0.75 111.421 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 27.3 Cg_endo -93.74 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.25 2.633 . . . . 1.5800000000000001 111.649 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.37 -125.32 7.25 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.517 -0.849 . . . . 2.0499999999999998 111.958 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 97' ' ' SER . 3.3 t-20 -105.41 1.16 27.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.61 0.719 . . . . 2.0299999999999998 109.352 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.9 m -79.56 152.15 30.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.323 -0.853 . . . . 1.1399999999999999 110.632 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.555 HG13 ' HB3' ' A' ' 49' ' ' GLU . 6.5 p -90.14 135.03 27.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.197 -0.456 . . . . 0.47999999999999998 110.686 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 49' ' ' GLU . 6.2 mp -126.67 167.01 16.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.75 0.31 . . . . 0.51000000000000001 110.991 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.957 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -117.26 114.53 23.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.184 -0.673 . . . . 0.69999999999999996 109.184 174.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -113.13 122.04 46.33 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.944 -0.303 . . . . 0.42999999999999999 110.721 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.57 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 33.6 mt-10 -86.12 130.05 34.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.003 -0.74 . . . . 1.46 109.003 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 82' ' ' VAL . 70.7 mt -113.5 127.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.997 -0.547 . . . . 0.47999999999999998 111.504 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -115.91 115.34 26.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.462 -0.79 . . . . 1.8799999999999999 110.815 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.789 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 6.0 tt -91.35 102.24 14.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.871 -0.789 . . . . 1.1200000000000001 108.871 173.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 123' ' ' LEU . 1.2 pt? -97.85 -34.43 10.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.184 -177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.0 t -146.57 144.01 29.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.72 0.295 . . . . 1.1899999999999999 110.759 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.566 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -165.39 148.41 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.71999999999999997 109.873 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.524 ' CG ' ' HB3' ' A' ' 39' ' ' GLU . 7.8 ptp85 -127.49 129.48 47.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 2.98 109.988 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -96.27 135.07 38.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 110.951 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.5 tp 74.97 105.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.283 0.989 . . . . 3.3500000000000001 111.974 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 130' ' ' HIS . 7.7 tp10 -125.49 154.91 41.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.205 -0.907 . . . . 5.3899999999999997 109.298 175.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 20.9 m80 74.83 172.29 0.27 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.016 0.822 . . . . 7.04 111.699 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 t60 52.02 69.95 0.61 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.13 -0.941 . . . . 7.21 111.413 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -128.55 174.19 9.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.954 -0.566 . . . . 9.0199999999999996 109.973 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 171.1 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.497 -0.32 . . . . 9.75 110.758 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.7 m80 65.55 26.77 11.66 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.654 0.596 . . . . 12.26 110.672 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.597 -0.716 . . . . 13.35 109.362 177.57 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.744 0.307 . . . . 7.4800000000000004 110.395 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 p -86.29 141.19 29.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.448 -0.342 . . . . 5.9000000000000004 110.537 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m -93.63 12.46 25.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.632 0.729 . . . . 4.4400000000000004 109.989 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -111.46 173.97 6.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.342 -0.844 . . . . 4.4400000000000004 110.995 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -85.98 133.93 33.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.748 -0.66 . . . . 4.1500000000000004 110.202 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -95.82 18.73 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.616 0.722 . . . . 3.6099999999999999 109.77 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -83.29 149.1 26.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.432 -0.804 . . . . 3.6000000000000001 110.497 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.93 150.26 21.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 2.71 110.63 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -101.67 141.72 34.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 1.8799999999999999 109.129 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.67 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 16.9 t -102.47 109.57 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.092 0.472 . . . . 0.58999999999999997 111.217 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.13 108.79 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.73 -0.668 . . . . 2.1600000000000001 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.487 ' H ' HD13 ' A' ' 19' ' ' ILE . 23.0 tp 53.05 72.54 0.42 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.638 0.586 . . . . 1.45 111.201 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.67 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 6.8 t -80.43 156.6 26.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.78000000000000003 111.349 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 1.67 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.81000000000000005 111.972 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.6 3.38 3.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.577 0.227 . . . . 2.3999999999999999 110.835 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.26 6.82 8.02 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.091 -0.576 . . . . 0.68000000000000005 112.974 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.01 70.32 1.33 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.708 -0.758 . . . . 0.60999999999999999 113.928 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.89 145.17 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.786 -0.45 . . . . 0.48999999999999999 109.786 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.1 mm -85.53 109.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.46999999999999997 110.323 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 13' ' ' THR . 18.2 pttp -131.05 143.67 50.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.13 0.491 . . . . 1.3400000000000001 111.011 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -110.73 121.73 46.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.609 -0.723 . . . . 0.5 110.237 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.83 134.87 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 0.67000000000000004 110.15 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.4 -74.02 0.62 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.019 -0.363 . . . . 0.82999999999999996 110.019 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -88.26 153.17 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.833 -0.803 . . . . 1.5600000000000001 108.833 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -126.28 120.08 29.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.212 0.53 . . . . 2.9500000000000002 111.001 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.45 27.31 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.124 -0.944 . . . . 1.3200000000000001 112.13 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.92 -65.81 0.97 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.766 0.317 . . . . 2.77 110.877 -176.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 2.7 pp20? -99.69 139.07 35.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.848 0.356 . . . . 2.6400000000000001 110.493 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.679 ' HA3' ' HD3' ' A' ' 86' ' ' ARG . . . -157.17 36.77 0.56 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.567 -0.613 . . . . 1.04 111.567 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.519 0.676 . . . . 2.29 109.188 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -112.09 4.33 17.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.215 -0.902 . . . . 2.6400000000000001 110.353 176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.531 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 11.7 m120 -114.55 78.82 1.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.608 -0.437 . . . . 1.45 111.254 -176.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.1 mm -128.33 114.99 19.89 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.61 -0.723 . . . . 0.81000000000000005 109.559 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.08 106.21 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.132 2.555 . . . . 0.75 111.84 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 31.5 mmtp -118.7 158.21 25.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.749 0.309 . . . . 2.6600000000000001 110.671 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 1.018 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -80.56 150.65 29.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 2.5099999999999998 111.384 -175.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.64 -26.06 25.41 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.808 -0.633 . . . . 1.1200000000000001 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -93.46 157.7 16.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.823 0.344 . . . . 1.3799999999999999 110.186 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -71.67 95.71 1.49 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 2.2000000000000002 110.805 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 125' ' ' PHE . 10.4 m -114.49 153.03 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.459 -0.337 . . . . 0.67000000000000004 110.351 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 ' HD2' ' A' ' 66' ' ' LYS . 9.1 m -128.27 107.09 9.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.447 -0.342 . . . . 0.65000000000000002 110.406 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -123.75 143.37 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.87 111.534 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -112.99 145.44 40.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.561 -0.745 . . . . 2.75 110.236 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.688 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 24.2 p90 -132.94 141.42 48.34 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.18 0.3 . . . . 0.76000000000000001 110.831 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p -168.24 154.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.271 -0.641 . . . . 0.48999999999999999 109.271 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 117' ' ' LEU . . . 177.92 -120.31 0.71 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.83 -1.176 . . . . 0.35999999999999999 113.225 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.826 ' HG3' HD13 ' A' ' 117' ' ' LEU . 21.0 pttp -157.53 173.28 17.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.545 0.212 . . . . 1.4299999999999999 111.06 -178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.835 HD22 HG13 ' A' ' 110' ' ' ILE . 59.3 tp -90.9 106.66 18.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.688 -0.486 . . . . 0.38 109.688 176.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' A' ' 117' ' ' LEU . 3.0 tp10 -68.73 -25.61 64.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 1.96 110.793 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 114' ' ' SER . 17.1 t -55.0 -35.1 64.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.118 -0.946 . . . . 0.67000000000000004 111.461 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 53' ' ' LYS . 2.8 t -125.21 -20.64 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.346 -0.388 . . . . 0.72999999999999998 111.083 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.25 11.58 51.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.916 -0.659 . . . . 0.78000000000000003 112.771 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 51' ' ' THR . 29.0 mmmt -85.02 131.03 34.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.955 -0.387 . . . . 2.8900000000000001 109.955 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.671 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 7.5 p -79.1 164.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.315 -0.402 . . . . 0.58999999999999997 110.097 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.449 ' CE2' ' HE1' ' A' ' 118' ' ' PHE . 7.3 m-30 -73.61 98.47 2.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.367 0.603 . . . . 0.78000000000000003 110.791 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.32 85.7 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.454 -0.793 . . . . 2.1800000000000002 109.706 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.693 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 19.0 m -135.89 169.24 17.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.376 -0.829 . . . . 1.24 109.54 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 m -57.91 -44.57 86.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.818 0.673 . . . . 1.49 112.818 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -91.01 -48.26 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 1.8 111.456 -171.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.693 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 1.6 m-20 -54.4 -44.74 72.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.985 -1.007 . . . . 2.1899999999999999 112.73 -169.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -83.83 0.7 46.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.851 -0.34 . . . . 2.7799999999999998 111.657 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.594 HD22 HG13 ' A' ' 63' ' ' VAL . 10.7 t30 -104.09 -42.25 5.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.447 -0.342 . . . . 1.1000000000000001 110.807 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.594 HG13 HD22 ' A' ' 62' ' ' ASN . 8.4 m -124.24 125.82 25.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.843 0.354 . . . . 2.0299999999999998 111.521 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 1.7 Cg_endo -85.57 139.57 6.81 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.256 2.637 . . . . 1.76 112.451 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.79 148.95 32.44 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.891 0.377 . . . . 1.3100000000000001 111.179 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HD2' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -136.51 157.62 46.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.998 -0.546 . . . . 1.3600000000000001 110.198 177.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -140.34 176.95 8.35 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.034 0.445 . . . . 0.56999999999999995 111.982 -175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 55.4 m80 -107.75 148.46 29.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.98 110.659 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 36' ' ' LYS . 24.0 tp -78.72 124.45 28.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.103 -0.703 . . . . 0.94999999999999996 109.103 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 1.018 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 1.4 mm-40 63.51 79.57 0.25 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.457 1.122 . . . . 2.0800000000000001 110.255 -168.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 68' ' ' HIS . 27.6 tt0 -130.61 -3.73 4.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.653 -1.612 . . . . 1.98 109.836 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.22 -11.06 61.64 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.557 -0.747 . . . . 0.71999999999999997 111.847 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.02 -18.77 16.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.96999999999999997 110.836 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -111.74 127.95 68.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 0.57999999999999996 110.282 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.68 -76.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.299 0.481 . . . . 0.62 112.299 -176.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' H ' HG12 ' A' ' 75' ' ' ILE . 37.2 mtpt -127.59 -49.87 1.38 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.472 0.545 . . . . 2.04 112.472 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.4 -53.06 33.53 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.955 -0.64 . . . . 0.32000000000000001 113.342 -171.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.6 m-90 -76.03 -44.27 40.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.639 0.257 . . . . 0.48999999999999999 110.571 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.14 -49.32 69.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.587 -0.733 . . . . 1.1399999999999999 112.026 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -73.37 -36.42 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.165 -0.47 . . . . 0.78000000000000003 111.413 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.703 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 46.3 t -72.46 -42.84 64.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.687 -0.233 . . . . 0.55000000000000004 111.426 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.885 HG12 HG21 ' A' ' 120' ' ' ILE . 27.4 m -64.06 -32.53 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.895 0.379 . . . . 0.83999999999999997 111.121 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -79.11 5.1 12.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.062 0.458 . . . . 1.4299999999999999 110.863 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -113.38 5.73 16.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 1.23 110.824 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.751 ' HE1' ' HB2' ' A' ' 122' ' ' LEU . 55.9 mtm -93.75 -172.73 2.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.519 0.676 . . . . 2.27 112.288 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.679 ' HD3' ' HA3' ' A' ' 29' ' ' GLY . 1.6 ttm180 -145.55 165.51 28.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.153 -1.054 . . . . 4.1900000000000004 108.153 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -63.2 -23.81 67.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.924 0.392 . . . . 1.9399999999999999 111.715 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -117.49 24.91 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.072 0.463 . . . . 1.23 110.065 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.603 ' OE1' ' HA ' ' A' ' 85' ' ' MET . 5.3 tm-20 -123.07 152.85 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.775 -0.648 . . . . 1.6000000000000001 109.629 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -155.23 124.67 6.37 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.146 -0.316 . . . . 1.1699999999999999 110.146 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.69 171.17 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 1.2 111.383 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.85 137.41 52.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.73 110.32 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.703 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 6.2 p -111.73 149.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.89 -0.595 . . . . 0.73999999999999999 111.075 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -104.14 112.56 25.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.566 -0.531 . . . . 1.71 109.566 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.515 HD11 HG13 ' A' ' 93' ' ' VAL . 2.6 mp -92.2 106.57 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.52000000000000002 110.504 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.526 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 28.5 tt0 -90.48 168.29 11.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.393 -0.822 . . . . 1.3700000000000001 108.932 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.419 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 8.8 m -51.03 -39.32 55.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.5 ptp -77.39 -7.91 56.85 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.61 0.243 . . . . 1.79 111.487 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.526 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -99.05 -3.35 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.549 0.214 . . . . 0.75 110.772 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.504 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -135.01 -177.51 15.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.253 -0.499 . . . . 0.70999999999999996 112.015 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -76.32 -51.41 12.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.697 0.248 . . . . 1.52 111.175 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 -165.75 20.13 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.445 -0.883 . . . . 2.2999999999999998 112.84 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -62.95 -40.21 96.99 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.853 0.461 . . . . 5.8600000000000003 111.519 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.12 -11.57 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 4.2699999999999996 111.033 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.88 162.34 24.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.759 -0.734 . . . . 2.1600000000000001 112.354 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.3 m -67.74 127.97 34.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 3.3399999999999999 110.505 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.452 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -127.07 163.46 20.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.848 -0.691 . . . . 1.2 111.855 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -77.94 -72.51 0.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.99 0.424 . . . . 3.0800000000000001 111.23 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.552 ' HB2' HD13 ' A' ' 110' ' ' ILE . 3.4 m -104.5 -72.26 0.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.96 -0.564 . . . . 1.52 110.803 -176.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.835 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.63 85.95 50.54 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.75 110.818 178.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.452 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 83.1 Cg_endo -78.55 -175.59 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.292 1.995 . . . . 1.5800000000000001 111.905 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.53 -132.44 5.12 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.456 -0.878 . . . . 2.0499999999999998 112.117 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -122.77 36.53 4.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 2.0299999999999998 109.965 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 21.3 p -114.84 179.31 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.1399999999999999 110.819 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.1 p -104.98 129.17 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.146 0.498 . . . . 0.47999999999999998 111.016 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.1 mp -119.94 172.73 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.51000000000000001 110.382 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.826 HD13 ' HG3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -128.08 130.83 48.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.695 -0.483 . . . . 0.69999999999999996 109.695 177.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.678 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 34.7 m-85 -130.4 128.34 41.15 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.672 0.272 . . . . 0.42999999999999999 110.672 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 62.5 mt-10 -71.28 126.44 29.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.265 -1.013 . . . . 1.46 108.265 169.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.885 HG21 HG12 ' A' ' 82' ' ' VAL . 34.8 mt -107.67 123.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.212 -0.595 . . . . 0.47999999999999998 109.677 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.96 114.7 20.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.682 -0.69 . . . . 1.8799999999999999 110.678 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.751 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 35.9 tp -87.29 90.62 8.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.51 . . . . 1.1200000000000001 109.753 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 124' ' ' SER . 3.5 pp -86.48 -25.26 25.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.741 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.425 ' N ' HD12 ' A' ' 123' ' ' LEU . 75.7 m -159.46 148.23 17.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.361 -0.381 . . . . 1.1899999999999999 110.292 177.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.596 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -167.02 -176.22 3.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.71999999999999997 109.877 -178.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.88 170.54 22.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.524 -0.307 . . . . 2.98 110.178 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.86 153.72 50.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.908 -1.145 . . . . 3.3799999999999999 107.908 171.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.38 74.88 1.55 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.639 -0.424 . . . . 3.3500000000000001 111.3 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.754 ' HG3' ' H ' ' A' ' 131' ' ' HIS . 9.3 tp10 -86.17 141.02 29.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.208 -0.451 . . . . 5.3899999999999997 110.053 173.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -103.73 10.52 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.298 -0.41 . . . . 7.04 110.338 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.754 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 5.7 t-160 -85.92 47.11 1.4 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 7.21 111.23 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.99 -63.85 1.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.305 -0.628 . . . . 9.0199999999999996 109.305 174.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -171.48 79.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.48 0.657 . . . . 9.75 111.431 172.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -139.1 146.45 40.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.58 -0.896 . . . . 12.26 108.58 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.388 -0.815 . . . . 13.35 110.952 -173.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.166 -0.309 . . . . 7.4800000000000004 110.166 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 m -88.63 120.32 29.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.934 -0.395 . . . . 5.9000000000000004 109.934 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -94.52 -68.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.41 -0.359 . . . . 4.4400000000000004 110.751 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -144.83 157.58 44.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.072 -0.344 . . . . 4.4400000000000004 110.072 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.9 88.93 5.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.611 0.243 . . . . 4.1500000000000004 111.531 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -96.92 85.75 3.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.386 -0.598 . . . . 3.6099999999999999 109.386 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.14 155.86 32.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.074 -0.512 . . . . 3.6000000000000001 110.896 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.42 139.01 36.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 2.71 109.899 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -113.51 151.4 31.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 1.8799999999999999 110.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.518 ' CG1' ' HB ' ' A' ' 13' ' ' THR . 21.6 t -114.0 120.55 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.58999999999999997 111.352 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.93 112.56 25.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 2.1600000000000001 111.138 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.419 ' H ' HD13 ' A' ' 19' ' ' ILE . 83.2 mt 49.74 74.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.752 0.657 . . . . 1.45 112.022 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.518 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 3.5 t -86.34 163.01 17.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.78000000000000003 110.739 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.03 -5.45 13.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.363 0.601 . . . . 0.81000000000000005 110.685 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB3' HG23 ' A' ' 13' ' ' THR . 38.4 t70 -74.52 6.87 3.36 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.629 -0.714 . . . . 2.3999999999999999 111.084 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.28 16.52 3.48 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.67 -0.776 . . . . 0.68000000000000005 113.851 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.41 62.38 6.07 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.293 -0.479 . . . . 0.60999999999999999 113.82 173.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 80' ' ' ILE . 47.3 t -136.57 145.47 30.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.04 -0.356 . . . . 0.48999999999999999 110.04 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 12' ' ' LEU . 32.6 mm -85.78 109.95 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.46999999999999997 110.372 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -138.38 146.78 42.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 110.835 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -119.63 137.56 53.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.5 110.524 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -80.27 126.9 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.051 0.453 . . . . 0.67000000000000004 110.844 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' HD23 ' A' ' 92' ' ' LEU . 4.5 mm? -118.03 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.82999999999999996 110.423 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 39.5 ttpt -116.63 106.44 13.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.56 -0.533 . . . . 1.5600000000000001 109.56 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -88.02 148.94 24.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.245 -0.434 . . . . 2.9500000000000002 110.944 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.93 124.37 8.1 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.635 -0.986 . . . . 1.3200000000000001 110.635 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -61.99 -54.81 36.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.642 0.221 . . . . 2.77 111.493 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.9 151.71 40.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.107 0.48 . . . . 2.6400000000000001 110.719 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.3 34.12 0.11 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.274 -0.875 . . . . 1.04 110.937 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.11 -41.33 78.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 2.29 111.541 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -110.62 26.55 10.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.761 0.791 . . . . 2.6400000000000001 109.274 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.38 77.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.446 -0.797 . . . . 1.45 110.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -123.95 119.48 26.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.956 0.407 . . . . 0.81000000000000005 111.155 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.93 128.68 20.26 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.74 2.293 . . . . 0.75 111.525 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB2' ' CG ' ' A' ' 38' ' ' ASN . 7.9 mmmm -121.24 147.74 45.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.172 -0.467 . . . . 2.6600000000000001 111.442 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.583 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 7.5 ttmm -76.61 129.72 36.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.617 -0.72 . . . . 2.5099999999999998 109.111 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.9 -21.67 44.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.784 -0.722 . . . . 1.1200000000000001 111.904 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.406 ' CG ' ' HB2' ' A' ' 35' ' ' LYS . 3.2 m-20 -83.0 156.61 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.65 95.49 3.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.559 -0.534 . . . . 2.2000000000000002 109.559 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.603 HG12 ' HB2' ' A' ' 125' ' ' PHE . 4.5 m -125.06 147.69 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.67000000000000004 110.615 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.497 HG23 ' HD3' ' A' ' 66' ' ' LYS . 82.3 m -124.66 119.69 29.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.182 -0.463 . . . . 0.65000000000000002 109.998 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 122' ' ' LEU . 15.5 m -126.95 157.62 38.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.87 111.576 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.459 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 9.8 t60 -110.17 131.04 55.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.347 -0.842 . . . . 2.75 109.898 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 14.4 p90 -133.7 135.75 44.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.076 0.465 . . . . 0.76000000000000001 111.221 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 p -168.32 151.73 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.295 -1.002 . . . . 0.48999999999999999 108.295 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.78 -126.83 0.98 Allowed Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.504 -1.331 . . . . 0.35999999999999999 112.714 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.666 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 65.8 pttt -155.87 170.5 21.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.099 0.476 . . . . 1.4299999999999999 111.441 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 114' ' ' SER . 54.4 tp -92.52 109.71 21.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.774 -0.648 . . . . 0.38 110.392 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB3' HG13 ' A' ' 115' ' ' VAL . 7.8 tm-20 -66.44 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 1.96 109.942 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -55.29 -20.11 10.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.67000000000000004 112.444 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -136.52 -26.57 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.274 -0.266 . . . . 0.72999999999999998 111.584 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.73 20.03 18.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 0.78000000000000003 112.004 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.9 mmtt -91.99 126.37 37.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.625 0.25 . . . . 2.8900000000000001 111.441 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.666 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 9.4 p -76.0 159.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.58999999999999997 109.956 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.555 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 4.8 m-30 -73.97 110.69 8.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.454 0.645 . . . . 0.78000000000000003 111.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -139.34 89.08 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.09 . . . . 2.1800000000000002 109.02 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.552 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 47.5 m -126.99 -171.01 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.801 -0.636 . . . . 1.24 109.947 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -72.84 -48.0 41.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.478 0.547 . . . . 1.49 112.478 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -95.64 -47.52 6.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.283 0.475 . . . . 1.8 112.283 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 6.3 p-10 -57.51 -29.86 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.859 -0.61 . . . . 2.1899999999999999 111.878 -172.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -70.83 -14.35 62.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 2.7799999999999998 111.329 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -125.51 -56.4 1.5 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.788 0.328 . . . . 1.1000000000000001 111.656 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -99.01 113.37 64.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 2.0299999999999998 110.538 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HB3' ' CE1' ' A' ' 43' ' ' HIS . 22.4 Cg_exo -65.29 137.66 52.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.966 2.444 . . . . 1.76 112.515 -177.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.99 127.28 39.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 1.3100000000000001 109.836 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HD3' HG23 ' A' ' 41' ' ' THR . 3.0 pptp? -125.22 158.2 34.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.947 -0.57 . . . . 1.3600000000000001 109.922 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -148.14 171.75 15.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.652 0.263 . . . . 0.56999999999999995 110.357 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 12.0 m170 -112.82 148.47 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 1.98 108.888 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.62 HD13 ' CG2' ' A' ' 82' ' ' VAL . 10.5 tp -66.63 114.25 5.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.546 0.689 . . . . 0.94999999999999996 111.834 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.22 75.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 113.986 -1.461 . . . . 2.0800000000000001 111.081 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 68' ' ' HIS . 6.3 pt20 -113.16 20.98 15.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 1.98 109.748 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 -10.02 64.8 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.841 -0.618 . . . . 0.71999999999999997 111.908 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.41 -24.91 17.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.998 0.428 . . . . 0.96999999999999997 110.921 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.23 128.14 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.682 -0.488 . . . . 0.57999999999999996 109.682 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.593 HD11 ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -95.75 -64.49 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.536 0.939 . . . . 0.62 113.536 -174.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.461 ' H ' HG12 ' A' ' 75' ' ' ILE . 27.5 mtpt -133.07 -48.58 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.214 0.82 . . . . 2.04 113.214 -172.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.452 ' HA3' HG13 ' A' ' 95' ' ' ILE . . . -52.41 -53.03 33.73 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.815 -0.707 . . . . 0.32000000000000001 113.225 -171.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.513 ' O ' HG22 ' A' ' 82' ' ' VAL . 6.3 m-90 -76.76 -38.29 54.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.888 0.375 . . . . 0.48999999999999999 110.285 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' HD11 ' A' ' 69' ' ' LEU . 11.6 t70 -54.28 -53.59 51.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.103 -0.953 . . . . 1.1399999999999999 112.74 -172.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.461 ' HB ' HG21 ' A' ' 18' ' ' VAL . 1.9 mp -66.34 -40.22 86.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 0.78000000000000003 110.629 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 85' ' ' MET . 49.9 t -62.66 -50.02 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.55000000000000004 111.117 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.62 ' CG2' HD13 ' A' ' 69' ' ' LEU . 30.6 m -71.59 -32.84 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.338 0.496 . . . . 0.83999999999999997 112.338 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.509 ' HB3' HD21 ' A' ' 69' ' ' LEU . 32.8 p -74.61 -9.61 58.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.837 0.31 . . . . 1.4299999999999999 111.837 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 t -118.67 38.87 3.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.404 0.621 . . . . 1.23 109.39 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.902 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 5.7 mmt -111.9 -173.93 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.83 . . . . 2.27 111.083 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.514 ' H ' ' HB3' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -134.63 171.0 14.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.148 -1.056 . . . . 4.1900000000000004 108.148 171.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HA ' HD22 ' A' ' 122' ' ' LEU . 58.8 tttm -62.7 -31.54 72.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.204 0.446 . . . . 1.9399999999999999 112.204 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.42 25.63 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 1.23 110.741 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 86' ' ' ARG . 26.4 tt0 -104.23 148.58 26.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 1.6000000000000001 110.525 -176.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.671 ' HE3' ' HB3' ' A' ' 119' ' ' GLU . 79.9 tttt -145.49 129.93 17.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.946 -0.57 . . . . 1.1699999999999999 110.711 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 98.1 m -136.23 162.87 31.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.053 0.454 . . . . 1.2 111.267 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.537 HD23 ' HG ' ' A' ' 23' ' ' LEU . 3.8 mm? -102.22 119.79 39.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.541 -0.754 . . . . 1.73 109.791 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.0 140.53 28.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.966 -0.561 . . . . 0.73999999999999999 110.927 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.836 ' HE ' HD23 ' A' ' 117' ' ' LEU . 1.3 mpt_? -99.43 112.4 24.59 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.756 -0.461 . . . . 1.71 109.756 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.616 HD13 ' HD2' ' A' ' 118' ' ' PHE . 1.8 mp -88.38 105.66 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.237 0.541 . . . . 0.52000000000000002 110.145 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 1.1 tm-20 -79.37 163.79 24.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.645 -1.162 . . . . 1.3700000000000001 107.933 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.9 p -58.74 -29.81 67.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.504 0.192 . . . . 1.0 110.778 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 17.4 ptm -75.93 -9.67 58.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.883 0.373 . . . . 1.79 111.249 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.3 m-30 -100.93 -4.48 27.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.676 -0.238 . . . . 0.75 111.422 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.593 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -141.55 171.36 24.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.638 . . . . 0.70999999999999996 112.371 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -75.12 -57.65 3.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.735 0.303 . . . . 1.52 110.614 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 -106.44 1.79 Allowed Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.798 -0.715 . . . . 2.2999999999999998 111.861 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -82.4 -23.4 34.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.314 0.578 . . . . 5.8600000000000003 110.23 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -82.06 11.3 5.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.568 0.699 . . . . 4.2699999999999996 110.649 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.23 -164.85 28.44 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.008 -0.837 . . . . 2.1600000000000001 111.008 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 81.8 m -90.93 104.38 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.173 0.486 . . . . 3.3399999999999999 110.415 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 111' ' ' PRO . . . -72.83 146.17 37.92 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.959 -0.639 . . . . 1.2 112.266 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 1.0 OUTLIER -66.97 -70.61 0.24 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.977 0.418 . . . . 3.0800000000000001 110.94 -176.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' HD13 ' A' ' 110' ' ' ILE . 37.4 m -112.15 -74.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 1.52 111.788 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.641 HG13 HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -143.21 60.64 9.21 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.137 0.421 . . . . 0.75 112.137 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 110' ' ' ILE . 31.7 Cg_endo -96.04 93.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.963 2.442 . . . . 1.5800000000000001 111.992 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.36 82.47 0.19 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.273 -0.731 . . . . 2.0499999999999998 111.273 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.1 m120 63.11 21.84 13.09 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.919 0.866 . . . . 2.0299999999999998 109.468 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.817 ' HB2' HD11 ' A' ' 48' ' ' LEU . 8.0 p -118.7 131.75 56.15 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.726 -1.125 . . . . 1.1399999999999999 110.389 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 49' ' ' GLU . 7.4 p -86.89 135.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 0.47999999999999998 110.419 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.488 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 5.0 mp -123.03 168.3 12.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.51000000000000001 110.763 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.836 HD23 ' HE ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -122.33 112.01 17.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.052 -0.722 . . . . 0.69999999999999996 109.052 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.616 ' HD2' HD13 ' A' ' 95' ' ' ILE . 45.3 m-85 -104.07 128.29 51.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.076 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.671 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 44.2 mt-10 -75.65 112.14 11.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 171.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.581 HG21 HG12 ' A' ' 82' ' ' VAL . 25.4 mt -105.88 120.85 57.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.062 0.458 . . . . 0.47999999999999998 110.254 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.33 -0.85 . . . . 1.8799999999999999 109.287 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 87' ' ' LYS . 7.9 tt -91.9 135.52 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.439 . . . . 1.1200000000000001 109.813 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.97 -31.27 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.663 -0.415 . . . . 1.0 112.025 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.9 m -149.99 139.38 21.42 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.124 -0.36 . . . . 1.1899999999999999 111.399 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.603 ' HB2' HG12 ' A' ' 40' ' ' VAL . 3.4 p90 -167.62 171.34 10.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.905 -0.776 . . . . 0.71999999999999997 108.905 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.1 153.47 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.697 0.284 . . . . 2.98 110.99 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.04 150.41 48.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 3.3799999999999999 110.36 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 23.9 tp -162.18 45.42 0.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.334 -0.988 . . . . 3.3500000000000001 108.334 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -91.29 90.22 7.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.898 -1.046 . . . . 5.3899999999999997 112.684 -167.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -160.14 5.22 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 7.04 111.247 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -93.4 5.5 51.36 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.34 -0.544 . . . . 7.21 111.338 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -133.38 82.46 1.99 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.741 -0.384 . . . . 9.0199999999999996 110.912 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -172.84 136.61 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.697 -0.853 . . . . 9.75 108.697 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.3 t60 62.47 -141.73 0.41 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.269 -0.641 . . . . 12.26 109.269 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.681 -0.676 . . . . 13.35 110.278 176.456 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.792 0.329 . . . . 7.4800000000000004 110.536 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 p -144.42 145.67 32.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.75 -0.659 . . . . 5.9000000000000004 109.635 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -72.13 140.64 48.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.536 -0.913 . . . . 4.4400000000000004 108.536 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -78.67 69.97 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.586 -0.279 . . . . 4.4400000000000004 111.707 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 63.82 115.93 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.226 -0.897 . . . . 4.1500000000000004 113.074 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.28 70.69 6.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.924 -0.58 . . . . 3.6099999999999999 109.65 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.12 138.6 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.028 -0.533 . . . . 3.6000000000000001 110.959 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -96.62 156.98 16.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.888 -0.596 . . . . 2.71 109.605 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 7.0 mptt -101.64 142.63 32.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.344 -0.243 . . . . 1.8799999999999999 110.344 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.7 t -103.89 118.73 51.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.73 -0.47 . . . . 0.58999999999999997 109.73 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.88 126.99 46.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.419 -0.355 . . . . 2.1600000000000001 110.842 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt 50.1 51.15 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.589 -0.732 . . . . 1.45 112.12 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -55.51 151.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.78000000000000003 110.967 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -8.54 13.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.363 0.505 . . . . 0.81000000000000005 112.363 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 80' ' ' ILE . 7.1 t70 -82.31 24.33 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.022 0.439 . . . . 2.3999999999999999 111.066 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.07 -7.42 9.27 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.026 -0.607 . . . . 0.68000000000000005 114.163 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.43 76.07 1.08 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.415 -0.898 . . . . 0.60999999999999999 113.942 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 t -143.76 150.21 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.611 -0.514 . . . . 0.48999999999999999 109.611 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mm -85.27 109.89 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 123.237 0.335 . . . . 0.46999999999999997 110.162 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -123.64 147.08 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.272 0.558 . . . . 1.3400000000000001 111.349 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.1 m -119.08 122.26 41.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.502 -0.772 . . . . 0.5 110.365 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.599 HD12 ' SG ' ' A' ' 91' ' ' CYS . 6.7 tp -71.7 131.95 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 0.67000000000000004 111.315 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 91' ' ' CYS . 1.6 mm? -121.94 -59.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.82999999999999996 110.916 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 88' ' ' ASN . 37.1 ttpt -128.65 154.82 45.88 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.217 -0.66 . . . . 1.5600000000000001 109.217 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -125.23 156.39 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.894 0.378 . . . . 2.9500000000000002 111.106 -173.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.39 163.2 14.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.815 -0.914 . . . . 1.3200000000000001 110.815 170.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -87.51 -97.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.336 0.568 . . . . 2.77 110.648 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.94 155.99 18.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.515 -0.55 . . . . 2.6400000000000001 109.515 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . 171.68 62.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.092 -1.051 . . . . 1.04 112.299 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.83 -41.65 99.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.009 0.433 . . . . 2.29 110.318 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.79 20.81 13.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.728 0.775 . . . . 2.6400000000000001 110.466 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.456 ' HB3' HH21 ' A' ' 86' ' ' ARG . 0.2 OUTLIER -135.9 78.3 1.71 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 1.45 109.929 175.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 35' ' ' LYS . 36.0 mm -136.58 123.87 14.34 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.81000000000000005 110.811 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 121.49 7.86 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.69 2.26 . . . . 0.75 110.911 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -135.73 150.47 49.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.013 -0.429 . . . . 2.6600000000000001 111.263 -178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.596 ' HD3' ' HG3' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -60.4 132.03 52.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.774 -0.648 . . . . 2.5099999999999998 109.857 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -22.36 31.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.475 -0.65 . . . . 1.1200000000000001 111.475 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -104.05 130.97 51.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.851 -0.425 . . . . 1.3799999999999999 109.851 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -69.07 109.21 3.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.051 -0.522 . . . . 2.2000000000000002 111.765 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 69' ' ' LEU . 22.3 m -99.56 154.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.693 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -122.43 113.01 18.76 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.407 -0.59 . . . . 0.65000000000000002 109.407 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.84 159.85 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.019 0.748 . . . . 0.87 113.019 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -111.85 128.21 56.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 2.75 108.901 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 55.0 p90 -131.25 139.34 49.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.205 0.526 . . . . 0.76000000000000001 111.54 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -168.63 158.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.401 -0.962 . . . . 0.48999999999999999 108.401 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.53 -130.87 1.74 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.926 -1.13 . . . . 0.35999999999999999 112.434 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.717 ' CB ' ' HA ' ' A' ' 54' ' ' VAL . 62.4 pttt -156.19 170.05 23.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.13 0.49 . . . . 1.4299999999999999 111.028 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 57.8 tp -82.76 101.64 11.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.811 -0.632 . . . . 0.38 110.079 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.65 ' HB2' ' HG ' ' A' ' 117' ' ' LEU . 44.5 tt0 -57.54 -33.1 67.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.88 0.371 . . . . 1.96 110.942 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -57.27 -19.62 22.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.67000000000000004 112.106 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 53' ' ' LYS . 7.5 t -138.22 -8.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.792 -0.363 . . . . 0.72999999999999998 111.709 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.07 83.14 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.217 -0.516 . . . . 0.78000000000000003 112.981 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 12.8 mmmm -87.99 120.96 29.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.707 0.289 . . . . 2.8900000000000001 110.99 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.717 ' HA ' ' CB ' ' A' ' 47' ' ' LYS . 13.6 p -75.56 151.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.591 . . . . 0.58999999999999997 110.195 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.48 ' CE1' HD11 ' A' ' 110' ' ' ILE . 17.7 m-30 -73.85 127.39 32.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.78000000000000003 111.015 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -141.39 85.76 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.868 0.842 . . . . 2.1800000000000002 110.2 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 m -122.57 -175.93 3.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.234 -0.654 . . . . 1.24 109.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.4 m -72.31 -47.03 53.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.752 0.31 . . . . 1.49 111.604 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -96.42 -36.76 10.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.964 0.727 . . . . 1.8 112.964 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 55' ' ' PHE . 47.7 p-10 -60.62 -45.38 94.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.586 0.587 . . . . 2.1899999999999999 112.586 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -86.89 15.38 5.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.214 0.531 . . . . 2.7799999999999998 110.775 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.05 -47.09 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 1.1000000000000001 111.793 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 7.1 p -114.38 124.89 29.96 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 2.0299999999999998 110.947 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 63' ' ' VAL . 2.8 Cg_exo -75.83 120.67 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.046 2.497 . . . . 1.76 111.788 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.44 146.72 23.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.436 -0.579 . . . . 1.3100000000000001 109.436 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.83 162.08 37.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.331 -0.395 . . . . 1.3600000000000001 110.755 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CE1' HG11 ' A' ' 74' ' ' VAL . 41.0 p90 -144.74 175.63 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.56999999999999995 110.302 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 6.8 m-70 -111.4 147.79 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.296 -0.631 . . . . 1.98 109.296 173.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HB2' HG22 ' A' ' 40' ' ' VAL . 16.9 tp -72.02 127.02 31.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.403 . . . . 0.94999999999999996 109.911 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.596 ' HG3' ' HD3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 64.44 72.78 0.44 Allowed 'General case' 0 C--N 1.331 -0.206 0 O-C-N 124.15 0.906 . . . . 2.0800000000000001 111.453 -175.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 73' ' ' GLU . 11.9 pt20 -130.35 14.71 5.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.326 -0.852 . . . . 1.98 109.597 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.92 -17.44 31.73 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.71999999999999997 113.11 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HB2' HE21 ' A' ' 71' ' ' GLN . 14.2 mm-40 -84.36 -39.41 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.058 0.456 . . . . 0.96999999999999997 111.465 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 67' ' ' PHE . 18.1 m -97.97 127.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.108 -0.496 . . . . 0.57999999999999996 110.456 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.689 HG12 ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -95.61 -68.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.537 0.569 . . . . 0.62 112.537 -175.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.689 ' H ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -139.95 -45.97 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.231 0.456 . . . . 2.04 112.231 -175.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.75 -53.16 34.31 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.12 -0.562 . . . . 0.32000000000000001 113.275 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.463 ' O ' HG22 ' A' ' 82' ' ' VAL . 20.2 m-90 -75.8 -31.87 59.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.9 0.381 . . . . 0.48999999999999999 110.628 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.487 ' OD1' HD11 ' A' ' 69' ' ' LEU . 22.1 t0 -53.98 -52.88 59.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.201 -0.909 . . . . 1.1399999999999999 112.068 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 15' ' ' ASP . 1.8 mp -68.87 -41.07 81.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.903 0.383 . . . . 0.78000000000000003 111.191 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.664 ' SG ' ' HB ' ' A' ' 93' ' ' VAL . 25.4 t -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.712 -0.395 . . . . 0.55000000000000004 111.385 -176.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 69' ' ' LEU . 34.9 m -67.96 -32.03 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.97 0.414 . . . . 0.83999999999999997 110.173 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -64.76 -27.17 68.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 1.4299999999999999 110.802 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 t -101.43 24.66 9.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.815 -0.629 . . . . 1.23 110.812 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.046 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 5.1 mmt -104.98 -173.32 2.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.561 -0.29 . . . . 2.27 110.921 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 24.1 mtp-105 -151.99 175.01 12.95 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.937 -0.764 . . . . 4.1900000000000004 108.937 170.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -61.27 -24.32 66.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.061 0.458 . . . . 1.9399999999999999 111.254 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.465 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 35.3 m-80 -130.37 28.62 4.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.444 -0.344 . . . . 1.23 110.966 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 28.4 tt0 -121.19 142.85 49.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.58 -0.526 . . . . 1.6000000000000001 109.58 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.556 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 1.6 tmtp? -147.32 130.24 16.23 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.713 -0.477 . . . . 1.1699999999999999 109.713 -171.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.599 ' SG ' HD12 ' A' ' 22' ' ' ILE . 96.9 m -141.96 171.68 13.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 1.2 111.996 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.7 134.76 46.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.36 -0.836 . . . . 1.73 110.015 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.664 ' HB ' ' SG ' ' A' ' 81' ' ' CYS . 9.1 p -112.93 140.96 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.901 0.382 . . . . 0.73999999999999999 111.165 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.625 ' HD2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.09 112.48 25.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.919 -0.582 . . . . 1.71 110.263 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.8 mp -95.84 102.1 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.52000000000000002 110.03 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.425 ' H ' ' HD2' ' A' ' 99' ' ' TYR . 24.7 tt0 -83.89 168.74 15.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.43 -0.952 . . . . 1.3700000000000001 108.43 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.4 p -53.22 -36.05 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 22.8 ptp -75.52 -7.47 54.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.366 -0.379 . . . . 1.79 111.801 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.425 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 23.4 m-30 -100.44 0.03 38.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.576 0.227 . . . . 0.75 111.265 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 75' ' ' ILE . . . -127.07 -165.15 11.86 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.891 -0.671 . . . . 0.70999999999999996 111.928 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -82.61 -48.7 10.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.876 0.338 . . . . 1.52 111.102 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.09 -168.48 21.4 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.096 -1.049 . . . . 2.2999999999999998 113.108 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.93 -36.26 79.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.038 0.535 . . . . 5.8600000000000003 111.647 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -87.08 7.25 28.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.763 -0.653 . . . . 4.2699999999999996 111.427 -171.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.93 164.71 12.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.765 -0.731 . . . . 2.1600000000000001 111.769 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.5 m -90.03 123.43 33.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.973 0.416 . . . . 3.3399999999999999 111.029 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA3' ' HG3' ' A' ' 111' ' ' PRO . . . -111.43 -158.55 15.05 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.927 -0.579 . . . . 1.2 111.826 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.35 -71.42 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.217 0.508 . . . . 3.0800000000000001 111.865 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -79.76 -76.02 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 1.52 111.985 -172.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.48 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -152.69 87.34 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.139 -0.689 . . . . 0.75 109.139 175.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.612 ' HG3' ' HA3' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -95.73 -171.7 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.489 2.793 . . . . 1.5800000000000001 113.196 -174.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.87 -143.51 13.85 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.61 -0.596 . . . . 2.0499999999999998 111.61 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -101.14 1.52 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.907 0.384 . . . . 2.0299999999999998 110.599 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 p -82.43 158.27 23.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.928 -0.578 . . . . 1.1399999999999999 110.939 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.83 132.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.47999999999999998 111.095 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 48' ' ' LEU . 6.4 mp -119.18 155.13 32.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.51000000000000001 109.695 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.65 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -124.67 127.64 47.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 0.69999999999999996 110.48 172.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -122.74 141.31 51.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.814 -0.63 . . . . 0.42999999999999999 110.589 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.7 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 40.3 mt-10 -76.54 121.5 23.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.846 -0.798 . . . . 1.46 108.846 169.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.535 HD12 ' HB3' ' A' ' 81' ' ' CYS . 13.1 mt -106.8 127.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.524 -0.547 . . . . 0.47999999999999998 109.524 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -134.16 111.02 9.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.051 -0.977 . . . . 1.8799999999999999 110.354 -169.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.459 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 24.9 tp -84.8 96.92 9.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 1.1200000000000001 109.991 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.14 -21.9 24.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.349 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -173.17 163.54 4.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.503 -0.317 . . . . 1.1899999999999999 110.203 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.24 174.12 8.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.71999999999999997 110.201 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -137.21 138.79 40.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.431 . . . . 2.98 110.904 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -100.04 128.58 46.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.555 -0.748 . . . . 3.3799999999999999 110.207 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.5 tp -165.95 134.45 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 3.3500000000000001 111.157 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -92.34 -78.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.546 -0.538 . . . . 5.3899999999999997 109.546 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -173.29 155.26 2.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.627 -0.879 . . . . 7.04 108.627 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -111.36 151.1 28.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.604 0.24 . . . . 7.21 111.323 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 70.96 158.17 0.18 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.195 0.935 . . . . 9.0199999999999996 112.822 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.0 m170 70.0 179.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.931 -1.031 . . . . 9.75 111.147 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 74.77 139.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.565 0.746 . . . . 12.26 111.156 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.4 p80 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.856 -0.593 . . . . 13.35 110.144 176.606 . . . . . . . . 0 0 . 1 stop_ save_